data_2jsf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jsf _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 20.7 m . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.471 ' O ' ' O ' ' A' ' 16' ' ' GLY . 5.9 t -88.79 -6.82 57.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.138 -0.976 . . . . 0.0 111.755 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.497 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -61.2 -129.74 0.01 OUTLIER Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.529 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -125.09 177.99 5.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.228 -1.16 . . . . 0.0 110.008 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.601 ' CE1' ' HD2' ' A' ' 48' ' ' PRO . 33.0 m-85 -135.36 142.85 45.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.925 -1.11 . . . . 0.0 111.638 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.432 ' HE2' ' HB3' ' A' ' 37' ' ' GLN . 37.6 ttpt -113.43 117.68 32.4 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.501 ' CG2' HD11 ' A' ' 99' ' ' LEU . 54.9 t -59.3 124.54 13.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 120.659 -1.276 . . . . 0.0 109.501 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.509 ' CG1' ' HG2' ' A' ' 35' ' ' ARG . 70.3 t -98.07 -29.62 3.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.58 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 0.5 OUTLIER -150.46 138.05 19.78 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.391 0.615 . . . . 0.0 109.887 177.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -56.15 153.43 9.22 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.297 0.57 . . . . 0.0 110.261 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.573 HG22 ' CE3' ' A' ' 103' ' ' TRP . 0.6 OUTLIER -49.35 131.3 7.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.109 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.529 ' O ' ' CG2' ' A' ' 32' ' ' ILE . . . -108.47 172.1 7.04 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 16.8 pt-20 -113.0 130.67 56.05 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.881 -1.137 . . . . 0.0 110.335 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.51 ' O ' ' CB ' ' A' ' 28' ' ' GLN . 17.5 p -74.99 0.41 15.96 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.461 -0.774 . . . . 0.0 110.292 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.51 ' CB ' ' O ' ' A' ' 27' ' ' THR . 0.5 OUTLIER 70.03 10.69 7.49 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.302 -0.874 . . . . 0.0 110.131 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.42 11.55 6.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.918 . . . . 0.0 110.292 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.453 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 110.17 -20.19 26.33 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.59 ' CG2' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -92.1 -174.27 3.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.224 -1.162 . . . . 0.0 110.476 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -148.38 160.24 6.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.745 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.515 ' CG1' ' HB3' ' A' ' 78' ' ' ASN . 99.0 t -123.58 131.54 72.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 C-N-CA 118.982 -1.087 . . . . 0.0 111.752 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 78' ' ' ASN . 0.3 OUTLIER -114.91 114.29 46.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.431 -0.793 . . . . 0.0 109.741 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.58 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -95.27 125.79 40.15 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.058 -1.026 . . . . 0.0 108.467 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.589 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.8 m -150.13 159.11 5.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.274 -0.891 . . . . 0.0 108.609 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 74' ' ' ASP 0.26 25.6 tt0 -103.85 124.7 49.43 Favored 'General case' 0 C--N 1.27 -2.872 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -179.165 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 14' ' ' CYS . 1.2 t80 -60.75 122.35 14.58 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 119.016 -1.074 . . . . 0.0 110.509 -178.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 17' ' ' LYS . 23.1 mm-40 -106.87 152.06 24.4 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.374 -0.829 . . . . 0.0 108.921 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.519 ' O ' ' CE ' ' A' ' 73' ' ' LYS . . . 105.7 -145.75 15.97 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.455 ' O ' ' OH ' ' A' ' 38' ' ' TYR . 0.5 OUTLIER -130.4 127.95 40.38 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.525 -0.986 . . . . 0.0 109.942 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.04 -29.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.331 -1.414 . . . . 0.0 110.854 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.632 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.4 OUTLIER 56.39 -154.09 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 120.621 -1.517 . . . . 0.0 108.224 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.632 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 44.9 Cg_exo -52.23 89.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 N-CA-C 109.811 -0.88 . . . . 0.0 109.811 179.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.526 ' SG ' ' O ' ' A' ' 43' ' ' SER . 10.0 p -142.12 174.57 10.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.928 . . . . 0.0 110.636 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.605 ' HG3' ' CD1' ' A' ' 69' ' ' ILE . 2.3 mtpt -87.73 162.49 17.02 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.041 0.924 . . . . 0.0 111.915 -178.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.616 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 14.9 mm -105.44 124.24 36.97 Favored Pre-proline 0 C--N 1.3 -1.546 0 O-C-N 121.635 -0.665 . . . . 0.0 111.487 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.601 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 31.4 Cg_exo -62.14 145.12 96.48 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.064 1.56 . . . . 0.0 110.746 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.598 ' CE2' ' CG2' ' A' ' 79' ' ' ILE . 5.0 t80 -153.76 154.26 33.7 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.495 -0.753 . . . . 0.0 109.187 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.533 ' O ' ' CG2' ' A' ' 51' ' ' ILE . 18.3 tt0 -157.51 115.4 3.11 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.884 -1.135 . . . . 0.0 110.335 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.552 ' CG2' ' HA ' ' A' ' 90' ' ' ILE . 19.4 pt . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.534 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.493 2.471 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.481 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -131.49 166.89 20.34 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.18 -1.188 . . . . 0.0 110.515 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.581 HD22 ' CD1' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -121.87 121.02 36.2 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.301 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.59 ' CD1' ' CG2' ' A' ' 31' ' ' THR . 1.6 mp -85.98 -27.42 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 106.706 -1.591 . . . . 0.0 106.706 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.587 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.255 3.0 m -110.75 42.8 1.53 Allowed 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.338 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.594 ' CG1' ' ND2' ' A' ' 67' ' ' ASN . 6.7 t -30.94 133.06 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 121.275 0.56 . . . . 0.0 111.021 -178.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.594 ' ND2' ' CG1' ' A' ' 66' ' ' VAL . 23.0 p30 27.52 74.92 0.35 Allowed Pre-proline 0 N--CA 1.488 1.458 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.575 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.511 ' O ' ' HA ' ' A' ' 46' ' ' LYS . 8.4 Cg_endo -60.8 -171.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.707 1.372 . . . . 0.0 108.851 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.605 ' CD1' ' HG3' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -142.79 144.49 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.816 -1.177 . . . . 0.0 112.227 -179.157 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.616 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 43.7 t -100.66 156.76 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 175.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.413 ' N ' HG13 ' A' ' 70' ' ' VAL . 11.8 m -111.28 -20.8 12.17 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.791 -1.164 . . . . 0.0 111.224 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 7.4 mt-10 -132.25 15.9 4.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.842 -1.161 . . . . 0.0 111.244 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.522 ' O ' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER 71.63 -4.18 1.96 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.259 -0.901 . . . . 0.0 110.87 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.483 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 5.5 t70 -137.31 -0.04 2.26 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.885 -1.134 . . . . 0.0 110.26 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.9 t -73.07 112.24 14.74 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.244 -0.91 . . . . 0.0 109.248 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 74' ' ' ASP . 33.2 Cg_exo -51.38 112.87 0.91 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.783 1.412 . . . . 0.0 109.738 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.1 130.74 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.322 -0.861 . . . . 0.0 111.516 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.59 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 12.0 m-80 -93.12 135.26 34.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.401 -0.812 . . . . 0.0 108.972 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.598 ' CG2' ' CE2' ' A' ' 49' ' ' PHE . 6.1 mt -114.53 117.26 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 117.69 -1.604 . . . . 0.0 111.979 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.561 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 0.8 OUTLIER -86.03 114.14 22.67 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.333 179.362 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.514 ' CB ' HD23 ' A' ' 63' ' ' LEU . . . -133.45 153.28 51.74 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.024 -1.048 . . . . 0.0 110.505 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 0.8 OUTLIER -101.56 101.95 19.91 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.186 -0.946 . . . . 0.0 110.425 -179.611 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.544 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 33.7 Cg_endo -70.57 142.41 44.31 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.127 1.593 . . . . 0.0 110.325 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.534 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 32.3 Cg_endo . . . . . 0 C--N 1.304 -1.796 0 O-C-N 124.09 1.574 . . . . 0.0 110.348 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.515 ' CD1' ' HB2' ' A' ' 102' ' ' ASN . 19.9 m-85 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.097 0.475 . . . . 0.0 109.963 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.583 ' CG2' ' CZ ' ' A' ' 49' ' ' PHE . 2.2 mt -73.9 133.74 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 109.544 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.501 ' HB ' ' HB3' ' A' ' 50' ' ' GLU . 84.6 mt -106.2 134.62 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.908 -1.12 . . . . 0.0 110.583 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.554 ' CD1' HG23 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -124.21 144.87 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.492 -0.755 . . . . 0.0 109.569 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.542 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 82.68 -162.67 41.56 Favored Glycine 0 N--CA 1.482 1.714 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.555 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -119.78 146.88 23.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 O-C-N 121.257 -1.143 . . . . 0.0 109.932 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.569 ' O ' ' N ' ' A' ' 97' ' ' GLY . 3.9 mt-10 -17.85 -58.22 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.181 0 N-CA-C 111.655 0.242 . . . . 0.0 111.655 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 10.0 Cg_endo -53.17 71.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 124.112 1.585 . . . . 0.0 111.962 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 92.73 1.59 67.96 Favored Glycine 0 N--CA 1.495 2.605 0 O-C-N 120.97 -1.082 . . . . 0.0 111.04 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.499 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -50.04 160.81 0.31 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.895 -1.356 . . . . 0.0 109.839 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' A' ' 18' ' ' PHE . 8.7 mt -98.96 175.78 5.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.102 -0.999 . . . . 0.0 111.053 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.467 ' HG3' HG12 ' A' ' 91' ' ' ILE . 0.8 OUTLIER -154.72 137.5 15.3 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.559 -0.713 . . . . 0.0 109.811 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.583 ' N ' ' CD1' ' A' ' 101' ' ' LEU . 2.0 mp -143.33 125.54 15.5 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.094 -1.004 . . . . 0.0 110.527 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.515 ' HB2' ' CD1' ' A' ' 89' ' ' TYR . 32.4 t30 -90.35 133.79 34.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.286 -0.884 . . . . 0.0 110.403 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.573 ' CE3' HG22 ' A' ' 24' ' ' ILE . 60.5 t-105 . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.353 -0.842 . . . . 0.0 110.31 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 32.7 m . . . . . 0 N--CA 1.486 1.331 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.469 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 0.9 OUTLIER -126.6 -17.08 5.14 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.528 -1.357 . . . . 0.0 111.965 -178.468 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.539 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -59.77 -117.1 0.01 OUTLIER Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.4 -1.381 . . . . 0.0 109.786 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.536 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -135.35 -179.9 5.92 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.963 -1.316 . . . . 0.0 110.324 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.592 ' CE2' ' HD2' ' A' ' 48' ' ' PRO . 31.0 m-85 -136.57 149.67 48.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.04 -1.038 . . . . 0.0 111.851 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.438 ' HB2' ' CG ' ' A' ' 39' ' ' GLU . 17.6 ttpt -116.6 118.76 33.49 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.655 -0.653 . . . . 0.0 109.557 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.524 HG22 ' CD1' ' A' ' 99' ' ' LEU . 51.3 t -59.63 131.52 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.784 -1.198 . . . . 0.0 108.772 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.529 ' CG2' ' HB2' ' A' ' 37' ' ' GLN . 76.8 t -105.62 -26.44 3.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.545 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 12.5 tttt -157.53 133.34 9.3 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -52.47 155.39 2.15 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.535 0.683 . . . . 0.0 111.243 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.586 HD13 ' CA ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -49.76 133.22 8.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 C-N-CA 119.996 -0.681 . . . . 0.0 109.957 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.504 ' O ' ' CG2' ' A' ' 32' ' ' ILE . . . -108.24 171.52 7.36 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.2 pm0 -116.91 132.62 56.65 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.87 -1.144 . . . . 0.0 110.454 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.457 ' OG1' ' OG1' ' A' ' 31' ' ' THR . 13.7 p -90.57 179.61 5.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.334 -0.854 . . . . 0.0 110.127 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -93.25 29.86 1.81 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -0.93 . . . . 0.0 110.379 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.53 6.89 3.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 110.357 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.42 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 95.64 5.56 60.04 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.582 ' CG2' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -98.86 -173.1 2.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.316 -1.108 . . . . 0.0 110.135 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.581 HG21 ' CD1' ' A' ' 103' ' ' TRP . 0.0 OUTLIER -144.33 159.42 15.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 85.5 t -125.28 128.72 72.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 O-C-N 120.864 -1.148 . . . . 0.0 112.457 -177.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.627 ' O ' ' HA ' ' A' ' 78' ' ' ASN . 0.3 OUTLIER -110.81 118.16 56.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.379 -0.826 . . . . 0.0 109.476 178.672 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.545 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -103.77 114.76 29.26 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.61 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.8 m -133.95 -172.15 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.223 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.529 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 10.9 tt0 -132.37 126.79 34.05 Favored 'General case' 0 C--N 1.276 -2.615 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 14' ' ' CYS . 1.5 t80 -60.55 123.99 19.03 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 118.716 -1.194 . . . . 0.0 109.92 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.438 ' CG ' ' HB2' ' A' ' 19' ' ' LYS . 43.4 mm-40 -103.65 -21.95 13.65 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.124 -0.985 . . . . 0.0 109.156 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.539 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -67.17 -164.85 2.25 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.467 ' HA ' ' HG3' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -137.63 94.04 2.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.578 -0.954 . . . . 0.0 109.976 179.716 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 43' ' ' SER . . . -149.12 12.19 1.06 Allowed Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.348 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.603 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER 47.31 -158.65 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.352 0 O-C-N 120.788 -1.419 . . . . 0.0 109.127 179.491 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.603 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 89.2 Cg_exo -42.86 94.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 122.87 0.931 . . . . 0.0 110.186 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.535 ' SG ' ' CE2' ' A' ' 38' ' ' TYR . 25.7 p -143.13 163.77 31.96 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.742 -0.599 . . . . 0.0 109.566 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.567 ' O ' ' N ' ' A' ' 14' ' ' CYS . 1.6 mttt -86.65 156.9 19.81 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.027 -1.046 . . . . 0.0 111.428 -178.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.6 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 11.3 mm -99.72 125.07 41.85 Favored Pre-proline 0 C--N 1.294 -1.83 0 O-C-N 121.474 -0.766 . . . . 0.0 111.808 -177.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.592 ' HD2' ' CE2' ' A' ' 18' ' ' PHE . 33.2 Cg_exo -60.85 148.17 93.08 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.223 1.644 . . . . 0.0 111.046 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.631 ' CE2' ' CG2' ' A' ' 79' ' ' ILE . 4.9 t80 -154.22 151.54 29.28 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.487 -0.758 . . . . 0.0 109.582 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.49 ' HB3' ' HB ' ' A' ' 91' ' ' ILE . 3.8 tp10 -162.76 113.59 1.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.806 -1.184 . . . . 0.0 110.761 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.9 mt . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.388 -0.82 . . . . 0.0 109.744 179.529 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.519 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.482 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -131.3 170.51 14.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -1.148 . . . . 0.0 110.465 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.582 HD23 ' CD1' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -124.19 121.63 35.61 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.553 -0.717 . . . . 0.0 109.678 179.314 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.588 ' CD1' ' N ' ' A' ' 64' ' ' ILE . 1.5 mp -85.11 -24.47 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.59 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.258 2.9 m -115.29 38.43 3.23 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.583 ' CG1' ' ND2' ' A' ' 67' ' ' ASN . 10.5 t -25.41 132.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 121.347 0.594 . . . . 0.0 111.5 -178.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.583 ' ND2' ' CG1' ' A' ' 66' ' ' VAL . 25.4 p30 30.47 70.23 0.63 Allowed Pre-proline 0 C--N 1.303 -1.446 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.745 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.56 ' O ' ' HA ' ' A' ' 46' ' ' LYS . 1.2 Cg_endo -55.74 -175.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.644 0 N-CA-C 107.977 -1.586 . . . . 0.0 107.977 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.538 HG12 ' HA ' ' A' ' 46' ' ' LYS . 1.1 mt -144.93 146.12 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 C-N-CA 118.56 -1.256 . . . . 0.0 112.174 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.6 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 22.0 t -102.26 157.82 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.1 m -114.26 -16.12 12.07 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 118.973 -1.091 . . . . 0.0 111.656 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.527 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 12.4 mt-10 -136.75 16.55 3.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.574 -1.329 . . . . 0.0 111.619 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.557 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 2.4 ttpt 71.57 -5.08 1.71 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.149 -0.969 . . . . 0.0 110.994 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.48 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 5.1 t70 -137.86 -1.51 2.0 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.969 -1.082 . . . . 0.0 110.32 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.2 t -72.36 112.24 14.01 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.209 -0.932 . . . . 0.0 109.259 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 49.7 Cg_exo -48.51 126.51 14.29 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.828 1.436 . . . . 0.0 109.744 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.469 HG23 HG23 ' A' ' 70' ' ' VAL . 74.8 t -114.31 133.41 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.015 -1.053 . . . . 0.0 111.45 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.627 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 5.3 m-80 -99.65 131.8 45.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.493 -0.754 . . . . 0.0 109.12 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.631 ' CG2' ' CE2' ' A' ' 49' ' ' PHE . 10.9 mt -114.17 119.62 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.099 -1.626 . . . . 0.0 111.636 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.541 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 1.7 tp10 -92.4 118.59 31.09 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.94 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . . . -135.93 152.55 51.1 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.006 -1.059 . . . . 0.0 110.78 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.529 ' CA ' HG23 ' A' ' 31' ' ' THR . 2.0 tt0 -102.36 102.63 26.32 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.367 -0.833 . . . . 0.0 110.266 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.53 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 35.7 Cg_endo -71.96 151.56 56.45 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.086 1.571 . . . . 0.0 110.564 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.519 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 15.5 Cg_endo . . . . . 0 C--N 1.304 -1.771 0 O-C-N 124.081 1.569 . . . . 0.0 110.249 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 15.4 m-85 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.186 0.517 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.606 ' CG2' ' CZ ' ' A' ' 49' ' ' PHE . 1.3 mp -73.94 125.03 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.21 -0.931 . . . . 0.0 109.447 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.498 ' CG2' ' CD ' ' A' ' 98' ' ' GLN . 81.0 mt -96.5 144.14 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.156 -0.965 . . . . 0.0 110.503 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.552 ' CD1' HG23 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -129.76 137.87 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.502 -0.749 . . . . 0.0 109.596 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 48' ' ' PRO . . . 86.7 -163.78 35.43 Favored Glycine 0 N--CA 1.481 1.681 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.57 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -118.15 143.92 27.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 O-C-N 121.049 -1.265 . . . . 0.0 110.32 -179.478 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.576 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -14.54 -59.26 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.139 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -179.692 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.553 ' CD ' ' CB ' ' A' ' 95' ' ' GLU . 5.9 Cg_endo -49.86 74.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 124.235 1.65 . . . . 0.0 111.752 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 86.68 -2.37 87.25 Favored Glycine 0 N--CA 1.494 2.519 0 O-C-N 121.045 -1.034 . . . . 0.0 111.096 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.498 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -43.41 162.73 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.812 -1.405 . . . . 0.0 109.897 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.524 ' CD1' HG22 ' A' ' 20' ' ' VAL . 10.5 mt -98.91 174.88 6.15 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.069 -1.019 . . . . 0.0 110.889 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.46 ' HG3' HG12 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -152.1 130.32 11.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.603 -0.686 . . . . 0.0 109.871 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 89' ' ' TYR . 4.2 mp -131.73 123.9 28.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.145 -0.972 . . . . 0.0 110.394 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -86.96 128.98 35.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.325 -0.859 . . . . 0.0 110.207 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.581 ' CD1' HG21 ' A' ' 32' ' ' ILE . 61.7 t-105 . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.16 -0.963 . . . . 0.0 110.275 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.596 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 39.6 m . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.539 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 3.7 p -95.52 -1.98 49.53 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.18 -0.95 . . . . 0.0 112.07 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.556 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -66.84 -110.59 0.01 OUTLIER Glycine 0 N--CA 1.49 2.295 0 C-N-CA 118.844 -1.645 . . . . 0.0 109.048 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.53 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -143.47 173.62 11.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.985 -1.303 . . . . 0.0 110.103 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.603 ' CE1' ' HD2' ' A' ' 48' ' ' PRO . 33.6 m-85 -133.66 151.12 51.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.993 -1.067 . . . . 0.0 111.631 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.495 ' HE2' ' NE2' ' A' ' 37' ' ' GLN . 5.2 ttpt -117.75 115.95 26.04 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.61 -0.681 . . . . 0.0 109.239 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.487 ' CG2' HD13 ' A' ' 99' ' ' LEU . 40.6 t -59.67 124.7 14.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 120.655 -1.278 . . . . 0.0 109.131 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.54 ' HB ' ' CG ' ' A' ' 35' ' ' ARG . 60.6 t -98.25 -26.37 3.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.602 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 7.7 tttt -158.06 133.6 8.95 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -50.58 160.22 0.44 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.618 0.723 . . . . 0.0 111.465 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.563 HD11 ' CA ' ' A' ' 34' ' ' ILE . 0.7 OUTLIER -55.24 132.88 18.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 121.545 0.688 . . . . 0.0 110.277 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.478 ' O ' HG21 ' A' ' 32' ' ' ILE . . . -108.94 168.19 9.54 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 4.2 pm0 -114.77 134.65 54.94 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.613 -1.304 . . . . 0.0 110.695 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.46 ' OG1' ' OG1' ' A' ' 31' ' ' THR . 9.5 p -91.79 172.06 8.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.521 -0.737 . . . . 0.0 110.041 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -87.85 31.03 0.79 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.234 -0.916 . . . . 0.0 110.378 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.95 6.38 3.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.244 -0.91 . . . . 0.0 110.249 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.467 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 94.73 10.32 57.9 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.59 ' CG2' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -106.08 -178.21 3.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.392 -1.064 . . . . 0.0 110.273 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.539 ' O ' ' HA ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -139.51 150.63 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' A' ' 25' ' ' ALA . 54.1 t -117.45 134.2 61.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 O-C-N 121.184 -0.947 . . . . 0.0 112.126 -177.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.604 ' CD1' ' CG1' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -116.85 119.88 63.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.366 -0.834 . . . . 0.0 109.761 178.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.602 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 1.1 ttm180 -101.12 123.66 45.62 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.604 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.4 m -149.2 161.56 4.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.148 -0.97 . . . . 0.0 108.766 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.495 ' NE2' ' HE2' ' A' ' 19' ' ' LYS 0.262 1.6 tt0 -107.35 125.62 51.43 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.581 ' CE1' ' HA3' ' A' ' 40' ' ' GLY . 3.3 t80 -59.87 122.94 15.5 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 118.909 -1.117 . . . . 0.0 110.126 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.403 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 1.3 mm-40 -98.57 -23.89 15.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.319 -0.863 . . . . 0.0 109.168 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.581 ' HA3' ' CE1' ' A' ' 38' ' ' TYR . . . -65.59 -161.6 0.82 Allowed Glycine 0 N--CA 1.484 1.89 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.466 ' HA ' ' HD2' ' A' ' 73' ' ' LYS . 30.9 t0 -128.23 146.46 50.73 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.468 -1.019 . . . . 0.0 110.185 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.402 ' O ' ' CB ' ' A' ' 43' ' ' SER . . . 156.69 -14.39 0.35 Allowed Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.59 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.606 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.8 OUTLIER 60.49 -152.95 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 120.639 -1.506 . . . . 0.0 108.16 -179.723 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 88.5 Cg_exo -42.39 97.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.32 -0.959 0 N-CA-C 108.819 -1.262 . . . . 0.0 108.819 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.596 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -146.77 171.28 15.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.767 -0.583 . . . . 0.0 110.02 -177.714 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.585 ' CG ' ' CD1' ' A' ' 69' ' ' ILE . 16.6 mtmt -85.79 175.01 8.93 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.35 -0.844 . . . . 0.0 111.664 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.594 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 15.7 mm -123.05 125.78 26.17 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.401 -0.812 . . . . 0.0 112.299 -178.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.603 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 30.2 Cg_exo -65.42 146.8 86.3 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.963 1.507 . . . . 0.0 110.686 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.579 ' CD2' HD23 ' A' ' 63' ' ' LEU . 11.4 t80 -155.88 159.9 39.71 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.255 -0.903 . . . . 0.0 110.422 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.506 ' OE1' ' N ' ' A' ' 51' ' ' ILE . 5.9 tp10 -176.29 114.38 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.067 -1.021 . . . . 0.0 110.554 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.506 ' N ' ' OE1' ' A' ' 50' ' ' GLU . 55.9 mt . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 110.094 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.459 ' HA2' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.499 ' O ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -120.6 149.96 41.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.18 -1.188 . . . . 0.0 110.113 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.579 HD23 ' CD2' ' A' ' 49' ' ' PHE . 3.2 mt -110.15 118.15 35.61 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.197 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.602 ' CD1' ' N ' ' A' ' 64' ' ' ILE . 1.5 mp -77.49 -22.97 14.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.61 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.272 1.0 OUTLIER -113.69 29.77 7.75 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.439 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.537 ' C ' ' O ' ' A' ' 65' ' ' THR . 52.0 t -12.47 112.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.534 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.511 ' ND2' ' HE3' ' A' ' 46' ' ' LYS . 20.8 t-20 41.24 70.0 1.79 Allowed Pre-proline 0 C--N 1.302 -1.488 0 O-C-N 121.647 -0.658 . . . . 0.0 110.4 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.532 ' CG ' HG12 ' A' ' 79' ' ' ILE . 1.7 Cg_endo -51.85 -176.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.01 1.532 . . . . 0.0 109.723 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.585 ' CD1' ' CG ' ' A' ' 46' ' ' LYS . 0.9 OUTLIER -140.7 142.07 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.947 -178.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.594 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 24.8 t -93.39 169.51 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.2 m -124.15 -20.73 5.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.883 -1.136 . . . . 0.0 110.929 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.531 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 6.9 mt-10 -135.87 14.44 3.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.026 -1.046 . . . . 0.0 110.754 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.531 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 10.6 ttpt 73.81 -7.52 1.58 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.422 -0.798 . . . . 0.0 110.818 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.482 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 5.7 t70 -136.78 -1.15 2.26 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.965 -1.085 . . . . 0.0 110.23 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.2 t -73.19 112.46 15.78 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.194 -0.941 . . . . 0.0 109.44 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 74' ' ' ASP . 35.0 Cg_exo -50.93 113.52 1.12 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.806 1.424 . . . . 0.0 109.912 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 74.0 t -99.13 155.19 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.318 -0.864 . . . . 0.0 110.714 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -111.77 134.86 53.06 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.465 -0.772 . . . . 0.0 109.96 179.667 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.574 HG21 ' CD1' ' A' ' 49' ' ' PHE . 3.8 mt -115.35 114.23 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 117.731 -1.588 . . . . 0.0 111.289 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 1.1 tt0 -90.78 115.0 27.52 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.983 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.559 ' HB2' ' CD2' ' A' ' 63' ' ' LEU . . . -131.61 149.16 52.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.908 -1.12 . . . . 0.0 110.768 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.519 ' CA ' HG21 ' A' ' 31' ' ' THR . 2.2 tt0 -98.82 104.99 28.23 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 110.337 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.476 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 30.8 Cg_endo -70.32 131.97 21.49 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.001 1.527 . . . . 0.0 110.298 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.459 ' HD3' ' HA2' ' A' ' 61' ' ' GLY . 23.0 Cg_endo . . . . . 0 C--N 1.305 -1.72 0 O-C-N 123.933 1.491 . . . . 0.0 110.398 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 9.7 m-85 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.124 0.488 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 100' ' ' LYS . 20.6 mt -73.81 163.63 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.49 ' CG2' ' CD ' ' A' ' 98' ' ' GLN . 80.2 mt -126.25 139.54 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.496 -1.377 . . . . 0.0 112.04 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.552 ' CD1' HG22 ' A' ' 34' ' ' ILE . 0.5 OUTLIER -128.44 136.12 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.242 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.529 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 87.71 -161.17 31.97 Favored Glycine 0 N--CA 1.481 1.649 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.563 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -121.18 146.84 25.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 121.04 -1.27 . . . . 0.0 110.154 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.566 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.3 OUTLIER -17.03 -58.6 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.203 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 7.1 Cg_endo -51.18 75.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 124.216 1.64 . . . . 0.0 111.735 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 87.02 -0.27 86.02 Favored Glycine 0 N--CA 1.494 2.501 0 O-C-N 120.96 -1.087 . . . . 0.0 111.043 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.49 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -44.65 164.48 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.744 -1.445 . . . . 0.0 109.807 179.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.523 ' CD1' ' O ' ' A' ' 18' ' ' PHE . 7.2 mt -102.35 170.67 7.93 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.104 -0.998 . . . . 0.0 111.263 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -146.41 132.84 19.65 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.602 -0.687 . . . . 0.0 109.478 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.525 HD13 ' CD1' ' A' ' 92' ' ' ILE . 1.0 OUTLIER -122.99 135.41 54.46 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.002 -1.061 . . . . 0.0 110.744 -179.534 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -84.74 130.63 34.66 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.372 -0.83 . . . . 0.0 110.657 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.513 ' NE1' HG22 ' A' ' 32' ' ' ILE . 26.2 t-105 . . . . . 0 N--CA 1.487 1.416 0 O-C-N 121.325 -0.86 . . . . 0.0 109.965 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.587 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 42.9 m . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.534 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -88.8 -7.36 56.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.385 -0.822 . . . . 0.0 111.766 -178.375 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.555 ' HA3' ' CA ' ' A' ' 40' ' ' GLY . . . -61.55 -110.83 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 C-N-CA 118.775 -1.679 . . . . 0.0 108.966 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.54 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -145.99 171.8 14.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.98 -1.306 . . . . 0.0 110.253 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.589 ' CE1' ' HD2' ' A' ' 48' ' ' PRO . 38.1 m-85 -130.49 148.69 52.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.062 -1.024 . . . . 0.0 111.48 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.479 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 4.2 ttpp -114.13 114.68 26.4 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.481 -0.762 . . . . 0.0 109.131 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.497 HG23 ' CD1' ' A' ' 99' ' ' LEU . 21.5 t -59.49 124.15 13.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 120.606 -1.309 . . . . 0.0 109.015 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.553 ' HB ' ' CG ' ' A' ' 35' ' ' ARG . 64.4 t -97.56 -25.54 4.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.582 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 3.8 tttp -158.68 133.54 8.27 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 177.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -51.68 163.27 0.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.671 0.748 . . . . 0.0 111.305 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.569 HG12 HG12 ' A' ' 34' ' ' ILE . 0.7 OUTLIER -57.09 132.81 21.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 121.647 0.736 . . . . 0.0 110.2 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 32' ' ' ILE . . . -108.05 169.83 8.38 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 2.9 pm0 -116.01 132.94 56.51 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.784 -1.197 . . . . 0.0 110.425 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.479 ' OG1' ' OG1' ' A' ' 31' ' ' THR . 16.5 p -91.17 -179.32 5.4 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.659 -0.817 . . . . 0.0 110.103 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -94.16 17.22 12.97 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.184 -0.947 . . . . 0.0 110.373 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.28 8.09 12.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.293 -0.879 . . . . 0.0 110.062 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.34 11.33 59.82 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.589 ' CG2' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -104.91 -174.38 2.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.39 -1.064 . . . . 0.0 110.345 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -141.13 155.67 21.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.49 ' N ' ' O ' ' A' ' 25' ' ' ALA . 76.7 t -120.76 129.95 75.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 119.101 -1.04 . . . . 0.0 112.231 -178.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.596 ' CD1' ' CG1' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -113.7 117.65 56.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 121.399 -0.813 . . . . 0.0 109.79 178.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.582 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 3.1 ttm180 -100.77 119.91 39.33 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.596 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.4 m -146.87 158.72 10.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.2 -0.937 . . . . 0.0 109.014 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.462 ' OE1' ' O ' ' A' ' 74' ' ' ASP 0.252 11.9 tt0 -106.08 125.57 51.15 Favored 'General case' 0 C--N 1.271 -2.817 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.393 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.581 ' CE1' ' HA3' ' A' ' 40' ' ' GLY . 3.7 t80 -59.78 123.04 15.73 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 119.003 -1.079 . . . . 0.0 110.079 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.479 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 8.3 mt-10 -98.86 -23.54 15.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.359 -0.838 . . . . 0.0 109.206 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.581 ' HA3' ' CE1' ' A' ' 38' ' ' TYR . . . -65.01 -162.12 0.68 Allowed Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.442 ' OD1' ' HE2' ' A' ' 73' ' ' LYS . 17.7 m-20 -129.15 146.52 51.06 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.457 -1.025 . . . . 0.0 110.307 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 43' ' ' SER . . . 155.37 -12.8 0.43 Allowed Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.597 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.608 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.7 OUTLIER 61.08 -153.29 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 120.661 -1.493 . . . . 0.0 108.32 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.608 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 88.4 Cg_exo -42.16 97.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.32 -0.958 0 N-CA-C 108.964 -1.206 . . . . 0.0 108.964 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.587 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -146.66 170.19 17.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.829 -0.545 . . . . 0.0 110.143 -177.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.574 ' CG ' ' CD1' ' A' ' 69' ' ' ILE . 1.2 mtpm? -84.67 175.09 9.44 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.173 -0.955 . . . . 0.0 112.033 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.611 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 15.5 mm -123.65 124.2 26.22 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.68 -0.638 . . . . 0.0 111.539 -178.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.589 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 31.7 Cg_exo -61.92 144.71 96.83 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.06 1.558 . . . . 0.0 110.384 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.638 ' CE1' ' CG2' ' A' ' 79' ' ' ILE . 4.8 t80 -151.69 156.21 39.89 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.203 -0.935 . . . . 0.0 110.324 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.524 ' CG ' HD13 ' A' ' 91' ' ' ILE . 23.1 tp10 -173.76 95.6 0.1 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.073 -1.017 . . . . 0.0 110.184 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . 97.2 mt . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.302 -0.874 . . . . 0.0 110.265 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.519 ' N ' ' HG3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -150.54 163.93 37.25 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.267 -1.137 . . . . 0.0 109.525 179.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.594 ' CD2' ' CB ' ' A' ' 81' ' ' ALA . 11.8 mt -122.01 121.41 36.96 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 118.837 -1.145 . . . . 0.0 110.539 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.612 ' CD1' ' N ' ' A' ' 64' ' ' ILE . 1.4 mp -82.54 -27.62 8.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.607 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.26 1.1 m -96.78 32.61 2.04 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 122.781 1.277 . . . . 0.0 107.673 178.726 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 63' ' ' LEU . 16.3 t -34.74 140.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.25 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.57 ' N ' ' CD ' ' A' ' 68' ' ' PRO . 38.9 t-20 56.55 46.4 2.24 Favored Pre-proline 0 C--N 1.302 -1.493 0 O-C-N 121.577 -0.702 . . . . 0.0 110.585 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.596 ' CB ' ' CD1' ' A' ' 79' ' ' ILE . 8.1 Cg_endo -59.15 146.36 94.71 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.673 1.354 . . . . 0.0 109.043 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.574 ' CD1' ' CG ' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -141.3 149.86 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 119.127 -1.029 . . . . 0.0 112.915 -177.652 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.611 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 41.9 t -97.28 168.86 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.41 ' N ' HG11 ' A' ' 70' ' ' VAL . 4.8 m -122.78 -21.25 5.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.857 -1.152 . . . . 0.0 111.201 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.535 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 15.6 mt-10 -136.51 17.23 3.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.816 -1.177 . . . . 0.0 111.192 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER 72.54 -5.63 1.79 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.281 -0.887 . . . . 0.0 110.981 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.462 ' O ' ' OE1' ' A' ' 37' ' ' GLN . 5.8 t70 -138.81 0.27 1.98 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.923 -1.111 . . . . 0.0 110.429 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.456 ' O ' HG23 ' A' ' 77' ' ' VAL . 22.8 t -73.09 108.59 4.76 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.15 -0.969 . . . . 0.0 109.476 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 1.6 Cg_endo -50.22 110.66 0.41 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.697 1.367 . . . . 0.0 109.736 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 82.0 t -94.34 146.0 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.269 -0.894 . . . . 0.0 111.044 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.589 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.1 m120 -106.64 131.09 54.18 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.638 ' CG2' ' CE1' ' A' ' 49' ' ' PHE . 3.9 mm -112.2 117.46 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.079 -1.638 . . . . 0.0 111.803 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.566 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 1.6 tp10 -93.57 106.97 18.89 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.302 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.594 ' CB ' ' CD2' ' A' ' 63' ' ' LEU . . . -130.24 153.86 48.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.88 -1.137 . . . . 0.0 111.308 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 62' ' ' ARG . 24.6 tt0 -97.82 103.55 17.47 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.647 -0.658 . . . . 0.0 110.409 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.53 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 37.4 Cg_endo -70.77 144.56 49.02 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.984 1.518 . . . . 0.0 110.539 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.519 ' HG3' ' N ' ' A' ' 61' ' ' GLY . 23.7 Cg_exo . . . . . 0 C--N 1.305 -1.761 0 O-C-N 124.095 1.577 . . . . 0.0 110.155 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 17.9 m-85 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.213 0.53 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.579 ' CG2' ' CZ ' ' A' ' 49' ' ' PHE . 4.1 mt -74.14 116.94 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 109.469 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.524 HD13 ' CG ' ' A' ' 50' ' ' GLU . 37.9 mt -94.62 147.44 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.177 -0.952 . . . . 0.0 110.395 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.558 ' CD1' HG22 ' A' ' 34' ' ' ILE . 1.6 mt -133.36 139.66 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.464 -0.772 . . . . 0.0 109.478 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.531 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 83.13 -161.17 39.28 Favored Glycine 0 N--CA 1.481 1.651 0 N-CA-C 108.624 -1.791 . . . . 0.0 108.624 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.554 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -122.12 149.1 25.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 121.213 -1.169 . . . . 0.0 110.169 -179.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.577 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.6 OUTLIER -17.15 -58.42 0.04 OUTLIER Pre-proline 0 N--CA 1.501 2.117 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 8.6 Cg_endo -51.87 71.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 124.279 1.673 . . . . 0.0 112.116 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 90.6 0.57 75.58 Favored Glycine 0 N--CA 1.494 2.537 0 O-C-N 120.941 -1.1 . . . . 0.0 110.943 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.504 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -48.38 159.97 0.18 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.952 -1.322 . . . . 0.0 110.199 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.497 ' CD1' HG23 ' A' ' 20' ' ' VAL . 12.2 mt -96.87 177.84 5.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.239 -0.913 . . . . 0.0 110.623 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.42 ' HG3' HG12 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -157.62 137.28 12.16 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.477 -0.765 . . . . 0.0 110.16 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.519 HD22 ' CD1' ' A' ' 34' ' ' ILE . 2.8 mp -138.21 116.94 12.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.207 -0.933 . . . . 0.0 110.373 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 9.1 p-10 -83.31 128.06 34.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 110.405 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.513 ' NE1' HG22 ' A' ' 32' ' ' ILE . 10.6 t-105 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.243 -0.911 . . . . 0.0 110.155 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.584 ' HB3' ' CE1' ' A' ' 38' ' ' TYR . 1.3 m . . . . . 0 N--CA 1.485 1.314 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.538 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 1.2 p -116.39 4.95 13.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.132 -0.98 . . . . 0.0 111.716 -178.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.54 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -62.02 -115.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.532 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -136.49 174.06 11.03 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.989 -1.3 . . . . 0.0 109.946 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.588 ' CE1' ' HD2' ' A' ' 48' ' ' PRO . 42.8 m-85 -133.02 140.84 47.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.965 -1.084 . . . . 0.0 111.814 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.522 ' HB2' ' CG ' ' A' ' 39' ' ' GLU . 7.9 ttpt -107.67 117.65 34.67 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.633 -0.667 . . . . 0.0 109.277 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.522 HG21 ' CD1' ' A' ' 99' ' ' LEU . 21.2 t -59.64 132.91 25.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 120.835 -1.166 . . . . 0.0 109.042 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.52 ' N ' ' HA ' ' A' ' 36' ' ' VAL . 92.1 t -105.78 -24.12 4.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.575 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 16.2 tttt -161.64 134.48 6.11 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -53.23 158.84 1.46 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.699 0.761 . . . . 0.0 111.421 -178.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.574 HD11 ' CA ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -52.86 133.08 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-O 121.587 0.708 . . . . 0.0 110.202 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 32' ' ' ILE . . . -109.64 171.73 7.27 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 5.3 pm0 -116.65 134.68 54.53 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.833 -1.167 . . . . 0.0 110.56 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.519 ' CG2' ' OE2' ' A' ' 80' ' ' GLU . 14.0 p -92.8 175.03 6.96 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.255 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -88.62 31.25 0.84 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.905 . . . . 0.0 110.234 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.3 m170 -133.87 5.78 3.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.894 . . . . 0.0 110.183 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.85 1.23 61.74 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.161 -1.575 . . . . 0.0 109.161 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.584 ' CG2' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -95.32 -176.73 3.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -1.144 . . . . 0.0 110.355 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.569 ' O ' ' HA ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -140.21 153.34 22.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.763 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.478 ' N ' ' O ' ' A' ' 25' ' ' ALA . 55.1 t -118.97 132.24 69.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 119.113 -1.035 . . . . 0.0 112.351 -177.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.62 ' CD1' ' CG1' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -113.55 120.54 63.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 O-C-N 121.355 -0.841 . . . . 0.0 109.61 178.601 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.575 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 2.9 ttm180 -105.19 110.85 23.39 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.62 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.5 m -132.59 -169.91 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.438 -0.789 . . . . 0.0 109.312 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.444 ' N ' HG21 ' A' ' 36' ' ' VAL . 17.1 tt0 -136.58 128.19 28.77 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.584 ' CE1' ' HB3' ' A' ' 14' ' ' CYS . 16.1 t80 -61.02 118.66 7.04 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 117.983 -1.487 . . . . 0.0 110.633 -178.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.522 ' CG ' ' HB2' ' A' ' 19' ' ' LYS . 7.5 mm-40 -97.25 -0.79 46.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.503 -0.748 . . . . 0.0 109.327 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.567 ' HA3' ' CZ ' ' A' ' 38' ' ' TYR . . . -93.57 -161.77 35.81 Favored Glycine 0 N--CA 1.484 1.855 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 41' ' ' ASP . 2.0 p30 -127.52 134.77 49.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.461 -1.023 . . . . 0.0 109.929 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' ' 43' ' ' SER . . . 171.92 -23.03 0.08 OUTLIER Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.483 -1.342 . . . . 0.0 110.664 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.602 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.5 OUTLIER 64.12 -154.95 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 120.602 -1.529 . . . . 0.0 108.073 -179.563 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.602 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 88.2 Cg_exo -42.54 94.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -0.993 0 N-CA-C 109.059 -1.169 . . . . 0.0 109.059 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.557 ' N ' ' O ' ' A' ' 43' ' ' SER . 31.6 p -148.02 178.36 8.59 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.792 -0.568 . . . . 0.0 109.576 -178.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 68' ' ' PRO . 1.0 OUTLIER -96.05 175.04 6.62 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.943 -1.098 . . . . 0.0 111.412 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.611 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 17.7 mm -121.94 131.75 24.36 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.346 -0.846 . . . . 0.0 112.591 -177.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.588 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 26.1 Cg_exo -66.94 143.52 66.61 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 124.115 1.587 . . . . 0.0 110.768 178.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.642 ' CE2' ' CG2' ' A' ' 79' ' ' ILE . 9.2 t80 -152.96 158.65 42.39 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.313 -0.867 . . . . 0.0 110.248 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.503 ' HG2' ' CD1' ' A' ' 91' ' ' ILE . 5.3 tt0 -173.29 111.49 0.2 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.067 -1.02 . . . . 0.0 110.324 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.443 HD13 ' HB1' ' A' ' 81' ' ' ALA . 68.5 mt . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 110.34 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.502 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.492 2.382 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -158.93 166.69 31.24 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.073 -1.251 . . . . 0.0 109.596 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.596 HD22 ' CE1' ' A' ' 49' ' ' PHE . 10.5 mt -124.17 122.75 38.65 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 118.804 -1.158 . . . . 0.0 111.077 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.611 ' CD1' ' N ' ' A' ' 64' ' ' ILE . 1.5 mp -84.82 -23.35 7.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 178.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.582 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.28 2.0 m -108.26 37.17 2.55 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 122.476 1.132 . . . . 0.0 108.096 179.514 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.522 HG13 ' N ' ' A' ' 67' ' ' ASN . 37.3 t -38.22 152.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-O 121.504 0.668 . . . . 0.0 111.077 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.527 ' HB2' ' CD ' ' A' ' 46' ' ' LYS . 5.3 p-10 37.53 59.36 4.32 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.851 -0.53 . . . . 0.0 111.253 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.598 ' CB ' ' CD1' ' A' ' 79' ' ' ILE . 19.3 Cg_exo -58.64 164.8 8.86 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 N-CA-C 108.325 -1.452 . . . . 0.0 108.325 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.544 ' CG2' ' O ' ' A' ' 45' ' ' CYS . 1.1 mt -143.45 146.22 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 118.418 -1.313 . . . . 0.0 113.001 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.611 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 15.3 t -103.77 163.33 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 176.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.468 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 3.1 m -124.85 -12.04 7.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.823 -1.173 . . . . 0.0 111.654 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 4.4 mt-10 -140.88 10.52 2.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.719 -1.238 . . . . 0.0 111.311 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 15.8 mtmt 78.16 -16.75 0.63 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.744 -0.597 . . . . 0.0 111.036 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.498 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 6.2 t70 -132.52 0.52 3.65 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.071 -1.018 . . . . 0.0 109.801 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.7 t -71.71 111.53 10.8 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 38.2 Cg_exo -49.76 131.51 29.3 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.901 1.474 . . . . 0.0 110.332 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 89.2 t -110.36 154.52 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.172 -0.955 . . . . 0.0 110.515 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 0.4 OUTLIER -116.63 132.42 56.69 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.525 -0.735 . . . . 0.0 109.289 179.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.642 ' CG2' ' CE2' ' A' ' 49' ' ' PHE . 25.2 mm -117.76 117.05 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 117.497 -1.681 . . . . 0.0 112.105 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.569 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 1.6 tp10 -94.76 110.72 22.55 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.418 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.566 ' CB ' ' CD2' ' A' ' 63' ' ' LEU . . . -131.15 155.94 46.15 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.781 -1.199 . . . . 0.0 111.386 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 62' ' ' ARG . 35.3 tp10 -99.79 102.36 16.93 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.593 -0.692 . . . . 0.0 110.418 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.538 ' HG3' ' CD1' ' A' ' 32' ' ' ILE . 56.9 Cg_endo -75.23 148.42 34.39 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.997 1.525 . . . . 0.0 110.747 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.502 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 12.2 Cg_endo . . . . . 0 C--N 1.305 -1.739 0 O-C-N 124.099 1.579 . . . . 0.0 110.108 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.546 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 2.0 m-85 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.158 0.504 . . . . 0.0 110.092 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.573 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 1.6 mp -74.01 118.44 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.203 -0.936 . . . . 0.0 109.522 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.503 ' CD1' ' HG2' ' A' ' 50' ' ' GLU . 70.9 mt -98.68 148.16 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 110.643 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.543 ' CD1' HG23 ' A' ' 34' ' ' ILE . 1.7 mt -135.88 138.2 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.643 -0.661 . . . . 0.0 109.333 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.537 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 83.9 -159.39 36.03 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.558 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -124.22 149.96 28.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 O-C-N 121.198 -1.178 . . . . 0.0 110.18 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.572 ' O ' ' N ' ' A' ' 97' ' ' GLY . 2.3 mt-10 -17.97 -57.88 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.121 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 9.0 Cg_endo -52.08 71.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 124.157 1.609 . . . . 0.0 112.177 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 89.81 2.74 74.9 Favored Glycine 0 N--CA 1.494 2.526 0 O-C-N 120.935 -1.103 . . . . 0.0 110.898 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.503 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -49.75 159.5 0.37 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.958 -1.319 . . . . 0.0 110.161 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.522 ' CD1' HG21 ' A' ' 20' ' ' VAL . 10.4 mt -94.91 172.66 8.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 110.445 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -156.15 133.28 10.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.392 -0.817 . . . . 0.0 110.201 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 89' ' ' TYR . 2.2 mp -134.11 122.72 23.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.257 -0.902 . . . . 0.0 110.058 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.25 134.85 33.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.19 -0.944 . . . . 0.0 110.366 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 22.3 t-105 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.364 -0.835 . . . . 0.0 110.185 179.919 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.582 ' HB3' ' CE1' ' A' ' 38' ' ' TYR . 33.5 m . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 121.312 0.577 . . . . 0.0 109.764 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.525 ' HA ' ' CG2' ' A' ' 94' ' ' VAL . 71.2 p -97.53 -5.05 36.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 111.081 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.536 ' HA3' ' CA ' ' A' ' 40' ' ' GLY . . . -59.32 -110.37 0.01 OUTLIER Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.116 -1.516 . . . . 0.0 109.381 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.563 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 1.1 ttpt -142.95 162.56 35.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.039 -1.271 . . . . 0.0 109.924 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.597 ' CE1' ' HD2' ' A' ' 48' ' ' PRO . 21.0 m-85 -126.82 136.37 52.27 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.939 -1.101 . . . . 0.0 111.224 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.476 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 10.9 ttpp -108.0 119.24 38.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.418 -0.802 . . . . 0.0 109.678 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.512 HG21 ' CD1' ' A' ' 99' ' ' LEU . 48.3 t -59.93 130.76 24.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.829 -1.17 . . . . 0.0 108.995 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.53 ' HB ' ' CG ' ' A' ' 35' ' ' ARG . 61.3 t -102.98 -24.81 3.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 1.5 tttt -161.98 133.71 5.46 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -52.34 156.67 1.65 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.611 0.719 . . . . 0.0 111.193 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.565 HD13 ' CA ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -49.94 132.66 9.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-O 121.616 0.722 . . . . 0.0 109.843 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.503 ' O ' ' CG2' ' A' ' 32' ' ' ILE . . . -108.32 172.32 6.91 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.4 pm0 -115.23 130.58 56.95 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.834 -1.166 . . . . 0.0 110.516 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.512 ' CG2' ' OE2' ' A' ' 80' ' ' GLU . 26.4 p -84.57 177.22 8.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.439 -0.788 . . . . 0.0 109.967 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -92.24 28.61 1.86 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.882 . . . . 0.0 110.158 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -133.65 5.19 3.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.242 -0.911 . . . . 0.0 110.312 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.451 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 101.35 -3.3 54.32 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.591 ' CG2' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -92.19 -175.73 4.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.205 -1.174 . . . . 0.0 110.478 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -139.15 156.88 27.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.476 ' N ' ' O ' ' A' ' 25' ' ' ALA . 59.4 t -122.06 132.03 71.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 119.079 -1.049 . . . . 0.0 112.322 -177.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.611 ' CD1' ' CG1' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -112.2 120.16 61.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 O-C-N 121.197 -0.94 . . . . 0.0 109.7 178.767 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.557 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -104.47 114.96 29.54 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.638 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.611 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.3 m -137.27 -176.35 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.336 -0.853 . . . . 0.0 109.125 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.491 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 4.2 tt0 -129.36 131.47 46.86 Favored 'General case' 0 C--N 1.276 -2.613 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.582 ' CE1' ' HB3' ' A' ' 14' ' ' CYS . 6.2 t80 -60.88 122.54 15.12 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 118.724 -1.191 . . . . 0.0 110.731 -178.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 6.8 mt-10 -111.57 26.14 10.95 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.062 -1.024 . . . . 0.0 108.869 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.536 ' CA ' ' HA3' ' A' ' 16' ' ' GLY . . . -121.22 -161.07 11.25 Favored Glycine 0 N--CA 1.484 1.863 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 40.8 p-10 -125.0 149.18 48.01 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.384 -1.068 . . . . 0.0 110.392 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.48 -2.51 1.1 Allowed Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.555 -1.307 . . . . 0.0 110.958 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.611 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.6 OUTLIER 49.48 -153.57 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 120.534 -1.568 . . . . 0.0 108.353 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.611 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 86.1 Cg_exo -41.46 97.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.321 -0.906 0 N-CA-C 109.121 -1.146 . . . . 0.0 109.121 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.579 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -143.65 169.66 17.31 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.192 0.52 . . . . 0.0 109.648 -178.095 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.528 ' CD ' ' OD1' ' A' ' 67' ' ' ASN . 6.1 mtpm? -83.53 175.46 9.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.155 -0.966 . . . . 0.0 112.163 -178.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.612 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 15.4 mm -124.55 123.64 25.75 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.696 -0.627 . . . . 0.0 111.373 -178.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.597 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 31.7 Cg_exo -62.33 144.97 95.95 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.097 1.577 . . . . 0.0 110.901 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.644 ' CE1' ' CG2' ' A' ' 79' ' ' ILE . 5.8 t80 -152.97 155.71 37.48 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.374 -0.829 . . . . 0.0 110.033 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.5 ' HG2' ' CD1' ' A' ' 91' ' ' ILE . 21.7 tt0 -171.42 103.05 0.2 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.092 -1.005 . . . . 0.0 110.382 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.433 HD13 ' HB1' ' A' ' 81' ' ' ALA . 79.3 mt . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.295 -0.878 . . . . 0.0 110.134 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.442 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.525 ' CB ' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -158.3 167.08 30.73 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.211 -1.17 . . . . 0.0 109.381 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.582 HD22 ' CE2' ' A' ' 49' ' ' PHE . 11.6 mt -122.69 122.08 37.92 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 118.916 -1.114 . . . . 0.0 110.814 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.608 ' CD1' ' N ' ' A' ' 64' ' ' ILE . 1.4 mp -83.44 -28.16 7.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.583 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.27 1.3 m -96.98 34.57 1.7 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.447 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' A' ' 63' ' ' LEU . 13.9 t -36.81 142.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.713 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.557 ' N ' ' HD3' ' A' ' 68' ' ' PRO . 46.5 t-20 49.62 59.77 16.3 Favored Pre-proline 0 C--N 1.299 -1.604 0 O-C-N 121.485 -0.759 . . . . 0.0 110.096 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.594 ' CB ' ' CD1' ' A' ' 79' ' ' ILE . 3.0 Cg_exo -68.91 154.89 70.14 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.719 1.378 . . . . 0.0 108.703 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' ' 68' ' ' PRO . 0.8 OUTLIER -142.91 146.5 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.13 -1.028 . . . . 0.0 112.247 -178.63 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.612 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 54.5 t -96.86 154.28 3.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.43 -21.89 12.28 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 120.913 -1.117 . . . . 0.0 108.714 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.539 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 32.1 mt-10 -139.22 146.47 40.53 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.545 ' O ' ' O ' ' A' ' 38' ' ' TYR . 0.5 OUTLIER -53.61 -13.9 0.75 Allowed 'General case' 0 C--N 1.296 -1.756 0 O-C-N 120.808 -1.182 . . . . 0.0 110.948 -178.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.486 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 15.7 t0 -126.91 6.99 6.65 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.58 -1.325 . . . . 0.0 110.671 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.492 ' CB ' ' HB2' ' A' ' 72' ' ' GLU . 0.1 OUTLIER -72.73 112.23 14.35 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.035 -1.041 . . . . 0.0 108.618 178.803 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.58 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 31.5 Cg_exo -56.34 126.71 23.23 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 O-C-N 124.008 1.531 . . . . 0.0 110.68 -178.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.503 HG13 ' N ' ' A' ' 78' ' ' ASN . 53.9 t -105.56 158.62 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.097 -1.002 . . . . 0.0 110.448 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.602 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -121.13 131.21 54.12 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.417 -0.802 . . . . 0.0 109.484 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.644 ' CG2' ' CE1' ' A' ' 49' ' ' PHE . 15.4 mm -114.86 115.13 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 117.598 -1.641 . . . . 0.0 111.674 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 1.5 tp10 -94.23 108.06 19.96 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.562 ' CB ' ' CD2' ' A' ' 63' ' ' LEU . . . -129.4 155.7 45.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.874 -1.141 . . . . 0.0 111.093 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.525 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 1.2 tp10 -95.97 110.72 53.29 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.577 -0.702 . . . . 0.0 110.165 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.534 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 38.1 Cg_endo -71.41 144.84 46.49 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.027 1.541 . . . . 0.0 110.501 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.442 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 13.4 Cg_endo . . . . . 0 C--N 1.304 -1.815 0 O-C-N 124.006 1.529 . . . . 0.0 110.081 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.583 ' CE2' ' ND2' ' A' ' 102' ' ' ASN . 11.6 m-85 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.198 0.523 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.572 ' CG2' ' CZ ' ' A' ' 49' ' ' PHE . 1.5 mp -74.26 121.78 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.908 . . . . 0.0 109.752 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.5 ' CD1' ' HG2' ' A' ' 50' ' ' GLU . 14.2 mt -96.13 146.93 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -0.946 . . . . 0.0 110.176 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.544 ' CD1' HG22 ' A' ' 34' ' ' ILE . 1.7 mt -135.3 140.82 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.307 -0.87 . . . . 0.0 110.073 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.531 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 80.22 -156.77 39.98 Favored Glycine 0 N--CA 1.484 1.881 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' A' ' 98' ' ' GLN . 0.4 OUTLIER -130.99 156.83 43.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 O-C-N 121.055 -1.262 . . . . 0.0 110.685 -179.511 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.624 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 2.3 mt-10 -30.44 -54.08 0.37 Allowed Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.861 -0.524 . . . . 0.0 111.569 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 3.3 Cg_endo -48.43 -20.67 2.65 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.506 1.267 . . . . 0.0 111.125 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.563 ' HA3' ' CG ' ' A' ' 17' ' ' LYS . . . -176.81 46.42 0.11 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -95.21 153.72 17.53 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.88 -1.365 . . . . 0.0 111.138 -178.591 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.528 ' CD1' ' O ' ' A' ' 18' ' ' PHE . 24.2 mt -103.71 -177.52 3.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.547 -0.721 . . . . 0.0 110.268 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.406 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 0.7 OUTLIER -156.48 137.06 13.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.526 -0.734 . . . . 0.0 110.117 179.671 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 89' ' ' TYR . 2.5 mp -139.59 119.98 13.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.102 -0.999 . . . . 0.0 110.338 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.583 ' ND2' ' CE2' ' A' ' 89' ' ' TYR . 16.6 t-20 -87.26 130.22 34.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.314 -0.866 . . . . 0.0 110.314 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.484 ' CZ3' ' O ' ' A' ' 24' ' ' ILE . 21.9 t-105 . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 110.066 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.591 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 32.5 m . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 121.423 0.63 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 16' ' ' GLY . 4.3 t -94.0 -9.52 36.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.336 -0.852 . . . . 0.0 111.722 -178.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.534 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -59.86 -123.56 0.01 OUTLIER Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.543 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -135.19 174.98 10.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.011 -1.288 . . . . 0.0 109.909 -179.749 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.602 ' CE1' ' HD2' ' A' ' 48' ' ' PRO . 35.0 m-85 -133.81 140.33 46.84 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.92 -1.112 . . . . 0.0 111.311 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.449 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 4.0 ttpt -109.89 117.18 33.12 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.584 -0.698 . . . . 0.0 109.366 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.481 ' CG2' HD11 ' A' ' 99' ' ' LEU . 46.9 t -59.76 123.07 11.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 120.688 -1.258 . . . . 0.0 109.013 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.57 ' HB ' ' CG ' ' A' ' 35' ' ' ARG . 53.2 t -96.95 -25.08 4.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.583 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 4.9 tttt -158.93 133.9 8.26 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -52.33 159.55 0.96 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.645 0.736 . . . . 0.0 111.186 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.568 HD13 ' CA ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -51.82 133.24 13.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.514 0.673 . . . . 0.0 110.202 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.521 ' O ' ' CG2' ' A' ' 32' ' ' ILE . . . -105.74 169.91 8.2 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 0.4 OUTLIER -117.32 123.17 45.87 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.883 -1.135 . . . . 0.0 110.55 -179.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.457 ' OG1' ' OG1' ' A' ' 31' ' ' THR . 5.1 p -78.47 -175.71 4.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.402 -0.811 . . . . 0.0 109.808 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -100.25 34.54 2.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.186 -0.946 . . . . 0.0 110.058 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -140.64 8.57 2.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.247 -0.908 . . . . 0.0 110.434 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.38 -3.5 58.01 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.588 ' CG2' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -91.74 -176.39 4.45 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -1.167 . . . . 0.0 110.262 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -142.23 168.53 14.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.591 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.53 ' CG1' ' HB3' ' A' ' 78' ' ' ASN . 93.4 t -131.83 126.17 56.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 C-N-CA 118.71 -1.196 . . . . 0.0 111.995 -178.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.597 ' CD1' ' CG1' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -109.27 115.84 50.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.309 -0.869 . . . . 0.0 109.852 178.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.583 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 1.4 ttm180 -99.13 120.48 39.56 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.597 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.4 m -147.38 158.14 9.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.326 -0.859 . . . . 0.0 108.919 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 74' ' ' ASP 0.252 0.3 OUTLIER -105.65 125.22 50.74 Favored 'General case' 0 C--N 1.272 -2.796 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.291 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.499 ' O ' ' O ' ' A' ' 73' ' ' LYS . 2.1 t80 -60.1 124.12 19.27 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 119.07 -1.052 . . . . 0.0 110.289 -178.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 17' ' ' LYS . 21.4 mm-40 -112.23 92.05 3.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.874 . . . . 0.0 109.872 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.534 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 164.47 -151.05 19.98 Favored Glycine 0 N--CA 1.486 1.97 0 C-N-CA 119.404 -1.379 . . . . 0.0 109.858 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.449 ' O ' ' OH ' ' A' ' 38' ' ' TYR . 4.4 m-20 -112.4 125.07 53.8 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.5 -1.0 . . . . 0.0 110.48 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 43' ' ' SER . . . 177.66 -27.92 0.06 OUTLIER Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.504 -1.332 . . . . 0.0 110.614 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.609 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.7 OUTLIER 48.56 -153.92 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 120.723 -1.457 . . . . 0.0 107.594 -179.421 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.609 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 53.6 Cg_exo -46.81 94.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.198 0 N-CA-C 108.385 -1.429 . . . . 0.0 108.385 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -150.47 172.67 15.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.582 -0.699 . . . . 0.0 110.063 -177.696 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.518 ' CD ' ' HB2' ' A' ' 67' ' ' ASN . 22.0 mtmt -81.09 175.71 10.43 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.236 -0.915 . . . . 0.0 112.102 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.62 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 15.7 mm -124.26 127.48 25.3 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.62 -0.675 . . . . 0.0 111.427 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.602 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 38.3 Cg_exo -63.86 144.13 87.64 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.048 1.551 . . . . 0.0 110.42 178.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.586 ' CD2' HD23 ' A' ' 63' ' ' LEU . 9.6 t80 -151.83 160.28 43.6 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.259 -0.901 . . . . 0.0 110.286 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.521 ' O ' ' CD1' ' A' ' 91' ' ' ILE . 0.9 OUTLIER -175.2 98.78 0.08 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.214 -0.929 . . . . 0.0 109.532 179.569 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.49 ' CG2' ' O ' ' A' ' 51' ' ' ILE . 64.0 mt . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.15 -0.969 . . . . 0.0 111.37 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.499 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -131.57 155.46 47.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -1.156 . . . . 0.0 110.36 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.586 HD23 ' CD2' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -115.1 116.33 28.24 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.221 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.588 ' CD1' ' CG2' ' A' ' 31' ' ' THR . 1.7 mp -80.07 -27.35 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.63 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.259 1.2 m -98.47 34.08 2.09 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.062 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.548 ' O ' ' ND2' ' A' ' 67' ' ' ASN . 40.6 t -26.62 145.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.526 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.548 ' ND2' ' O ' ' A' ' 66' ' ' VAL . 4.0 p30 39.81 53.12 5.06 Favored Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 121.778 -0.576 . . . . 0.0 111.475 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.533 ' O ' HG12 ' A' ' 69' ' ' ILE . 1.8 Cg_endo -55.41 154.69 23.18 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 N-CA-C 108.758 -1.285 . . . . 0.0 108.758 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 68' ' ' PRO . 0.7 OUTLIER -141.45 146.47 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 119.049 -1.061 . . . . 0.0 112.819 -177.667 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.62 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 95.7 t -92.75 167.63 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.523 ' N ' HG13 ' A' ' 70' ' ' VAL . 3.1 m -118.74 -21.93 7.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.735 -1.228 . . . . 0.0 111.033 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.517 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 4.0 mt-10 -138.06 19.19 2.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.956 -1.09 . . . . 0.0 110.991 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.523 ' CD ' ' O ' ' A' ' 40' ' ' GLY . 0.3 OUTLIER 72.64 -7.34 1.44 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.398 -0.814 . . . . 0.0 111.11 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.475 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 6.1 t0 -137.43 0.33 2.28 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.864 -1.147 . . . . 0.0 110.451 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.466 ' O ' HG21 ' A' ' 77' ' ' VAL . 32.9 t -73.06 108.39 4.49 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.166 -0.959 . . . . 0.0 109.613 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.504 ' HB3' ' CG2' ' A' ' 21' ' ' VAL . 3.4 Cg_endo -51.57 110.51 0.43 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.735 1.387 . . . . 0.0 109.672 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 88.8 t -99.41 143.45 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.326 -0.859 . . . . 0.0 111.741 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.592 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 3.6 m-80 -98.17 130.97 44.91 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.569 HG22 ' CE1' ' A' ' 49' ' ' PHE . 5.8 mt -108.81 114.33 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.067 -1.646 . . . . 0.0 111.71 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.563 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 3.4 tt0 -84.23 115.29 22.37 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.676 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.537 ' CB ' HD22 ' A' ' 63' ' ' LEU . . . -137.85 152.61 49.24 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.987 -1.071 . . . . 0.0 110.919 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 62' ' ' ARG . 34.9 tt0 -100.82 101.24 14.98 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.366 -0.834 . . . . 0.0 110.308 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.532 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 43.2 Cg_endo -73.23 134.08 20.48 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.036 1.545 . . . . 0.0 110.381 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 83' ' ' PRO . 34.3 Cg_exo . . . . . 0 C--N 1.306 -1.71 0 O-C-N 123.923 1.486 . . . . 0.0 110.101 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.564 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 2.0 m-30 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.181 0.515 . . . . 0.0 110.009 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.535 HG21 ' CZ ' ' A' ' 49' ' ' PHE . 1.6 mp -74.32 121.87 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.141 -0.975 . . . . 0.0 109.346 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.521 ' CD1' ' O ' ' A' ' 50' ' ' GLU . 1.9 mp -100.03 148.25 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.047 -1.033 . . . . 0.0 110.143 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.56 ' CD1' HG21 ' A' ' 34' ' ' ILE . 1.6 mt -134.05 145.54 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.454 -0.779 . . . . 0.0 109.907 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.548 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 80.04 -161.03 45.15 Favored Glycine 0 N--CA 1.481 1.642 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.547 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -122.15 150.48 25.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 O-C-N 121.366 -1.079 . . . . 0.0 110.064 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.571 ' O ' ' N ' ' A' ' 97' ' ' GLY . 5.4 mt-10 -20.68 -56.95 0.07 OUTLIER Pre-proline 0 N--CA 1.5 2.04 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 9.2 Cg_endo -54.71 68.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 124.066 1.561 . . . . 0.0 111.963 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 94.33 6.57 61.26 Favored Glycine 0 N--CA 1.495 2.612 0 O-C-N 120.951 -1.093 . . . . 0.0 111.026 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.501 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -55.64 161.58 2.02 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.933 -1.334 . . . . 0.0 109.993 179.811 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' A' ' 18' ' ' PHE . 12.8 mt -99.26 177.43 5.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.234 -0.916 . . . . 0.0 110.963 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.431 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 4.3 ttpt -154.8 138.51 16.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.57 -0.706 . . . . 0.0 109.953 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.501 HD21 ' CD1' ' A' ' 34' ' ' ILE . 4.9 mp -143.43 124.58 14.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.136 -0.978 . . . . 0.0 110.36 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 8.7 p-10 -92.12 130.61 37.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.357 -0.839 . . . . 0.0 110.596 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.535 ' CZ3' HG23 ' A' ' 24' ' ' ILE . 38.2 t-105 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.884 . . . . 0.0 109.998 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.58 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 30.8 m . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 121.337 0.589 . . . . 0.0 109.575 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.491 ' O ' ' O ' ' A' ' 16' ' ' GLY . 3.4 p -87.84 -8.08 56.37 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.375 -0.828 . . . . 0.0 111.711 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.545 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -60.33 -131.55 0.01 OUTLIER Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.522 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -134.37 -178.91 5.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.02 -1.282 . . . . 0.0 109.822 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.596 ' CE1' HG22 ' A' ' 47' ' ' ILE . 44.1 m-85 -138.01 142.62 40.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.894 -1.129 . . . . 0.0 111.851 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.471 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 31.9 ttpt -110.4 117.92 34.89 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.515 ' CG2' HD12 ' A' ' 99' ' ' LEU . 60.6 t -59.56 124.23 13.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 120.666 -1.271 . . . . 0.0 109.459 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.548 ' HB ' ' CG ' ' A' ' 35' ' ' ARG . 83.3 t -96.27 -27.09 4.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.567 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 0.2 OUTLIER -154.31 138.06 16.16 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.332 177.11 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.54 158.43 4.45 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.383 0.611 . . . . 0.0 110.364 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.561 HD13 ' CB ' ' A' ' 34' ' ' ILE . 0.7 OUTLIER -55.4 130.64 17.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.051 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 32' ' ' ILE . . . -108.65 168.74 9.12 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 12.9 pt-20 -113.87 134.94 54.49 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.786 -1.196 . . . . 0.0 110.479 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.534 ' CG2' ' OE2' ' A' ' 80' ' ' GLU . 16.5 p -90.52 -172.67 3.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.5 -0.75 . . . . 0.0 110.278 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -95.91 4.41 52.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.269 -0.895 . . . . 0.0 110.419 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -106.67 6.82 30.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.201 -0.937 . . . . 0.0 110.223 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.53 7.64 61.62 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.548 ' CG2' HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -97.48 -171.95 2.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -1.092 . . . . 0.0 110.457 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.565 HG21 ' CD1' ' A' ' 103' ' ' TRP . 0.0 OUTLIER -142.69 147.21 21.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.485 ' N ' ' O ' ' A' ' 25' ' ' ALA . 66.8 t -111.64 134.79 52.91 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 O-C-N 121.346 -0.846 . . . . 0.0 112.08 -177.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.607 ' CD1' ' CG1' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -120.95 118.76 57.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 121.409 -0.807 . . . . 0.0 109.988 179.11 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.567 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -100.07 122.99 43.8 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 119.026 -1.07 . . . . 0.0 108.34 179.23 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.607 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.3 m -149.0 158.52 6.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.175 -0.953 . . . . 0.0 109.053 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 74' ' ' ASP 0.256 1.8 tt0 -107.61 126.74 52.94 Favored 'General case' 0 C--N 1.27 -2.848 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.503 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.529 ' O ' ' O ' ' A' ' 73' ' ' LYS . 1.9 t80 -59.18 125.46 23.68 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.182 -178.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 17' ' ' LYS . 5.2 mm-40 -111.85 87.96 2.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.18 -0.95 . . . . 0.0 109.715 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.545 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 164.65 -150.58 18.85 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.456 ' O ' ' OH ' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -117.82 137.02 53.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.594 -0.945 . . . . 0.0 110.496 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 43' ' ' SER . . . 173.32 -24.76 0.08 OUTLIER Glycine 0 N--CA 1.488 2.109 0 C-N-CA 119.649 -1.262 . . . . 0.0 110.641 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.599 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.4 OUTLIER 49.36 -156.54 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 120.732 -1.452 . . . . 0.0 107.813 -179.501 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.599 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 50.8 Cg_exo -48.15 94.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.318 0 N-CA-C 107.951 -1.596 . . . . 0.0 107.951 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.58 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -148.06 173.62 12.74 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.633 -0.667 . . . . 0.0 109.333 -177.584 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.542 ' HG3' ' CD1' ' A' ' 69' ' ' ILE . 0.3 OUTLIER -88.6 173.84 8.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.0 -1.062 . . . . 0.0 111.78 -178.73 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.604 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 19.2 mm -124.18 129.64 24.65 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.64 -0.662 . . . . 0.0 112.033 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.593 ' HD2' ' CE2' ' A' ' 18' ' ' PHE . 36.8 Cg_exo -63.71 147.82 92.42 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 124.05 1.552 . . . . 0.0 111.034 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.647 ' CE2' ' CG2' ' A' ' 79' ' ' ILE . 11.0 t80 -155.51 157.6 37.16 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.324 -0.86 . . . . 0.0 110.552 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.488 ' HG2' ' CD1' ' A' ' 91' ' ' ILE . 22.4 tt0 -175.72 95.91 0.07 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.147 -0.971 . . . . 0.0 110.306 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.533 HD12 ' CB ' ' A' ' 81' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.313 -0.867 . . . . 0.0 109.74 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.535 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -150.34 163.49 38.21 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.271 -1.134 . . . . 0.0 109.496 179.749 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.583 ' CD2' ' CB ' ' A' ' 81' ' ' ALA . 11.1 mt -123.6 121.2 34.96 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 118.639 -1.224 . . . . 0.0 110.408 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.548 HG12 ' CG2' ' A' ' 31' ' ' THR . 4.1 mm -83.34 -29.32 7.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.585 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.267 1.9 m -99.37 35.87 1.86 Allowed 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 63' ' ' LEU . 44.7 t -37.79 155.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-O 121.489 0.662 . . . . 0.0 110.995 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.53 ' HB2' ' CD ' ' A' ' 46' ' ' LYS . 24.3 p30 36.46 53.97 2.56 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 122.065 -0.397 . . . . 0.0 111.378 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.59 ' CB ' ' CD1' ' A' ' 79' ' ' ILE . 15.7 Cg_exo -55.05 161.56 6.44 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 N-CA-C 108.472 -1.395 . . . . 0.0 108.472 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.542 ' CD1' ' HG3' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -142.79 145.8 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 118.844 -1.143 . . . . 0.0 112.813 -178.431 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.604 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 55.8 t -101.38 160.59 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 176.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.47 ' N ' HG11 ' A' ' 70' ' ' VAL . 2.8 m -116.09 -19.48 10.28 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.653 -1.279 . . . . 0.0 111.326 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 3.2 mt-10 -137.61 14.71 2.94 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.831 -1.168 . . . . 0.0 111.272 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.529 ' O ' ' O ' ' A' ' 38' ' ' TYR . 3.2 mtmt 75.11 -11.3 1.09 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.517 -0.739 . . . . 0.0 111.03 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.463 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 6.4 t0 -133.67 0.92 3.32 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.979 -1.076 . . . . 0.0 110.204 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.437 ' HA ' ' HD2' ' A' ' 76' ' ' PRO . 25.1 t -72.83 108.76 4.87 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.202 -0.937 . . . . 0.0 109.528 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 74' ' ' ASP . 4.2 Cg_endo -52.16 113.59 1.26 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.766 1.403 . . . . 0.0 109.921 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 62.0 t -99.35 153.67 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.268 -0.895 . . . . 0.0 110.982 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.596 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.3 m-20 -112.39 133.11 54.66 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.647 ' CG2' ' CE2' ' A' ' 49' ' ' PHE . 7.2 mm -115.47 121.86 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.1 -1.625 . . . . 0.0 111.588 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.534 ' OE2' ' CG2' ' A' ' 27' ' ' THR . 1.0 OUTLIER -99.15 106.59 18.79 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.681 -0.637 . . . . 0.0 109.815 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.583 ' CB ' ' CD2' ' A' ' 63' ' ' LEU . . . -123.2 156.25 35.49 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.989 -1.069 . . . . 0.0 111.178 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 62' ' ' ARG . 4.7 tt0 -101.64 101.03 15.83 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.632 -0.668 . . . . 0.0 110.283 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.537 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 23.3 Cg_endo -67.82 151.22 78.72 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 124.045 1.55 . . . . 0.0 110.467 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.535 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 15.2 Cg_endo . . . . . 0 C--N 1.305 -1.716 0 O-C-N 124.047 1.551 . . . . 0.0 110.337 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.486 ' CE1' ' ND2' ' A' ' 102' ' ' ASN . 10.2 m-85 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.222 0.534 . . . . 0.0 110.163 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.524 HD11 ' CD1' ' A' ' 32' ' ' ILE . 1.6 mp -74.16 111.47 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.152 -0.968 . . . . 0.0 109.381 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.488 ' CD1' ' HG2' ' A' ' 50' ' ' GLU . 33.7 mt -92.23 146.8 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.243 -0.911 . . . . 0.0 110.435 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.546 ' CD1' HG21 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -134.71 137.1 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.617 -0.677 . . . . 0.0 109.54 -179.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.509 ' O ' ' HB2' ' A' ' 48' ' ' PRO . . . 85.91 -162.6 35.77 Favored Glycine 0 N--CA 1.482 1.735 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.56 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -120.27 147.92 23.71 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 O-C-N 121.146 -1.208 . . . . 0.0 110.179 -179.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.579 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.8 mt-10 -16.86 -58.31 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.149 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 6.9 Cg_endo -51.07 72.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 124.164 1.613 . . . . 0.0 111.992 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 89.36 -1.78 82.53 Favored Glycine 0 N--CA 1.494 2.551 0 O-C-N 121.032 -1.042 . . . . 0.0 110.809 178.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.486 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -45.83 159.3 0.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.986 -1.302 . . . . 0.0 110.042 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 18' ' ' PHE . 10.2 mt -96.06 173.26 7.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 110.6 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.454 ' HG3' HG12 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -154.57 131.03 10.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.388 -0.82 . . . . 0.0 110.007 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.513 HD22 ' CG1' ' A' ' 34' ' ' ILE . 5.5 mp -134.33 121.46 21.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 0.0 110.432 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.486 ' ND2' ' CE1' ' A' ' 89' ' ' TYR . 5.6 t-20 -89.78 130.94 35.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.285 -0.884 . . . . 0.0 110.141 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.565 ' CD1' HG21 ' A' ' 32' ' ' ILE . 10.7 t-105 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.227 -0.921 . . . . 0.0 110.205 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.584 ' HB3' ' CE1' ' A' ' 38' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.489 ' O ' ' O ' ' A' ' 16' ' ' GLY . 1.2 p -68.74 -5.65 21.78 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.479 -0.763 . . . . 0.0 111.755 -178.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.514 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -59.3 -149.74 0.01 OUTLIER Glycine 0 N--CA 1.48 1.623 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.563 ' CG ' ' CA ' ' A' ' 97' ' ' GLY . 1.4 tmpt? -123.61 160.77 26.38 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.37 -1.076 . . . . 0.0 108.929 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.595 ' CE1' ' HD2' ' A' ' 48' ' ' PRO . 34.5 m-85 -118.76 137.55 53.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.497 -1.377 . . . . 0.0 112.144 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.504 ' HE2' ' NE2' ' A' ' 37' ' ' GLN . 7.7 ttpp -109.21 119.33 39.2 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.703 -0.623 . . . . 0.0 109.435 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.417 ' HA ' HG11 ' A' ' 36' ' ' VAL . 27.4 t -59.46 129.54 21.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 120.709 -1.244 . . . . 0.0 108.836 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.528 ' CG2' ' HB2' ' A' ' 37' ' ' GLN . 64.3 t -104.75 -24.75 3.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.546 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 15.3 tttt -159.91 134.6 7.76 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 177.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -52.6 155.02 2.36 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.6 0.714 . . . . 0.0 111.094 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.574 HD12 ' CA ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -47.87 133.85 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.967 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.522 ' O ' ' CG2' ' A' ' 32' ' ' ILE . . . -106.84 173.33 6.37 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.5 pm0 -116.98 126.11 52.41 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.905 -1.122 . . . . 0.0 110.582 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.47 ' OG1' ' OG1' ' A' ' 31' ' ' THR . 11.9 p -79.85 -163.74 0.57 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.355 -0.841 . . . . 0.0 110.035 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -110.44 31.56 5.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 109.874 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -139.84 10.36 2.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.344 -0.848 . . . . 0.0 110.447 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.85 -1.44 59.65 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.584 ' CG2' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -91.81 -175.46 4.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -1.117 . . . . 0.0 110.269 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -142.93 165.98 15.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.505 ' O ' ' N ' ' A' ' 25' ' ' ALA . 93.7 t -130.26 125.87 60.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 120.724 -1.235 . . . . 0.0 112.44 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.615 ' O ' ' HA ' ' A' ' 78' ' ' ASN . 0.3 OUTLIER -106.51 116.68 50.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.363 -0.836 . . . . 0.0 109.566 178.803 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.546 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 3.4 ttm180 -101.49 120.07 39.74 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.595 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.8 m -140.69 -173.68 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.528 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 1.9 tt0 -133.89 124.57 26.66 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.584 ' CE1' ' HB3' ' A' ' 14' ' ' CYS . 89.3 t80 -61.32 140.64 57.95 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.368 -1.333 . . . . 0.0 110.527 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 17' ' ' LYS . 3.3 mm-40 -134.74 83.34 2.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.491 -0.756 . . . . 0.0 109.805 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.514 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 174.0 -147.07 9.09 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.483 ' HA ' ' HD2' ' A' ' 73' ' ' LYS . 50.0 t0 -113.93 132.79 55.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.627 -0.925 . . . . 0.0 110.38 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.453 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . 165.01 -24.7 0.17 Allowed Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.726 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.608 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.5 OUTLIER 49.24 -156.13 0.01 OUTLIER Pre-proline 0 N--CA 1.487 1.395 0 O-C-N 120.598 -1.531 . . . . 0.0 108.105 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.608 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 74.6 Cg_exo -44.02 96.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.35 0 N-CA-C 109.283 -1.083 . . . . 0.0 109.283 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.522 ' O ' HG22 ' A' ' 69' ' ' ILE . 24.5 p -143.34 169.31 17.89 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.634 -0.666 . . . . 0.0 110.134 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.6 ' CG ' ' CD1' ' A' ' 69' ' ' ILE . 0.5 OUTLIER -83.86 172.74 11.86 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.411 -0.806 . . . . 0.0 110.358 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.597 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 15.8 mm -114.76 126.6 27.71 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 111.957 -177.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.595 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 33.8 Cg_exo -63.02 144.6 93.23 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.993 1.523 . . . . 0.0 110.846 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.636 ' CD1' ' CD2' ' A' ' 63' ' ' LEU . 3.9 t80 -154.29 153.11 31.13 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.537 -0.727 . . . . 0.0 109.678 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.501 ' HB3' ' HB ' ' A' ' 91' ' ' ILE . 19.3 tp10 -166.37 98.06 0.59 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.928 -1.107 . . . . 0.0 110.546 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.433 ' CD1' ' HB2' ' A' ' 81' ' ' ALA . 4.8 mt . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.29 -0.881 . . . . 0.0 109.821 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.525 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -143.25 169.35 17.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -1.143 . . . . 0.0 110.373 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.636 ' CD2' ' CD1' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -120.89 121.26 37.68 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.479 179.39 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.584 ' CD1' ' CG2' ' A' ' 31' ' ' THR . 1.4 mp -85.53 -27.79 6.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 106.735 -1.579 . . . . 0.0 106.735 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.584 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.254 2.3 m -110.93 39.79 2.17 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.283 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.541 ' CG2' ' HB3' ' A' ' 63' ' ' LEU . 6.8 t -25.9 121.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 CA-C-O 121.711 0.767 . . . . 0.0 111.813 -178.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.561 ' ND2' ' HB3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER 41.8 69.96 1.88 Allowed Pre-proline 0 C--N 1.297 -1.696 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.77 178.537 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.53 ' O ' ' N ' ' A' ' 47' ' ' ILE . 1.2 Cg_endo -55.6 -171.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.725 1.382 . . . . 0.0 108.826 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.6 ' CD1' ' CG ' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -143.53 145.62 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 118.926 -1.109 . . . . 0.0 112.44 -179.409 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.597 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 60.1 t -97.86 162.12 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 176.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.477 ' N ' HG11 ' A' ' 70' ' ' VAL . 2.6 m -117.26 -17.21 10.24 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.666 -1.213 . . . . 0.0 111.351 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.54 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 15.4 mt-10 -142.03 16.87 2.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.875 -1.141 . . . . 0.0 111.054 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.1 OUTLIER 75.71 -12.71 0.96 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.48 -0.763 . . . . 0.0 110.97 179.745 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.479 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 12.5 t70 -133.41 -1.94 3.13 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.051 -1.031 . . . . 0.0 110.234 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.2 t -71.97 112.27 13.77 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.246 -0.909 . . . . 0.0 108.69 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.571 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 42.7 Cg_exo -49.03 126.29 14.89 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.9 1.473 . . . . 0.0 110.387 -178.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.2 t -115.65 143.37 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.072 -1.018 . . . . 0.0 111.254 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.615 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 1.5 m-20 -104.74 136.18 44.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.412 -0.805 . . . . 0.0 109.562 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.634 ' CG2' ' CE2' ' A' ' 49' ' ' PHE . 7.3 mt -115.41 116.94 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.134 -1.604 . . . . 0.0 111.552 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.566 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 3.8 tt0 -88.06 114.0 24.25 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.455 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.515 ' O ' HG13 ' A' ' 32' ' ' ILE . . . -132.77 149.32 52.29 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.943 -1.098 . . . . 0.0 110.915 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 62' ' ' ARG . 2.8 tp10 -99.99 99.15 8.6 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.305 -0.872 . . . . 0.0 110.196 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.52 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 21.9 Cg_endo -66.21 152.6 80.73 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.064 1.56 . . . . 0.0 110.494 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.525 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 17.8 Cg_endo . . . . . 0 C--N 1.305 -1.716 0 O-C-N 123.993 1.522 . . . . 0.0 110.241 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.42 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 2.9 m-85 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.154 0.502 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.579 HG22 ' CE1' ' A' ' 49' ' ' PHE . 11.0 mt -74.33 138.7 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.267 -0.896 . . . . 0.0 109.67 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.501 ' HB ' ' HB3' ' A' ' 50' ' ' GLU . 14.6 mt -98.83 150.11 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.051 -1.031 . . . . 0.0 110.216 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.545 ' CD1' HG23 ' A' ' 34' ' ' ILE . 0.6 OUTLIER -138.61 142.73 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.49 -0.756 . . . . 0.0 109.928 -179.506 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.549 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 80.03 -157.15 40.84 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.58 ' N ' ' HB2' ' A' ' 98' ' ' GLN . 0.8 OUTLIER -129.08 157.33 41.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 121.077 -1.249 . . . . 0.0 110.023 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.524 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 4.0 mt-10 -33.05 -54.62 0.63 Allowed Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.635 -0.666 . . . . 0.0 110.442 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 62.0 Cg_exo -44.31 -37.94 10.82 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.154 1.607 . . . . 0.0 110.458 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.563 ' CA ' ' CG ' ' A' ' 17' ' ' LYS . . . -157.17 53.22 0.4 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.58 ' HB2' ' N ' ' A' ' 94' ' ' VAL . 0.6 OUTLIER -109.62 149.39 29.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.04 -1.271 . . . . 0.0 111.0 -178.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.539 ' CD1' HG21 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -119.88 -163.05 0.96 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.197 -0.94 . . . . 0.0 109.869 178.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -146.49 153.72 40.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.519 -0.738 . . . . 0.0 110.284 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.525 ' CD1' HG13 ' A' ' 34' ' ' ILE . 1.1 mt -138.26 113.12 9.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.922 . . . . 0.0 110.162 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -87.36 130.5 34.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.869 . . . . 0.0 110.459 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.52 ' CE3' HG22 ' A' ' 24' ' ' ILE . 53.2 t-105 . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.336 -0.852 . . . . 0.0 110.073 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.577 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 31.1 m . . . . . 0 N--CA 1.488 1.452 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.511 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 77.6 p -101.14 -4.72 26.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.159 -0.963 . . . . 0.0 111.764 -178.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.541 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -60.13 -124.14 0.01 OUTLIER Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 39' ' ' GLU . 1.5 ttpt -134.74 154.7 51.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.043 -1.269 . . . . 0.0 109.774 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.597 ' CE1' ' HD2' ' A' ' 48' ' ' PRO . 37.2 m-85 -118.25 137.84 52.76 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.805 -1.185 . . . . 0.0 111.768 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -107.95 119.53 39.71 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.548 -0.72 . . . . 0.0 109.274 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.519 ' CG2' HD12 ' A' ' 99' ' ' LEU . 43.4 t -60.12 124.76 15.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 120.736 -1.228 . . . . 0.0 109.364 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.556 ' HB ' ' CG ' ' A' ' 35' ' ' ARG . 88.6 t -95.35 -27.02 4.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.649 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 5.1 tttp -159.26 133.51 7.69 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -48.59 160.31 0.18 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.569 0.699 . . . . 0.0 111.367 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.568 HG12 HG12 ' A' ' 34' ' ' ILE . 0.6 OUTLIER -56.53 133.13 20.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-O 121.662 0.744 . . . . 0.0 110.193 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 33' ' ' VAL . . . -108.58 169.72 8.47 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.7 pm0 -115.09 134.37 55.23 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.556 -1.34 . . . . 0.0 110.591 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.522 ' CG2' ' OE2' ' A' ' 80' ' ' GLU . 16.1 p -92.42 171.92 8.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.44 -0.788 . . . . 0.0 110.255 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -86.98 26.78 1.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.213 -0.929 . . . . 0.0 110.529 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.93 6.82 5.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.237 -0.915 . . . . 0.0 110.192 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.93 5.81 59.54 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.539 HG21 ' CA ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -101.78 178.42 4.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -1.124 . . . . 0.0 110.427 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.539 ' CD1' ' HG3' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -134.76 153.02 34.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.481 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 25' ' ' ALA . 48.5 t -117.96 132.13 68.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 C-N-CA 119.167 -1.013 . . . . 0.0 112.076 -177.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.6 ' CD1' ' CG1' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -117.76 119.98 63.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.327 -0.858 . . . . 0.0 110.009 179.128 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.649 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -102.45 124.04 47.29 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.241 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.6 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.2 m -147.7 161.93 7.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.157 -0.964 . . . . 0.0 108.834 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.513 ' NE2' ' OD2' ' A' ' 74' ' ' ASP 0.271 12.5 tt0 -107.37 122.93 47.59 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -178.588 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.561 ' CE1' ' HB3' ' A' ' 14' ' ' CYS . 12.9 t80 -62.71 122.12 15.1 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 118.814 -1.154 . . . . 0.0 110.282 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 17' ' ' LYS . 2.7 mm-40 -115.87 98.61 6.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 110.019 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.541 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 160.16 -151.97 22.69 Favored Glycine 0 N--CA 1.486 2.005 0 C-N-CA 119.282 -1.437 . . . . 0.0 110.074 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 1.5 m-20 -105.85 106.37 16.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.704 -0.88 . . . . 0.0 109.954 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 43' ' ' SER . . . -165.32 -41.51 0.02 OUTLIER Glycine 0 N--CA 1.489 2.175 0 C-N-CA 119.539 -1.315 . . . . 0.0 110.394 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.63 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 1.0 OUTLIER 49.3 -150.23 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.366 0 O-C-N 120.869 -1.371 . . . . 0.0 107.485 -179.442 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.63 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 51.7 Cg_exo -47.83 92.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -1.022 0 N-CA-C 108.431 -1.411 . . . . 0.0 108.431 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.577 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -153.91 173.98 15.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.683 -0.636 . . . . 0.0 109.396 -177.78 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.586 ' CG ' ' CD1' ' A' ' 69' ' ' ILE . 14.9 mttp -85.18 174.94 9.27 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.287 -0.883 . . . . 0.0 111.594 -178.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.61 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 14.5 mm -123.06 128.72 25.23 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.401 -0.812 . . . . 0.0 111.936 -178.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.597 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 37.7 Cg_exo -63.68 145.03 90.83 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.58 1.52 . . . . 0.0 111.24 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.632 ' CD2' ' CD2' ' A' ' 63' ' ' LEU . 10.6 t80 -155.46 146.1 22.14 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.407 -0.808 . . . . 0.0 110.434 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.584 ' CG ' ' CG2' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -156.84 111.22 2.73 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.006 -1.059 . . . . 0.0 110.367 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.448 ' CD1' ' HB1' ' A' ' 81' ' ' ALA . 5.7 mt . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.184 -0.947 . . . . 0.0 110.296 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.53 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.474 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -129.13 162.34 27.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -1.138 . . . . 0.0 110.408 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.632 ' CD2' ' CD2' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -124.51 112.7 17.18 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.45 -0.781 . . . . 0.0 109.609 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.539 ' CB ' ' HG2' ' A' ' 80' ' ' GLU . 7.2 mm -72.23 -27.38 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 122.351 1.072 . . . . 0.0 108.287 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.647 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.258 0.8 OUTLIER -109.13 32.2 5.12 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.534 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.559 ' C ' ' O ' ' A' ' 65' ' ' THR . 33.6 t -14.99 112.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.817 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.526 ' ND2' ' HD3' ' A' ' 46' ' ' LYS . 14.5 t-20 44.71 69.13 2.67 Favored Pre-proline 0 C--N 1.297 -1.688 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.699 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.53 ' HG3' ' CG2' ' A' ' 65' ' ' THR . 6.3 Cg_exo -48.95 -178.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 124.246 1.656 . . . . 0.0 109.484 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.586 ' CD1' ' CG ' ' A' ' 46' ' ' LYS . 0.9 OUTLIER -140.7 139.37 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 118.971 -1.092 . . . . 0.0 112.241 -178.831 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.61 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 47.3 t -92.23 172.53 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 176.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.472 ' O ' ' HD3' ' A' ' 44' ' ' PRO . 22.9 m -122.13 -24.04 5.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.769 -1.207 . . . . 0.0 110.968 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.592 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 3.9 mm-40 -130.09 -46.78 1.12 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.015 -1.053 . . . . 0.0 110.032 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.592 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.1 OUTLIER 155.59 -61.46 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.513 ' OD2' ' NE2' ' A' ' 37' ' ' GLN . 2.4 t0 -89.65 12.9 15.5 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.207 -0.933 . . . . 0.0 110.371 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.463 ' HB3' HG11 ' A' ' 70' ' ' VAL . 48.0 t -72.65 108.95 5.03 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.149 -0.969 . . . . 0.0 108.821 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 74' ' ' ASP . 9.7 Cg_endo -56.95 113.8 1.63 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.829 1.436 . . . . 0.0 110.469 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 57.7 t -102.8 148.14 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.377 -0.827 . . . . 0.0 110.937 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.597 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 1.9 m-20 -106.22 138.2 42.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.322 -0.861 . . . . 0.0 109.981 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.581 HG22 ' CD1' ' A' ' 49' ' ' PHE . 4.5 mt -118.09 119.51 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 117.778 -1.569 . . . . 0.0 111.41 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.539 ' HG2' ' CB ' ' A' ' 64' ' ' ILE . 1.7 tp10 -94.01 110.2 21.9 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.509 ' CB ' HD23 ' A' ' 63' ' ' LEU . . . -124.31 147.49 48.11 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.069 -1.019 . . . . 0.0 111.011 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.539 ' CA ' HG21 ' A' ' 31' ' ' THR . 23.6 tt0 -107.61 94.7 12.47 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.597 -0.689 . . . . 0.0 110.617 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.539 ' HG3' ' CD1' ' A' ' 32' ' ' ILE . 40.3 Cg_endo -72.51 153.88 55.16 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.971 1.511 . . . . 0.0 110.219 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.53 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 10.8 Cg_endo . . . . . 0 C--N 1.305 -1.727 0 O-C-N 123.963 1.507 . . . . 0.0 110.159 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.52 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 4.1 m-85 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.197 0.522 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.525 ' O ' ' N ' ' A' ' 101' ' ' LEU . 12.7 mm -74.74 108.87 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.159 -0.963 . . . . 0.0 109.477 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.584 ' CG2' ' CG ' ' A' ' 50' ' ' GLU . 32.5 mt -100.98 154.22 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.92 -1.112 . . . . 0.0 110.004 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.559 ' O ' ' N ' ' A' ' 99' ' ' LEU . 2.7 mt -140.28 150.61 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.258 -0.901 . . . . 0.0 110.447 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.539 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 77.65 -157.1 45.34 Favored Glycine 0 N--CA 1.485 1.9 0 C-N-CA 119.319 -1.42 . . . . 0.0 109.658 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.559 ' O ' ' N ' ' A' ' 98' ' ' GLN . 0.2 OUTLIER -130.36 157.08 42.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.116 -1.226 . . . . 0.0 110.318 -179.596 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.515 ' C ' ' O ' ' A' ' 94' ' ' VAL . 1.0 OUTLIER -30.47 -55.71 0.36 Allowed Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.847 -0.533 . . . . 0.0 110.723 -179.739 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.515 ' CD ' ' CB ' ' A' ' 95' ' ' GLU . 76.4 Cg_exo -41.02 -40.58 3.88 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 124.055 1.555 . . . . 0.0 110.615 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.539 ' HA3' ' CG ' ' A' ' 17' ' ' LYS . . . -160.76 50.95 0.35 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.559 ' N ' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -94.56 149.5 21.18 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.976 -1.308 . . . . 0.0 110.903 -178.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.559 ' N ' ' O ' ' A' ' 92' ' ' ILE . 13.7 mt -94.44 177.74 5.84 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.553 -0.717 . . . . 0.0 109.941 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.461 ' HG3' HG12 ' A' ' 91' ' ' ILE . 0.4 OUTLIER -148.21 119.91 8.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.396 -0.815 . . . . 0.0 111.123 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.527 ' CD2' HG12 ' A' ' 24' ' ' ILE . 7.3 mp -128.81 -164.52 1.4 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 102' ' ' ASN . 14.5 p-10 -179.05 151.11 0.49 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.843 -1.161 . . . . 0.0 110.931 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.496 ' HA ' ' CE3' ' A' ' 103' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 110.047 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.59 ' HB3' ' CE1' ' A' ' 38' ' ' TYR . 22.9 m . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 121.336 0.589 . . . . 0.0 109.572 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.5 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 10.6 t -92.36 -7.95 46.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.357 -0.84 . . . . 0.0 111.564 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.531 ' HA3' ' CA ' ' A' ' 40' ' ' GLY . . . -60.52 -118.19 0.01 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.542 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -140.15 174.75 10.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.952 -1.323 . . . . 0.0 110.235 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.593 ' CE1' ' HD2' ' A' ' 48' ' ' PRO . 37.7 m-85 -134.84 138.59 44.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.038 -1.039 . . . . 0.0 111.406 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.478 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 2.9 ttpt -106.53 116.92 32.76 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.425 -0.797 . . . . 0.0 109.175 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.521 ' CG2' HD13 ' A' ' 99' ' ' LEU . 46.3 t -59.58 125.12 15.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 120.625 -1.297 . . . . 0.0 109.647 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.555 ' HB ' ' CG ' ' A' ' 35' ' ' ARG . 80.3 t -97.03 -28.23 3.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.558 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -153.38 137.72 16.64 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.236 177.178 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -56.08 158.77 3.74 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.3 0.572 . . . . 0.0 110.285 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.559 HD11 ' CB ' ' A' ' 34' ' ' ILE . 0.7 OUTLIER -55.6 130.35 17.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.274 -0.971 . . . . 0.0 109.795 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 32' ' ' ILE . . . -108.18 168.11 9.53 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 12.3 pt-20 -112.69 132.43 55.2 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.782 -1.199 . . . . 0.0 110.423 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.53 ' CG2' ' OE2' ' A' ' 80' ' ' GLU . 21.5 p -86.91 175.75 8.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.526 -0.734 . . . . 0.0 110.238 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -89.16 29.1 1.11 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.299 -0.876 . . . . 0.0 110.203 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -133.6 5.55 3.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.23 -0.919 . . . . 0.0 110.326 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.34 -0.3 58.45 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.59 ' CG2' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -95.02 -175.94 3.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.208 -1.172 . . . . 0.0 110.472 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -139.46 153.41 23.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.648 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.495 ' N ' ' O ' ' A' ' 25' ' ' ALA . 70.0 t -118.51 135.31 59.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 O-C-N 121.192 -0.943 . . . . 0.0 111.765 -178.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.604 ' CD1' ' CG1' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -119.97 118.75 58.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 O-C-N 121.382 -0.824 . . . . 0.0 110.049 179.2 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.558 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.6 OUTLIER -100.19 123.51 44.5 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.123 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.604 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.3 m -147.85 162.86 6.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 121.082 -1.011 . . . . 0.0 108.819 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 74' ' ' ASP 0.254 10.2 tt0 -109.75 130.67 55.49 Favored 'General case' 0 C--N 1.27 -2.867 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.631 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.59 ' CE1' ' HB3' ' A' ' 14' ' ' CYS . 9.6 t80 -59.06 121.11 10.44 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.412 -178.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.478 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 5.8 mt-10 -106.86 21.18 17.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.107 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.531 ' CA ' ' HA3' ' A' ' 16' ' ' GLY . . . -115.84 -161.48 12.86 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.516 ' N ' ' OH ' ' A' ' 38' ' ' TYR . 13.5 t0 -125.66 145.19 50.27 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.455 -1.026 . . . . 0.0 110.245 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.21 -5.91 0.67 Allowed Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.421 -1.371 . . . . 0.0 111.02 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.614 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.7 OUTLIER 51.33 -153.06 0.01 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 120.436 -1.626 . . . . 0.0 108.198 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.614 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 83.1 Cg_exo -41.47 96.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.321 -0.9 0 N-CA-C 109.241 -1.1 . . . . 0.0 109.241 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.559 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -145.59 169.29 18.71 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.339 0.59 . . . . 0.0 109.701 -178.162 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.51 ' HD2' ' ND2' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -82.74 174.85 10.61 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.223 -0.923 . . . . 0.0 111.829 -178.9 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.61 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 13.3 mm -123.64 123.74 26.3 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.835 -0.541 . . . . 0.0 111.396 -178.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.593 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 31.7 Cg_exo -61.47 143.89 97.68 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.109 1.584 . . . . 0.0 110.368 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.641 ' CE1' ' CG2' ' A' ' 79' ' ' ILE . 5.3 t80 -152.06 159.83 43.6 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 110.469 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.487 ' HB3' ' HB ' ' A' ' 91' ' ' ILE . 32.0 tp10 -178.74 100.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 110.037 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . 36.0 mt . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.179 -0.951 . . . . 0.0 110.245 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.47 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -154.69 167.64 29.5 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.273 -1.133 . . . . 0.0 109.297 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.579 HD23 ' CE2' ' A' ' 49' ' ' PHE . 11.7 mt -121.52 121.88 38.47 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 118.746 -1.182 . . . . 0.0 110.737 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.611 ' CD1' ' N ' ' A' ' 64' ' ' ILE . 1.4 mp -82.09 -26.8 9.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.623 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.256 1.0 OUTLIER -96.67 33.19 1.89 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.241 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.546 ' CG2' ' O ' ' A' ' 63' ' ' LEU . 8.9 t -34.72 140.97 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.032 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.57 ' N ' ' CD ' ' A' ' 68' ' ' PRO . 22.1 t-20 56.99 46.34 2.07 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.608 -0.682 . . . . 0.0 110.422 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.582 ' CB ' ' CD1' ' A' ' 79' ' ' ILE . 9.2 Cg_endo -58.93 148.22 85.63 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.611 1.322 . . . . 0.0 108.979 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.556 HG12 ' O ' ' A' ' 68' ' ' PRO . 0.7 OUTLIER -142.69 144.65 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 119.255 -0.978 . . . . 0.0 112.111 -178.151 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.61 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 54.4 t -94.2 153.02 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.94 -21.4 12.35 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 120.932 -1.105 . . . . 0.0 108.57 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.535 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 2.3 mt-10 -138.45 145.8 41.32 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.54 ' O ' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -54.23 -14.15 1.07 Allowed 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.989 -1.069 . . . . 0.0 110.773 -178.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.492 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 7.1 t70 -126.31 9.21 7.26 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.589 -1.32 . . . . 0.0 110.578 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.48 ' CB ' ' HB2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -73.18 111.86 13.35 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.119 -0.988 . . . . 0.0 108.776 178.945 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.501 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 22.2 Cg_exo -59.91 114.45 2.08 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.864 1.455 . . . . 0.0 110.536 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.509 HG21 ' CG2' ' A' ' 70' ' ' VAL . 53.0 t -95.79 150.99 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.23 -0.919 . . . . 0.0 110.54 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 11.2 m-80 -114.4 130.05 56.68 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.641 ' CG2' ' CE1' ' A' ' 49' ' ' PHE . 9.5 mm -112.73 118.28 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 117.638 -1.625 . . . . 0.0 111.934 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 1.7 tp10 -95.79 107.44 19.67 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.578 ' CB ' ' CD2' ' A' ' 63' ' ' LEU . . . -129.3 155.47 45.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.797 -1.19 . . . . 0.0 111.287 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 62' ' ' ARG . 43.8 tp10 -100.8 103.25 23.39 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.531 -0.731 . . . . 0.0 110.466 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.535 ' HG3' ' CD1' ' A' ' 32' ' ' ILE . 60.7 Cg_endo -77.68 152.44 29.26 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.958 1.504 . . . . 0.0 110.484 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.47 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 28.2 Cg_endo . . . . . 0 C--N 1.305 -1.738 0 O-C-N 123.993 1.523 . . . . 0.0 109.888 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.553 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 6.1 m-85 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.135 0.493 . . . . 0.0 109.992 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.575 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 2.0 mp -73.87 107.96 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.312 -0.868 . . . . 0.0 109.578 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.497 ' CG2' ' CD ' ' A' ' 98' ' ' GLN . 30.7 mt -91.97 148.29 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.264 -0.898 . . . . 0.0 110.468 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.554 ' CD1' HG23 ' A' ' 34' ' ' ILE . 1.8 mt -133.28 140.64 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.565 -0.709 . . . . 0.0 109.606 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.536 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 82.13 -161.4 41.46 Favored Glycine 0 N--CA 1.481 1.655 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.54 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -122.61 149.84 26.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 O-C-N 121.225 -1.162 . . . . 0.0 110.181 -179.627 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.578 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.9 OUTLIER -17.03 -58.24 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.189 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 8.2 Cg_endo -51.65 71.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 124.219 1.641 . . . . 0.0 112.171 179.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 89.51 1.23 78.24 Favored Glycine 0 N--CA 1.494 2.511 0 O-C-N 120.943 -1.098 . . . . 0.0 110.878 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.497 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -48.63 159.68 0.22 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.975 -1.309 . . . . 0.0 110.27 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.521 HD13 ' CG2' ' A' ' 20' ' ' VAL . 13.0 mt -96.14 176.91 5.91 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.296 -0.877 . . . . 0.0 110.418 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.47 ' HG3' HG12 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -157.19 138.8 14.02 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.309 -0.869 . . . . 0.0 110.408 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.504 HD21 ' CG1' ' A' ' 34' ' ' ILE . 3.5 mp -141.06 118.1 11.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.247 -0.908 . . . . 0.0 110.026 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 1.9 t-20 -87.44 129.74 34.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 110.759 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 8.5 t-105 . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 0.0 109.739 179.596 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 56.2 m . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 16' ' ' GLY . 3.2 t -79.13 -11.34 59.98 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.067 -1.02 . . . . 0.0 111.419 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.51 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -60.93 -131.76 0.01 OUTLIER Glycine 0 N--CA 1.485 1.944 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.544 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -130.1 -177.88 4.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -1.167 . . . . 0.0 109.809 -179.73 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.603 ' CE1' ' HD2' ' A' ' 48' ' ' PRO . 32.5 m-85 -137.6 141.87 41.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.741 -1.224 . . . . 0.0 111.968 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.464 ' HB2' ' OE2' ' A' ' 39' ' ' GLU . 33.3 ttpt -113.44 118.28 34.06 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.444 HG21 HD23 ' A' ' 99' ' ' LEU . 40.9 t -59.47 125.01 14.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 120.576 -1.328 . . . . 0.0 109.036 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.548 ' HB ' ' CG ' ' A' ' 35' ' ' ARG . 62.8 t -98.26 -27.16 3.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.585 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 3.0 tttp -156.77 133.12 9.9 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -50.87 162.13 0.3 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.716 0.769 . . . . 0.0 111.411 -178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.565 HG12 HG12 ' A' ' 34' ' ' ILE . 0.7 OUTLIER -57.73 132.22 22.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 121.584 0.707 . . . . 0.0 110.289 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 33' ' ' VAL . . . -109.17 163.17 13.59 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 5.3 pm0 -112.46 134.11 54.17 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.344 -1.472 . . . . 0.0 110.553 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.523 ' CG2' ' OE2' ' A' ' 80' ' ' GLU . 4.7 p -94.22 165.21 12.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.524 -0.735 . . . . 0.0 110.336 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -78.58 -1.02 32.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.42 -0.8 . . . . 0.0 110.123 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.06 3.51 55.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.9 . . . . 0.0 110.34 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.473 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 88.88 25.81 28.48 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.584 ' CG2' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -121.77 -177.17 3.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.54 -0.976 . . . . 0.0 110.363 -179.779 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.571 HD11 ' CD1' ' A' ' 103' ' ' TRP . 0.0 OUTLIER -136.34 142.73 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.638 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.53 ' N ' ' O ' ' A' ' 25' ' ' ALA . 43.0 t -110.26 133.81 54.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 O-C-N 121.47 -0.768 . . . . 0.0 112.279 -177.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.601 ' CD1' ' CG1' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -118.74 119.54 61.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 O-C-N 121.339 -0.85 . . . . 0.0 109.865 178.738 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 1.0 OUTLIER -101.86 123.34 45.62 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 179.428 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.601 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.5 m -148.79 161.45 5.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 108.773 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.443 ' HB2' ' CG2' ' A' ' 21' ' ' VAL 0.254 0.1 OUTLIER -106.75 124.6 49.85 Favored 'General case' 0 C--N 1.273 -2.757 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -179.43 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.576 ' CZ ' ' HB3' ' A' ' 14' ' ' CYS . 2.1 t80 -61.15 125.52 24.03 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.017 -1.073 . . . . 0.0 110.425 -178.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.474 ' N ' ' O ' ' A' ' 17' ' ' LYS . 22.2 mm-40 -98.08 -148.91 0.33 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.022 -1.049 . . . . 0.0 109.19 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.51 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 44.24 -145.5 1.77 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.478 ' HA ' ' HD2' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -134.52 143.62 47.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.679 -0.895 . . . . 0.0 110.139 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.94 -25.32 0.04 OUTLIER Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.42 -1.372 . . . . 0.0 110.95 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.617 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.4 OUTLIER 56.24 -156.1 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 120.726 -1.455 . . . . 0.0 108.267 -179.545 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.617 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 50.9 Cg_exo -48.45 92.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.506 0 N-CA-C 109.61 -0.958 . . . . 0.0 109.61 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.569 ' SG ' ' CE2' ' A' ' 38' ' ' TYR . 21.8 p -143.32 167.75 21.43 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.422 -0.799 . . . . 0.0 110.389 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.585 ' CG ' ' CD1' ' A' ' 69' ' ' ILE . 47.0 mttp -85.38 154.99 21.5 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 122.142 0.972 . . . . 0.0 111.176 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.607 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 12.4 mm -101.92 123.32 44.14 Favored Pre-proline 0 C--N 1.297 -1.699 0 O-C-N 121.591 -0.693 . . . . 0.0 111.782 -177.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.603 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 32.2 Cg_exo -61.59 149.32 90.3 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.181 1.621 . . . . 0.0 110.457 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.597 ' CE2' ' CG2' ' A' ' 79' ' ' ILE . 5.9 t80 -159.4 155.25 26.34 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.389 -0.82 . . . . 0.0 110.165 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.527 ' O ' ' CD1' ' A' ' 91' ' ' ILE . 0.5 OUTLIER -177.67 106.62 0.05 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.277 -0.889 . . . . 0.0 109.873 179.721 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.532 ' CG2' ' O ' ' A' ' 51' ' ' ILE . 3.0 mt . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.349 -0.844 . . . . 0.0 110.126 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.456 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.537 ' CB ' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -159.19 166.57 31.14 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.256 -1.143 . . . . 0.0 109.617 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.577 HD21 ' CE1' ' A' ' 49' ' ' PHE . 11.3 mt -122.77 123.92 42.16 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 118.819 -1.152 . . . . 0.0 111.077 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.605 ' CD1' ' N ' ' A' ' 64' ' ' ILE . 1.5 mp -85.22 -28.45 6.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.602 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.257 1.8 m -99.32 35.69 1.89 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.662 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.519 HG13 ' ND2' ' A' ' 67' ' ' ASN . 43.0 t -37.85 152.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.667 0.746 . . . . 0.0 111.231 -178.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.519 ' ND2' HG13 ' A' ' 66' ' ' VAL . 24.5 p30 37.22 52.35 2.46 Favored Pre-proline 0 C--N 1.302 -1.47 0 O-C-N 121.968 -0.458 . . . . 0.0 111.568 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.571 ' CB ' ' CD1' ' A' ' 79' ' ' ILE . 1.9 Cg_endo -59.85 162.98 14.55 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 N-CA-C 108.363 -1.437 . . . . 0.0 108.363 178.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.585 ' CD1' ' CG ' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -143.94 148.66 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 C-N-CA 118.817 -1.153 . . . . 0.0 112.744 -178.471 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.607 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 44.0 t -102.46 159.43 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 175.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.3 m -112.89 -19.85 11.8 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.809 -1.156 . . . . 0.0 111.448 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 16.3 mt-10 -131.38 15.14 5.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.777 -1.202 . . . . 0.0 111.502 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.535 ' O ' ' O ' ' A' ' 38' ' ' TYR . 2.3 ttpt 71.56 -5.58 1.6 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.221 -0.925 . . . . 0.0 111.034 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.481 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 7.8 t0 -137.76 -1.2 2.05 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.877 -1.14 . . . . 0.0 110.257 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.7 t -72.6 112.26 14.32 Favored Pre-proline 0 N--CA 1.486 1.363 0 O-C-N 121.208 -0.932 . . . . 0.0 109.362 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 74' ' ' ASP . 32.6 Cg_exo -51.56 111.8 0.67 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.82 1.431 . . . . 0.0 109.915 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 92.5 t -95.15 143.46 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.325 -0.859 . . . . 0.0 110.997 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.598 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.9 m120 -105.9 131.25 53.45 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.597 ' CG2' ' CE2' ' A' ' 49' ' ' PHE . 10.5 mm -116.35 119.89 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 117.567 -1.653 . . . . 0.0 111.767 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 1.1 tp10 -94.44 110.79 22.55 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.16 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.558 ' CB ' ' CD2' ' A' ' 63' ' ' LEU . . . -125.28 159.9 30.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.926 -1.109 . . . . 0.0 110.752 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.537 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -93.68 113.9 61.57 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.527 -0.733 . . . . 0.0 110.323 -179.284 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.514 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 46.4 Cg_endo -73.3 133.03 18.64 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.853 1.449 . . . . 0.0 110.525 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.456 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 19.4 Cg_endo . . . . . 0 C--N 1.306 -1.706 0 O-C-N 123.925 1.487 . . . . 0.0 109.928 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.587 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 3.2 m-85 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.215 0.531 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.579 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 5.2 mt -74.08 111.34 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.164 -0.96 . . . . 0.0 109.442 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' A' ' 50' ' ' GLU . 2.1 mp -90.99 140.23 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.949 . . . . 0.0 110.178 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.547 ' CD1' HG21 ' A' ' 34' ' ' ILE . 1.4 mt -126.44 138.03 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.423 -0.798 . . . . 0.0 109.83 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 48' ' ' PRO . . . 85.99 -163.71 36.56 Favored Glycine 0 N--CA 1.482 1.754 0 C-N-CA 119.112 -1.518 . . . . 0.0 109.488 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.547 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -118.62 146.95 22.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 O-C-N 121.135 -1.215 . . . . 0.0 110.16 -179.623 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.578 ' O ' ' N ' ' A' ' 97' ' ' GLY . 3.9 mt-10 -16.89 -58.47 0.04 OUTLIER Pre-proline 0 N--CA 1.501 2.103 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 6.8 Cg_endo -51.08 72.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 124.219 1.641 . . . . 0.0 112.034 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 89.42 -1.35 81.92 Favored Glycine 0 N--CA 1.494 2.538 0 O-C-N 120.995 -1.065 . . . . 0.0 110.865 178.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.491 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -45.79 159.19 0.07 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.891 -1.358 . . . . 0.0 109.932 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.516 ' CD1' ' O ' ' A' ' 18' ' ' PHE . 10.9 mt -96.68 177.44 5.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.245 -0.91 . . . . 0.0 110.645 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -154.59 135.49 13.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.415 -0.803 . . . . 0.0 110.115 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 90' ' ' ILE . 4.8 mp -137.16 122.44 19.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.181 -0.949 . . . . 0.0 110.328 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 3.7 t-20 -87.92 125.25 34.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 110.277 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.571 ' CD1' HD11 ' A' ' 32' ' ' ILE . 20.7 t-105 . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.905 . . . . 0.0 110.075 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.584 ' HB3' ' CE1' ' A' ' 38' ' ' TYR . 1.7 m . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 121.155 0.502 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.539 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 0.6 OUTLIER -126.85 15.28 7.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -0.909 . . . . 0.0 111.129 -179.227 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.561 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -69.94 -96.04 0.05 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.548 ' CD ' ' HA3' ' A' ' 97' ' ' GLY . 1.1 ttmt -149.4 161.27 42.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.04 -1.271 . . . . 0.0 109.833 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.604 ' CE1' ' HD2' ' A' ' 48' ' ' PRO . 50.3 m-85 -126.36 147.82 49.69 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.866 -1.146 . . . . 0.0 111.584 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.458 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 15.0 ttpp -114.15 115.88 28.21 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.595 -0.69 . . . . 0.0 109.161 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.514 ' CG2' HD12 ' A' ' 99' ' ' LEU . 43.5 t -59.63 123.03 11.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 120.541 -1.349 . . . . 0.0 109.049 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.547 ' HB ' ' CG ' ' A' ' 35' ' ' ARG . 53.2 t -96.82 -26.02 4.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.562 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 4.0 tttp -158.63 133.56 8.34 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -52.17 157.82 1.28 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.524 0.678 . . . . 0.0 111.063 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.577 HD13 ' CA ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -48.85 132.72 6.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.132 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.533 ' O ' ' CA ' ' A' ' 32' ' ' ILE . . . -102.8 169.86 8.35 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 7.0 pm0 -113.54 132.24 55.78 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.924 -1.11 . . . . 0.0 110.519 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.471 ' OG1' ' OG1' ' A' ' 31' ' ' THR . 11.1 p -90.1 178.76 6.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.408 -0.807 . . . . 0.0 109.865 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -95.62 31.87 1.94 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.168 -0.957 . . . . 0.0 110.183 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.88 10.42 2.41 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.256 -0.902 . . . . 0.0 110.315 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.35 -0.86 60.17 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.586 ' CG2' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -96.04 -177.17 3.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.274 -1.133 . . . . 0.0 110.291 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.576 ' O ' ' HA ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -140.22 178.95 2.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.616 -1.254 . . . . 0.0 107.616 178.175 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.517 ' HB ' ' CB ' ' A' ' 25' ' ' ALA . 64.8 t -138.92 124.01 21.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 118.909 -1.117 . . . . 0.0 111.838 -178.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.595 ' CD1' ' CG1' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -106.69 115.16 47.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.203 -0.936 . . . . 0.0 109.974 179.132 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -98.94 118.17 35.11 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.595 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.5 m -145.04 155.31 13.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.342 -0.848 . . . . 0.0 109.032 -178.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.523 ' CG ' ' O ' ' A' ' 74' ' ' ASP 0.252 0.2 OUTLIER -103.5 123.41 46.84 Favored 'General case' 0 C--N 1.272 -2.776 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.277 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.587 ' CZ ' ' HA3' ' A' ' 40' ' ' GLY . 23.8 t80 -60.37 120.57 10.13 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 118.783 -1.167 . . . . 0.0 110.481 -178.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 17' ' ' LYS . 4.1 mt-10 -91.56 -26.09 18.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.466 -0.771 . . . . 0.0 109.321 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.587 ' HA3' ' CZ ' ' A' ' 38' ' ' TYR . . . -63.75 -161.3 0.38 Allowed Glycine 0 N--CA 1.484 1.834 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.52 ' N ' ' OH ' ' A' ' 38' ' ' TYR . 15.8 p-10 -127.55 134.76 49.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.511 -0.994 . . . . 0.0 110.162 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 43' ' ' SER . . . 171.83 -23.4 0.08 OUTLIER Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.458 -1.353 . . . . 0.0 110.575 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.596 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.6 OUTLIER 61.42 -154.38 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.688 -1.478 . . . . 0.0 108.096 -179.541 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.596 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 87.6 Cg_exo -42.24 96.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -0.994 0 N-CA-C 109.042 -1.176 . . . . 0.0 109.042 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.566 ' O ' ' CG2' ' A' ' 69' ' ' ILE . 31.5 p -151.47 -178.8 6.89 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.919 -0.488 . . . . 0.0 109.864 -177.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.565 ' HG3' ' CD1' ' A' ' 69' ' ' ILE . 12.0 mtpt -94.57 170.17 9.67 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.975 -1.078 . . . . 0.0 111.305 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.605 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 11.6 mm -122.84 130.41 24.63 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.444 -0.785 . . . . 0.0 112.384 -177.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.604 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 38.1 Cg_exo -64.16 143.01 82.76 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 124.197 1.63 . . . . 0.0 110.793 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.632 ' CE2' ' CD2' ' A' ' 63' ' ' LEU . 16.5 t80 -152.99 162.17 41.65 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.288 -0.883 . . . . 0.0 110.501 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.519 ' CG ' HD13 ' A' ' 91' ' ' ILE . 37.2 tt0 178.61 89.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.131 -0.981 . . . . 0.0 110.459 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.53 HD11 ' CB ' ' A' ' 81' ' ' ALA . 6.7 mt . . . . . 0 N--CA 1.493 1.706 0 O-C-N 121.175 -0.953 . . . . 0.0 109.958 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 83' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -140.35 167.45 22.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -1.052 . . . . 0.0 109.985 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.632 ' CD2' ' CE2' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -117.28 120.68 38.98 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.382 -0.824 . . . . 0.0 108.928 179.414 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.586 ' CD1' ' CG2' ' A' ' 31' ' ' THR . 1.4 mp -81.6 -29.88 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.567 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.266 1.5 m -97.74 36.79 1.47 Allowed 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.807 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.518 HG21 ' HB3' ' A' ' 63' ' ' LEU . 24.2 t -29.16 119.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.279 -178.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.507 ' OD1' ' HE3' ' A' ' 46' ' ' LYS . 3.8 t-20 59.62 69.1 1.34 Allowed Pre-proline 0 C--N 1.298 -1.632 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.969 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.52 ' O ' HG12 ' A' ' 69' ' ' ILE . 5.3 Cg_exo -65.41 171.27 9.57 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.044 1.549 . . . . 0.0 109.575 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.566 ' CG2' ' O ' ' A' ' 45' ' ' CYS . 1.1 mt -145.56 141.22 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 118.99 -1.084 . . . . 0.0 112.264 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.605 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 46.2 t -93.07 165.54 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.461 ' N ' HG12 ' A' ' 70' ' ' VAL . 2.2 m -118.44 -24.34 6.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.782 -1.199 . . . . 0.0 111.113 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 2.5 mt-10 -131.37 13.84 5.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.941 -1.099 . . . . 0.0 110.711 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 14.3 ttpt 74.78 -10.69 1.15 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.657 -0.652 . . . . 0.0 111.074 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.523 ' O ' ' CG ' ' A' ' 37' ' ' GLN . 8.2 t0 -134.07 -3.24 2.82 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.971 -1.081 . . . . 0.0 110.359 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.7 t -72.83 112.51 15.54 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.179 -0.951 . . . . 0.0 109.286 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.505 ' HB3' ' CG2' ' A' ' 21' ' ' VAL . 34.3 Cg_exo -51.04 111.41 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.858 1.452 . . . . 0.0 109.899 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.464 HG21 ' HA ' ' A' ' 70' ' ' VAL . 98.5 t -96.01 144.34 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.353 -0.842 . . . . 0.0 111.166 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.574 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.9 m120 -100.04 130.51 46.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.534 -0.729 . . . . 0.0 109.5 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.582 HG22 ' CD1' ' A' ' 49' ' ' PHE . 5.5 mt -109.66 116.21 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 117.902 -1.519 . . . . 0.0 110.912 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 0.9 OUTLIER -84.08 117.25 23.32 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.812 179.476 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.565 ' CB ' HD23 ' A' ' 63' ' ' LEU . . . -135.92 146.85 47.78 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.959 -1.088 . . . . 0.0 111.248 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.53 ' CA ' HG23 ' A' ' 31' ' ' THR . 29.2 tt0 -106.09 86.93 2.19 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.452 -0.78 . . . . 0.0 110.727 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.549 ' HG3' ' CD1' ' A' ' 32' ' ' ILE . 56.8 Cg_endo -75.12 160.57 39.6 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.812 1.428 . . . . 0.0 110.348 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo . . . . . 0 C--N 1.304 -1.801 0 O-C-N 123.963 1.507 . . . . 0.0 110.0 179.333 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 15.8 m-85 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.233 0.54 . . . . 0.0 109.716 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.575 HG21 ' CZ ' ' A' ' 49' ' ' PHE . 2.1 mp -74.09 108.29 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.926 . . . . 0.0 109.907 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.519 HD13 ' CG ' ' A' ' 50' ' ' GLU . 94.9 mt -89.17 142.53 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -0.899 . . . . 0.0 110.045 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.543 ' CD1' HG21 ' A' ' 34' ' ' ILE . 1.5 mt -133.24 141.0 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.4 -0.812 . . . . 0.0 110.111 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.527 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 80.59 -155.99 38.19 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' ' 15' ' ' THR . 0.1 OUTLIER -130.45 154.75 41.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.062 -1.258 . . . . 0.0 111.226 -179.394 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.549 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 1.7 mm-40 -28.44 -55.12 0.25 Allowed Pre-proline 0 N--CA 1.499 2.02 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.635 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 86.8 Cg_exo -34.02 -30.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.993 1.522 . . . . 0.0 111.011 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.548 ' HA3' ' CD ' ' A' ' 17' ' ' LYS . . . 179.34 37.83 0.07 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.371 -1.892 . . . . 0.0 108.371 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.521 ' N ' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -72.15 160.3 32.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.807 -0.819 . . . . 0.0 110.881 -179.05 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' A' ' 18' ' ' PHE . 9.4 mt -101.16 179.29 4.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.392 -0.818 . . . . 0.0 110.139 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.8 135.48 11.6 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.337 -0.852 . . . . 0.0 110.456 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 90' ' ' ILE . 5.7 mp -137.17 118.8 14.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.371 -0.831 . . . . 0.0 109.737 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 4.7 p-10 -88.25 131.94 34.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.853 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.516 ' NE1' HG22 ' A' ' 32' ' ' ILE . 3.5 t-105 . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.101 -1.0 . . . . 0.0 110.265 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.574 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 22.6 m . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 121.366 0.603 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.489 ' O ' ' O ' ' A' ' 16' ' ' GLY . 0.9 OUTLIER -86.65 -9.1 56.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.464 -0.773 . . . . 0.0 111.935 -178.359 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -59.55 -124.46 0.01 OUTLIER Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.489 -1.339 . . . . 0.0 109.84 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.549 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -135.75 173.86 11.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.018 -1.283 . . . . 0.0 109.99 -179.568 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.589 ' CE1' ' HD2' ' A' ' 48' ' ' PRO . 34.6 m-85 -133.44 136.89 45.47 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.969 -1.082 . . . . 0.0 111.51 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.453 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 23.4 ttpt -108.21 120.54 42.66 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.627 -0.671 . . . . 0.0 109.366 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.442 HG21 HD12 ' A' ' 99' ' ' LEU . 34.5 t -59.76 131.49 24.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.85 -1.156 . . . . 0.0 109.043 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.531 ' HB ' ' CG ' ' A' ' 35' ' ' ARG . 92.3 t -105.28 -26.39 3.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 1.8 tttp -157.37 133.61 9.65 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -51.94 159.58 0.84 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.723 0.773 . . . . 0.0 111.327 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.575 HD12 ' CA ' ' A' ' 34' ' ' ILE . 0.7 OUTLIER -55.79 132.04 19.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-O 121.577 0.703 . . . . 0.0 110.476 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 33' ' ' VAL . . . -109.57 158.95 17.51 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.498 ' N ' ' OE1' ' A' ' 26' ' ' GLU . 7.0 pm0 -110.43 133.35 53.36 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 120.166 -1.584 . . . . 0.0 110.494 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.521 ' CG2' ' OE2' ' A' ' 80' ' ' GLU . 2.8 p -92.14 169.5 10.57 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.567 -0.708 . . . . 0.0 110.216 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.88 -16.34 60.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 110.538 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -80.41 0.47 33.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.085 -1.009 . . . . 0.0 110.34 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.73 8.1 60.99 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.529 HG21 ' CG1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -98.39 175.34 6.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.314 -1.11 . . . . 0.0 110.381 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.584 HG21 ' CE2' ' A' ' 103' ' ' TRP . 0.0 OUTLIER -129.17 141.86 45.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.764 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.514 ' N ' ' O ' ' A' ' 25' ' ' ALA . 24.6 t -109.6 132.53 57.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 O-C-N 121.441 -0.787 . . . . 0.0 111.847 -177.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.63 ' O ' ' HA ' ' A' ' 78' ' ' ASN . 0.3 OUTLIER -118.28 121.29 66.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.435 -0.791 . . . . 0.0 109.413 178.799 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.557 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -105.67 111.19 23.78 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.621 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.5 m -131.09 -168.12 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.435 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 4.2 tt0 -135.86 128.2 30.22 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.573 ' CE2' ' SG ' ' A' ' 14' ' ' CYS . 1.7 t80 -60.25 124.01 18.96 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 118.633 -1.227 . . . . 0.0 110.032 -178.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 17' ' ' LYS . 2.4 mm-40 -116.61 86.19 2.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -0.887 . . . . 0.0 110.09 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 165.0 -150.38 18.24 Favored Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.425 -1.369 . . . . 0.0 109.986 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.462 ' O ' ' OH ' ' A' ' 38' ' ' TYR . 0.5 OUTLIER -113.24 128.62 56.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.665 -0.903 . . . . 0.0 110.408 -179.75 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 43' ' ' SER . . . 177.77 -26.71 0.06 OUTLIER Glycine 0 N--CA 1.487 2.087 0 C-N-CA 119.555 -1.307 . . . . 0.0 110.57 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.599 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.5 OUTLIER 48.94 -154.89 0.01 OUTLIER Pre-proline 0 N--CA 1.487 1.378 0 O-C-N 120.706 -1.467 . . . . 0.0 107.779 -179.58 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.599 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 53.3 Cg_exo -46.84 94.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.259 0 N-CA-C 108.241 -1.484 . . . . 0.0 108.241 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.574 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -148.97 173.15 13.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.615 -0.678 . . . . 0.0 109.853 -177.681 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.561 ' HG3' ' CD1' ' A' ' 69' ' ' ILE . 28.5 mttm -87.82 175.13 7.97 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.309 -0.87 . . . . 0.0 111.61 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.611 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 16.0 mm -119.92 128.82 25.66 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.499 -0.75 . . . . 0.0 112.237 -177.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.589 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 29.8 Cg_exo -65.31 144.75 81.61 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 121.593 1.529 . . . . 0.0 110.993 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.63 ' CD2' ' CD2' ' A' ' 63' ' ' LEU . 10.9 t80 -155.69 159.01 39.19 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.226 -0.921 . . . . 0.0 110.088 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.481 ' HB3' ' HB ' ' A' ' 91' ' ' ILE . 21.3 tt0 -175.17 114.54 0.15 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.981 -1.074 . . . . 0.0 110.496 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.53 ' CG2' ' HB3' ' A' ' 83' ' ' PRO . 10.0 mt . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.28 -0.887 . . . . 0.0 110.057 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.529 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.491 ' HG3' ' NH1' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -122.91 164.27 18.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.13 -1.217 . . . . 0.0 110.65 -179.65 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.63 ' CD2' ' CD2' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -129.73 110.84 12.09 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.569 -0.707 . . . . 0.0 109.529 179.109 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.541 ' CB ' ' HG2' ' A' ' 80' ' ' GLU . 5.5 mm -69.02 -33.34 58.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 122.342 1.068 . . . . 0.0 108.328 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.638 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.259 0.7 OUTLIER -100.99 31.33 3.65 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.375 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.553 ' C ' ' O ' ' A' ' 65' ' ' THR . 42.7 t -15.03 109.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.927 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.5 ' ND2' ' HD3' ' A' ' 46' ' ' LYS . 19.2 t-20 47.12 69.25 2.8 Favored Pre-proline 0 C--N 1.3 -1.58 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.785 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.532 ' HG3' ' CG2' ' A' ' 65' ' ' THR . 3.0 Cg_endo -50.06 -176.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.074 1.565 . . . . 0.0 109.538 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.561 ' CD1' ' HG3' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -141.96 144.09 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 119.171 -1.012 . . . . 0.0 112.171 -178.869 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.611 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 21.5 t -100.97 166.29 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.9 m -123.84 -15.41 6.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.745 -1.222 . . . . 0.0 111.166 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 26.1 mt-10 -140.03 14.48 2.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.929 -1.107 . . . . 0.0 111.016 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.1 OUTLIER 74.34 -9.83 1.23 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.42 -0.8 . . . . 0.0 111.006 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.468 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 6.9 t70 -135.96 0.18 2.61 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.932 -1.105 . . . . 0.0 110.059 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.428 ' HA ' ' HD2' ' A' ' 76' ' ' PRO . 22.0 t -72.54 108.21 4.05 Favored Pre-proline 0 N--CA 1.486 1.344 0 O-C-N 121.201 -0.937 . . . . 0.0 108.826 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.576 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 5.6 Cg_exo -45.07 130.71 10.72 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.757 1.398 . . . . 0.0 110.117 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 74.8 t -115.35 145.03 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.041 -1.037 . . . . 0.0 111.351 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.63 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.0 m-20 -106.52 133.25 51.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.516 -0.74 . . . . 0.0 109.597 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.58 HG22 ' CD1' ' A' ' 49' ' ' PHE . 3.6 mt -118.15 118.86 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 117.65 -1.62 . . . . 0.0 111.364 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.541 ' HG2' ' CB ' ' A' ' 64' ' ' ILE . 1.7 tp10 -94.45 109.77 21.62 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.53 ' CB ' HD22 ' A' ' 63' ' ' LEU . . . -118.24 147.34 43.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.041 -1.037 . . . . 0.0 110.774 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.522 ' CA ' HG22 ' A' ' 31' ' ' THR . 4.6 tt0 -112.37 58.64 0.55 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.45 -0.781 . . . . 0.0 111.051 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.53 ' HB3' ' CG2' ' A' ' 51' ' ' ILE . 37.1 Cg_endo -69.73 162.02 43.66 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.727 1.383 . . . . 0.0 110.63 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.485 ' HD3' ' HA2' ' A' ' 61' ' ' GLY . 23.4 Cg_exo . . . . . 0 C--N 1.305 -1.726 0 O-C-N 124.096 1.577 . . . . 0.0 110.594 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.57 ' CE1' ' OD1' ' A' ' 102' ' ' ASN . 85.3 m-85 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.131 0.491 . . . . 0.0 109.842 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.588 ' CG2' ' CZ ' ' A' ' 49' ' ' PHE . 88.1 mt -73.71 134.16 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.179 -0.951 . . . . 0.0 109.475 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.503 ' CG2' ' CD ' ' A' ' 98' ' ' GLN . 57.5 mt -106.42 145.71 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.122 -0.987 . . . . 0.0 110.981 -179.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.546 ' CD1' HG23 ' A' ' 34' ' ' ILE . 1.9 mt -132.77 139.21 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.535 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 83.22 -159.52 37.35 Favored Glycine 0 N--CA 1.481 1.665 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.55 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -123.86 150.08 28.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 121.183 -1.187 . . . . 0.0 110.194 -179.568 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.574 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.7 OUTLIER -19.1 -57.47 0.05 OUTLIER Pre-proline 0 N--CA 1.5 2.045 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 10.3 Cg_endo -53.18 70.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 124.214 1.639 . . . . 0.0 111.952 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 90.76 5.11 69.0 Favored Glycine 0 N--CA 1.494 2.531 0 O-C-N 121.012 -1.055 . . . . 0.0 110.985 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.503 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -51.46 160.77 0.55 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.998 -1.295 . . . . 0.0 110.187 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' A' ' 18' ' ' PHE . 8.4 mt -97.52 177.4 5.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.214 -0.929 . . . . 0.0 110.35 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -159.14 141.35 13.77 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.266 -0.896 . . . . 0.0 110.456 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 89' ' ' TYR . 3.0 mp -141.11 120.82 13.4 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.242 -0.911 . . . . 0.0 110.239 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.57 ' OD1' ' CE1' ' A' ' 89' ' ' TYR . 4.0 t30 -72.13 131.2 42.49 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.292 -0.88 . . . . 0.0 110.7 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.584 ' CE2' HG21 ' A' ' 32' ' ' ILE . 6.9 t-105 . . . . . 0 N--CA 1.492 1.63 0 O-C-N 120.823 -1.173 . . . . 0.0 111.193 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 4.0 m . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 16' ' ' GLY . 49.4 p -64.56 -11.31 33.24 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.491 -0.756 . . . . 0.0 111.33 -178.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.511 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -60.08 -145.97 0.01 OUTLIER Glycine 0 N--CA 1.481 1.675 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.548 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -127.91 174.42 9.18 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.299 -1.118 . . . . 0.0 109.345 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.606 ' CE1' ' HD2' ' A' ' 48' ' ' PRO . 46.9 m-85 -131.24 133.62 45.63 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.743 -1.223 . . . . 0.0 112.099 -179.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -108.01 121.62 45.17 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.489 ' N ' HD11 ' A' ' 99' ' ' LEU . 48.0 t -59.66 130.39 23.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.196 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.524 ' N ' ' HA ' ' A' ' 36' ' ' VAL . 69.7 t -105.21 -26.91 3.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.55 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 19.6 tttt -156.32 133.06 10.3 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.15 155.95 1.77 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.542 0.687 . . . . 0.0 111.215 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.586 HD13 ' CA ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -50.98 132.51 12.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.536 -0.727 . . . . 0.0 109.862 179.839 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 32' ' ' ILE . . . -107.23 170.58 7.87 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 5.2 pm0 -116.36 130.58 56.84 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.809 -1.182 . . . . 0.0 110.569 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.524 ' CG2' ' OE2' ' A' ' 80' ' ' GLU . 14.5 p -89.2 173.93 8.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.361 -0.837 . . . . 0.0 110.056 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -88.07 29.2 0.96 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.154 -0.966 . . . . 0.0 110.472 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -132.25 6.19 4.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.16 -0.962 . . . . 0.0 110.291 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.77 -2.46 60.3 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.576 ' CG2' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -92.54 -178.14 4.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.303 -1.116 . . . . 0.0 110.384 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -139.18 158.46 28.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.568 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.496 ' N ' ' O ' ' A' ' 25' ' ' ALA . 73.6 t -123.08 128.15 74.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 C-N-CA 118.933 -1.107 . . . . 0.0 112.372 -177.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.62 ' O ' ' HA ' ' A' ' 78' ' ' ASN . 0.3 OUTLIER -111.24 118.47 57.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 121.357 -0.84 . . . . 0.0 109.716 178.895 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.55 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 2.9 ttm180 -104.71 114.65 29.0 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.612 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.6 m -133.46 -168.46 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 O-C-N 121.469 -0.769 . . . . 0.0 109.31 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.473 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 9.8 tt0 -135.14 126.25 27.93 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 14' ' ' CYS . 1.5 t80 -61.04 127.32 30.95 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.975 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 17' ' ' LYS . 3.5 mt-10 -125.28 89.63 3.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.044 -1.035 . . . . 0.0 110.172 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.529 ' O ' ' CD ' ' A' ' 73' ' ' LYS . . . 162.45 -151.69 21.69 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.474 ' HA ' ' HD2' ' A' ' 73' ' ' LYS . 11.1 t0 -107.48 118.23 36.18 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.565 -0.962 . . . . 0.0 110.217 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.06 -36.48 0.04 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.601 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER 52.43 -158.15 0.01 OUTLIER Pre-proline 0 C--N 1.305 -1.346 0 O-C-N 120.945 -1.327 . . . . 0.0 108.665 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.601 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 76.2 Cg_exo -45.21 93.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.229 0 N-CA-C 109.376 -1.048 . . . . 0.0 109.376 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.545 ' SG ' ' N ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -154.92 175.65 13.52 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.611 -0.681 . . . . 0.0 109.811 -179.093 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.599 ' HG3' ' CD1' ' A' ' 69' ' ' ILE . 2.6 mttp -82.01 175.37 10.42 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.393 -0.817 . . . . 0.0 112.07 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.613 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 16.8 mm -120.03 128.01 26.07 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.636 -0.665 . . . . 0.0 111.672 -178.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.606 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 34.2 Cg_exo -63.06 145.1 93.84 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 124.043 1.549 . . . . 0.0 110.495 178.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.653 ' CD1' ' CD2' ' A' ' 63' ' ' LEU . 5.4 t80 -154.11 162.45 41.18 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.268 -0.895 . . . . 0.0 110.101 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.531 ' O ' ' CD1' ' A' ' 91' ' ' ILE . 7.0 tp10 -179.19 97.88 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.192 -0.943 . . . . 0.0 110.03 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.505 ' CD1' ' HB2' ' A' ' 81' ' ' ALA . 16.1 mt . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.161 -0.962 . . . . 0.0 110.575 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.517 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.5 ' CB ' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -137.75 168.29 19.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.197 -1.178 . . . . 0.0 110.416 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.653 ' CD2' ' CD1' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -122.59 122.68 39.43 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.581 -0.699 . . . . 0.0 109.295 179.161 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.597 ' CD1' ' N ' ' A' ' 64' ' ' ILE . 1.4 mp -85.3 -30.73 6.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.577 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.262 2.9 m -107.75 42.87 1.27 Allowed 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.258 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.534 ' CG2' ' HB3' ' A' ' 63' ' ' LEU . 18.7 t -30.07 121.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-O 121.604 0.716 . . . . 0.0 111.503 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 12.9 t-20 43.09 71.91 1.31 Allowed Pre-proline 0 C--N 1.297 -1.683 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.617 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.532 ' O ' ' HA ' ' A' ' 46' ' ' LYS . 1.1 Cg_endo -56.0 -171.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.909 1.479 . . . . 0.0 108.967 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.599 ' CD1' ' HG3' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -143.6 148.01 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 119.041 -1.064 . . . . 0.0 112.285 -179.241 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.613 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 54.3 t -104.79 164.69 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 176.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.452 ' N ' HG13 ' A' ' 70' ' ' VAL . 4.3 m -118.89 -19.39 8.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.878 -1.139 . . . . 0.0 111.5 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.528 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 19.0 mt-10 -140.2 18.78 2.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.76 -1.213 . . . . 0.0 111.386 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.529 ' CD ' ' O ' ' A' ' 40' ' ' GLY . 9.0 ttpt 72.61 -6.7 1.56 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.247 -0.908 . . . . 0.0 110.949 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.476 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 18.1 t0 -137.94 -2.2 1.92 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.0 -1.062 . . . . 0.0 110.33 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.2 t -72.64 112.42 15.01 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.071 -1.018 . . . . 0.0 108.939 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 50.5 Cg_exo -47.82 128.2 15.64 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.9 1.474 . . . . 0.0 110.067 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 66.3 t -114.94 142.32 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.04 -1.038 . . . . 0.0 111.534 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.62 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.1 m-20 -104.99 133.43 49.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.468 -0.77 . . . . 0.0 109.312 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.611 ' CG2' ' CE2' ' A' ' 49' ' ' PHE . 5.5 mt -117.39 119.66 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.075 -1.641 . . . . 0.0 111.582 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.563 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 1.9 tp10 -91.84 115.92 28.46 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.229 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.515 ' CB ' HD23 ' A' ' 63' ' ' LEU . . . -131.85 151.7 51.52 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.982 -1.074 . . . . 0.0 110.775 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.5 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 35.2 tt0 -100.76 103.09 22.18 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.234 -0.916 . . . . 0.0 110.247 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.531 ' HG3' ' CD1' ' A' ' 32' ' ' ILE . 42.8 Cg_endo -73.6 145.85 37.98 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.032 1.543 . . . . 0.0 110.655 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.517 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 43.8 Cg_endo . . . . . 0 C--N 1.304 -1.785 0 O-C-N 124.154 1.607 . . . . 0.0 110.256 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.61 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 8.5 m-85 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.242 0.544 . . . . 0.0 110.044 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.567 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 1.7 mp -74.32 121.94 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.194 -0.941 . . . . 0.0 109.81 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.531 ' CD1' ' O ' ' A' ' 50' ' ' GLU . 3.2 mt -101.06 145.88 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.17 -0.956 . . . . 0.0 110.04 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.551 ' CD1' HG21 ' A' ' 34' ' ' ILE . 4.0 mt -132.73 146.18 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.465 -0.772 . . . . 0.0 110.359 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.54 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 78.74 -161.05 47.59 Favored Glycine 0 N--CA 1.484 1.896 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.528 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.1 OUTLIER -124.19 140.98 45.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.187 -1.184 . . . . 0.0 110.866 -179.632 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.552 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.8 OUTLIER -16.6 -58.97 0.04 OUTLIER Pre-proline 0 N--CA 1.505 2.309 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.876 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 24.4 Cg_exo -32.32 -32.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 124.013 1.533 . . . . 0.0 110.956 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.548 ' HA3' ' CG ' ' A' ' 17' ' ' LYS . . . -175.67 35.98 0.1 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.494 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -71.43 164.69 25.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.697 -0.884 . . . . 0.0 110.74 -179.247 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.514 ' CD1' ' O ' ' A' ' 18' ' ' PHE . 8.2 mt -100.99 176.95 5.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.432 -0.793 . . . . 0.0 110.128 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.46 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -154.84 135.59 13.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.318 -0.864 . . . . 0.0 110.259 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 89' ' ' TYR . 2.4 mp -142.02 122.87 14.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.267 -0.895 . . . . 0.0 110.231 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 7.4 p-10 -86.02 131.31 34.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.15 -0.969 . . . . 0.0 110.241 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.521 ' CD1' HG22 ' A' ' 32' ' ' ILE . 49.4 t-105 . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.949 . . . . 0.0 110.317 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 56.4 m . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.515 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -83.35 -4.6 58.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.302 -0.874 . . . . 0.0 111.656 -178.553 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.524 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -61.23 -128.75 0.01 OUTLIER Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.545 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -123.24 176.29 6.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.235 -1.156 . . . . 0.0 109.971 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.598 ' CZ ' ' HD2' ' A' ' 48' ' ' PRO . 34.4 m-85 -135.93 141.38 44.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.879 -1.138 . . . . 0.0 111.704 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -112.33 117.62 32.99 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.473 ' CG2' HD13 ' A' ' 99' ' ' LEU . 44.2 t -59.67 123.94 13.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 120.586 -1.321 . . . . 0.0 108.94 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.557 ' HB ' ' CG ' ' A' ' 35' ' ' ARG . 53.9 t -97.62 -26.63 3.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.585 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 18.8 tttt -157.17 133.21 9.56 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -50.62 161.69 0.31 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.694 0.759 . . . . 0.0 111.325 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.572 HG12 HG12 ' A' ' 34' ' ' ILE . 0.7 OUTLIER -55.83 132.64 19.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-O 121.716 0.769 . . . . 0.0 110.311 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 33' ' ' VAL . . . -109.5 167.22 10.29 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 6.9 pm0 -113.91 130.37 56.51 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 120.595 -1.316 . . . . 0.0 110.681 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.493 HG21 ' CG ' ' A' ' 80' ' ' GLU . 8.4 p -81.72 -167.59 1.57 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.455 -0.778 . . . . 0.0 110.005 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -103.94 23.02 13.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 110.281 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -128.48 7.08 5.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.204 -0.935 . . . . 0.0 110.178 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.469 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 97.95 0.94 58.61 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.528 HG21 ' CA ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -91.93 -177.28 4.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.285 -1.127 . . . . 0.0 110.254 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.548 ' CD1' ' HG3' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -140.69 150.4 20.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.611 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.508 ' CG2' ' HG3' ' A' ' 80' ' ' GLU . 69.7 t -116.5 131.71 68.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 O-C-N 121.151 -0.968 . . . . 0.0 111.875 -178.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.598 ' O ' ' HA ' ' A' ' 78' ' ' ASN . 0.4 OUTLIER -114.72 117.06 54.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.401 -0.812 . . . . 0.0 109.694 179.056 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -98.65 122.41 41.84 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.864 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.596 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.7 m -149.25 158.17 6.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.942 0.877 . . . . 0.0 109.022 -178.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.511 ' NE2' ' HD3' ' A' ' 76' ' ' PRO 0.256 2.7 tt0 -104.43 122.33 45.28 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.318 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.591 ' CZ ' ' HB3' ' A' ' 14' ' ' CYS . 7.6 t80 -61.47 144.98 53.29 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.081 -1.047 . . . . 0.0 110.148 -178.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 17' ' ' LYS . 45.3 mm-40 -119.19 -143.8 0.36 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.276 -0.89 . . . . 0.0 108.848 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.524 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 43.86 -139.77 3.62 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.464 ' HA ' ' HD2' ' A' ' 73' ' ' LYS . 1.3 m-20 -135.18 143.35 46.4 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.737 -0.861 . . . . 0.0 110.001 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.02 -27.17 0.05 OUTLIER Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.475 -1.345 . . . . 0.0 110.626 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.643 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.4 OUTLIER 56.31 -153.88 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 120.637 -1.508 . . . . 0.0 108.324 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.643 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 38.9 Cg_exo -53.5 90.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 N-CA-C 109.981 -0.815 . . . . 0.0 109.981 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 43' ' ' SER . 6.6 p -142.46 173.68 11.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.137 -0.977 . . . . 0.0 110.541 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.55 ' HG3' ' CD1' ' A' ' 69' ' ' ILE . 12.1 mtmm -84.42 168.97 15.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.411 -0.806 . . . . 0.0 111.347 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.612 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 13.3 mm -112.06 127.18 27.21 Favored Pre-proline 0 C--N 1.304 -1.391 0 O-C-N 121.241 -0.912 . . . . 0.0 112.31 -177.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.598 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 34.6 Cg_exo -63.71 144.17 88.55 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 124.055 1.555 . . . . 0.0 110.258 178.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.644 ' CD1' ' CD2' ' A' ' 63' ' ' LEU . 7.1 t80 -153.05 162.01 41.83 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.259 -0.9 . . . . 0.0 110.603 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.489 ' HB3' ' HB ' ' A' ' 91' ' ' ILE . 9.4 tp10 -179.83 108.7 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.345 -0.847 . . . . 0.0 109.729 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.472 HG23 HD13 ' A' ' 51' ' ' ILE . 5.0 mt . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.064 -1.023 . . . . 0.0 110.547 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.525 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -149.43 170.16 19.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.216 -1.167 . . . . 0.0 110.812 -179.682 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.644 ' CD2' ' CD1' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -119.7 121.99 40.46 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.422 179.302 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.561 ' CD1' ' N ' ' A' ' 64' ' ' ILE . 1.3 mp -84.69 -30.86 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.604 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.259 1.9 m -108.52 43.84 1.19 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.159 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.586 ' CG1' ' ND2' ' A' ' 67' ' ' ASN . 9.0 t -29.52 135.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 CA-C-O 121.33 0.586 . . . . 0.0 111.396 -178.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.586 ' ND2' ' CG1' ' A' ' 66' ' ' VAL . 23.6 p30 26.52 73.14 0.37 Allowed Pre-proline 0 N--CA 1.49 1.538 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.753 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.53 ' O ' ' HA ' ' A' ' 46' ' ' LYS . 3.2 Cg_endo -57.1 -174.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.902 1.475 . . . . 0.0 108.821 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.55 ' CD1' ' HG3' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -140.83 142.57 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 C-N-CA 118.847 -1.141 . . . . 0.0 112.346 -179.071 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.612 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 46.6 t -98.63 160.05 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 176.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.462 ' N ' HG11 ' A' ' 70' ' ' VAL . 16.5 m -113.8 -21.65 10.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.954 -1.092 . . . . 0.0 110.964 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.512 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 6.6 mt-10 -132.02 15.62 4.7 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.963 -1.086 . . . . 0.0 111.05 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.53 ' O ' ' O ' ' A' ' 38' ' ' TYR . 0.2 OUTLIER 72.37 -4.36 2.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.353 -0.842 . . . . 0.0 110.984 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 12.6 t70 -137.38 1.87 2.44 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.06 -1.025 . . . . 0.0 110.188 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.433 ' HA ' ' HD2' ' A' ' 76' ' ' PRO . 40.3 t -73.0 109.28 5.87 Favored Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.192 -0.943 . . . . 0.0 109.454 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.511 ' HD3' ' NE2' ' A' ' 37' ' ' GLN . 3.7 Cg_endo -52.59 111.15 0.57 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.817 1.43 . . . . 0.0 109.713 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 48.7 t -102.65 145.49 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.331 -0.856 . . . . 0.0 111.712 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.598 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 1.5 m120 -101.93 134.12 45.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.488 -0.757 . . . . 0.0 109.207 179.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.577 HG22 ' CE2' ' A' ' 49' ' ' PHE . 6.6 mt -114.85 117.42 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.21 -1.556 . . . . 0.0 111.626 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.532 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 2.6 tt0 -88.18 111.52 21.71 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.59 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.533 ' CB ' HD21 ' A' ' 63' ' ' LEU . . . -127.23 149.39 50.02 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.032 -1.043 . . . . 0.0 110.836 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.528 ' CA ' HG21 ' A' ' 31' ' ' THR . 1.0 OUTLIER -99.47 104.15 25.41 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.243 -0.91 . . . . 0.0 110.51 -179.692 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.548 ' HG3' ' CD1' ' A' ' 32' ' ' ILE . 74.6 Cg_endo -81.15 147.58 16.46 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.004 1.528 . . . . 0.0 110.609 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.525 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 9.7 Cg_endo . . . . . 0 C--N 1.305 -1.73 0 O-C-N 123.872 1.459 . . . . 0.0 109.769 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.52 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 3.4 m-85 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.133 0.492 . . . . 0.0 109.728 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.583 ' CG2' ' CZ ' ' A' ' 49' ' ' PHE . 3.4 mt -73.91 120.04 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.148 -0.97 . . . . 0.0 109.575 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.505 ' CG2' ' CD ' ' A' ' 98' ' ' GLN . 1.9 mp -98.53 140.16 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.046 -1.034 . . . . 0.0 110.048 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.561 ' CD1' HG23 ' A' ' 34' ' ' ILE . 1.2 mt -126.14 142.22 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.452 -0.78 . . . . 0.0 109.994 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.529 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 82.59 -160.36 39.48 Favored Glycine 0 N--CA 1.481 1.65 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.553 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -122.77 149.82 26.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 O-C-N 121.307 -1.113 . . . . 0.0 110.091 -179.652 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.568 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -19.19 -57.56 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.109 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 9.7 Cg_endo -53.84 69.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 124.137 1.598 . . . . 0.0 112.145 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 93.57 4.61 63.82 Favored Glycine 0 N--CA 1.495 2.6 0 O-C-N 120.876 -1.14 . . . . 0.0 111.033 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.505 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -53.87 159.78 1.61 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.046 -1.267 . . . . 0.0 110.193 179.873 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.519 ' CD1' ' O ' ' A' ' 18' ' ' PHE . 9.1 mt -97.91 177.4 5.45 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.215 -0.928 . . . . 0.0 110.758 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.415 ' HG3' HG13 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -157.07 128.37 6.89 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.47 -0.769 . . . . 0.0 110.094 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 90' ' ' ILE . 4.7 mp -130.5 124.98 33.2 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.279 -0.888 . . . . 0.0 109.972 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.512 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 10.1 t-20 -90.91 132.21 36.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 110.89 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.524 ' NE1' HG21 ' A' ' 32' ' ' ILE . 3.4 t-105 . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.049 -1.032 . . . . 0.0 110.243 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.597 ' HB3' ' CE1' ' A' ' 38' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 121.209 0.528 . . . . 0.0 109.889 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 16' ' ' GLY . 14.8 t -107.71 -2.37 20.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.267 -0.895 . . . . 0.0 111.385 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.54 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -60.8 -125.08 0.01 OUTLIER Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.545 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -132.49 178.12 7.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.028 -1.278 . . . . 0.0 110.029 -179.793 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.593 ' CE1' ' HD2' ' A' ' 48' ' ' PRO . 34.1 m-85 -136.12 133.92 37.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.948 -1.095 . . . . 0.0 111.63 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.525 ' CE ' ' HB3' ' A' ' 37' ' ' GLN . 0.3 OUTLIER -104.26 119.71 39.56 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.622 -0.674 . . . . 0.0 109.444 179.2 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.497 ' N ' HD11 ' A' ' 99' ' ' LEU . 41.6 t -59.72 131.12 24.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 118.588 -1.245 . . . . 0.0 108.275 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.526 ' N ' ' HA ' ' A' ' 36' ' ' VAL . 75.9 t -105.27 -26.15 3.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.551 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 2.2 tttt -157.11 133.08 9.53 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -52.3 158.86 1.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.523 0.677 . . . . 0.0 111.304 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.578 HD13 ' CA ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -54.39 132.38 17.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.588 0.708 . . . . 0.0 109.903 -179.964 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 32' ' ' ILE . . . -107.29 169.7 8.41 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.5 pm0 -115.85 133.54 55.92 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.65 -1.281 . . . . 0.0 110.406 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.527 ' CG2' ' OE2' ' A' ' 80' ' ' GLU . 13.2 p -93.13 172.45 8.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.393 -0.817 . . . . 0.0 110.181 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -87.73 29.23 0.92 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.266 -0.896 . . . . 0.0 110.328 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.87 5.82 4.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.924 . . . . 0.0 110.179 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.88 8.06 59.47 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.538 HG23 ' CA ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -102.66 -174.84 2.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -1.08 . . . . 0.0 110.081 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.535 ' O ' ' HA ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -141.91 156.91 20.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 178.632 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.499 ' N ' ' O ' ' A' ' 25' ' ' ALA . 76.3 t -121.69 128.18 75.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 O-C-N 120.974 -1.079 . . . . 0.0 112.222 -177.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.623 ' O ' ' HA ' ' A' ' 78' ' ' ASN . 0.3 OUTLIER -112.89 118.97 59.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 O-C-N 121.437 -0.789 . . . . 0.0 109.685 178.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.551 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 3.4 ttm180 -105.67 112.81 26.03 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.617 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.7 m -132.34 -168.01 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.476 -0.765 . . . . 0.0 109.422 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.525 ' HB3' ' CE ' ' A' ' 19' ' ' LYS . 21.6 tt0 -138.26 127.06 23.76 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.597 ' CE1' ' HB3' ' A' ' 14' ' ' CYS . 75.5 t80 -60.31 128.34 36.25 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 118.29 -1.364 . . . . 0.0 110.579 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.467 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 61.8 mm-40 -116.01 82.85 1.84 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.484 -0.76 . . . . 0.0 109.62 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.54 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 171.62 -145.01 8.48 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.472 ' O ' ' OH ' ' A' ' 38' ' ' TYR . 7.5 m-20 -128.54 140.83 51.6 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.637 -0.919 . . . . 0.0 110.56 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 166.9 -20.61 0.1 OUTLIER Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.689 -1.243 . . . . 0.0 110.66 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.606 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER 56.03 -157.98 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 120.705 -1.468 . . . . 0.0 108.413 -179.702 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 72.9 Cg_exo -44.35 94.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.262 0 N-CA-C 108.944 -1.214 . . . . 0.0 108.944 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.533 ' N ' ' O ' ' A' ' 43' ' ' SER . 26.3 p -141.17 165.88 26.31 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.746 -0.596 . . . . 0.0 110.286 -178.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.591 ' CG ' ' CD1' ' A' ' 69' ' ' ILE . 10.9 mttp -82.59 177.43 8.71 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.407 -0.808 . . . . 0.0 110.358 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.592 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 14.2 mm -121.51 127.88 25.89 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.102 -0.999 . . . . 0.0 111.92 -178.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.593 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 35.1 Cg_exo -63.06 143.72 91.23 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.881 1.464 . . . . 0.0 110.627 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.598 ' CD1' ' CD2' ' A' ' 63' ' ' LEU . 5.6 t80 -155.53 132.28 10.55 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.335 -0.853 . . . . 0.0 110.021 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.521 ' HG2' ' CG2' ' A' ' 91' ' ' ILE . 0.8 OUTLIER -144.1 97.68 3.09 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.03 -1.044 . . . . 0.0 110.305 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.479 ' CD1' ' HB2' ' A' ' 81' ' ' ALA . 11.9 mt . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.274 -0.891 . . . . 0.0 110.184 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.523 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.464 ' CB ' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -130.78 166.95 19.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.268 -1.136 . . . . 0.0 110.157 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.598 ' CD2' ' CD1' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -128.42 111.22 13.08 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.346 -0.847 . . . . 0.0 109.934 179.701 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.528 ' CB ' ' HG2' ' A' ' 80' ' ' GLU . 5.6 mm -71.08 -25.45 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 122.148 0.975 . . . . 0.0 108.525 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.641 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.253 0.7 OUTLIER -111.87 31.46 6.19 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.718 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.56 ' C ' ' O ' ' A' ' 65' ' ' THR . 32.6 t -13.83 112.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.186 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.522 ' ND2' ' HD3' ' A' ' 46' ' ' LYS . 12.5 t-20 43.78 68.66 2.87 Favored Pre-proline 0 C--N 1.298 -1.66 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.295 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.532 ' O ' HG12 ' A' ' 69' ' ' ILE . 2.1 Cg_endo -51.41 -174.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.982 1.517 . . . . 0.0 109.142 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.591 ' CD1' ' CG ' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -142.28 144.41 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 119.088 -1.045 . . . . 0.0 112.488 -178.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.592 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 26.5 t -98.62 166.87 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 176.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.418 ' N ' HG11 ' A' ' 70' ' ' VAL . 3.3 m -123.62 -18.9 5.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.842 -1.161 . . . . 0.0 111.12 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.539 ' O ' ' CD ' ' A' ' 73' ' ' LYS . 8.0 mt-10 -138.0 15.37 2.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.926 -1.109 . . . . 0.0 110.685 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.539 ' CD ' ' O ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER 75.05 -13.39 0.85 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.773 -0.579 . . . . 0.0 111.224 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.462 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 6.3 t70 -131.83 -0.07 3.87 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.89 -1.131 . . . . 0.0 110.163 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.433 ' HA ' ' HD2' ' A' ' 76' ' ' PRO . 8.9 t -72.04 108.36 4.05 Favored Pre-proline 0 C--N 1.304 -1.372 0 O-C-N 121.257 -0.902 . . . . 0.0 108.707 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 2.0 Cg_endo -46.92 131.03 16.51 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.77 1.405 . . . . 0.0 110.297 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 63.2 t -118.39 144.81 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.099 -1.001 . . . . 0.0 111.296 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.623 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 4.9 m-80 -105.51 134.82 47.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.431 -0.793 . . . . 0.0 109.574 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.59 HG21 ' CE2' ' A' ' 49' ' ' PHE . 5.2 mt -118.37 119.05 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 119.957 -1.715 . . . . 0.0 111.344 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 1.7 tp10 -93.19 114.12 26.52 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.634 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.522 ' CB ' HD23 ' A' ' 63' ' ' LEU . . . -131.0 150.43 52.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.048 -1.033 . . . . 0.0 110.873 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.538 ' CA ' HG23 ' A' ' 31' ' ' THR . 4.4 tt0 -101.09 100.2 12.56 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.34 -0.85 . . . . 0.0 110.084 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.523 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 32.4 Cg_endo -69.05 144.64 58.52 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.102 1.58 . . . . 0.0 110.58 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.523 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 19.0 Cg_endo . . . . . 0 C--N 1.306 -1.679 0 O-C-N 124.034 1.544 . . . . 0.0 110.229 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 21.6 m-85 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.227 0.537 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.584 ' CG2' ' CZ ' ' A' ' 49' ' ' PHE . 1.8 mp -73.9 113.45 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.213 -0.93 . . . . 0.0 109.394 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.521 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 9.5 mt -94.1 144.56 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.144 -0.972 . . . . 0.0 110.282 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.543 ' CD1' HG22 ' A' ' 34' ' ' ILE . 1.8 mt -128.65 141.25 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.406 -0.808 . . . . 0.0 109.697 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.54 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 82.2 -160.36 40.24 Favored Glycine 0 N--CA 1.483 1.786 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.563 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -122.58 148.24 26.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 O-C-N 121.218 -1.166 . . . . 0.0 109.918 -179.73 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.571 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.4 OUTLIER -16.38 -58.56 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.173 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.776 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 7.3 Cg_endo -51.01 73.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 124.131 1.595 . . . . 0.0 112.067 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 88.39 -0.27 83.14 Favored Glycine 0 N--CA 1.495 2.581 0 O-C-N 121.02 -1.05 . . . . 0.0 110.9 178.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.507 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -47.04 160.52 0.09 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.967 -1.314 . . . . 0.0 110.325 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 18' ' ' PHE . 10.6 mt -96.9 177.69 5.54 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.218 -0.926 . . . . 0.0 110.363 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.466 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -158.72 136.25 10.16 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.297 -0.877 . . . . 0.0 110.104 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 90' ' ' ILE . 2.6 mp -141.48 121.5 13.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.148 -0.97 . . . . 0.0 110.393 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -87.44 129.65 34.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.257 -0.902 . . . . 0.0 110.336 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.514 ' NE1' HG23 ' A' ' 32' ' ' ILE . 24.5 t-105 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 110.202 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 21.5 m . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.525 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 1.2 t -114.82 2.6 14.41 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.932 -1.105 . . . . 0.0 111.974 -178.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.54 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -65.07 -100.03 0.01 OUTLIER Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.104 -1.522 . . . . 0.0 109.437 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.562 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 1.1 tmpt? -141.1 161.86 36.85 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.077 -1.249 . . . . 0.0 109.807 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.604 ' CZ ' ' HD2' ' A' ' 48' ' ' PRO . 18.7 m-85 -126.11 134.92 51.21 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.763 -1.211 . . . . 0.0 111.93 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.521 ' HE2' ' NE2' ' A' ' 37' ' ' GLN . 3.9 ttpt -109.4 120.04 41.3 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.566 -0.709 . . . . 0.0 109.652 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.527 ' CG2' HD11 ' A' ' 99' ' ' LEU . 49.0 t -60.08 131.9 25.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.866 -1.147 . . . . 0.0 108.927 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.523 ' N ' ' HA ' ' A' ' 36' ' ' VAL . 72.4 t -105.55 -27.3 3.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.545 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 5.9 tttp -156.04 133.23 10.7 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 177.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -51.84 156.38 1.48 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.555 0.693 . . . . 0.0 111.284 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.567 HD13 ' CA ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -52.88 132.61 15.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.527 -0.733 . . . . 0.0 109.991 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 33' ' ' VAL . . . -109.5 170.87 7.78 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 0.7 OUTLIER -115.78 134.29 55.17 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.73 -1.231 . . . . 0.0 110.552 -179.735 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.522 ' CG2' ' OE2' ' A' ' 80' ' ' GLU . 14.5 p -93.46 172.33 8.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.502 -0.749 . . . . 0.0 110.372 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -88.6 29.89 0.96 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.328 -0.857 . . . . 0.0 110.191 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.76 5.48 4.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.278 -0.889 . . . . 0.0 110.104 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.06 14.01 52.97 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.533 HG21 ' CG1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -110.87 -178.82 3.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.397 -1.061 . . . . 0.0 110.292 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.536 HG21 ' CD1' ' A' ' 103' ' ' TRP . 0.0 OUTLIER -137.44 152.69 27.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 178.605 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' A' ' 25' ' ' ALA . 52.9 t -118.15 130.92 72.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 121.051 -1.031 . . . . 0.0 112.357 -177.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.626 ' O ' ' HA ' ' A' ' 78' ' ' ASN . 0.3 OUTLIER -114.59 120.21 63.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.557 -0.715 . . . . 0.0 109.423 178.734 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.545 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -105.7 115.78 30.82 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.614 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.616 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.8 m -134.48 -170.74 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 C-N-CA 119.564 -0.854 . . . . 0.0 109.322 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.521 ' NE2' ' HE2' ' A' ' 19' ' ' LYS . 1.9 tt0 -132.42 127.32 35.11 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 14' ' ' CYS . 1.5 t80 -60.63 122.49 14.84 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 118.703 -1.199 . . . . 0.0 110.113 -178.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 17' ' ' LYS . 4.0 mt-10 -112.29 38.62 2.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -0.867 . . . . 0.0 109.193 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.569 ' HA3' ' CE1' ' A' ' 38' ' ' TYR . . . -125.16 -160.68 10.79 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 37.3 p-10 -135.1 85.59 2.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.516 -0.991 . . . . 0.0 110.277 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 43' ' ' SER . . . -147.83 10.04 1.21 Allowed Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.725 -1.226 . . . . 0.0 110.307 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.605 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER 46.67 -158.61 0.01 OUTLIER Pre-proline 0 N--CA 1.487 1.42 0 O-C-N 120.834 -1.392 . . . . 0.0 108.951 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.605 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 87.9 Cg_exo -43.49 95.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 122.72 0.853 . . . . 0.0 110.54 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 43' ' ' SER . 8.0 p -141.52 171.19 14.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.491 -0.756 . . . . 0.0 110.607 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.539 ' HG3' ' CD1' ' A' ' 69' ' ' ILE . 33.3 mttt -84.69 169.41 14.33 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.685 0.755 . . . . 0.0 111.627 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.589 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 12.7 mm -111.33 124.7 32.06 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.269 -0.894 . . . . 0.0 112.234 -177.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.604 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 34.5 Cg_exo -63.12 144.09 91.62 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.974 1.513 . . . . 0.0 110.815 178.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.617 ' CD2' ' CD2' ' A' ' 63' ' ' LEU . 7.6 t80 -154.97 158.88 39.89 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.299 -0.876 . . . . 0.0 110.142 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.477 ' HB3' ' HB ' ' A' ' 91' ' ' ILE . 23.9 tp10 -172.91 107.21 0.16 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.092 -1.005 . . . . 0.0 110.493 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.432 ' CD1' ' HB1' ' A' ' 81' ' ' ALA . 54.1 mt . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.885 . . . . 0.0 110.222 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.521 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.509 ' CB ' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -135.35 161.3 35.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.349 -1.089 . . . . 0.0 110.165 179.9 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.617 ' CD2' ' CD2' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -123.4 111.46 16.39 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.365 -0.835 . . . . 0.0 109.864 179.698 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.547 ' CB ' ' HG2' ' A' ' 80' ' ' GLU . 6.5 mm -70.55 -29.23 37.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 122.272 1.034 . . . . 0.0 108.297 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.632 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.257 0.7 OUTLIER -106.81 30.56 6.0 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.708 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.557 ' C ' ' O ' ' A' ' 65' ' ' THR . 39.3 t -13.04 111.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.281 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.519 ' ND2' ' HD3' ' A' ' 46' ' ' LYS . 12.6 t-20 43.43 69.32 2.39 Favored Pre-proline 0 C--N 1.298 -1.647 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.274 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.545 ' O ' ' N ' ' A' ' 47' ' ' ILE . 1.6 Cg_endo -52.19 -175.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.962 1.506 . . . . 0.0 109.319 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 68' ' ' PRO . 0.7 OUTLIER -142.7 142.67 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.961 -179.316 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.589 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 30.8 t -99.76 161.11 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.418 ' N ' HG13 ' A' ' 70' ' ' VAL . 5.6 m -115.65 -16.81 11.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.988 -1.07 . . . . 0.0 111.853 -178.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.522 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 14.1 mt-10 -141.3 19.42 2.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.665 -1.272 . . . . 0.0 111.687 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.566 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 0.0 OUTLIER 72.04 -6.37 1.52 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.15 -0.969 . . . . 0.0 111.103 179.73 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.484 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 4.9 t70 -137.8 -0.93 2.07 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.847 -1.158 . . . . 0.0 110.373 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.2 t -72.37 112.3 14.26 Favored Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 121.17 -0.956 . . . . 0.0 109.027 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 45.7 Cg_exo -49.22 126.69 16.03 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.885 1.466 . . . . 0.0 110.002 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.458 HG21 HG21 ' A' ' 70' ' ' VAL . 76.3 t -112.66 140.34 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.031 -1.043 . . . . 0.0 111.606 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.626 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.3 m120 -105.38 133.82 49.51 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.455 -0.778 . . . . 0.0 109.377 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.581 HG22 ' CE1' ' A' ' 49' ' ' PHE . 4.4 mt -118.15 119.97 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 119.984 -1.697 . . . . 0.0 111.609 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.547 ' HG2' ' CB ' ' A' ' 64' ' ' ILE . 1.6 tp10 -94.07 110.16 21.88 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.525 ' CB ' HD23 ' A' ' 63' ' ' LEU . . . -125.4 147.37 49.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.986 -1.071 . . . . 0.0 111.041 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.531 ' CA ' HG22 ' A' ' 31' ' ' THR . 3.0 tt0 -99.53 101.89 14.83 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 109.916 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.514 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 12.4 Cg_endo -61.11 143.83 99.01 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.012 1.533 . . . . 0.0 110.504 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.521 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 19.4 Cg_endo . . . . . 0 C--N 1.305 -1.759 0 O-C-N 124.051 1.553 . . . . 0.0 110.334 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 12.3 m-85 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.233 0.54 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.571 HG22 ' CZ ' ' A' ' 49' ' ' PHE . 1.4 mp -74.27 110.97 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.222 -0.924 . . . . 0.0 109.748 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.502 ' CG2' ' CD ' ' A' ' 98' ' ' GLN . 87.1 mt -92.1 142.18 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 110.152 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.55 ' CD1' HG22 ' A' ' 34' ' ' ILE . 3.6 mt -132.51 141.27 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.386 -0.821 . . . . 0.0 109.983 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.539 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 80.95 -156.7 38.41 Favored Glycine 0 N--CA 1.484 1.868 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 98' ' ' GLN . 0.2 OUTLIER -130.59 156.52 42.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.129 -1.218 . . . . 0.0 110.338 -179.548 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.509 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 3.0 mt-10 -30.33 -55.81 0.35 Allowed Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.849 -0.532 . . . . 0.0 110.848 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.509 ' CD ' ' CB ' ' A' ' 95' ' ' GLU . 73.4 Cg_exo -40.56 -36.98 1.97 Allowed 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.052 1.553 . . . . 0.0 110.686 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.562 ' HA3' ' CG ' ' A' ' 17' ' ' LYS . . . -164.71 49.04 0.29 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.557 ' N ' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -93.85 151.9 19.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.204 -1.174 . . . . 0.0 111.08 -178.57 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.527 HD11 ' CG2' ' A' ' 20' ' ' VAL . 13.6 mt -100.54 179.7 4.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.492 -0.755 . . . . 0.0 110.089 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -152.8 135.79 15.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.43 -0.794 . . . . 0.0 110.334 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.509 HD13 ' N ' ' A' ' 101' ' ' LEU . 5.2 mp -140.33 116.91 10.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.213 -0.93 . . . . 0.0 110.199 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 3.3 p-10 -87.82 120.26 28.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 0.0 110.318 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.563 ' CE3' HG22 ' A' ' 24' ' ' ILE . 50.7 t-105 . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.922 . . . . 0.0 110.227 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 20.3 m . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.527 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 0.5 OUTLIER -99.75 -1.14 38.5 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.021 -1.049 . . . . 0.0 112.363 -178.028 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.55 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -66.46 -108.12 0.01 OUTLIER Glycine 0 N--CA 1.493 2.44 0 C-N-CA 118.942 -1.599 . . . . 0.0 109.301 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.537 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -136.98 177.79 7.59 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.958 -1.319 . . . . 0.0 110.22 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.602 ' CZ ' ' HD2' ' A' ' 48' ' ' PRO . 26.7 m-85 -137.57 144.62 42.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.012 -1.055 . . . . 0.0 111.826 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.443 ' HB2' ' CG ' ' A' ' 39' ' ' GLU . 11.5 ttpt -114.54 117.84 32.05 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.702 -0.624 . . . . 0.0 109.411 179.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.517 ' CG2' HD11 ' A' ' 99' ' ' LEU . 46.1 t -59.66 132.45 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.78 -1.2 . . . . 0.0 108.958 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.522 ' CG2' ' HB2' ' A' ' 37' ' ' GLN . 73.6 t -106.84 -26.24 3.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.54 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 3.4 tttt -156.87 133.15 9.81 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -52.12 156.49 1.6 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.65 0.738 . . . . 0.0 111.374 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.573 HD13 ' CA ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -52.99 132.79 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.505 -0.747 . . . . 0.0 109.944 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 33' ' ' VAL . . . -109.62 170.9 7.77 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.5 pm0 -115.93 134.5 54.91 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.78 -1.2 . . . . 0.0 110.37 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.526 ' CG2' ' OE2' ' A' ' 80' ' ' GLU . 16.0 p -92.4 175.55 6.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.474 -0.766 . . . . 0.0 110.387 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -88.96 27.34 1.36 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.466 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -130.89 6.68 4.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.201 -0.937 . . . . 0.0 110.194 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.59 3.03 61.3 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.532 HG23 ' CA ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -96.65 -177.59 3.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.335 -1.097 . . . . 0.0 110.31 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.519 HG23 ' NE1' ' A' ' 103' ' ' TRP . 0.0 OUTLIER -138.88 153.84 25.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.668 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.495 ' N ' ' O ' ' A' ' 25' ' ' ALA . 55.5 t -119.78 130.68 73.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 O-C-N 121.003 -1.061 . . . . 0.0 112.41 -177.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.623 ' O ' ' HA ' ' A' ' 78' ' ' ASN . 0.3 OUTLIER -114.61 120.84 65.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 121.408 -0.807 . . . . 0.0 109.412 178.51 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.54 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -106.52 113.59 27.2 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.614 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.7 m -132.05 -169.78 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 C-N-CA 119.689 -0.805 . . . . 0.0 109.283 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.522 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 9.9 tt0 -134.83 127.66 31.23 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.606 ' CZ ' ' HB3' ' A' ' 14' ' ' CYS . 1.6 t80 -60.46 124.02 19.07 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 118.796 -1.161 . . . . 0.0 110.033 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.443 ' CG ' ' HB2' ' A' ' 19' ' ' LYS . 22.6 mm-40 -103.5 -22.23 13.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.243 -0.911 . . . . 0.0 109.25 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.55 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -64.94 -161.2 0.57 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.524 ' HA ' ' CD ' ' A' ' 73' ' ' LYS . 3.3 p-10 -143.21 93.98 2.56 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.598 -0.943 . . . . 0.0 110.054 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -150.92 15.24 0.9 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.606 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER 48.39 -160.0 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.366 0 O-C-N 121.033 -1.274 . . . . 0.0 109.298 179.422 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 85.7 Cg_exo -43.19 95.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 122.946 0.971 . . . . 0.0 110.622 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.53 ' SG ' ' CE2' ' A' ' 38' ' ' TYR . 11.6 p -140.94 170.92 14.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.536 -0.728 . . . . 0.0 110.637 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.548 ' HG3' ' CD1' ' A' ' 69' ' ' ILE . 20.7 mttt -87.32 165.71 15.42 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.438 -0.789 . . . . 0.0 111.413 -178.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.606 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 12.6 mm -108.64 124.87 33.12 Favored Pre-proline 0 C--N 1.303 -1.415 0 O-C-N 121.18 -0.95 . . . . 0.0 112.643 -177.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.602 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 34.7 Cg_exo -63.24 146.17 93.72 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 124.023 1.538 . . . . 0.0 110.436 178.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.635 ' CD2' ' CD2' ' A' ' 63' ' ' LEU . 10.2 t80 -155.22 160.22 40.69 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.147 -0.971 . . . . 0.0 110.6 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.518 ' O ' ' CD1' ' A' ' 91' ' ' ILE . 19.2 tp10 -177.69 115.49 0.09 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.307 -0.87 . . . . 0.0 110.212 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.456 HD11 ' HB2' ' A' ' 81' ' ' ALA . 43.4 mt . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.205 -0.934 . . . . 0.0 110.372 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.46 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -115.33 167.4 10.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -1.182 . . . . 0.0 110.039 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.635 ' CD2' ' CD2' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -130.93 110.76 11.5 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.387 -0.821 . . . . 0.0 109.916 179.672 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.534 ' CB ' ' HG2' ' A' ' 80' ' ' GLU . 4.9 mm -69.98 -25.6 28.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-O 122.15 0.976 . . . . 0.0 108.53 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.627 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.251 0.6 OUTLIER -110.95 30.1 7.17 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.658 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.559 ' C ' ' O ' ' A' ' 65' ' ' THR . 40.3 t -11.9 112.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.394 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.522 ' ND2' ' HD3' ' A' ' 46' ' ' LYS . 13.7 t-20 41.63 69.63 1.99 Allowed Pre-proline 0 C--N 1.299 -1.598 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.463 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.527 ' HG3' ' CG2' ' A' ' 65' ' ' THR . 1.4 Cg_endo -51.88 -174.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.886 1.466 . . . . 0.0 109.456 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.548 ' CD1' ' HG3' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -142.81 143.58 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 119.148 -1.021 . . . . 0.0 112.06 -179.136 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.606 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 22.2 t -101.91 159.6 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 176.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.3 m -116.67 -14.53 10.82 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.046 -1.062 . . . . 0.0 111.853 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 73' ' ' LYS . 19.6 mt-10 -142.0 22.51 2.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.619 -1.301 . . . . 0.0 111.756 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.58 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 0.8 OUTLIER 66.7 -1.57 1.29 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.095 -1.003 . . . . 0.0 111.087 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.455 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 9.7 t0 -142.47 -0.35 1.24 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.944 -1.098 . . . . 0.0 110.574 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.444 ' HB3' HG12 ' A' ' 70' ' ' VAL . 39.4 t -72.76 108.43 4.41 Favored Pre-proline 0 N--CA 1.486 1.344 0 O-C-N 120.977 -1.077 . . . . 0.0 109.218 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 2.3 Cg_endo -47.25 127.41 13.01 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.743 1.391 . . . . 0.0 109.684 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 58.7 t -115.46 143.43 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.954 -1.091 . . . . 0.0 111.611 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.623 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 4.0 m120 -106.18 134.12 49.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.551 -0.718 . . . . 0.0 109.525 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.582 HG23 ' CD1' ' A' ' 49' ' ' PHE . 4.2 mt -117.5 119.75 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 119.988 -1.695 . . . . 0.0 111.402 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.534 ' HG2' ' CB ' ' A' ' 64' ' ' ILE . 1.8 tp10 -95.24 110.74 22.68 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.509 ' CB ' HD23 ' A' ' 63' ' ' LEU . . . -126.46 150.1 48.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.077 -1.014 . . . . 0.0 111.004 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.532 ' CA ' HG23 ' A' ' 31' ' ' THR . 9.6 tp10 -101.83 101.68 19.45 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.354 -0.841 . . . . 0.0 110.127 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.519 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 20.3 Cg_endo -66.71 144.56 72.28 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.08 1.568 . . . . 0.0 110.427 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo . . . . . 0 C--N 1.303 -1.837 0 O-C-N 124.052 1.554 . . . . 0.0 110.327 179.908 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.521 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 8.1 m-85 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.231 0.539 . . . . 0.0 110.153 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.578 HG21 ' CZ ' ' A' ' 49' ' ' PHE . 1.3 mp -74.16 108.39 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -0.906 . . . . 0.0 109.482 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.518 ' CD1' ' O ' ' A' ' 50' ' ' GLU . 7.0 mt -92.09 142.37 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.131 -0.98 . . . . 0.0 110.42 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.547 ' CD1' HG21 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -129.61 138.26 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.545 -0.722 . . . . 0.0 109.521 -179.905 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.52 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 86.06 -161.87 34.9 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.554 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -121.89 148.38 25.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 O-C-N 121.264 -1.139 . . . . 0.0 110.129 -179.721 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.571 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -18.07 -58.02 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.145 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 9.3 Cg_endo -52.62 70.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 124.198 1.631 . . . . 0.0 112.148 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 91.34 2.89 70.08 Favored Glycine 0 N--CA 1.495 2.584 0 O-C-N 120.875 -1.141 . . . . 0.0 110.912 178.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.508 ' HB2' ' N ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -51.64 159.12 0.82 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.965 -1.315 . . . . 0.0 110.229 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.517 HD11 ' CG2' ' A' ' 20' ' ' VAL . 5.7 mt -96.24 174.68 6.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.224 -0.922 . . . . 0.0 110.297 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.454 ' C ' ' CD1' ' A' ' 101' ' ' LEU . 3.8 ttmt -152.71 143.09 22.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.34 -0.85 . . . . 0.0 110.328 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.524 HD23 ' CG1' ' A' ' 34' ' ' ILE . 5.6 mp -144.59 113.45 6.79 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.168 -0.957 . . . . 0.0 110.222 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 9.8 t-20 -79.64 131.18 35.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.243 -0.91 . . . . 0.0 110.334 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.519 ' NE1' HG23 ' A' ' 32' ' ' ILE . 32.5 t-105 . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 0.0 110.196 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.587 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 35.8 m . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 121.355 0.598 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.534 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 39.6 p -95.79 -5.8 41.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 111.652 -178.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.554 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -61.21 -117.65 0.01 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.542 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -138.51 173.08 11.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.956 -1.32 . . . . 0.0 110.139 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.589 ' CE1' ' HD2' ' A' ' 48' ' ' PRO . 30.8 m-85 -132.69 141.51 48.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.012 -1.055 . . . . 0.0 111.693 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.464 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 14.9 ttpt -110.51 119.84 40.47 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.627 -0.67 . . . . 0.0 109.444 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.514 ' N ' HD12 ' A' ' 99' ' ' LEU . 31.4 t -60.23 132.74 25.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 120.91 -1.119 . . . . 0.0 109.205 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.515 ' N ' ' HA ' ' A' ' 36' ' ' VAL . 90.1 t -106.04 -27.12 3.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.565 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 14.1 tttt -156.96 133.45 9.95 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -51.26 160.17 0.57 Allowed 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.702 0.763 . . . . 0.0 111.72 -178.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.565 HD11 ' CA ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -57.93 133.45 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 CA-C-O 121.579 0.704 . . . . 0.0 110.248 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' A' ' 33' ' ' VAL . . . -112.05 158.35 19.68 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.6 pm0 -110.67 132.77 53.91 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 120.295 -1.503 . . . . 0.0 110.27 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.53 ' CG2' ' OE2' ' A' ' 80' ' ' GLU . 1.8 p -91.21 175.44 6.94 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.163 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -80.8 -16.7 53.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.238 -0.914 . . . . 0.0 110.495 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -80.6 1.53 29.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 0.0 110.292 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.92 9.33 61.03 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.527 HG21 ' CA ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -98.31 174.8 6.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -1.097 . . . . 0.0 110.395 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.517 ' CG2' HG22 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -129.22 142.96 42.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.621 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.548 ' N ' ' O ' ' A' ' 25' ' ' ALA . 26.7 t -110.91 131.1 63.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 O-C-N 121.388 -0.82 . . . . 0.0 111.775 -177.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.632 ' O ' ' HA ' ' A' ' 78' ' ' ASN . 0.3 OUTLIER -119.34 121.3 66.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.456 -0.777 . . . . 0.0 109.349 178.809 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.565 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -106.14 111.62 24.31 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.737 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.62 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.5 m -131.44 -167.92 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.175 -178.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.441 ' NE2' ' HE2' ' A' ' 19' ' ' LYS . 10.6 tt0 -135.59 129.25 32.63 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.579 ' CE2' ' SG ' ' A' ' 14' ' ' CYS . 1.7 t80 -60.2 122.33 14.19 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 118.544 -1.262 . . . . 0.0 110.361 -178.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.464 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 4.6 mt-10 -112.05 39.26 2.45 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.453 -0.779 . . . . 0.0 108.973 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.576 ' HA3' ' CE1' ' A' ' 38' ' ' TYR . . . -133.06 -160.64 9.56 Favored Glycine 0 N--CA 1.484 1.894 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.46 ' HA ' ' HD2' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -121.98 141.9 50.86 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.537 -0.978 . . . . 0.0 110.267 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 154.92 -11.43 0.43 Allowed Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.857 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.607 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.7 OUTLIER 54.88 -153.29 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 120.542 -1.563 . . . . 0.0 108.119 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.607 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 83.1 Cg_exo -41.83 97.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.322 -0.864 0 N-CA-C 108.904 -1.229 . . . . 0.0 108.904 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.587 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -145.89 170.82 15.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.794 -0.567 . . . . 0.0 109.958 -177.647 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.582 ' CG ' ' CD1' ' A' ' 69' ' ' ILE . 33.8 mttm -87.29 176.11 7.7 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.417 -0.802 . . . . 0.0 111.653 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.61 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 16.2 mm -122.47 129.05 25.21 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.305 -0.872 . . . . 0.0 112.405 -178.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.589 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 24.8 Cg_exo -67.47 146.55 74.82 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.689 1.593 . . . . 0.0 111.246 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.629 ' CD2' ' CD2' ' A' ' 63' ' ' LEU . 9.7 t80 -155.53 154.55 31.93 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.419 -0.8 . . . . 0.0 109.741 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.528 ' HG2' ' CD1' ' A' ' 91' ' ' ILE . 0.3 OUTLIER -164.14 125.26 2.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.842 -1.161 . . . . 0.0 110.661 179.666 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.528 ' CG2' ' HB3' ' A' ' 83' ' ' PRO . 11.1 mt . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.493 -0.754 . . . . 0.0 109.842 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.537 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.491 ' CB ' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -122.85 165.99 15.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.174 -1.192 . . . . 0.0 110.433 -179.866 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.629 ' CD2' ' CD2' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -131.8 111.27 11.48 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.701 179.269 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.546 ' CB ' ' HG2' ' A' ' 80' ' ' GLU . 5.2 mm -69.13 -30.26 45.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-O 122.126 0.965 . . . . 0.0 108.576 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.612 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.253 0.6 OUTLIER -104.98 29.92 5.94 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.554 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.556 ' C ' ' O ' ' A' ' 65' ' ' THR . 48.0 t -12.65 110.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.247 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.474 ' ND2' ' HD3' ' A' ' 46' ' ' LYS . 19.6 t-20 44.23 69.1 2.62 Favored Pre-proline 0 C--N 1.299 -1.612 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.048 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.535 ' HG3' ' CG2' ' A' ' 65' ' ' THR . 2.3 Cg_endo -50.18 -178.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 124.033 1.544 . . . . 0.0 109.474 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.582 ' CD1' ' CG ' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -140.71 143.93 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 119.183 -1.007 . . . . 0.0 112.104 -178.89 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.61 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 20.2 t -99.78 170.33 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.413 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 5.2 m -126.73 -17.2 5.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.959 -1.088 . . . . 0.0 111.173 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 7.4 mt-10 -140.01 15.67 2.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.944 -1.097 . . . . 0.0 110.918 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 11.4 ttpp 73.59 -7.11 1.63 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.307 -0.871 . . . . 0.0 110.781 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.458 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 5.3 t70 -137.68 1.46 2.34 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.024 -1.048 . . . . 0.0 110.096 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.419 ' HA ' ' HD2' ' A' ' 76' ' ' PRO . 12.4 t -72.74 108.28 4.21 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 121.128 -0.982 . . . . 0.0 108.921 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.574 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 1.9 Cg_endo -47.52 130.19 17.7 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.801 1.421 . . . . 0.0 110.071 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 60.1 t -118.01 145.43 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.022 -1.049 . . . . 0.0 111.415 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.632 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 3.9 m120 -105.6 134.53 48.56 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.511 -0.743 . . . . 0.0 109.537 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.578 HG22 ' CE1' ' A' ' 49' ' ' PHE . 3.4 mt -117.88 119.89 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 119.953 -1.717 . . . . 0.0 111.358 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.546 ' HG2' ' CB ' ' A' ' 64' ' ' ILE . 2.4 tp10 -95.45 106.86 18.97 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . . . -112.19 147.39 36.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.09 -1.006 . . . . 0.0 110.655 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.527 ' CA ' HG21 ' A' ' 31' ' ' THR . 3.0 tt0 -113.2 53.89 0.53 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.408 -0.807 . . . . 0.0 110.932 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.537 ' HA ' ' CA ' ' A' ' 61' ' ' GLY . 23.1 Cg_endo -66.16 159.74 48.21 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 123.675 1.355 . . . . 0.0 110.402 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.402 ' HD3' ' HA2' ' A' ' 61' ' ' GLY . 11.5 Cg_endo . . . . . 0 C--N 1.305 -1.716 0 O-C-N 123.948 1.499 . . . . 0.0 109.827 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 24.6 m-85 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.228 0.537 . . . . 0.0 111.853 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.526 ' CG2' HD13 ' A' ' 101' ' ' LEU . 0.7 OUTLIER -74.46 168.25 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.017 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.528 ' CD1' ' HG2' ' A' ' 50' ' ' GLU . 94.7 mt -131.21 143.36 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.318 -1.489 . . . . 0.0 111.868 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.552 ' CD1' HG21 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -133.96 138.06 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.502 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.532 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 86.18 -158.96 32.07 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.541 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -123.89 149.53 28.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 O-C-N 121.061 -1.258 . . . . 0.0 110.411 -179.462 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.571 ' O ' ' N ' ' A' ' 97' ' ' GLY . 5.4 mt-10 -20.35 -57.39 0.07 OUTLIER Pre-proline 0 N--CA 1.501 2.078 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.563 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 9.7 Cg_endo -53.9 70.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 124.108 1.583 . . . . 0.0 111.898 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 91.42 6.75 65.9 Favored Glycine 0 N--CA 1.494 2.512 0 O-C-N 120.967 -1.083 . . . . 0.0 110.896 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.502 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -52.42 161.21 0.71 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.972 -1.31 . . . . 0.0 110.019 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.527 ' CD1' ' O ' ' A' ' 18' ' ' PHE . 4.9 mt -95.77 170.06 9.58 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.189 -0.944 . . . . 0.0 110.773 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -152.61 142.74 22.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.5 -0.75 . . . . 0.0 109.722 179.573 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.526 HD13 ' CG2' ' A' ' 90' ' ' ILE . 4.0 mp -138.89 117.68 12.32 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.98 -1.075 . . . . 0.0 110.878 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -59.92 146.26 42.93 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.283 -0.886 . . . . 0.0 110.201 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 9.1 t-105 . . . . . 0 N--CA 1.488 1.438 0 O-C-N 121.212 -0.93 . . . . 0.0 110.417 -179.248 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 mtt . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.255 0.55 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -115.19 24.7 11.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -0.894 . . . . 0.0 110.177 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -117.02 151.66 36.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.227 -0.921 . . . . 0.0 110.279 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.477 ' C ' ' CG ' ' A' ' 5' ' ' GLN . 0.3 OUTLIER -166.74 62.08 0.09 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.181 -0.95 . . . . 0.0 110.15 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.477 ' CG ' ' C ' ' A' ' 4' ' ' LEU . 59.4 mt-30 -153.45 -46.26 0.09 Allowed 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.294 -0.879 . . . . 0.0 110.259 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.54 78.69 3.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.21 -0.931 . . . . 0.0 110.234 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.33 101.75 13.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 110.169 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 132.34 131.77 3.25 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 47.49 53.37 11.14 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.223 -1.163 . . . . 0.0 110.125 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.7 p -130.02 160.49 33.5 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.306 -0.871 . . . . 0.0 110.253 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.544 ' CZ ' ' HB2' ' A' ' 44' ' ' PRO . 1.3 t80 -149.16 -74.48 0.17 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.351 -0.843 . . . . 0.0 109.613 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.517 ' HB3' ' HA ' ' A' ' 45' ' ' CYS . 3.6 t -142.84 -122.29 0.09 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.174 -0.954 . . . . 0.0 109.199 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.442 ' HB3' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -176.91 98.24 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.724 -1.235 . . . . 0.0 110.075 179.529 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 20.7 m -62.85 93.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.386 -0.821 . . . . 0.0 109.002 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.471 ' O ' ' O ' ' A' ' 16' ' ' GLY . 5.9 t -88.79 -6.82 57.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.138 -0.976 . . . . 0.0 111.755 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.497 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -61.2 -129.74 0.01 OUTLIER Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.529 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -125.09 177.99 5.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.228 -1.16 . . . . 0.0 110.008 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.601 ' CE1' ' HD2' ' A' ' 48' ' ' PRO . 33.0 m-85 -135.36 142.85 45.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.925 -1.11 . . . . 0.0 111.638 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.432 ' HE2' ' HB3' ' A' ' 37' ' ' GLN . 37.6 ttpt -113.43 117.68 32.4 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.501 ' CG2' HD11 ' A' ' 99' ' ' LEU . 54.9 t -59.3 124.54 13.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 120.659 -1.276 . . . . 0.0 109.501 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.509 ' CG1' ' HG2' ' A' ' 35' ' ' ARG . 70.3 t -98.07 -29.62 3.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.58 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 0.5 OUTLIER -150.46 138.05 19.78 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.391 0.615 . . . . 0.0 109.887 177.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -56.15 153.43 9.22 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.297 0.57 . . . . 0.0 110.261 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.573 HG22 ' CE3' ' A' ' 103' ' ' TRP . 0.6 OUTLIER -49.35 131.3 7.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.109 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.529 ' O ' ' CG2' ' A' ' 32' ' ' ILE . . . -108.47 172.1 7.04 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 16.8 pt-20 -113.0 130.67 56.05 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.881 -1.137 . . . . 0.0 110.335 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.51 ' O ' ' CB ' ' A' ' 28' ' ' GLN . 17.5 p -74.99 0.41 15.96 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.461 -0.774 . . . . 0.0 110.292 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.51 ' CB ' ' O ' ' A' ' 27' ' ' THR . 0.5 OUTLIER 70.03 10.69 7.49 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.302 -0.874 . . . . 0.0 110.131 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.42 11.55 6.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.918 . . . . 0.0 110.292 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.453 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 110.17 -20.19 26.33 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.59 ' CG2' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -92.1 -174.27 3.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.224 -1.162 . . . . 0.0 110.476 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -148.38 160.24 6.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.745 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.515 ' CG1' ' HB3' ' A' ' 78' ' ' ASN . 99.0 t -123.58 131.54 72.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 C-N-CA 118.982 -1.087 . . . . 0.0 111.752 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 78' ' ' ASN . 0.3 OUTLIER -114.91 114.29 46.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.431 -0.793 . . . . 0.0 109.741 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.58 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -95.27 125.79 40.15 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.058 -1.026 . . . . 0.0 108.467 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.589 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.8 m -150.13 159.11 5.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.274 -0.891 . . . . 0.0 108.609 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 74' ' ' ASP 0.26 25.6 tt0 -103.85 124.7 49.43 Favored 'General case' 0 C--N 1.27 -2.872 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -179.165 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 14' ' ' CYS . 1.2 t80 -60.75 122.35 14.58 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 119.016 -1.074 . . . . 0.0 110.509 -178.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 17' ' ' LYS . 23.1 mm-40 -106.87 152.06 24.4 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.374 -0.829 . . . . 0.0 108.921 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.519 ' O ' ' CE ' ' A' ' 73' ' ' LYS . . . 105.7 -145.75 15.97 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.455 ' O ' ' OH ' ' A' ' 38' ' ' TYR . 0.5 OUTLIER -130.4 127.95 40.38 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.525 -0.986 . . . . 0.0 109.942 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.04 -29.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.331 -1.414 . . . . 0.0 110.854 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.632 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.4 OUTLIER 56.39 -154.09 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 120.621 -1.517 . . . . 0.0 108.224 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.632 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 44.9 Cg_exo -52.23 89.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 N-CA-C 109.811 -0.88 . . . . 0.0 109.811 179.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.526 ' SG ' ' O ' ' A' ' 43' ' ' SER . 10.0 p -142.12 174.57 10.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.928 . . . . 0.0 110.636 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.605 ' HG3' ' CD1' ' A' ' 69' ' ' ILE . 2.3 mtpt -87.73 162.49 17.02 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.041 0.924 . . . . 0.0 111.915 -178.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.616 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 14.9 mm -105.44 124.24 36.97 Favored Pre-proline 0 C--N 1.3 -1.546 0 O-C-N 121.635 -0.665 . . . . 0.0 111.487 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.601 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 31.4 Cg_exo -62.14 145.12 96.48 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.064 1.56 . . . . 0.0 110.746 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.598 ' CE2' ' CG2' ' A' ' 79' ' ' ILE . 5.0 t80 -153.76 154.26 33.7 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.495 -0.753 . . . . 0.0 109.187 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.533 ' O ' ' CG2' ' A' ' 51' ' ' ILE . 18.3 tt0 -157.51 115.4 3.11 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.884 -1.135 . . . . 0.0 110.335 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.552 ' CG2' ' HA ' ' A' ' 90' ' ' ILE . 19.4 pt -159.64 70.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.485 ' O ' ' HB3' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -129.08 -67.65 0.77 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.1 -1.0 . . . . 0.0 110.777 -179.49 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.485 ' HB3' ' O ' ' A' ' 52' ' ' MET . 1.2 p-10 172.67 -161.39 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.306 -0.871 . . . . 0.0 110.333 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.45 ' HB3' ' O ' ' A' ' 53' ' ' ASP . 11.1 tp 58.59 -105.36 0.25 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 0.0 110.044 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.14 18.83 4.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.923 -1.111 . . . . 0.0 109.658 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.537 ' CD ' ' N ' ' A' ' 56' ' ' LYS . 8.5 mptt -98.93 -10.33 22.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.431 -0.793 . . . . 0.0 110.221 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.432 ' CB ' ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER 66.19 18.29 10.92 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.226 -0.921 . . . . 0.0 110.086 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.586 ' NE2' ' CB ' ' A' ' 88' ' ' SER . 0.5 OUTLIER -125.72 -140.0 0.28 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.887 . . . . 0.0 110.253 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.535 ' CG2' ' N ' ' A' ' 60' ' ' LEU . 3.7 m -141.0 -42.98 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.188 -0.945 . . . . 0.0 110.376 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.535 ' N ' ' CG2' ' A' ' 59' ' ' VAL . 0.1 OUTLIER 176.88 81.77 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.098 -1.001 . . . . 0.0 110.757 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.534 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . -97.4 168.96 24.48 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.481 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -131.49 166.89 20.34 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.18 -1.188 . . . . 0.0 110.515 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.581 HD22 ' CD1' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -121.87 121.02 36.2 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.301 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.59 ' CD1' ' CG2' ' A' ' 31' ' ' THR . 1.6 mp -85.98 -27.42 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 106.706 -1.591 . . . . 0.0 106.706 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.587 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.255 3.0 m -110.75 42.8 1.53 Allowed 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.338 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.594 ' CG1' ' ND2' ' A' ' 67' ' ' ASN . 6.7 t -30.94 133.06 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 121.275 0.56 . . . . 0.0 111.021 -178.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.594 ' ND2' ' CG1' ' A' ' 66' ' ' VAL . 23.0 p30 27.52 74.92 0.35 Allowed Pre-proline 0 N--CA 1.488 1.458 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.575 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.511 ' O ' ' HA ' ' A' ' 46' ' ' LYS . 8.4 Cg_endo -60.8 -171.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.707 1.372 . . . . 0.0 108.851 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.605 ' CD1' ' HG3' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -142.79 144.49 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.816 -1.177 . . . . 0.0 112.227 -179.157 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.616 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 43.7 t -100.66 156.76 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 175.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.413 ' N ' HG13 ' A' ' 70' ' ' VAL . 11.8 m -111.28 -20.8 12.17 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.791 -1.164 . . . . 0.0 111.224 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 7.4 mt-10 -132.25 15.9 4.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.842 -1.161 . . . . 0.0 111.244 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.522 ' O ' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER 71.63 -4.18 1.96 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.259 -0.901 . . . . 0.0 110.87 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.483 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 5.5 t70 -137.31 -0.04 2.26 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.885 -1.134 . . . . 0.0 110.26 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.9 t -73.07 112.24 14.74 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.244 -0.91 . . . . 0.0 109.248 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 74' ' ' ASP . 33.2 Cg_exo -51.38 112.87 0.91 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.783 1.412 . . . . 0.0 109.738 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.1 130.74 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.322 -0.861 . . . . 0.0 111.516 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.59 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 12.0 m-80 -93.12 135.26 34.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.401 -0.812 . . . . 0.0 108.972 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.598 ' CG2' ' CE2' ' A' ' 49' ' ' PHE . 6.1 mt -114.53 117.26 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 117.69 -1.604 . . . . 0.0 111.979 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.561 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 0.8 OUTLIER -86.03 114.14 22.67 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.333 179.362 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.514 ' CB ' HD23 ' A' ' 63' ' ' LEU . . . -133.45 153.28 51.74 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.024 -1.048 . . . . 0.0 110.505 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 0.8 OUTLIER -101.56 101.95 19.91 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.186 -0.946 . . . . 0.0 110.425 -179.611 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.574 ' HG2' ' CD2' ' A' ' 104' ' ' PHE . 33.7 Cg_endo -70.57 142.41 44.31 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.127 1.593 . . . . 0.0 110.325 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.576 ' HG2' ' CE1' ' A' ' 58' ' ' HIS . 32.3 Cg_endo -71.97 -75.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.09 1.574 . . . . 0.0 110.348 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.61 ' CD1' ' N ' ' A' ' 86' ' ' GLY . 50.5 t80 -179.43 168.45 1.45 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.243 -0.91 . . . . 0.0 110.18 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.61 ' N ' ' CD1' ' A' ' 85' ' ' PHE . . . 64.56 -176.13 11.18 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 89' ' ' TYR . 6.1 m-20 -46.06 114.1 0.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -1.15 . . . . 0.0 109.999 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.586 ' CB ' ' NE2' ' A' ' 58' ' ' HIS . 34.9 m -117.17 93.17 4.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.185 -0.947 . . . . 0.0 110.567 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.575 ' CZ ' ' HB3' ' A' ' 87' ' ' ASP . 19.9 m-85 -85.15 100.97 12.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.225 -0.922 . . . . 0.0 109.963 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.583 ' CG2' ' CZ ' ' A' ' 49' ' ' PHE . 2.2 mt -73.9 133.74 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 109.544 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.501 ' HB ' ' HB3' ' A' ' 50' ' ' GLU . 84.6 mt -106.2 134.62 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.908 -1.12 . . . . 0.0 110.583 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.554 ' CD1' HG23 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -124.21 144.87 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.492 -0.755 . . . . 0.0 109.569 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.542 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 82.68 -162.67 41.56 Favored Glycine 0 N--CA 1.482 1.714 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.555 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -119.78 146.88 23.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 O-C-N 121.257 -1.143 . . . . 0.0 109.932 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.569 ' O ' ' N ' ' A' ' 97' ' ' GLY . 3.9 mt-10 -17.85 -58.22 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.181 0 N-CA-C 111.655 0.242 . . . . 0.0 111.655 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 10.0 Cg_endo -53.17 71.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 124.112 1.585 . . . . 0.0 111.962 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 92.73 1.59 67.96 Favored Glycine 0 N--CA 1.495 2.605 0 O-C-N 120.97 -1.082 . . . . 0.0 111.04 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.499 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -50.04 160.81 0.31 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.895 -1.356 . . . . 0.0 109.839 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' A' ' 18' ' ' PHE . 8.7 mt -98.96 175.78 5.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.102 -0.999 . . . . 0.0 111.053 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.467 ' HG3' HG12 ' A' ' 91' ' ' ILE . 0.8 OUTLIER -154.72 137.5 15.3 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.559 -0.713 . . . . 0.0 109.811 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.583 ' N ' ' CD1' ' A' ' 101' ' ' LEU . 2.0 mp -143.33 125.54 15.5 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.094 -1.004 . . . . 0.0 110.527 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.515 ' HB2' ' CD1' ' A' ' 89' ' ' TYR . 32.4 t30 -90.35 133.79 34.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.286 -0.884 . . . . 0.0 110.403 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.573 ' CE3' HG22 ' A' ' 24' ' ' ILE . 60.5 t-105 -145.88 173.04 12.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.353 -0.842 . . . . 0.0 110.31 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.574 ' CD2' ' HG2' ' A' ' 83' ' ' PRO . 0.2 OUTLIER 67.67 -74.97 0.07 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.319 -0.863 . . . . 0.0 110.44 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.465 ' HA ' ' N ' ' A' ' 87' ' ' ASP . 1.6 tttp 64.79 -155.52 0.29 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.943 . . . . 0.0 110.154 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.422 ' CG ' ' N ' ' A' ' 107' ' ' GLY . 0.0 OUTLIER -76.4 -89.67 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.308 -0.87 . . . . 0.0 110.214 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.422 ' N ' ' CG ' ' A' ' 106' ' ' LYS . . . -127.36 -38.06 0.43 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.11 164.82 21.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.216 -1.167 . . . . 0.0 110.139 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.55 139.36 35.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.326 -0.859 . . . . 0.0 110.174 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.466 ' O ' ' N ' ' A' ' 112' ' ' HIS . 28.8 tp 53.38 81.76 0.09 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 110.233 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -61.21 80.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.247 -0.908 . . . . 0.0 110.248 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.466 ' N ' ' O ' ' A' ' 110' ' ' LEU . 1.6 t-80 -84.07 93.82 8.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -0.895 . . . . 0.0 110.262 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 30.0 m-70 -157.85 135.99 10.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.313 -0.867 . . . . 0.0 110.184 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -167.33 133.06 2.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.18 -0.95 . . . . 0.0 110.226 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -92.85 160.02 15.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.907 . . . . 0.0 110.169 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -160.25 -49.34 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 110.213 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 10.5 t60 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.267 179.977 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mtm . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.267 0.556 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.93 60.87 1.0 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.915 . . . . 0.0 110.162 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.77 29.58 7.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.913 . . . . 0.0 110.209 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.442 ' O ' ' CB ' ' A' ' 5' ' ' GLN . 6.4 tp -51.73 120.3 5.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.279 -0.888 . . . . 0.0 110.169 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.442 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER 171.49 87.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.171 -0.955 . . . . 0.0 110.217 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.477 ' O ' ' N ' ' A' ' 8' ' ' GLY . 1.4 tp -85.22 60.58 6.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.2 -0.938 . . . . 0.0 110.242 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.62 -82.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.294 -0.879 . . . . 0.0 110.194 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 6' ' ' LEU . . . -166.44 -40.09 0.02 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.8 ttm -135.14 -69.42 0.51 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.172 -1.193 . . . . 0.0 110.281 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.47 144.74 17.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.179 -0.951 . . . . 0.0 110.319 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -87.83 -74.09 0.46 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.297 -0.877 . . . . 0.0 109.698 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.554 ' HB3' ' CB ' ' A' ' 45' ' ' CYS . 3.3 t -145.61 -27.09 0.45 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.267 -0.896 . . . . 0.0 111.135 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.486 ' HB3' ' O ' ' A' ' 12' ' ' SER . 8.3 ttt 60.16 91.1 0.05 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.361 -0.837 . . . . 0.0 109.471 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 32.7 m -49.14 138.57 12.0 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.469 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 0.9 OUTLIER -126.6 -17.08 5.14 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.528 -1.357 . . . . 0.0 111.965 -178.468 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.539 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -59.77 -117.1 0.01 OUTLIER Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.4 -1.381 . . . . 0.0 109.786 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.536 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -135.35 -179.9 5.92 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.963 -1.316 . . . . 0.0 110.324 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.592 ' CE2' ' HD2' ' A' ' 48' ' ' PRO . 31.0 m-85 -136.57 149.67 48.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.04 -1.038 . . . . 0.0 111.851 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.438 ' HB2' ' CG ' ' A' ' 39' ' ' GLU . 17.6 ttpt -116.6 118.76 33.49 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.655 -0.653 . . . . 0.0 109.557 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.524 HG22 ' CD1' ' A' ' 99' ' ' LEU . 51.3 t -59.63 131.52 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.784 -1.198 . . . . 0.0 108.772 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.529 ' CG2' ' HB2' ' A' ' 37' ' ' GLN . 76.8 t -105.62 -26.44 3.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.545 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 12.5 tttt -157.53 133.34 9.3 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -52.47 155.39 2.15 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.535 0.683 . . . . 0.0 111.243 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.586 HD13 ' CA ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -49.76 133.22 8.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 C-N-CA 119.996 -0.681 . . . . 0.0 109.957 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.504 ' O ' ' CG2' ' A' ' 32' ' ' ILE . . . -108.24 171.52 7.36 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.2 pm0 -116.91 132.62 56.65 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.87 -1.144 . . . . 0.0 110.454 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.457 ' OG1' ' OG1' ' A' ' 31' ' ' THR . 13.7 p -90.57 179.61 5.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.334 -0.854 . . . . 0.0 110.127 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -93.25 29.86 1.81 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -0.93 . . . . 0.0 110.379 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.53 6.89 3.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 110.357 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.42 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 95.64 5.56 60.04 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.582 ' CG2' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -98.86 -173.1 2.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.316 -1.108 . . . . 0.0 110.135 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.581 HG21 ' CD1' ' A' ' 103' ' ' TRP . 0.0 OUTLIER -144.33 159.42 15.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 85.5 t -125.28 128.72 72.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 O-C-N 120.864 -1.148 . . . . 0.0 112.457 -177.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.627 ' O ' ' HA ' ' A' ' 78' ' ' ASN . 0.3 OUTLIER -110.81 118.16 56.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.379 -0.826 . . . . 0.0 109.476 178.672 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.545 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -103.77 114.76 29.26 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.61 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.8 m -133.95 -172.15 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.223 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.529 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 10.9 tt0 -132.37 126.79 34.05 Favored 'General case' 0 C--N 1.276 -2.615 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 14' ' ' CYS . 1.5 t80 -60.55 123.99 19.03 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 118.716 -1.194 . . . . 0.0 109.92 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.438 ' CG ' ' HB2' ' A' ' 19' ' ' LYS . 43.4 mm-40 -103.65 -21.95 13.65 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.124 -0.985 . . . . 0.0 109.156 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.539 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -67.17 -164.85 2.25 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.467 ' HA ' ' HG3' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -137.63 94.04 2.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.578 -0.954 . . . . 0.0 109.976 179.716 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 43' ' ' SER . . . -149.12 12.19 1.06 Allowed Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.348 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.603 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER 47.31 -158.65 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.352 0 O-C-N 120.788 -1.419 . . . . 0.0 109.127 179.491 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.603 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 89.2 Cg_exo -42.86 94.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 122.87 0.931 . . . . 0.0 110.186 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.554 ' CB ' ' HB3' ' A' ' 12' ' ' SER . 25.7 p -143.13 163.77 31.96 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.742 -0.599 . . . . 0.0 109.566 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.567 ' O ' ' N ' ' A' ' 14' ' ' CYS . 1.6 mttt -86.65 156.9 19.81 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.027 -1.046 . . . . 0.0 111.428 -178.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.6 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 11.3 mm -99.72 125.07 41.85 Favored Pre-proline 0 C--N 1.294 -1.83 0 O-C-N 121.474 -0.766 . . . . 0.0 111.808 -177.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.592 ' HD2' ' CE2' ' A' ' 18' ' ' PHE . 33.2 Cg_exo -60.85 148.17 93.08 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.223 1.644 . . . . 0.0 111.046 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.631 ' CE2' ' CG2' ' A' ' 79' ' ' ILE . 4.9 t80 -154.22 151.54 29.28 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.487 -0.758 . . . . 0.0 109.582 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.49 ' HB3' ' HB ' ' A' ' 91' ' ' ILE . 3.8 tp10 -162.76 113.59 1.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.806 -1.184 . . . . 0.0 110.761 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.9 mt -112.24 128.04 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.388 -0.82 . . . . 0.0 109.744 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.517 ' HG2' ' CG ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -153.7 -49.87 0.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.047 -1.033 . . . . 0.0 110.69 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.573 ' OD2' ' CE2' ' A' ' 89' ' ' TYR . 16.3 t70 45.21 80.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.023 -1.048 . . . . 0.0 110.11 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.509 ' CB ' ' O ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER 69.49 4.53 4.71 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.171 -0.955 . . . . 0.0 110.267 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.411 ' OE1' HD12 ' A' ' 60' ' ' LEU . 1.4 tm-20 -136.36 52.11 1.98 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.286 -0.884 . . . . 0.0 110.002 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.517 ' CG ' ' HG2' ' A' ' 52' ' ' MET . 0.0 OUTLIER -97.85 25.65 5.77 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.403 -0.811 . . . . 0.0 110.209 -179.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.84 -10.69 14.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -0.899 . . . . 0.0 109.891 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -141.7 -143.48 0.15 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.401 -0.812 . . . . 0.0 110.064 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.6 t -121.91 124.24 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.225 -0.922 . . . . 0.0 110.343 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.411 HD12 ' OE1' ' A' ' 55' ' ' GLU . 0.6 OUTLIER -134.32 -76.6 0.47 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.905 . . . . 0.0 110.19 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.519 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . -67.1 164.24 44.18 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.482 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -131.3 170.51 14.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -1.148 . . . . 0.0 110.465 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.582 HD23 ' CD1' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -124.19 121.63 35.61 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.553 -0.717 . . . . 0.0 109.678 179.314 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.588 ' CD1' ' N ' ' A' ' 64' ' ' ILE . 1.5 mp -85.11 -24.47 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.59 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.258 2.9 m -115.29 38.43 3.23 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.583 ' CG1' ' ND2' ' A' ' 67' ' ' ASN . 10.5 t -25.41 132.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 121.347 0.594 . . . . 0.0 111.5 -178.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.583 ' ND2' ' CG1' ' A' ' 66' ' ' VAL . 25.4 p30 30.47 70.23 0.63 Allowed Pre-proline 0 C--N 1.303 -1.446 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.745 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.56 ' O ' ' HA ' ' A' ' 46' ' ' LYS . 1.2 Cg_endo -55.74 -175.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.644 0 N-CA-C 107.977 -1.586 . . . . 0.0 107.977 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.538 HG12 ' HA ' ' A' ' 46' ' ' LYS . 1.1 mt -144.93 146.12 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 C-N-CA 118.56 -1.256 . . . . 0.0 112.174 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.6 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 22.0 t -102.26 157.82 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.1 m -114.26 -16.12 12.07 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 118.973 -1.091 . . . . 0.0 111.656 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.527 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 12.4 mt-10 -136.75 16.55 3.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.574 -1.329 . . . . 0.0 111.619 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.557 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 2.4 ttpt 71.57 -5.08 1.71 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.149 -0.969 . . . . 0.0 110.994 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.48 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 5.1 t70 -137.86 -1.51 2.0 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.969 -1.082 . . . . 0.0 110.32 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.2 t -72.36 112.24 14.01 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.209 -0.932 . . . . 0.0 109.259 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 49.7 Cg_exo -48.51 126.51 14.29 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.828 1.436 . . . . 0.0 109.744 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.469 HG23 HG23 ' A' ' 70' ' ' VAL . 74.8 t -114.31 133.41 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.015 -1.053 . . . . 0.0 111.45 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.627 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 5.3 m-80 -99.65 131.8 45.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.493 -0.754 . . . . 0.0 109.12 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.631 ' CG2' ' CE2' ' A' ' 49' ' ' PHE . 10.9 mt -114.17 119.62 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.099 -1.626 . . . . 0.0 111.636 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.541 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 1.7 tp10 -92.4 118.59 31.09 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.94 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . . . -135.93 152.55 51.1 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.006 -1.059 . . . . 0.0 110.78 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.529 ' CA ' HG23 ' A' ' 31' ' ' THR . 2.0 tt0 -102.36 102.63 26.32 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.367 -0.833 . . . . 0.0 110.266 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.53 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 35.7 Cg_endo -71.96 151.56 56.45 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.086 1.571 . . . . 0.0 110.564 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.575 ' O ' ' CG ' ' A' ' 85' ' ' PHE . 15.5 Cg_endo -62.74 -79.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.081 1.569 . . . . 0.0 110.249 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.575 ' CG ' ' O ' ' A' ' 84' ' ' PRO . 2.6 m-85 -173.32 151.57 2.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.915 . . . . 0.0 110.214 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.44 -162.72 54.22 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.408 ' O ' ' CB ' ' A' ' 88' ' ' SER . 51.7 p-10 -55.96 176.69 0.07 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.298 -1.119 . . . . 0.0 110.126 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.451 ' HA ' ' HB2' ' A' ' 53' ' ' ASP . 0.5 OUTLIER 173.91 131.37 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.194 -0.941 . . . . 0.0 110.325 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.573 ' CE2' ' OD2' ' A' ' 53' ' ' ASP . 15.4 m-85 -105.02 100.01 9.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.137 -0.977 . . . . 0.0 110.085 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.606 ' CG2' ' CZ ' ' A' ' 49' ' ' PHE . 1.3 mp -73.94 125.03 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.21 -0.931 . . . . 0.0 109.447 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.498 ' CG2' ' CD ' ' A' ' 98' ' ' GLN . 81.0 mt -96.5 144.14 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.156 -0.965 . . . . 0.0 110.503 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.552 ' CD1' HG23 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -129.76 137.87 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.502 -0.749 . . . . 0.0 109.596 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 48' ' ' PRO . . . 86.7 -163.78 35.43 Favored Glycine 0 N--CA 1.481 1.681 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.57 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -118.15 143.92 27.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 O-C-N 121.049 -1.265 . . . . 0.0 110.32 -179.478 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.576 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -14.54 -59.26 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.139 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -179.692 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.553 ' CD ' ' CB ' ' A' ' 95' ' ' GLU . 5.9 Cg_endo -49.86 74.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 124.235 1.65 . . . . 0.0 111.752 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 86.68 -2.37 87.25 Favored Glycine 0 N--CA 1.494 2.519 0 O-C-N 121.045 -1.034 . . . . 0.0 111.096 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.498 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -43.41 162.73 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.812 -1.405 . . . . 0.0 109.897 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.524 ' CD1' HG22 ' A' ' 20' ' ' VAL . 10.5 mt -98.91 174.88 6.15 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.069 -1.019 . . . . 0.0 110.889 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.46 ' HG3' HG12 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -152.1 130.32 11.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.603 -0.686 . . . . 0.0 109.871 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 89' ' ' TYR . 4.2 mp -131.73 123.9 28.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.145 -0.972 . . . . 0.0 110.394 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -86.96 128.98 35.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.325 -0.859 . . . . 0.0 110.207 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.581 ' CD1' HG21 ' A' ' 32' ' ' ILE . 61.7 t-105 -136.69 169.07 18.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.16 -0.963 . . . . 0.0 110.275 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 104' ' ' PHE . 16.9 p90 -137.7 149.59 46.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.286 -0.883 . . . . 0.0 110.261 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.0 138.63 28.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -0.925 . . . . 0.0 110.198 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.2 pttm -158.58 152.31 23.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.908 . . . . 0.0 110.162 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 162.37 -147.0 12.62 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.9 t -57.01 134.53 55.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -1.103 . . . . 0.0 110.219 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 54.5 p -172.99 95.7 0.12 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.315 -0.865 . . . . 0.0 110.149 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.93 -65.77 0.64 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.231 -0.918 . . . . 0.0 110.256 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 55.98 83.04 0.1 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 110.18 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -135.35 -44.57 0.69 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.224 -0.923 . . . . 0.0 110.239 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -62.7 176.21 0.7 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.268 -0.895 . . . . 0.0 110.095 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.418 ' ND1' ' O ' ' A' ' 114' ' ' HIS . 21.3 t-80 -98.93 90.53 4.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.296 -0.878 . . . . 0.0 110.363 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -86.36 129.04 34.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 110.155 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.419 ' CD2' ' O ' ' A' ' 116' ' ' HIS . 15.2 t-160 -129.84 40.9 3.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.279 -0.888 . . . . 0.0 110.276 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.207 179.978 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.28 0.562 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 4' ' ' LEU . 2.9 p-10 -165.82 171.39 12.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 110.255 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 53.18 -88.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.283 -0.886 . . . . 0.0 110.248 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 2' ' ' ASP . 0.7 OUTLIER -72.16 -151.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.239 -0.913 . . . . 0.0 110.137 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.445 ' CG ' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER 172.23 -84.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.203 -0.936 . . . . 0.0 110.114 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.474 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 11.3 mp 43.79 -163.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.311 -0.868 . . . . 0.0 110.215 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER 178.03 37.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.238 -0.914 . . . . 0.0 110.185 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.3 49.76 3.39 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -112.93 18.05 18.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -1.18 . . . . 0.0 110.262 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.528 ' HA ' ' CE ' ' A' ' 46' ' ' LYS . 19.5 t -81.84 162.34 22.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 110.238 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -137.29 -74.05 0.42 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.283 -0.886 . . . . 0.0 110.373 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.467 ' O ' ' HB3' ' A' ' 13' ' ' MET . 3.2 t -136.94 -5.0 1.92 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.998 -1.064 . . . . 0.0 111.258 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.511 ' HG2' ' CG2' ' A' ' 15' ' ' THR . 21.7 ttm 56.6 85.42 0.08 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.946 -1.096 . . . . 0.0 108.923 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.596 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 39.6 m -57.57 98.04 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.449 -0.782 . . . . 0.0 109.31 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.539 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 3.7 p -95.52 -1.98 49.53 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.18 -0.95 . . . . 0.0 112.07 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.556 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -66.84 -110.59 0.01 OUTLIER Glycine 0 N--CA 1.49 2.295 0 C-N-CA 118.844 -1.645 . . . . 0.0 109.048 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.53 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -143.47 173.62 11.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.985 -1.303 . . . . 0.0 110.103 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.603 ' CE1' ' HD2' ' A' ' 48' ' ' PRO . 33.6 m-85 -133.66 151.12 51.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.993 -1.067 . . . . 0.0 111.631 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.495 ' HE2' ' NE2' ' A' ' 37' ' ' GLN . 5.2 ttpt -117.75 115.95 26.04 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.61 -0.681 . . . . 0.0 109.239 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.487 ' CG2' HD13 ' A' ' 99' ' ' LEU . 40.6 t -59.67 124.7 14.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 120.655 -1.278 . . . . 0.0 109.131 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.54 ' HB ' ' CG ' ' A' ' 35' ' ' ARG . 60.6 t -98.25 -26.37 3.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.602 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 7.7 tttt -158.06 133.6 8.95 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -50.58 160.22 0.44 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.618 0.723 . . . . 0.0 111.465 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.563 HD11 ' CA ' ' A' ' 34' ' ' ILE . 0.7 OUTLIER -55.24 132.88 18.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 121.545 0.688 . . . . 0.0 110.277 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.478 ' O ' HG21 ' A' ' 32' ' ' ILE . . . -108.94 168.19 9.54 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 4.2 pm0 -114.77 134.65 54.94 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.613 -1.304 . . . . 0.0 110.695 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.46 ' OG1' ' OG1' ' A' ' 31' ' ' THR . 9.5 p -91.79 172.06 8.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.521 -0.737 . . . . 0.0 110.041 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -87.85 31.03 0.79 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.234 -0.916 . . . . 0.0 110.378 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.95 6.38 3.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.244 -0.91 . . . . 0.0 110.249 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.467 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 94.73 10.32 57.9 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.59 ' CG2' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -106.08 -178.21 3.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.392 -1.064 . . . . 0.0 110.273 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.539 ' O ' ' HA ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -139.51 150.63 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' A' ' 25' ' ' ALA . 54.1 t -117.45 134.2 61.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 O-C-N 121.184 -0.947 . . . . 0.0 112.126 -177.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.604 ' CD1' ' CG1' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -116.85 119.88 63.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.366 -0.834 . . . . 0.0 109.761 178.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.602 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 1.1 ttm180 -101.12 123.66 45.62 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.604 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.4 m -149.2 161.56 4.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.148 -0.97 . . . . 0.0 108.766 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.495 ' NE2' ' HE2' ' A' ' 19' ' ' LYS 0.262 1.6 tt0 -107.35 125.62 51.43 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.581 ' CE1' ' HA3' ' A' ' 40' ' ' GLY . 3.3 t80 -59.87 122.94 15.5 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 118.909 -1.117 . . . . 0.0 110.126 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.403 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 1.3 mm-40 -98.57 -23.89 15.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.319 -0.863 . . . . 0.0 109.168 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.581 ' HA3' ' CE1' ' A' ' 38' ' ' TYR . . . -65.59 -161.6 0.82 Allowed Glycine 0 N--CA 1.484 1.89 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.466 ' HA ' ' HD2' ' A' ' 73' ' ' LYS . 30.9 t0 -128.23 146.46 50.73 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.468 -1.019 . . . . 0.0 110.185 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.402 ' O ' ' CB ' ' A' ' 43' ' ' SER . . . 156.69 -14.39 0.35 Allowed Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.59 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.606 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.8 OUTLIER 60.49 -152.95 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 120.639 -1.506 . . . . 0.0 108.16 -179.723 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 88.5 Cg_exo -42.39 97.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.32 -0.959 0 N-CA-C 108.819 -1.262 . . . . 0.0 108.819 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.596 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -146.77 171.28 15.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.767 -0.583 . . . . 0.0 110.02 -177.714 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.585 ' CG ' ' CD1' ' A' ' 69' ' ' ILE . 16.6 mtmt -85.79 175.01 8.93 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.35 -0.844 . . . . 0.0 111.664 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.594 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 15.7 mm -123.05 125.78 26.17 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.401 -0.812 . . . . 0.0 112.299 -178.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.603 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 30.2 Cg_exo -65.42 146.8 86.3 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.963 1.507 . . . . 0.0 110.686 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.579 ' CD2' HD23 ' A' ' 63' ' ' LEU . 11.4 t80 -155.88 159.9 39.71 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.255 -0.903 . . . . 0.0 110.422 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.506 ' OE1' ' N ' ' A' ' 51' ' ' ILE . 5.9 tp10 -176.29 114.38 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.067 -1.021 . . . . 0.0 110.554 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.506 ' N ' ' OE1' ' A' ' 50' ' ' GLU . 55.9 mt -106.89 97.7 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 110.094 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.517 ' CE ' HD21 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -129.57 -67.04 0.78 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 110.317 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 54' ' ' LEU . 5.5 p30 174.06 -36.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.241 -0.912 . . . . 0.0 110.347 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.508 ' N ' ' OD1' ' A' ' 53' ' ' ASP . 1.0 OUTLIER -128.91 -89.56 0.51 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 0.0 110.288 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.462 ' HA ' HD12 ' A' ' 91' ' ' ILE . 11.5 tt0 -153.93 52.05 0.69 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.939 . . . . 0.0 110.271 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.491 ' CD ' ' HE3' ' A' ' 52' ' ' MET . 0.1 OUTLIER -119.74 139.25 52.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 0.0 110.156 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.575 ' O ' ' CG ' ' A' ' 58' ' ' HIS . 8.1 mtp180 -97.81 124.96 42.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.232 -0.918 . . . . 0.0 110.303 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 57' ' ' ARG . 15.8 m80 -162.22 -91.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 110.267 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 58' ' ' HIS . 1.9 p 175.88 100.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.187 -0.946 . . . . 0.0 110.133 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.517 HD21 ' CE ' ' A' ' 52' ' ' MET . 0.5 OUTLIER -126.86 -50.63 1.46 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -0.923 . . . . 0.0 110.25 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.459 ' HA2' ' HD3' ' A' ' 84' ' ' PRO . . . -106.35 -174.37 23.31 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.499 ' O ' HD21 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -120.6 149.96 41.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.18 -1.188 . . . . 0.0 110.113 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.579 HD23 ' CD2' ' A' ' 49' ' ' PHE . 3.2 mt -110.15 118.15 35.61 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.197 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.602 ' CD1' ' N ' ' A' ' 64' ' ' ILE . 1.5 mp -77.49 -22.97 14.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.61 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.272 1.0 OUTLIER -113.69 29.77 7.75 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.439 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.537 ' C ' ' O ' ' A' ' 65' ' ' THR . 52.0 t -12.47 112.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.534 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.511 ' ND2' ' HE3' ' A' ' 46' ' ' LYS . 20.8 t-20 41.24 70.0 1.79 Allowed Pre-proline 0 C--N 1.302 -1.488 0 O-C-N 121.647 -0.658 . . . . 0.0 110.4 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.532 ' CG ' HG12 ' A' ' 79' ' ' ILE . 1.7 Cg_endo -51.85 -176.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.01 1.532 . . . . 0.0 109.723 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.585 ' CD1' ' CG ' ' A' ' 46' ' ' LYS . 0.9 OUTLIER -140.7 142.07 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.947 -178.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.594 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 24.8 t -93.39 169.51 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.2 m -124.15 -20.73 5.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.883 -1.136 . . . . 0.0 110.929 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.531 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 6.9 mt-10 -135.87 14.44 3.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.026 -1.046 . . . . 0.0 110.754 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.531 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 10.6 ttpt 73.81 -7.52 1.58 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.422 -0.798 . . . . 0.0 110.818 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.482 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 5.7 t70 -136.78 -1.15 2.26 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.965 -1.085 . . . . 0.0 110.23 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.2 t -73.19 112.46 15.78 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.194 -0.941 . . . . 0.0 109.44 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 74' ' ' ASP . 35.0 Cg_exo -50.93 113.52 1.12 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.806 1.424 . . . . 0.0 109.912 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 74.0 t -99.13 155.19 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.318 -0.864 . . . . 0.0 110.714 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -111.77 134.86 53.06 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.465 -0.772 . . . . 0.0 109.96 179.667 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.574 HG21 ' CD1' ' A' ' 49' ' ' PHE . 3.8 mt -115.35 114.23 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 117.731 -1.588 . . . . 0.0 111.289 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 1.1 tt0 -90.78 115.0 27.52 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.983 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.559 ' HB2' ' CD2' ' A' ' 63' ' ' LEU . . . -131.61 149.16 52.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.908 -1.12 . . . . 0.0 110.768 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.519 ' CA ' HG21 ' A' ' 31' ' ' THR . 2.2 tt0 -98.82 104.99 28.23 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 110.337 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.526 ' CB ' ' OD2' ' A' ' 87' ' ' ASP . 30.8 Cg_endo -70.32 131.97 21.49 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.001 1.527 . . . . 0.0 110.298 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.466 ' HD2' ' OD1' ' A' ' 87' ' ' ASP . 23.0 Cg_endo -67.38 -70.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.933 1.491 . . . . 0.0 110.398 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -165.63 70.4 0.14 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.295 -0.878 . . . . 0.0 110.293 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 105' ' ' LYS . . . 140.75 -94.17 0.19 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.526 ' OD2' ' CB ' ' A' ' 83' ' ' PRO . 12.9 m-20 63.5 -70.39 0.07 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.479 -1.012 . . . . 0.0 110.307 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.543 ' O ' ' N ' ' A' ' 103' ' ' TRP . 0.8 OUTLIER 64.71 -73.09 0.06 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.151 -0.968 . . . . 0.0 110.777 179.795 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 9.7 m-85 -97.11 90.9 5.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.75 -1.219 . . . . 0.0 111.231 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 100' ' ' LYS . 20.6 mt -73.81 163.63 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.49 ' CG2' ' CD ' ' A' ' 98' ' ' GLN . 80.2 mt -126.25 139.54 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.496 -1.377 . . . . 0.0 112.04 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.552 ' CD1' HG22 ' A' ' 34' ' ' ILE . 0.5 OUTLIER -128.44 136.12 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.242 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.529 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 87.71 -161.17 31.97 Favored Glycine 0 N--CA 1.481 1.649 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.563 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -121.18 146.84 25.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 121.04 -1.27 . . . . 0.0 110.154 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.566 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.3 OUTLIER -17.03 -58.6 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.203 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 7.1 Cg_endo -51.18 75.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 124.216 1.64 . . . . 0.0 111.735 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 87.02 -0.27 86.02 Favored Glycine 0 N--CA 1.494 2.501 0 O-C-N 120.96 -1.087 . . . . 0.0 111.043 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.49 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -44.65 164.48 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.744 -1.445 . . . . 0.0 109.807 179.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.523 ' CD1' ' O ' ' A' ' 18' ' ' PHE . 7.2 mt -102.35 170.67 7.93 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.104 -0.998 . . . . 0.0 111.263 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -146.41 132.84 19.65 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.602 -0.687 . . . . 0.0 109.478 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.525 HD13 ' CD1' ' A' ' 92' ' ' ILE . 1.0 OUTLIER -122.99 135.41 54.46 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.002 -1.061 . . . . 0.0 110.744 -179.534 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 88' ' ' SER . 2.6 p-10 -84.74 130.63 34.66 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.372 -0.83 . . . . 0.0 110.657 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.543 ' N ' ' O ' ' A' ' 88' ' ' SER . 26.2 t-105 -161.07 97.52 1.14 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.325 -0.86 . . . . 0.0 109.965 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -73.36 105.99 4.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.21 -0.931 . . . . 0.0 110.241 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -111.37 65.17 0.62 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.201 -0.937 . . . . 0.0 110.202 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.52 -42.17 0.45 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 110.278 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.88 -147.2 18.43 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 47.69 75.41 0.13 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.233 -1.157 . . . . 0.0 110.13 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.28 94.8 4.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -0.899 . . . . 0.0 110.269 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.88 50.13 1.27 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.284 -0.885 . . . . 0.0 110.184 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.88 -43.42 1.36 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 110.243 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.52 -171.49 3.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.907 . . . . 0.0 110.243 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -95.41 121.24 36.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 110.199 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -99.24 84.37 3.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 0.0 110.26 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.442 ' O ' ' HB3' ' A' ' 116' ' ' HIS . 0.4 OUTLIER -167.78 -62.14 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.328 -0.858 . . . . 0.0 110.163 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.442 ' HB3' ' O ' ' A' ' 115' ' ' HIS . 13.0 t-160 57.28 102.64 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.235 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.486 ' CG ' ' OXT' ' A' ' 117' ' ' HIS . 11.6 t-160 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.087 -0.958 . . . . 0.0 110.249 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.226 0.536 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.405 ' OD1' ' C ' ' A' ' 2' ' ' ASP . 2.6 p30 -156.29 177.52 11.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 110.216 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -109.7 -61.46 1.64 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.288 -0.883 . . . . 0.0 110.139 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.461 ' O ' ' CB ' ' A' ' 5' ' ' GLN . 0.5 OUTLIER -85.56 -154.24 0.19 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.241 -0.912 . . . . 0.0 110.149 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER 172.25 -71.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.295 -0.878 . . . . 0.0 110.129 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 8' ' ' GLY . 0.1 OUTLIER 66.25 -64.4 0.22 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.255 -0.903 . . . . 0.0 110.262 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 5' ' ' GLN . 3.0 mtpp 52.53 -89.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.247 -0.908 . . . . 0.0 110.205 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 6' ' ' LEU . . . -118.49 -88.62 1.23 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.518 ' O ' ' ND2' ' A' ' 67' ' ' ASN . 0.0 OUTLIER 65.43 128.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -1.162 . . . . 0.0 110.229 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.533 ' HA ' ' CD ' ' A' ' 46' ' ' LYS . 43.6 t -141.77 145.74 35.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.927 . . . . 0.0 110.125 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -93.31 -73.59 0.56 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.164 -0.96 . . . . 0.0 110.216 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.454 ' O ' ' HB3' ' A' ' 13' ' ' MET . 3.3 t -135.93 -6.44 2.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.117 -0.989 . . . . 0.0 110.925 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.454 ' HB3' ' O ' ' A' ' 12' ' ' SER . 5.4 ttm 56.13 80.42 0.15 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.001 -1.062 . . . . 0.0 108.756 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.587 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 42.9 m -55.27 92.87 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.413 -0.805 . . . . 0.0 109.2 -178.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.534 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -88.8 -7.36 56.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.385 -0.822 . . . . 0.0 111.766 -178.375 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.555 ' HA3' ' CA ' ' A' ' 40' ' ' GLY . . . -61.55 -110.83 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 C-N-CA 118.775 -1.679 . . . . 0.0 108.966 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.54 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -145.99 171.8 14.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.98 -1.306 . . . . 0.0 110.253 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.589 ' CE1' ' HD2' ' A' ' 48' ' ' PRO . 38.1 m-85 -130.49 148.69 52.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.062 -1.024 . . . . 0.0 111.48 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.479 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 4.2 ttpp -114.13 114.68 26.4 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.481 -0.762 . . . . 0.0 109.131 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.497 HG23 ' CD1' ' A' ' 99' ' ' LEU . 21.5 t -59.49 124.15 13.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 120.606 -1.309 . . . . 0.0 109.015 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.553 ' HB ' ' CG ' ' A' ' 35' ' ' ARG . 64.4 t -97.56 -25.54 4.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.582 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 3.8 tttp -158.68 133.54 8.27 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 177.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -51.68 163.27 0.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.671 0.748 . . . . 0.0 111.305 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.569 HG12 HG12 ' A' ' 34' ' ' ILE . 0.7 OUTLIER -57.09 132.81 21.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 121.647 0.736 . . . . 0.0 110.2 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 32' ' ' ILE . . . -108.05 169.83 8.38 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 2.9 pm0 -116.01 132.94 56.51 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.784 -1.197 . . . . 0.0 110.425 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.479 ' OG1' ' OG1' ' A' ' 31' ' ' THR . 16.5 p -91.17 -179.32 5.4 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.659 -0.817 . . . . 0.0 110.103 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -94.16 17.22 12.97 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.184 -0.947 . . . . 0.0 110.373 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.28 8.09 12.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.293 -0.879 . . . . 0.0 110.062 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.34 11.33 59.82 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.589 ' CG2' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -104.91 -174.38 2.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.39 -1.064 . . . . 0.0 110.345 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -141.13 155.67 21.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.49 ' N ' ' O ' ' A' ' 25' ' ' ALA . 76.7 t -120.76 129.95 75.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 119.101 -1.04 . . . . 0.0 112.231 -178.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.596 ' CD1' ' CG1' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -113.7 117.65 56.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 121.399 -0.813 . . . . 0.0 109.79 178.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.582 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 3.1 ttm180 -100.77 119.91 39.33 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.596 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.4 m -146.87 158.72 10.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.2 -0.937 . . . . 0.0 109.014 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.462 ' OE1' ' O ' ' A' ' 74' ' ' ASP 0.252 11.9 tt0 -106.08 125.57 51.15 Favored 'General case' 0 C--N 1.271 -2.817 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.393 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.581 ' CE1' ' HA3' ' A' ' 40' ' ' GLY . 3.7 t80 -59.78 123.04 15.73 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 119.003 -1.079 . . . . 0.0 110.079 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.479 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 8.3 mt-10 -98.86 -23.54 15.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.359 -0.838 . . . . 0.0 109.206 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.581 ' HA3' ' CE1' ' A' ' 38' ' ' TYR . . . -65.01 -162.12 0.68 Allowed Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.442 ' OD1' ' HE2' ' A' ' 73' ' ' LYS . 17.7 m-20 -129.15 146.52 51.06 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.457 -1.025 . . . . 0.0 110.307 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 43' ' ' SER . . . 155.37 -12.8 0.43 Allowed Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.597 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.608 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.7 OUTLIER 61.08 -153.29 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 120.661 -1.493 . . . . 0.0 108.32 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.608 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 88.4 Cg_exo -42.16 97.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.32 -0.958 0 N-CA-C 108.964 -1.206 . . . . 0.0 108.964 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.587 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -146.66 170.19 17.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.829 -0.545 . . . . 0.0 110.143 -177.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.574 ' CG ' ' CD1' ' A' ' 69' ' ' ILE . 1.2 mtpm? -84.67 175.09 9.44 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.173 -0.955 . . . . 0.0 112.033 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.611 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 15.5 mm -123.65 124.2 26.22 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.68 -0.638 . . . . 0.0 111.539 -178.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.589 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 31.7 Cg_exo -61.92 144.71 96.83 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.06 1.558 . . . . 0.0 110.384 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.638 ' CE1' ' CG2' ' A' ' 79' ' ' ILE . 4.8 t80 -151.69 156.21 39.89 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.203 -0.935 . . . . 0.0 110.324 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.524 ' CG ' HD13 ' A' ' 91' ' ' ILE . 23.1 tp10 -173.76 95.6 0.1 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.073 -1.017 . . . . 0.0 110.184 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . 97.2 mt -85.48 88.05 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.302 -0.874 . . . . 0.0 110.265 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.467 ' HB3' ' HG3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -148.97 -65.47 0.23 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.198 -0.939 . . . . 0.0 110.228 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.513 ' O ' ' NZ ' ' A' ' 100' ' ' LYS . 9.5 t70 -168.02 -55.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.176 -0.953 . . . . 0.0 110.188 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.505 ' CA ' HD12 ' A' ' 91' ' ' ILE . 4.5 tp -169.4 -38.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -0.915 . . . . 0.0 110.146 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.456 ' OE2' ' OE1' ' A' ' 95' ' ' GLU . 15.8 tt0 -161.03 61.99 0.29 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.379 -0.826 . . . . 0.0 109.991 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.467 ' HG3' ' HB3' ' A' ' 52' ' ' MET . 1.1 mtpt -108.49 138.74 44.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.281 -0.887 . . . . 0.0 110.239 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.5 ttm180 -62.76 -63.68 1.14 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.217 -0.927 . . . . 0.0 110.105 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -51.88 147.68 6.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.253 -0.905 . . . . 0.0 110.136 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.672 ' O ' ' CB ' ' A' ' 60' ' ' LEU . 55.4 t -91.12 -71.24 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.963 . . . . 0.0 110.336 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.672 ' CB ' ' O ' ' A' ' 59' ' ' VAL . 13.3 tp 96.82 -63.6 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.522 0 CA-C-O 121.245 0.545 . . . . 0.0 109.646 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.519 ' N ' ' HG3' ' A' ' 84' ' ' PRO . . . -73.21 -160.45 5.89 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -150.54 163.93 37.25 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.267 -1.137 . . . . 0.0 109.525 179.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.594 ' CD2' ' CB ' ' A' ' 81' ' ' ALA . 11.8 mt -122.01 121.41 36.96 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 118.837 -1.145 . . . . 0.0 110.539 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.612 ' CD1' ' N ' ' A' ' 64' ' ' ILE . 1.4 mp -82.54 -27.62 8.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.607 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.26 1.1 m -96.78 32.61 2.04 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 122.781 1.277 . . . . 0.0 107.673 178.726 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 63' ' ' LEU . 16.3 t -34.74 140.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.25 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.57 ' N ' ' CD ' ' A' ' 68' ' ' PRO . 38.9 t-20 56.55 46.4 2.24 Favored Pre-proline 0 C--N 1.302 -1.493 0 O-C-N 121.577 -0.702 . . . . 0.0 110.585 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.596 ' CB ' ' CD1' ' A' ' 79' ' ' ILE . 8.1 Cg_endo -59.15 146.36 94.71 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.673 1.354 . . . . 0.0 109.043 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.574 ' CD1' ' CG ' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -141.3 149.86 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 119.127 -1.029 . . . . 0.0 112.915 -177.652 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.611 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 41.9 t -97.28 168.86 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.41 ' N ' HG11 ' A' ' 70' ' ' VAL . 4.8 m -122.78 -21.25 5.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.857 -1.152 . . . . 0.0 111.201 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.535 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 15.6 mt-10 -136.51 17.23 3.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.816 -1.177 . . . . 0.0 111.192 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER 72.54 -5.63 1.79 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.281 -0.887 . . . . 0.0 110.981 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.462 ' O ' ' OE1' ' A' ' 37' ' ' GLN . 5.8 t70 -138.81 0.27 1.98 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.923 -1.111 . . . . 0.0 110.429 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.456 ' O ' HG23 ' A' ' 77' ' ' VAL . 22.8 t -73.09 108.59 4.76 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.15 -0.969 . . . . 0.0 109.476 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 1.6 Cg_endo -50.22 110.66 0.41 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.697 1.367 . . . . 0.0 109.736 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 82.0 t -94.34 146.0 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.269 -0.894 . . . . 0.0 111.044 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.589 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.1 m120 -106.64 131.09 54.18 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.638 ' CG2' ' CE1' ' A' ' 49' ' ' PHE . 3.9 mm -112.2 117.46 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.079 -1.638 . . . . 0.0 111.803 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.566 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 1.6 tp10 -93.57 106.97 18.89 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.302 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.594 ' CB ' ' CD2' ' A' ' 63' ' ' LEU . . . -130.24 153.86 48.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.88 -1.137 . . . . 0.0 111.308 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 62' ' ' ARG . 24.6 tt0 -97.82 103.55 17.47 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.647 -0.658 . . . . 0.0 110.409 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.53 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 37.4 Cg_endo -70.77 144.56 49.02 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.984 1.518 . . . . 0.0 110.539 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.519 ' HG3' ' N ' ' A' ' 61' ' ' GLY . 23.7 Cg_exo -59.91 -142.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.095 1.577 . . . . 0.0 110.155 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.559 ' CD2' ' HD3' ' A' ' 106' ' ' LYS . 1.4 m-30 -108.75 155.62 20.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 110.245 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.521 ' CA ' ' O ' ' A' ' 105' ' ' LYS . . . 72.12 -165.19 54.19 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -54.2 171.69 0.1 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.258 -1.142 . . . . 0.0 110.196 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.437 ' OG ' ' HD2' ' A' ' 84' ' ' PRO . 0.6 OUTLIER -174.41 122.98 0.29 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.881 . . . . 0.0 110.346 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 17.9 m-85 -99.9 103.44 15.03 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.182 -0.949 . . . . 0.0 110.259 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.579 ' CG2' ' CZ ' ' A' ' 49' ' ' PHE . 4.1 mt -74.14 116.94 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 109.469 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.524 HD13 ' CG ' ' A' ' 50' ' ' GLU . 37.9 mt -94.62 147.44 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.177 -0.952 . . . . 0.0 110.395 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.558 ' CD1' HG22 ' A' ' 34' ' ' ILE . 1.6 mt -133.36 139.66 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.464 -0.772 . . . . 0.0 109.478 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.531 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 83.13 -161.17 39.28 Favored Glycine 0 N--CA 1.481 1.651 0 N-CA-C 108.624 -1.791 . . . . 0.0 108.624 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.554 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -122.12 149.1 25.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 121.213 -1.169 . . . . 0.0 110.169 -179.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.577 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.6 OUTLIER -17.15 -58.42 0.04 OUTLIER Pre-proline 0 N--CA 1.501 2.117 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 8.6 Cg_endo -51.87 71.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 124.279 1.673 . . . . 0.0 112.116 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 90.6 0.57 75.58 Favored Glycine 0 N--CA 1.494 2.537 0 O-C-N 120.941 -1.1 . . . . 0.0 110.943 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.504 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -48.38 159.97 0.18 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.952 -1.322 . . . . 0.0 110.199 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.497 ' CD1' HG23 ' A' ' 20' ' ' VAL . 12.2 mt -96.87 177.84 5.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.239 -0.913 . . . . 0.0 110.623 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 53' ' ' ASP . 0.5 OUTLIER -157.62 137.28 12.16 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.477 -0.765 . . . . 0.0 110.16 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.519 HD22 ' CD1' ' A' ' 34' ' ' ILE . 2.8 mp -138.21 116.94 12.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.207 -0.933 . . . . 0.0 110.373 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 9.1 p-10 -83.31 128.06 34.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 110.405 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.513 ' NE1' HG22 ' A' ' 32' ' ' ILE . 10.6 t-105 -120.4 141.28 50.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.243 -0.911 . . . . 0.0 110.155 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -98.52 100.33 11.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -0.926 . . . . 0.0 110.116 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.521 ' O ' ' CA ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -108.2 120.85 43.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 110.288 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.559 ' HD3' ' CD2' ' A' ' 85' ' ' PHE . 1.2 ttpp 62.55 102.06 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.215 -0.928 . . . . 0.0 110.209 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.11 -149.19 25.37 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.74 -163.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.155 -1.203 . . . . 0.0 110.134 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' A' ' 110' ' ' LEU . 7.6 t -92.67 55.26 2.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 110.249 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.44 ' HB2' ' O ' ' A' ' 109' ' ' SER . 5.3 mp 58.67 -89.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 110.169 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 109' ' ' SER . 1.4 tp10 60.39 116.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.305 -0.872 . . . . 0.0 110.288 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.43 -63.01 0.56 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 110.186 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.406 ' O ' ' CB ' ' A' ' 114' ' ' HIS . 0.5 OUTLIER -104.64 14.72 29.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.277 -0.889 . . . . 0.0 110.182 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.406 ' CB ' ' O ' ' A' ' 113' ' ' HIS . 19.0 t60 62.97 59.55 1.33 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.277 -0.889 . . . . 0.0 110.221 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -99.12 90.54 4.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -0.929 . . . . 0.0 110.202 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 22.6 m170 -107.32 -26.6 10.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 110.169 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.215 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mtt . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.21 0.529 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 4' ' ' LEU . 2.0 p30 -137.52 144.28 42.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.891 . . . . 0.0 110.202 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 2' ' ' ASP . 0.0 OUTLIER 62.32 -75.24 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.32 -0.863 . . . . 0.0 110.205 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 2' ' ' ASP . 1.1 mp -74.12 119.65 18.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 110.171 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.47 ' HB3' ' O ' ' A' ' 4' ' ' LEU . 3.1 pt20 175.65 137.54 0.05 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.893 . . . . 0.0 110.152 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.5 pp -165.09 156.91 15.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 110.262 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -134.19 24.44 3.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.24 -0.913 . . . . 0.0 110.222 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.76 11.65 66.3 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.28 55.64 1.36 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.339 -1.095 . . . . 0.0 110.221 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.94 -34.42 11.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 0.0 110.241 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.581 ' CE2' ' O ' ' A' ' 44' ' ' PRO . 2.2 t80 -145.19 -74.56 0.23 Allowed 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.175 -0.953 . . . . 0.0 110.237 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.54 ' HB3' ' CB ' ' A' ' 45' ' ' CYS . 3.3 t -137.16 -36.18 0.67 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.166 -0.959 . . . . 0.0 110.474 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.479 ' HB3' ' O ' ' A' ' 12' ' ' SER . 1.1 ttt 57.87 92.41 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.452 -0.78 . . . . 0.0 109.303 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.584 ' HB3' ' CE1' ' A' ' 38' ' ' TYR . 1.3 m -72.66 126.64 30.37 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.209 -0.932 . . . . 0.0 109.65 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.538 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 1.2 p -116.39 4.95 13.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.132 -0.98 . . . . 0.0 111.716 -178.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.54 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -62.02 -115.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.532 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -136.49 174.06 11.03 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.989 -1.3 . . . . 0.0 109.946 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.588 ' CE1' ' HD2' ' A' ' 48' ' ' PRO . 42.8 m-85 -133.02 140.84 47.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.965 -1.084 . . . . 0.0 111.814 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.522 ' HB2' ' CG ' ' A' ' 39' ' ' GLU . 7.9 ttpt -107.67 117.65 34.67 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.633 -0.667 . . . . 0.0 109.277 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.522 HG21 ' CD1' ' A' ' 99' ' ' LEU . 21.2 t -59.64 132.91 25.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 120.835 -1.166 . . . . 0.0 109.042 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.52 ' N ' ' HA ' ' A' ' 36' ' ' VAL . 92.1 t -105.78 -24.12 4.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.575 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 16.2 tttt -161.64 134.48 6.11 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -53.23 158.84 1.46 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.699 0.761 . . . . 0.0 111.421 -178.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.574 HD11 ' CA ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -52.86 133.08 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-O 121.587 0.708 . . . . 0.0 110.202 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 32' ' ' ILE . . . -109.64 171.73 7.27 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 5.3 pm0 -116.65 134.68 54.53 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.833 -1.167 . . . . 0.0 110.56 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.519 ' CG2' ' OE2' ' A' ' 80' ' ' GLU . 14.0 p -92.8 175.03 6.96 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.255 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -88.62 31.25 0.84 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.905 . . . . 0.0 110.234 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.3 m170 -133.87 5.78 3.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.894 . . . . 0.0 110.183 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.85 1.23 61.74 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.161 -1.575 . . . . 0.0 109.161 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.584 ' CG2' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -95.32 -176.73 3.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -1.144 . . . . 0.0 110.355 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.569 ' O ' ' HA ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -140.21 153.34 22.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.763 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.478 ' N ' ' O ' ' A' ' 25' ' ' ALA . 55.1 t -118.97 132.24 69.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 119.113 -1.035 . . . . 0.0 112.351 -177.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.62 ' CD1' ' CG1' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -113.55 120.54 63.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 O-C-N 121.355 -0.841 . . . . 0.0 109.61 178.601 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.575 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 2.9 ttm180 -105.19 110.85 23.39 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.62 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.5 m -132.59 -169.91 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.438 -0.789 . . . . 0.0 109.312 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.444 ' N ' HG21 ' A' ' 36' ' ' VAL . 17.1 tt0 -136.58 128.19 28.77 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.584 ' CE1' ' HB3' ' A' ' 14' ' ' CYS . 16.1 t80 -61.02 118.66 7.04 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 117.983 -1.487 . . . . 0.0 110.633 -178.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.522 ' CG ' ' HB2' ' A' ' 19' ' ' LYS . 7.5 mm-40 -97.25 -0.79 46.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.503 -0.748 . . . . 0.0 109.327 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.567 ' HA3' ' CZ ' ' A' ' 38' ' ' TYR . . . -93.57 -161.77 35.81 Favored Glycine 0 N--CA 1.484 1.855 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 41' ' ' ASP . 2.0 p30 -127.52 134.77 49.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.461 -1.023 . . . . 0.0 109.929 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' ' 43' ' ' SER . . . 171.92 -23.03 0.08 OUTLIER Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.483 -1.342 . . . . 0.0 110.664 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.602 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.5 OUTLIER 64.12 -154.95 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 120.602 -1.529 . . . . 0.0 108.073 -179.563 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.602 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 88.2 Cg_exo -42.54 94.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -0.993 0 N-CA-C 109.059 -1.169 . . . . 0.0 109.059 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.557 ' N ' ' O ' ' A' ' 43' ' ' SER . 31.6 p -148.02 178.36 8.59 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.792 -0.568 . . . . 0.0 109.576 -178.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 68' ' ' PRO . 1.0 OUTLIER -96.05 175.04 6.62 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.943 -1.098 . . . . 0.0 111.412 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.611 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 17.7 mm -121.94 131.75 24.36 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.346 -0.846 . . . . 0.0 112.591 -177.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.588 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 26.1 Cg_exo -66.94 143.52 66.61 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 124.115 1.587 . . . . 0.0 110.768 178.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.642 ' CE2' ' CG2' ' A' ' 79' ' ' ILE . 9.2 t80 -152.96 158.65 42.39 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.313 -0.867 . . . . 0.0 110.248 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.503 ' HG2' ' CD1' ' A' ' 91' ' ' ILE . 5.3 tt0 -173.29 111.49 0.2 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.067 -1.02 . . . . 0.0 110.324 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.443 HD13 ' HB1' ' A' ' 81' ' ' ALA . 68.5 mt -95.78 69.94 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 110.34 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.526 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 23.5 mtt -149.93 -67.36 0.21 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.121 -0.987 . . . . 0.0 110.318 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.527 ' HB3' ' CG ' ' A' ' 56' ' ' LYS . 6.3 t70 174.93 171.37 0.26 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.321 -0.862 . . . . 0.0 110.082 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.525 HD12 ' CD ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -82.05 -0.35 44.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.203 -0.935 . . . . 0.0 110.489 -179.866 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -163.17 63.46 0.18 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 110.238 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.527 ' CG ' ' HB3' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -118.84 -172.2 2.24 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.326 -0.859 . . . . 0.0 110.276 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -127.89 -51.57 1.34 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 110.203 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 17.9 t60 -146.99 107.19 4.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.187 -0.946 . . . . 0.0 110.24 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.526 ' CG2' ' HB3' ' A' ' 52' ' ' MET . 11.1 t -119.01 -120.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.153 -0.967 . . . . 0.0 110.012 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.476 ' HB3' ' HB3' ' A' ' 84' ' ' PRO . 1.4 mt -161.01 -158.66 0.6 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.851 -1.156 . . . . 0.0 110.353 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.502 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . 100.16 174.3 30.2 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -158.93 166.69 31.24 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.073 -1.251 . . . . 0.0 109.596 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.596 HD22 ' CE1' ' A' ' 49' ' ' PHE . 10.5 mt -124.17 122.75 38.65 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 118.804 -1.158 . . . . 0.0 111.077 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.611 ' CD1' ' N ' ' A' ' 64' ' ' ILE . 1.5 mp -84.82 -23.35 7.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 178.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.582 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.28 2.0 m -108.26 37.17 2.55 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 122.476 1.132 . . . . 0.0 108.096 179.514 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.522 HG13 ' N ' ' A' ' 67' ' ' ASN . 37.3 t -38.22 152.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-O 121.504 0.668 . . . . 0.0 111.077 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.527 ' HB2' ' CD ' ' A' ' 46' ' ' LYS . 5.3 p-10 37.53 59.36 4.32 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.851 -0.53 . . . . 0.0 111.253 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.598 ' CB ' ' CD1' ' A' ' 79' ' ' ILE . 19.3 Cg_exo -58.64 164.8 8.86 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 N-CA-C 108.325 -1.452 . . . . 0.0 108.325 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.544 ' CG2' ' O ' ' A' ' 45' ' ' CYS . 1.1 mt -143.45 146.22 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 118.418 -1.313 . . . . 0.0 113.001 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.611 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 15.3 t -103.77 163.33 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 176.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.468 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 3.1 m -124.85 -12.04 7.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.823 -1.173 . . . . 0.0 111.654 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 4.4 mt-10 -140.88 10.52 2.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.719 -1.238 . . . . 0.0 111.311 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 15.8 mtmt 78.16 -16.75 0.63 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.744 -0.597 . . . . 0.0 111.036 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.498 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 6.2 t70 -132.52 0.52 3.65 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.071 -1.018 . . . . 0.0 109.801 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.7 t -71.71 111.53 10.8 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 38.2 Cg_exo -49.76 131.51 29.3 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.901 1.474 . . . . 0.0 110.332 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 89.2 t -110.36 154.52 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.172 -0.955 . . . . 0.0 110.515 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 0.4 OUTLIER -116.63 132.42 56.69 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.525 -0.735 . . . . 0.0 109.289 179.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.642 ' CG2' ' CE2' ' A' ' 49' ' ' PHE . 25.2 mm -117.76 117.05 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 117.497 -1.681 . . . . 0.0 112.105 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.569 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 1.6 tp10 -94.76 110.72 22.55 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.418 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.566 ' CB ' ' CD2' ' A' ' 63' ' ' LEU . . . -131.15 155.94 46.15 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.781 -1.199 . . . . 0.0 111.386 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 62' ' ' ARG . 35.3 tp10 -99.79 102.36 16.93 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.593 -0.692 . . . . 0.0 110.418 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.538 ' HG3' ' CD1' ' A' ' 32' ' ' ILE . 56.9 Cg_endo -75.23 148.42 34.39 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.997 1.525 . . . . 0.0 110.747 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.502 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 12.2 Cg_endo -61.84 -157.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.099 1.579 . . . . 0.0 110.108 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.548 ' CD1' ' O ' ' A' ' 85' ' ' PHE . 24.0 p90 -104.17 135.67 45.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.193 -0.942 . . . . 0.0 110.067 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 99.01 -147.94 18.65 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.9 p30 -69.49 156.56 38.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.2 -1.177 . . . . 0.0 110.185 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.5 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 0.4 OUTLIER -163.71 135.44 4.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.179 -0.95 . . . . 0.0 110.354 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.546 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 2.0 m-85 -114.19 105.45 13.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.184 -0.948 . . . . 0.0 110.092 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.573 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 1.6 mp -74.01 118.44 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.203 -0.936 . . . . 0.0 109.522 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.503 ' CD1' ' HG2' ' A' ' 50' ' ' GLU . 70.9 mt -98.68 148.16 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 110.643 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.543 ' CD1' HG23 ' A' ' 34' ' ' ILE . 1.7 mt -135.88 138.2 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.643 -0.661 . . . . 0.0 109.333 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.537 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 83.9 -159.39 36.03 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.558 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -124.22 149.96 28.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 O-C-N 121.198 -1.178 . . . . 0.0 110.18 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.572 ' O ' ' N ' ' A' ' 97' ' ' GLY . 2.3 mt-10 -17.97 -57.88 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.121 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 9.0 Cg_endo -52.08 71.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 124.157 1.609 . . . . 0.0 112.177 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 89.81 2.74 74.9 Favored Glycine 0 N--CA 1.494 2.526 0 O-C-N 120.935 -1.103 . . . . 0.0 110.898 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.503 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -49.75 159.5 0.37 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.958 -1.319 . . . . 0.0 110.161 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.522 ' CD1' HG21 ' A' ' 20' ' ' VAL . 10.4 mt -94.91 172.66 8.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 110.445 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.525 ' CD ' HD12 ' A' ' 54' ' ' LEU . 4.5 ttpt -156.15 133.28 10.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.392 -0.817 . . . . 0.0 110.201 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 89' ' ' TYR . 2.2 mp -134.11 122.72 23.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.257 -0.902 . . . . 0.0 110.058 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.403 ' OD1' ' CG ' ' A' ' 117' ' ' HIS . 0.9 OUTLIER -87.25 134.85 33.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.19 -0.944 . . . . 0.0 110.366 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.424 ' N ' ' O ' ' A' ' 88' ' ' SER . 22.3 t-105 -130.65 143.81 51.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.364 -0.835 . . . . 0.0 110.185 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -103.62 133.63 48.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.194 -0.941 . . . . 0.0 110.109 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -134.97 127.49 30.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.273 -0.892 . . . . 0.0 110.242 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 51.98 -167.62 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.292 -0.88 . . . . 0.0 110.26 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 162.13 102.45 0.17 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.5 m -69.88 -52.86 21.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.231 -1.159 . . . . 0.0 110.236 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.4 m -147.91 42.23 1.03 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.898 . . . . 0.0 110.165 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 pp -50.93 167.0 0.08 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 110.119 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -119.57 159.94 23.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.934 . . . . 0.0 110.275 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -84.1 92.66 7.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.233 -0.917 . . . . 0.0 110.251 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 14.9 t-160 -80.87 125.59 30.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.895 . . . . 0.0 110.262 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.07 61.46 4.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 110.191 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -175.69 -47.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.243 -0.911 . . . . 0.0 110.268 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 58.67 -166.01 0.17 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.878 . . . . 0.0 110.276 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.403 ' CG ' ' OD1' ' A' ' 102' ' ' ASN . 3.1 t60 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.894 -1.05 . . . . 0.0 110.288 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.414 ' O ' ' HB2' ' A' ' 2' ' ' ASP . 5.9 tpp . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.26 0.553 . . . . 0.0 110.264 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 1' ' ' MET . 77.4 m-20 54.06 51.43 14.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 110.169 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.7 57.02 0.83 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.318 -0.864 . . . . 0.0 110.252 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.455 ' O ' ' HB3' ' A' ' 5' ' ' GLN . 0.5 OUTLIER -146.4 125.65 13.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.229 -0.919 . . . . 0.0 110.189 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.455 ' HB3' ' O ' ' A' ' 4' ' ' LEU . 0.8 OUTLIER 178.77 97.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.284 -0.885 . . . . 0.0 110.222 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.75 97.01 3.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.177 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.52 -15.4 20.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.281 -0.887 . . . . 0.0 110.236 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 129.69 135.3 3.87 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.452 ' O ' ' O ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -174.42 -54.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.239 -1.154 . . . . 0.0 110.289 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.519 ' HA ' ' CD ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER 57.94 156.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -0.921 . . . . 0.0 110.15 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.451 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 4.2 t80 -90.91 -72.85 0.56 Allowed 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.207 -0.933 . . . . 0.0 110.08 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 13' ' ' MET . 3.3 t -135.08 -6.83 2.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.052 -1.03 . . . . 0.0 110.946 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.515 ' HG2' ' CG2' ' A' ' 15' ' ' THR . 1.5 ttt 55.69 81.99 0.11 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.873 -1.142 . . . . 0.0 108.659 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.582 ' HB3' ' CE1' ' A' ' 38' ' ' TYR . 33.5 m -56.43 100.44 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.388 -0.82 . . . . 0.0 109.764 -178.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.525 ' HA ' ' CG2' ' A' ' 94' ' ' VAL . 71.2 p -97.53 -5.05 36.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 111.081 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.536 ' HA3' ' CA ' ' A' ' 40' ' ' GLY . . . -59.32 -110.37 0.01 OUTLIER Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.116 -1.516 . . . . 0.0 109.381 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.563 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 1.1 ttpt -142.95 162.56 35.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.039 -1.271 . . . . 0.0 109.924 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.597 ' CE1' ' HD2' ' A' ' 48' ' ' PRO . 21.0 m-85 -126.82 136.37 52.27 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.939 -1.101 . . . . 0.0 111.224 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.476 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 10.9 ttpp -108.0 119.24 38.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.418 -0.802 . . . . 0.0 109.678 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.512 HG21 ' CD1' ' A' ' 99' ' ' LEU . 48.3 t -59.93 130.76 24.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.829 -1.17 . . . . 0.0 108.995 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.53 ' HB ' ' CG ' ' A' ' 35' ' ' ARG . 61.3 t -102.98 -24.81 3.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 1.5 tttt -161.98 133.71 5.46 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -52.34 156.67 1.65 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.611 0.719 . . . . 0.0 111.193 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.565 HD13 ' CA ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -49.94 132.66 9.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-O 121.616 0.722 . . . . 0.0 109.843 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.503 ' O ' ' CG2' ' A' ' 32' ' ' ILE . . . -108.32 172.32 6.91 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.4 pm0 -115.23 130.58 56.95 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.834 -1.166 . . . . 0.0 110.516 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.512 ' CG2' ' OE2' ' A' ' 80' ' ' GLU . 26.4 p -84.57 177.22 8.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.439 -0.788 . . . . 0.0 109.967 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -92.24 28.61 1.86 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.882 . . . . 0.0 110.158 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -133.65 5.19 3.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.242 -0.911 . . . . 0.0 110.312 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.451 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 101.35 -3.3 54.32 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.591 ' CG2' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -92.19 -175.73 4.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.205 -1.174 . . . . 0.0 110.478 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -139.15 156.88 27.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.476 ' N ' ' O ' ' A' ' 25' ' ' ALA . 59.4 t -122.06 132.03 71.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 119.079 -1.049 . . . . 0.0 112.322 -177.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.611 ' CD1' ' CG1' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -112.2 120.16 61.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 O-C-N 121.197 -0.94 . . . . 0.0 109.7 178.767 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.557 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -104.47 114.96 29.54 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.638 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.611 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.3 m -137.27 -176.35 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.336 -0.853 . . . . 0.0 109.125 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.491 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 4.2 tt0 -129.36 131.47 46.86 Favored 'General case' 0 C--N 1.276 -2.613 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.582 ' CE1' ' HB3' ' A' ' 14' ' ' CYS . 6.2 t80 -60.88 122.54 15.12 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 118.724 -1.191 . . . . 0.0 110.731 -178.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 6.8 mt-10 -111.57 26.14 10.95 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.062 -1.024 . . . . 0.0 108.869 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.536 ' CA ' ' HA3' ' A' ' 16' ' ' GLY . . . -121.22 -161.07 11.25 Favored Glycine 0 N--CA 1.484 1.863 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 40.8 p-10 -125.0 149.18 48.01 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.384 -1.068 . . . . 0.0 110.392 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.48 -2.51 1.1 Allowed Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.555 -1.307 . . . . 0.0 110.958 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.611 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.6 OUTLIER 49.48 -153.57 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 120.534 -1.568 . . . . 0.0 108.353 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.611 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 86.1 Cg_exo -41.46 97.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.321 -0.906 0 N-CA-C 109.121 -1.146 . . . . 0.0 109.121 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.579 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -143.65 169.66 17.31 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.192 0.52 . . . . 0.0 109.648 -178.095 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.528 ' CD ' ' OD1' ' A' ' 67' ' ' ASN . 6.1 mtpm? -83.53 175.46 9.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.155 -0.966 . . . . 0.0 112.163 -178.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.612 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 15.4 mm -124.55 123.64 25.75 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.696 -0.627 . . . . 0.0 111.373 -178.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.597 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 31.7 Cg_exo -62.33 144.97 95.95 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.097 1.577 . . . . 0.0 110.901 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.644 ' CE1' ' CG2' ' A' ' 79' ' ' ILE . 5.8 t80 -152.97 155.71 37.48 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.374 -0.829 . . . . 0.0 110.033 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.5 ' HG2' ' CD1' ' A' ' 91' ' ' ILE . 21.7 tt0 -171.42 103.05 0.2 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.092 -1.005 . . . . 0.0 110.382 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.459 ' O ' ' HE2' ' A' ' 52' ' ' MET . 79.3 mt -94.56 86.63 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.295 -0.878 . . . . 0.0 110.134 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.502 ' CE ' ' HB2' ' A' ' 60' ' ' LEU . 0.4 OUTLIER -153.91 -65.78 0.14 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.135 -0.978 . . . . 0.0 110.276 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.402 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 5.5 t0 -157.98 -71.93 0.09 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.875 . . . . 0.0 110.236 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.484 HD21 ' CD ' ' A' ' 100' ' ' LYS . 0.4 OUTLIER -149.7 -39.24 0.15 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.883 . . . . 0.0 110.298 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.405 ' HG3' ' HG3' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -164.85 55.68 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -0.955 . . . . 0.0 110.266 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.449 ' O ' ' SD ' ' A' ' 52' ' ' MET . 0.1 OUTLIER -131.89 89.62 2.71 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -0.891 . . . . 0.0 110.24 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.59 137.35 58.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 110.26 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -173.65 -153.22 0.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.349 -0.844 . . . . 0.0 110.158 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.7 t -106.53 77.96 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.217 -0.927 . . . . 0.0 110.278 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.502 ' HB2' ' CE ' ' A' ' 52' ' ' MET . 0.4 OUTLIER -137.23 143.97 42.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.26 -0.9 . . . . 0.0 110.184 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.442 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . 51.08 -171.35 0.21 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.525 ' CB ' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -158.3 167.08 30.73 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.211 -1.17 . . . . 0.0 109.381 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.582 HD22 ' CE2' ' A' ' 49' ' ' PHE . 11.6 mt -122.69 122.08 37.92 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 118.916 -1.114 . . . . 0.0 110.814 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.608 ' CD1' ' N ' ' A' ' 64' ' ' ILE . 1.4 mp -83.44 -28.16 7.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.583 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.27 1.3 m -96.98 34.57 1.7 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.447 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' A' ' 63' ' ' LEU . 13.9 t -36.81 142.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.713 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.557 ' N ' ' HD3' ' A' ' 68' ' ' PRO . 46.5 t-20 49.62 59.77 16.3 Favored Pre-proline 0 C--N 1.299 -1.604 0 O-C-N 121.485 -0.759 . . . . 0.0 110.096 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.594 ' CB ' ' CD1' ' A' ' 79' ' ' ILE . 3.0 Cg_exo -68.91 154.89 70.14 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.719 1.378 . . . . 0.0 108.703 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' ' 68' ' ' PRO . 0.8 OUTLIER -142.91 146.5 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.13 -1.028 . . . . 0.0 112.247 -178.63 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.612 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 54.5 t -96.86 154.28 3.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.43 -21.89 12.28 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 120.913 -1.117 . . . . 0.0 108.714 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.539 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 32.1 mt-10 -139.22 146.47 40.53 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.545 ' O ' ' O ' ' A' ' 38' ' ' TYR . 0.5 OUTLIER -53.61 -13.9 0.75 Allowed 'General case' 0 C--N 1.296 -1.756 0 O-C-N 120.808 -1.182 . . . . 0.0 110.948 -178.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.486 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 15.7 t0 -126.91 6.99 6.65 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.58 -1.325 . . . . 0.0 110.671 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.492 ' CB ' ' HB2' ' A' ' 72' ' ' GLU . 0.1 OUTLIER -72.73 112.23 14.35 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.035 -1.041 . . . . 0.0 108.618 178.803 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.58 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 31.5 Cg_exo -56.34 126.71 23.23 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 O-C-N 124.008 1.531 . . . . 0.0 110.68 -178.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.503 HG13 ' N ' ' A' ' 78' ' ' ASN . 53.9 t -105.56 158.62 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.097 -1.002 . . . . 0.0 110.448 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.602 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -121.13 131.21 54.12 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.417 -0.802 . . . . 0.0 109.484 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.644 ' CG2' ' CE1' ' A' ' 49' ' ' PHE . 15.4 mm -114.86 115.13 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 117.598 -1.641 . . . . 0.0 111.674 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 1.5 tp10 -94.23 108.06 19.96 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.562 ' CB ' ' CD2' ' A' ' 63' ' ' LEU . . . -129.4 155.7 45.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.874 -1.141 . . . . 0.0 111.093 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.525 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 1.2 tp10 -95.97 110.72 53.29 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.577 -0.702 . . . . 0.0 110.165 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.534 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 38.1 Cg_endo -71.41 144.84 46.49 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.027 1.541 . . . . 0.0 110.501 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 85' ' ' PHE . 13.4 Cg_endo -61.71 -72.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.006 1.529 . . . . 0.0 110.081 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.483 ' CB ' ' O ' ' A' ' 84' ' ' PRO . 0.1 OUTLIER 170.44 142.31 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.163 -0.961 . . . . 0.0 110.237 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.12 -145.57 27.08 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.62 126.58 30.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -1.137 . . . . 0.0 110.175 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.4 m -139.98 128.79 23.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.908 . . . . 0.0 110.259 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.583 ' CE2' ' ND2' ' A' ' 102' ' ' ASN . 11.6 m-85 -104.08 103.48 13.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -0.961 . . . . 0.0 110.256 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.572 ' CG2' ' CZ ' ' A' ' 49' ' ' PHE . 1.5 mp -74.26 121.78 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.908 . . . . 0.0 109.752 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.5 ' CD1' ' HG2' ' A' ' 50' ' ' GLU . 14.2 mt -96.13 146.93 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -0.946 . . . . 0.0 110.176 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.544 ' CD1' HG22 ' A' ' 34' ' ' ILE . 1.7 mt -135.3 140.82 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.307 -0.87 . . . . 0.0 110.073 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.531 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 80.22 -156.77 39.98 Favored Glycine 0 N--CA 1.484 1.881 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' A' ' 98' ' ' GLN . 0.4 OUTLIER -130.99 156.83 43.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 O-C-N 121.055 -1.262 . . . . 0.0 110.685 -179.511 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.624 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 2.3 mt-10 -30.44 -54.08 0.37 Allowed Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.861 -0.524 . . . . 0.0 111.569 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 3.3 Cg_endo -48.43 -20.67 2.65 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.506 1.267 . . . . 0.0 111.125 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.563 ' HA3' ' CG ' ' A' ' 17' ' ' LYS . . . -176.81 46.42 0.11 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -95.21 153.72 17.53 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.88 -1.365 . . . . 0.0 111.138 -178.591 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.528 ' CD1' ' O ' ' A' ' 18' ' ' PHE . 24.2 mt -103.71 -177.52 3.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.547 -0.721 . . . . 0.0 110.268 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.484 ' CD ' HD21 ' A' ' 54' ' ' LEU . 0.7 OUTLIER -156.48 137.06 13.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.526 -0.734 . . . . 0.0 110.117 179.671 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 89' ' ' TYR . 2.5 mp -139.59 119.98 13.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.102 -0.999 . . . . 0.0 110.338 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.583 ' ND2' ' CE2' ' A' ' 89' ' ' TYR . 16.6 t-20 -87.26 130.22 34.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.314 -0.866 . . . . 0.0 110.314 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.484 ' CZ3' ' O ' ' A' ' 24' ' ' ILE . 21.9 t-105 -119.62 120.76 37.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 110.066 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.51 ' CE2' ' HD3' ' A' ' 106' ' ' LYS . 35.8 t80 -88.05 80.71 7.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.24 -0.912 . . . . 0.0 110.24 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.92 105.76 9.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.259 -0.9 . . . . 0.0 110.211 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.522 ' O ' ' CG ' ' A' ' 106' ' ' LYS . 6.0 pttt -112.11 120.38 41.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.31 -0.869 . . . . 0.0 110.284 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 108' ' ' SER . . . 49.69 -126.24 20.38 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 0.3 OUTLIER 173.19 -30.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -1.132 . . . . 0.0 110.146 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.85 115.96 26.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.28 -0.887 . . . . 0.0 110.232 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.402 ' O ' ' HB2' ' A' ' 111' ' ' GLU . 0.8 OUTLIER -102.74 44.65 1.0 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.168 -0.957 . . . . 0.0 110.224 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 27.6 tt0 -177.52 84.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 110.169 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.444 ' CD2' ' O ' ' A' ' 112' ' ' HIS . 50.8 p-80 -112.45 44.15 1.5 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 110.194 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -109.21 86.55 2.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 110.189 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.81 -58.74 1.87 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -0.918 . . . . 0.0 110.213 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 38.1 m170 -73.53 -8.64 56.76 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.258 -0.901 . . . . 0.0 110.242 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 72.8 m-70 -131.01 175.43 9.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.91 . . . . 0.0 110.223 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.482 ' N ' ' ND1' ' A' ' 117' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.28 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 tpt . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.243 0.544 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.428 ' O ' ' C ' ' A' ' 3' ' ' LYS . 4.7 p-10 -55.89 -20.32 15.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 110.264 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 2' ' ' ASP . 0.7 OUTLIER 42.88 -146.49 0.06 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.933 . . . . 0.0 110.229 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.472 ' O ' ' CB ' ' A' ' 5' ' ' GLN . 0.4 OUTLIER -66.16 124.16 21.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 110.196 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.472 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER 170.87 95.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.261 -0.899 . . . . 0.0 110.051 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.0 mp -124.98 76.01 1.49 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 110.201 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.16 20.7 0.25 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.207 -0.933 . . . . 0.0 110.163 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -154.97 -40.89 0.02 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 42.9 mtp -80.65 -29.84 36.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.287 -1.125 . . . . 0.0 110.219 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.523 ' CA ' ' HE2' ' A' ' 46' ' ' LYS . 24.6 p -45.65 139.95 3.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.208 -0.933 . . . . 0.0 110.077 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.86 -74.12 0.56 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.138 -0.976 . . . . 0.0 110.312 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.464 ' O ' ' HB3' ' A' ' 13' ' ' MET . 3.1 t -141.09 -2.9 1.25 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.006 -1.059 . . . . 0.0 111.219 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.464 ' HB3' ' O ' ' A' ' 12' ' ' SER . 1.7 ttm 56.22 84.4 0.08 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.908 -1.12 . . . . 0.0 108.536 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.591 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 32.5 m -54.81 106.27 0.21 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.375 -0.828 . . . . 0.0 109.65 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 16' ' ' GLY . 4.3 t -94.0 -9.52 36.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.336 -0.852 . . . . 0.0 111.722 -178.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.534 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -59.86 -123.56 0.01 OUTLIER Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.543 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -135.19 174.98 10.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.011 -1.288 . . . . 0.0 109.909 -179.749 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.602 ' CE1' ' HD2' ' A' ' 48' ' ' PRO . 35.0 m-85 -133.81 140.33 46.84 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.92 -1.112 . . . . 0.0 111.311 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.449 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 4.0 ttpt -109.89 117.18 33.12 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.584 -0.698 . . . . 0.0 109.366 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.481 ' CG2' HD11 ' A' ' 99' ' ' LEU . 46.9 t -59.76 123.07 11.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 120.688 -1.258 . . . . 0.0 109.013 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.57 ' HB ' ' CG ' ' A' ' 35' ' ' ARG . 53.2 t -96.95 -25.08 4.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.583 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 4.9 tttt -158.93 133.9 8.26 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -52.33 159.55 0.96 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.645 0.736 . . . . 0.0 111.186 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.568 HD13 ' CA ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -51.82 133.24 13.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.514 0.673 . . . . 0.0 110.202 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.521 ' O ' ' CG2' ' A' ' 32' ' ' ILE . . . -105.74 169.91 8.2 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 0.4 OUTLIER -117.32 123.17 45.87 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.883 -1.135 . . . . 0.0 110.55 -179.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.457 ' OG1' ' OG1' ' A' ' 31' ' ' THR . 5.1 p -78.47 -175.71 4.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.402 -0.811 . . . . 0.0 109.808 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -100.25 34.54 2.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.186 -0.946 . . . . 0.0 110.058 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -140.64 8.57 2.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.247 -0.908 . . . . 0.0 110.434 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.38 -3.5 58.01 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.588 ' CG2' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -91.74 -176.39 4.45 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -1.167 . . . . 0.0 110.262 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -142.23 168.53 14.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.591 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.53 ' CG1' ' HB3' ' A' ' 78' ' ' ASN . 93.4 t -131.83 126.17 56.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 C-N-CA 118.71 -1.196 . . . . 0.0 111.995 -178.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.597 ' CD1' ' CG1' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -109.27 115.84 50.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.309 -0.869 . . . . 0.0 109.852 178.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.583 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 1.4 ttm180 -99.13 120.48 39.56 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.597 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.4 m -147.38 158.14 9.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.326 -0.859 . . . . 0.0 108.919 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 74' ' ' ASP 0.252 0.3 OUTLIER -105.65 125.22 50.74 Favored 'General case' 0 C--N 1.272 -2.796 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.291 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.499 ' O ' ' O ' ' A' ' 73' ' ' LYS . 2.1 t80 -60.1 124.12 19.27 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 119.07 -1.052 . . . . 0.0 110.289 -178.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 17' ' ' LYS . 21.4 mm-40 -112.23 92.05 3.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.874 . . . . 0.0 109.872 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.534 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 164.47 -151.05 19.98 Favored Glycine 0 N--CA 1.486 1.97 0 C-N-CA 119.404 -1.379 . . . . 0.0 109.858 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.449 ' O ' ' OH ' ' A' ' 38' ' ' TYR . 4.4 m-20 -112.4 125.07 53.8 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.5 -1.0 . . . . 0.0 110.48 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 43' ' ' SER . . . 177.66 -27.92 0.06 OUTLIER Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.504 -1.332 . . . . 0.0 110.614 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.609 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.7 OUTLIER 48.56 -153.92 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 120.723 -1.457 . . . . 0.0 107.594 -179.421 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.609 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 53.6 Cg_exo -46.81 94.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.198 0 N-CA-C 108.385 -1.429 . . . . 0.0 108.385 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -150.47 172.67 15.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.582 -0.699 . . . . 0.0 110.063 -177.696 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.523 ' HE2' ' CA ' ' A' ' 10' ' ' SER . 22.0 mtmt -81.09 175.71 10.43 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.236 -0.915 . . . . 0.0 112.102 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.62 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 15.7 mm -124.26 127.48 25.3 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.62 -0.675 . . . . 0.0 111.427 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.602 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 38.3 Cg_exo -63.86 144.13 87.64 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.048 1.551 . . . . 0.0 110.42 178.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.586 ' CD2' HD23 ' A' ' 63' ' ' LEU . 9.6 t80 -151.83 160.28 43.6 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.259 -0.901 . . . . 0.0 110.286 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.521 ' O ' ' CD1' ' A' ' 91' ' ' ILE . 0.9 OUTLIER -175.2 98.78 0.08 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.214 -0.929 . . . . 0.0 109.532 179.569 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.49 ' CG2' ' O ' ' A' ' 51' ' ' ILE . 64.0 mt -83.7 23.26 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.15 -0.969 . . . . 0.0 111.37 -178.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.556 ' CG ' ' N ' ' A' ' 53' ' ' ASP . 11.2 ptt? -154.8 -49.55 0.09 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.935 -1.103 . . . . 0.0 110.701 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.556 ' N ' ' CG ' ' A' ' 52' ' ' MET . 0.4 OUTLIER 49.3 -153.9 0.11 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.071 -1.018 . . . . 0.0 110.333 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.73 0.11 53.72 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.375 -0.828 . . . . 0.0 110.335 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.416 ' O ' ' HD3' ' A' ' 56' ' ' LYS . 1.3 mm-40 -86.96 -11.57 50.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.269 -0.894 . . . . 0.0 109.725 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.575 ' HE2' ' CE2' ' A' ' 89' ' ' TYR . 1.6 mmtp -120.08 -42.06 2.61 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.273 -0.892 . . . . 0.0 110.235 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 56' ' ' LYS . 6.1 ttt85 42.91 79.76 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.141 -0.974 . . . . 0.0 110.182 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 174.92 -67.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.291 -0.881 . . . . 0.0 110.137 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.523 HG11 ' CG ' ' A' ' 84' ' ' PRO . 10.6 p -132.57 131.04 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.898 . . . . 0.0 110.202 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.515 ' CA ' ' SD ' ' A' ' 52' ' ' MET . 0.6 OUTLIER -91.2 29.98 1.33 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 110.187 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 60' ' ' LEU . . . 43.7 -164.52 0.04 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.499 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -131.57 155.46 47.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -1.156 . . . . 0.0 110.36 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.586 HD23 ' CD2' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -115.1 116.33 28.24 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.221 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.588 ' CD1' ' CG2' ' A' ' 31' ' ' THR . 1.7 mp -80.07 -27.35 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.63 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.259 1.2 m -98.47 34.08 2.09 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.062 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.548 ' O ' ' ND2' ' A' ' 67' ' ' ASN . 40.6 t -26.62 145.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.526 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.548 ' ND2' ' O ' ' A' ' 66' ' ' VAL . 4.0 p30 39.81 53.12 5.06 Favored Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 121.778 -0.576 . . . . 0.0 111.475 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.533 ' O ' HG12 ' A' ' 69' ' ' ILE . 1.8 Cg_endo -55.41 154.69 23.18 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 N-CA-C 108.758 -1.285 . . . . 0.0 108.758 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 68' ' ' PRO . 0.7 OUTLIER -141.45 146.47 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 119.049 -1.061 . . . . 0.0 112.819 -177.667 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.62 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 95.7 t -92.75 167.63 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.523 ' N ' HG13 ' A' ' 70' ' ' VAL . 3.1 m -118.74 -21.93 7.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.735 -1.228 . . . . 0.0 111.033 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.517 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 4.0 mt-10 -138.06 19.19 2.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.956 -1.09 . . . . 0.0 110.991 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.523 ' CD ' ' O ' ' A' ' 40' ' ' GLY . 0.3 OUTLIER 72.64 -7.34 1.44 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.398 -0.814 . . . . 0.0 111.11 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.475 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 6.1 t0 -137.43 0.33 2.28 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.864 -1.147 . . . . 0.0 110.451 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.466 ' O ' HG21 ' A' ' 77' ' ' VAL . 32.9 t -73.06 108.39 4.49 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.166 -0.959 . . . . 0.0 109.613 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.504 ' HB3' ' CG2' ' A' ' 21' ' ' VAL . 3.4 Cg_endo -51.57 110.51 0.43 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.735 1.387 . . . . 0.0 109.672 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 88.8 t -99.41 143.45 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.326 -0.859 . . . . 0.0 111.741 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.592 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 3.6 m-80 -98.17 130.97 44.91 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.569 HG22 ' CE1' ' A' ' 49' ' ' PHE . 5.8 mt -108.81 114.33 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.067 -1.646 . . . . 0.0 111.71 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.563 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 3.4 tt0 -84.23 115.29 22.37 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.676 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.537 ' CB ' HD22 ' A' ' 63' ' ' LEU . . . -137.85 152.61 49.24 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.987 -1.071 . . . . 0.0 110.919 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 62' ' ' ARG . 34.9 tt0 -100.82 101.24 14.98 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.366 -0.834 . . . . 0.0 110.308 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.532 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 43.2 Cg_endo -73.23 134.08 20.48 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.036 1.545 . . . . 0.0 110.381 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.523 ' CG ' HG11 ' A' ' 59' ' ' VAL . 34.3 Cg_exo -53.51 -165.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.923 1.486 . . . . 0.0 110.101 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -91.86 138.87 31.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.149 -0.97 . . . . 0.0 110.361 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.66 -170.02 25.06 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -60.69 158.53 12.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.283 -1.127 . . . . 0.0 110.081 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.424 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 0.4 OUTLIER -163.81 134.04 4.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.218 -0.926 . . . . 0.0 110.469 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.575 ' CE2' ' HE2' ' A' ' 56' ' ' LYS . 2.0 m-30 -107.48 103.73 13.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.212 -0.93 . . . . 0.0 110.009 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.535 HG21 ' CZ ' ' A' ' 49' ' ' PHE . 1.6 mp -74.32 121.87 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.141 -0.975 . . . . 0.0 109.346 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.521 ' CD1' ' O ' ' A' ' 50' ' ' GLU . 1.9 mp -100.03 148.25 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.047 -1.033 . . . . 0.0 110.143 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.56 ' CD1' HG21 ' A' ' 34' ' ' ILE . 1.6 mt -134.05 145.54 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.454 -0.779 . . . . 0.0 109.907 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.548 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 80.04 -161.03 45.15 Favored Glycine 0 N--CA 1.481 1.642 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.547 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -122.15 150.48 25.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 O-C-N 121.366 -1.079 . . . . 0.0 110.064 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.571 ' O ' ' N ' ' A' ' 97' ' ' GLY . 5.4 mt-10 -20.68 -56.95 0.07 OUTLIER Pre-proline 0 N--CA 1.5 2.04 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 9.2 Cg_endo -54.71 68.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 124.066 1.561 . . . . 0.0 111.963 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 94.33 6.57 61.26 Favored Glycine 0 N--CA 1.495 2.612 0 O-C-N 120.951 -1.093 . . . . 0.0 111.026 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.501 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -55.64 161.58 2.02 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.933 -1.334 . . . . 0.0 109.993 179.811 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' A' ' 18' ' ' PHE . 12.8 mt -99.26 177.43 5.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.234 -0.916 . . . . 0.0 110.963 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.431 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 4.3 ttpt -154.8 138.51 16.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.57 -0.706 . . . . 0.0 109.953 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.501 HD21 ' CD1' ' A' ' 34' ' ' ILE . 4.9 mp -143.43 124.58 14.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.136 -0.978 . . . . 0.0 110.36 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 8.7 p-10 -92.12 130.61 37.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.357 -0.839 . . . . 0.0 110.596 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.535 ' CZ3' HG23 ' A' ' 24' ' ' ILE . 38.2 t-105 -126.08 148.99 49.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.884 . . . . 0.0 109.998 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.63 123.48 44.9 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -0.892 . . . . 0.0 110.229 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -115.32 60.4 0.7 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -0.932 . . . . 0.0 110.227 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' A' ' 105' ' ' LYS . 0.1 OUTLIER 173.9 119.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.22 -0.925 . . . . 0.0 110.244 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.63 -158.85 16.54 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.4 m -69.35 119.7 14.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.22 -1.165 . . . . 0.0 110.298 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 111' ' ' GLU . 0.3 OUTLIER -170.06 137.98 1.64 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.254 -0.904 . . . . 0.0 110.22 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.2 mt -53.84 88.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.321 -0.862 . . . . 0.0 110.178 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -138.55 67.6 1.4 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -0.933 . . . . 0.0 110.259 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -61.78 113.07 2.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.258 -0.901 . . . . 0.0 110.214 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 24.5 m170 52.97 -155.65 0.19 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.351 -0.843 . . . . 0.0 110.16 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.466 ' CE1' ' OE2' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -152.31 162.74 40.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.298 -0.876 . . . . 0.0 110.196 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.481 ' N ' ' CD2' ' A' ' 115' ' ' HIS . 0.5 OUTLIER -74.93 64.17 1.28 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 0.0 110.159 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -119.13 173.74 6.74 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.336 -0.853 . . . . 0.0 110.17 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.164 -179.975 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 ttp . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.229 0.538 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.424 ' O ' ' CB ' ' A' ' 3' ' ' LYS . 32.6 m-20 -139.71 90.83 2.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 0.0 110.193 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 2' ' ' ASP . 0.3 OUTLIER 173.64 125.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 110.256 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.466 ' O ' ' HB3' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -171.72 150.21 2.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.282 -0.886 . . . . 0.0 110.252 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.466 ' HB3' ' O ' ' A' ' 4' ' ' LEU . 2.5 pm0 179.45 59.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.288 -0.882 . . . . 0.0 110.06 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -166.0 -43.45 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.298 -0.876 . . . . 0.0 110.196 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.1 mttt 47.26 47.05 16.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.913 . . . . 0.0 110.157 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 9' ' ' MET . . . -149.22 16.12 1.15 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.456 ' O ' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER 48.77 -178.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -1.147 . . . . 0.0 110.208 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.527 ' HA ' ' CD ' ' A' ' 46' ' ' LYS . 80.3 p -139.81 -173.56 3.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.251 -0.906 . . . . 0.0 110.105 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -143.46 -74.16 0.27 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.183 -0.948 . . . . 0.0 110.396 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.469 ' HB3' ' HB2' ' A' ' 45' ' ' CYS . 2.9 t -139.23 1.96 2.04 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.966 -1.083 . . . . 0.0 110.832 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.429 ' C ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER 45.95 83.23 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.042 -1.036 . . . . 0.0 108.386 -179.528 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.58 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 30.8 m -54.0 102.4 0.06 Allowed 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.575 -178.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.491 ' O ' ' O ' ' A' ' 16' ' ' GLY . 3.4 p -87.84 -8.08 56.37 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.375 -0.828 . . . . 0.0 111.711 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.545 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -60.33 -131.55 0.01 OUTLIER Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.522 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -134.37 -178.91 5.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.02 -1.282 . . . . 0.0 109.822 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.596 ' CE1' HG22 ' A' ' 47' ' ' ILE . 44.1 m-85 -138.01 142.62 40.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.894 -1.129 . . . . 0.0 111.851 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.471 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 31.9 ttpt -110.4 117.92 34.89 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.515 ' CG2' HD12 ' A' ' 99' ' ' LEU . 60.6 t -59.56 124.23 13.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 120.666 -1.271 . . . . 0.0 109.459 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.548 ' HB ' ' CG ' ' A' ' 35' ' ' ARG . 83.3 t -96.27 -27.09 4.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.567 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 0.2 OUTLIER -154.31 138.06 16.16 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.332 177.11 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.54 158.43 4.45 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.383 0.611 . . . . 0.0 110.364 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.561 HD13 ' CB ' ' A' ' 34' ' ' ILE . 0.7 OUTLIER -55.4 130.64 17.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.051 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 32' ' ' ILE . . . -108.65 168.74 9.12 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 12.9 pt-20 -113.87 134.94 54.49 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.786 -1.196 . . . . 0.0 110.479 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.534 ' CG2' ' OE2' ' A' ' 80' ' ' GLU . 16.5 p -90.52 -172.67 3.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.5 -0.75 . . . . 0.0 110.278 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -95.91 4.41 52.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.269 -0.895 . . . . 0.0 110.419 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -106.67 6.82 30.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.201 -0.937 . . . . 0.0 110.223 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.53 7.64 61.62 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.548 ' CG2' HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -97.48 -171.95 2.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -1.092 . . . . 0.0 110.457 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.565 HG21 ' CD1' ' A' ' 103' ' ' TRP . 0.0 OUTLIER -142.69 147.21 21.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.485 ' N ' ' O ' ' A' ' 25' ' ' ALA . 66.8 t -111.64 134.79 52.91 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 O-C-N 121.346 -0.846 . . . . 0.0 112.08 -177.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.607 ' CD1' ' CG1' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -120.95 118.76 57.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 121.409 -0.807 . . . . 0.0 109.988 179.11 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.567 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -100.07 122.99 43.8 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 119.026 -1.07 . . . . 0.0 108.34 179.23 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.607 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.3 m -149.0 158.52 6.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.175 -0.953 . . . . 0.0 109.053 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 74' ' ' ASP 0.256 1.8 tt0 -107.61 126.74 52.94 Favored 'General case' 0 C--N 1.27 -2.848 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.503 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.529 ' O ' ' O ' ' A' ' 73' ' ' LYS . 1.9 t80 -59.18 125.46 23.68 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.182 -178.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 17' ' ' LYS . 5.2 mm-40 -111.85 87.96 2.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.18 -0.95 . . . . 0.0 109.715 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.545 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 164.65 -150.58 18.85 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.456 ' O ' ' OH ' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -117.82 137.02 53.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.594 -0.945 . . . . 0.0 110.496 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 43' ' ' SER . . . 173.32 -24.76 0.08 OUTLIER Glycine 0 N--CA 1.488 2.109 0 C-N-CA 119.649 -1.262 . . . . 0.0 110.641 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.599 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.4 OUTLIER 49.36 -156.54 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 120.732 -1.452 . . . . 0.0 107.813 -179.501 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.599 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 50.8 Cg_exo -48.15 94.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.318 0 N-CA-C 107.951 -1.596 . . . . 0.0 107.951 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.58 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -148.06 173.62 12.74 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.633 -0.667 . . . . 0.0 109.333 -177.584 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.542 ' HG3' ' CD1' ' A' ' 69' ' ' ILE . 0.3 OUTLIER -88.6 173.84 8.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.0 -1.062 . . . . 0.0 111.78 -178.73 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.604 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 19.2 mm -124.18 129.64 24.65 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.64 -0.662 . . . . 0.0 112.033 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.593 ' HD2' ' CE2' ' A' ' 18' ' ' PHE . 36.8 Cg_exo -63.71 147.82 92.42 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 124.05 1.552 . . . . 0.0 111.034 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.647 ' CE2' ' CG2' ' A' ' 79' ' ' ILE . 11.0 t80 -155.51 157.6 37.16 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.324 -0.86 . . . . 0.0 110.552 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.488 ' HG2' ' CD1' ' A' ' 91' ' ' ILE . 22.4 tt0 -175.72 95.91 0.07 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.147 -0.971 . . . . 0.0 110.306 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.533 HD12 ' CB ' ' A' ' 81' ' ' ALA . 0.5 OUTLIER -58.65 -35.58 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.313 -0.867 . . . . 0.0 109.74 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.458 ' O ' ' C ' ' A' ' 53' ' ' ASP . 1.0 OUTLIER -154.71 -67.74 0.13 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.126 -0.984 . . . . 0.0 110.189 179.587 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 55' ' ' GLU . 5.8 t0 37.44 -150.29 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.553 -0.717 . . . . 0.0 110.677 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.427 HD13 ' CD ' ' A' ' 50' ' ' GLU . 6.3 mp 43.98 -92.12 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.415 -0.803 . . . . 0.0 110.517 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 53' ' ' ASP . 3.4 pt-20 -166.41 64.44 0.1 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.062 -1.024 . . . . 0.0 110.248 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.446 ' HB2' ' SD ' ' A' ' 52' ' ' MET . 39.7 mmtt -98.59 -175.63 3.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.26 -0.9 . . . . 0.0 110.077 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -43.16 -26.71 0.18 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.907 . . . . 0.0 110.06 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.418 ' N ' ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -172.45 -177.09 1.69 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.288 -0.883 . . . . 0.0 110.119 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 59' ' ' VAL . 4.9 p -148.96 80.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.951 . . . . 0.0 110.289 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.55 4.68 2.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 110.317 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.535 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . -59.07 174.7 3.26 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -150.34 163.49 38.21 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.271 -1.134 . . . . 0.0 109.496 179.749 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.583 ' CD2' ' CB ' ' A' ' 81' ' ' ALA . 11.1 mt -123.6 121.2 34.96 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 118.639 -1.224 . . . . 0.0 110.408 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.548 HG12 ' CG2' ' A' ' 31' ' ' THR . 4.1 mm -83.34 -29.32 7.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.585 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.267 1.9 m -99.37 35.87 1.86 Allowed 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 63' ' ' LEU . 44.7 t -37.79 155.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-O 121.489 0.662 . . . . 0.0 110.995 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.53 ' HB2' ' CD ' ' A' ' 46' ' ' LYS . 24.3 p30 36.46 53.97 2.56 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 122.065 -0.397 . . . . 0.0 111.378 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.59 ' CB ' ' CD1' ' A' ' 79' ' ' ILE . 15.7 Cg_exo -55.05 161.56 6.44 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 N-CA-C 108.472 -1.395 . . . . 0.0 108.472 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.542 ' CD1' ' HG3' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -142.79 145.8 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 118.844 -1.143 . . . . 0.0 112.813 -178.431 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.604 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 55.8 t -101.38 160.59 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 176.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.47 ' N ' HG11 ' A' ' 70' ' ' VAL . 2.8 m -116.09 -19.48 10.28 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.653 -1.279 . . . . 0.0 111.326 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 3.2 mt-10 -137.61 14.71 2.94 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.831 -1.168 . . . . 0.0 111.272 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.529 ' O ' ' O ' ' A' ' 38' ' ' TYR . 3.2 mtmt 75.11 -11.3 1.09 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.517 -0.739 . . . . 0.0 111.03 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.463 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 6.4 t0 -133.67 0.92 3.32 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.979 -1.076 . . . . 0.0 110.204 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.437 ' HA ' ' HD2' ' A' ' 76' ' ' PRO . 25.1 t -72.83 108.76 4.87 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.202 -0.937 . . . . 0.0 109.528 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 74' ' ' ASP . 4.2 Cg_endo -52.16 113.59 1.26 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.766 1.403 . . . . 0.0 109.921 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 62.0 t -99.35 153.67 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.268 -0.895 . . . . 0.0 110.982 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.596 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.3 m-20 -112.39 133.11 54.66 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.647 ' CG2' ' CE2' ' A' ' 49' ' ' PHE . 7.2 mm -115.47 121.86 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.1 -1.625 . . . . 0.0 111.588 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.534 ' OE2' ' CG2' ' A' ' 27' ' ' THR . 1.0 OUTLIER -99.15 106.59 18.79 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.681 -0.637 . . . . 0.0 109.815 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.583 ' CB ' ' CD2' ' A' ' 63' ' ' LEU . . . -123.2 156.25 35.49 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.989 -1.069 . . . . 0.0 111.178 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 62' ' ' ARG . 4.7 tt0 -101.64 101.03 15.83 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.632 -0.668 . . . . 0.0 110.283 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.537 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 23.3 Cg_endo -67.82 151.22 78.72 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 124.045 1.55 . . . . 0.0 110.467 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.535 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 15.2 Cg_endo -62.16 -74.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.047 1.551 . . . . 0.0 110.337 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -175.84 160.56 2.39 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.288 -0.882 . . . . 0.0 110.214 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.506 ' CA ' ' O ' ' A' ' 105' ' ' LYS . . . 62.63 -143.43 48.65 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -67.86 152.44 45.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -1.129 . . . . 0.0 110.256 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 103' ' ' TRP . 2.6 t -155.76 125.53 6.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.308 -0.87 . . . . 0.0 110.167 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.486 ' CE1' ' ND2' ' A' ' 102' ' ' ASN . 10.2 m-85 -100.43 100.25 10.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.938 . . . . 0.0 110.163 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.524 HD11 ' CD1' ' A' ' 32' ' ' ILE . 1.6 mp -74.16 111.47 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.152 -0.968 . . . . 0.0 109.381 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.488 ' CD1' ' HG2' ' A' ' 50' ' ' GLU . 33.7 mt -92.23 146.8 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.243 -0.911 . . . . 0.0 110.435 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.546 ' CD1' HG21 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -134.71 137.1 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.617 -0.677 . . . . 0.0 109.54 -179.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.509 ' O ' ' HB2' ' A' ' 48' ' ' PRO . . . 85.91 -162.6 35.77 Favored Glycine 0 N--CA 1.482 1.735 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.56 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -120.27 147.92 23.71 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 O-C-N 121.146 -1.208 . . . . 0.0 110.179 -179.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.579 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.8 mt-10 -16.86 -58.31 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.149 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 6.9 Cg_endo -51.07 72.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 124.164 1.613 . . . . 0.0 111.992 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 89.36 -1.78 82.53 Favored Glycine 0 N--CA 1.494 2.551 0 O-C-N 121.032 -1.042 . . . . 0.0 110.809 178.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.486 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -45.83 159.3 0.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.986 -1.302 . . . . 0.0 110.042 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 18' ' ' PHE . 10.2 mt -96.06 173.26 7.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 110.6 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.454 ' HG3' HG12 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -154.57 131.03 10.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.388 -0.82 . . . . 0.0 110.007 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.513 HD22 ' CG1' ' A' ' 34' ' ' ILE . 5.5 mp -134.33 121.46 21.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 0.0 110.432 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.486 ' ND2' ' CE1' ' A' ' 89' ' ' TYR . 5.6 t-20 -89.78 130.94 35.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.285 -0.884 . . . . 0.0 110.141 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.565 ' CD1' HG21 ' A' ' 32' ' ' ILE . 10.7 t-105 -113.72 135.29 54.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.227 -0.921 . . . . 0.0 110.205 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.38 77.21 5.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.373 -0.829 . . . . 0.0 110.135 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.506 ' O ' ' CA ' ' A' ' 86' ' ' GLY . 0.1 OUTLIER -94.0 93.23 7.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.287 -0.883 . . . . 0.0 110.261 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -100.06 -81.74 0.46 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.28 -0.888 . . . . 0.0 110.173 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 108' ' ' SER . . . -98.1 -114.06 3.3 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 107' ' ' GLY . 1.1 m 44.13 57.22 4.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -1.152 . . . . 0.0 110.206 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.6 t -104.43 164.4 11.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 110.163 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.13 123.78 5.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 0.0 110.222 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -174.72 172.13 3.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.914 . . . . 0.0 110.234 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 59.55 91.4 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -0.906 . . . . 0.0 110.258 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.482 ' CG ' ' N ' ' A' ' 114' ' ' HIS . 7.3 p-80 -172.16 -142.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.268 -0.895 . . . . 0.0 110.132 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.592 ' N ' ' CD2' ' A' ' 114' ' ' HIS . 2.3 p80 -153.37 115.73 4.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 110.164 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -94.75 -172.06 2.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 0.0 110.231 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 3.7 m80 -97.9 78.84 2.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.171 -0.956 . . . . 0.0 110.247 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.546 ' O ' ' CG ' ' A' ' 117' ' ' HIS . 11.8 p80 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.158 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.199 0.524 . . . . 0.0 110.289 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -110.03 -47.86 3.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.262 -0.899 . . . . 0.0 110.152 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.46 ' O ' ' O ' ' A' ' 4' ' ' LEU . 60.7 mttt -69.23 -172.96 0.48 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 110.282 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.462 ' O ' ' HG3' ' A' ' 5' ' ' GLN . 14.5 tp 60.8 131.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 110.052 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -179.49 -72.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.127 -0.983 . . . . 0.0 110.28 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 62.13 106.67 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 0.0 110.18 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.11 133.04 36.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.296 -0.877 . . . . 0.0 110.207 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.92 -113.26 0.01 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.36 -158.38 0.24 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.282 -1.128 . . . . 0.0 110.225 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 10' ' ' SER . 1.9 t -89.95 59.35 4.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.268 -0.895 . . . . 0.0 110.063 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.589 ' CE1' ' CD1' ' A' ' 69' ' ' ILE . 0.8 OUTLIER -165.13 23.96 0.05 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.248 -0.908 . . . . 0.0 109.463 -179.789 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.506 ' HA ' ' HD3' ' A' ' 46' ' ' LYS . 3.2 t -135.76 -21.73 1.47 Allowed 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.622 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.591 ' O ' ' CG ' ' A' ' 13' ' ' MET . 0.3 OUTLIER -174.8 75.83 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.018 -1.051 . . . . 0.0 111.194 -179.109 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.584 ' HB3' ' CE1' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -45.03 103.83 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.714 -1.241 . . . . 0.0 109.127 179.365 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.489 ' O ' ' O ' ' A' ' 16' ' ' GLY . 1.2 p -68.74 -5.65 21.78 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.479 -0.763 . . . . 0.0 111.755 -178.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.514 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -59.3 -149.74 0.01 OUTLIER Glycine 0 N--CA 1.48 1.623 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.563 ' CG ' ' CA ' ' A' ' 97' ' ' GLY . 1.4 tmpt? -123.61 160.77 26.38 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.37 -1.076 . . . . 0.0 108.929 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.595 ' CE1' ' HD2' ' A' ' 48' ' ' PRO . 34.5 m-85 -118.76 137.55 53.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.497 -1.377 . . . . 0.0 112.144 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.504 ' HE2' ' NE2' ' A' ' 37' ' ' GLN . 7.7 ttpp -109.21 119.33 39.2 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.703 -0.623 . . . . 0.0 109.435 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.417 ' HA ' HG11 ' A' ' 36' ' ' VAL . 27.4 t -59.46 129.54 21.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 120.709 -1.244 . . . . 0.0 108.836 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.528 ' CG2' ' HB2' ' A' ' 37' ' ' GLN . 64.3 t -104.75 -24.75 3.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.546 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 15.3 tttt -159.91 134.6 7.76 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 177.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -52.6 155.02 2.36 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.6 0.714 . . . . 0.0 111.094 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.574 HD12 ' CA ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -47.87 133.85 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.967 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.522 ' O ' ' CG2' ' A' ' 32' ' ' ILE . . . -106.84 173.33 6.37 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.5 pm0 -116.98 126.11 52.41 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.905 -1.122 . . . . 0.0 110.582 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.47 ' OG1' ' OG1' ' A' ' 31' ' ' THR . 11.9 p -79.85 -163.74 0.57 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.355 -0.841 . . . . 0.0 110.035 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -110.44 31.56 5.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 109.874 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -139.84 10.36 2.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.344 -0.848 . . . . 0.0 110.447 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.85 -1.44 59.65 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.584 ' CG2' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -91.81 -175.46 4.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -1.117 . . . . 0.0 110.269 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -142.93 165.98 15.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.505 ' O ' ' N ' ' A' ' 25' ' ' ALA . 93.7 t -130.26 125.87 60.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 120.724 -1.235 . . . . 0.0 112.44 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.615 ' O ' ' HA ' ' A' ' 78' ' ' ASN . 0.3 OUTLIER -106.51 116.68 50.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.363 -0.836 . . . . 0.0 109.566 178.803 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.546 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 3.4 ttm180 -101.49 120.07 39.74 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.595 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.8 m -140.69 -173.68 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.528 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 1.9 tt0 -133.89 124.57 26.66 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.584 ' CE1' ' HB3' ' A' ' 14' ' ' CYS . 89.3 t80 -61.32 140.64 57.95 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.368 -1.333 . . . . 0.0 110.527 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 17' ' ' LYS . 3.3 mm-40 -134.74 83.34 2.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.491 -0.756 . . . . 0.0 109.805 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.514 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 174.0 -147.07 9.09 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.483 ' HA ' ' HD2' ' A' ' 73' ' ' LYS . 50.0 t0 -113.93 132.79 55.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.627 -0.925 . . . . 0.0 110.38 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.464 ' O ' ' OG ' ' A' ' 10' ' ' SER . . . 165.01 -24.7 0.17 Allowed Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.726 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.608 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.5 OUTLIER 49.24 -156.13 0.01 OUTLIER Pre-proline 0 N--CA 1.487 1.395 0 O-C-N 120.598 -1.531 . . . . 0.0 108.105 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.608 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 74.6 Cg_exo -44.02 96.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.35 0 N-CA-C 109.283 -1.083 . . . . 0.0 109.283 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.522 ' O ' HG22 ' A' ' 69' ' ' ILE . 24.5 p -143.34 169.31 17.89 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.634 -0.666 . . . . 0.0 110.134 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.6 ' CG ' ' CD1' ' A' ' 69' ' ' ILE . 0.5 OUTLIER -83.86 172.74 11.86 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.411 -0.806 . . . . 0.0 110.358 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.597 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 15.8 mm -114.76 126.6 27.71 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 111.957 -177.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.595 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 33.8 Cg_exo -63.02 144.6 93.23 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.993 1.523 . . . . 0.0 110.846 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.636 ' CD1' ' CD2' ' A' ' 63' ' ' LEU . 3.9 t80 -154.29 153.11 31.13 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.537 -0.727 . . . . 0.0 109.678 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.501 ' HB3' ' HB ' ' A' ' 91' ' ' ILE . 19.3 tp10 -166.37 98.06 0.59 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.928 -1.107 . . . . 0.0 110.546 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.433 ' CD1' ' HB2' ' A' ' 81' ' ' ALA . 4.8 mt -92.07 136.08 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.29 -0.881 . . . . 0.0 109.821 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.495 ' O ' ' CB ' ' A' ' 53' ' ' ASP . 3.7 ptt? -136.19 -49.6 0.68 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.08 -1.013 . . . . 0.0 110.548 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' A' ' 52' ' ' MET . 12.4 t0 68.28 -58.76 0.46 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.1 -1.0 . . . . 0.0 110.202 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.403 ' N ' ' O ' ' A' ' 52' ' ' MET . 11.7 mt -83.02 -75.62 0.31 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.923 . . . . 0.0 110.2 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 56' ' ' LYS . 8.0 mm-40 -124.86 -76.9 0.59 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.154 -0.966 . . . . 0.0 110.202 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 55' ' ' GLU . 0.1 OUTLIER 179.1 67.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.193 -0.942 . . . . 0.0 110.239 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.22 174.99 6.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 0.0 110.146 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.529 ' O ' ' CG ' ' A' ' 58' ' ' HIS . 47.1 t-80 -101.49 25.32 8.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 110.159 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.0 m -117.43 3.22 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 110.228 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.412 HD22 ' HB3' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -117.88 119.2 34.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.192 -0.943 . . . . 0.0 110.257 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.525 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . 84.04 162.76 34.53 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -143.25 169.35 17.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -1.143 . . . . 0.0 110.373 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.636 ' CD2' ' CD1' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -120.89 121.26 37.68 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.479 179.39 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.584 ' CD1' ' CG2' ' A' ' 31' ' ' THR . 1.4 mp -85.53 -27.79 6.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 106.735 -1.579 . . . . 0.0 106.735 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.584 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.254 2.3 m -110.93 39.79 2.17 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.283 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.541 ' CG2' ' HB3' ' A' ' 63' ' ' LEU . 6.8 t -25.9 121.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 CA-C-O 121.711 0.767 . . . . 0.0 111.813 -178.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.561 ' ND2' ' HB3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER 41.8 69.96 1.88 Allowed Pre-proline 0 C--N 1.297 -1.696 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.77 178.537 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.53 ' O ' ' N ' ' A' ' 47' ' ' ILE . 1.2 Cg_endo -55.6 -171.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.725 1.382 . . . . 0.0 108.826 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.6 ' CD1' ' CG ' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -143.53 145.62 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 118.926 -1.109 . . . . 0.0 112.44 -179.409 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.597 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 60.1 t -97.86 162.12 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 176.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.477 ' N ' HG11 ' A' ' 70' ' ' VAL . 2.6 m -117.26 -17.21 10.24 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.666 -1.213 . . . . 0.0 111.351 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.54 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 15.4 mt-10 -142.03 16.87 2.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.875 -1.141 . . . . 0.0 111.054 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.1 OUTLIER 75.71 -12.71 0.96 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.48 -0.763 . . . . 0.0 110.97 179.745 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.479 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 12.5 t70 -133.41 -1.94 3.13 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.051 -1.031 . . . . 0.0 110.234 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.2 t -71.97 112.27 13.77 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.246 -0.909 . . . . 0.0 108.69 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.571 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 42.7 Cg_exo -49.03 126.29 14.89 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.9 1.473 . . . . 0.0 110.387 -178.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.2 t -115.65 143.37 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.072 -1.018 . . . . 0.0 111.254 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.615 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 1.5 m-20 -104.74 136.18 44.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.412 -0.805 . . . . 0.0 109.562 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.634 ' CG2' ' CE2' ' A' ' 49' ' ' PHE . 7.3 mt -115.41 116.94 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.134 -1.604 . . . . 0.0 111.552 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.566 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 3.8 tt0 -88.06 114.0 24.25 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.455 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.515 ' O ' HG13 ' A' ' 32' ' ' ILE . . . -132.77 149.32 52.29 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.943 -1.098 . . . . 0.0 110.915 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 62' ' ' ARG . 2.8 tp10 -99.99 99.15 8.6 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.305 -0.872 . . . . 0.0 110.196 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.52 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 21.9 Cg_endo -66.21 152.6 80.73 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.064 1.56 . . . . 0.0 110.494 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.525 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 17.8 Cg_endo -65.1 -74.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.993 1.522 . . . . 0.0 110.241 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.508 ' CD1' ' O ' ' A' ' 85' ' ' PHE . 10.2 p90 -179.07 151.73 0.52 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.88 . . . . 0.0 110.187 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.06 -166.09 52.68 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 53' ' ' ASP . 2.6 p30 -61.43 146.22 49.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.238 -1.154 . . . . 0.0 110.118 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.46 ' OG ' ' HB2' ' A' ' 53' ' ' ASP . 0.3 OUTLIER -157.86 120.72 3.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.294 -0.879 . . . . 0.0 110.231 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.42 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 2.9 m-85 -90.36 98.31 11.7 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.19 -0.944 . . . . 0.0 110.167 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.579 HG22 ' CE1' ' A' ' 49' ' ' PHE . 11.0 mt -74.33 138.7 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.267 -0.896 . . . . 0.0 109.67 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.501 ' HB ' ' HB3' ' A' ' 50' ' ' GLU . 14.6 mt -98.83 150.11 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.051 -1.031 . . . . 0.0 110.216 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.545 ' CD1' HG23 ' A' ' 34' ' ' ILE . 0.6 OUTLIER -138.61 142.73 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.49 -0.756 . . . . 0.0 109.928 -179.506 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.549 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 80.03 -157.15 40.84 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.58 ' N ' ' HB2' ' A' ' 98' ' ' GLN . 0.8 OUTLIER -129.08 157.33 41.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 121.077 -1.249 . . . . 0.0 110.023 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.524 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 4.0 mt-10 -33.05 -54.62 0.63 Allowed Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.635 -0.666 . . . . 0.0 110.442 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 62.0 Cg_exo -44.31 -37.94 10.82 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.154 1.607 . . . . 0.0 110.458 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.563 ' CA ' ' CG ' ' A' ' 17' ' ' LYS . . . -157.17 53.22 0.4 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.58 ' HB2' ' N ' ' A' ' 94' ' ' VAL . 0.6 OUTLIER -109.62 149.39 29.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.04 -1.271 . . . . 0.0 111.0 -178.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.539 ' CD1' HG21 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -119.88 -163.05 0.96 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.197 -0.94 . . . . 0.0 109.869 178.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -146.49 153.72 40.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.519 -0.738 . . . . 0.0 110.284 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.525 ' CD1' HG13 ' A' ' 34' ' ' ILE . 1.1 mt -138.26 113.12 9.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.922 . . . . 0.0 110.162 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 88' ' ' SER . 4.8 p-10 -87.36 130.5 34.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.869 . . . . 0.0 110.459 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.52 ' CE3' HG22 ' A' ' 24' ' ' ILE . 53.2 t-105 -133.58 144.84 49.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.336 -0.852 . . . . 0.0 110.073 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -104.0 110.4 22.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 110.188 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -111.75 73.17 0.8 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.939 . . . . 0.0 110.229 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.53 -175.24 4.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.277 -0.89 . . . . 0.0 110.11 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.91 60.54 0.33 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.6 t -83.77 -39.19 20.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -1.16 . . . . 0.0 110.098 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 45.7 t -176.56 139.48 0.32 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.269 -0.894 . . . . 0.0 110.161 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.474 HD21 ' N ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -147.85 68.0 1.11 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.227 -0.921 . . . . 0.0 110.209 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -173.6 152.42 2.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.315 -0.865 . . . . 0.0 110.173 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -151.21 64.9 0.89 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.284 -0.885 . . . . 0.0 110.277 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.486 ' O ' ' CG ' ' A' ' 114' ' ' HIS . 43.2 p-80 -127.51 143.97 51.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.216 -0.927 . . . . 0.0 110.238 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.486 ' CG ' ' O ' ' A' ' 113' ' ' HIS . 42.4 m80 -156.2 -69.88 0.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.894 . . . . 0.0 110.262 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.48 ' O ' ' N ' ' A' ' 117' ' ' HIS . 0.0 OUTLIER -61.64 145.26 52.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 110.196 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 59.29 -82.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.303 -0.873 . . . . 0.0 110.23 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.48 ' N ' ' O ' ' A' ' 115' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.198 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttm . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.317 0.579 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.415 ' C ' ' HD3' ' A' ' 3' ' ' LYS . 17.3 m-20 -134.61 43.63 2.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.302 -0.874 . . . . 0.0 110.156 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.415 ' HD3' ' C ' ' A' ' 2' ' ' ASP . 4.1 mppt? -135.15 47.05 2.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.229 -0.919 . . . . 0.0 110.221 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.434 ' O ' ' HG3' ' A' ' 5' ' ' GLN . 1.8 mt -97.47 -137.73 0.27 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.334 -0.854 . . . . 0.0 110.137 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 4' ' ' LEU . 0.7 OUTLIER -176.91 -40.53 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.112 -0.993 . . . . 0.0 110.192 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.05 161.98 16.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.294 -0.879 . . . . 0.0 110.132 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -120.22 -6.42 9.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.168 -0.957 . . . . 0.0 110.203 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 9' ' ' MET . . . -156.34 53.57 0.41 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.411 ' O ' ' O ' ' A' ' 8' ' ' GLY . 15.7 mmt 47.88 -173.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -1.155 . . . . 0.0 110.206 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.529 ' CA ' ' HD2' ' A' ' 46' ' ' LYS . 1.4 m -115.03 -177.12 3.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.187 -0.946 . . . . 0.0 110.15 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -91.47 -73.14 0.55 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.164 -0.96 . . . . 0.0 110.184 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.463 ' O ' ' HB3' ' A' ' 13' ' ' MET . 3.4 t -133.56 -5.83 2.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.121 -0.987 . . . . 0.0 110.778 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.463 ' HB3' ' O ' ' A' ' 12' ' ' SER . 3.8 ttp 56.35 79.08 0.18 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.067 -1.021 . . . . 0.0 108.976 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.577 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 31.1 m -54.6 109.02 0.44 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.417 -0.802 . . . . 0.0 109.398 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.511 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 77.6 p -101.14 -4.72 26.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.159 -0.963 . . . . 0.0 111.764 -178.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.541 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -60.13 -124.14 0.01 OUTLIER Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 39' ' ' GLU . 1.5 ttpt -134.74 154.7 51.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.043 -1.269 . . . . 0.0 109.774 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.597 ' CE1' ' HD2' ' A' ' 48' ' ' PRO . 37.2 m-85 -118.25 137.84 52.76 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.805 -1.185 . . . . 0.0 111.768 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -107.95 119.53 39.71 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.548 -0.72 . . . . 0.0 109.274 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.519 ' CG2' HD12 ' A' ' 99' ' ' LEU . 43.4 t -60.12 124.76 15.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 120.736 -1.228 . . . . 0.0 109.364 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.556 ' HB ' ' CG ' ' A' ' 35' ' ' ARG . 88.6 t -95.35 -27.02 4.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.649 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 5.1 tttp -159.26 133.51 7.69 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -48.59 160.31 0.18 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.569 0.699 . . . . 0.0 111.367 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.568 HG12 HG12 ' A' ' 34' ' ' ILE . 0.6 OUTLIER -56.53 133.13 20.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-O 121.662 0.744 . . . . 0.0 110.193 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 33' ' ' VAL . . . -108.58 169.72 8.47 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.7 pm0 -115.09 134.37 55.23 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.556 -1.34 . . . . 0.0 110.591 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.522 ' CG2' ' OE2' ' A' ' 80' ' ' GLU . 16.1 p -92.42 171.92 8.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.44 -0.788 . . . . 0.0 110.255 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -86.98 26.78 1.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.213 -0.929 . . . . 0.0 110.529 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.93 6.82 5.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.237 -0.915 . . . . 0.0 110.192 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.93 5.81 59.54 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.539 HG21 ' CA ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -101.78 178.42 4.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -1.124 . . . . 0.0 110.427 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.539 ' CD1' ' HG3' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -134.76 153.02 34.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.481 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 25' ' ' ALA . 48.5 t -117.96 132.13 68.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 C-N-CA 119.167 -1.013 . . . . 0.0 112.076 -177.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.6 ' CD1' ' CG1' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -117.76 119.98 63.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.327 -0.858 . . . . 0.0 110.009 179.128 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.649 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -102.45 124.04 47.29 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.241 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.6 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.2 m -147.7 161.93 7.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.157 -0.964 . . . . 0.0 108.834 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.513 ' NE2' ' OD2' ' A' ' 74' ' ' ASP 0.271 12.5 tt0 -107.37 122.93 47.59 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -178.588 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.561 ' CE1' ' HB3' ' A' ' 14' ' ' CYS . 12.9 t80 -62.71 122.12 15.1 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 118.814 -1.154 . . . . 0.0 110.282 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 17' ' ' LYS . 2.7 mm-40 -115.87 98.61 6.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 110.019 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.541 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 160.16 -151.97 22.69 Favored Glycine 0 N--CA 1.486 2.005 0 C-N-CA 119.282 -1.437 . . . . 0.0 110.074 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 1.5 m-20 -105.85 106.37 16.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.704 -0.88 . . . . 0.0 109.954 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 43' ' ' SER . . . -165.32 -41.51 0.02 OUTLIER Glycine 0 N--CA 1.489 2.175 0 C-N-CA 119.539 -1.315 . . . . 0.0 110.394 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.63 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 1.0 OUTLIER 49.3 -150.23 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.366 0 O-C-N 120.869 -1.371 . . . . 0.0 107.485 -179.442 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.63 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 51.7 Cg_exo -47.83 92.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -1.022 0 N-CA-C 108.431 -1.411 . . . . 0.0 108.431 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.577 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -153.91 173.98 15.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.683 -0.636 . . . . 0.0 109.396 -177.78 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.586 ' CG ' ' CD1' ' A' ' 69' ' ' ILE . 14.9 mttp -85.18 174.94 9.27 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.287 -0.883 . . . . 0.0 111.594 -178.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.61 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 14.5 mm -123.06 128.72 25.23 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.401 -0.812 . . . . 0.0 111.936 -178.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.597 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 37.7 Cg_exo -63.68 145.03 90.83 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.58 1.52 . . . . 0.0 111.24 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.632 ' CD2' ' CD2' ' A' ' 63' ' ' LEU . 10.6 t80 -155.46 146.1 22.14 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.407 -0.808 . . . . 0.0 110.434 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.584 ' CG ' ' CG2' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -156.84 111.22 2.73 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.006 -1.059 . . . . 0.0 110.367 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.448 ' CD1' ' HB1' ' A' ' 81' ' ' ALA . 5.7 mt -98.69 56.65 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.184 -0.947 . . . . 0.0 110.296 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.465 ' O ' ' N ' ' A' ' 54' ' ' LEU . 2.4 mmt -154.68 -58.04 0.11 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.21 -0.931 . . . . 0.0 110.263 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.453 ' HB3' ' O ' ' A' ' 52' ' ' MET . 26.1 t0 66.29 -58.35 0.35 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.352 -0.842 . . . . 0.0 110.563 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.465 ' N ' ' O ' ' A' ' 52' ' ' MET . 1.7 mt -86.94 1.88 51.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 110.696 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -171.56 69.82 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.166 -0.959 . . . . 0.0 110.205 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.435 ' HG2' ' CB ' ' A' ' 52' ' ' MET . 24.1 mtmt -97.86 46.01 1.02 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.409 -0.807 . . . . 0.0 110.201 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.467 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 1.6 tpm_? -121.54 -15.5 8.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.312 -0.867 . . . . 0.0 110.077 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -107.15 -158.15 0.64 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.311 -0.868 . . . . 0.0 110.094 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.1 t -109.94 82.23 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.307 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 61' ' ' GLY . 0.2 OUTLIER -112.29 146.86 37.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.855 . . . . 0.0 110.179 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.53 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . 57.19 160.36 0.02 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.474 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -129.13 162.34 27.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -1.138 . . . . 0.0 110.408 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.632 ' CD2' ' CD2' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -124.51 112.7 17.18 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.45 -0.781 . . . . 0.0 109.609 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.539 ' CB ' ' HG2' ' A' ' 80' ' ' GLU . 7.2 mm -72.23 -27.38 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 122.351 1.072 . . . . 0.0 108.287 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.647 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.258 0.8 OUTLIER -109.13 32.2 5.12 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.534 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.559 ' C ' ' O ' ' A' ' 65' ' ' THR . 33.6 t -14.99 112.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.817 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.526 ' ND2' ' HD3' ' A' ' 46' ' ' LYS . 14.5 t-20 44.71 69.13 2.67 Favored Pre-proline 0 C--N 1.297 -1.688 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.699 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.53 ' HG3' ' CG2' ' A' ' 65' ' ' THR . 6.3 Cg_exo -48.95 -178.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 124.246 1.656 . . . . 0.0 109.484 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.586 ' CD1' ' CG ' ' A' ' 46' ' ' LYS . 0.9 OUTLIER -140.7 139.37 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 118.971 -1.092 . . . . 0.0 112.241 -178.831 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.61 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 47.3 t -92.23 172.53 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 176.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.472 ' O ' ' HD3' ' A' ' 44' ' ' PRO . 22.9 m -122.13 -24.04 5.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.769 -1.207 . . . . 0.0 110.968 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.592 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 3.9 mm-40 -130.09 -46.78 1.12 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.015 -1.053 . . . . 0.0 110.032 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.592 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.1 OUTLIER 155.59 -61.46 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.513 ' OD2' ' NE2' ' A' ' 37' ' ' GLN . 2.4 t0 -89.65 12.9 15.5 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.207 -0.933 . . . . 0.0 110.371 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.463 ' HB3' HG11 ' A' ' 70' ' ' VAL . 48.0 t -72.65 108.95 5.03 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.149 -0.969 . . . . 0.0 108.821 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 74' ' ' ASP . 9.7 Cg_endo -56.95 113.8 1.63 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.829 1.436 . . . . 0.0 110.469 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 57.7 t -102.8 148.14 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.377 -0.827 . . . . 0.0 110.937 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.597 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 1.9 m-20 -106.22 138.2 42.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.322 -0.861 . . . . 0.0 109.981 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.581 HG22 ' CD1' ' A' ' 49' ' ' PHE . 4.5 mt -118.09 119.51 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 117.778 -1.569 . . . . 0.0 111.41 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.539 ' HG2' ' CB ' ' A' ' 64' ' ' ILE . 1.7 tp10 -94.01 110.2 21.9 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.509 ' CB ' HD23 ' A' ' 63' ' ' LEU . . . -124.31 147.49 48.11 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.069 -1.019 . . . . 0.0 111.011 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.539 ' CA ' HG21 ' A' ' 31' ' ' THR . 23.6 tt0 -107.61 94.7 12.47 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.597 -0.689 . . . . 0.0 110.617 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.539 ' HG3' ' CD1' ' A' ' 32' ' ' ILE . 40.3 Cg_endo -72.51 153.88 55.16 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.971 1.511 . . . . 0.0 110.219 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.53 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 10.8 Cg_endo -59.11 -74.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.963 1.507 . . . . 0.0 110.159 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -120.6 176.23 5.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.244 -0.91 . . . . 0.0 109.896 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.513 ' HA3' ' N ' ' A' ' 105' ' ' LYS . . . -76.83 74.93 1.75 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 86' ' ' GLY . 19.1 p30 179.68 63.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -1.103 . . . . 0.0 109.847 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 0.4 OUTLIER -141.74 174.37 10.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 0.0 110.3 -179.649 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.52 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 4.1 m-85 -118.11 108.65 15.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.91 . . . . 0.0 110.145 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.525 ' O ' ' N ' ' A' ' 101' ' ' LEU . 12.7 mm -74.74 108.87 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.159 -0.963 . . . . 0.0 109.477 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.584 ' CG2' ' CG ' ' A' ' 50' ' ' GLU . 32.5 mt -100.98 154.22 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.92 -1.112 . . . . 0.0 110.004 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.559 ' O ' ' N ' ' A' ' 99' ' ' LEU . 2.7 mt -140.28 150.61 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.258 -0.901 . . . . 0.0 110.447 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.539 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 77.65 -157.1 45.34 Favored Glycine 0 N--CA 1.485 1.9 0 C-N-CA 119.319 -1.42 . . . . 0.0 109.658 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.559 ' O ' ' N ' ' A' ' 98' ' ' GLN . 0.2 OUTLIER -130.36 157.08 42.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.116 -1.226 . . . . 0.0 110.318 -179.596 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.515 ' C ' ' O ' ' A' ' 94' ' ' VAL . 1.0 OUTLIER -30.47 -55.71 0.36 Allowed Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.847 -0.533 . . . . 0.0 110.723 -179.739 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.515 ' CD ' ' CB ' ' A' ' 95' ' ' GLU . 76.4 Cg_exo -41.02 -40.58 3.88 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 124.055 1.555 . . . . 0.0 110.615 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.539 ' HA3' ' CG ' ' A' ' 17' ' ' LYS . . . -160.76 50.95 0.35 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.559 ' N ' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -94.56 149.5 21.18 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.976 -1.308 . . . . 0.0 110.903 -178.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.559 ' N ' ' O ' ' A' ' 92' ' ' ILE . 13.7 mt -94.44 177.74 5.84 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.553 -0.717 . . . . 0.0 109.941 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.461 ' HG3' HG12 ' A' ' 91' ' ' ILE . 0.4 OUTLIER -148.21 119.91 8.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.396 -0.815 . . . . 0.0 111.123 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.527 ' CD2' HG12 ' A' ' 24' ' ' ILE . 7.3 mp -128.81 -164.52 1.4 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 102' ' ' ASN . 14.5 p-10 -179.05 151.11 0.49 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.843 -1.161 . . . . 0.0 110.931 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.496 ' HA ' ' CE3' ' A' ' 103' ' ' TRP . 0.5 OUTLIER -120.59 135.75 55.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 110.047 179.702 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.474 ' O ' ' HB2' ' A' ' 105' ' ' LYS . 19.1 p90 -121.69 135.91 54.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.34 -0.85 . . . . 0.0 110.253 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.513 ' N ' ' HA3' ' A' ' 86' ' ' GLY . 13.5 ttpt 171.36 121.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.378 -0.827 . . . . 0.0 109.994 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.5 ptmt -93.47 -141.45 0.22 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.244 -0.91 . . . . 0.0 110.168 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.78 -126.05 0.56 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.3 t -150.68 72.37 1.08 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.295 -1.121 . . . . 0.0 110.167 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.8 t -169.48 96.5 0.32 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 110.249 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.6 pp -135.84 4.7 3.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 110.243 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.18 37.41 3.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.264 -0.897 . . . . 0.0 110.223 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.514 ' O ' ' CG ' ' A' ' 113' ' ' HIS . 0.9 OUTLIER -154.77 125.07 6.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.91 . . . . 0.0 110.144 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.514 ' CG ' ' O ' ' A' ' 112' ' ' HIS . 0.3 OUTLIER 178.45 -44.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.269 -0.894 . . . . 0.0 110.275 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 1.4 m170 57.67 167.71 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -0.947 . . . . 0.0 110.169 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.48 ' CD2' ' O ' ' A' ' 115' ' ' HIS . 34.6 p-80 -108.04 41.79 1.48 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.932 . . . . 0.0 110.19 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 4.2 m170 -86.25 -173.85 4.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.269 -0.894 . . . . 0.0 110.177 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.195 -179.982 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.27 0.557 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.44 77.0 9.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.288 -0.883 . . . . 0.0 110.21 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.6 tptt -54.83 -25.98 32.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.295 -0.878 . . . . 0.0 110.234 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.47 ' O ' ' CG ' ' A' ' 5' ' ' GLN . 3.0 tt -58.09 92.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.276 -0.89 . . . . 0.0 110.128 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.47 ' CG ' ' O ' ' A' ' 4' ' ' LEU . 0.6 OUTLIER 171.61 83.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.206 -0.933 . . . . 0.0 110.191 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.41 -19.48 10.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.891 . . . . 0.0 110.171 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 61.79 32.21 18.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.229 -0.92 . . . . 0.0 110.161 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -166.13 174.06 41.69 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.412 ' O ' ' C ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -131.22 -169.68 2.22 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.327 -1.102 . . . . 0.0 110.087 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 9' ' ' MET . 1.5 p -44.16 147.75 0.5 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.239 -0.913 . . . . 0.0 110.153 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.525 ' HB2' ' CD1' ' A' ' 69' ' ' ILE . 0.6 OUTLIER -90.72 -72.37 0.58 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.192 -0.942 . . . . 0.0 110.083 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.458 ' O ' ' HB3' ' A' ' 13' ' ' MET . 3.2 t -133.52 -4.38 2.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.159 -0.963 . . . . 0.0 110.578 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.499 ' O ' ' CG ' ' A' ' 13' ' ' MET . 5.6 ttm 56.34 76.15 0.31 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.078 -1.013 . . . . 0.0 108.986 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.59 ' HB3' ' CE1' ' A' ' 38' ' ' TYR . 22.9 m -51.76 100.96 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.424 -0.798 . . . . 0.0 109.572 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.5 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 10.6 t -92.36 -7.95 46.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.357 -0.84 . . . . 0.0 111.564 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.531 ' HA3' ' CA ' ' A' ' 40' ' ' GLY . . . -60.52 -118.19 0.01 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.542 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -140.15 174.75 10.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.952 -1.323 . . . . 0.0 110.235 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.593 ' CE1' ' HD2' ' A' ' 48' ' ' PRO . 37.7 m-85 -134.84 138.59 44.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.038 -1.039 . . . . 0.0 111.406 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.478 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 2.9 ttpt -106.53 116.92 32.76 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.425 -0.797 . . . . 0.0 109.175 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.521 ' CG2' HD13 ' A' ' 99' ' ' LEU . 46.3 t -59.58 125.12 15.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 120.625 -1.297 . . . . 0.0 109.647 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.555 ' HB ' ' CG ' ' A' ' 35' ' ' ARG . 80.3 t -97.03 -28.23 3.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.558 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -153.38 137.72 16.64 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.236 177.178 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -56.08 158.77 3.74 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.3 0.572 . . . . 0.0 110.285 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.559 HD11 ' CB ' ' A' ' 34' ' ' ILE . 0.7 OUTLIER -55.6 130.35 17.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.274 -0.971 . . . . 0.0 109.795 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 32' ' ' ILE . . . -108.18 168.11 9.53 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 12.3 pt-20 -112.69 132.43 55.2 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.782 -1.199 . . . . 0.0 110.423 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.53 ' CG2' ' OE2' ' A' ' 80' ' ' GLU . 21.5 p -86.91 175.75 8.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.526 -0.734 . . . . 0.0 110.238 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -89.16 29.1 1.11 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.299 -0.876 . . . . 0.0 110.203 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -133.6 5.55 3.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.23 -0.919 . . . . 0.0 110.326 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.34 -0.3 58.45 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.59 ' CG2' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -95.02 -175.94 3.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.208 -1.172 . . . . 0.0 110.472 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -139.46 153.41 23.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.648 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.495 ' N ' ' O ' ' A' ' 25' ' ' ALA . 70.0 t -118.51 135.31 59.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 O-C-N 121.192 -0.943 . . . . 0.0 111.765 -178.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.604 ' CD1' ' CG1' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -119.97 118.75 58.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 O-C-N 121.382 -0.824 . . . . 0.0 110.049 179.2 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.558 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.6 OUTLIER -100.19 123.51 44.5 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.123 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.604 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.3 m -147.85 162.86 6.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 121.082 -1.011 . . . . 0.0 108.819 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 74' ' ' ASP 0.254 10.2 tt0 -109.75 130.67 55.49 Favored 'General case' 0 C--N 1.27 -2.867 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.631 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.59 ' CE1' ' HB3' ' A' ' 14' ' ' CYS . 9.6 t80 -59.06 121.11 10.44 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.412 -178.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.478 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 5.8 mt-10 -106.86 21.18 17.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.107 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.531 ' CA ' ' HA3' ' A' ' 16' ' ' GLY . . . -115.84 -161.48 12.86 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.516 ' N ' ' OH ' ' A' ' 38' ' ' TYR . 13.5 t0 -125.66 145.19 50.27 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.455 -1.026 . . . . 0.0 110.245 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.21 -5.91 0.67 Allowed Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.421 -1.371 . . . . 0.0 111.02 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.614 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.7 OUTLIER 51.33 -153.06 0.01 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 120.436 -1.626 . . . . 0.0 108.198 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.614 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 83.1 Cg_exo -41.47 96.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.321 -0.9 0 N-CA-C 109.241 -1.1 . . . . 0.0 109.241 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.559 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -145.59 169.29 18.71 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.339 0.59 . . . . 0.0 109.701 -178.162 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.51 ' HD2' ' ND2' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -82.74 174.85 10.61 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.223 -0.923 . . . . 0.0 111.829 -178.9 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.61 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 13.3 mm -123.64 123.74 26.3 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.835 -0.541 . . . . 0.0 111.396 -178.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.593 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 31.7 Cg_exo -61.47 143.89 97.68 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.109 1.584 . . . . 0.0 110.368 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.641 ' CE1' ' CG2' ' A' ' 79' ' ' ILE . 5.3 t80 -152.06 159.83 43.6 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 110.469 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.487 ' HB3' ' HB ' ' A' ' 91' ' ' ILE . 32.0 tp10 -178.74 100.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 110.037 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 90' ' ' ILE . 36.0 mt -87.7 71.29 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.179 -0.951 . . . . 0.0 110.245 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.455 ' HE1' ' CD1' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -154.56 -66.33 0.13 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 0.0 110.278 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 55' ' ' GLU . 0.4 OUTLIER 176.86 109.68 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.194 -0.941 . . . . 0.0 110.245 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.574 ' N ' ' CD1' ' A' ' 91' ' ' ILE . 0.2 OUTLIER 56.05 -84.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.236 -0.915 . . . . 0.0 110.146 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 53' ' ' ASP . 9.8 tt0 -165.6 63.8 0.11 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.172 -0.955 . . . . 0.0 110.127 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -119.64 125.76 49.51 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.222 -0.924 . . . . 0.0 110.392 -179.816 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 56' ' ' LYS . 1.7 mmt85 41.81 -164.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.36 -0.838 . . . . 0.0 110.376 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.423 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 11.1 t-80 -176.23 36.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.32 -0.863 . . . . 0.0 110.222 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.439 HG21 ' HD2' ' A' ' 57' ' ' ARG . 16.3 t -107.28 46.02 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.251 -0.905 . . . . 0.0 110.283 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.455 ' CD1' ' HE1' ' A' ' 52' ' ' MET . 0.5 OUTLIER -125.7 -74.12 0.61 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.295 -0.878 . . . . 0.0 110.158 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.47 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . -84.46 -162.11 34.16 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -154.69 167.64 29.5 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.273 -1.133 . . . . 0.0 109.297 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.579 HD23 ' CE2' ' A' ' 49' ' ' PHE . 11.7 mt -121.52 121.88 38.47 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 118.746 -1.182 . . . . 0.0 110.737 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.611 ' CD1' ' N ' ' A' ' 64' ' ' ILE . 1.4 mp -82.09 -26.8 9.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.623 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.256 1.0 OUTLIER -96.67 33.19 1.89 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.241 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.546 ' CG2' ' O ' ' A' ' 63' ' ' LEU . 8.9 t -34.72 140.97 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.032 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.57 ' N ' ' CD ' ' A' ' 68' ' ' PRO . 22.1 t-20 56.99 46.34 2.07 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.608 -0.682 . . . . 0.0 110.422 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.582 ' CB ' ' CD1' ' A' ' 79' ' ' ILE . 9.2 Cg_endo -58.93 148.22 85.63 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.611 1.322 . . . . 0.0 108.979 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.556 HG12 ' O ' ' A' ' 68' ' ' PRO . 0.7 OUTLIER -142.69 144.65 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 119.255 -0.978 . . . . 0.0 112.111 -178.151 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.61 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 54.4 t -94.2 153.02 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.94 -21.4 12.35 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 120.932 -1.105 . . . . 0.0 108.57 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.535 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 2.3 mt-10 -138.45 145.8 41.32 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.54 ' O ' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -54.23 -14.15 1.07 Allowed 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.989 -1.069 . . . . 0.0 110.773 -178.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.492 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 7.1 t70 -126.31 9.21 7.26 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.589 -1.32 . . . . 0.0 110.578 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.48 ' CB ' ' HB2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -73.18 111.86 13.35 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.119 -0.988 . . . . 0.0 108.776 178.945 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.501 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 22.2 Cg_exo -59.91 114.45 2.08 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.864 1.455 . . . . 0.0 110.536 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.509 HG21 ' CG2' ' A' ' 70' ' ' VAL . 53.0 t -95.79 150.99 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.23 -0.919 . . . . 0.0 110.54 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 11.2 m-80 -114.4 130.05 56.68 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.641 ' CG2' ' CE1' ' A' ' 49' ' ' PHE . 9.5 mm -112.73 118.28 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 117.638 -1.625 . . . . 0.0 111.934 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 1.7 tp10 -95.79 107.44 19.67 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.578 ' CB ' ' CD2' ' A' ' 63' ' ' LEU . . . -129.3 155.47 45.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.797 -1.19 . . . . 0.0 111.287 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 62' ' ' ARG . 43.8 tp10 -100.8 103.25 23.39 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.531 -0.731 . . . . 0.0 110.466 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.535 ' HG3' ' CD1' ' A' ' 32' ' ' ILE . 60.7 Cg_endo -77.68 152.44 29.26 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.958 1.504 . . . . 0.0 110.484 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.47 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 28.2 Cg_endo -70.0 123.74 10.31 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.993 1.523 . . . . 0.0 109.888 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.435 ' C ' ' O ' ' A' ' 84' ' ' PRO . 0.6 OUTLIER -41.42 113.06 0.37 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.264 -0.898 . . . . 0.0 110.498 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.444 ' N ' ' HA ' ' A' ' 105' ' ' LYS . . . 131.97 -150.64 19.62 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -76.26 137.51 39.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.236 -1.155 . . . . 0.0 110.049 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.459 ' OG ' ' HG2' ' A' ' 84' ' ' PRO . 4.3 m -158.49 149.93 20.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.168 -0.957 . . . . 0.0 110.538 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.553 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 6.1 m-85 -124.43 104.46 8.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.915 . . . . 0.0 109.992 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.575 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 2.0 mp -73.87 107.96 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.312 -0.868 . . . . 0.0 109.578 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.574 ' CD1' ' N ' ' A' ' 54' ' ' LEU . 30.7 mt -91.97 148.29 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.264 -0.898 . . . . 0.0 110.468 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.554 ' CD1' HG23 ' A' ' 34' ' ' ILE . 1.8 mt -133.28 140.64 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.565 -0.709 . . . . 0.0 109.606 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.536 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 82.13 -161.4 41.46 Favored Glycine 0 N--CA 1.481 1.655 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.54 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -122.61 149.84 26.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 O-C-N 121.225 -1.162 . . . . 0.0 110.181 -179.627 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.578 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.9 OUTLIER -17.03 -58.24 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.189 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 8.2 Cg_endo -51.65 71.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 124.219 1.641 . . . . 0.0 112.171 179.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 89.51 1.23 78.24 Favored Glycine 0 N--CA 1.494 2.511 0 O-C-N 120.943 -1.098 . . . . 0.0 110.878 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.497 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -48.63 159.68 0.22 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.975 -1.309 . . . . 0.0 110.27 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.521 HD13 ' CG2' ' A' ' 20' ' ' VAL . 13.0 mt -96.14 176.91 5.91 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.296 -0.877 . . . . 0.0 110.418 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.47 ' HG3' HG12 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -157.19 138.8 14.02 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.309 -0.869 . . . . 0.0 110.408 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.504 HD21 ' CG1' ' A' ' 34' ' ' ILE . 3.5 mp -141.06 118.1 11.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.247 -0.908 . . . . 0.0 110.026 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 1.9 t-20 -87.44 129.74 34.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 110.759 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 8.5 t-105 -119.51 129.19 54.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 0.0 109.739 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.51 ' O ' ' N ' ' A' ' 106' ' ' LYS . 1.0 OUTLIER -91.02 138.49 31.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.938 . . . . 0.0 110.507 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.444 ' HA ' ' N ' ' A' ' 86' ' ' GLY . 19.3 mttt 44.38 -92.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.292 -0.88 . . . . 0.0 110.355 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -151.94 16.87 0.67 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.205 -0.935 . . . . 0.0 110.123 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.81 179.33 43.57 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -102.88 -68.27 0.84 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.311 -1.111 . . . . 0.0 110.215 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 108' ' ' SER . 48.0 t 43.61 77.37 0.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 0.0 110.187 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.3 -33.61 23.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.312 -0.868 . . . . 0.0 110.175 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -134.96 115.99 14.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.16 -0.963 . . . . 0.0 110.257 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -60.25 178.54 0.19 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.204 -0.935 . . . . 0.0 110.227 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 13.3 p-80 -161.4 134.16 6.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.212 -0.93 . . . . 0.0 110.22 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -56.44 153.7 9.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.244 -0.91 . . . . 0.0 110.223 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -169.3 153.74 5.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -0.926 . . . . 0.0 110.237 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.546 ' N ' ' CD2' ' A' ' 116' ' ' HIS . 5.2 p80 -166.7 42.31 0.05 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 110.218 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.234 180.0 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.281 0.563 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 2' ' ' ASP . 14.7 p30 -159.55 158.6 32.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 110.208 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -114.77 20.06 15.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 0.0 110.175 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.469 ' O ' ' HB3' ' A' ' 5' ' ' GLN . 8.5 mp -77.9 140.64 39.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.2 -0.938 . . . . 0.0 110.251 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.469 ' HB3' ' O ' ' A' ' 4' ' ' LEU . 1.7 pt20 -178.04 50.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.314 -0.866 . . . . 0.0 110.119 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.6 mt -155.8 145.9 21.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.142 -0.974 . . . . 0.0 110.225 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.27 148.29 26.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.23 -0.919 . . . . 0.0 110.219 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.11 175.57 34.73 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.467 ' O ' ' HE2' ' A' ' 46' ' ' LYS . 10.9 mtt -61.58 149.96 37.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -1.164 . . . . 0.0 110.196 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.49 161.23 15.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.919 . . . . 0.0 110.182 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -143.0 -74.89 0.27 Allowed 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.273 -0.892 . . . . 0.0 110.169 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.554 ' HB3' ' CB ' ' A' ' 45' ' ' CYS . 3.6 t -136.97 -25.82 1.06 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.321 -0.862 . . . . 0.0 110.902 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.521 ' O ' ' N ' ' A' ' 15' ' ' THR . 0.4 OUTLIER 59.23 93.24 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.28 -0.887 . . . . 0.0 109.525 -179.609 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 56.2 m -50.55 90.28 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.445 -0.784 . . . . 0.0 109.558 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 13' ' ' MET . 3.2 t -79.13 -11.34 59.98 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.067 -1.02 . . . . 0.0 111.419 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.51 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -60.93 -131.76 0.01 OUTLIER Glycine 0 N--CA 1.485 1.944 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.544 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -130.1 -177.88 4.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -1.167 . . . . 0.0 109.809 -179.73 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.603 ' CE1' ' HD2' ' A' ' 48' ' ' PRO . 32.5 m-85 -137.6 141.87 41.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.741 -1.224 . . . . 0.0 111.968 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.464 ' HB2' ' OE2' ' A' ' 39' ' ' GLU . 33.3 ttpt -113.44 118.28 34.06 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.444 HG21 HD23 ' A' ' 99' ' ' LEU . 40.9 t -59.47 125.01 14.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 120.576 -1.328 . . . . 0.0 109.036 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.548 ' HB ' ' CG ' ' A' ' 35' ' ' ARG . 62.8 t -98.26 -27.16 3.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.585 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 3.0 tttp -156.77 133.12 9.9 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -50.87 162.13 0.3 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.716 0.769 . . . . 0.0 111.411 -178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.565 HG12 HG12 ' A' ' 34' ' ' ILE . 0.7 OUTLIER -57.73 132.22 22.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 121.584 0.707 . . . . 0.0 110.289 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 33' ' ' VAL . . . -109.17 163.17 13.59 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 5.3 pm0 -112.46 134.11 54.17 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.344 -1.472 . . . . 0.0 110.553 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.523 ' CG2' ' OE2' ' A' ' 80' ' ' GLU . 4.7 p -94.22 165.21 12.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.524 -0.735 . . . . 0.0 110.336 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -78.58 -1.02 32.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.42 -0.8 . . . . 0.0 110.123 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.06 3.51 55.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.9 . . . . 0.0 110.34 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.473 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 88.88 25.81 28.48 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.584 ' CG2' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -121.77 -177.17 3.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.54 -0.976 . . . . 0.0 110.363 -179.779 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.571 HD11 ' CD1' ' A' ' 103' ' ' TRP . 0.0 OUTLIER -136.34 142.73 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.638 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.53 ' N ' ' O ' ' A' ' 25' ' ' ALA . 43.0 t -110.26 133.81 54.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 O-C-N 121.47 -0.768 . . . . 0.0 112.279 -177.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.601 ' CD1' ' CG1' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -118.74 119.54 61.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 O-C-N 121.339 -0.85 . . . . 0.0 109.865 178.738 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 1.0 OUTLIER -101.86 123.34 45.62 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 179.428 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.601 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.5 m -148.79 161.45 5.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 108.773 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.443 ' HB2' ' CG2' ' A' ' 21' ' ' VAL 0.254 0.1 OUTLIER -106.75 124.6 49.85 Favored 'General case' 0 C--N 1.273 -2.757 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -179.43 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.576 ' CZ ' ' HB3' ' A' ' 14' ' ' CYS . 2.1 t80 -61.15 125.52 24.03 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.017 -1.073 . . . . 0.0 110.425 -178.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.474 ' N ' ' O ' ' A' ' 17' ' ' LYS . 22.2 mm-40 -98.08 -148.91 0.33 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.022 -1.049 . . . . 0.0 109.19 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.51 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 44.24 -145.5 1.77 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.478 ' HA ' ' HD2' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -134.52 143.62 47.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.679 -0.895 . . . . 0.0 110.139 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.94 -25.32 0.04 OUTLIER Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.42 -1.372 . . . . 0.0 110.95 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.617 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.4 OUTLIER 56.24 -156.1 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 120.726 -1.455 . . . . 0.0 108.267 -179.545 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.617 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 50.9 Cg_exo -48.45 92.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.506 0 N-CA-C 109.61 -0.958 . . . . 0.0 109.61 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.569 ' SG ' ' CE2' ' A' ' 38' ' ' TYR . 21.8 p -143.32 167.75 21.43 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.422 -0.799 . . . . 0.0 110.389 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.585 ' CG ' ' CD1' ' A' ' 69' ' ' ILE . 47.0 mttp -85.38 154.99 21.5 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 122.142 0.972 . . . . 0.0 111.176 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.607 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 12.4 mm -101.92 123.32 44.14 Favored Pre-proline 0 C--N 1.297 -1.699 0 O-C-N 121.591 -0.693 . . . . 0.0 111.782 -177.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.603 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 32.2 Cg_exo -61.59 149.32 90.3 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.181 1.621 . . . . 0.0 110.457 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.597 ' CE2' ' CG2' ' A' ' 79' ' ' ILE . 5.9 t80 -159.4 155.25 26.34 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.389 -0.82 . . . . 0.0 110.165 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.528 ' HG2' ' CB ' ' A' ' 53' ' ' ASP . 0.5 OUTLIER -177.67 106.62 0.05 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.277 -0.889 . . . . 0.0 109.873 179.721 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.532 ' CG2' ' O ' ' A' ' 51' ' ' ILE . 3.0 mt -81.16 10.65 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.349 -0.844 . . . . 0.0 110.126 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.543 ' CB ' ' HB3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -145.97 -66.87 0.29 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.121 -0.987 . . . . 0.0 110.468 179.443 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.528 ' CB ' ' HG2' ' A' ' 50' ' ' GLU . 0.4 OUTLIER 71.24 52.94 0.25 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.045 -1.034 . . . . 0.0 110.623 179.762 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.54 ' O ' ' CB ' ' A' ' 55' ' ' GLU . 33.5 mt 59.69 142.35 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.156 -0.965 . . . . 0.0 110.356 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.54 ' CB ' ' O ' ' A' ' 54' ' ' LEU . 0.1 OUTLIER 73.65 13.87 4.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.473 -0.767 . . . . 0.0 109.089 -179.416 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.543 ' HB3' ' CB ' ' A' ' 52' ' ' MET . 0.1 OUTLIER -125.57 18.63 8.09 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.026 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.502 ' HG3' ' N ' ' A' ' 58' ' ' HIS . 11.3 ptt180 -52.89 -30.97 37.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.299 -0.875 . . . . 0.0 110.341 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.502 ' N ' ' HG3' ' A' ' 57' ' ' ARG . 4.7 m170 -57.71 -15.68 8.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.913 . . . . 0.0 110.146 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 56' ' ' LYS . 6.0 m -144.58 87.4 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.922 . . . . 0.0 110.156 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' A' ' 84' ' ' PRO . 6.5 mt -84.38 108.12 17.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 110.189 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.456 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . -94.94 -163.87 35.13 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.537 ' CB ' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -159.19 166.57 31.14 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.256 -1.143 . . . . 0.0 109.617 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.577 HD21 ' CE1' ' A' ' 49' ' ' PHE . 11.3 mt -122.77 123.92 42.16 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 118.819 -1.152 . . . . 0.0 111.077 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.605 ' CD1' ' N ' ' A' ' 64' ' ' ILE . 1.5 mp -85.22 -28.45 6.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.602 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.257 1.8 m -99.32 35.69 1.89 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.662 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.519 HG13 ' ND2' ' A' ' 67' ' ' ASN . 43.0 t -37.85 152.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.667 0.746 . . . . 0.0 111.231 -178.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.519 ' ND2' HG13 ' A' ' 66' ' ' VAL . 24.5 p30 37.22 52.35 2.46 Favored Pre-proline 0 C--N 1.302 -1.47 0 O-C-N 121.968 -0.458 . . . . 0.0 111.568 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.571 ' CB ' ' CD1' ' A' ' 79' ' ' ILE . 1.9 Cg_endo -59.85 162.98 14.55 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 N-CA-C 108.363 -1.437 . . . . 0.0 108.363 178.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.585 ' CD1' ' CG ' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -143.94 148.66 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 C-N-CA 118.817 -1.153 . . . . 0.0 112.744 -178.471 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.607 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 44.0 t -102.46 159.43 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 175.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.3 m -112.89 -19.85 11.8 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.809 -1.156 . . . . 0.0 111.448 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 16.3 mt-10 -131.38 15.14 5.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.777 -1.202 . . . . 0.0 111.502 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.535 ' O ' ' O ' ' A' ' 38' ' ' TYR . 2.3 ttpt 71.56 -5.58 1.6 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.221 -0.925 . . . . 0.0 111.034 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.481 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 7.8 t0 -137.76 -1.2 2.05 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.877 -1.14 . . . . 0.0 110.257 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.7 t -72.6 112.26 14.32 Favored Pre-proline 0 N--CA 1.486 1.363 0 O-C-N 121.208 -0.932 . . . . 0.0 109.362 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 74' ' ' ASP . 32.6 Cg_exo -51.56 111.8 0.67 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.82 1.431 . . . . 0.0 109.915 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 92.5 t -95.15 143.46 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.325 -0.859 . . . . 0.0 110.997 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.598 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.9 m120 -105.9 131.25 53.45 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.597 ' CG2' ' CE2' ' A' ' 49' ' ' PHE . 10.5 mm -116.35 119.89 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 117.567 -1.653 . . . . 0.0 111.767 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 1.1 tp10 -94.44 110.79 22.55 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.16 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.558 ' CB ' ' CD2' ' A' ' 63' ' ' LEU . . . -125.28 159.9 30.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.926 -1.109 . . . . 0.0 110.752 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.537 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -93.68 113.9 61.57 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.527 -0.733 . . . . 0.0 110.323 -179.284 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.514 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 46.4 Cg_endo -73.3 133.03 18.64 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.853 1.449 . . . . 0.0 110.525 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.456 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 19.4 Cg_endo -64.38 -158.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.925 1.487 . . . . 0.0 109.928 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -105.39 103.88 13.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.141 -0.975 . . . . 0.0 110.129 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 121.49 -153.75 16.66 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.433 ' OD1' ' ND2' ' A' ' 102' ' ' ASN . 5.8 t70 -71.63 161.34 31.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.288 -1.125 . . . . 0.0 110.212 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.444 ' OG ' ' CG ' ' A' ' 84' ' ' PRO . 0.3 OUTLIER -170.46 147.17 2.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.212 -0.93 . . . . 0.0 110.294 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.587 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 3.2 m-85 -118.5 104.8 11.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 110.174 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.579 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 5.2 mt -74.08 111.34 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.164 -0.96 . . . . 0.0 109.442 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' A' ' 50' ' ' GLU . 2.1 mp -90.99 140.23 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.949 . . . . 0.0 110.178 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.547 ' CD1' HG21 ' A' ' 34' ' ' ILE . 1.4 mt -126.44 138.03 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.423 -0.798 . . . . 0.0 109.83 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 48' ' ' PRO . . . 85.99 -163.71 36.56 Favored Glycine 0 N--CA 1.482 1.754 0 C-N-CA 119.112 -1.518 . . . . 0.0 109.488 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.547 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -118.62 146.95 22.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 O-C-N 121.135 -1.215 . . . . 0.0 110.16 -179.623 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.578 ' O ' ' N ' ' A' ' 97' ' ' GLY . 3.9 mt-10 -16.89 -58.47 0.04 OUTLIER Pre-proline 0 N--CA 1.501 2.103 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 6.8 Cg_endo -51.08 72.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 124.219 1.641 . . . . 0.0 112.034 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 89.42 -1.35 81.92 Favored Glycine 0 N--CA 1.494 2.538 0 O-C-N 120.995 -1.065 . . . . 0.0 110.865 178.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.491 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -45.79 159.19 0.07 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.891 -1.358 . . . . 0.0 109.932 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.516 ' CD1' ' O ' ' A' ' 18' ' ' PHE . 10.9 mt -96.68 177.44 5.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.245 -0.91 . . . . 0.0 110.645 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -154.59 135.49 13.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.415 -0.803 . . . . 0.0 110.115 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 90' ' ' ILE . 4.8 mp -137.16 122.44 19.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.181 -0.949 . . . . 0.0 110.328 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.44 ' HA ' ' O ' ' A' ' 88' ' ' SER . 3.7 t-20 -87.92 125.25 34.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 110.277 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.571 ' CD1' HD11 ' A' ' 32' ' ' ILE . 20.7 t-105 -123.98 154.21 40.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.905 . . . . 0.0 110.075 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.441 ' CD1' ' C ' ' A' ' 104' ' ' PHE . 27.6 p90 -119.43 146.12 45.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.229 -0.919 . . . . 0.0 110.308 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -138.84 101.95 4.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 110.175 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -133.04 42.01 3.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.211 -0.931 . . . . 0.0 110.255 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -137.9 124.0 2.86 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.56 128.6 53.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -1.158 . . . . 0.0 110.189 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -50.34 141.3 11.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.893 . . . . 0.0 110.252 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.89 -53.83 53.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.196 -0.94 . . . . 0.0 110.14 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -70.29 137.56 50.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.921 . . . . 0.0 110.196 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -107.66 17.81 22.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.908 . . . . 0.0 110.217 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -52.71 -22.13 4.84 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.259 -0.901 . . . . 0.0 110.176 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -86.81 83.54 7.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 0.0 110.21 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -106.55 165.05 11.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.3 -0.875 . . . . 0.0 110.261 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -170.18 68.98 0.05 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.312 -0.867 . . . . 0.0 110.199 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.223 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.209 0.528 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -54.79 -84.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 0.0 110.219 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 4' ' ' LEU . 1.3 ttpp -87.13 176.19 7.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.896 . . . . 0.0 110.336 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.464 ' O ' ' HB3' ' A' ' 5' ' ' GLN . 0.0 OUTLIER 63.75 133.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.253 -0.905 . . . . 0.0 110.32 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.468 ' CD ' ' N ' ' A' ' 5' ' ' GLN . 0.4 OUTLIER -179.37 31.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.325 -0.859 . . . . 0.0 110.093 179.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 tp -145.6 171.53 14.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.293 -0.879 . . . . 0.0 110.208 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.415 ' HD3' ' O ' ' A' ' 7' ' ' LYS . 2.8 tmtt? -95.34 26.84 3.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 110.255 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.34 146.88 6.41 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.44 27.71 1.22 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -1.141 . . . . 0.0 110.204 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.64 157.04 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.192 -0.943 . . . . 0.0 110.184 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -146.09 -74.2 0.22 Allowed 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.135 -0.978 . . . . 0.0 110.131 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.521 ' O ' ' CE ' ' A' ' 46' ' ' LYS . 2.8 t -139.33 -128.35 0.12 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.049 -1.032 . . . . 0.0 109.938 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.414 ' HB3' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER 179.92 100.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.992 -1.067 . . . . 0.0 109.62 179.81 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.584 ' HB3' ' CE1' ' A' ' 38' ' ' TYR . 1.7 m -86.22 126.04 33.98 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.224 -0.923 . . . . 0.0 110.035 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.539 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 0.6 OUTLIER -126.85 15.28 7.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -0.909 . . . . 0.0 111.129 -179.227 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.561 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -69.94 -96.04 0.05 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.548 ' CD ' ' HA3' ' A' ' 97' ' ' GLY . 1.1 ttmt -149.4 161.27 42.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.04 -1.271 . . . . 0.0 109.833 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.604 ' CE1' ' HD2' ' A' ' 48' ' ' PRO . 50.3 m-85 -126.36 147.82 49.69 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.866 -1.146 . . . . 0.0 111.584 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.458 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 15.0 ttpp -114.15 115.88 28.21 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.595 -0.69 . . . . 0.0 109.161 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.514 ' CG2' HD12 ' A' ' 99' ' ' LEU . 43.5 t -59.63 123.03 11.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 120.541 -1.349 . . . . 0.0 109.049 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.547 ' HB ' ' CG ' ' A' ' 35' ' ' ARG . 53.2 t -96.82 -26.02 4.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.562 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 4.0 tttp -158.63 133.56 8.34 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -52.17 157.82 1.28 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.524 0.678 . . . . 0.0 111.063 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.577 HD13 ' CA ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -48.85 132.72 6.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.132 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.533 ' O ' ' CA ' ' A' ' 32' ' ' ILE . . . -102.8 169.86 8.35 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 7.0 pm0 -113.54 132.24 55.78 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.924 -1.11 . . . . 0.0 110.519 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.471 ' OG1' ' OG1' ' A' ' 31' ' ' THR . 11.1 p -90.1 178.76 6.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.408 -0.807 . . . . 0.0 109.865 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -95.62 31.87 1.94 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.168 -0.957 . . . . 0.0 110.183 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.88 10.42 2.41 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.256 -0.902 . . . . 0.0 110.315 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.35 -0.86 60.17 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.586 ' CG2' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -96.04 -177.17 3.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.274 -1.133 . . . . 0.0 110.291 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.576 ' O ' ' HA ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -140.22 178.95 2.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.616 -1.254 . . . . 0.0 107.616 178.175 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.517 ' HB ' ' CB ' ' A' ' 25' ' ' ALA . 64.8 t -138.92 124.01 21.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 118.909 -1.117 . . . . 0.0 111.838 -178.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.595 ' CD1' ' CG1' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -106.69 115.16 47.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.203 -0.936 . . . . 0.0 109.974 179.132 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -98.94 118.17 35.11 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.595 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.5 m -145.04 155.31 13.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.342 -0.848 . . . . 0.0 109.032 -178.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.523 ' CG ' ' O ' ' A' ' 74' ' ' ASP 0.252 0.2 OUTLIER -103.5 123.41 46.84 Favored 'General case' 0 C--N 1.272 -2.776 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.277 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.587 ' CZ ' ' HA3' ' A' ' 40' ' ' GLY . 23.8 t80 -60.37 120.57 10.13 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 118.783 -1.167 . . . . 0.0 110.481 -178.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 17' ' ' LYS . 4.1 mt-10 -91.56 -26.09 18.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.466 -0.771 . . . . 0.0 109.321 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.587 ' HA3' ' CZ ' ' A' ' 38' ' ' TYR . . . -63.75 -161.3 0.38 Allowed Glycine 0 N--CA 1.484 1.834 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.52 ' N ' ' OH ' ' A' ' 38' ' ' TYR . 15.8 p-10 -127.55 134.76 49.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.511 -0.994 . . . . 0.0 110.162 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 43' ' ' SER . . . 171.83 -23.4 0.08 OUTLIER Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.458 -1.353 . . . . 0.0 110.575 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.596 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.6 OUTLIER 61.42 -154.38 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.688 -1.478 . . . . 0.0 108.096 -179.541 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.596 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 87.6 Cg_exo -42.24 96.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -0.994 0 N-CA-C 109.042 -1.176 . . . . 0.0 109.042 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.566 ' O ' ' CG2' ' A' ' 69' ' ' ILE . 31.5 p -151.47 -178.8 6.89 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.919 -0.488 . . . . 0.0 109.864 -177.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.565 ' HG3' ' CD1' ' A' ' 69' ' ' ILE . 12.0 mtpt -94.57 170.17 9.67 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.975 -1.078 . . . . 0.0 111.305 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.605 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 11.6 mm -122.84 130.41 24.63 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.444 -0.785 . . . . 0.0 112.384 -177.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.604 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 38.1 Cg_exo -64.16 143.01 82.76 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 124.197 1.63 . . . . 0.0 110.793 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.632 ' CE2' ' CD2' ' A' ' 63' ' ' LEU . 16.5 t80 -152.99 162.17 41.65 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.288 -0.883 . . . . 0.0 110.501 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.519 ' CG ' HD13 ' A' ' 91' ' ' ILE . 37.2 tt0 178.61 89.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.131 -0.981 . . . . 0.0 110.459 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.53 HD11 ' CB ' ' A' ' 81' ' ' ALA . 6.7 mt -61.14 -51.36 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.175 -0.953 . . . . 0.0 109.958 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.527 ' HA ' ' CG ' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -136.41 -66.98 0.52 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.891 . . . . 0.0 110.05 179.845 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.468 ' HB2' ' HG3' ' A' ' 50' ' ' GLU . 0.4 OUTLIER 61.76 -158.77 0.32 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.389 179.784 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.7 mt -75.12 0.2 17.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.379 -0.826 . . . . 0.0 110.329 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.7 -18.02 39.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.357 -0.839 . . . . 0.0 109.486 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.527 ' CG ' ' HA ' ' A' ' 52' ' ' MET . 3.6 mmtm -117.31 -45.74 2.72 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.413 -0.804 . . . . 0.0 110.014 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 3.6 tpp180 -179.75 -142.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.305 -0.872 . . . . 0.0 109.978 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -70.17 -162.92 0.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.288 -0.883 . . . . 0.0 110.085 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 59' ' ' VAL . 27.7 m -91.48 123.16 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.155 -0.966 . . . . 0.0 110.157 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.447 ' HB3' ' HB3' ' A' ' 84' ' ' PRO . 18.9 mt -140.02 -56.28 0.55 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.209 -0.932 . . . . 0.0 110.348 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 83' ' ' PRO . . . -70.13 157.39 53.52 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -140.35 167.45 22.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -1.052 . . . . 0.0 109.985 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.632 ' CD2' ' CE2' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -117.28 120.68 38.98 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.382 -0.824 . . . . 0.0 108.928 179.414 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.586 ' CD1' ' CG2' ' A' ' 31' ' ' THR . 1.4 mp -81.6 -29.88 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.567 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.266 1.5 m -97.74 36.79 1.47 Allowed 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.807 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.518 HG21 ' HB3' ' A' ' 63' ' ' LEU . 24.2 t -29.16 119.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.279 -178.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.507 ' OD1' ' HE3' ' A' ' 46' ' ' LYS . 3.8 t-20 59.62 69.1 1.34 Allowed Pre-proline 0 C--N 1.298 -1.632 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.969 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.52 ' O ' HG12 ' A' ' 69' ' ' ILE . 5.3 Cg_exo -65.41 171.27 9.57 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.044 1.549 . . . . 0.0 109.575 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.566 ' CG2' ' O ' ' A' ' 45' ' ' CYS . 1.1 mt -145.56 141.22 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 118.99 -1.084 . . . . 0.0 112.264 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.605 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 46.2 t -93.07 165.54 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.461 ' N ' HG12 ' A' ' 70' ' ' VAL . 2.2 m -118.44 -24.34 6.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.782 -1.199 . . . . 0.0 111.113 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 2.5 mt-10 -131.37 13.84 5.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.941 -1.099 . . . . 0.0 110.711 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 14.3 ttpt 74.78 -10.69 1.15 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.657 -0.652 . . . . 0.0 111.074 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.523 ' O ' ' CG ' ' A' ' 37' ' ' GLN . 8.2 t0 -134.07 -3.24 2.82 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.971 -1.081 . . . . 0.0 110.359 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.7 t -72.83 112.51 15.54 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.179 -0.951 . . . . 0.0 109.286 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.505 ' HB3' ' CG2' ' A' ' 21' ' ' VAL . 34.3 Cg_exo -51.04 111.41 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.858 1.452 . . . . 0.0 109.899 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.464 HG21 ' HA ' ' A' ' 70' ' ' VAL . 98.5 t -96.01 144.34 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.353 -0.842 . . . . 0.0 111.166 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.574 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.9 m120 -100.04 130.51 46.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.534 -0.729 . . . . 0.0 109.5 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.582 HG22 ' CD1' ' A' ' 49' ' ' PHE . 5.5 mt -109.66 116.21 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 117.902 -1.519 . . . . 0.0 110.912 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 0.9 OUTLIER -84.08 117.25 23.32 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.812 179.476 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.565 ' CB ' HD23 ' A' ' 63' ' ' LEU . . . -135.92 146.85 47.78 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.959 -1.088 . . . . 0.0 111.248 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.53 ' CA ' HG23 ' A' ' 31' ' ' THR . 29.2 tt0 -106.09 86.93 2.19 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.452 -0.78 . . . . 0.0 110.727 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.549 ' HG3' ' CD1' ' A' ' 32' ' ' ILE . 56.8 Cg_endo -75.12 160.57 39.6 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.812 1.428 . . . . 0.0 110.348 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 85' ' ' PHE . 12.5 Cg_endo -61.32 -157.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.963 1.507 . . . . 0.0 110.0 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.459 ' O ' ' N ' ' A' ' 87' ' ' ASP . 1.9 m-85 -45.41 170.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.992 -1.067 . . . . 0.0 109.95 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.532 ' HA3' ' N ' ' A' ' 105' ' ' LYS . . . -63.2 80.87 0.04 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.46 ' HB3' ' O ' ' A' ' 86' ' ' GLY . 10.7 p30 176.44 81.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.393 -1.063 . . . . 0.0 109.537 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.559 ' O ' ' CD1' ' A' ' 89' ' ' TYR . 0.6 OUTLIER -151.6 -162.22 1.49 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.35 -0.844 . . . . 0.0 110.6 -179.237 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.559 ' CD1' ' O ' ' A' ' 88' ' ' SER . 15.8 m-85 -151.64 104.49 3.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.681 -0.637 . . . . 0.0 109.716 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.575 HG21 ' CZ ' ' A' ' 49' ' ' PHE . 2.1 mp -74.09 108.29 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.926 . . . . 0.0 109.907 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.519 HD13 ' CG ' ' A' ' 50' ' ' GLU . 94.9 mt -89.17 142.53 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -0.899 . . . . 0.0 110.045 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.543 ' CD1' HG21 ' A' ' 34' ' ' ILE . 1.5 mt -133.24 141.0 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.4 -0.812 . . . . 0.0 110.111 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.527 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 80.59 -155.99 38.19 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' ' 15' ' ' THR . 0.1 OUTLIER -130.45 154.75 41.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.062 -1.258 . . . . 0.0 111.226 -179.394 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.549 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 1.7 mm-40 -28.44 -55.12 0.25 Allowed Pre-proline 0 N--CA 1.499 2.02 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.635 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 86.8 Cg_exo -34.02 -30.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.993 1.522 . . . . 0.0 111.011 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.548 ' HA3' ' CD ' ' A' ' 17' ' ' LYS . . . 179.34 37.83 0.07 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.371 -1.892 . . . . 0.0 108.371 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.521 ' N ' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -72.15 160.3 32.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.807 -0.819 . . . . 0.0 110.881 -179.05 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' A' ' 18' ' ' PHE . 9.4 mt -101.16 179.29 4.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.392 -0.818 . . . . 0.0 110.139 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.8 135.48 11.6 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.337 -0.852 . . . . 0.0 110.456 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 90' ' ' ILE . 5.7 mp -137.17 118.8 14.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.371 -0.831 . . . . 0.0 109.737 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.52 ' HA ' ' O ' ' A' ' 88' ' ' SER . 4.7 p-10 -88.25 131.94 34.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.853 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.516 ' NE1' HG22 ' A' ' 32' ' ' ILE . 3.5 t-105 -110.9 126.29 54.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.101 -1.0 . . . . 0.0 110.265 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.506 ' O ' ' CG ' ' A' ' 105' ' ' LYS . 0.1 OUTLIER -115.09 152.31 32.75 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.263 -0.898 . . . . 0.0 110.241 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.532 ' N ' ' HA3' ' A' ' 86' ' ' GLY . 0.0 OUTLIER 169.03 105.22 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.302 -0.873 . . . . 0.0 110.247 -179.871 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.453 ' O ' ' O ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -58.47 -152.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.271 -0.893 . . . . 0.0 110.218 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -114.05 53.75 0.59 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.3 m 52.64 -144.19 0.65 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.246 -1.149 . . . . 0.0 110.225 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.1 m -163.14 70.28 0.24 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.176 -0.953 . . . . 0.0 110.198 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.23 -34.27 3.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.339 -0.85 . . . . 0.0 110.172 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -45.57 147.02 0.94 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.26 -0.9 . . . . 0.0 110.253 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.79 -160.6 0.75 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 0.0 110.233 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -150.1 -162.12 1.49 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.212 -0.93 . . . . 0.0 110.12 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -164.72 58.05 0.13 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 110.31 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -76.05 -163.5 0.3 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.26 -0.9 . . . . 0.0 110.183 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -111.81 -179.74 3.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.222 -0.924 . . . . 0.0 110.206 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.193 -179.976 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.194 0.521 . . . . 0.0 110.179 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.16 -13.14 61.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 0.0 110.187 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -80.02 66.44 5.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 110.236 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.436 ' O ' ' HB2' ' A' ' 5' ' ' GLN . 1.6 pp -46.43 157.86 0.12 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -0.887 . . . . 0.0 110.288 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 0.4 OUTLIER 174.97 52.89 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 110.182 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.99 150.12 21.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 0.0 110.246 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.0 tttt -110.98 -32.47 6.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.93 . . . . 0.0 110.196 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.66 8.97 73.13 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 56.65 175.73 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.197 -1.179 . . . . 0.0 110.18 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.532 ' HA ' ' CE ' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -136.43 169.36 17.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.916 . . . . 0.0 110.205 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.07 -72.69 0.54 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.22 -0.925 . . . . 0.0 109.868 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' A' ' 13' ' ' MET . 3.2 t -137.24 -2.31 2.05 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.158 -0.964 . . . . 0.0 110.721 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.491 ' O ' ' CG ' ' A' ' 13' ' ' MET . 0.9 OUTLIER 55.45 79.98 0.14 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.97 -1.081 . . . . 0.0 108.575 -179.333 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.574 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 22.6 m -52.55 98.07 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.377 -0.827 . . . . 0.0 109.435 -178.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.489 ' O ' ' O ' ' A' ' 16' ' ' GLY . 0.9 OUTLIER -86.65 -9.1 56.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.464 -0.773 . . . . 0.0 111.935 -178.359 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -59.55 -124.46 0.01 OUTLIER Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.489 -1.339 . . . . 0.0 109.84 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.549 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -135.75 173.86 11.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.018 -1.283 . . . . 0.0 109.99 -179.568 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.589 ' CE1' ' HD2' ' A' ' 48' ' ' PRO . 34.6 m-85 -133.44 136.89 45.47 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.969 -1.082 . . . . 0.0 111.51 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.453 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 23.4 ttpt -108.21 120.54 42.66 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.627 -0.671 . . . . 0.0 109.366 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.442 HG21 HD12 ' A' ' 99' ' ' LEU . 34.5 t -59.76 131.49 24.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.85 -1.156 . . . . 0.0 109.043 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.531 ' HB ' ' CG ' ' A' ' 35' ' ' ARG . 92.3 t -105.28 -26.39 3.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 1.8 tttp -157.37 133.61 9.65 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -51.94 159.58 0.84 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.723 0.773 . . . . 0.0 111.327 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.575 HD12 ' CA ' ' A' ' 34' ' ' ILE . 0.7 OUTLIER -55.79 132.04 19.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-O 121.577 0.703 . . . . 0.0 110.476 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 33' ' ' VAL . . . -109.57 158.95 17.51 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.498 ' N ' ' OE1' ' A' ' 26' ' ' GLU . 7.0 pm0 -110.43 133.35 53.36 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 120.166 -1.584 . . . . 0.0 110.494 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.521 ' CG2' ' OE2' ' A' ' 80' ' ' GLU . 2.8 p -92.14 169.5 10.57 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.567 -0.708 . . . . 0.0 110.216 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.88 -16.34 60.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 110.538 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -80.41 0.47 33.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.085 -1.009 . . . . 0.0 110.34 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.73 8.1 60.99 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.529 HG21 ' CG1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -98.39 175.34 6.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.314 -1.11 . . . . 0.0 110.381 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.584 HG21 ' CE2' ' A' ' 103' ' ' TRP . 0.0 OUTLIER -129.17 141.86 45.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.764 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.514 ' N ' ' O ' ' A' ' 25' ' ' ALA . 24.6 t -109.6 132.53 57.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 O-C-N 121.441 -0.787 . . . . 0.0 111.847 -177.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.63 ' O ' ' HA ' ' A' ' 78' ' ' ASN . 0.3 OUTLIER -118.28 121.29 66.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.435 -0.791 . . . . 0.0 109.413 178.799 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.557 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -105.67 111.19 23.78 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.621 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.5 m -131.09 -168.12 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.435 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 4.2 tt0 -135.86 128.2 30.22 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.573 ' CE2' ' SG ' ' A' ' 14' ' ' CYS . 1.7 t80 -60.25 124.01 18.96 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 118.633 -1.227 . . . . 0.0 110.032 -178.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 17' ' ' LYS . 2.4 mm-40 -116.61 86.19 2.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -0.887 . . . . 0.0 110.09 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 165.0 -150.38 18.24 Favored Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.425 -1.369 . . . . 0.0 109.986 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.462 ' O ' ' OH ' ' A' ' 38' ' ' TYR . 0.5 OUTLIER -113.24 128.62 56.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.665 -0.903 . . . . 0.0 110.408 -179.75 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 43' ' ' SER . . . 177.77 -26.71 0.06 OUTLIER Glycine 0 N--CA 1.487 2.087 0 C-N-CA 119.555 -1.307 . . . . 0.0 110.57 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.599 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.5 OUTLIER 48.94 -154.89 0.01 OUTLIER Pre-proline 0 N--CA 1.487 1.378 0 O-C-N 120.706 -1.467 . . . . 0.0 107.779 -179.58 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.599 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 53.3 Cg_exo -46.84 94.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.259 0 N-CA-C 108.241 -1.484 . . . . 0.0 108.241 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.574 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -148.97 173.15 13.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.615 -0.678 . . . . 0.0 109.853 -177.681 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.561 ' HG3' ' CD1' ' A' ' 69' ' ' ILE . 28.5 mttm -87.82 175.13 7.97 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.309 -0.87 . . . . 0.0 111.61 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.611 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 16.0 mm -119.92 128.82 25.66 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.499 -0.75 . . . . 0.0 112.237 -177.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.589 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 29.8 Cg_exo -65.31 144.75 81.61 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 121.593 1.529 . . . . 0.0 110.993 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.63 ' CD2' ' CD2' ' A' ' 63' ' ' LEU . 10.9 t80 -155.69 159.01 39.19 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.226 -0.921 . . . . 0.0 110.088 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.481 ' HB3' ' HB ' ' A' ' 91' ' ' ILE . 21.3 tt0 -175.17 114.54 0.15 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.981 -1.074 . . . . 0.0 110.496 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.53 ' CG2' ' HB3' ' A' ' 83' ' ' PRO . 10.0 mt -107.46 103.29 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.28 -0.887 . . . . 0.0 110.057 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.453 ' SD ' ' HA ' ' A' ' 58' ' ' HIS . 1.8 mtt -141.48 -66.68 0.41 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.24 -0.913 . . . . 0.0 110.209 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 52' ' ' MET . 0.1 OUTLIER 172.95 -160.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.257 -0.902 . . . . 0.0 110.236 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -45.32 -73.19 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.313 -0.867 . . . . 0.0 110.246 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.462 ' O ' ' CG ' ' A' ' 56' ' ' LYS . 3.4 mm-40 -93.6 -64.97 1.03 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.344 -0.847 . . . . 0.0 110.221 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.462 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 2.9 mtpp 173.36 85.37 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.315 -0.865 . . . . 0.0 110.174 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.95 18.21 6.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.232 -0.918 . . . . 0.0 110.183 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.453 ' HA ' ' SD ' ' A' ' 52' ' ' MET . 34.4 m80 49.32 89.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.906 . . . . 0.0 110.162 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.45 ' CG2' ' HA ' ' A' ' 52' ' ' MET . 24.8 t -101.06 -113.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.314 -0.866 . . . . 0.0 110.077 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.42 ' CB ' ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER 174.23 65.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.887 -1.133 . . . . 0.0 110.186 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.529 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -103.32 170.68 19.74 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.491 ' HG3' ' NH1' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -122.91 164.27 18.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.13 -1.217 . . . . 0.0 110.65 -179.65 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.63 ' CD2' ' CD2' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -129.73 110.84 12.09 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.569 -0.707 . . . . 0.0 109.529 179.109 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.541 ' CB ' ' HG2' ' A' ' 80' ' ' GLU . 5.5 mm -69.02 -33.34 58.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 122.342 1.068 . . . . 0.0 108.328 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.638 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.259 0.7 OUTLIER -100.99 31.33 3.65 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.375 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.553 ' C ' ' O ' ' A' ' 65' ' ' THR . 42.7 t -15.03 109.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.927 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.5 ' ND2' ' HD3' ' A' ' 46' ' ' LYS . 19.2 t-20 47.12 69.25 2.8 Favored Pre-proline 0 C--N 1.3 -1.58 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.785 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.532 ' HG3' ' CG2' ' A' ' 65' ' ' THR . 3.0 Cg_endo -50.06 -176.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.074 1.565 . . . . 0.0 109.538 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.561 ' CD1' ' HG3' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -141.96 144.09 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 119.171 -1.012 . . . . 0.0 112.171 -178.869 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.611 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 21.5 t -100.97 166.29 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.9 m -123.84 -15.41 6.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.745 -1.222 . . . . 0.0 111.166 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 26.1 mt-10 -140.03 14.48 2.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.929 -1.107 . . . . 0.0 111.016 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.1 OUTLIER 74.34 -9.83 1.23 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.42 -0.8 . . . . 0.0 111.006 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.468 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 6.9 t70 -135.96 0.18 2.61 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.932 -1.105 . . . . 0.0 110.059 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.428 ' HA ' ' HD2' ' A' ' 76' ' ' PRO . 22.0 t -72.54 108.21 4.05 Favored Pre-proline 0 N--CA 1.486 1.344 0 O-C-N 121.201 -0.937 . . . . 0.0 108.826 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.576 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 5.6 Cg_exo -45.07 130.71 10.72 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.757 1.398 . . . . 0.0 110.117 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 74.8 t -115.35 145.03 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.041 -1.037 . . . . 0.0 111.351 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.63 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.0 m-20 -106.52 133.25 51.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.516 -0.74 . . . . 0.0 109.597 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.58 HG22 ' CD1' ' A' ' 49' ' ' PHE . 3.6 mt -118.15 118.86 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 117.65 -1.62 . . . . 0.0 111.364 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.541 ' HG2' ' CB ' ' A' ' 64' ' ' ILE . 1.7 tp10 -94.45 109.77 21.62 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.53 ' CB ' HD22 ' A' ' 63' ' ' LEU . . . -118.24 147.34 43.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.041 -1.037 . . . . 0.0 110.774 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.522 ' CA ' HG22 ' A' ' 31' ' ' THR . 4.6 tt0 -112.37 58.64 0.55 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.45 -0.781 . . . . 0.0 111.051 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 37.1 Cg_endo -69.73 162.02 43.66 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.727 1.383 . . . . 0.0 110.63 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.485 ' HD3' ' HA2' ' A' ' 61' ' ' GLY . 23.4 Cg_exo -59.19 -145.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.096 1.577 . . . . 0.0 110.594 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -145.81 176.86 9.34 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.198 -0.939 . . . . 0.0 110.345 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.56 ' O ' ' CA ' ' A' ' 105' ' ' LYS . . . 113.6 -83.4 0.33 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.52 ' N ' ' HB3' ' A' ' 104' ' ' PHE . 11.5 t0 -170.81 119.83 0.53 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.04 -1.271 . . . . 0.0 109.549 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.589 ' HB2' ' CG ' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -155.68 -155.34 0.55 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.968 -1.083 . . . . 0.0 111.384 -179.387 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.57 ' CE1' ' OD1' ' A' ' 102' ' ' ASN . 85.3 m-85 -156.09 110.91 2.88 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.131 0.491 . . . . 0.0 109.842 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.588 ' CG2' ' CZ ' ' A' ' 49' ' ' PHE . 88.1 mt -73.71 134.16 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.179 -0.951 . . . . 0.0 109.475 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.503 ' CG2' ' CD ' ' A' ' 98' ' ' GLN . 57.5 mt -106.42 145.71 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.122 -0.987 . . . . 0.0 110.981 -179.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.546 ' CD1' HG23 ' A' ' 34' ' ' ILE . 1.9 mt -132.77 139.21 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.535 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 83.22 -159.52 37.35 Favored Glycine 0 N--CA 1.481 1.665 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.55 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -123.86 150.08 28.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 121.183 -1.187 . . . . 0.0 110.194 -179.568 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.574 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.7 OUTLIER -19.1 -57.47 0.05 OUTLIER Pre-proline 0 N--CA 1.5 2.045 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 10.3 Cg_endo -53.18 70.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 124.214 1.639 . . . . 0.0 111.952 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 90.76 5.11 69.0 Favored Glycine 0 N--CA 1.494 2.531 0 O-C-N 121.012 -1.055 . . . . 0.0 110.985 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.503 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -51.46 160.77 0.55 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.998 -1.295 . . . . 0.0 110.187 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' A' ' 18' ' ' PHE . 8.4 mt -97.52 177.4 5.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.214 -0.929 . . . . 0.0 110.35 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -159.14 141.35 13.77 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.266 -0.896 . . . . 0.0 110.456 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 89' ' ' TYR . 3.0 mp -141.11 120.82 13.4 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.242 -0.911 . . . . 0.0 110.239 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.57 ' OD1' ' CE1' ' A' ' 89' ' ' TYR . 4.0 t30 -72.13 131.2 42.49 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.292 -0.88 . . . . 0.0 110.7 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.584 ' CE2' HG21 ' A' ' 32' ' ' ILE . 6.9 t-105 -141.22 -143.94 0.16 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.823 -1.173 . . . . 0.0 111.193 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.589 ' CG ' ' HB2' ' A' ' 88' ' ' SER . 7.5 m-85 67.64 -82.43 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -178.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.56 ' CA ' ' O ' ' A' ' 86' ' ' GLY . 5.9 mtmt 63.02 170.49 0.15 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.86 -1.15 . . . . 0.0 110.295 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.58 125.34 30.27 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.913 . . . . 0.0 110.188 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -161.78 83.29 0.12 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 98.6 p -67.37 129.39 39.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.275 -1.132 . . . . 0.0 110.167 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.14 -36.54 3.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.317 -0.865 . . . . 0.0 110.11 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.01 37.32 3.22 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.339 -0.85 . . . . 0.0 110.179 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -139.41 114.42 9.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.255 -0.903 . . . . 0.0 110.251 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.8 26.85 0.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.899 . . . . 0.0 110.167 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.415 ' CD2' ' NE2' ' A' ' 115' ' ' HIS . 7.3 p-80 -140.8 179.16 6.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 0.0 110.236 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.38 136.67 46.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.906 . . . . 0.0 110.219 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.415 ' NE2' ' CD2' ' A' ' 113' ' ' HIS . 48.3 m170 -94.15 155.82 16.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 110.134 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 58.09 -179.33 0.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 110.077 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 23.5 m170 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.188 -179.982 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.416 ' O ' ' OD1' ' A' ' 2' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.226 0.536 . . . . 0.0 110.205 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 1' ' ' MET . 0.6 OUTLIER -149.74 -60.91 0.21 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.278 -0.889 . . . . 0.0 110.191 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.3 mmtm -120.58 -24.67 5.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.256 -0.903 . . . . 0.0 110.201 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.463 ' O ' ' HB3' ' A' ' 5' ' ' GLN . 0.9 OUTLIER -139.02 -171.33 3.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 110.238 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' A' ' 4' ' ' LEU . 3.5 pt20 178.54 42.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.314 -0.867 . . . . 0.0 110.218 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 5' ' ' GLN . 1.1 mp 46.19 97.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.358 -0.839 . . . . 0.0 110.387 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -109.73 124.29 50.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -0.889 . . . . 0.0 110.25 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.89 156.12 8.39 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.63 -10.61 19.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.206 -1.173 . . . . 0.0 110.223 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 44' ' ' PRO . 61.4 p -143.23 37.97 1.4 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.266 -0.896 . . . . 0.0 110.122 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 0.3 OUTLIER -171.75 35.12 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.236 -0.915 . . . . 0.0 109.366 -179.699 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.481 ' HA ' ' HD3' ' A' ' 46' ' ' LYS . 2.7 t -147.33 -35.99 0.23 Allowed 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.843 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.44 ' O ' ' N ' ' A' ' 15' ' ' THR . 7.7 tmm? -160.95 87.54 0.73 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.141 -0.974 . . . . 0.0 111.137 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 4.0 m -52.3 96.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.043 -1.036 . . . . 0.0 109.003 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 16' ' ' GLY . 49.4 p -64.56 -11.31 33.24 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.491 -0.756 . . . . 0.0 111.33 -178.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.511 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -60.08 -145.97 0.01 OUTLIER Glycine 0 N--CA 1.481 1.675 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.548 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -127.91 174.42 9.18 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.299 -1.118 . . . . 0.0 109.345 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.606 ' CE1' ' HD2' ' A' ' 48' ' ' PRO . 46.9 m-85 -131.24 133.62 45.63 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.743 -1.223 . . . . 0.0 112.099 -179.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -108.01 121.62 45.17 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.489 ' N ' HD11 ' A' ' 99' ' ' LEU . 48.0 t -59.66 130.39 23.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.196 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.524 ' N ' ' HA ' ' A' ' 36' ' ' VAL . 69.7 t -105.21 -26.91 3.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.55 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 19.6 tttt -156.32 133.06 10.3 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.15 155.95 1.77 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.542 0.687 . . . . 0.0 111.215 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.586 HD13 ' CA ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -50.98 132.51 12.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.536 -0.727 . . . . 0.0 109.862 179.839 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 32' ' ' ILE . . . -107.23 170.58 7.87 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 5.2 pm0 -116.36 130.58 56.84 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.809 -1.182 . . . . 0.0 110.569 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.524 ' CG2' ' OE2' ' A' ' 80' ' ' GLU . 14.5 p -89.2 173.93 8.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.361 -0.837 . . . . 0.0 110.056 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -88.07 29.2 0.96 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.154 -0.966 . . . . 0.0 110.472 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -132.25 6.19 4.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.16 -0.962 . . . . 0.0 110.291 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.77 -2.46 60.3 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.576 ' CG2' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -92.54 -178.14 4.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.303 -1.116 . . . . 0.0 110.384 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -139.18 158.46 28.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.568 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.496 ' N ' ' O ' ' A' ' 25' ' ' ALA . 73.6 t -123.08 128.15 74.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 C-N-CA 118.933 -1.107 . . . . 0.0 112.372 -177.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.62 ' O ' ' HA ' ' A' ' 78' ' ' ASN . 0.3 OUTLIER -111.24 118.47 57.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 121.357 -0.84 . . . . 0.0 109.716 178.895 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.55 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 2.9 ttm180 -104.71 114.65 29.0 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.612 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.6 m -133.46 -168.46 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 O-C-N 121.469 -0.769 . . . . 0.0 109.31 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.473 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 9.8 tt0 -135.14 126.25 27.93 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 14' ' ' CYS . 1.5 t80 -61.04 127.32 30.95 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.975 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 17' ' ' LYS . 3.5 mt-10 -125.28 89.63 3.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.044 -1.035 . . . . 0.0 110.172 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.529 ' O ' ' CD ' ' A' ' 73' ' ' LYS . . . 162.45 -151.69 21.69 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.474 ' HA ' ' HD2' ' A' ' 73' ' ' LYS . 11.1 t0 -107.48 118.23 36.18 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.565 -0.962 . . . . 0.0 110.217 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.06 -36.48 0.04 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.601 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER 52.43 -158.15 0.01 OUTLIER Pre-proline 0 C--N 1.305 -1.346 0 O-C-N 120.945 -1.327 . . . . 0.0 108.665 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.601 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 76.2 Cg_exo -45.21 93.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.229 0 N-CA-C 109.376 -1.048 . . . . 0.0 109.376 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -154.92 175.65 13.52 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.611 -0.681 . . . . 0.0 109.811 -179.093 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.599 ' HG3' ' CD1' ' A' ' 69' ' ' ILE . 2.6 mttp -82.01 175.37 10.42 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.393 -0.817 . . . . 0.0 112.07 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.613 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 16.8 mm -120.03 128.01 26.07 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.636 -0.665 . . . . 0.0 111.672 -178.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.606 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 34.2 Cg_exo -63.06 145.1 93.84 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 124.043 1.549 . . . . 0.0 110.495 178.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.653 ' CD1' ' CD2' ' A' ' 63' ' ' LEU . 5.4 t80 -154.11 162.45 41.18 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.268 -0.895 . . . . 0.0 110.101 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.531 ' O ' ' CD1' ' A' ' 91' ' ' ILE . 7.0 tp10 -179.19 97.88 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.192 -0.943 . . . . 0.0 110.03 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.505 ' CD1' ' HB2' ' A' ' 81' ' ' ALA . 16.1 mt -77.99 6.05 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.161 -0.962 . . . . 0.0 110.575 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.538 ' HA ' ' CG ' ' A' ' 56' ' ' LYS . 2.2 mpp? -142.88 -55.16 0.41 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.089 -1.007 . . . . 0.0 110.182 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.515 ' O ' ' CB ' ' A' ' 54' ' ' LEU . 22.1 t0 70.85 20.55 5.43 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.27 -0.894 . . . . 0.0 110.373 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.515 ' CB ' ' O ' ' A' ' 53' ' ' ASP . 0.9 OUTLIER 71.63 -0.62 3.09 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.272 -0.893 . . . . 0.0 110.746 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -98.32 -0.61 43.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.15 -0.969 . . . . 0.0 110.237 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.577 ' HE3' ' CD1' ' A' ' 89' ' ' TYR . 0.6 OUTLIER -111.1 58.98 0.61 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.178 -0.951 . . . . 0.0 110.184 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.433 ' O ' ' HB2' ' A' ' 58' ' ' HIS . 0.3 OUTLIER -60.4 96.63 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 110.265 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.433 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 2.1 t60 178.26 -48.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.256 -0.902 . . . . 0.0 110.202 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.451 HG21 ' CG ' ' A' ' 84' ' ' PRO . 34.2 m -139.65 -155.56 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.285 -0.884 . . . . 0.0 110.176 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -158.88 117.31 2.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.302 -0.874 . . . . 0.0 110.237 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.517 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . -83.67 179.39 52.33 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.5 ' CB ' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -137.75 168.29 19.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.197 -1.178 . . . . 0.0 110.416 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.653 ' CD2' ' CD1' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -122.59 122.68 39.43 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.581 -0.699 . . . . 0.0 109.295 179.161 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.597 ' CD1' ' N ' ' A' ' 64' ' ' ILE . 1.4 mp -85.3 -30.73 6.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.577 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.262 2.9 m -107.75 42.87 1.27 Allowed 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.258 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.534 ' CG2' ' HB3' ' A' ' 63' ' ' LEU . 18.7 t -30.07 121.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-O 121.604 0.716 . . . . 0.0 111.503 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 12.9 t-20 43.09 71.91 1.31 Allowed Pre-proline 0 C--N 1.297 -1.683 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.617 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.532 ' O ' ' HA ' ' A' ' 46' ' ' LYS . 1.1 Cg_endo -56.0 -171.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.909 1.479 . . . . 0.0 108.967 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.599 ' CD1' ' HG3' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -143.6 148.01 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 119.041 -1.064 . . . . 0.0 112.285 -179.241 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.613 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 54.3 t -104.79 164.69 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 176.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.452 ' N ' HG13 ' A' ' 70' ' ' VAL . 4.3 m -118.89 -19.39 8.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.878 -1.139 . . . . 0.0 111.5 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.528 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 19.0 mt-10 -140.2 18.78 2.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.76 -1.213 . . . . 0.0 111.386 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.529 ' CD ' ' O ' ' A' ' 40' ' ' GLY . 9.0 ttpt 72.61 -6.7 1.56 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.247 -0.908 . . . . 0.0 110.949 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.476 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 18.1 t0 -137.94 -2.2 1.92 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.0 -1.062 . . . . 0.0 110.33 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.2 t -72.64 112.42 15.01 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.071 -1.018 . . . . 0.0 108.939 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 50.5 Cg_exo -47.82 128.2 15.64 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.9 1.474 . . . . 0.0 110.067 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 66.3 t -114.94 142.32 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.04 -1.038 . . . . 0.0 111.534 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.62 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.1 m-20 -104.99 133.43 49.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.468 -0.77 . . . . 0.0 109.312 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.611 ' CG2' ' CE2' ' A' ' 49' ' ' PHE . 5.5 mt -117.39 119.66 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.075 -1.641 . . . . 0.0 111.582 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.563 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 1.9 tp10 -91.84 115.92 28.46 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.229 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.515 ' CB ' HD23 ' A' ' 63' ' ' LEU . . . -131.85 151.7 51.52 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.982 -1.074 . . . . 0.0 110.775 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.5 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 35.2 tt0 -100.76 103.09 22.18 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.234 -0.916 . . . . 0.0 110.247 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.531 ' HG3' ' CD1' ' A' ' 32' ' ' ILE . 42.8 Cg_endo -73.6 145.85 37.98 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.032 1.543 . . . . 0.0 110.655 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.517 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 43.8 Cg_endo -75.72 -160.17 0.1 Allowed 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.154 1.607 . . . . 0.0 110.256 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -97.52 149.21 22.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 110.069 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 105' ' ' LYS . . . 95.69 -159.73 22.4 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.88 137.24 36.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -1.162 . . . . 0.0 110.005 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 0.4 OUTLIER -141.41 150.83 42.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.218 -0.926 . . . . 0.0 110.534 -179.821 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.61 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 8.5 m-85 -129.88 108.49 10.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.348 -0.845 . . . . 0.0 110.044 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.567 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 1.7 mp -74.32 121.94 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.194 -0.941 . . . . 0.0 109.81 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.531 ' CD1' ' O ' ' A' ' 50' ' ' GLU . 3.2 mt -101.06 145.88 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.17 -0.956 . . . . 0.0 110.04 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.551 ' CD1' HG21 ' A' ' 34' ' ' ILE . 4.0 mt -132.73 146.18 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.465 -0.772 . . . . 0.0 110.359 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.54 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 78.74 -161.05 47.59 Favored Glycine 0 N--CA 1.484 1.896 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.528 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.1 OUTLIER -124.19 140.98 45.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.187 -1.184 . . . . 0.0 110.866 -179.632 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.552 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.8 OUTLIER -16.6 -58.97 0.04 OUTLIER Pre-proline 0 N--CA 1.505 2.309 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.876 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 24.4 Cg_exo -32.32 -32.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 124.013 1.533 . . . . 0.0 110.956 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.548 ' HA3' ' CG ' ' A' ' 17' ' ' LYS . . . -175.67 35.98 0.1 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.494 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -71.43 164.69 25.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.697 -0.884 . . . . 0.0 110.74 -179.247 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.514 ' CD1' ' O ' ' A' ' 18' ' ' PHE . 8.2 mt -100.99 176.95 5.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.432 -0.793 . . . . 0.0 110.128 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.46 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -154.84 135.59 13.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.318 -0.864 . . . . 0.0 110.259 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 89' ' ' TYR . 2.4 mp -142.02 122.87 14.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.267 -0.895 . . . . 0.0 110.231 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 7.4 p-10 -86.02 131.31 34.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.15 -0.969 . . . . 0.0 110.241 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.521 ' CD1' HG22 ' A' ' 32' ' ' ILE . 49.4 t-105 -141.48 169.68 17.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.949 . . . . 0.0 110.317 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.498 ' O ' ' CB ' ' A' ' 105' ' ' LYS . 0.2 OUTLIER 63.63 -163.14 0.27 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.301 -0.875 . . . . 0.0 110.235 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 86' ' ' GLY . 0.1 OUTLIER 169.42 -175.86 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.273 -0.892 . . . . 0.0 110.172 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.466 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 25.5 mtpt -58.23 -29.52 65.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.306 -0.871 . . . . 0.0 110.327 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -168.97 -169.72 32.7 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.67 -173.22 2.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -1.152 . . . . 0.0 110.171 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.5 m 50.25 -168.52 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.192 -0.942 . . . . 0.0 110.19 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.435 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -48.67 139.78 9.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 110.191 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -105.56 -62.79 1.31 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 110.324 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 57.99 69.53 0.73 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 110.19 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -168.23 -50.19 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.268 -0.895 . . . . 0.0 110.197 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -108.15 6.66 27.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.208 -0.932 . . . . 0.0 110.195 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.4 ' O ' ' CB ' ' A' ' 116' ' ' HIS . 0.0 OUTLIER -90.22 -4.21 57.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.864 . . . . 0.0 110.203 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.4 ' CB ' ' O ' ' A' ' 115' ' ' HIS . 4.4 t-160 63.03 86.3 0.12 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.292 -0.88 . . . . 0.0 110.15 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.201 179.904 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.433 ' O ' ' CB ' ' A' ' 2' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.211 0.529 . . . . 0.0 110.193 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.433 ' CB ' ' O ' ' A' ' 1' ' ' MET . 6.4 t0 64.62 -179.9 0.18 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.869 . . . . 0.0 110.233 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 2' ' ' ASP . 10.8 mttt 54.86 95.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.9 . . . . 0.0 110.329 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.5 ' CD1' ' O ' ' A' ' 4' ' ' LEU . 1.1 pp -132.09 53.93 1.97 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.306 -0.871 . . . . 0.0 110.135 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.9 35.17 3.57 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.304 -0.872 . . . . 0.0 110.231 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.1 mt -128.4 96.77 4.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 110.239 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.79 86.66 2.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 110.271 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.42 155.14 25.07 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.514 ' O ' ' N ' ' A' ' 11' ' ' TYR . 1.5 ttt -90.29 -44.53 9.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.223 -1.163 . . . . 0.0 110.327 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.9 t 46.46 -92.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.279 -0.888 . . . . 0.0 110.104 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.545 ' CZ ' ' HB2' ' A' ' 44' ' ' PRO . 1.1 t80 -148.88 -74.88 0.17 Allowed 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.144 -0.973 . . . . 0.0 110.143 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.515 ' HB3' ' CB ' ' A' ' 45' ' ' CYS . 2.4 t -145.85 -127.89 0.07 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.201 -0.937 . . . . 0.0 109.509 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.522 ' O ' ' N ' ' A' ' 15' ' ' THR . 1.5 ptt? -178.55 97.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.94 -1.1 . . . . 0.0 110.394 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 56.4 m -60.44 80.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.884 . . . . 0.0 108.999 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 13' ' ' MET . 0.1 OUTLIER -83.35 -4.6 58.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.302 -0.874 . . . . 0.0 111.656 -178.553 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.524 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -61.23 -128.75 0.01 OUTLIER Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.545 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -123.24 176.29 6.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.235 -1.156 . . . . 0.0 109.971 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.598 ' CZ ' ' HD2' ' A' ' 48' ' ' PRO . 34.4 m-85 -135.93 141.38 44.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.879 -1.138 . . . . 0.0 111.704 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -112.33 117.62 32.99 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.473 ' CG2' HD13 ' A' ' 99' ' ' LEU . 44.2 t -59.67 123.94 13.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 120.586 -1.321 . . . . 0.0 108.94 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.557 ' HB ' ' CG ' ' A' ' 35' ' ' ARG . 53.9 t -97.62 -26.63 3.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.585 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 18.8 tttt -157.17 133.21 9.56 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -50.62 161.69 0.31 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.694 0.759 . . . . 0.0 111.325 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.572 HG12 HG12 ' A' ' 34' ' ' ILE . 0.7 OUTLIER -55.83 132.64 19.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-O 121.716 0.769 . . . . 0.0 110.311 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 33' ' ' VAL . . . -109.5 167.22 10.29 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 6.9 pm0 -113.91 130.37 56.51 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 120.595 -1.316 . . . . 0.0 110.681 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.493 HG21 ' CG ' ' A' ' 80' ' ' GLU . 8.4 p -81.72 -167.59 1.57 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.455 -0.778 . . . . 0.0 110.005 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -103.94 23.02 13.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 110.281 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -128.48 7.08 5.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.204 -0.935 . . . . 0.0 110.178 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.469 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 97.95 0.94 58.61 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.528 HG21 ' CA ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -91.93 -177.28 4.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.285 -1.127 . . . . 0.0 110.254 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.548 ' CD1' ' HG3' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -140.69 150.4 20.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.611 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.508 ' CG2' ' HG3' ' A' ' 80' ' ' GLU . 69.7 t -116.5 131.71 68.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 O-C-N 121.151 -0.968 . . . . 0.0 111.875 -178.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.598 ' O ' ' HA ' ' A' ' 78' ' ' ASN . 0.4 OUTLIER -114.72 117.06 54.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.401 -0.812 . . . . 0.0 109.694 179.056 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -98.65 122.41 41.84 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.864 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.596 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.7 m -149.25 158.17 6.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.942 0.877 . . . . 0.0 109.022 -178.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.511 ' NE2' ' HD3' ' A' ' 76' ' ' PRO 0.256 2.7 tt0 -104.43 122.33 45.28 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.318 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.591 ' CZ ' ' HB3' ' A' ' 14' ' ' CYS . 7.6 t80 -61.47 144.98 53.29 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.081 -1.047 . . . . 0.0 110.148 -178.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 17' ' ' LYS . 45.3 mm-40 -119.19 -143.8 0.36 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.276 -0.89 . . . . 0.0 108.848 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.524 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 43.86 -139.77 3.62 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.464 ' HA ' ' HD2' ' A' ' 73' ' ' LYS . 1.3 m-20 -135.18 143.35 46.4 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.737 -0.861 . . . . 0.0 110.001 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.02 -27.17 0.05 OUTLIER Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.475 -1.345 . . . . 0.0 110.626 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.643 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.4 OUTLIER 56.31 -153.88 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 120.637 -1.508 . . . . 0.0 108.324 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.643 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 38.9 Cg_exo -53.5 90.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 N-CA-C 109.981 -0.815 . . . . 0.0 109.981 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 43' ' ' SER . 6.6 p -142.46 173.68 11.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.137 -0.977 . . . . 0.0 110.541 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.55 ' HG3' ' CD1' ' A' ' 69' ' ' ILE . 12.1 mtmm -84.42 168.97 15.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.411 -0.806 . . . . 0.0 111.347 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.612 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 13.3 mm -112.06 127.18 27.21 Favored Pre-proline 0 C--N 1.304 -1.391 0 O-C-N 121.241 -0.912 . . . . 0.0 112.31 -177.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.598 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 34.6 Cg_exo -63.71 144.17 88.55 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 124.055 1.555 . . . . 0.0 110.258 178.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.644 ' CD1' ' CD2' ' A' ' 63' ' ' LEU . 7.1 t80 -153.05 162.01 41.83 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.259 -0.9 . . . . 0.0 110.603 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.533 ' CG ' ' HB2' ' A' ' 53' ' ' ASP . 9.4 tp10 -179.83 108.7 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.345 -0.847 . . . . 0.0 109.729 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.472 HG23 HD13 ' A' ' 51' ' ' ILE . 5.0 mt -86.52 25.08 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.064 -1.023 . . . . 0.0 110.547 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.478 ' HA ' ' HG3' ' A' ' 56' ' ' LYS . 39.6 mtm -148.57 -67.54 0.23 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.233 -0.917 . . . . 0.0 110.277 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.533 ' HB2' ' CG ' ' A' ' 50' ' ' GLU . 6.7 t0 40.47 -163.96 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.331 -0.855 . . . . 0.0 110.686 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 45.05 -92.47 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.39 -0.819 . . . . 0.0 110.319 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 53' ' ' ASP . 19.1 pt-20 -163.12 61.77 0.18 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.175 -0.953 . . . . 0.0 110.066 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.478 ' HG3' ' HA ' ' A' ' 52' ' ' MET . 43.9 mmtt -98.64 81.55 2.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -0.883 . . . . 0.0 109.948 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' A' ' 56' ' ' LYS . 1.3 mtt180 -50.21 -177.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.403 -0.811 . . . . 0.0 110.389 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 55.27 85.84 0.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.322 -0.861 . . . . 0.0 110.075 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.2 t -76.88 127.23 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 110.265 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 84' ' ' PRO . 3.7 mt -150.86 -45.07 0.12 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.273 -0.892 . . . . 0.0 110.254 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.525 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . -45.08 160.09 0.14 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -149.43 170.16 19.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.216 -1.167 . . . . 0.0 110.812 -179.682 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.644 ' CD2' ' CD1' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -119.7 121.99 40.46 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.422 179.302 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.561 ' CD1' ' N ' ' A' ' 64' ' ' ILE . 1.3 mp -84.69 -30.86 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.604 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.259 1.9 m -108.52 43.84 1.19 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.159 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.586 ' CG1' ' ND2' ' A' ' 67' ' ' ASN . 9.0 t -29.52 135.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 CA-C-O 121.33 0.586 . . . . 0.0 111.396 -178.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.586 ' ND2' ' CG1' ' A' ' 66' ' ' VAL . 23.6 p30 26.52 73.14 0.37 Allowed Pre-proline 0 N--CA 1.49 1.538 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.753 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.53 ' O ' ' HA ' ' A' ' 46' ' ' LYS . 3.2 Cg_endo -57.1 -174.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.902 1.475 . . . . 0.0 108.821 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.55 ' CD1' ' HG3' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -140.83 142.57 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 C-N-CA 118.847 -1.141 . . . . 0.0 112.346 -179.071 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.612 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 46.6 t -98.63 160.05 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 176.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.462 ' N ' HG11 ' A' ' 70' ' ' VAL . 16.5 m -113.8 -21.65 10.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.954 -1.092 . . . . 0.0 110.964 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.512 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 6.6 mt-10 -132.02 15.62 4.7 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.963 -1.086 . . . . 0.0 111.05 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.53 ' O ' ' O ' ' A' ' 38' ' ' TYR . 0.2 OUTLIER 72.37 -4.36 2.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.353 -0.842 . . . . 0.0 110.984 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 12.6 t70 -137.38 1.87 2.44 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.06 -1.025 . . . . 0.0 110.188 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.433 ' HA ' ' HD2' ' A' ' 76' ' ' PRO . 40.3 t -73.0 109.28 5.87 Favored Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.192 -0.943 . . . . 0.0 109.454 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.511 ' HD3' ' NE2' ' A' ' 37' ' ' GLN . 3.7 Cg_endo -52.59 111.15 0.57 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.817 1.43 . . . . 0.0 109.713 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 48.7 t -102.65 145.49 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.331 -0.856 . . . . 0.0 111.712 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.598 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 1.5 m120 -101.93 134.12 45.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.488 -0.757 . . . . 0.0 109.207 179.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.577 HG22 ' CE2' ' A' ' 49' ' ' PHE . 6.6 mt -114.85 117.42 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.21 -1.556 . . . . 0.0 111.626 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.532 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 2.6 tt0 -88.18 111.52 21.71 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.59 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.533 ' CB ' HD21 ' A' ' 63' ' ' LEU . . . -127.23 149.39 50.02 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.032 -1.043 . . . . 0.0 110.836 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.528 ' CA ' HG21 ' A' ' 31' ' ' THR . 1.0 OUTLIER -99.47 104.15 25.41 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.243 -0.91 . . . . 0.0 110.51 -179.692 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.548 ' HG3' ' CD1' ' A' ' 32' ' ' ILE . 74.6 Cg_endo -81.15 147.58 16.46 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.004 1.528 . . . . 0.0 110.609 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.525 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 9.7 Cg_endo -58.32 -52.46 5.6 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.872 1.459 . . . . 0.0 109.769 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.46 ' HB3' ' OD1' ' A' ' 87' ' ' ASP . 1.0 OUTLIER -151.98 176.43 11.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.401 -0.812 . . . . 0.0 109.657 179.682 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.547 ' HA3' ' N ' ' A' ' 105' ' ' LYS . . . -74.17 76.24 1.09 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 87' ' ' ASP . 5.7 p-10 175.11 81.38 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.491 -1.005 . . . . 0.0 109.339 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -158.67 -159.05 0.75 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 110.651 -179.081 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.52 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 3.4 m-85 -151.13 100.72 2.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.69 -0.631 . . . . 0.0 109.728 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.583 ' CG2' ' CZ ' ' A' ' 49' ' ' PHE . 3.4 mt -73.91 120.04 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.148 -0.97 . . . . 0.0 109.575 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.505 ' CG2' ' CD ' ' A' ' 98' ' ' GLN . 1.9 mp -98.53 140.16 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.046 -1.034 . . . . 0.0 110.048 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.561 ' CD1' HG23 ' A' ' 34' ' ' ILE . 1.2 mt -126.14 142.22 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.452 -0.78 . . . . 0.0 109.994 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.529 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 82.59 -160.36 39.48 Favored Glycine 0 N--CA 1.481 1.65 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.553 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -122.77 149.82 26.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 O-C-N 121.307 -1.113 . . . . 0.0 110.091 -179.652 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.568 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -19.19 -57.56 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.109 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 9.7 Cg_endo -53.84 69.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 124.137 1.598 . . . . 0.0 112.145 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 93.57 4.61 63.82 Favored Glycine 0 N--CA 1.495 2.6 0 O-C-N 120.876 -1.14 . . . . 0.0 111.033 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.505 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -53.87 159.78 1.61 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.046 -1.267 . . . . 0.0 110.193 179.873 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.519 ' CD1' ' O ' ' A' ' 18' ' ' PHE . 9.1 mt -97.91 177.4 5.45 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.215 -0.928 . . . . 0.0 110.758 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.415 ' HG3' HG13 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -157.07 128.37 6.89 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.47 -0.769 . . . . 0.0 110.094 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 90' ' ' ILE . 4.7 mp -130.5 124.98 33.2 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.279 -0.888 . . . . 0.0 109.972 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.52 ' HA ' ' O ' ' A' ' 88' ' ' SER . 10.1 t-20 -90.91 132.21 36.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 110.89 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.524 ' NE1' HG21 ' A' ' 32' ' ' ILE . 3.4 t-105 -113.22 122.57 47.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.049 -1.032 . . . . 0.0 110.243 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.505 ' O ' ' CB ' ' A' ' 105' ' ' LYS . 1.3 t80 -117.52 145.5 44.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.187 -0.946 . . . . 0.0 110.326 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.547 ' N ' ' HA3' ' A' ' 86' ' ' GLY . 0.0 OUTLIER 168.22 117.19 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.271 -0.893 . . . . 0.0 110.293 -179.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.57 -20.97 14.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 110.136 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 60.41 51.43 58.82 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 60.4 p -66.8 -74.55 0.11 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -1.146 . . . . 0.0 110.217 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 35.5 m -156.19 104.49 2.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.186 -0.946 . . . . 0.0 110.245 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.482 ' CD1' ' N ' ' A' ' 110' ' ' LEU . 7.4 mp -78.4 -80.01 0.12 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 110.184 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 110' ' ' LEU . 1.1 mt-10 43.57 69.73 0.38 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.293 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -145.62 -62.77 0.33 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.337 -0.852 . . . . 0.0 110.112 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -92.81 77.01 4.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 110.125 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.481 ' O ' ' CD2' ' A' ' 114' ' ' HIS . 22.4 p-80 -136.67 93.32 2.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 110.18 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -63.44 155.47 29.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.917 . . . . 0.0 110.204 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.404 ' O ' ' CB ' ' A' ' 117' ' ' HIS . 0.1 OUTLIER -137.78 174.97 10.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.282 -0.886 . . . . 0.0 110.213 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.404 ' CB ' ' O ' ' A' ' 116' ' ' HIS . 1.9 t-160 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.232 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.247 0.546 . . . . 0.0 110.185 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.413 ' O ' ' CG ' ' A' ' 2' ' ' ASP . 11.0 p-10 -165.08 117.72 1.2 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.896 . . . . 0.0 110.203 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.7 mttm -144.59 23.86 1.58 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.912 . . . . 0.0 110.215 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.447 ' O ' ' HB3' ' A' ' 5' ' ' GLN . 3.5 mm? -80.52 82.46 6.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.32 -0.863 . . . . 0.0 110.239 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.464 ' O ' ' O ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -179.38 41.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.266 -0.896 . . . . 0.0 110.23 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 5' ' ' GLN . 4.7 mp 50.75 176.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 110.201 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.1 mtmt -80.46 -9.49 59.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 0.0 110.107 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 9' ' ' MET . . . -170.94 -58.21 0.04 OUTLIER Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER 177.34 163.92 0.55 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -1.169 . . . . 0.0 110.229 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.6 m -57.99 124.49 19.47 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.225 -0.922 . . . . 0.0 110.141 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.54 ' CE2' ' O ' ' A' ' 44' ' ' PRO . 1.8 t80 -88.66 -74.0 0.48 Allowed 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.257 -0.902 . . . . 0.0 110.166 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.482 ' O ' ' HB3' ' A' ' 13' ' ' MET . 3.4 t -133.13 -28.25 1.54 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.363 -0.835 . . . . 0.0 110.645 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.482 ' HB3' ' O ' ' A' ' 12' ' ' SER . 2.7 ttm 58.28 95.52 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.309 -0.869 . . . . 0.0 108.972 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.597 ' HB3' ' CE1' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -71.61 126.55 29.97 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.889 -179.183 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 16' ' ' GLY . 14.8 t -107.71 -2.37 20.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.267 -0.895 . . . . 0.0 111.385 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.54 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -60.8 -125.08 0.01 OUTLIER Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.545 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -132.49 178.12 7.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.028 -1.278 . . . . 0.0 110.029 -179.793 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.593 ' CE1' ' HD2' ' A' ' 48' ' ' PRO . 34.1 m-85 -136.12 133.92 37.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.948 -1.095 . . . . 0.0 111.63 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.525 ' CE ' ' HB3' ' A' ' 37' ' ' GLN . 0.3 OUTLIER -104.26 119.71 39.56 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.622 -0.674 . . . . 0.0 109.444 179.2 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.497 ' N ' HD11 ' A' ' 99' ' ' LEU . 41.6 t -59.72 131.12 24.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 118.588 -1.245 . . . . 0.0 108.275 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.526 ' N ' ' HA ' ' A' ' 36' ' ' VAL . 75.9 t -105.27 -26.15 3.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.551 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 2.2 tttt -157.11 133.08 9.53 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -52.3 158.86 1.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.523 0.677 . . . . 0.0 111.304 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.578 HD13 ' CA ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -54.39 132.38 17.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.588 0.708 . . . . 0.0 109.903 -179.964 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 32' ' ' ILE . . . -107.29 169.7 8.41 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.5 pm0 -115.85 133.54 55.92 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.65 -1.281 . . . . 0.0 110.406 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.527 ' CG2' ' OE2' ' A' ' 80' ' ' GLU . 13.2 p -93.13 172.45 8.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.393 -0.817 . . . . 0.0 110.181 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -87.73 29.23 0.92 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.266 -0.896 . . . . 0.0 110.328 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.87 5.82 4.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.924 . . . . 0.0 110.179 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.88 8.06 59.47 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.538 HG23 ' CA ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -102.66 -174.84 2.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -1.08 . . . . 0.0 110.081 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.535 ' O ' ' HA ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -141.91 156.91 20.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 178.632 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.499 ' N ' ' O ' ' A' ' 25' ' ' ALA . 76.3 t -121.69 128.18 75.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 O-C-N 120.974 -1.079 . . . . 0.0 112.222 -177.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.623 ' O ' ' HA ' ' A' ' 78' ' ' ASN . 0.3 OUTLIER -112.89 118.97 59.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 O-C-N 121.437 -0.789 . . . . 0.0 109.685 178.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.551 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 3.4 ttm180 -105.67 112.81 26.03 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.617 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.7 m -132.34 -168.01 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.476 -0.765 . . . . 0.0 109.422 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.525 ' HB3' ' CE ' ' A' ' 19' ' ' LYS . 21.6 tt0 -138.26 127.06 23.76 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.597 ' CE1' ' HB3' ' A' ' 14' ' ' CYS . 75.5 t80 -60.31 128.34 36.25 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 118.29 -1.364 . . . . 0.0 110.579 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.467 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 61.8 mm-40 -116.01 82.85 1.84 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.484 -0.76 . . . . 0.0 109.62 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.54 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 171.62 -145.01 8.48 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.472 ' O ' ' OH ' ' A' ' 38' ' ' TYR . 7.5 m-20 -128.54 140.83 51.6 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.637 -0.919 . . . . 0.0 110.56 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 166.9 -20.61 0.1 OUTLIER Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.689 -1.243 . . . . 0.0 110.66 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.606 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER 56.03 -157.98 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 120.705 -1.468 . . . . 0.0 108.413 -179.702 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 72.9 Cg_exo -44.35 94.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.262 0 N-CA-C 108.944 -1.214 . . . . 0.0 108.944 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.533 ' N ' ' O ' ' A' ' 43' ' ' SER . 26.3 p -141.17 165.88 26.31 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.746 -0.596 . . . . 0.0 110.286 -178.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.591 ' CG ' ' CD1' ' A' ' 69' ' ' ILE . 10.9 mttp -82.59 177.43 8.71 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.407 -0.808 . . . . 0.0 110.358 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.592 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 14.2 mm -121.51 127.88 25.89 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.102 -0.999 . . . . 0.0 111.92 -178.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.593 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 35.1 Cg_exo -63.06 143.72 91.23 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.881 1.464 . . . . 0.0 110.627 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.598 ' CD1' ' CD2' ' A' ' 63' ' ' LEU . 5.6 t80 -155.53 132.28 10.55 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.335 -0.853 . . . . 0.0 110.021 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.521 ' HG2' ' CG2' ' A' ' 91' ' ' ILE . 0.8 OUTLIER -144.1 97.68 3.09 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.03 -1.044 . . . . 0.0 110.305 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.479 ' CD1' ' HB2' ' A' ' 81' ' ' ALA . 11.9 mt -86.02 61.53 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.274 -0.891 . . . . 0.0 110.184 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.459 ' HB2' ' HG2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -142.93 -65.1 0.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.312 -0.868 . . . . 0.0 110.345 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER 58.42 106.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.121 -0.987 . . . . 0.0 110.002 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.525 ' CB ' ' O ' ' A' ' 53' ' ' ASP . 2.4 tp 72.7 -1.08 3.11 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.34 -0.85 . . . . 0.0 110.514 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -142.65 52.62 1.41 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.905 . . . . 0.0 110.106 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.459 ' HG2' ' HB2' ' A' ' 52' ' ' MET . 18.4 mtmt -98.69 102.66 14.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.3 -0.875 . . . . 0.0 110.235 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -165.67 -56.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.0 110.28 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.3 -156.47 0.5 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.23 -0.919 . . . . 0.0 110.149 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.4 t -101.32 99.39 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.341 -0.849 . . . . 0.0 110.261 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.09 132.07 56.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.194 -0.941 . . . . 0.0 110.226 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.523 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . 68.33 161.5 2.06 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.464 ' CB ' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -130.78 166.95 19.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.268 -1.136 . . . . 0.0 110.157 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.598 ' CD2' ' CD1' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -128.42 111.22 13.08 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.346 -0.847 . . . . 0.0 109.934 179.701 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.528 ' CB ' ' HG2' ' A' ' 80' ' ' GLU . 5.6 mm -71.08 -25.45 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 122.148 0.975 . . . . 0.0 108.525 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.641 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.253 0.7 OUTLIER -111.87 31.46 6.19 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.718 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.56 ' C ' ' O ' ' A' ' 65' ' ' THR . 32.6 t -13.83 112.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.186 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.522 ' ND2' ' HD3' ' A' ' 46' ' ' LYS . 12.5 t-20 43.78 68.66 2.87 Favored Pre-proline 0 C--N 1.298 -1.66 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.295 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.532 ' O ' HG12 ' A' ' 69' ' ' ILE . 2.1 Cg_endo -51.41 -174.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.982 1.517 . . . . 0.0 109.142 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.591 ' CD1' ' CG ' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -142.28 144.41 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 119.088 -1.045 . . . . 0.0 112.488 -178.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.592 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 26.5 t -98.62 166.87 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 176.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.418 ' N ' HG11 ' A' ' 70' ' ' VAL . 3.3 m -123.62 -18.9 5.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.842 -1.161 . . . . 0.0 111.12 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.539 ' O ' ' CD ' ' A' ' 73' ' ' LYS . 8.0 mt-10 -138.0 15.37 2.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.926 -1.109 . . . . 0.0 110.685 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.539 ' CD ' ' O ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER 75.05 -13.39 0.85 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.773 -0.579 . . . . 0.0 111.224 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.462 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 6.3 t70 -131.83 -0.07 3.87 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.89 -1.131 . . . . 0.0 110.163 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.433 ' HA ' ' HD2' ' A' ' 76' ' ' PRO . 8.9 t -72.04 108.36 4.05 Favored Pre-proline 0 C--N 1.304 -1.372 0 O-C-N 121.257 -0.902 . . . . 0.0 108.707 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 2.0 Cg_endo -46.92 131.03 16.51 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.77 1.405 . . . . 0.0 110.297 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 63.2 t -118.39 144.81 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.099 -1.001 . . . . 0.0 111.296 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.623 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 4.9 m-80 -105.51 134.82 47.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.431 -0.793 . . . . 0.0 109.574 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.59 HG21 ' CE2' ' A' ' 49' ' ' PHE . 5.2 mt -118.37 119.05 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 119.957 -1.715 . . . . 0.0 111.344 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 1.7 tp10 -93.19 114.12 26.52 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.634 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.522 ' CB ' HD23 ' A' ' 63' ' ' LEU . . . -131.0 150.43 52.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.048 -1.033 . . . . 0.0 110.873 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.538 ' CA ' HG23 ' A' ' 31' ' ' THR . 4.4 tt0 -101.09 100.2 12.56 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.34 -0.85 . . . . 0.0 110.084 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.523 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 32.4 Cg_endo -69.05 144.64 58.52 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.102 1.58 . . . . 0.0 110.58 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.523 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 19.0 Cg_endo -63.62 -163.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.034 1.544 . . . . 0.0 110.229 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.57 ' O ' ' CD2' ' A' ' 85' ' ' PHE . 37.4 p90 -91.19 125.49 35.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.918 . . . . 0.0 110.243 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.24 -173.23 17.82 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -57.72 167.5 1.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -1.167 . . . . 0.0 110.194 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -172.95 130.05 0.49 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 110.266 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 102' ' ' ASN . 21.6 m-85 -100.9 102.66 13.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.913 . . . . 0.0 110.16 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.584 ' CG2' ' CZ ' ' A' ' 49' ' ' PHE . 1.8 mp -73.9 113.45 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.213 -0.93 . . . . 0.0 109.394 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.521 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 9.5 mt -94.1 144.56 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.144 -0.972 . . . . 0.0 110.282 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.543 ' CD1' HG22 ' A' ' 34' ' ' ILE . 1.8 mt -128.65 141.25 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.406 -0.808 . . . . 0.0 109.697 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.54 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 82.2 -160.36 40.24 Favored Glycine 0 N--CA 1.483 1.786 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.563 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -122.58 148.24 26.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 O-C-N 121.218 -1.166 . . . . 0.0 109.918 -179.73 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.571 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.4 OUTLIER -16.38 -58.56 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.173 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.776 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 7.3 Cg_endo -51.01 73.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 124.131 1.595 . . . . 0.0 112.067 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 88.39 -0.27 83.14 Favored Glycine 0 N--CA 1.495 2.581 0 O-C-N 121.02 -1.05 . . . . 0.0 110.9 178.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.507 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -47.04 160.52 0.09 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.967 -1.314 . . . . 0.0 110.325 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 18' ' ' PHE . 10.6 mt -96.9 177.69 5.54 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.218 -0.926 . . . . 0.0 110.363 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.466 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -158.72 136.25 10.16 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.297 -0.877 . . . . 0.0 110.104 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 90' ' ' ILE . 2.6 mp -141.48 121.5 13.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.148 -0.97 . . . . 0.0 110.393 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -87.44 129.65 34.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.257 -0.902 . . . . 0.0 110.336 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.514 ' NE1' HG23 ' A' ' 32' ' ' ILE . 24.5 t-105 -126.09 152.94 45.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 110.202 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -109.95 118.35 36.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.274 -0.891 . . . . 0.0 110.217 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -116.91 57.6 0.78 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 110.221 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -78.62 -173.67 3.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 0.0 110.163 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 140.28 167.0 10.88 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.7 -145.84 0.29 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.283 -1.128 . . . . 0.0 110.188 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 111' ' ' GLU . 1.5 m -48.71 -36.77 16.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.169 -0.957 . . . . 0.0 110.32 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 52.62 -88.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.955 . . . . 0.0 110.14 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 109' ' ' SER . 11.8 tt0 -167.68 40.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.94 . . . . 0.0 110.217 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -165.79 107.9 0.76 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 110.19 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.42 ' O ' ' CG ' ' A' ' 114' ' ' HIS . 6.9 p-80 -165.69 -179.55 5.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.259 -0.9 . . . . 0.0 110.211 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.42 ' CG ' ' O ' ' A' ' 113' ' ' HIS . 2.3 m-70 -166.15 90.04 0.42 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.175 -0.953 . . . . 0.0 110.237 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.414 ' HB3' ' O ' ' A' ' 114' ' ' HIS . 1.0 OUTLIER -178.81 -161.41 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 110.205 179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -164.05 168.14 19.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.207 -0.933 . . . . 0.0 110.262 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 6.8 t60 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.265 179.99 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 mtp . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.208 0.528 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.3 t0 62.76 65.42 0.82 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 110.212 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -85.53 163.03 18.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.221 -0.925 . . . . 0.0 110.258 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.74 112.39 3.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.322 -0.861 . . . . 0.0 110.147 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -110.1 6.42 22.85 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.316 -0.865 . . . . 0.0 110.266 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -156.48 -161.28 1.09 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.925 . . . . 0.0 110.174 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.17 -73.12 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.934 . . . . 0.0 110.283 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.422 ' O ' ' CB ' ' A' ' 9' ' ' MET . . . -166.88 -122.08 0.59 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.422 ' CB ' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER 64.32 138.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.287 -1.125 . . . . 0.0 110.152 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.0 p -175.46 135.27 0.32 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.264 -0.898 . . . . 0.0 110.158 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.587 ' CZ ' ' HB2' ' A' ' 44' ' ' PRO . 1.2 t80 -149.26 -75.0 0.17 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.206 -0.933 . . . . 0.0 109.994 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.531 ' HB3' ' HA ' ' A' ' 45' ' ' CYS . 2.1 t -148.4 -126.21 0.05 Allowed 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.112 -0.993 . . . . 0.0 109.054 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.467 ' HB3' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -178.3 98.41 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.741 -1.224 . . . . 0.0 110.66 179.429 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 21.5 m -61.85 104.87 0.49 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.066 -1.022 . . . . 0.0 108.401 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.525 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 1.2 t -114.82 2.6 14.41 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.932 -1.105 . . . . 0.0 111.974 -178.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.54 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -65.07 -100.03 0.01 OUTLIER Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.104 -1.522 . . . . 0.0 109.437 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.562 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 1.1 tmpt? -141.1 161.86 36.85 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.077 -1.249 . . . . 0.0 109.807 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.604 ' CZ ' ' HD2' ' A' ' 48' ' ' PRO . 18.7 m-85 -126.11 134.92 51.21 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.763 -1.211 . . . . 0.0 111.93 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.521 ' HE2' ' NE2' ' A' ' 37' ' ' GLN . 3.9 ttpt -109.4 120.04 41.3 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.566 -0.709 . . . . 0.0 109.652 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.527 ' CG2' HD11 ' A' ' 99' ' ' LEU . 49.0 t -60.08 131.9 25.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.866 -1.147 . . . . 0.0 108.927 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.523 ' N ' ' HA ' ' A' ' 36' ' ' VAL . 72.4 t -105.55 -27.3 3.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.545 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 5.9 tttp -156.04 133.23 10.7 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 177.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -51.84 156.38 1.48 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.555 0.693 . . . . 0.0 111.284 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.567 HD13 ' CA ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -52.88 132.61 15.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.527 -0.733 . . . . 0.0 109.991 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 33' ' ' VAL . . . -109.5 170.87 7.78 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 0.7 OUTLIER -115.78 134.29 55.17 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.73 -1.231 . . . . 0.0 110.552 -179.735 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.522 ' CG2' ' OE2' ' A' ' 80' ' ' GLU . 14.5 p -93.46 172.33 8.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.502 -0.749 . . . . 0.0 110.372 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -88.6 29.89 0.96 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.328 -0.857 . . . . 0.0 110.191 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.76 5.48 4.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.278 -0.889 . . . . 0.0 110.104 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.06 14.01 52.97 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.533 HG21 ' CG1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -110.87 -178.82 3.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.397 -1.061 . . . . 0.0 110.292 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.536 HG21 ' CD1' ' A' ' 103' ' ' TRP . 0.0 OUTLIER -137.44 152.69 27.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 178.605 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' A' ' 25' ' ' ALA . 52.9 t -118.15 130.92 72.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 121.051 -1.031 . . . . 0.0 112.357 -177.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.626 ' O ' ' HA ' ' A' ' 78' ' ' ASN . 0.3 OUTLIER -114.59 120.21 63.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.557 -0.715 . . . . 0.0 109.423 178.734 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.545 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -105.7 115.78 30.82 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.614 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.616 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.8 m -134.48 -170.74 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 C-N-CA 119.564 -0.854 . . . . 0.0 109.322 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.521 ' NE2' ' HE2' ' A' ' 19' ' ' LYS . 1.9 tt0 -132.42 127.32 35.11 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 14' ' ' CYS . 1.5 t80 -60.63 122.49 14.84 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 118.703 -1.199 . . . . 0.0 110.113 -178.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 17' ' ' LYS . 4.0 mt-10 -112.29 38.62 2.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -0.867 . . . . 0.0 109.193 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.569 ' HA3' ' CE1' ' A' ' 38' ' ' TYR . . . -125.16 -160.68 10.79 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 37.3 p-10 -135.1 85.59 2.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.516 -0.991 . . . . 0.0 110.277 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 43' ' ' SER . . . -147.83 10.04 1.21 Allowed Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.725 -1.226 . . . . 0.0 110.307 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.605 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER 46.67 -158.61 0.01 OUTLIER Pre-proline 0 N--CA 1.487 1.42 0 O-C-N 120.834 -1.392 . . . . 0.0 108.951 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.605 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 87.9 Cg_exo -43.49 95.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 122.72 0.853 . . . . 0.0 110.54 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 43' ' ' SER . 8.0 p -141.52 171.19 14.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.491 -0.756 . . . . 0.0 110.607 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.539 ' HG3' ' CD1' ' A' ' 69' ' ' ILE . 33.3 mttt -84.69 169.41 14.33 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.685 0.755 . . . . 0.0 111.627 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.589 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 12.7 mm -111.33 124.7 32.06 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.269 -0.894 . . . . 0.0 112.234 -177.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.604 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 34.5 Cg_exo -63.12 144.09 91.62 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.974 1.513 . . . . 0.0 110.815 178.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.617 ' CD2' ' CD2' ' A' ' 63' ' ' LEU . 7.6 t80 -154.97 158.88 39.89 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.299 -0.876 . . . . 0.0 110.142 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.477 ' HB3' ' HB ' ' A' ' 91' ' ' ILE . 23.9 tp10 -172.91 107.21 0.16 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.092 -1.005 . . . . 0.0 110.493 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.432 ' CD1' ' HB1' ' A' ' 81' ' ' ALA . 54.1 mt -99.11 94.78 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.885 . . . . 0.0 110.222 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.488 ' SD ' ' N ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -150.93 -66.78 0.19 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.207 -0.933 . . . . 0.0 110.181 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.419 ' O ' HD11 ' A' ' 91' ' ' ILE . 0.4 OUTLIER -177.53 -144.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.294 -0.879 . . . . 0.0 110.22 -179.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.79 -60.34 3.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.887 . . . . 0.0 110.192 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.504 ' O ' ' CG ' ' A' ' 56' ' ' LYS . 17.6 mt-10 -103.58 -77.14 0.57 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.0 110.212 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.504 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER 176.37 159.84 0.32 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.19 -0.944 . . . . 0.0 110.245 -179.956 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.488 ' N ' ' SD ' ' A' ' 52' ' ' MET . 0.4 OUTLIER 174.58 119.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.25 -0.906 . . . . 0.0 110.159 179.93 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.422 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 29.6 t60 63.53 152.54 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.925 . . . . 0.0 110.179 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.455 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 14.1 m -90.83 121.41 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 110.163 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 59' ' ' VAL . 24.6 mt -147.86 155.59 41.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -0.89 . . . . 0.0 110.262 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.521 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . 80.12 162.26 25.63 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.509 ' CB ' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -135.35 161.3 35.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.349 -1.089 . . . . 0.0 110.165 179.9 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.617 ' CD2' ' CD2' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -123.4 111.46 16.39 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.365 -0.835 . . . . 0.0 109.864 179.698 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.547 ' CB ' ' HG2' ' A' ' 80' ' ' GLU . 6.5 mm -70.55 -29.23 37.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 122.272 1.034 . . . . 0.0 108.297 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.632 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.257 0.7 OUTLIER -106.81 30.56 6.0 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.708 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.557 ' C ' ' O ' ' A' ' 65' ' ' THR . 39.3 t -13.04 111.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.281 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.519 ' ND2' ' HD3' ' A' ' 46' ' ' LYS . 12.6 t-20 43.43 69.32 2.39 Favored Pre-proline 0 C--N 1.298 -1.647 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.274 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.545 ' O ' ' N ' ' A' ' 47' ' ' ILE . 1.6 Cg_endo -52.19 -175.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.962 1.506 . . . . 0.0 109.319 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 68' ' ' PRO . 0.7 OUTLIER -142.7 142.67 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.961 -179.316 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.589 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 30.8 t -99.76 161.11 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.418 ' N ' HG13 ' A' ' 70' ' ' VAL . 5.6 m -115.65 -16.81 11.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.988 -1.07 . . . . 0.0 111.853 -178.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.522 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 14.1 mt-10 -141.3 19.42 2.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.665 -1.272 . . . . 0.0 111.687 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.566 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 0.0 OUTLIER 72.04 -6.37 1.52 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.15 -0.969 . . . . 0.0 111.103 179.73 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.484 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 4.9 t70 -137.8 -0.93 2.07 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.847 -1.158 . . . . 0.0 110.373 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.2 t -72.37 112.3 14.26 Favored Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 121.17 -0.956 . . . . 0.0 109.027 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 45.7 Cg_exo -49.22 126.69 16.03 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.885 1.466 . . . . 0.0 110.002 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.458 HG21 HG21 ' A' ' 70' ' ' VAL . 76.3 t -112.66 140.34 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.031 -1.043 . . . . 0.0 111.606 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.626 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.3 m120 -105.38 133.82 49.51 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.455 -0.778 . . . . 0.0 109.377 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.581 HG22 ' CE1' ' A' ' 49' ' ' PHE . 4.4 mt -118.15 119.97 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 119.984 -1.697 . . . . 0.0 111.609 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.547 ' HG2' ' CB ' ' A' ' 64' ' ' ILE . 1.6 tp10 -94.07 110.16 21.88 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.525 ' CB ' HD23 ' A' ' 63' ' ' LEU . . . -125.4 147.37 49.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.986 -1.071 . . . . 0.0 111.041 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.531 ' CA ' HG22 ' A' ' 31' ' ' THR . 3.0 tt0 -99.53 101.89 14.83 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 109.916 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.514 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 12.4 Cg_endo -61.11 143.83 99.01 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.012 1.533 . . . . 0.0 110.504 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.521 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 19.4 Cg_endo -64.14 -71.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.051 1.553 . . . . 0.0 110.334 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -177.89 151.23 0.68 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.164 -0.96 . . . . 0.0 110.281 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.08 -161.0 54.14 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -61.21 132.38 53.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -1.132 . . . . 0.0 110.23 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.24 122.89 22.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 110.244 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 12.3 m-85 -95.96 105.14 17.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.179 -0.951 . . . . 0.0 110.199 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.571 HG22 ' CZ ' ' A' ' 49' ' ' PHE . 1.4 mp -74.27 110.97 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.222 -0.924 . . . . 0.0 109.748 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.502 ' CG2' ' CD ' ' A' ' 98' ' ' GLN . 87.1 mt -92.1 142.18 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 110.152 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.55 ' CD1' HG22 ' A' ' 34' ' ' ILE . 3.6 mt -132.51 141.27 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.386 -0.821 . . . . 0.0 109.983 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.539 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 80.95 -156.7 38.41 Favored Glycine 0 N--CA 1.484 1.868 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 98' ' ' GLN . 0.2 OUTLIER -130.59 156.52 42.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.129 -1.218 . . . . 0.0 110.338 -179.548 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.509 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 3.0 mt-10 -30.33 -55.81 0.35 Allowed Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.849 -0.532 . . . . 0.0 110.848 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.509 ' CD ' ' CB ' ' A' ' 95' ' ' GLU . 73.4 Cg_exo -40.56 -36.98 1.97 Allowed 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.052 1.553 . . . . 0.0 110.686 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.562 ' HA3' ' CG ' ' A' ' 17' ' ' LYS . . . -164.71 49.04 0.29 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.557 ' N ' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -93.85 151.9 19.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.204 -1.174 . . . . 0.0 111.08 -178.57 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.527 HD11 ' CG2' ' A' ' 20' ' ' VAL . 13.6 mt -100.54 179.7 4.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.492 -0.755 . . . . 0.0 110.089 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -152.8 135.79 15.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.43 -0.794 . . . . 0.0 110.334 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.509 HD13 ' N ' ' A' ' 101' ' ' LEU . 5.2 mp -140.33 116.91 10.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.213 -0.93 . . . . 0.0 110.199 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 3.3 p-10 -87.82 120.26 28.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 0.0 110.318 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.563 ' CE3' HG22 ' A' ' 24' ' ' ILE . 50.7 t-105 -117.52 124.32 48.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.922 . . . . 0.0 110.227 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -72.35 123.14 22.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 110.176 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.426 ' HG2' ' HG2' ' A' ' 83' ' ' PRO . 0.1 OUTLIER -131.43 47.12 2.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 0.0 110.216 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.12 -60.34 2.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.293 -0.88 . . . . 0.0 110.163 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 149.68 -82.72 0.18 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.33 65.95 1.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -1.111 . . . . 0.0 110.208 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.5 p -144.81 -158.3 0.87 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.292 -0.88 . . . . 0.0 110.187 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 53.81 58.27 5.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.893 . . . . 0.0 110.238 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -97.13 56.74 1.41 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 0.0 110.246 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -75.25 -6.37 49.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.17 -0.956 . . . . 0.0 110.152 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -61.04 -63.66 1.22 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 110.228 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 62.7 22.8 13.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 110.176 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -92.56 127.66 38.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.869 . . . . 0.0 110.26 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -83.82 174.84 10.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.163 -0.96 . . . . 0.0 110.215 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.205 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ttm . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.258 0.552 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 47.37 61.0 3.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.205 -0.935 . . . . 0.0 110.17 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 4' ' ' LEU . 0.9 OUTLIER -140.61 110.94 6.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -0.883 . . . . 0.0 110.254 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 3' ' ' LYS . 3.4 mm? 50.92 101.85 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.326 -0.859 . . . . 0.0 110.213 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.42 ' HG2' ' C ' ' A' ' 4' ' ' LEU . 83.3 mm-40 -139.91 -45.17 0.43 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.238 -0.914 . . . . 0.0 110.285 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.55 128.28 35.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.897 . . . . 0.0 110.152 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.88 97.61 4.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.894 . . . . 0.0 110.257 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 10' ' ' SER . . . 179.96 94.72 0.1 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.451 ' O ' ' HB3' ' A' ' 10' ' ' SER . 0.0 OUTLIER 57.09 -82.02 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.385 -1.068 . . . . 0.0 110.298 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 8' ' ' GLY . 0.2 OUTLIER 60.62 158.3 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.268 -0.895 . . . . 0.0 110.168 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.603 ' CZ ' ' HB2' ' A' ' 44' ' ' PRO . 1.4 t80 -150.37 -74.74 0.16 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.166 -0.959 . . . . 0.0 109.905 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.529 ' HB3' ' HA ' ' A' ' 45' ' ' CYS . 3.9 t -142.15 -119.23 0.1 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.215 -0.928 . . . . 0.0 109.056 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.463 ' HG3' ' O ' ' A' ' 13' ' ' MET . 2.2 ptt? -179.6 95.56 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.569 -1.332 . . . . 0.0 110.655 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 20.3 m -60.49 94.17 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.527 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 0.5 OUTLIER -99.75 -1.14 38.5 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.021 -1.049 . . . . 0.0 112.363 -178.028 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.55 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -66.46 -108.12 0.01 OUTLIER Glycine 0 N--CA 1.493 2.44 0 C-N-CA 118.942 -1.599 . . . . 0.0 109.301 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.537 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -136.98 177.79 7.59 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.958 -1.319 . . . . 0.0 110.22 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.602 ' CZ ' ' HD2' ' A' ' 48' ' ' PRO . 26.7 m-85 -137.57 144.62 42.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.012 -1.055 . . . . 0.0 111.826 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.443 ' HB2' ' CG ' ' A' ' 39' ' ' GLU . 11.5 ttpt -114.54 117.84 32.05 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.702 -0.624 . . . . 0.0 109.411 179.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.517 ' CG2' HD11 ' A' ' 99' ' ' LEU . 46.1 t -59.66 132.45 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.78 -1.2 . . . . 0.0 108.958 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.522 ' CG2' ' HB2' ' A' ' 37' ' ' GLN . 73.6 t -106.84 -26.24 3.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.54 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 3.4 tttt -156.87 133.15 9.81 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -52.12 156.49 1.6 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.65 0.738 . . . . 0.0 111.374 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.573 HD13 ' CA ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -52.99 132.79 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.505 -0.747 . . . . 0.0 109.944 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 33' ' ' VAL . . . -109.62 170.9 7.77 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.5 pm0 -115.93 134.5 54.91 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.78 -1.2 . . . . 0.0 110.37 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.526 ' CG2' ' OE2' ' A' ' 80' ' ' GLU . 16.0 p -92.4 175.55 6.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.474 -0.766 . . . . 0.0 110.387 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -88.96 27.34 1.36 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.466 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -130.89 6.68 4.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.201 -0.937 . . . . 0.0 110.194 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.59 3.03 61.3 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.532 HG23 ' CA ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -96.65 -177.59 3.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.335 -1.097 . . . . 0.0 110.31 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.519 HG23 ' NE1' ' A' ' 103' ' ' TRP . 0.0 OUTLIER -138.88 153.84 25.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.668 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.495 ' N ' ' O ' ' A' ' 25' ' ' ALA . 55.5 t -119.78 130.68 73.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 O-C-N 121.003 -1.061 . . . . 0.0 112.41 -177.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.623 ' O ' ' HA ' ' A' ' 78' ' ' ASN . 0.3 OUTLIER -114.61 120.84 65.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 121.408 -0.807 . . . . 0.0 109.412 178.51 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.54 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -106.52 113.59 27.2 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.614 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.7 m -132.05 -169.78 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 C-N-CA 119.689 -0.805 . . . . 0.0 109.283 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.522 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 9.9 tt0 -134.83 127.66 31.23 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.606 ' CZ ' ' HB3' ' A' ' 14' ' ' CYS . 1.6 t80 -60.46 124.02 19.07 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 118.796 -1.161 . . . . 0.0 110.033 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.443 ' CG ' ' HB2' ' A' ' 19' ' ' LYS . 22.6 mm-40 -103.5 -22.23 13.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.243 -0.911 . . . . 0.0 109.25 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.55 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -64.94 -161.2 0.57 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.524 ' HA ' ' CD ' ' A' ' 73' ' ' LYS . 3.3 p-10 -143.21 93.98 2.56 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.598 -0.943 . . . . 0.0 110.054 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -150.92 15.24 0.9 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.606 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER 48.39 -160.0 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.366 0 O-C-N 121.033 -1.274 . . . . 0.0 109.298 179.422 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 85.7 Cg_exo -43.19 95.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 122.946 0.971 . . . . 0.0 110.622 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.53 ' SG ' ' CE2' ' A' ' 38' ' ' TYR . 11.6 p -140.94 170.92 14.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.536 -0.728 . . . . 0.0 110.637 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.548 ' HG3' ' CD1' ' A' ' 69' ' ' ILE . 20.7 mttt -87.32 165.71 15.42 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.438 -0.789 . . . . 0.0 111.413 -178.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.606 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 12.6 mm -108.64 124.87 33.12 Favored Pre-proline 0 C--N 1.303 -1.415 0 O-C-N 121.18 -0.95 . . . . 0.0 112.643 -177.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.602 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 34.7 Cg_exo -63.24 146.17 93.72 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 124.023 1.538 . . . . 0.0 110.436 178.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.635 ' CD2' ' CD2' ' A' ' 63' ' ' LEU . 10.2 t80 -155.22 160.22 40.69 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.147 -0.971 . . . . 0.0 110.6 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.518 ' O ' ' CD1' ' A' ' 91' ' ' ILE . 19.2 tp10 -177.69 115.49 0.09 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.307 -0.87 . . . . 0.0 110.212 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.46 ' O ' ' SD ' ' A' ' 52' ' ' MET . 43.4 mt -105.94 63.6 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.205 -0.934 . . . . 0.0 110.372 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.504 ' O ' ' N ' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -154.63 -67.17 0.13 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.14 -0.975 . . . . 0.0 110.262 179.831 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.457 ' OD2' HD11 ' A' ' 91' ' ' ILE . 0.6 OUTLIER 61.59 -73.83 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.296 -0.878 . . . . 0.0 110.595 179.815 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 52' ' ' MET . 0.3 OUTLIER -67.92 -7.46 28.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.206 -0.934 . . . . 0.0 110.427 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 52' ' ' MET . 1.5 tt0 -149.8 55.74 0.96 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.189 -0.944 . . . . 0.0 110.268 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.466 ' HD3' ' OE1' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -98.76 77.87 2.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.935 . . . . 0.0 110.301 -179.938 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 58' ' ' HIS . 5.9 ttt180 -109.92 -29.74 8.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.215 -0.928 . . . . 0.0 110.136 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.457 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 44.4 t-80 -177.54 -60.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.251 -0.906 . . . . 0.0 110.369 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.4 m -86.78 159.61 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.195 -0.941 . . . . 0.0 110.394 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 61' ' ' GLY . 0.9 OUTLIER -178.47 -173.68 0.35 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -0.867 . . . . 0.0 110.17 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 60' ' ' LEU . . . -51.39 -176.45 0.03 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.46 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -115.33 167.4 10.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -1.182 . . . . 0.0 110.039 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.635 ' CD2' ' CD2' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -130.93 110.76 11.5 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.387 -0.821 . . . . 0.0 109.916 179.672 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.534 ' CB ' ' HG2' ' A' ' 80' ' ' GLU . 4.9 mm -69.98 -25.6 28.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-O 122.15 0.976 . . . . 0.0 108.53 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.627 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.251 0.6 OUTLIER -110.95 30.1 7.17 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.658 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.559 ' C ' ' O ' ' A' ' 65' ' ' THR . 40.3 t -11.9 112.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.394 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.522 ' ND2' ' HD3' ' A' ' 46' ' ' LYS . 13.7 t-20 41.63 69.63 1.99 Allowed Pre-proline 0 C--N 1.299 -1.598 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.463 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.527 ' HG3' ' CG2' ' A' ' 65' ' ' THR . 1.4 Cg_endo -51.88 -174.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.886 1.466 . . . . 0.0 109.456 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.548 ' CD1' ' HG3' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -142.81 143.58 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 119.148 -1.021 . . . . 0.0 112.06 -179.136 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.606 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 22.2 t -101.91 159.6 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 176.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.3 m -116.67 -14.53 10.82 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.046 -1.062 . . . . 0.0 111.853 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 73' ' ' LYS . 19.6 mt-10 -142.0 22.51 2.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.619 -1.301 . . . . 0.0 111.756 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.58 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 0.8 OUTLIER 66.7 -1.57 1.29 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.095 -1.003 . . . . 0.0 111.087 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.455 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 9.7 t0 -142.47 -0.35 1.24 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.944 -1.098 . . . . 0.0 110.574 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.444 ' HB3' HG12 ' A' ' 70' ' ' VAL . 39.4 t -72.76 108.43 4.41 Favored Pre-proline 0 N--CA 1.486 1.344 0 O-C-N 120.977 -1.077 . . . . 0.0 109.218 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 2.3 Cg_endo -47.25 127.41 13.01 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.743 1.391 . . . . 0.0 109.684 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 58.7 t -115.46 143.43 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.954 -1.091 . . . . 0.0 111.611 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.623 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 4.0 m120 -106.18 134.12 49.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.551 -0.718 . . . . 0.0 109.525 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.582 HG23 ' CD1' ' A' ' 49' ' ' PHE . 4.2 mt -117.5 119.75 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 119.988 -1.695 . . . . 0.0 111.402 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.534 ' HG2' ' CB ' ' A' ' 64' ' ' ILE . 1.8 tp10 -95.24 110.74 22.68 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.509 ' CB ' HD23 ' A' ' 63' ' ' LEU . . . -126.46 150.1 48.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.077 -1.014 . . . . 0.0 111.004 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.532 ' CA ' HG23 ' A' ' 31' ' ' THR . 9.6 tp10 -101.83 101.68 19.45 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.354 -0.841 . . . . 0.0 110.127 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.519 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 20.3 Cg_endo -66.71 144.56 72.28 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.08 1.568 . . . . 0.0 110.427 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.452 ' O ' ' HB3' ' A' ' 85' ' ' PHE . 15.1 Cg_endo -62.8 -74.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 124.052 1.554 . . . . 0.0 110.327 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.452 ' HB3' ' O ' ' A' ' 84' ' ' PRO . 17.5 p90 177.21 154.42 0.26 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.913 . . . . 0.0 110.282 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.443 ' HA2' ' HB2' ' A' ' 106' ' ' LYS . . . 78.24 -161.68 49.04 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -64.77 140.92 58.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -1.147 . . . . 0.0 110.12 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -149.31 159.0 44.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.352 -0.842 . . . . 0.0 110.243 -179.842 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.521 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 8.1 m-85 -132.2 108.14 9.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.325 -0.859 . . . . 0.0 110.153 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.578 HG21 ' CZ ' ' A' ' 49' ' ' PHE . 1.3 mp -74.16 108.39 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -0.906 . . . . 0.0 109.482 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.518 ' CD1' ' O ' ' A' ' 50' ' ' GLU . 7.0 mt -92.09 142.37 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.131 -0.98 . . . . 0.0 110.42 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.547 ' CD1' HG21 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -129.61 138.26 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.545 -0.722 . . . . 0.0 109.521 -179.905 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.52 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 86.06 -161.87 34.9 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.554 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -121.89 148.38 25.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 O-C-N 121.264 -1.139 . . . . 0.0 110.129 -179.721 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.571 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -18.07 -58.02 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.145 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 9.3 Cg_endo -52.62 70.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 124.198 1.631 . . . . 0.0 112.148 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 91.34 2.89 70.08 Favored Glycine 0 N--CA 1.495 2.584 0 O-C-N 120.875 -1.141 . . . . 0.0 110.912 178.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.508 ' HB2' ' N ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -51.64 159.12 0.82 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.965 -1.315 . . . . 0.0 110.229 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.517 HD11 ' CG2' ' A' ' 20' ' ' VAL . 5.7 mt -96.24 174.68 6.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.224 -0.922 . . . . 0.0 110.297 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.454 ' C ' ' CD1' ' A' ' 101' ' ' LEU . 3.8 ttmt -152.71 143.09 22.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.34 -0.85 . . . . 0.0 110.328 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.524 HD23 ' CG1' ' A' ' 34' ' ' ILE . 5.6 mp -144.59 113.45 6.79 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.168 -0.957 . . . . 0.0 110.222 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 9.8 t-20 -79.64 131.18 35.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.243 -0.91 . . . . 0.0 110.334 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.519 ' NE1' HG23 ' A' ' 32' ' ' ILE . 32.5 t-105 -127.73 123.87 36.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 0.0 110.196 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -82.9 128.02 34.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 0.0 110.285 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.15 47.88 1.6 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.138 -0.976 . . . . 0.0 110.232 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.443 ' HB2' ' HA2' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -115.67 138.41 51.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.256 -0.902 . . . . 0.0 110.179 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.28 -149.82 16.97 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.39 -46.54 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.27 -1.135 . . . . 0.0 110.221 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 109' ' ' SER . 3.9 t -171.68 29.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.169 -0.957 . . . . 0.0 110.247 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.41 35.25 2.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.905 . . . . 0.0 110.167 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.46 161.18 16.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 110.267 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 47.5 87.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 110.24 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.97 -179.94 4.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.925 . . . . 0.0 110.141 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -143.94 -73.5 0.27 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.237 -0.915 . . . . 0.0 110.135 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 62.09 -150.39 0.37 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 110.254 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.427 ' O ' ' O ' ' A' ' 117' ' ' HIS . 9.3 t60 -85.83 -15.7 41.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.321 -0.862 . . . . 0.0 110.219 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.427 ' O ' ' O ' ' A' ' 116' ' ' HIS . 36.7 t-80 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.146 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.4 mtm . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.272 0.558 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 36.7 p-10 -82.58 -165.84 1.14 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.208 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER -119.8 22.17 11.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.302 -0.874 . . . . 0.0 110.229 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.477 ' O ' ' CB ' ' A' ' 5' ' ' GLN . 0.5 OUTLIER -43.17 146.78 0.4 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.231 -0.918 . . . . 0.0 110.244 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.477 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER 171.28 56.4 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -0.923 . . . . 0.0 110.197 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 10' ' ' SER . 0.7 OUTLIER -54.24 -57.69 10.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.217 -0.927 . . . . 0.0 110.098 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -6.14 47.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.9 . . . . 0.0 110.062 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.67 -25.97 63.97 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.469 ' O ' ' O ' ' A' ' 10' ' ' SER . 13.4 mtm -140.15 -91.43 0.17 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -1.169 . . . . 0.0 110.23 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.487 ' HA ' ' CE ' ' A' ' 46' ' ' LYS . 8.1 t 56.09 161.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.2 -0.938 . . . . 0.0 110.147 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -92.37 -72.89 0.57 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.137 -0.977 . . . . 0.0 110.137 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.461 ' O ' ' HB3' ' A' ' 13' ' ' MET . 3.1 t -136.28 -6.89 2.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.086 -1.009 . . . . 0.0 111.067 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.511 ' HG2' ' CG2' ' A' ' 15' ' ' THR . 4.2 ttp 55.98 81.59 0.12 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.952 -1.093 . . . . 0.0 108.683 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.587 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 35.8 m -56.39 101.54 0.06 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.483 -0.761 . . . . 0.0 109.491 -178.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.534 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 39.6 p -95.79 -5.8 41.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 111.652 -178.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.554 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -61.21 -117.65 0.01 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.542 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -138.51 173.08 11.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.956 -1.32 . . . . 0.0 110.139 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.589 ' CE1' ' HD2' ' A' ' 48' ' ' PRO . 30.8 m-85 -132.69 141.51 48.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.012 -1.055 . . . . 0.0 111.693 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.464 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 14.9 ttpt -110.51 119.84 40.47 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.627 -0.67 . . . . 0.0 109.444 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.514 ' N ' HD12 ' A' ' 99' ' ' LEU . 31.4 t -60.23 132.74 25.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 120.91 -1.119 . . . . 0.0 109.205 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.515 ' N ' ' HA ' ' A' ' 36' ' ' VAL . 90.1 t -106.04 -27.12 3.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.565 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 14.1 tttt -156.96 133.45 9.95 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -51.26 160.17 0.57 Allowed 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.702 0.763 . . . . 0.0 111.72 -178.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.565 HD11 ' CA ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -57.93 133.45 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 CA-C-O 121.579 0.704 . . . . 0.0 110.248 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' A' ' 33' ' ' VAL . . . -112.05 158.35 19.68 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.6 pm0 -110.67 132.77 53.91 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 120.295 -1.503 . . . . 0.0 110.27 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.53 ' CG2' ' OE2' ' A' ' 80' ' ' GLU . 1.8 p -91.21 175.44 6.94 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.163 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -80.8 -16.7 53.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.238 -0.914 . . . . 0.0 110.495 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -80.6 1.53 29.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 0.0 110.292 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.92 9.33 61.03 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.527 HG21 ' CA ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -98.31 174.8 6.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -1.097 . . . . 0.0 110.395 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.517 ' CG2' HG22 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -129.22 142.96 42.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.621 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.548 ' N ' ' O ' ' A' ' 25' ' ' ALA . 26.7 t -110.91 131.1 63.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 O-C-N 121.388 -0.82 . . . . 0.0 111.775 -177.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.632 ' O ' ' HA ' ' A' ' 78' ' ' ASN . 0.3 OUTLIER -119.34 121.3 66.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.456 -0.777 . . . . 0.0 109.349 178.809 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.565 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -106.14 111.62 24.31 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.737 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.62 ' CG1' ' CD1' ' A' ' 34' ' ' ILE . 1.5 m -131.44 -167.92 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.175 -178.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.441 ' NE2' ' HE2' ' A' ' 19' ' ' LYS . 10.6 tt0 -135.59 129.25 32.63 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.579 ' CE2' ' SG ' ' A' ' 14' ' ' CYS . 1.7 t80 -60.2 122.33 14.19 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 118.544 -1.262 . . . . 0.0 110.361 -178.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.464 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 4.6 mt-10 -112.05 39.26 2.45 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.453 -0.779 . . . . 0.0 108.973 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.576 ' HA3' ' CE1' ' A' ' 38' ' ' TYR . . . -133.06 -160.64 9.56 Favored Glycine 0 N--CA 1.484 1.894 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.46 ' HA ' ' HD2' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -121.98 141.9 50.86 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.537 -0.978 . . . . 0.0 110.267 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 154.92 -11.43 0.43 Allowed Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.857 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.607 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.7 OUTLIER 54.88 -153.29 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 120.542 -1.563 . . . . 0.0 108.119 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.607 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 83.1 Cg_exo -41.83 97.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.322 -0.864 0 N-CA-C 108.904 -1.229 . . . . 0.0 108.904 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.587 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -145.89 170.82 15.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.794 -0.567 . . . . 0.0 109.958 -177.647 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.582 ' CG ' ' CD1' ' A' ' 69' ' ' ILE . 33.8 mttm -87.29 176.11 7.7 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.417 -0.802 . . . . 0.0 111.653 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.61 ' CD1' ' CG2' ' A' ' 70' ' ' VAL . 16.2 mm -122.47 129.05 25.21 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.305 -0.872 . . . . 0.0 112.405 -178.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.589 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 24.8 Cg_exo -67.47 146.55 74.82 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.689 1.593 . . . . 0.0 111.246 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.629 ' CD2' ' CD2' ' A' ' 63' ' ' LEU . 9.7 t80 -155.53 154.55 31.93 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.419 -0.8 . . . . 0.0 109.741 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.528 ' HG2' ' CD1' ' A' ' 91' ' ' ILE . 0.3 OUTLIER -164.14 125.26 2.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.842 -1.161 . . . . 0.0 110.661 179.666 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.591 ' CG2' ' CB ' ' A' ' 87' ' ' ASP . 11.1 mt -123.91 123.3 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.493 -0.754 . . . . 0.0 109.842 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.484 ' O ' ' N ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -129.41 -58.31 1.12 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.187 -0.946 . . . . 0.0 110.379 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' A' ' 52' ' ' MET . 25.5 t0 66.56 -67.48 0.16 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.254 -0.904 . . . . 0.0 110.12 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 52' ' ' MET . 1.7 tt -44.66 -69.19 0.14 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 110.073 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.535 ' O ' ' CB ' ' A' ' 56' ' ' LYS . 13.2 tt0 -142.11 -81.63 0.21 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.261 -0.899 . . . . 0.0 109.965 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER 166.3 35.97 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.38 -0.825 . . . . 0.0 110.134 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.574 ' O ' ' CG ' ' A' ' 58' ' ' HIS . 6.2 mtp85 -146.58 26.75 1.14 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.201 -0.937 . . . . 0.0 110.418 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.574 ' CG ' ' O ' ' A' ' 57' ' ' ARG . 4.4 m-70 -165.8 105.65 0.71 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.938 . . . . 0.0 110.408 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.3 p -76.88 97.81 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.317 -0.864 . . . . 0.0 110.022 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.459 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 0.6 OUTLIER -103.07 16.84 25.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 110.387 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.537 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -110.5 172.68 15.64 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.491 ' CB ' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -122.85 165.99 15.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.174 -1.192 . . . . 0.0 110.433 -179.866 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.629 ' CD2' ' CD2' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -131.8 111.27 11.48 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.701 179.269 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.546 ' CB ' ' HG2' ' A' ' 80' ' ' GLU . 5.2 mm -69.13 -30.26 45.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-O 122.126 0.965 . . . . 0.0 108.576 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.612 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.253 0.6 OUTLIER -104.98 29.92 5.94 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.554 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.556 ' C ' ' O ' ' A' ' 65' ' ' THR . 48.0 t -12.65 110.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.247 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.474 ' ND2' ' HD3' ' A' ' 46' ' ' LYS . 19.6 t-20 44.23 69.1 2.62 Favored Pre-proline 0 C--N 1.299 -1.612 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.048 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.535 ' HG3' ' CG2' ' A' ' 65' ' ' THR . 2.3 Cg_endo -50.18 -178.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 124.033 1.544 . . . . 0.0 109.474 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.582 ' CD1' ' CG ' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -140.71 143.93 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 119.183 -1.007 . . . . 0.0 112.104 -178.89 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.61 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 20.2 t -99.78 170.33 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.413 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 5.2 m -126.73 -17.2 5.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.959 -1.088 . . . . 0.0 111.173 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 7.4 mt-10 -140.01 15.67 2.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.944 -1.097 . . . . 0.0 110.918 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 11.4 ttpp 73.59 -7.11 1.63 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.307 -0.871 . . . . 0.0 110.781 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.458 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 5.3 t70 -137.68 1.46 2.34 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.024 -1.048 . . . . 0.0 110.096 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.419 ' HA ' ' HD2' ' A' ' 76' ' ' PRO . 12.4 t -72.74 108.28 4.21 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 121.128 -0.982 . . . . 0.0 108.921 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.574 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 1.9 Cg_endo -47.52 130.19 17.7 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.801 1.421 . . . . 0.0 110.071 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 35' ' ' ARG . 60.1 t -118.01 145.43 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.022 -1.049 . . . . 0.0 111.415 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.632 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 3.9 m120 -105.6 134.53 48.56 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.511 -0.743 . . . . 0.0 109.537 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.578 HG22 ' CE1' ' A' ' 49' ' ' PHE . 3.4 mt -117.88 119.89 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 119.953 -1.717 . . . . 0.0 111.358 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.546 ' HG2' ' CB ' ' A' ' 64' ' ' ILE . 2.4 tp10 -95.45 106.86 18.97 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . . . -112.19 147.39 36.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.09 -1.006 . . . . 0.0 110.655 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.527 ' CA ' HG21 ' A' ' 31' ' ' THR . 3.0 tt0 -113.2 53.89 0.53 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.408 -0.807 . . . . 0.0 110.932 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.537 ' HA ' ' CA ' ' A' ' 61' ' ' GLY . 23.1 Cg_endo -66.16 159.74 48.21 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 123.675 1.355 . . . . 0.0 110.402 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 60' ' ' LEU . 11.5 Cg_endo -60.58 84.6 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.948 1.499 . . . . 0.0 109.827 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.422 ' CB ' ' O ' ' A' ' 84' ' ' PRO . 0.2 OUTLIER 65.19 -168.58 0.21 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.273 -0.892 . . . . 0.0 109.856 -179.495 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 105' ' ' LYS . . . -54.64 109.27 1.16 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.591 ' CB ' ' CG2' ' A' ' 51' ' ' ILE . 7.6 p-10 -84.32 41.48 0.83 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.359 -1.083 . . . . 0.0 110.216 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.532 ' O ' ' N ' ' A' ' 103' ' ' TRP . 31.3 p 39.68 -121.06 0.34 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.409 -0.807 . . . . 0.0 111.089 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 24.6 m-85 -78.19 100.75 6.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.877 -1.14 . . . . 0.0 111.853 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.526 ' CG2' HD13 ' A' ' 101' ' ' LEU . 0.7 OUTLIER -74.46 168.25 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.017 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.528 ' CD1' ' HG2' ' A' ' 50' ' ' GLU . 94.7 mt -131.21 143.36 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.318 -1.489 . . . . 0.0 111.868 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.552 ' CD1' HG21 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -133.96 138.06 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.502 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.532 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 86.18 -158.96 32.07 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.541 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -123.89 149.53 28.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 O-C-N 121.061 -1.258 . . . . 0.0 110.411 -179.462 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.571 ' O ' ' N ' ' A' ' 97' ' ' GLY . 5.4 mt-10 -20.35 -57.39 0.07 OUTLIER Pre-proline 0 N--CA 1.501 2.078 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.563 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 9.7 Cg_endo -53.9 70.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 124.108 1.583 . . . . 0.0 111.898 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 91.42 6.75 65.9 Favored Glycine 0 N--CA 1.494 2.512 0 O-C-N 120.967 -1.083 . . . . 0.0 110.896 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.502 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -52.42 161.21 0.71 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.972 -1.31 . . . . 0.0 110.019 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.527 ' CD1' ' O ' ' A' ' 18' ' ' PHE . 4.9 mt -95.77 170.06 9.58 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.189 -0.944 . . . . 0.0 110.773 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -152.61 142.74 22.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.5 -0.75 . . . . 0.0 109.722 179.573 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.526 HD13 ' CG2' ' A' ' 90' ' ' ILE . 4.0 mp -138.89 117.68 12.32 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.98 -1.075 . . . . 0.0 110.878 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -59.92 146.26 42.93 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.283 -0.886 . . . . 0.0 110.201 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.532 ' N ' ' O ' ' A' ' 88' ' ' SER . 9.1 t-105 -167.84 58.64 0.07 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.212 -0.93 . . . . 0.0 110.417 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.521 ' O ' ' N ' ' A' ' 106' ' ' LYS . 6.9 t80 -63.28 110.05 1.76 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.119 -0.988 . . . . 0.0 110.535 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.471 ' O ' ' HA3' ' A' ' 86' ' ' GLY . 0.9 OUTLIER 56.39 -81.83 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.416 -0.803 . . . . 0.0 110.616 179.72 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 104' ' ' PHE . 0.5 OUTLIER -169.41 -65.34 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.149 -0.969 . . . . 0.0 110.227 -179.827 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 160.63 -92.26 0.11 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 108' ' ' SER . 38.0 p -107.62 94.28 5.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.234 -1.157 . . . . 0.0 110.247 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.63 108.47 10.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.892 . . . . 0.0 110.206 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.11 30.27 6.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 110.177 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.18 -39.86 0.09 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 110.208 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.426 ' O ' ' HB3' ' A' ' 113' ' ' HIS . 1.3 t60 -95.54 122.02 37.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.878 . . . . 0.0 110.196 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.44 ' O ' ' HB3' ' A' ' 114' ' ' HIS . 49.8 p-80 -176.37 -151.36 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.202 -0.936 . . . . 0.0 110.2 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.44 ' HB3' ' O ' ' A' ' 113' ' ' HIS . 8.6 p-80 179.39 -173.94 0.2 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.277 -0.889 . . . . 0.0 110.189 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.403 ' O ' ' CB ' ' A' ' 116' ' ' HIS . 43.9 m-70 -145.59 -89.54 0.1 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.195 -0.941 . . . . 0.0 110.258 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.403 ' CB ' ' O ' ' A' ' 115' ' ' HIS . 0.1 OUTLIER 173.73 134.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.931 . . . . 0.0 110.186 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.231 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 20.7 m . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.471 ' O ' ' O ' ' A' ' 16' ' ' GLY . 5.9 t -88.79 -6.82 57.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.138 -0.976 . . . . 0.0 111.755 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.518 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -61.2 -129.74 0.01 OUTLIER Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.531 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -125.09 177.99 5.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.228 -1.16 . . . . 0.0 110.008 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.04 ' CE2' HG23 ' A' ' 47' ' ' ILE . 33.0 m-85 -135.36 142.85 45.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.925 -1.11 . . . . 0.0 111.638 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.478 ' HE2' ' HB3' ' A' ' 37' ' ' GLN . 37.6 ttpt -113.43 117.68 32.4 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.644 ' CG2' HD13 ' A' ' 99' ' ' LEU . 54.9 t -59.3 124.54 13.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 120.659 -1.276 . . . . 0.0 109.501 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.633 HG23 ' HA ' ' A' ' 36' ' ' VAL . 70.3 t -98.07 -29.62 3.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.647 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 0.5 OUTLIER -150.46 138.05 19.78 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.391 0.615 . . . . 0.0 109.887 177.619 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -56.15 153.43 9.22 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.297 0.57 . . . . 0.0 110.261 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.722 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -49.35 131.3 7.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.109 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.878 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -108.47 172.1 7.04 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 16.8 pt-20 -113.0 130.67 56.05 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.881 -1.137 . . . . 0.0 110.335 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.51 ' O ' ' CB ' ' A' ' 28' ' ' GLN . 17.5 p -74.99 0.41 15.96 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.461 -0.774 . . . . 0.0 110.292 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.51 ' CB ' ' O ' ' A' ' 27' ' ' THR . 0.5 OUTLIER 70.03 10.69 7.49 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.302 -0.874 . . . . 0.0 110.131 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.42 11.55 6.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.918 . . . . 0.0 110.292 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.456 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 110.17 -20.19 26.33 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.912 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -92.1 -174.27 3.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.224 -1.162 . . . . 0.0 110.476 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.878 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -148.38 160.24 6.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.745 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.698 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 99.0 t -123.58 131.54 72.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 C-N-CA 118.982 -1.087 . . . . 0.0 111.752 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.141 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -114.91 114.29 46.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.431 -0.793 . . . . 0.0 109.741 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.647 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -95.27 125.79 40.15 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.058 -1.026 . . . . 0.0 108.467 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.698 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.8 m -150.13 159.11 5.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.274 -0.891 . . . . 0.0 108.609 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.485 ' N ' HG23 ' A' ' 21' ' ' VAL 0.26 25.6 tt0 -103.85 124.7 49.43 Favored 'General case' 0 C--N 1.27 -2.872 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -179.165 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 1.02 ' HB2' HG21 ' A' ' 70' ' ' VAL . 1.2 t80 -60.75 122.35 14.58 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 119.016 -1.074 . . . . 0.0 110.509 -178.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 17' ' ' LYS . 23.1 mm-40 -106.87 152.06 24.4 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.374 -0.829 . . . . 0.0 108.921 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.519 ' O ' ' CE ' ' A' ' 73' ' ' LYS . . . 105.7 -145.75 15.97 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.455 ' O ' ' OH ' ' A' ' 38' ' ' TYR . 0.5 OUTLIER -130.4 127.95 40.38 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.525 -0.986 . . . . 0.0 109.942 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.04 -29.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.331 -1.414 . . . . 0.0 110.854 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.632 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.4 OUTLIER 56.39 -154.09 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 120.621 -1.517 . . . . 0.0 108.224 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.632 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 44.9 Cg_exo -52.23 89.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 N-CA-C 109.811 -0.88 . . . . 0.0 109.811 179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.748 ' O ' HG23 ' A' ' 69' ' ' ILE . 10.0 p -142.12 174.57 10.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.928 . . . . 0.0 110.636 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.632 ' HG3' ' CD1' ' A' ' 69' ' ' ILE . 2.3 mtpt -87.73 162.49 17.02 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.041 0.924 . . . . 0.0 111.915 -178.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.04 HG23 ' CE2' ' A' ' 18' ' ' PHE . 14.9 mm -105.44 124.24 36.97 Favored Pre-proline 0 C--N 1.3 -1.546 0 O-C-N 121.635 -0.665 . . . . 0.0 111.487 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.626 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 31.4 Cg_exo -62.14 145.12 96.48 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.064 1.56 . . . . 0.0 110.746 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.939 ' CD2' HG21 ' A' ' 79' ' ' ILE . 5.0 t80 -153.76 154.26 33.7 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.495 -0.753 . . . . 0.0 109.187 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.624 ' O ' HG23 ' A' ' 51' ' ' ILE . 18.3 tt0 -157.51 115.4 3.11 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.884 -1.135 . . . . 0.0 110.335 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.687 HG22 ' HA ' ' A' ' 90' ' ' ILE . 19.4 pt . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.537 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.493 2.471 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.53 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -131.49 166.89 20.34 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.18 -1.188 . . . . 0.0 110.515 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.676 HD12 ' N ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -121.87 121.02 36.2 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.301 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.912 HG12 HG21 ' A' ' 31' ' ' THR . 1.6 mp -85.98 -27.42 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 106.706 -1.591 . . . . 0.0 106.706 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.843 HG22 ' O ' ' A' ' 65' ' ' THR 0.255 3.0 m -110.75 42.8 1.53 Allowed 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.338 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.676 ' N ' HD12 ' A' ' 63' ' ' LEU . 6.7 t -30.94 133.06 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 121.275 0.56 . . . . 0.0 111.021 -178.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.673 ' CG ' HG12 ' A' ' 66' ' ' VAL . 0.4 OUTLIER 27.52 74.92 0.35 Allowed Pre-proline 0 N--CA 1.488 1.458 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.575 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.546 ' O ' ' HA ' ' A' ' 46' ' ' LYS . 8.4 Cg_endo -60.8 -171.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.707 1.372 . . . . 0.0 108.851 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.748 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.8 OUTLIER -142.79 144.49 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.816 -1.177 . . . . 0.0 112.227 -179.157 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.02 HG21 ' HB2' ' A' ' 38' ' ' TYR . 43.7 t -100.66 156.76 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 175.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.8 m -111.28 -20.8 12.17 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.791 -1.164 . . . . 0.0 111.224 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 7.4 mt-10 -132.25 15.9 4.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.842 -1.161 . . . . 0.0 111.244 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.522 ' O ' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER 71.63 -4.18 1.96 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.259 -0.901 . . . . 0.0 110.87 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.482 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 5.5 t70 -137.31 -0.04 2.26 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.885 -1.134 . . . . 0.0 110.26 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.685 ' O ' HG23 ' A' ' 77' ' ' VAL . 33.9 t -73.07 112.24 14.74 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.244 -0.91 . . . . 0.0 109.248 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 74' ' ' ASP . 33.2 Cg_exo -51.38 112.87 0.91 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.783 1.412 . . . . 0.0 109.738 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.944 HG21 HG22 ' A' ' 70' ' ' VAL . 59.9 t -102.1 130.74 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.322 -0.861 . . . . 0.0 111.516 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.649 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 12.0 m-80 -93.12 135.26 34.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.401 -0.812 . . . . 0.0 108.972 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.939 HG21 ' CD2' ' A' ' 49' ' ' PHE . 6.1 mt -114.53 117.26 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 117.69 -1.604 . . . . 0.0 111.979 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.685 ' HG3' HG22 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -86.03 114.14 22.67 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.333 179.362 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.693 ' C ' HG22 ' A' ' 31' ' ' THR . . . -133.45 153.28 51.74 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.024 -1.048 . . . . 0.0 110.505 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 0.8 OUTLIER -101.56 101.95 19.91 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.186 -0.946 . . . . 0.0 110.425 -179.611 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.562 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 33.7 Cg_endo -70.57 142.41 44.31 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.127 1.593 . . . . 0.0 110.325 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.537 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 32.3 Cg_endo . . . . . 0 C--N 1.304 -1.796 0 O-C-N 124.09 1.574 . . . . 0.0 110.348 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 19.9 m-85 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.097 0.475 . . . . 0.0 109.963 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.687 ' HA ' HG22 ' A' ' 51' ' ' ILE . 2.2 mt -73.9 133.74 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 109.544 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.588 HD12 ' HG2' ' A' ' 50' ' ' GLU . 84.6 mt -106.2 134.62 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.908 -1.12 . . . . 0.0 110.583 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.141 HD11 HG21 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -124.21 144.87 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.492 -0.755 . . . . 0.0 109.569 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.547 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 82.68 -162.67 41.56 Favored Glycine 0 N--CA 1.482 1.714 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.555 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -119.78 146.88 23.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 O-C-N 121.257 -1.143 . . . . 0.0 109.932 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.569 ' O ' ' N ' ' A' ' 97' ' ' GLY . 3.9 mt-10 -17.85 -58.22 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.181 0 N-CA-C 111.655 0.242 . . . . 0.0 111.655 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 10.0 Cg_endo -53.17 71.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 124.112 1.585 . . . . 0.0 111.962 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 92.73 1.59 67.96 Favored Glycine 0 N--CA 1.495 2.605 0 O-C-N 120.97 -1.082 . . . . 0.0 111.04 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.499 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -50.04 160.81 0.31 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.895 -1.356 . . . . 0.0 109.839 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.644 HD13 ' CG2' ' A' ' 20' ' ' VAL . 8.7 mt -98.96 175.78 5.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.102 -0.999 . . . . 0.0 111.053 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.695 ' C ' HD12 ' A' ' 101' ' ' LEU . 0.8 OUTLIER -154.72 137.5 15.3 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.559 -0.713 . . . . 0.0 109.811 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.801 ' N ' HD12 ' A' ' 101' ' ' LEU . 2.0 mp -143.33 125.54 15.5 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.094 -1.004 . . . . 0.0 110.527 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.506 ' HB2' ' CD1' ' A' ' 89' ' ' TYR . 32.4 t30 -90.35 133.79 34.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.286 -0.884 . . . . 0.0 110.403 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.648 ' CE3' HG22 ' A' ' 24' ' ' ILE . 60.5 t-105 . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.353 -0.842 . . . . 0.0 110.31 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.633 ' SG ' HD13 ' A' ' 47' ' ' ILE . 32.7 m . . . . . 0 N--CA 1.486 1.331 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.469 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 0.9 OUTLIER -126.6 -17.08 5.14 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.528 -1.357 . . . . 0.0 111.965 -178.468 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.573 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -59.77 -117.1 0.01 OUTLIER Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.4 -1.381 . . . . 0.0 109.786 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.535 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -135.35 -179.9 5.92 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.963 -1.316 . . . . 0.0 110.324 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.977 ' CE1' HG23 ' A' ' 47' ' ' ILE . 31.0 m-85 -136.57 149.67 48.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.04 -1.038 . . . . 0.0 111.851 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.455 ' HB2' ' CG ' ' A' ' 39' ' ' GLU . 17.6 ttpt -116.6 118.76 33.49 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.655 -0.653 . . . . 0.0 109.557 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.5 ' CG2' HD13 ' A' ' 99' ' ' LEU . 51.3 t -59.63 131.52 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.784 -1.198 . . . . 0.0 108.772 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.605 HG23 ' HA ' ' A' ' 36' ' ' VAL . 76.8 t -105.62 -26.44 3.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.562 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 12.5 tttt -157.53 133.34 9.3 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -52.47 155.39 2.15 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.535 0.683 . . . . 0.0 111.243 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.679 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -49.76 133.22 8.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 C-N-CA 119.996 -0.681 . . . . 0.0 109.957 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.867 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -108.24 171.52 7.36 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.2 pm0 -116.91 132.62 56.65 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.87 -1.144 . . . . 0.0 110.454 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.861 HG21 ' CD ' ' A' ' 80' ' ' GLU . 13.7 p -90.57 179.61 5.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.334 -0.854 . . . . 0.0 110.127 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -93.25 29.86 1.81 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -0.93 . . . . 0.0 110.379 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.53 6.89 3.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 110.357 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.427 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 95.64 5.56 60.04 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.89 HG22 ' C ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -98.86 -173.1 2.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.316 -1.108 . . . . 0.0 110.135 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.867 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -144.33 159.42 15.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.629 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.8 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 85.5 t -125.28 128.72 72.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 O-C-N 120.864 -1.148 . . . . 0.0 112.457 -177.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.986 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -110.81 118.16 56.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.379 -0.826 . . . . 0.0 109.476 178.672 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -103.77 114.76 29.26 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.806 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.8 m -133.95 -172.15 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.223 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.535 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 10.9 tt0 -132.37 126.79 34.05 Favored 'General case' 0 C--N 1.276 -2.615 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 1.021 ' HB2' HG21 ' A' ' 70' ' ' VAL . 1.5 t80 -60.55 123.99 19.03 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 118.716 -1.194 . . . . 0.0 109.92 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.455 ' CG ' ' HB2' ' A' ' 19' ' ' LYS . 43.4 mm-40 -103.65 -21.95 13.65 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.124 -0.985 . . . . 0.0 109.156 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.573 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -67.17 -164.85 2.25 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.511 ' HA ' ' HG3' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -137.63 94.04 2.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.578 -0.954 . . . . 0.0 109.976 179.716 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 43' ' ' SER . . . -149.12 12.19 1.06 Allowed Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.348 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.606 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.3 OUTLIER 47.31 -158.65 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.352 0 O-C-N 120.788 -1.419 . . . . 0.0 109.127 179.491 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.606 ' HD2' ' CB ' ' A' ' 43' ' ' SER . 89.2 Cg_exo -42.86 94.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 122.87 0.931 . . . . 0.0 110.186 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.889 ' O ' HG23 ' A' ' 69' ' ' ILE . 25.7 p -143.13 163.77 31.96 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.742 -0.599 . . . . 0.0 109.566 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.594 ' HA ' ' O ' ' A' ' 68' ' ' PRO . 1.6 mttt -86.65 156.9 19.81 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.027 -1.046 . . . . 0.0 111.428 -178.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.01 ' CD1' HG23 ' A' ' 70' ' ' VAL . 11.3 mm -99.72 125.07 41.85 Favored Pre-proline 0 C--N 1.294 -1.83 0 O-C-N 121.474 -0.766 . . . . 0.0 111.808 -177.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.618 ' HD2' ' CE2' ' A' ' 18' ' ' PHE . 33.2 Cg_exo -60.85 148.17 93.08 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.223 1.644 . . . . 0.0 111.046 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.928 ' CD2' HG21 ' A' ' 79' ' ' ILE . 4.9 t80 -154.22 151.54 29.28 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.487 -0.758 . . . . 0.0 109.582 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.493 ' HB3' ' HB ' ' A' ' 91' ' ' ILE . 3.8 tp10 -162.76 113.59 1.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.806 -1.184 . . . . 0.0 110.761 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.572 HD11 ' HE1' ' A' ' 49' ' ' PHE . 31.9 mt . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.388 -0.82 . . . . 0.0 109.744 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.522 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.529 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -131.3 170.51 14.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -1.148 . . . . 0.0 110.465 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.87 HD21 ' CD1' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -124.19 121.63 35.61 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.553 -0.717 . . . . 0.0 109.678 179.314 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.822 HG12 HG21 ' A' ' 31' ' ' THR . 1.5 mp -85.11 -24.47 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.801 HG22 ' O ' ' A' ' 65' ' ' THR 0.258 2.9 m -115.29 38.43 3.23 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.705 HG12 ' OD1' ' A' ' 67' ' ' ASN . 10.5 t -25.41 132.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 121.347 0.594 . . . . 0.0 111.5 -178.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.705 ' OD1' HG12 ' A' ' 66' ' ' VAL . 0.4 OUTLIER 30.47 70.23 0.63 Allowed Pre-proline 0 C--N 1.303 -1.446 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.745 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.605 ' HG3' HG23 ' A' ' 79' ' ' ILE . 1.2 Cg_endo -55.74 -175.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.644 0 N-CA-C 107.977 -1.586 . . . . 0.0 107.977 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.889 HG23 ' O ' ' A' ' 45' ' ' CYS . 1.1 mt -144.93 146.12 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 C-N-CA 118.56 -1.256 . . . . 0.0 112.174 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.021 HG21 ' HB2' ' A' ' 38' ' ' TYR . 22.0 t -102.26 157.82 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.1 m -114.26 -16.12 12.07 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 118.973 -1.091 . . . . 0.0 111.656 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.527 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 12.4 mt-10 -136.75 16.55 3.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.574 -1.329 . . . . 0.0 111.619 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.576 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 2.4 ttpt 71.57 -5.08 1.71 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.149 -0.969 . . . . 0.0 110.994 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.478 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 5.1 t70 -137.86 -1.51 2.0 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.969 -1.082 . . . . 0.0 110.32 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.606 ' O ' HG23 ' A' ' 77' ' ' VAL . 39.2 t -72.36 112.24 14.01 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.209 -0.932 . . . . 0.0 109.259 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.602 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 49.7 Cg_exo -48.51 126.51 14.29 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.828 1.436 . . . . 0.0 109.744 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.999 HG21 HG22 ' A' ' 70' ' ' VAL . 74.8 t -114.31 133.41 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.015 -1.053 . . . . 0.0 111.45 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.681 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 5.3 m-80 -99.65 131.8 45.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.493 -0.754 . . . . 0.0 109.12 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.928 HG21 ' CD2' ' A' ' 49' ' ' PHE . 10.9 mt -114.17 119.62 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.099 -1.626 . . . . 0.0 111.636 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.861 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.7 tp10 -92.4 118.59 31.09 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.94 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.89 ' C ' HG22 ' A' ' 31' ' ' THR . . . -135.93 152.55 51.1 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.006 -1.059 . . . . 0.0 110.78 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.529 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 2.0 tt0 -102.36 102.63 26.32 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.367 -0.833 . . . . 0.0 110.266 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.54 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 35.7 Cg_endo -71.96 151.56 56.45 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.086 1.571 . . . . 0.0 110.564 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.522 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 15.5 Cg_endo . . . . . 0 C--N 1.304 -1.771 0 O-C-N 124.081 1.569 . . . . 0.0 110.249 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.505 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 15.4 m-85 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.186 0.517 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.606 ' CG2' ' CZ ' ' A' ' 49' ' ' PHE . 1.3 mp -73.94 125.03 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.21 -0.931 . . . . 0.0 109.447 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.498 ' CG2' ' CD ' ' A' ' 98' ' ' GLN . 81.0 mt -96.5 144.14 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.156 -0.965 . . . . 0.0 110.503 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.986 HD11 HG21 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -129.76 137.87 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.502 -0.749 . . . . 0.0 109.596 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.562 ' O ' ' HB2' ' A' ' 48' ' ' PRO . . . 86.7 -163.78 35.43 Favored Glycine 0 N--CA 1.481 1.681 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.57 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -118.15 143.92 27.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 O-C-N 121.049 -1.265 . . . . 0.0 110.32 -179.478 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.576 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -14.54 -59.26 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.139 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -179.692 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 5.9 Cg_endo -49.86 74.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 124.235 1.65 . . . . 0.0 111.752 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 86.68 -2.37 87.25 Favored Glycine 0 N--CA 1.494 2.519 0 O-C-N 121.045 -1.034 . . . . 0.0 111.096 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.511 ' HB3' ' C ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -43.41 162.73 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.812 -1.405 . . . . 0.0 109.897 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.603 HD11 ' O ' ' A' ' 18' ' ' PHE . 10.5 mt -98.91 174.88 6.15 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.069 -1.019 . . . . 0.0 110.889 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.494 ' HG3' HG12 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -152.1 130.32 11.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.603 -0.686 . . . . 0.0 109.871 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' A' ' 89' ' ' TYR . 4.2 mp -131.73 123.9 28.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.145 -0.972 . . . . 0.0 110.394 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -86.96 128.98 35.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.325 -0.859 . . . . 0.0 110.207 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.61 ' CE3' HG22 ' A' ' 24' ' ' ILE . 61.7 t-105 . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.16 -0.963 . . . . 0.0 110.275 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.596 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 39.6 m . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.539 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 3.7 p -95.52 -1.98 49.53 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.18 -0.95 . . . . 0.0 112.07 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.594 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -66.84 -110.59 0.01 OUTLIER Glycine 0 N--CA 1.49 2.295 0 C-N-CA 118.844 -1.645 . . . . 0.0 109.048 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.529 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -143.47 173.62 11.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.985 -1.303 . . . . 0.0 110.103 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.863 ' CE2' HG23 ' A' ' 47' ' ' ILE . 33.6 m-85 -133.66 151.12 51.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.993 -1.067 . . . . 0.0 111.631 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.44 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 5.2 ttpt -117.75 115.95 26.04 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.61 -0.681 . . . . 0.0 109.239 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.64 ' CG2' HD13 ' A' ' 99' ' ' LEU . 40.6 t -59.67 124.7 14.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 120.655 -1.278 . . . . 0.0 109.131 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.569 HG23 ' HA ' ' A' ' 36' ' ' VAL . 60.6 t -98.25 -26.37 3.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.614 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 7.7 tttt -158.06 133.6 8.95 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -50.58 160.22 0.44 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.618 0.723 . . . . 0.0 111.465 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.679 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.7 OUTLIER -55.24 132.88 18.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 121.545 0.688 . . . . 0.0 110.277 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.74 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -108.94 168.19 9.54 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 4.2 pm0 -114.77 134.65 54.94 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.613 -1.304 . . . . 0.0 110.695 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.66 HG21 ' CD ' ' A' ' 80' ' ' GLU . 9.5 p -91.79 172.06 8.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.521 -0.737 . . . . 0.0 110.041 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -87.85 31.03 0.79 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.234 -0.916 . . . . 0.0 110.378 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.95 6.38 3.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.244 -0.91 . . . . 0.0 110.249 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.473 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 94.73 10.32 57.9 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.863 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -106.08 -178.21 3.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.392 -1.064 . . . . 0.0 110.273 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.74 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -139.51 150.63 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.595 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 54.1 t -117.45 134.2 61.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 O-C-N 121.184 -0.947 . . . . 0.0 112.126 -177.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.015 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -116.85 119.88 63.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.366 -0.834 . . . . 0.0 109.761 178.944 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.614 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 1.1 ttm180 -101.12 123.66 45.62 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.798 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.4 m -149.2 161.56 4.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.148 -0.97 . . . . 0.0 108.766 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 74' ' ' ASP 0.262 1.9 tt0 -107.35 125.62 51.43 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.859 ' HB2' HG21 ' A' ' 70' ' ' VAL . 3.3 t80 -59.87 122.94 15.5 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 118.909 -1.117 . . . . 0.0 110.126 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.44 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 1.3 mm-40 -98.57 -23.89 15.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.319 -0.863 . . . . 0.0 109.168 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.594 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -65.59 -161.6 0.82 Allowed Glycine 0 N--CA 1.484 1.89 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.448 ' HA ' ' HD2' ' A' ' 73' ' ' LYS . 30.9 t0 -128.23 146.46 50.73 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.468 -1.019 . . . . 0.0 110.185 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.402 ' O ' ' CB ' ' A' ' 43' ' ' SER . . . 156.69 -14.39 0.35 Allowed Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.59 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.606 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.8 OUTLIER 60.49 -152.95 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 120.639 -1.506 . . . . 0.0 108.16 -179.723 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 88.5 Cg_exo -42.39 97.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.32 -0.959 0 N-CA-C 108.819 -1.262 . . . . 0.0 108.819 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.708 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -146.77 171.28 15.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.767 -0.583 . . . . 0.0 110.02 -177.714 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.699 ' HG3' HD11 ' A' ' 69' ' ' ILE . 16.6 mtmt -85.79 175.01 8.93 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.35 -0.844 . . . . 0.0 111.664 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.067 HD11 ' CG2' ' A' ' 70' ' ' VAL . 15.7 mm -123.05 125.78 26.17 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.401 -0.812 . . . . 0.0 112.299 -178.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.625 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 30.2 Cg_exo -65.42 146.8 86.3 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.963 1.507 . . . . 0.0 110.686 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.709 ' CD2' HD11 ' A' ' 63' ' ' LEU . 11.4 t80 -155.88 159.9 39.71 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.255 -0.903 . . . . 0.0 110.422 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.506 ' OE1' ' N ' ' A' ' 51' ' ' ILE . 5.9 tp10 -176.29 114.38 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.067 -1.021 . . . . 0.0 110.554 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.643 HD11 ' HE2' ' A' ' 49' ' ' PHE . 55.9 mt . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 110.094 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.471 ' HA2' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.559 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -120.6 149.96 41.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.18 -1.188 . . . . 0.0 110.113 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.726 ' O ' HG23 ' A' ' 66' ' ' VAL . 3.2 mt -110.15 118.15 35.61 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.197 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.863 HG12 HG21 ' A' ' 31' ' ' THR . 1.5 mp -77.49 -22.97 14.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.669 HG22 ' O ' ' A' ' 65' ' ' THR 0.272 1.0 OUTLIER -113.69 29.77 7.75 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.439 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 63' ' ' LEU . 52.0 t -12.47 112.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.534 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.494 ' OD1' ' HB3' ' A' ' 46' ' ' LYS . 20.8 t-20 41.24 70.0 1.79 Allowed Pre-proline 0 C--N 1.302 -1.488 0 O-C-N 121.647 -0.658 . . . . 0.0 110.4 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.525 ' CG ' HG12 ' A' ' 79' ' ' ILE . 1.7 Cg_endo -51.85 -176.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.01 1.532 . . . . 0.0 109.723 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.708 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.9 OUTLIER -140.7 142.07 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.947 -178.919 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.067 ' CG2' HD11 ' A' ' 47' ' ' ILE . 24.8 t -93.39 169.51 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.2 m -124.15 -20.73 5.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.883 -1.136 . . . . 0.0 110.929 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.531 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 6.9 mt-10 -135.87 14.44 3.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.026 -1.046 . . . . 0.0 110.754 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.531 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 10.6 ttpt 73.81 -7.52 1.58 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.422 -0.798 . . . . 0.0 110.818 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.487 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 5.7 t70 -136.78 -1.15 2.26 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.965 -1.085 . . . . 0.0 110.23 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.564 ' O ' HG23 ' A' ' 77' ' ' VAL . 36.2 t -73.19 112.46 15.78 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.194 -0.941 . . . . 0.0 109.44 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 35.0 Cg_exo -50.93 113.52 1.12 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.806 1.424 . . . . 0.0 109.912 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.719 HG21 HG22 ' A' ' 70' ' ' VAL . 74.0 t -99.13 155.19 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.318 -0.864 . . . . 0.0 110.714 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.654 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -111.77 134.86 53.06 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.465 -0.772 . . . . 0.0 109.96 179.667 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.688 ' HB ' HG22 ' A' ' 34' ' ' ILE . 3.8 mt -115.35 114.23 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 117.731 -1.588 . . . . 0.0 111.289 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.66 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.1 tt0 -90.78 115.0 27.52 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.983 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.818 ' C ' HG22 ' A' ' 31' ' ' THR . . . -131.61 149.16 52.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.908 -1.12 . . . . 0.0 110.768 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' A' ' 62' ' ' ARG . 2.2 tt0 -98.82 104.99 28.23 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 110.337 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.508 ' HD3' HG13 ' A' ' 32' ' ' ILE . 30.8 Cg_endo -70.32 131.97 21.49 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.001 1.527 . . . . 0.0 110.298 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.471 ' HD3' ' HA2' ' A' ' 61' ' ' GLY . 23.0 Cg_endo . . . . . 0 C--N 1.305 -1.72 0 O-C-N 123.933 1.491 . . . . 0.0 110.398 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.536 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 9.7 m-85 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.124 0.488 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.528 HD11 HD12 ' A' ' 32' ' ' ILE . 20.6 mt -73.81 163.63 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.49 ' CG2' ' CD ' ' A' ' 98' ' ' GLN . 80.2 mt -126.25 139.54 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.496 -1.377 . . . . 0.0 112.04 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.015 HD11 HG21 ' A' ' 34' ' ' ILE . 0.5 OUTLIER -128.44 136.12 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.242 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.533 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 87.71 -161.17 31.97 Favored Glycine 0 N--CA 1.481 1.649 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.563 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -121.18 146.84 25.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 121.04 -1.27 . . . . 0.0 110.154 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.581 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.3 OUTLIER -17.03 -58.6 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.203 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 7.1 Cg_endo -51.18 75.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 124.216 1.64 . . . . 0.0 111.735 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 87.02 -0.27 86.02 Favored Glycine 0 N--CA 1.494 2.501 0 O-C-N 120.96 -1.087 . . . . 0.0 111.043 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.51 ' HB3' ' C ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -44.65 164.48 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.744 -1.445 . . . . 0.0 109.807 179.864 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.64 HD13 ' CG2' ' A' ' 20' ' ' VAL . 7.2 mt -102.35 170.67 7.93 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.104 -0.998 . . . . 0.0 111.263 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -146.41 132.84 19.65 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.602 -0.687 . . . . 0.0 109.478 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.944 HD11 HD12 ' A' ' 92' ' ' ILE . 1.0 OUTLIER -122.99 135.41 54.46 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.002 -1.061 . . . . 0.0 110.744 -179.534 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -84.74 130.63 34.66 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.372 -0.83 . . . . 0.0 110.657 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.476 ' NE1' HG21 ' A' ' 32' ' ' ILE . 26.2 t-105 . . . . . 0 N--CA 1.487 1.416 0 O-C-N 121.325 -0.86 . . . . 0.0 109.965 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.587 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 42.9 m . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.534 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -88.8 -7.36 56.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.385 -0.822 . . . . 0.0 111.766 -178.375 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.581 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -61.55 -110.83 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 C-N-CA 118.775 -1.679 . . . . 0.0 108.966 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.538 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -145.99 171.8 14.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.98 -1.306 . . . . 0.0 110.253 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.087 ' CE2' HG23 ' A' ' 47' ' ' ILE . 38.1 m-85 -130.49 148.69 52.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.062 -1.024 . . . . 0.0 111.48 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.498 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 4.2 ttpp -114.13 114.68 26.4 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.481 -0.762 . . . . 0.0 109.131 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.73 HG22 HD13 ' A' ' 99' ' ' LEU . 21.5 t -59.49 124.15 13.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 120.606 -1.309 . . . . 0.0 109.015 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.68 HG21 ' HB3' ' A' ' 76' ' ' PRO . 64.4 t -97.56 -25.54 4.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.602 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 3.8 tttp -158.68 133.54 8.27 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 177.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -51.68 163.27 0.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.671 0.748 . . . . 0.0 111.305 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.676 HG12 HD22 ' A' ' 101' ' ' LEU . 0.7 OUTLIER -57.09 132.81 21.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 121.647 0.736 . . . . 0.0 110.2 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.81 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -108.05 169.83 8.38 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 2.9 pm0 -116.01 132.94 56.51 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.784 -1.197 . . . . 0.0 110.425 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.925 HG21 ' CD ' ' A' ' 80' ' ' GLU . 16.5 p -91.17 -179.32 5.4 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.659 -0.817 . . . . 0.0 110.103 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -94.16 17.22 12.97 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.184 -0.947 . . . . 0.0 110.373 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.28 8.09 12.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.293 -0.879 . . . . 0.0 110.062 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.34 11.33 59.82 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.846 HG22 ' C ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -104.91 -174.38 2.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.39 -1.064 . . . . 0.0 110.345 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.81 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -141.13 155.67 21.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.96 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.795 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 76.7 t -120.76 129.95 75.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 119.101 -1.04 . . . . 0.0 112.231 -178.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.056 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -113.7 117.65 56.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 121.399 -0.813 . . . . 0.0 109.79 178.89 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.602 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 3.1 ttm180 -100.77 119.91 39.33 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.796 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.4 m -146.87 158.72 10.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.2 -0.937 . . . . 0.0 109.014 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.468 ' N ' HG23 ' A' ' 21' ' ' VAL 0.252 11.9 tt0 -106.08 125.57 51.15 Favored 'General case' 0 C--N 1.271 -2.817 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.393 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.935 ' HB2' HG21 ' A' ' 70' ' ' VAL . 3.7 t80 -59.78 123.04 15.73 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 119.003 -1.079 . . . . 0.0 110.079 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.498 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 8.3 mt-10 -98.86 -23.54 15.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.359 -0.838 . . . . 0.0 109.206 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.581 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -65.01 -162.12 0.68 Allowed Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.472 ' OD1' ' HE2' ' A' ' 73' ' ' LYS . 17.7 m-20 -129.15 146.52 51.06 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.457 -1.025 . . . . 0.0 110.307 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 43' ' ' SER . . . 155.37 -12.8 0.43 Allowed Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.597 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.608 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.7 OUTLIER 61.08 -153.29 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 120.661 -1.493 . . . . 0.0 108.32 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.608 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 88.4 Cg_exo -42.16 97.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.32 -0.958 0 N-CA-C 108.964 -1.206 . . . . 0.0 108.964 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.883 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -146.66 170.19 17.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.829 -0.545 . . . . 0.0 110.143 -177.906 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.639 ' CG ' HD11 ' A' ' 69' ' ' ILE . 1.2 mtpm? -84.67 175.09 9.44 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.173 -0.955 . . . . 0.0 112.033 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.087 HG23 ' CE2' ' A' ' 18' ' ' PHE . 15.5 mm -123.65 124.2 26.22 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.68 -0.638 . . . . 0.0 111.539 -178.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.618 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 31.7 Cg_exo -61.92 144.71 96.83 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.06 1.558 . . . . 0.0 110.384 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 1.005 ' CE1' HG21 ' A' ' 79' ' ' ILE . 4.8 t80 -151.69 156.21 39.89 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.203 -0.935 . . . . 0.0 110.324 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.535 ' HG3' HD12 ' A' ' 91' ' ' ILE . 23.1 tp10 -173.76 95.6 0.1 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.073 -1.017 . . . . 0.0 110.184 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.503 HD11 ' CB ' ' A' ' 81' ' ' ALA . 97.2 mt . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.302 -0.874 . . . . 0.0 110.265 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.528 ' N ' ' HG3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.555 ' O ' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -150.54 163.93 37.25 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.267 -1.137 . . . . 0.0 109.525 179.846 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.103 HD23 ' HB2' ' A' ' 81' ' ' ALA . 11.8 mt -122.01 121.41 36.96 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 118.837 -1.145 . . . . 0.0 110.539 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.828 HG12 HG21 ' A' ' 31' ' ' THR . 1.4 mp -82.54 -27.62 8.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.728 HG22 ' O ' ' A' ' 65' ' ' THR 0.26 1.1 m -96.78 32.61 2.04 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 122.781 1.277 . . . . 0.0 107.673 178.726 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 1.008 HG23 ' O ' ' A' ' 63' ' ' LEU . 16.3 t -34.74 140.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.25 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.57 ' N ' ' CD ' ' A' ' 68' ' ' PRO . 38.9 t-20 56.55 46.4 2.24 Favored Pre-proline 0 C--N 1.302 -1.493 0 O-C-N 121.577 -0.702 . . . . 0.0 110.585 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.596 ' CB ' ' CD1' ' A' ' 79' ' ' ILE . 8.1 Cg_endo -59.15 146.36 94.71 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.673 1.354 . . . . 0.0 109.043 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.883 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.7 OUTLIER -141.3 149.86 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 119.127 -1.029 . . . . 0.0 112.915 -177.652 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.016 ' CG2' HD11 ' A' ' 47' ' ' ILE . 41.9 t -97.28 168.86 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.412 ' N ' HG12 ' A' ' 70' ' ' VAL . 4.8 m -122.78 -21.25 5.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.857 -1.152 . . . . 0.0 111.201 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.535 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 15.6 mt-10 -136.51 17.23 3.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.816 -1.177 . . . . 0.0 111.192 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER 72.54 -5.63 1.79 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.281 -0.887 . . . . 0.0 110.981 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.477 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 5.8 t70 -138.81 0.27 1.98 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.923 -1.111 . . . . 0.0 110.429 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.508 ' O ' HG23 ' A' ' 77' ' ' VAL . 22.8 t -73.09 108.59 4.76 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.15 -0.969 . . . . 0.0 109.476 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.68 ' HB3' HG21 ' A' ' 21' ' ' VAL . 1.6 Cg_endo -50.22 110.66 0.41 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.697 1.367 . . . . 0.0 109.736 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.551 HG21 HG22 ' A' ' 70' ' ' VAL . 82.0 t -94.34 146.0 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.269 -0.894 . . . . 0.0 111.044 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.639 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.1 m120 -106.64 131.09 54.18 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 1.005 HG21 ' CE1' ' A' ' 49' ' ' PHE . 3.9 mm -112.2 117.46 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.079 -1.638 . . . . 0.0 111.803 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.925 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.6 tp10 -93.57 106.97 18.89 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.302 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 1.103 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -130.24 153.86 48.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.88 -1.137 . . . . 0.0 111.308 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 62' ' ' ARG . 24.6 tt0 -97.82 103.55 17.47 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.647 -0.658 . . . . 0.0 110.409 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.541 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 37.4 Cg_endo -70.77 144.56 49.02 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.984 1.518 . . . . 0.0 110.539 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.528 ' HG3' ' N ' ' A' ' 61' ' ' GLY . 23.7 Cg_exo . . . . . 0 C--N 1.305 -1.761 0 O-C-N 124.095 1.577 . . . . 0.0 110.155 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 17.9 m-85 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.213 0.53 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.753 HD11 HD13 ' A' ' 32' ' ' ILE . 4.1 mt -74.14 116.94 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 109.469 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.535 HD12 ' HG3' ' A' ' 50' ' ' GLU . 37.9 mt -94.62 147.44 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.177 -0.952 . . . . 0.0 110.395 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.056 HD11 HG21 ' A' ' 34' ' ' ILE . 1.6 mt -133.36 139.66 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.464 -0.772 . . . . 0.0 109.478 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.532 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 83.13 -161.17 39.28 Favored Glycine 0 N--CA 1.481 1.651 0 N-CA-C 108.624 -1.791 . . . . 0.0 108.624 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.554 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -122.12 149.1 25.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 121.213 -1.169 . . . . 0.0 110.169 -179.745 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.577 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.6 OUTLIER -17.15 -58.42 0.04 OUTLIER Pre-proline 0 N--CA 1.501 2.117 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 8.6 Cg_endo -51.87 71.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 124.279 1.673 . . . . 0.0 112.116 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 90.6 0.57 75.58 Favored Glycine 0 N--CA 1.494 2.537 0 O-C-N 120.941 -1.1 . . . . 0.0 110.943 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.507 ' HB3' ' C ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -48.38 159.97 0.18 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.952 -1.322 . . . . 0.0 110.199 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.73 HD13 HG22 ' A' ' 20' ' ' VAL . 12.2 mt -96.87 177.84 5.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.239 -0.913 . . . . 0.0 110.623 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.459 ' HG3' HG12 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -157.62 137.28 12.16 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.477 -0.765 . . . . 0.0 110.16 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.676 HD22 HG12 ' A' ' 24' ' ' ILE . 2.8 mp -138.21 116.94 12.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.207 -0.933 . . . . 0.0 110.373 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 9.1 p-10 -83.31 128.06 34.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 110.405 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 10.6 t-105 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.243 -0.911 . . . . 0.0 110.155 179.921 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.587 ' HB3' ' CE1' ' A' ' 38' ' ' TYR . 1.3 m . . . . . 0 N--CA 1.485 1.314 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.538 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 1.2 p -116.39 4.95 13.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.132 -0.98 . . . . 0.0 111.716 -178.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.582 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -62.02 -115.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.531 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -136.49 174.06 11.03 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.989 -1.3 . . . . 0.0 109.946 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.997 ' CE2' HG23 ' A' ' 47' ' ' ILE . 42.8 m-85 -133.02 140.84 47.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.965 -1.084 . . . . 0.0 111.814 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.538 ' HB2' ' CG ' ' A' ' 39' ' ' GLU . 7.9 ttpt -107.67 117.65 34.67 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.633 -0.667 . . . . 0.0 109.277 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.735 HG22 HD13 ' A' ' 99' ' ' LEU . 21.2 t -59.64 132.91 25.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 120.835 -1.166 . . . . 0.0 109.042 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.644 HG23 ' HA ' ' A' ' 36' ' ' VAL . 92.1 t -105.78 -24.12 4.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.593 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 16.2 tttt -161.64 134.48 6.11 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -53.23 158.84 1.46 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.699 0.761 . . . . 0.0 111.421 -178.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.584 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -52.86 133.08 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-O 121.587 0.708 . . . . 0.0 110.202 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.848 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -109.64 171.73 7.27 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 5.3 pm0 -116.65 134.68 54.53 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.833 -1.167 . . . . 0.0 110.56 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.926 HG21 ' CD ' ' A' ' 80' ' ' GLU . 14.0 p -92.8 175.03 6.96 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.255 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -88.62 31.25 0.84 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.905 . . . . 0.0 110.234 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.3 m170 -133.87 5.78 3.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.894 . . . . 0.0 110.183 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.85 1.23 61.74 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.161 -1.575 . . . . 0.0 109.161 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.889 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -95.32 -176.73 3.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -1.144 . . . . 0.0 110.355 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.848 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -140.21 153.34 22.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.763 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.678 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 55.1 t -118.97 132.24 69.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 119.113 -1.035 . . . . 0.0 112.351 -177.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.059 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -113.55 120.54 63.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 O-C-N 121.355 -0.841 . . . . 0.0 109.61 178.601 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.593 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 2.9 ttm180 -105.19 110.85 23.39 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.842 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.5 m -132.59 -169.91 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.438 -0.789 . . . . 0.0 109.312 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.448 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 17.1 tt0 -136.58 128.19 28.77 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.841 ' HB2' HG21 ' A' ' 70' ' ' VAL . 16.1 t80 -61.02 118.66 7.04 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 117.983 -1.487 . . . . 0.0 110.633 -178.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.538 ' CG ' ' HB2' ' A' ' 19' ' ' LYS . 7.5 mm-40 -97.25 -0.79 46.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.503 -0.748 . . . . 0.0 109.327 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.582 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -93.57 -161.77 35.81 Favored Glycine 0 N--CA 1.484 1.855 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 41' ' ' ASP . 2.0 p30 -127.52 134.77 49.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.461 -1.023 . . . . 0.0 109.929 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' ' 43' ' ' SER . . . 171.92 -23.03 0.08 OUTLIER Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.483 -1.342 . . . . 0.0 110.664 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.611 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.5 OUTLIER 64.12 -154.95 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 120.602 -1.529 . . . . 0.0 108.073 -179.563 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.611 ' HD2' ' CB ' ' A' ' 43' ' ' SER . 88.2 Cg_exo -42.54 94.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -0.993 0 N-CA-C 109.059 -1.169 . . . . 0.0 109.059 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.95 ' O ' HG23 ' A' ' 69' ' ' ILE . 31.6 p -148.02 178.36 8.59 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.792 -0.568 . . . . 0.0 109.576 -178.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 68' ' ' PRO . 1.0 OUTLIER -96.05 175.04 6.62 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.943 -1.098 . . . . 0.0 111.412 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.038 HD11 ' CG2' ' A' ' 70' ' ' VAL . 17.7 mm -121.94 131.75 24.36 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.346 -0.846 . . . . 0.0 112.591 -177.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.62 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 26.1 Cg_exo -66.94 143.52 66.61 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 124.115 1.587 . . . . 0.0 110.768 178.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.961 ' CE2' HG21 ' A' ' 79' ' ' ILE . 9.2 t80 -152.96 158.65 42.39 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.313 -0.867 . . . . 0.0 110.248 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 1.036 ' HG2' HD12 ' A' ' 91' ' ' ILE . 5.3 tt0 -173.29 111.49 0.2 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.067 -1.02 . . . . 0.0 110.324 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.931 HD11 ' HB1' ' A' ' 81' ' ' ALA . 68.5 mt . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 110.34 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.503 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.492 2.382 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.526 ' CB ' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -158.93 166.69 31.24 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.073 -1.251 . . . . 0.0 109.596 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.038 HD23 ' HB2' ' A' ' 81' ' ' ALA . 10.5 mt -124.17 122.75 38.65 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 118.804 -1.158 . . . . 0.0 111.077 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.889 HG12 HG21 ' A' ' 31' ' ' THR . 1.5 mp -84.82 -23.35 7.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 178.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 65' ' ' THR 0.28 2.0 m -108.26 37.17 2.55 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 122.476 1.132 . . . . 0.0 108.096 179.514 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' ' 63' ' ' LEU . 37.3 t -38.22 152.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-O 121.504 0.668 . . . . 0.0 111.077 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.651 ' OD1' HG12 ' A' ' 66' ' ' VAL . 5.3 p-10 37.53 59.36 4.32 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.851 -0.53 . . . . 0.0 111.253 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.94 ' CG ' HD12 ' A' ' 79' ' ' ILE . 19.3 Cg_exo -58.64 164.8 8.86 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 N-CA-C 108.325 -1.452 . . . . 0.0 108.325 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.95 HG23 ' O ' ' A' ' 45' ' ' CYS . 1.1 mt -143.45 146.22 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 118.418 -1.313 . . . . 0.0 113.001 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.038 ' CG2' HD11 ' A' ' 47' ' ' ILE . 15.3 t -103.77 163.33 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 176.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.481 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 3.1 m -124.85 -12.04 7.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.823 -1.173 . . . . 0.0 111.654 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 4.4 mt-10 -140.88 10.52 2.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.719 -1.238 . . . . 0.0 111.311 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 15.8 mtmt 78.16 -16.75 0.63 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.744 -0.597 . . . . 0.0 111.036 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.492 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 6.2 t70 -132.52 0.52 3.65 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.071 -1.018 . . . . 0.0 109.801 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.7 t -71.71 111.53 10.8 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.643 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 38.2 Cg_exo -49.76 131.51 29.3 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.901 1.474 . . . . 0.0 110.332 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.776 HG21 HG22 ' A' ' 70' ' ' VAL . 89.2 t -110.36 154.52 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.172 -0.955 . . . . 0.0 110.515 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.659 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 0.9 OUTLIER -116.63 132.42 56.69 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.525 -0.735 . . . . 0.0 109.289 179.627 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.961 HG21 ' CE2' ' A' ' 49' ' ' PHE . 25.2 mm -117.76 117.05 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 117.497 -1.681 . . . . 0.0 112.105 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.926 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.6 tp10 -94.76 110.72 22.55 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.418 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 1.038 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -131.15 155.94 46.15 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.781 -1.199 . . . . 0.0 111.386 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.526 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 35.3 tp10 -99.79 102.36 16.93 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.593 -0.692 . . . . 0.0 110.418 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.544 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 56.9 Cg_endo -75.23 148.42 34.39 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.997 1.525 . . . . 0.0 110.747 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.503 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 12.2 Cg_endo . . . . . 0 C--N 1.305 -1.739 0 O-C-N 124.099 1.579 . . . . 0.0 110.108 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.546 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 2.0 m-85 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.158 0.504 . . . . 0.0 110.092 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.806 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 1.6 mp -74.01 118.44 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.203 -0.936 . . . . 0.0 109.522 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 1.036 HD12 ' HG2' ' A' ' 50' ' ' GLU . 70.9 mt -98.68 148.16 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 110.643 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.059 HD11 HG21 ' A' ' 34' ' ' ILE . 1.7 mt -135.88 138.2 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.643 -0.661 . . . . 0.0 109.333 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.54 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 83.9 -159.39 36.03 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.558 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -124.22 149.96 28.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 O-C-N 121.198 -1.178 . . . . 0.0 110.18 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.578 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 2.3 mt-10 -17.97 -57.88 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.121 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 9.0 Cg_endo -52.08 71.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 124.157 1.609 . . . . 0.0 112.177 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 89.81 2.74 74.9 Favored Glycine 0 N--CA 1.494 2.526 0 O-C-N 120.935 -1.103 . . . . 0.0 110.898 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.507 ' HB3' ' C ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -49.75 159.5 0.37 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.958 -1.319 . . . . 0.0 110.161 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.735 HD13 HG22 ' A' ' 20' ' ' VAL . 10.4 mt -94.91 172.66 8.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 110.445 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -156.15 133.28 10.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.392 -0.817 . . . . 0.0 110.201 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.581 HD13 HG13 ' A' ' 34' ' ' ILE . 2.2 mp -134.11 122.72 23.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.257 -0.902 . . . . 0.0 110.058 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -87.25 134.85 33.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.19 -0.944 . . . . 0.0 110.366 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 22.3 t-105 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.364 -0.835 . . . . 0.0 110.185 179.919 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.579 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 33.5 m . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 121.312 0.577 . . . . 0.0 109.764 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.596 ' HA ' HG21 ' A' ' 94' ' ' VAL . 71.2 p -97.53 -5.05 36.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 111.081 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.549 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -59.32 -110.37 0.01 OUTLIER Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.116 -1.516 . . . . 0.0 109.381 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.591 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 1.1 ttpt -142.95 162.56 35.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.039 -1.271 . . . . 0.0 109.924 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.024 ' CE2' HG23 ' A' ' 47' ' ' ILE . 21.0 m-85 -126.82 136.37 52.27 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.939 -1.101 . . . . 0.0 111.224 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.489 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 10.9 ttpp -108.0 119.24 38.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.418 -0.802 . . . . 0.0 109.678 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.834 ' CG2' HD13 ' A' ' 99' ' ' LEU . 48.3 t -59.93 130.76 24.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.829 -1.17 . . . . 0.0 108.995 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.615 HG23 ' HA ' ' A' ' 36' ' ' VAL . 61.3 t -102.98 -24.81 3.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.573 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 1.5 tttt -161.98 133.71 5.46 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -52.34 156.67 1.65 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.611 0.719 . . . . 0.0 111.193 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.577 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -49.94 132.66 9.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-O 121.616 0.722 . . . . 0.0 109.843 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.873 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -108.32 172.32 6.91 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.4 pm0 -115.23 130.58 56.95 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.834 -1.166 . . . . 0.0 110.516 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.945 HG21 ' CD ' ' A' ' 80' ' ' GLU . 26.4 p -84.57 177.22 8.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.439 -0.788 . . . . 0.0 109.967 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -92.24 28.61 1.86 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.882 . . . . 0.0 110.158 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -133.65 5.19 3.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.242 -0.911 . . . . 0.0 110.312 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.462 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 101.35 -3.3 54.32 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.873 HG22 ' C ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -92.19 -175.73 4.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.205 -1.174 . . . . 0.0 110.478 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.873 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -139.15 156.88 27.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.627 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.706 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 59.4 t -122.06 132.03 71.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 119.079 -1.049 . . . . 0.0 112.322 -177.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.026 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -112.2 120.16 61.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 O-C-N 121.197 -0.94 . . . . 0.0 109.7 178.767 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.573 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -104.47 114.96 29.54 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.638 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.834 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.3 m -137.27 -176.35 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.336 -0.853 . . . . 0.0 109.125 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.494 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 4.2 tt0 -129.36 131.47 46.86 Favored 'General case' 0 C--N 1.276 -2.613 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.929 ' HB2' HG21 ' A' ' 70' ' ' VAL . 6.2 t80 -60.88 122.54 15.12 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 118.724 -1.191 . . . . 0.0 110.731 -178.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 6.8 mt-10 -111.57 26.14 10.95 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.062 -1.024 . . . . 0.0 108.869 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.549 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -121.22 -161.07 11.25 Favored Glycine 0 N--CA 1.484 1.863 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 40.8 p-10 -125.0 149.18 48.01 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.384 -1.068 . . . . 0.0 110.392 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.48 -2.51 1.1 Allowed Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.555 -1.307 . . . . 0.0 110.958 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.612 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.6 OUTLIER 49.48 -153.57 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 120.534 -1.568 . . . . 0.0 108.353 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.612 ' HD2' ' CB ' ' A' ' 43' ' ' SER . 86.1 Cg_exo -41.46 97.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.321 -0.906 0 N-CA-C 109.121 -1.146 . . . . 0.0 109.121 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.896 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -143.65 169.66 17.31 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.192 0.52 . . . . 0.0 109.648 -178.095 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.592 ' O ' HD13 ' A' ' 47' ' ' ILE . 6.1 mtpm? -83.53 175.46 9.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.155 -0.966 . . . . 0.0 112.163 -178.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.097 ' CD1' HG23 ' A' ' 70' ' ' VAL . 15.4 mm -124.55 123.64 25.75 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.696 -0.627 . . . . 0.0 111.373 -178.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.627 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 31.7 Cg_exo -62.33 144.97 95.95 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.097 1.577 . . . . 0.0 110.901 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.999 ' CE1' HG21 ' A' ' 79' ' ' ILE . 5.8 t80 -152.97 155.71 37.48 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.374 -0.829 . . . . 0.0 110.033 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.742 ' HG2' HD12 ' A' ' 91' ' ' ILE . 21.7 tt0 -171.42 103.05 0.2 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.092 -1.005 . . . . 0.0 110.382 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.53 HD11 ' HB1' ' A' ' 81' ' ' ALA . 79.3 mt . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.295 -0.878 . . . . 0.0 110.134 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.428 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.6 ' O ' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -158.3 167.08 30.73 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.211 -1.17 . . . . 0.0 109.381 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.058 HD23 ' HB2' ' A' ' 81' ' ' ALA . 11.6 mt -122.69 122.08 37.92 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 118.916 -1.114 . . . . 0.0 110.814 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.848 HG12 HG21 ' A' ' 31' ' ' THR . 1.4 mp -83.44 -28.16 7.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.741 HG22 ' O ' ' A' ' 65' ' ' THR 0.27 1.3 m -96.98 34.57 1.7 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.447 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 1.0 HG23 ' O ' ' A' ' 63' ' ' LEU . 13.9 t -36.81 142.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.713 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.56 ' N ' ' HD3' ' A' ' 68' ' ' PRO . 46.5 t-20 49.62 59.77 16.3 Favored Pre-proline 0 C--N 1.299 -1.604 0 O-C-N 121.485 -0.759 . . . . 0.0 110.096 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.638 ' CG ' HD12 ' A' ' 79' ' ' ILE . 3.0 Cg_exo -68.91 154.89 70.14 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.719 1.378 . . . . 0.0 108.703 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.896 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.8 OUTLIER -142.91 146.5 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.13 -1.028 . . . . 0.0 112.247 -178.63 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.097 HG23 ' CD1' ' A' ' 47' ' ' ILE . 54.5 t -96.86 154.28 3.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.43 -21.89 12.28 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 120.913 -1.117 . . . . 0.0 108.714 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.539 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 32.1 mt-10 -139.22 146.47 40.53 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.545 ' O ' ' O ' ' A' ' 38' ' ' TYR . 0.5 OUTLIER -53.61 -13.9 0.75 Allowed 'General case' 0 C--N 1.296 -1.756 0 O-C-N 120.808 -1.182 . . . . 0.0 110.948 -178.873 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.471 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 15.7 t0 -126.91 6.99 6.65 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.58 -1.325 . . . . 0.0 110.671 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.499 ' CB ' ' HB2' ' A' ' 72' ' ' GLU . 0.1 OUTLIER -72.73 112.23 14.35 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.035 -1.041 . . . . 0.0 108.618 178.803 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.635 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 31.5 Cg_exo -56.34 126.71 23.23 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 O-C-N 124.008 1.531 . . . . 0.0 110.68 -178.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.774 HG21 HG22 ' A' ' 70' ' ' VAL . 53.9 t -105.56 158.62 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.097 -1.002 . . . . 0.0 110.448 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.648 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -121.13 131.21 54.12 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.417 -0.802 . . . . 0.0 109.484 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.999 HG21 ' CE1' ' A' ' 49' ' ' PHE . 15.4 mm -114.86 115.13 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 117.598 -1.641 . . . . 0.0 111.674 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.945 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.5 tp10 -94.23 108.06 19.96 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 1.058 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -129.4 155.7 45.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.874 -1.141 . . . . 0.0 111.093 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.539 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 1.2 tp10 -95.97 110.72 53.29 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.577 -0.702 . . . . 0.0 110.165 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.531 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 38.1 Cg_endo -71.41 144.84 46.49 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.027 1.541 . . . . 0.0 110.501 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.428 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 13.4 Cg_endo . . . . . 0 C--N 1.304 -1.815 0 O-C-N 124.006 1.529 . . . . 0.0 110.081 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 11.6 m-85 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.198 0.523 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.719 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.5 mp -74.26 121.78 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.908 . . . . 0.0 109.752 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.742 HD12 ' HG2' ' A' ' 50' ' ' GLU . 14.2 mt -96.13 146.93 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -0.946 . . . . 0.0 110.176 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.026 HD11 HG21 ' A' ' 34' ' ' ILE . 1.7 mt -135.3 140.82 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.307 -0.87 . . . . 0.0 110.073 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 48' ' ' PRO . . . 80.22 -156.77 39.98 Favored Glycine 0 N--CA 1.484 1.881 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.596 HG21 ' HA ' ' A' ' 15' ' ' THR . 0.4 OUTLIER -130.99 156.83 43.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 O-C-N 121.055 -1.262 . . . . 0.0 110.685 -179.511 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.642 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 2.3 mt-10 -30.44 -54.08 0.37 Allowed Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.861 -0.524 . . . . 0.0 111.569 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 3.3 Cg_endo -48.43 -20.67 2.65 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.506 1.267 . . . . 0.0 111.125 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.591 ' HA3' ' CG ' ' A' ' 17' ' ' LYS . . . -176.81 46.42 0.11 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -95.21 153.72 17.53 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.88 -1.365 . . . . 0.0 111.138 -178.591 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.834 HD13 ' CG2' ' A' ' 20' ' ' VAL . 24.2 mt -103.71 -177.52 3.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.547 -0.721 . . . . 0.0 110.268 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.413 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 0.7 OUTLIER -156.48 137.06 13.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.526 -0.734 . . . . 0.0 110.117 179.671 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.719 HD12 ' O ' ' A' ' 90' ' ' ILE . 2.5 mp -139.59 119.98 13.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.102 -0.999 . . . . 0.0 110.338 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.433 ' OD1' ' CE2' ' A' ' 89' ' ' TYR . 39.8 t30 -87.26 130.22 34.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.314 -0.866 . . . . 0.0 110.314 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.533 ' CE3' HG22 ' A' ' 24' ' ' ILE . 21.9 t-105 . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 110.066 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.591 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 32.5 m . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 121.423 0.63 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 16' ' ' GLY . 4.3 t -94.0 -9.52 36.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.336 -0.852 . . . . 0.0 111.722 -178.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.57 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -59.86 -123.56 0.01 OUTLIER Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.543 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -135.19 174.98 10.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.011 -1.288 . . . . 0.0 109.909 -179.749 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.076 ' CE2' HG23 ' A' ' 47' ' ' ILE . 35.0 m-85 -133.81 140.33 46.84 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.92 -1.112 . . . . 0.0 111.311 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.488 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 4.0 ttpt -109.89 117.18 33.12 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.584 -0.698 . . . . 0.0 109.366 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.735 ' CG2' HD13 ' A' ' 99' ' ' LEU . 46.9 t -59.76 123.07 11.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 120.688 -1.258 . . . . 0.0 109.013 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.946 HG21 ' HB3' ' A' ' 76' ' ' PRO . 53.2 t -96.95 -25.08 4.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.603 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 4.9 tttt -158.93 133.9 8.26 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -52.33 159.55 0.96 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.645 0.736 . . . . 0.0 111.186 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.597 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -51.82 133.24 13.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.514 0.673 . . . . 0.0 110.202 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 1.001 ' HB3' ' HB ' ' A' ' 33' ' ' VAL . . . -105.74 169.91 8.2 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 0.4 OUTLIER -117.32 123.17 45.87 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.883 -1.135 . . . . 0.0 110.55 -179.677 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.4 ' H ' HG23 ' A' ' 27' ' ' THR . 5.1 p -78.47 -175.71 4.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.402 -0.811 . . . . 0.0 109.808 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -100.25 34.54 2.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.186 -0.946 . . . . 0.0 110.058 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -140.64 8.57 2.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.247 -0.908 . . . . 0.0 110.434 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.38 -3.5 58.01 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.948 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -91.74 -176.39 4.45 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -1.167 . . . . 0.0 110.262 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.87 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -142.23 168.53 14.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.591 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.001 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 93.4 t -131.83 126.17 56.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 C-N-CA 118.71 -1.196 . . . . 0.0 111.995 -178.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.014 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -109.27 115.84 50.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.309 -0.869 . . . . 0.0 109.852 178.906 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.603 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 1.4 ttm180 -99.13 120.48 39.56 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.798 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.4 m -147.38 158.14 9.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.326 -0.859 . . . . 0.0 108.919 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 74' ' ' ASP 0.252 0.8 OUTLIER -105.65 125.22 50.74 Favored 'General case' 0 C--N 1.272 -2.796 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.291 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.905 ' HB2' HG21 ' A' ' 70' ' ' VAL . 2.1 t80 -60.1 124.12 19.27 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 119.07 -1.052 . . . . 0.0 110.289 -178.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.499 ' O ' ' N ' ' A' ' 17' ' ' LYS . 21.4 mm-40 -112.23 92.05 3.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.874 . . . . 0.0 109.872 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.57 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 164.47 -151.05 19.98 Favored Glycine 0 N--CA 1.486 1.97 0 C-N-CA 119.404 -1.379 . . . . 0.0 109.858 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.449 ' O ' ' OH ' ' A' ' 38' ' ' TYR . 4.4 m-20 -112.4 125.07 53.8 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.5 -1.0 . . . . 0.0 110.48 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 43' ' ' SER . . . 177.66 -27.92 0.06 OUTLIER Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.504 -1.332 . . . . 0.0 110.614 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.609 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.7 OUTLIER 48.56 -153.92 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 120.723 -1.457 . . . . 0.0 107.594 -179.421 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.609 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 53.6 Cg_exo -46.81 94.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.198 0 N-CA-C 108.385 -1.429 . . . . 0.0 108.385 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.858 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -150.47 172.67 15.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.582 -0.699 . . . . 0.0 110.063 -177.696 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.579 ' HG3' HD11 ' A' ' 69' ' ' ILE . 22.0 mtmt -81.09 175.71 10.43 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.236 -0.915 . . . . 0.0 112.102 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.076 HG23 ' CE2' ' A' ' 18' ' ' PHE . 15.7 mm -124.26 127.48 25.3 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.62 -0.675 . . . . 0.0 111.427 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.629 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 38.3 Cg_exo -63.86 144.13 87.64 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.048 1.551 . . . . 0.0 110.42 178.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.711 ' CZ ' HG23 ' A' ' 90' ' ' ILE . 9.6 t80 -151.83 160.28 43.6 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.259 -0.901 . . . . 0.0 110.286 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.678 ' O ' HD12 ' A' ' 91' ' ' ILE . 0.9 OUTLIER -175.2 98.78 0.08 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.214 -0.929 . . . . 0.0 109.532 179.569 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.923 HD11 ' HB1' ' A' ' 81' ' ' ALA . 64.0 mt . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.15 -0.969 . . . . 0.0 111.37 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.51 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -131.57 155.46 47.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -1.156 . . . . 0.0 110.36 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.907 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -115.1 116.33 28.24 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.221 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.948 HG12 HG21 ' A' ' 31' ' ' THR . 1.7 mp -80.07 -27.35 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.756 HG22 ' O ' ' A' ' 65' ' ' THR 0.259 1.2 m -98.47 34.08 2.09 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.062 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.907 HG23 ' O ' ' A' ' 63' ' ' LEU . 40.6 t -26.62 145.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.526 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.642 ' ND2' ' O ' ' A' ' 67' ' ' ASN . 1.2 p-10 39.81 53.12 5.06 Favored Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 121.778 -0.576 . . . . 0.0 111.475 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.543 ' O ' HG12 ' A' ' 69' ' ' ILE . 1.8 Cg_endo -55.41 154.69 23.18 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 N-CA-C 108.758 -1.285 . . . . 0.0 108.758 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.858 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.7 OUTLIER -141.45 146.47 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 119.049 -1.061 . . . . 0.0 112.819 -177.667 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.033 HG23 ' CD1' ' A' ' 47' ' ' ILE . 95.7 t -92.75 167.63 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.466 ' N ' HG12 ' A' ' 70' ' ' VAL . 3.1 m -118.74 -21.93 7.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.735 -1.228 . . . . 0.0 111.033 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.522 ' O ' ' HB3' ' A' ' 73' ' ' LYS . 4.0 mt-10 -138.06 19.19 2.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.956 -1.09 . . . . 0.0 110.991 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.523 ' CD ' ' O ' ' A' ' 40' ' ' GLY . 0.3 OUTLIER 72.64 -7.34 1.44 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.398 -0.814 . . . . 0.0 111.11 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.5 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 6.1 t0 -137.43 0.33 2.28 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.864 -1.147 . . . . 0.0 110.451 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.611 ' O ' HG23 ' A' ' 77' ' ' VAL . 32.9 t -73.06 108.39 4.49 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.166 -0.959 . . . . 0.0 109.613 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.946 ' HB3' HG21 ' A' ' 21' ' ' VAL . 3.4 Cg_endo -51.57 110.51 0.43 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.735 1.387 . . . . 0.0 109.672 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 75' ' ' SER . 88.8 t -99.41 143.45 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.326 -0.859 . . . . 0.0 111.741 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.645 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 3.6 m-80 -98.17 130.97 44.91 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.726 ' HB ' HG22 ' A' ' 34' ' ' ILE . 5.8 mt -108.81 114.33 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.067 -1.646 . . . . 0.0 111.71 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 3.4 tt0 -84.23 115.29 22.37 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.676 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.923 ' HB1' HD11 ' A' ' 51' ' ' ILE . . . -137.85 152.61 49.24 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.987 -1.071 . . . . 0.0 110.919 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.51 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 34.9 tt0 -100.82 101.24 14.98 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.366 -0.834 . . . . 0.0 110.308 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.548 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 43.2 Cg_endo -73.23 134.08 20.48 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.036 1.545 . . . . 0.0 110.381 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 83' ' ' PRO . 34.3 Cg_exo . . . . . 0 C--N 1.306 -1.71 0 O-C-N 123.923 1.486 . . . . 0.0 110.101 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.564 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 2.0 m-30 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.181 0.515 . . . . 0.0 110.009 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.711 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 1.6 mp -74.32 121.87 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.141 -0.975 . . . . 0.0 109.346 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.678 HD12 ' O ' ' A' ' 50' ' ' GLU . 1.9 mp -100.03 148.25 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.047 -1.033 . . . . 0.0 110.143 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.014 HD11 HG21 ' A' ' 34' ' ' ILE . 1.6 mt -134.05 145.54 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.454 -0.779 . . . . 0.0 109.907 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.555 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 80.04 -161.03 45.15 Favored Glycine 0 N--CA 1.481 1.642 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.547 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -122.15 150.48 25.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 O-C-N 121.366 -1.079 . . . . 0.0 110.064 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.576 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 5.4 mt-10 -20.68 -56.95 0.07 OUTLIER Pre-proline 0 N--CA 1.5 2.04 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 9.2 Cg_endo -54.71 68.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 124.066 1.561 . . . . 0.0 111.963 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 94.33 6.57 61.26 Favored Glycine 0 N--CA 1.495 2.612 0 O-C-N 120.951 -1.093 . . . . 0.0 111.026 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.506 ' HB3' ' C ' ' A' ' 94' ' ' VAL . 0.3 OUTLIER -55.64 161.58 2.02 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.933 -1.334 . . . . 0.0 109.993 179.811 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.735 HD13 ' CG2' ' A' ' 20' ' ' VAL . 12.8 mt -99.26 177.43 5.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.234 -0.916 . . . . 0.0 110.963 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.561 ' C ' HD12 ' A' ' 101' ' ' LEU . 4.3 ttpt -154.8 138.51 16.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.57 -0.706 . . . . 0.0 109.953 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.561 HD12 ' C ' ' A' ' 100' ' ' LYS . 4.9 mp -143.43 124.58 14.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.136 -0.978 . . . . 0.0 110.36 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 8.7 p-10 -92.12 130.61 37.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.357 -0.839 . . . . 0.0 110.596 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.563 ' CZ3' HG22 ' A' ' 24' ' ' ILE . 38.2 t-105 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.884 . . . . 0.0 109.998 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.58 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 30.8 m . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 121.337 0.589 . . . . 0.0 109.575 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.491 ' O ' ' O ' ' A' ' 16' ' ' GLY . 3.4 p -87.84 -8.08 56.37 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.375 -0.828 . . . . 0.0 111.711 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.579 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -60.33 -131.55 0.01 OUTLIER Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.518 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -134.37 -178.91 5.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.02 -1.282 . . . . 0.0 109.822 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.946 ' CZ ' HG23 ' A' ' 47' ' ' ILE . 44.1 m-85 -138.01 142.62 40.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.894 -1.129 . . . . 0.0 111.851 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.51 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 31.9 ttpt -110.4 117.92 34.89 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.695 ' CG2' HD13 ' A' ' 99' ' ' LEU . 60.6 t -59.56 124.23 13.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 120.666 -1.271 . . . . 0.0 109.459 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.717 HG23 ' HA ' ' A' ' 36' ' ' VAL . 83.3 t -96.27 -27.09 4.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.637 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 0.2 OUTLIER -154.31 138.06 16.16 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.332 177.11 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.54 158.43 4.45 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.383 0.611 . . . . 0.0 110.364 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.691 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.7 OUTLIER -55.4 130.64 17.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.051 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.782 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -108.65 168.74 9.12 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 12.9 pt-20 -113.87 134.94 54.49 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.786 -1.196 . . . . 0.0 110.479 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.915 HG21 ' CD ' ' A' ' 80' ' ' GLU . 16.5 p -90.52 -172.67 3.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.5 -0.75 . . . . 0.0 110.278 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -95.91 4.41 52.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.269 -0.895 . . . . 0.0 110.419 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -106.67 6.82 30.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.201 -0.937 . . . . 0.0 110.223 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.53 7.64 61.62 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.968 HG22 ' C ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -97.48 -171.95 2.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -1.092 . . . . 0.0 110.457 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.782 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -142.69 147.21 21.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.777 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.671 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 66.8 t -111.64 134.79 52.91 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 O-C-N 121.346 -0.846 . . . . 0.0 112.08 -177.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.082 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -120.95 118.76 57.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 121.409 -0.807 . . . . 0.0 109.988 179.11 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.637 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -100.07 122.99 43.8 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 119.026 -1.07 . . . . 0.0 108.34 179.23 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.799 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.3 m -149.0 158.52 6.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.175 -0.953 . . . . 0.0 109.053 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 74' ' ' ASP 0.256 1.8 tt0 -107.61 126.74 52.94 Favored 'General case' 0 C--N 1.27 -2.848 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.503 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.961 ' HB2' HG21 ' A' ' 70' ' ' VAL . 1.9 t80 -59.18 125.46 23.68 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.182 -178.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.51 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 5.2 mm-40 -111.85 87.96 2.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.18 -0.95 . . . . 0.0 109.715 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.579 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 164.65 -150.58 18.85 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.456 ' O ' ' OH ' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -117.82 137.02 53.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.594 -0.945 . . . . 0.0 110.496 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 43' ' ' SER . . . 173.32 -24.76 0.08 OUTLIER Glycine 0 N--CA 1.488 2.109 0 C-N-CA 119.649 -1.262 . . . . 0.0 110.641 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.599 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.4 OUTLIER 49.36 -156.54 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 120.732 -1.452 . . . . 0.0 107.813 -179.501 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.599 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 50.8 Cg_exo -48.15 94.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.318 0 N-CA-C 107.951 -1.596 . . . . 0.0 107.951 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.919 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -148.06 173.62 12.74 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.633 -0.667 . . . . 0.0 109.333 -177.584 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 68' ' ' PRO . 0.3 OUTLIER -88.6 173.84 8.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.0 -1.062 . . . . 0.0 111.78 -178.73 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.06 ' CD1' HG23 ' A' ' 70' ' ' VAL . 19.2 mm -124.18 129.64 24.65 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.64 -0.662 . . . . 0.0 112.033 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.613 ' HD2' ' CE2' ' A' ' 18' ' ' PHE . 36.8 Cg_exo -63.71 147.82 92.42 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 124.05 1.552 . . . . 0.0 111.034 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.912 ' CE2' HG21 ' A' ' 79' ' ' ILE . 11.0 t80 -155.51 157.6 37.16 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.324 -0.86 . . . . 0.0 110.552 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.889 ' HG2' HD12 ' A' ' 91' ' ' ILE . 22.4 tt0 -175.72 95.91 0.07 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.147 -0.971 . . . . 0.0 110.306 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.75 HD11 ' HB1' ' A' ' 81' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.313 -0.867 . . . . 0.0 109.74 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.534 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.54 ' CB ' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -150.34 163.49 38.21 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.271 -1.134 . . . . 0.0 109.496 179.749 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.034 HD23 ' HB2' ' A' ' 81' ' ' ALA . 11.1 mt -123.6 121.2 34.96 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 118.639 -1.224 . . . . 0.0 110.408 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.804 ' CG1' HG21 ' A' ' 31' ' ' THR . 4.1 mm -83.34 -29.32 7.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.776 HG22 ' O ' ' A' ' 65' ' ' THR 0.267 1.9 m -99.37 35.87 1.86 Allowed 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.868 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.947 HG23 ' O ' ' A' ' 63' ' ' LEU . 44.7 t -37.79 155.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-O 121.489 0.662 . . . . 0.0 110.995 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.623 ' ND2' ' O ' ' A' ' 66' ' ' VAL . 0.4 OUTLIER 36.46 53.97 2.56 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 122.065 -0.397 . . . . 0.0 111.378 179.302 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.826 ' CG ' HD12 ' A' ' 79' ' ' ILE . 15.7 Cg_exo -55.05 161.56 6.44 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 N-CA-C 108.472 -1.395 . . . . 0.0 108.472 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.919 HG23 ' O ' ' A' ' 45' ' ' CYS . 1.0 OUTLIER -142.79 145.8 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 118.844 -1.143 . . . . 0.0 112.813 -178.431 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.06 HG23 ' CD1' ' A' ' 47' ' ' ILE . 55.8 t -101.38 160.59 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 176.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.452 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 2.8 m -116.09 -19.48 10.28 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.653 -1.279 . . . . 0.0 111.326 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 3.2 mt-10 -137.61 14.71 2.94 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.831 -1.168 . . . . 0.0 111.272 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.529 ' O ' ' O ' ' A' ' 38' ' ' TYR . 3.2 mtmt 75.11 -11.3 1.09 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.517 -0.739 . . . . 0.0 111.03 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.489 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 6.4 t0 -133.67 0.92 3.32 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.979 -1.076 . . . . 0.0 110.204 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.561 ' O ' HG23 ' A' ' 77' ' ' VAL . 25.1 t -72.83 108.76 4.87 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.202 -0.937 . . . . 0.0 109.528 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.717 ' HB3' HG21 ' A' ' 21' ' ' VAL . 4.2 Cg_endo -52.16 113.59 1.26 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.766 1.403 . . . . 0.0 109.921 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 75' ' ' SER . 62.0 t -99.35 153.67 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.268 -0.895 . . . . 0.0 110.982 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.652 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.3 m-20 -112.39 133.11 54.66 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.912 HG21 ' CE2' ' A' ' 49' ' ' PHE . 7.2 mm -115.47 121.86 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.1 -1.625 . . . . 0.0 111.588 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.915 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.0 OUTLIER -99.15 106.59 18.79 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.681 -0.637 . . . . 0.0 109.815 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 1.034 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -123.2 156.25 35.49 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.989 -1.069 . . . . 0.0 111.178 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.54 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 4.7 tt0 -101.64 101.03 15.83 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.632 -0.668 . . . . 0.0 110.283 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.555 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 23.3 Cg_endo -67.82 151.22 78.72 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 124.045 1.55 . . . . 0.0 110.467 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.534 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 15.2 Cg_endo . . . . . 0 C--N 1.305 -1.716 0 O-C-N 124.047 1.551 . . . . 0.0 110.337 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 10.2 m-85 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.222 0.534 . . . . 0.0 110.163 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.809 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 1.6 mp -74.16 111.47 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.152 -0.968 . . . . 0.0 109.381 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.889 HD12 ' HG2' ' A' ' 50' ' ' GLU . 33.7 mt -92.23 146.8 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.243 -0.911 . . . . 0.0 110.435 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.082 HD11 HG21 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -134.71 137.1 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.617 -0.677 . . . . 0.0 109.54 -179.843 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 48' ' ' PRO . . . 85.91 -162.6 35.77 Favored Glycine 0 N--CA 1.482 1.735 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.56 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -120.27 147.92 23.71 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 O-C-N 121.146 -1.208 . . . . 0.0 110.179 -179.637 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.579 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.8 mt-10 -16.86 -58.31 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.149 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 6.9 Cg_endo -51.07 72.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 124.164 1.613 . . . . 0.0 111.992 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 89.36 -1.78 82.53 Favored Glycine 0 N--CA 1.494 2.551 0 O-C-N 121.032 -1.042 . . . . 0.0 110.809 178.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.51 ' HB3' ' C ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -45.83 159.3 0.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.986 -1.302 . . . . 0.0 110.042 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.695 HD13 ' CG2' ' A' ' 20' ' ' VAL . 10.2 mt -96.06 173.26 7.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 110.6 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.61 ' C ' HD12 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -154.57 131.03 10.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.388 -0.82 . . . . 0.0 110.007 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.61 HD12 ' C ' ' A' ' 100' ' ' LYS . 5.5 mp -134.33 121.46 21.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 0.0 110.432 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 10.8 t30 -89.78 130.94 35.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.285 -0.884 . . . . 0.0 110.141 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.428 ' CD1' HG21 ' A' ' 32' ' ' ILE . 10.7 t-105 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.227 -0.921 . . . . 0.0 110.205 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.579 ' HB3' ' CE1' ' A' ' 38' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.653 ' HA ' HG21 ' A' ' 94' ' ' VAL . 1.2 p -68.74 -5.65 21.78 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.479 -0.763 . . . . 0.0 111.755 -178.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.549 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -59.3 -149.74 0.01 OUTLIER Glycine 0 N--CA 1.48 1.623 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.572 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 1.4 tmpt? -123.61 160.77 26.38 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.37 -1.076 . . . . 0.0 108.929 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.065 ' CE2' HG23 ' A' ' 47' ' ' ILE . 34.5 m-85 -118.76 137.55 53.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.497 -1.377 . . . . 0.0 112.144 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.511 ' HE2' ' NE2' ' A' ' 37' ' ' GLN . 7.7 ttpp -109.21 119.33 39.2 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.703 -0.623 . . . . 0.0 109.435 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.425 ' HA ' HG12 ' A' ' 36' ' ' VAL . 27.4 t -59.46 129.54 21.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 120.709 -1.244 . . . . 0.0 108.836 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.635 HG23 ' HA ' ' A' ' 36' ' ' VAL . 64.3 t -104.75 -24.75 3.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.562 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 15.3 tttt -159.91 134.6 7.76 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 177.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -52.6 155.02 2.36 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.6 0.714 . . . . 0.0 111.094 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.609 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -47.87 133.85 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.967 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.921 ' HB3' ' HB ' ' A' ' 33' ' ' VAL . . . -106.84 173.33 6.37 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.5 pm0 -116.98 126.11 52.41 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.905 -1.122 . . . . 0.0 110.582 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.443 HG21 ' HG2' ' A' ' 80' ' ' GLU . 11.9 p -79.85 -163.74 0.57 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.355 -0.841 . . . . 0.0 110.035 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -110.44 31.56 5.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 109.874 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -139.84 10.36 2.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.344 -0.848 . . . . 0.0 110.447 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.85 -1.44 59.65 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.915 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -91.81 -175.46 4.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -1.117 . . . . 0.0 110.269 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.872 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -142.93 165.98 15.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.842 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.921 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 93.7 t -130.26 125.87 60.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 120.724 -1.235 . . . . 0.0 112.44 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.082 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -106.51 116.68 50.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.363 -0.836 . . . . 0.0 109.566 178.803 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 3.4 ttm180 -101.49 120.07 39.74 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.744 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.8 m -140.69 -173.68 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.536 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 1.9 tt0 -133.89 124.57 26.66 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.85 ' HB2' HG21 ' A' ' 70' ' ' VAL . 89.3 t80 -61.32 140.64 57.95 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.368 -1.333 . . . . 0.0 110.527 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 17' ' ' LYS . 3.3 mm-40 -134.74 83.34 2.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.491 -0.756 . . . . 0.0 109.805 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.549 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 174.0 -147.07 9.09 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.543 ' HA ' ' HD2' ' A' ' 73' ' ' LYS . 50.0 t0 -113.93 132.79 55.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.627 -0.925 . . . . 0.0 110.38 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.457 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . 165.01 -24.7 0.17 Allowed Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.726 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.608 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.5 OUTLIER 49.24 -156.13 0.01 OUTLIER Pre-proline 0 N--CA 1.487 1.395 0 O-C-N 120.598 -1.531 . . . . 0.0 108.105 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.608 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 74.6 Cg_exo -44.02 96.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.35 0 N-CA-C 109.283 -1.083 . . . . 0.0 109.283 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.726 ' O ' HG23 ' A' ' 69' ' ' ILE . 24.5 p -143.34 169.31 17.89 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.634 -0.666 . . . . 0.0 110.134 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.692 ' CG ' HD11 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -83.86 172.74 11.86 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.411 -0.806 . . . . 0.0 110.358 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.065 HG23 ' CE2' ' A' ' 18' ' ' PHE . 15.8 mm -114.76 126.6 27.71 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 111.957 -177.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.62 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 33.8 Cg_exo -63.02 144.6 93.23 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.993 1.523 . . . . 0.0 110.846 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.923 ' CD2' HG21 ' A' ' 79' ' ' ILE . 3.9 t80 -154.29 153.11 31.13 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.537 -0.727 . . . . 0.0 109.678 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.616 ' HG3' HD12 ' A' ' 91' ' ' ILE . 19.3 tp10 -166.37 98.06 0.59 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.928 -1.107 . . . . 0.0 110.546 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.719 HD11 ' HB1' ' A' ' 81' ' ' ALA . 4.8 mt . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.29 -0.881 . . . . 0.0 109.821 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.521 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.523 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -143.25 169.35 17.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -1.143 . . . . 0.0 110.373 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.751 HD21 ' CD1' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -120.89 121.26 37.68 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.479 179.39 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.915 HG12 HG21 ' A' ' 31' ' ' THR . 1.4 mp -85.53 -27.79 6.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 106.735 -1.579 . . . . 0.0 106.735 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.799 HG22 ' O ' ' A' ' 65' ' ' THR 0.254 2.3 m -110.93 39.79 2.17 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.283 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.738 ' N ' HD12 ' A' ' 63' ' ' LEU . 6.8 t -25.9 121.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 CA-C-O 121.711 0.767 . . . . 0.0 111.813 -178.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 7.2 t-20 41.8 69.96 1.88 Allowed Pre-proline 0 C--N 1.297 -1.696 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.77 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.726 ' HG3' HG23 ' A' ' 79' ' ' ILE . 1.2 Cg_endo -55.6 -171.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.725 1.382 . . . . 0.0 108.826 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.726 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.7 OUTLIER -143.53 145.62 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 118.926 -1.109 . . . . 0.0 112.44 -179.409 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.949 ' CG2' HD11 ' A' ' 47' ' ' ILE . 60.1 t -97.86 162.12 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 176.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.6 m -117.26 -17.21 10.24 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.666 -1.213 . . . . 0.0 111.351 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.54 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 15.4 mt-10 -142.03 16.87 2.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.875 -1.141 . . . . 0.0 111.054 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.543 ' HD2' ' HA ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER 75.71 -12.71 0.96 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.48 -0.763 . . . . 0.0 110.97 179.745 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.472 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 12.5 t70 -133.41 -1.94 3.13 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.051 -1.031 . . . . 0.0 110.234 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.608 ' O ' HG23 ' A' ' 77' ' ' VAL . 8.2 t -71.97 112.27 13.77 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.246 -0.909 . . . . 0.0 108.69 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.631 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 42.7 Cg_exo -49.03 126.29 14.89 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.9 1.473 . . . . 0.0 110.387 -178.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.705 HG21 HG22 ' A' ' 70' ' ' VAL . 58.2 t -115.65 143.37 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.072 -1.018 . . . . 0.0 111.254 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.672 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 1.5 m-20 -104.74 136.18 44.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.412 -0.805 . . . . 0.0 109.562 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.923 HG21 ' CD2' ' A' ' 49' ' ' PHE . 7.3 mt -115.41 116.94 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.134 -1.604 . . . . 0.0 111.552 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.712 ' HG3' HG22 ' A' ' 33' ' ' VAL . 3.8 tt0 -88.06 114.0 24.25 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.455 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.809 ' C ' HG22 ' A' ' 31' ' ' THR . . . -132.77 149.32 52.29 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.943 -1.098 . . . . 0.0 110.915 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.523 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 2.8 tp10 -99.99 99.15 8.6 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.305 -0.872 . . . . 0.0 110.196 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.541 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 21.9 Cg_endo -66.21 152.6 80.73 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.064 1.56 . . . . 0.0 110.494 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.521 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 17.8 Cg_endo . . . . . 0 C--N 1.305 -1.716 0 O-C-N 123.993 1.522 . . . . 0.0 110.241 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.42 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 2.9 m-85 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.154 0.502 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.643 HG21 ' CZ ' ' A' ' 49' ' ' PHE . 11.0 mt -74.33 138.7 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.267 -0.896 . . . . 0.0 109.67 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.616 HD12 ' HG3' ' A' ' 50' ' ' GLU . 14.6 mt -98.83 150.11 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.051 -1.031 . . . . 0.0 110.216 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.082 HD11 HG21 ' A' ' 34' ' ' ILE . 0.6 OUTLIER -138.61 142.73 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.49 -0.756 . . . . 0.0 109.928 -179.506 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.557 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 80.03 -157.15 40.84 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.653 HG21 ' HA ' ' A' ' 15' ' ' THR . 0.8 OUTLIER -129.08 157.33 41.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 121.077 -1.249 . . . . 0.0 110.023 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.537 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 4.0 mt-10 -33.05 -54.62 0.63 Allowed Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.635 -0.666 . . . . 0.0 110.442 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 62.0 Cg_exo -44.31 -37.94 10.82 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.154 1.607 . . . . 0.0 110.458 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.572 ' HA3' ' CG ' ' A' ' 17' ' ' LYS . . . -157.17 53.22 0.4 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.598 ' HB2' ' N ' ' A' ' 94' ' ' VAL . 0.6 OUTLIER -109.62 149.39 29.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.04 -1.271 . . . . 0.0 111.0 -178.678 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.898 HD21 ' O ' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -119.88 -163.05 0.96 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.197 -0.94 . . . . 0.0 109.869 178.847 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -146.49 153.72 40.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.519 -0.738 . . . . 0.0 110.284 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.813 HD13 HG13 ' A' ' 34' ' ' ILE . 1.1 mt -138.26 113.12 9.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.922 . . . . 0.0 110.162 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -87.36 130.5 34.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.869 . . . . 0.0 110.459 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.558 ' CE3' HG22 ' A' ' 24' ' ' ILE . 53.2 t-105 . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.336 -0.852 . . . . 0.0 110.073 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.577 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 31.1 m . . . . . 0 N--CA 1.488 1.452 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.511 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 77.6 p -101.14 -4.72 26.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.159 -0.963 . . . . 0.0 111.764 -178.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.573 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -60.13 -124.14 0.01 OUTLIER Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.567 ' HE3' ' N ' ' A' ' 18' ' ' PHE . 1.5 ttpt -134.74 154.7 51.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.043 -1.269 . . . . 0.0 109.774 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.074 ' CE2' HG23 ' A' ' 47' ' ' ILE . 37.2 m-85 -118.25 137.84 52.76 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.805 -1.185 . . . . 0.0 111.768 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.444 ' HE2' ' HB3' ' A' ' 37' ' ' GLN . 35.2 ttpt -107.95 119.53 39.71 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.548 -0.72 . . . . 0.0 109.274 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.824 ' CG2' HD13 ' A' ' 99' ' ' LEU . 43.4 t -60.12 124.76 15.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 120.736 -1.228 . . . . 0.0 109.364 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.78 HG23 ' HA ' ' A' ' 36' ' ' VAL . 88.6 t -95.35 -27.02 4.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.678 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 5.1 tttp -159.26 133.51 7.69 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -48.59 160.31 0.18 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.569 0.699 . . . . 0.0 111.367 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.704 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -56.53 133.13 20.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-O 121.662 0.744 . . . . 0.0 110.193 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.773 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -108.58 169.72 8.47 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.7 pm0 -115.09 134.37 55.23 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.556 -1.34 . . . . 0.0 110.591 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.942 HG21 ' CD ' ' A' ' 80' ' ' GLU . 16.1 p -92.42 171.92 8.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.44 -0.788 . . . . 0.0 110.255 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -86.98 26.78 1.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.213 -0.929 . . . . 0.0 110.529 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.93 6.82 5.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.237 -0.915 . . . . 0.0 110.192 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.93 5.81 59.54 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.902 HG22 ' C ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -101.78 178.42 4.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -1.124 . . . . 0.0 110.427 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.811 HD11 ' HG3' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -134.76 153.02 34.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.481 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.685 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 48.5 t -117.96 132.13 68.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 C-N-CA 119.167 -1.013 . . . . 0.0 112.076 -177.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.108 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -117.76 119.98 63.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.327 -0.858 . . . . 0.0 110.009 179.128 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.678 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -102.45 124.04 47.29 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.241 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.78 ' HA ' HG23 ' A' ' 21' ' ' VAL . 1.2 m -147.7 161.93 7.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.157 -0.964 . . . . 0.0 108.834 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.635 HE21 ' HD3' ' A' ' 76' ' ' PRO 0.271 11.6 tt0 -107.37 122.93 47.59 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -178.588 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.876 ' HB2' HG21 ' A' ' 70' ' ' VAL . 12.9 t80 -62.71 122.12 15.1 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 118.814 -1.154 . . . . 0.0 110.282 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.498 ' HB2' ' HE2' ' A' ' 17' ' ' LYS . 2.7 mm-40 -115.87 98.61 6.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 110.019 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.573 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 160.16 -151.97 22.69 Favored Glycine 0 N--CA 1.486 2.005 0 C-N-CA 119.282 -1.437 . . . . 0.0 110.074 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 1.5 m-20 -105.85 106.37 16.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.704 -0.88 . . . . 0.0 109.954 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 43' ' ' SER . . . -165.32 -41.51 0.02 OUTLIER Glycine 0 N--CA 1.489 2.175 0 C-N-CA 119.539 -1.315 . . . . 0.0 110.394 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.63 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 1.0 OUTLIER 49.3 -150.23 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.366 0 O-C-N 120.869 -1.371 . . . . 0.0 107.485 -179.442 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.63 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 51.7 Cg_exo -47.83 92.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -1.022 0 N-CA-C 108.431 -1.411 . . . . 0.0 108.431 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.709 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -153.91 173.98 15.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.683 -0.636 . . . . 0.0 109.396 -177.78 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.68 ' CG ' HD11 ' A' ' 69' ' ' ILE . 14.9 mttp -85.18 174.94 9.27 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.287 -0.883 . . . . 0.0 111.594 -178.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.074 HG23 ' CE2' ' A' ' 18' ' ' PHE . 14.5 mm -123.06 128.72 25.23 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.401 -0.812 . . . . 0.0 111.936 -178.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.622 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 37.7 Cg_exo -63.68 145.03 90.83 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.58 1.52 . . . . 0.0 111.24 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.733 ' CD2' HD21 ' A' ' 63' ' ' LEU . 10.6 t80 -155.46 146.1 22.14 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.407 -0.808 . . . . 0.0 110.434 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.584 ' CG ' ' CG2' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -156.84 111.22 2.73 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.006 -1.059 . . . . 0.0 110.367 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.829 HD11 ' HB1' ' A' ' 81' ' ' ALA . 5.7 mt . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.184 -0.947 . . . . 0.0 110.296 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.55 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.512 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -129.13 162.34 27.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -1.138 . . . . 0.0 110.408 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.742 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -124.51 112.7 17.18 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.45 -0.781 . . . . 0.0 109.609 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.899 ' CG1' HG21 ' A' ' 31' ' ' THR . 7.2 mm -72.23 -27.38 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 122.351 1.072 . . . . 0.0 108.287 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.647 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.258 0.8 OUTLIER -109.13 32.2 5.12 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.534 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 63' ' ' LEU . 33.6 t -14.99 112.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.817 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.541 ' ND2' ' HD3' ' A' ' 46' ' ' LYS . 14.5 t-20 44.71 69.13 2.67 Favored Pre-proline 0 C--N 1.297 -1.688 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.699 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.62 ' HG3' HG23 ' A' ' 79' ' ' ILE . 6.3 Cg_exo -48.95 -178.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 124.246 1.656 . . . . 0.0 109.484 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.709 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.9 OUTLIER -140.7 139.37 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 118.971 -1.092 . . . . 0.0 112.241 -178.831 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.014 ' CG2' HD11 ' A' ' 47' ' ' ILE . 47.3 t -92.23 172.53 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 176.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.481 ' N ' HG12 ' A' ' 70' ' ' VAL . 22.9 m -122.13 -24.04 5.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.769 -1.207 . . . . 0.0 110.968 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.592 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 3.9 mm-40 -130.09 -46.78 1.12 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.015 -1.053 . . . . 0.0 110.032 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.592 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.1 OUTLIER 155.59 -61.46 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.621 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 2.4 t0 -89.65 12.9 15.5 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.207 -0.933 . . . . 0.0 110.371 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 77' ' ' VAL . 48.0 t -72.65 108.95 5.03 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.149 -0.969 . . . . 0.0 108.821 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.635 ' HD3' HE21 ' A' ' 37' ' ' GLN . 9.7 Cg_endo -56.95 113.8 1.63 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.829 1.436 . . . . 0.0 110.469 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.557 HG21 HG22 ' A' ' 70' ' ' VAL . 57.7 t -102.8 148.14 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.377 -0.827 . . . . 0.0 110.937 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.658 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 1.9 m-20 -106.22 138.2 42.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.322 -0.861 . . . . 0.0 109.981 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.686 HG21 ' CD1' ' A' ' 49' ' ' PHE . 4.5 mt -118.09 119.51 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 117.778 -1.569 . . . . 0.0 111.41 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.942 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.7 tp10 -94.01 110.2 21.9 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.902 ' C ' HG22 ' A' ' 31' ' ' THR . . . -124.31 147.49 48.11 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.069 -1.019 . . . . 0.0 111.011 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.644 ' HB2' HG23 ' A' ' 31' ' ' THR . 23.6 tt0 -107.61 94.7 12.47 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.597 -0.689 . . . . 0.0 110.617 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.811 ' HG3' HD11 ' A' ' 32' ' ' ILE . 40.3 Cg_endo -72.51 153.88 55.16 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.971 1.511 . . . . 0.0 110.219 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.55 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 10.8 Cg_endo . . . . . 0 C--N 1.305 -1.727 0 O-C-N 123.963 1.507 . . . . 0.0 110.159 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.558 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 4.1 m-85 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.197 0.522 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.543 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 12.7 mm -74.74 108.87 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.159 -0.963 . . . . 0.0 109.477 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.584 ' CG2' ' CG ' ' A' ' 50' ' ' GLU . 32.5 mt -100.98 154.22 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.92 -1.112 . . . . 0.0 110.004 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.108 HD11 HG21 ' A' ' 34' ' ' ILE . 2.7 mt -140.28 150.61 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.258 -0.901 . . . . 0.0 110.447 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.546 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 77.65 -157.1 45.34 Favored Glycine 0 N--CA 1.485 1.9 0 C-N-CA 119.319 -1.42 . . . . 0.0 109.658 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.559 ' O ' ' N ' ' A' ' 98' ' ' GLN . 0.2 OUTLIER -130.36 157.08 42.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.116 -1.226 . . . . 0.0 110.318 -179.596 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.524 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 1.0 OUTLIER -30.47 -55.71 0.36 Allowed Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.847 -0.533 . . . . 0.0 110.723 -179.739 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 76.4 Cg_exo -41.02 -40.58 3.88 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 124.055 1.555 . . . . 0.0 110.615 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 17' ' ' LYS . . . -160.76 50.95 0.35 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.559 ' N ' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -94.56 149.5 21.18 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.976 -1.308 . . . . 0.0 110.903 -178.734 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.824 HD13 ' CG2' ' A' ' 20' ' ' VAL . 13.7 mt -94.44 177.74 5.84 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.553 -0.717 . . . . 0.0 109.941 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.742 ' C ' HD12 ' A' ' 101' ' ' LEU . 0.4 OUTLIER -148.21 119.91 8.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.396 -0.815 . . . . 0.0 111.123 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.742 HD12 ' C ' ' A' ' 100' ' ' LYS . 7.3 mp -128.81 -164.52 1.4 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 102' ' ' ASN . 14.5 p-10 -179.05 151.11 0.49 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.843 -1.161 . . . . 0.0 110.931 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.467 ' HA ' ' CE3' ' A' ' 103' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 110.047 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.581 ' HB3' ' CE1' ' A' ' 38' ' ' TYR . 22.9 m . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 121.336 0.589 . . . . 0.0 109.572 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.5 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 10.6 t -92.36 -7.95 46.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.357 -0.84 . . . . 0.0 111.564 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.56 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -60.52 -118.19 0.01 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.543 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -140.15 174.75 10.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.952 -1.323 . . . . 0.0 110.235 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.02 ' CE2' HG23 ' A' ' 47' ' ' ILE . 37.7 m-85 -134.84 138.59 44.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.038 -1.039 . . . . 0.0 111.406 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.496 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 2.9 ttpt -106.53 116.92 32.76 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.425 -0.797 . . . . 0.0 109.175 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.742 HG22 HD13 ' A' ' 99' ' ' LEU . 46.3 t -59.58 125.12 15.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 120.625 -1.297 . . . . 0.0 109.647 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.726 HG23 ' HA ' ' A' ' 36' ' ' VAL . 80.3 t -97.03 -28.23 3.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.627 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -153.38 137.72 16.64 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.236 177.178 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -56.08 158.77 3.74 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.3 0.572 . . . . 0.0 110.285 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.999 HG12 HD22 ' A' ' 101' ' ' LEU . 0.7 OUTLIER -55.6 130.35 17.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.274 -0.971 . . . . 0.0 109.795 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.804 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -108.18 168.11 9.53 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 12.3 pt-20 -112.69 132.43 55.2 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.782 -1.199 . . . . 0.0 110.423 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.956 HG21 ' CD ' ' A' ' 80' ' ' GLU . 21.5 p -86.91 175.75 8.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.526 -0.734 . . . . 0.0 110.238 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -89.16 29.1 1.11 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.299 -0.876 . . . . 0.0 110.203 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -133.6 5.55 3.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.23 -0.919 . . . . 0.0 110.326 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.34 -0.3 58.45 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.876 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -95.02 -175.94 3.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.208 -1.172 . . . . 0.0 110.472 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.804 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -139.46 153.41 23.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.648 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.621 HG23 ' CG2' ' A' ' 27' ' ' THR . 70.0 t -118.51 135.31 59.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 O-C-N 121.192 -0.943 . . . . 0.0 111.765 -178.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.077 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -119.97 118.75 58.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 O-C-N 121.382 -0.824 . . . . 0.0 110.049 179.2 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.627 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.6 OUTLIER -100.19 123.51 44.5 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.123 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.812 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.3 m -147.85 162.86 6.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 121.082 -1.011 . . . . 0.0 108.819 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 74' ' ' ASP 0.254 10.2 tt0 -109.75 130.67 55.49 Favored 'General case' 0 C--N 1.27 -2.867 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.631 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.924 ' HB2' HG21 ' A' ' 70' ' ' VAL . 9.6 t80 -59.06 121.11 10.44 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.412 -178.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.496 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 5.8 mt-10 -106.86 21.18 17.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.107 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.56 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -115.84 -161.48 12.86 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.516 ' N ' ' OH ' ' A' ' 38' ' ' TYR . 13.5 t0 -125.66 145.19 50.27 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.455 -1.026 . . . . 0.0 110.245 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.21 -5.91 0.67 Allowed Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.421 -1.371 . . . . 0.0 111.02 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.615 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.7 OUTLIER 51.33 -153.06 0.01 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 120.436 -1.626 . . . . 0.0 108.198 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.615 ' HD2' ' CB ' ' A' ' 43' ' ' SER . 83.1 Cg_exo -41.47 96.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.321 -0.9 0 N-CA-C 109.241 -1.1 . . . . 0.0 109.241 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.867 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -145.59 169.29 18.71 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.339 0.59 . . . . 0.0 109.701 -178.162 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.63 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -82.74 174.85 10.61 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.223 -0.923 . . . . 0.0 111.829 -178.9 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.096 ' CD1' HG23 ' A' ' 70' ' ' VAL . 13.3 mm -123.64 123.74 26.3 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.835 -0.541 . . . . 0.0 111.396 -178.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.619 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 31.7 Cg_exo -61.47 143.89 97.68 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.109 1.584 . . . . 0.0 110.368 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.991 ' CE1' HG21 ' A' ' 79' ' ' ILE . 5.3 t80 -152.06 159.83 43.6 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 110.469 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.488 ' HB3' ' HB ' ' A' ' 91' ' ' ILE . 32.0 tp10 -178.74 100.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 110.037 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.656 HD11 ' HB1' ' A' ' 81' ' ' ALA . 36.0 mt . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.179 -0.951 . . . . 0.0 110.245 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.473 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.587 ' O ' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -154.69 167.64 29.5 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.273 -1.133 . . . . 0.0 109.297 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.058 HD23 ' HB2' ' A' ' 81' ' ' ALA . 11.7 mt -121.52 121.88 38.47 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 118.746 -1.182 . . . . 0.0 110.737 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.876 HG12 HG21 ' A' ' 31' ' ' THR . 1.4 mp -82.09 -26.8 9.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.708 HG22 ' O ' ' A' ' 65' ' ' THR 0.256 1.0 OUTLIER -96.67 33.19 1.89 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.241 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 1.048 HG23 ' O ' ' A' ' 63' ' ' LEU . 8.9 t -34.72 140.97 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.032 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.621 ' ND2' ' O ' ' A' ' 67' ' ' ASN . 1.3 t30 56.99 46.34 2.07 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.608 -0.682 . . . . 0.0 110.422 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.582 ' CB ' ' CD1' ' A' ' 79' ' ' ILE . 9.2 Cg_endo -58.93 148.22 85.63 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.611 1.322 . . . . 0.0 108.979 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.867 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.7 OUTLIER -142.69 144.65 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 119.255 -0.978 . . . . 0.0 112.111 -178.151 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.096 HG23 ' CD1' ' A' ' 47' ' ' ILE . 54.4 t -94.2 153.02 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.94 -21.4 12.35 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 120.932 -1.105 . . . . 0.0 108.57 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.535 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 2.3 mt-10 -138.45 145.8 41.32 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.54 ' O ' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -54.23 -14.15 1.07 Allowed 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.989 -1.069 . . . . 0.0 110.773 -178.939 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.497 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 7.1 t70 -126.31 9.21 7.26 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.589 -1.32 . . . . 0.0 110.578 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.488 ' CB ' ' HB2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -73.18 111.86 13.35 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.119 -0.988 . . . . 0.0 108.776 178.945 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 22.2 Cg_exo -59.91 114.45 2.08 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.864 1.455 . . . . 0.0 110.536 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.678 HG21 HG22 ' A' ' 70' ' ' VAL . 53.0 t -95.79 150.99 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.23 -0.919 . . . . 0.0 110.54 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.656 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 11.2 m-80 -114.4 130.05 56.68 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.991 HG21 ' CE1' ' A' ' 49' ' ' PHE . 9.5 mm -112.73 118.28 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 117.638 -1.625 . . . . 0.0 111.934 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.956 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.7 tp10 -95.79 107.44 19.67 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 1.058 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -129.3 155.47 45.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.797 -1.19 . . . . 0.0 111.287 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 62' ' ' ARG . 43.8 tp10 -100.8 103.25 23.39 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.531 -0.731 . . . . 0.0 110.466 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.531 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 60.7 Cg_endo -77.68 152.44 29.26 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.958 1.504 . . . . 0.0 110.484 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.473 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 28.2 Cg_endo . . . . . 0 C--N 1.305 -1.738 0 O-C-N 123.993 1.523 . . . . 0.0 109.888 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.553 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 6.1 m-85 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.135 0.493 . . . . 0.0 109.992 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.792 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 2.0 mp -73.87 107.96 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.312 -0.868 . . . . 0.0 109.578 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.509 HG12 ' HG3' ' A' ' 100' ' ' LYS . 30.7 mt -91.97 148.29 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.264 -0.898 . . . . 0.0 110.468 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.077 HD11 HG21 ' A' ' 34' ' ' ILE . 1.8 mt -133.28 140.64 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.565 -0.709 . . . . 0.0 109.606 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.54 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 82.13 -161.4 41.46 Favored Glycine 0 N--CA 1.481 1.655 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.54 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -122.61 149.84 26.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 O-C-N 121.225 -1.162 . . . . 0.0 110.181 -179.627 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.578 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.9 OUTLIER -17.03 -58.24 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.189 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 8.2 Cg_endo -51.65 71.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 124.219 1.641 . . . . 0.0 112.171 179.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 89.51 1.23 78.24 Favored Glycine 0 N--CA 1.494 2.511 0 O-C-N 120.943 -1.098 . . . . 0.0 110.878 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.513 ' HB3' ' C ' ' A' ' 94' ' ' VAL . 0.3 OUTLIER -48.63 159.68 0.22 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.975 -1.309 . . . . 0.0 110.27 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.742 HD13 HG22 ' A' ' 20' ' ' VAL . 13.0 mt -96.14 176.91 5.91 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.296 -0.877 . . . . 0.0 110.418 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.509 ' HG3' HG12 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -157.19 138.8 14.02 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.309 -0.869 . . . . 0.0 110.408 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.999 HD22 HG12 ' A' ' 24' ' ' ILE . 3.5 mp -141.06 118.1 11.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.247 -0.908 . . . . 0.0 110.026 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 33.5 t30 -87.44 129.74 34.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 110.759 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 8.5 t-105 . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 0.0 109.739 179.596 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.734 ' SG ' HD13 ' A' ' 47' ' ' ILE . 56.2 m . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 16' ' ' GLY . 3.2 t -79.13 -11.34 59.98 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.067 -1.02 . . . . 0.0 111.419 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.531 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -60.93 -131.76 0.01 OUTLIER Glycine 0 N--CA 1.485 1.944 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.539 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -130.1 -177.88 4.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -1.167 . . . . 0.0 109.809 -179.73 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.995 ' CE2' HG23 ' A' ' 47' ' ' ILE . 32.5 m-85 -137.6 141.87 41.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.741 -1.224 . . . . 0.0 111.968 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.485 ' HB2' ' OE2' ' A' ' 39' ' ' GLU . 33.3 ttpt -113.44 118.28 34.06 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.607 ' CG2' HD13 ' A' ' 99' ' ' LEU . 40.9 t -59.47 125.01 14.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 120.576 -1.328 . . . . 0.0 109.036 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.565 ' HB ' ' CG ' ' A' ' 35' ' ' ARG . 62.8 t -98.26 -27.16 3.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.608 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 3.0 tttp -156.77 133.12 9.9 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -50.87 162.13 0.3 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.716 0.769 . . . . 0.0 111.411 -178.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.656 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.7 OUTLIER -57.73 132.22 22.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 121.584 0.707 . . . . 0.0 110.289 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.603 ' HB3' ' HB ' ' A' ' 33' ' ' VAL . . . -109.17 163.17 13.59 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 5.3 pm0 -112.46 134.11 54.17 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.344 -1.472 . . . . 0.0 110.553 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.908 HG21 ' CD ' ' A' ' 80' ' ' GLU . 4.7 p -94.22 165.21 12.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.524 -0.735 . . . . 0.0 110.336 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -78.58 -1.02 32.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.42 -0.8 . . . . 0.0 110.123 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.06 3.51 55.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.9 . . . . 0.0 110.34 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.491 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 88.88 25.81 28.48 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.866 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -121.77 -177.17 3.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.54 -0.976 . . . . 0.0 110.363 -179.779 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.747 HD12 HD11 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -136.34 142.73 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.638 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.629 HG23 ' CG2' ' A' ' 27' ' ' THR . 43.0 t -110.26 133.81 54.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 O-C-N 121.47 -0.768 . . . . 0.0 112.279 -177.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.093 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -118.74 119.54 61.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 O-C-N 121.339 -0.85 . . . . 0.0 109.865 178.738 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.608 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 1.0 OUTLIER -101.86 123.34 45.62 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 179.428 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.781 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.5 m -148.79 161.45 5.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 108.773 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.488 ' N ' HG23 ' A' ' 21' ' ' VAL 0.254 1.0 OUTLIER -106.75 124.6 49.85 Favored 'General case' 0 C--N 1.273 -2.757 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -179.43 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.981 ' HB2' HG21 ' A' ' 70' ' ' VAL . 2.1 t80 -61.15 125.52 24.03 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.017 -1.073 . . . . 0.0 110.425 -178.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.485 ' OE2' ' HB2' ' A' ' 19' ' ' LYS . 22.2 mm-40 -98.08 -148.91 0.33 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.022 -1.049 . . . . 0.0 109.19 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.531 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 44.24 -145.5 1.77 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.471 ' HA ' ' HD2' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -134.52 143.62 47.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.679 -0.895 . . . . 0.0 110.139 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.94 -25.32 0.04 OUTLIER Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.42 -1.372 . . . . 0.0 110.95 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.617 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.4 OUTLIER 56.24 -156.1 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 120.726 -1.455 . . . . 0.0 108.267 -179.545 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.617 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 50.9 Cg_exo -48.45 92.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.506 0 N-CA-C 109.61 -0.958 . . . . 0.0 109.61 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.789 ' O ' HG23 ' A' ' 69' ' ' ILE . 21.8 p -143.32 167.75 21.43 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.422 -0.799 . . . . 0.0 110.389 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.699 ' CG ' HD11 ' A' ' 69' ' ' ILE . 47.0 mttp -85.38 154.99 21.5 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 122.142 0.972 . . . . 0.0 111.176 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.053 ' CD1' HG23 ' A' ' 70' ' ' VAL . 12.4 mm -101.92 123.32 44.14 Favored Pre-proline 0 C--N 1.297 -1.699 0 O-C-N 121.591 -0.693 . . . . 0.0 111.782 -177.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.626 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 32.2 Cg_exo -61.59 149.32 90.3 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.181 1.621 . . . . 0.0 110.457 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.999 ' CD1' HD11 ' A' ' 63' ' ' LEU . 5.9 t80 -159.4 155.25 26.34 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.389 -0.82 . . . . 0.0 110.165 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.772 ' O ' HD12 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -177.67 106.62 0.05 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.277 -0.889 . . . . 0.0 109.873 179.721 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 51' ' ' ILE . 3.0 mt . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.349 -0.844 . . . . 0.0 110.126 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.446 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.623 ' O ' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -159.19 166.57 31.14 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.256 -1.143 . . . . 0.0 109.617 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.018 HD23 ' HB2' ' A' ' 81' ' ' ALA . 11.3 mt -122.77 123.92 42.16 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 118.819 -1.152 . . . . 0.0 111.077 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.866 HG12 HG21 ' A' ' 31' ' ' THR . 1.5 mp -85.22 -28.45 6.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.774 HG22 ' O ' ' A' ' 65' ' ' THR 0.257 1.8 m -99.32 35.69 1.89 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.662 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.925 HG23 ' O ' ' A' ' 63' ' ' LEU . 43.0 t -37.85 152.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.667 0.746 . . . . 0.0 111.231 -178.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.619 ' ND2' ' O ' ' A' ' 66' ' ' VAL . 0.4 OUTLIER 37.22 52.35 2.46 Favored Pre-proline 0 C--N 1.302 -1.47 0 O-C-N 121.968 -0.458 . . . . 0.0 111.568 179.526 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.927 ' CG ' HD12 ' A' ' 79' ' ' ILE . 1.9 Cg_endo -59.85 162.98 14.55 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 N-CA-C 108.363 -1.437 . . . . 0.0 108.363 178.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.789 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.8 OUTLIER -143.94 148.66 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 C-N-CA 118.817 -1.153 . . . . 0.0 112.744 -178.471 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.053 HG23 ' CD1' ' A' ' 47' ' ' ILE . 44.0 t -102.46 159.43 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 175.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.3 m -112.89 -19.85 11.8 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.809 -1.156 . . . . 0.0 111.448 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 16.3 mt-10 -131.38 15.14 5.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.777 -1.202 . . . . 0.0 111.502 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.535 ' O ' ' O ' ' A' ' 38' ' ' TYR . 2.3 ttpt 71.56 -5.58 1.6 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.221 -0.925 . . . . 0.0 111.034 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.477 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 7.8 t0 -137.76 -1.2 2.05 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.877 -1.14 . . . . 0.0 110.257 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.481 ' O ' HG23 ' A' ' 77' ' ' VAL . 47.7 t -72.6 112.26 14.32 Favored Pre-proline 0 N--CA 1.486 1.363 0 O-C-N 121.208 -0.932 . . . . 0.0 109.362 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 32.6 Cg_exo -51.56 111.8 0.67 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.82 1.431 . . . . 0.0 109.915 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.889 HG21 HG22 ' A' ' 70' ' ' VAL . 92.5 t -95.15 143.46 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.325 -0.859 . . . . 0.0 110.997 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.643 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 8.2 m-20 -105.9 131.25 53.45 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.945 HG21 ' CD2' ' A' ' 49' ' ' PHE . 10.5 mm -116.35 119.89 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 117.567 -1.653 . . . . 0.0 111.767 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.908 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.1 tp10 -94.44 110.79 22.55 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.16 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 1.018 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -125.28 159.9 30.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.926 -1.109 . . . . 0.0 110.752 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.555 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -93.68 113.9 61.57 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.527 -0.733 . . . . 0.0 110.323 -179.284 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.683 ' HB3' HD11 ' A' ' 32' ' ' ILE . 46.4 Cg_endo -73.3 133.03 18.64 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.853 1.449 . . . . 0.0 110.525 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.446 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 19.4 Cg_endo . . . . . 0 C--N 1.306 -1.706 0 O-C-N 123.925 1.487 . . . . 0.0 109.928 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.587 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 3.2 m-85 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.215 0.531 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.799 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 5.2 mt -74.08 111.34 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.164 -0.96 . . . . 0.0 109.442 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.772 HD12 ' O ' ' A' ' 50' ' ' GLU . 2.1 mp -90.99 140.23 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.949 . . . . 0.0 110.178 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.093 HD11 HG21 ' A' ' 34' ' ' ILE . 1.4 mt -126.44 138.03 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.423 -0.798 . . . . 0.0 109.83 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.578 ' O ' ' HB2' ' A' ' 48' ' ' PRO . . . 85.99 -163.71 36.56 Favored Glycine 0 N--CA 1.482 1.754 0 C-N-CA 119.112 -1.518 . . . . 0.0 109.488 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.547 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -118.62 146.95 22.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 O-C-N 121.135 -1.215 . . . . 0.0 110.16 -179.623 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.578 ' O ' ' N ' ' A' ' 97' ' ' GLY . 3.9 mt-10 -16.89 -58.47 0.04 OUTLIER Pre-proline 0 N--CA 1.501 2.103 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 6.8 Cg_endo -51.08 72.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 124.219 1.641 . . . . 0.0 112.034 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 89.42 -1.35 81.92 Favored Glycine 0 N--CA 1.494 2.538 0 O-C-N 120.995 -1.065 . . . . 0.0 110.865 178.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.503 ' HB3' ' C ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -45.79 159.19 0.07 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.891 -1.358 . . . . 0.0 109.932 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.607 HD13 ' CG2' ' A' ' 20' ' ' VAL . 10.9 mt -96.68 177.44 5.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.245 -0.91 . . . . 0.0 110.645 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.428 ' C ' HD12 ' A' ' 101' ' ' LEU . 3.3 tttt -154.59 135.49 13.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.415 -0.803 . . . . 0.0 110.115 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.617 HD22 HG12 ' A' ' 24' ' ' ILE . 4.8 mp -137.16 122.44 19.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.181 -0.949 . . . . 0.0 110.328 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 3.7 t-20 -87.92 125.25 34.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 110.277 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.485 ' CD1' HD13 ' A' ' 32' ' ' ILE . 20.7 t-105 . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.905 . . . . 0.0 110.075 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.592 ' HB3' ' CE1' ' A' ' 38' ' ' TYR . 1.7 m . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 121.155 0.502 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.539 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 0.6 OUTLIER -126.85 15.28 7.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -0.909 . . . . 0.0 111.129 -179.227 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.596 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -69.94 -96.04 0.05 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.56 ' CD ' ' HA3' ' A' ' 97' ' ' GLY . 1.1 ttmt -149.4 161.27 42.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.04 -1.271 . . . . 0.0 109.833 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.002 ' CE2' HG23 ' A' ' 47' ' ' ILE . 50.3 m-85 -126.36 147.82 49.69 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.866 -1.146 . . . . 0.0 111.584 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.481 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 15.0 ttpp -114.15 115.88 28.21 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.595 -0.69 . . . . 0.0 109.161 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.717 ' CG2' HD13 ' A' ' 99' ' ' LEU . 43.5 t -59.63 123.03 11.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 120.541 -1.349 . . . . 0.0 109.049 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.839 HG21 ' HB3' ' A' ' 76' ' ' PRO . 53.2 t -96.82 -26.02 4.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.584 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 4.0 tttp -158.63 133.56 8.34 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -52.17 157.82 1.28 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.524 0.678 . . . . 0.0 111.063 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.798 HG13 HD13 ' A' ' 90' ' ' ILE . 0.6 OUTLIER -48.85 132.72 6.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.132 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 1.046 ' HB3' ' HB ' ' A' ' 33' ' ' VAL . . . -102.8 169.86 8.35 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 7.0 pm0 -113.54 132.24 55.78 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.924 -1.11 . . . . 0.0 110.519 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.547 HG21 ' CD ' ' A' ' 80' ' ' GLU . 11.1 p -90.1 178.76 6.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.408 -0.807 . . . . 0.0 109.865 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -95.62 31.87 1.94 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.168 -0.957 . . . . 0.0 110.183 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.88 10.42 2.41 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.256 -0.902 . . . . 0.0 110.315 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.35 -0.86 60.17 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.922 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -96.04 -177.17 3.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.274 -1.133 . . . . 0.0 110.291 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.81 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -140.22 178.95 2.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.616 -1.254 . . . . 0.0 107.616 178.175 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.046 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 64.8 t -138.92 124.01 21.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 118.909 -1.117 . . . . 0.0 111.838 -178.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.107 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -106.69 115.16 47.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.203 -0.936 . . . . 0.0 109.974 179.132 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.584 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -98.94 118.17 35.11 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.815 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.5 m -145.04 155.31 13.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.342 -0.848 . . . . 0.0 109.032 -178.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.523 ' CG ' ' O ' ' A' ' 74' ' ' ASP 0.252 0.2 OUTLIER -103.5 123.41 46.84 Favored 'General case' 0 C--N 1.272 -2.776 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.277 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.75 ' HB2' HG21 ' A' ' 70' ' ' VAL . 23.8 t80 -60.37 120.57 10.13 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 118.783 -1.167 . . . . 0.0 110.481 -178.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 17' ' ' LYS . 4.1 mt-10 -91.56 -26.09 18.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.466 -0.771 . . . . 0.0 109.321 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.596 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -63.75 -161.3 0.38 Allowed Glycine 0 N--CA 1.484 1.834 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.52 ' N ' ' OH ' ' A' ' 38' ' ' TYR . 15.8 p-10 -127.55 134.76 49.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.511 -0.994 . . . . 0.0 110.162 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 43' ' ' SER . . . 171.83 -23.4 0.08 OUTLIER Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.458 -1.353 . . . . 0.0 110.575 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.612 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.6 OUTLIER 61.42 -154.38 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.688 -1.478 . . . . 0.0 108.096 -179.541 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.612 ' HD2' ' CB ' ' A' ' 43' ' ' SER . 87.6 Cg_exo -42.24 96.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -0.994 0 N-CA-C 109.042 -1.176 . . . . 0.0 109.042 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.959 ' O ' HG23 ' A' ' 69' ' ' ILE . 31.5 p -151.47 -178.8 6.89 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.919 -0.488 . . . . 0.0 109.864 -177.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.635 ' O ' HD13 ' A' ' 47' ' ' ILE . 12.0 mtpt -94.57 170.17 9.67 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.975 -1.078 . . . . 0.0 111.305 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.07 ' CD1' HG23 ' A' ' 70' ' ' VAL . 11.6 mm -122.84 130.41 24.63 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.444 -0.785 . . . . 0.0 112.384 -177.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.623 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 38.1 Cg_exo -64.16 143.01 82.76 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 124.197 1.63 . . . . 0.0 110.793 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 1.006 ' CZ ' HG23 ' A' ' 90' ' ' ILE . 16.5 t80 -152.99 162.17 41.65 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.288 -0.883 . . . . 0.0 110.501 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.822 ' HG2' HD12 ' A' ' 91' ' ' ILE . 37.2 tt0 178.61 89.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.131 -0.981 . . . . 0.0 110.459 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 1.06 HD11 ' HB1' ' A' ' 81' ' ' ALA . 6.7 mt . . . . . 0 N--CA 1.493 1.706 0 O-C-N 121.175 -0.953 . . . . 0.0 109.958 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 83' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -140.35 167.45 22.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -1.052 . . . . 0.0 109.985 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.884 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -117.28 120.68 38.98 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.382 -0.824 . . . . 0.0 108.928 179.414 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.922 HG12 HG21 ' A' ' 31' ' ' THR . 1.4 mp -81.6 -29.88 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.814 ' C ' HD12 ' A' ' 63' ' ' LEU 0.266 1.5 m -97.74 36.79 1.47 Allowed 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.807 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.884 HG23 ' O ' ' A' ' 63' ' ' LEU . 24.2 t -29.16 119.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.279 -178.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.502 ' OD1' ' HE3' ' A' ' 46' ' ' LYS . 3.8 t-20 59.62 69.1 1.34 Allowed Pre-proline 0 C--N 1.298 -1.632 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.969 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.676 ' HG3' HG23 ' A' ' 79' ' ' ILE . 5.3 Cg_exo -65.41 171.27 9.57 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.044 1.549 . . . . 0.0 109.575 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.959 HG23 ' O ' ' A' ' 45' ' ' CYS . 1.1 mt -145.56 141.22 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 118.99 -1.084 . . . . 0.0 112.264 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.07 HG23 ' CD1' ' A' ' 47' ' ' ILE . 46.2 t -93.07 165.54 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.438 ' O ' ' HD3' ' A' ' 44' ' ' PRO . 2.2 m -118.44 -24.34 6.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.782 -1.199 . . . . 0.0 111.113 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.526 ' O ' ' HB3' ' A' ' 73' ' ' LYS . 2.5 mt-10 -131.37 13.84 5.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.941 -1.099 . . . . 0.0 110.711 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.526 ' HB3' ' O ' ' A' ' 72' ' ' GLU . 14.3 ttpt 74.78 -10.69 1.15 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.657 -0.652 . . . . 0.0 111.074 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.523 ' O ' ' CG ' ' A' ' 37' ' ' GLN . 8.2 t0 -134.07 -3.24 2.82 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.971 -1.081 . . . . 0.0 110.359 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 77' ' ' VAL . 12.7 t -72.83 112.51 15.54 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.179 -0.951 . . . . 0.0 109.286 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.839 ' HB3' HG21 ' A' ' 21' ' ' VAL . 34.3 Cg_exo -51.04 111.41 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.858 1.452 . . . . 0.0 109.899 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 75' ' ' SER . 98.5 t -96.01 144.34 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.353 -0.842 . . . . 0.0 111.166 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.625 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.9 m120 -100.04 130.51 46.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.534 -0.729 . . . . 0.0 109.5 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.707 HG21 ' CD1' ' A' ' 49' ' ' PHE . 5.5 mt -109.66 116.21 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 117.902 -1.519 . . . . 0.0 110.912 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.778 ' OE1' HG22 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -84.08 117.25 23.32 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.812 179.476 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 1.06 ' HB1' HD11 ' A' ' 51' ' ' ILE . . . -135.92 146.85 47.78 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.959 -1.088 . . . . 0.0 111.248 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.629 ' HB2' HG23 ' A' ' 31' ' ' THR . 29.2 tt0 -106.09 86.93 2.19 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.452 -0.78 . . . . 0.0 110.727 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.672 ' HG3' HD11 ' A' ' 32' ' ' ILE . 56.8 Cg_endo -75.12 160.57 39.6 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.812 1.428 . . . . 0.0 110.348 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' A' ' 61' ' ' GLY . 12.5 Cg_endo . . . . . 0 C--N 1.304 -1.801 0 O-C-N 123.963 1.507 . . . . 0.0 110.0 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 15.8 m-85 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.233 0.54 . . . . 0.0 109.716 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 1.006 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 2.1 mp -74.09 108.29 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.926 . . . . 0.0 109.907 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.822 HD12 ' HG2' ' A' ' 50' ' ' GLU . 94.9 mt -89.17 142.53 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -0.899 . . . . 0.0 110.045 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.107 HD11 HG21 ' A' ' 34' ' ' ILE . 1.5 mt -133.24 141.0 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.4 -0.812 . . . . 0.0 110.111 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' A' ' 48' ' ' PRO . . . 80.59 -155.99 38.19 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' ' 15' ' ' THR . 0.1 OUTLIER -130.45 154.75 41.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.062 -1.258 . . . . 0.0 111.226 -179.394 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.568 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 1.7 mm-40 -28.44 -55.12 0.25 Allowed Pre-proline 0 N--CA 1.499 2.02 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.635 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 86.8 Cg_exo -34.02 -30.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.993 1.522 . . . . 0.0 111.011 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.56 ' HA3' ' CD ' ' A' ' 17' ' ' LYS . . . 179.34 37.83 0.07 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.371 -1.892 . . . . 0.0 108.371 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.524 ' HB2' ' N ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -72.15 160.3 32.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.807 -0.819 . . . . 0.0 110.881 -179.05 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.717 HD13 ' CG2' ' A' ' 20' ' ' VAL . 9.4 mt -101.16 179.29 4.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.392 -0.818 . . . . 0.0 110.139 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.706 ' C ' HD12 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -156.8 135.48 11.6 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.337 -0.852 . . . . 0.0 110.456 179.833 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.706 HD12 ' C ' ' A' ' 100' ' ' LYS . 5.7 mp -137.17 118.8 14.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.371 -0.831 . . . . 0.0 109.737 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 4.7 p-10 -88.25 131.94 34.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.853 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.457 ' HA ' ' CE3' ' A' ' 103' ' ' TRP . 3.5 t-105 . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.101 -1.0 . . . . 0.0 110.265 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.574 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 22.6 m . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 121.366 0.603 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.489 ' O ' ' O ' ' A' ' 16' ' ' GLY . 0.9 OUTLIER -86.65 -9.1 56.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.464 -0.773 . . . . 0.0 111.935 -178.359 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.584 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -59.55 -124.46 0.01 OUTLIER Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.489 -1.339 . . . . 0.0 109.84 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.552 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -135.75 173.86 11.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.018 -1.283 . . . . 0.0 109.99 -179.568 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.017 ' CE2' HG23 ' A' ' 47' ' ' ILE . 34.6 m-85 -133.44 136.89 45.47 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.969 -1.082 . . . . 0.0 111.51 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.467 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 23.4 ttpt -108.21 120.54 42.66 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.627 -0.671 . . . . 0.0 109.366 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.484 HG22 HD13 ' A' ' 99' ' ' LEU . 34.5 t -59.76 131.49 24.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.85 -1.156 . . . . 0.0 109.043 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.641 HG23 ' HA ' ' A' ' 36' ' ' VAL . 92.3 t -105.28 -26.39 3.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 1.8 tttp -157.37 133.61 9.65 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -51.94 159.58 0.84 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.723 0.773 . . . . 0.0 111.327 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.832 HG12 HD22 ' A' ' 101' ' ' LEU . 0.7 OUTLIER -55.79 132.04 19.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-O 121.577 0.703 . . . . 0.0 110.476 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' A' ' 33' ' ' VAL . . . -109.57 158.95 17.51 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.498 ' N ' ' OE1' ' A' ' 26' ' ' GLU . 7.0 pm0 -110.43 133.35 53.36 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 120.166 -1.584 . . . . 0.0 110.494 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.893 HG21 ' OE2' ' A' ' 80' ' ' GLU . 2.8 p -92.14 169.5 10.57 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.567 -0.708 . . . . 0.0 110.216 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.88 -16.34 60.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 110.538 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -80.41 0.47 33.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.085 -1.009 . . . . 0.0 110.34 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.73 8.1 60.99 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.888 HG22 ' C ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -98.39 175.34 6.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.314 -1.11 . . . . 0.0 110.381 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 1.008 HD13 ' CD1' ' A' ' 103' ' ' TRP . 0.0 OUTLIER -129.17 141.86 45.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.764 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.57 ' N ' ' O ' ' A' ' 25' ' ' ALA . 24.6 t -109.6 132.53 57.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 O-C-N 121.441 -0.787 . . . . 0.0 111.847 -177.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.081 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -118.28 121.29 66.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.435 -0.791 . . . . 0.0 109.413 178.799 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.574 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -105.67 111.19 23.78 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.866 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.5 m -131.09 -168.12 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.474 ' N ' HG23 ' A' ' 36' ' ' VAL . 4.2 tt0 -135.86 128.2 30.22 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.896 ' HB2' HG21 ' A' ' 70' ' ' VAL . 1.7 t80 -60.25 124.01 18.96 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 118.633 -1.227 . . . . 0.0 110.032 -178.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 17' ' ' LYS . 2.4 mm-40 -116.61 86.19 2.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -0.887 . . . . 0.0 110.09 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.584 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 165.0 -150.38 18.24 Favored Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.425 -1.369 . . . . 0.0 109.986 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.462 ' O ' ' OH ' ' A' ' 38' ' ' TYR . 0.5 OUTLIER -113.24 128.62 56.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.665 -0.903 . . . . 0.0 110.408 -179.75 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 43' ' ' SER . . . 177.77 -26.71 0.06 OUTLIER Glycine 0 N--CA 1.487 2.087 0 C-N-CA 119.555 -1.307 . . . . 0.0 110.57 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.599 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.5 OUTLIER 48.94 -154.89 0.01 OUTLIER Pre-proline 0 N--CA 1.487 1.378 0 O-C-N 120.706 -1.467 . . . . 0.0 107.779 -179.58 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.599 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 53.3 Cg_exo -46.84 94.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.259 0 N-CA-C 108.241 -1.484 . . . . 0.0 108.241 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.719 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -148.97 173.15 13.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.615 -0.678 . . . . 0.0 109.853 -177.681 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.704 ' HG3' HD11 ' A' ' 69' ' ' ILE . 28.5 mttm -87.82 175.13 7.97 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.309 -0.87 . . . . 0.0 111.61 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.07 HD11 ' CG2' ' A' ' 70' ' ' VAL . 16.0 mm -119.92 128.82 25.66 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.499 -0.75 . . . . 0.0 112.237 -177.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.62 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 29.8 Cg_exo -65.31 144.75 81.61 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 121.593 1.529 . . . . 0.0 110.993 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.638 ' CD1' HG21 ' A' ' 79' ' ' ILE . 10.9 t80 -155.69 159.01 39.19 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.226 -0.921 . . . . 0.0 110.088 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.758 ' HG2' HD12 ' A' ' 91' ' ' ILE . 21.3 tt0 -175.17 114.54 0.15 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.981 -1.074 . . . . 0.0 110.496 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.995 HG21 ' HB3' ' A' ' 83' ' ' PRO . 10.0 mt . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.28 -0.887 . . . . 0.0 110.057 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.534 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.493 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -122.91 164.27 18.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.13 -1.217 . . . . 0.0 110.65 -179.65 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.821 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -129.73 110.84 12.09 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.569 -0.707 . . . . 0.0 109.529 179.109 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.873 ' CG1' HG21 ' A' ' 31' ' ' THR . 5.5 mm -69.02 -33.34 58.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 122.342 1.068 . . . . 0.0 108.328 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.638 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.259 0.7 OUTLIER -100.99 31.33 3.65 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.375 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 63' ' ' LEU . 42.7 t -15.03 109.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.927 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.524 ' ND2' ' HD3' ' A' ' 46' ' ' LYS . 19.2 t-20 47.12 69.25 2.8 Favored Pre-proline 0 C--N 1.3 -1.58 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.785 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.561 ' O ' ' HA ' ' A' ' 46' ' ' LYS . 3.0 Cg_endo -50.06 -176.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.074 1.565 . . . . 0.0 109.538 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.719 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.7 OUTLIER -141.96 144.09 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 119.171 -1.012 . . . . 0.0 112.171 -178.869 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.07 ' CG2' HD11 ' A' ' 47' ' ' ILE . 21.5 t -100.97 166.29 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.9 m -123.84 -15.41 6.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.745 -1.222 . . . . 0.0 111.166 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 26.1 mt-10 -140.03 14.48 2.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.929 -1.107 . . . . 0.0 111.016 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.1 OUTLIER 74.34 -9.83 1.23 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.42 -0.8 . . . . 0.0 111.006 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.476 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 6.9 t70 -135.96 0.18 2.61 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.932 -1.105 . . . . 0.0 110.059 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.499 ' O ' HG23 ' A' ' 77' ' ' VAL . 22.0 t -72.54 108.21 4.05 Favored Pre-proline 0 N--CA 1.486 1.344 0 O-C-N 121.201 -0.937 . . . . 0.0 108.826 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.624 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 5.6 Cg_exo -45.07 130.71 10.72 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.757 1.398 . . . . 0.0 110.117 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.889 HG21 HG22 ' A' ' 70' ' ' VAL . 74.8 t -115.35 145.03 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.041 -1.037 . . . . 0.0 111.351 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.694 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.0 m-20 -106.52 133.25 51.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.516 -0.74 . . . . 0.0 109.597 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.663 ' HB ' HG22 ' A' ' 34' ' ' ILE . 3.6 mt -118.15 118.86 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 117.65 -1.62 . . . . 0.0 111.364 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.893 ' OE2' HG21 ' A' ' 27' ' ' THR . 1.7 tp10 -94.45 109.77 21.62 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.888 ' C ' HG22 ' A' ' 31' ' ' THR . . . -118.24 147.34 43.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.041 -1.037 . . . . 0.0 110.774 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.583 ' HB2' HG23 ' A' ' 31' ' ' THR . 4.6 tt0 -112.37 58.64 0.55 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.45 -0.781 . . . . 0.0 111.051 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.995 ' HB3' HG21 ' A' ' 51' ' ' ILE . 37.1 Cg_endo -69.73 162.02 43.66 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.727 1.383 . . . . 0.0 110.63 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.503 ' HD3' ' HA2' ' A' ' 61' ' ' GLY . 23.4 Cg_exo . . . . . 0 C--N 1.305 -1.726 0 O-C-N 124.096 1.577 . . . . 0.0 110.594 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.72 ' CE1' ' ND2' ' A' ' 102' ' ' ASN . 85.3 m-85 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.131 0.491 . . . . 0.0 109.842 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.855 HD11 HD12 ' A' ' 32' ' ' ILE . 88.1 mt -73.71 134.16 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.179 -0.951 . . . . 0.0 109.475 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.758 HD12 ' HG2' ' A' ' 50' ' ' GLU . 57.5 mt -106.42 145.71 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.122 -0.987 . . . . 0.0 110.981 -179.073 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.081 HD11 HG21 ' A' ' 34' ' ' ILE . 1.9 mt -132.77 139.21 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.538 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 83.22 -159.52 37.35 Favored Glycine 0 N--CA 1.481 1.665 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.55 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -123.86 150.08 28.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 121.183 -1.187 . . . . 0.0 110.194 -179.568 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.574 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.7 OUTLIER -19.1 -57.47 0.05 OUTLIER Pre-proline 0 N--CA 1.5 2.045 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 10.3 Cg_endo -53.18 70.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 124.214 1.639 . . . . 0.0 111.952 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 90.76 5.11 69.0 Favored Glycine 0 N--CA 1.494 2.531 0 O-C-N 121.012 -1.055 . . . . 0.0 110.985 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.503 ' HB3' ' C ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -51.46 160.77 0.55 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.998 -1.295 . . . . 0.0 110.187 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' A' ' 18' ' ' PHE . 8.4 mt -97.52 177.4 5.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.214 -0.929 . . . . 0.0 110.35 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -159.14 141.35 13.77 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.266 -0.896 . . . . 0.0 110.456 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.832 HD22 HG12 ' A' ' 24' ' ' ILE . 3.0 mp -141.11 120.82 13.4 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.242 -0.911 . . . . 0.0 110.239 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.72 ' ND2' ' CE1' ' A' ' 89' ' ' TYR . 20.3 t-20 -72.13 131.2 42.49 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.292 -0.88 . . . . 0.0 110.7 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 1.008 ' CD1' HD13 ' A' ' 32' ' ' ILE . 6.9 t-105 . . . . . 0 N--CA 1.492 1.63 0 O-C-N 120.823 -1.173 . . . . 0.0 111.193 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 4.0 m . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 16' ' ' GLY . 49.4 p -64.56 -11.31 33.24 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.491 -0.756 . . . . 0.0 111.33 -178.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.537 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -60.08 -145.97 0.01 OUTLIER Glycine 0 N--CA 1.481 1.675 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.546 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -127.91 174.42 9.18 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.299 -1.118 . . . . 0.0 109.345 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.075 ' CE2' HG23 ' A' ' 47' ' ' ILE . 46.9 m-85 -131.24 133.62 45.63 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.743 -1.223 . . . . 0.0 112.099 -179.318 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -108.01 121.62 45.17 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.575 ' CG2' HD13 ' A' ' 99' ' ' LEU . 48.0 t -59.66 130.39 23.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.196 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.626 HG23 ' HA ' ' A' ' 36' ' ' VAL . 69.7 t -105.21 -26.91 3.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.566 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 19.6 tttt -156.32 133.06 10.3 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.15 155.95 1.77 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.542 0.687 . . . . 0.0 111.215 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.69 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -50.98 132.51 12.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.536 -0.727 . . . . 0.0 109.862 179.839 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.83 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -107.23 170.58 7.87 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 5.2 pm0 -116.36 130.58 56.84 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.809 -1.182 . . . . 0.0 110.569 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.94 HG21 ' OE2' ' A' ' 80' ' ' GLU . 14.5 p -89.2 173.93 8.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.361 -0.837 . . . . 0.0 110.056 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -88.07 29.2 0.96 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.154 -0.966 . . . . 0.0 110.472 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -132.25 6.19 4.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.16 -0.962 . . . . 0.0 110.291 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.77 -2.46 60.3 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.996 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -92.54 -178.14 4.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.303 -1.116 . . . . 0.0 110.384 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.83 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -139.18 158.46 28.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.568 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.81 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 73.6 t -123.08 128.15 74.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 C-N-CA 118.933 -1.107 . . . . 0.0 112.372 -177.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.054 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -111.24 118.47 57.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 121.357 -0.84 . . . . 0.0 109.716 178.895 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.566 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 2.9 ttm180 -104.71 114.65 29.0 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.765 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.6 m -133.46 -168.46 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 O-C-N 121.469 -0.769 . . . . 0.0 109.31 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.478 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 9.8 tt0 -135.14 126.25 27.93 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.94 ' HB2' HG21 ' A' ' 70' ' ' VAL . 1.5 t80 -61.04 127.32 30.95 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.975 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 17' ' ' LYS . 3.5 mt-10 -125.28 89.63 3.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.044 -1.035 . . . . 0.0 110.172 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.537 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 162.45 -151.69 21.69 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.51 ' HA ' ' HD2' ' A' ' 73' ' ' LYS . 11.1 t0 -107.48 118.23 36.18 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.565 -0.962 . . . . 0.0 110.217 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.06 -36.48 0.04 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.601 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER 52.43 -158.15 0.01 OUTLIER Pre-proline 0 C--N 1.305 -1.346 0 O-C-N 120.945 -1.327 . . . . 0.0 108.665 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.601 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 76.2 Cg_exo -45.21 93.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.229 0 N-CA-C 109.376 -1.048 . . . . 0.0 109.376 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.735 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -154.92 175.65 13.52 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.611 -0.681 . . . . 0.0 109.811 -179.093 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.625 ' HG3' ' CD1' ' A' ' 69' ' ' ILE . 2.6 mttp -82.01 175.37 10.42 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.393 -0.817 . . . . 0.0 112.07 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.075 HG23 ' CE2' ' A' ' 18' ' ' PHE . 16.8 mm -120.03 128.01 26.07 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.636 -0.665 . . . . 0.0 111.672 -178.241 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.632 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 34.2 Cg_exo -63.06 145.1 93.84 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 124.043 1.549 . . . . 0.0 110.495 178.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.874 ' CD2' HG21 ' A' ' 79' ' ' ILE . 5.4 t80 -154.11 162.45 41.18 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.268 -0.895 . . . . 0.0 110.101 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.878 ' O ' HD12 ' A' ' 91' ' ' ILE . 7.0 tp10 -179.19 97.88 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.192 -0.943 . . . . 0.0 110.03 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 1.079 HD11 ' HB1' ' A' ' 81' ' ' ALA . 16.1 mt . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.161 -0.962 . . . . 0.0 110.575 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.51 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.528 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -137.75 168.29 19.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.197 -1.178 . . . . 0.0 110.416 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.843 HD12 ' N ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -122.59 122.68 39.43 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.581 -0.699 . . . . 0.0 109.295 179.161 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.996 HG12 HG21 ' A' ' 31' ' ' THR . 1.4 mp -85.3 -30.73 6.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.825 HG22 ' O ' ' A' ' 65' ' ' THR 0.262 2.9 m -107.75 42.87 1.27 Allowed 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.258 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.843 ' N ' HD12 ' A' ' 63' ' ' LEU . 18.7 t -30.07 121.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-O 121.604 0.716 . . . . 0.0 111.503 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.497 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 12.9 t-20 43.09 71.91 1.31 Allowed Pre-proline 0 C--N 1.297 -1.683 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.617 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.796 ' HG3' HG23 ' A' ' 79' ' ' ILE . 1.1 Cg_endo -56.0 -171.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.909 1.479 . . . . 0.0 108.967 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.735 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.8 OUTLIER -143.6 148.01 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 119.041 -1.064 . . . . 0.0 112.285 -179.241 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.004 ' CG2' HD11 ' A' ' 47' ' ' ILE . 54.3 t -104.79 164.69 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 176.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.3 m -118.89 -19.39 8.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.878 -1.139 . . . . 0.0 111.5 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.528 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 19.0 mt-10 -140.2 18.78 2.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.76 -1.213 . . . . 0.0 111.386 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.548 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 9.0 ttpt 72.61 -6.7 1.56 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.247 -0.908 . . . . 0.0 110.949 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.468 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 18.1 t0 -137.94 -2.2 1.92 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.0 -1.062 . . . . 0.0 110.33 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.553 ' O ' HG23 ' A' ' 77' ' ' VAL . 10.2 t -72.64 112.42 15.01 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.071 -1.018 . . . . 0.0 108.939 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.625 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 50.5 Cg_exo -47.82 128.2 15.64 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.9 1.474 . . . . 0.0 110.067 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.95 HG21 HG22 ' A' ' 70' ' ' VAL . 66.3 t -114.94 142.32 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.04 -1.038 . . . . 0.0 111.534 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.679 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.1 m-20 -104.99 133.43 49.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.468 -0.77 . . . . 0.0 109.312 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.874 HG21 ' CD2' ' A' ' 49' ' ' PHE . 5.5 mt -117.39 119.66 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.075 -1.641 . . . . 0.0 111.582 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.94 ' OE2' HG21 ' A' ' 27' ' ' THR . 1.9 tp10 -91.84 115.92 28.46 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.229 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 1.079 ' HB1' HD11 ' A' ' 51' ' ' ILE . . . -131.85 151.7 51.52 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.982 -1.074 . . . . 0.0 110.775 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.528 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 35.2 tt0 -100.76 103.09 22.18 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.234 -0.916 . . . . 0.0 110.247 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.536 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 42.8 Cg_endo -73.6 145.85 37.98 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.032 1.543 . . . . 0.0 110.655 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.51 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 43.8 Cg_endo . . . . . 0 C--N 1.304 -1.785 0 O-C-N 124.154 1.607 . . . . 0.0 110.256 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.61 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 8.5 m-85 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.242 0.544 . . . . 0.0 110.044 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.734 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 1.7 mp -74.32 121.94 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.194 -0.941 . . . . 0.0 109.81 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.878 HD12 ' O ' ' A' ' 50' ' ' GLU . 3.2 mt -101.06 145.88 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.17 -0.956 . . . . 0.0 110.04 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.054 HD11 HG21 ' A' ' 34' ' ' ILE . 4.0 mt -132.73 146.18 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.465 -0.772 . . . . 0.0 110.359 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.544 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 78.74 -161.05 47.59 Favored Glycine 0 N--CA 1.484 1.896 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.528 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.1 OUTLIER -124.19 140.98 45.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.187 -1.184 . . . . 0.0 110.866 -179.632 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.559 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.8 OUTLIER -16.6 -58.97 0.04 OUTLIER Pre-proline 0 N--CA 1.505 2.309 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.876 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 24.4 Cg_exo -32.32 -32.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 124.013 1.533 . . . . 0.0 110.956 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.546 ' HA3' ' CG ' ' A' ' 17' ' ' LYS . . . -175.67 35.98 0.1 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.58 ' HG3' HG23 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -71.43 164.69 25.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.697 -0.884 . . . . 0.0 110.74 -179.247 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.575 HD13 ' CG2' ' A' ' 20' ' ' VAL . 8.2 mt -100.99 176.95 5.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.432 -0.793 . . . . 0.0 110.128 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.469 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -154.84 135.59 13.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.318 -0.864 . . . . 0.0 110.259 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.643 HD12 ' O ' ' A' ' 90' ' ' ILE . 2.4 mp -142.02 122.87 14.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.267 -0.895 . . . . 0.0 110.231 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 7.4 p-10 -86.02 131.31 34.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.15 -0.969 . . . . 0.0 110.241 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 49.4 t-105 . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.949 . . . . 0.0 110.317 -179.991 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 56.4 m . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.515 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -83.35 -4.6 58.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.302 -0.874 . . . . 0.0 111.656 -178.553 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -61.23 -128.75 0.01 OUTLIER Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.544 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -123.24 176.29 6.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.235 -1.156 . . . . 0.0 109.971 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.98 ' CE2' HG23 ' A' ' 47' ' ' ILE . 34.4 m-85 -135.93 141.38 44.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.879 -1.138 . . . . 0.0 111.704 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -112.33 117.62 32.99 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.638 ' CG2' HD13 ' A' ' 99' ' ' LEU . 44.2 t -59.67 123.94 13.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 120.586 -1.321 . . . . 0.0 108.94 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.744 HG21 ' HB3' ' A' ' 76' ' ' PRO . 53.9 t -97.62 -26.63 3.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.605 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 18.8 tttt -157.17 133.21 9.56 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -50.62 161.69 0.31 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.694 0.759 . . . . 0.0 111.325 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.716 HG13 HD13 ' A' ' 90' ' ' ILE . 0.7 OUTLIER -55.83 132.64 19.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-O 121.716 0.769 . . . . 0.0 110.311 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.724 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -109.5 167.22 10.29 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 6.9 pm0 -113.91 130.37 56.51 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 120.595 -1.316 . . . . 0.0 110.681 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.534 HG22 HG23 ' A' ' 33' ' ' VAL . 8.4 p -81.72 -167.59 1.57 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.455 -0.778 . . . . 0.0 110.005 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -103.94 23.02 13.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 110.281 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -128.48 7.08 5.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.204 -0.935 . . . . 0.0 110.178 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.479 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 97.95 0.94 58.61 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.975 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -91.93 -177.28 4.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.285 -1.127 . . . . 0.0 110.254 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.824 HD12 HD11 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -140.69 150.4 20.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.611 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.703 HG22 ' HG3' ' A' ' 80' ' ' GLU . 69.7 t -116.5 131.71 68.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 O-C-N 121.151 -0.968 . . . . 0.0 111.875 -178.11 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.075 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -114.72 117.06 54.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.401 -0.812 . . . . 0.0 109.694 179.056 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.605 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -98.65 122.41 41.84 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.864 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.777 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.7 m -149.25 158.17 6.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.942 0.877 . . . . 0.0 109.022 -178.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.503 ' NE2' ' HD3' ' A' ' 76' ' ' PRO 0.256 2.7 tt0 -104.43 122.33 45.28 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.318 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.894 ' HB2' HG21 ' A' ' 70' ' ' VAL . 7.6 t80 -61.47 144.98 53.29 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.081 -1.047 . . . . 0.0 110.148 -178.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 17' ' ' LYS . 45.3 mm-40 -119.19 -143.8 0.36 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.276 -0.89 . . . . 0.0 108.848 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 43.86 -139.77 3.62 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.445 ' HA ' ' HD2' ' A' ' 73' ' ' LYS . 1.3 m-20 -135.18 143.35 46.4 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.737 -0.861 . . . . 0.0 110.001 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.02 -27.17 0.05 OUTLIER Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.475 -1.345 . . . . 0.0 110.626 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.643 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.4 OUTLIER 56.31 -153.88 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 120.637 -1.508 . . . . 0.0 108.324 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.643 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 38.9 Cg_exo -53.5 90.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 N-CA-C 109.981 -0.815 . . . . 0.0 109.981 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.703 ' O ' HG23 ' A' ' 69' ' ' ILE . 6.6 p -142.46 173.68 11.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.137 -0.977 . . . . 0.0 110.541 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.774 ' HG3' HD11 ' A' ' 69' ' ' ILE . 12.1 mtmm -84.42 168.97 15.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.411 -0.806 . . . . 0.0 111.347 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.031 HD11 ' CG2' ' A' ' 70' ' ' VAL . 13.3 mm -112.06 127.18 27.21 Favored Pre-proline 0 C--N 1.304 -1.391 0 O-C-N 121.241 -0.912 . . . . 0.0 112.31 -177.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.635 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 34.6 Cg_exo -63.71 144.17 88.55 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 124.055 1.555 . . . . 0.0 110.258 178.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.863 ' CD2' HG21 ' A' ' 79' ' ' ILE . 7.1 t80 -153.05 162.01 41.83 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.259 -0.9 . . . . 0.0 110.603 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.63 ' O ' HD12 ' A' ' 91' ' ' ILE . 9.4 tp10 -179.83 108.7 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.345 -0.847 . . . . 0.0 109.729 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 1.057 HD11 ' HB1' ' A' ' 81' ' ' ALA . 5.0 mt . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.064 -1.023 . . . . 0.0 110.547 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.541 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -149.43 170.16 19.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.216 -1.167 . . . . 0.0 110.812 -179.682 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.827 HD12 ' N ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -119.7 121.99 40.46 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.422 179.302 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.975 HG12 HG21 ' A' ' 31' ' ' THR . 1.3 mp -84.69 -30.86 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.83 HG22 ' O ' ' A' ' 65' ' ' THR 0.259 1.9 m -108.52 43.84 1.19 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.159 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.827 ' N ' HD12 ' A' ' 63' ' ' LEU . 9.0 t -29.52 135.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 CA-C-O 121.33 0.586 . . . . 0.0 111.396 -178.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.782 ' ND2' HG12 ' A' ' 66' ' ' VAL . 23.6 p30 26.52 73.14 0.37 Allowed Pre-proline 0 N--CA 1.49 1.538 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.753 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.581 ' O ' ' HA ' ' A' ' 46' ' ' LYS . 3.2 Cg_endo -57.1 -174.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.902 1.475 . . . . 0.0 108.821 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.774 HD11 ' HG3' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -140.83 142.57 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 C-N-CA 118.847 -1.141 . . . . 0.0 112.346 -179.071 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.031 ' CG2' HD11 ' A' ' 47' ' ' ILE . 46.6 t -98.63 160.05 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 176.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.5 m -113.8 -21.65 10.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.954 -1.092 . . . . 0.0 110.964 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.512 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 6.6 mt-10 -132.02 15.62 4.7 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.963 -1.086 . . . . 0.0 111.05 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.53 ' O ' ' O ' ' A' ' 38' ' ' TYR . 0.2 OUTLIER 72.37 -4.36 2.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.353 -0.842 . . . . 0.0 110.984 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.47 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 12.6 t70 -137.38 1.87 2.44 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.06 -1.025 . . . . 0.0 110.188 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.739 ' O ' HG23 ' A' ' 77' ' ' VAL . 40.3 t -73.0 109.28 5.87 Favored Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.192 -0.943 . . . . 0.0 109.454 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.744 ' HB3' HG21 ' A' ' 21' ' ' VAL . 3.7 Cg_endo -52.59 111.15 0.57 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.817 1.43 . . . . 0.0 109.713 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 75' ' ' SER . 48.7 t -102.65 145.49 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.331 -0.856 . . . . 0.0 111.712 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.652 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 1.5 m120 -101.93 134.12 45.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.488 -0.757 . . . . 0.0 109.207 179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.863 HG21 ' CD2' ' A' ' 49' ' ' PHE . 6.6 mt -114.85 117.42 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.21 -1.556 . . . . 0.0 111.626 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.703 ' HG3' HG22 ' A' ' 33' ' ' VAL . 2.6 tt0 -88.18 111.52 21.71 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.59 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 1.057 ' HB1' HD11 ' A' ' 51' ' ' ILE . . . -127.23 149.39 50.02 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.032 -1.043 . . . . 0.0 110.836 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -99.47 104.15 25.41 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.243 -0.91 . . . . 0.0 110.51 -179.692 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.537 ' HG3' ' CD1' ' A' ' 32' ' ' ILE . 74.6 Cg_endo -81.15 147.58 16.46 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.004 1.528 . . . . 0.0 110.609 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.541 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 9.7 Cg_endo . . . . . 0 C--N 1.305 -1.73 0 O-C-N 123.872 1.459 . . . . 0.0 109.769 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.52 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 3.4 m-85 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.133 0.492 . . . . 0.0 109.728 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.824 HD11 HD12 ' A' ' 32' ' ' ILE . 3.4 mt -73.91 120.04 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.148 -0.97 . . . . 0.0 109.575 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.63 HD12 ' O ' ' A' ' 50' ' ' GLU . 1.9 mp -98.53 140.16 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.046 -1.034 . . . . 0.0 110.048 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.075 HD11 HG21 ' A' ' 34' ' ' ILE . 1.2 mt -126.14 142.22 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.452 -0.78 . . . . 0.0 109.994 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.534 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 82.59 -160.36 39.48 Favored Glycine 0 N--CA 1.481 1.65 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.553 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -122.77 149.82 26.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 O-C-N 121.307 -1.113 . . . . 0.0 110.091 -179.652 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.569 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -19.19 -57.56 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.109 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 9.7 Cg_endo -53.84 69.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 124.137 1.598 . . . . 0.0 112.145 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 93.57 4.61 63.82 Favored Glycine 0 N--CA 1.495 2.6 0 O-C-N 120.876 -1.14 . . . . 0.0 111.033 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.505 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -53.87 159.78 1.61 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.046 -1.267 . . . . 0.0 110.193 179.873 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.638 HD13 ' CG2' ' A' ' 20' ' ' VAL . 9.1 mt -97.91 177.4 5.45 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.215 -0.928 . . . . 0.0 110.758 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.467 ' HG3' HG13 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -157.07 128.37 6.89 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.47 -0.769 . . . . 0.0 110.094 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 89' ' ' TYR . 4.7 mp -130.5 124.98 33.2 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.279 -0.888 . . . . 0.0 109.972 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.485 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 10.1 t-20 -90.91 132.21 36.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 110.89 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.466 ' HA ' ' CE3' ' A' ' 103' ' ' TRP . 3.4 t-105 . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.049 -1.032 . . . . 0.0 110.243 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.592 ' HB3' ' CE1' ' A' ' 38' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 121.209 0.528 . . . . 0.0 109.889 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 16' ' ' GLY . 14.8 t -107.71 -2.37 20.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.267 -0.895 . . . . 0.0 111.385 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.575 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -60.8 -125.08 0.01 OUTLIER Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.543 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -132.49 178.12 7.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.028 -1.278 . . . . 0.0 110.029 -179.793 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.043 ' CE2' HG23 ' A' ' 47' ' ' ILE . 34.1 m-85 -136.12 133.92 37.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.948 -1.095 . . . . 0.0 111.63 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.555 ' CE ' ' HB3' ' A' ' 37' ' ' GLN . 0.3 OUTLIER -104.26 119.71 39.56 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.622 -0.674 . . . . 0.0 109.444 179.2 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.596 HG22 HD13 ' A' ' 99' ' ' LEU . 41.6 t -59.72 131.12 24.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 118.588 -1.245 . . . . 0.0 108.275 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.624 HG23 ' HA ' ' A' ' 36' ' ' VAL . 75.9 t -105.27 -26.15 3.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.562 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 2.2 tttt -157.11 133.08 9.53 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -52.3 158.86 1.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.523 0.677 . . . . 0.0 111.304 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.68 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -54.39 132.38 17.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.588 0.708 . . . . 0.0 109.903 -179.964 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.848 ' HB3' ' HB ' ' A' ' 33' ' ' VAL . . . -107.29 169.7 8.41 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.5 pm0 -115.85 133.54 55.92 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.65 -1.281 . . . . 0.0 110.406 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.951 HG21 ' CD ' ' A' ' 80' ' ' GLU . 13.2 p -93.13 172.45 8.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.393 -0.817 . . . . 0.0 110.181 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -87.73 29.23 0.92 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.266 -0.896 . . . . 0.0 110.328 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.87 5.82 4.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.924 . . . . 0.0 110.179 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.88 8.06 59.47 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.926 HG22 ' C ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -102.66 -174.84 2.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -1.08 . . . . 0.0 110.081 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.773 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -141.91 156.91 20.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 178.632 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.848 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 76.3 t -121.69 128.18 75.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 O-C-N 120.974 -1.079 . . . . 0.0 112.222 -177.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.0 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -112.89 118.97 59.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 O-C-N 121.437 -0.789 . . . . 0.0 109.685 178.832 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 3.4 ttm180 -105.67 112.81 26.03 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.791 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.7 m -132.34 -168.01 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.476 -0.765 . . . . 0.0 109.422 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.555 ' HB3' ' CE ' ' A' ' 19' ' ' LYS . 33.0 tt0 -138.26 127.06 23.76 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.874 ' HB2' HG21 ' A' ' 70' ' ' VAL . 75.5 t80 -60.31 128.34 36.25 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 118.29 -1.364 . . . . 0.0 110.579 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.498 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 61.8 mm-40 -116.01 82.85 1.84 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.484 -0.76 . . . . 0.0 109.62 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.575 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 171.62 -145.01 8.48 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.472 ' O ' ' OH ' ' A' ' 38' ' ' TYR . 7.5 m-20 -128.54 140.83 51.6 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.637 -0.919 . . . . 0.0 110.56 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 166.9 -20.61 0.1 OUTLIER Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.689 -1.243 . . . . 0.0 110.66 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.606 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER 56.03 -157.98 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 120.705 -1.468 . . . . 0.0 108.413 -179.702 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 72.9 Cg_exo -44.35 94.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.262 0 N-CA-C 108.944 -1.214 . . . . 0.0 108.944 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.698 ' O ' HG23 ' A' ' 69' ' ' ILE . 26.3 p -141.17 165.88 26.31 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.746 -0.596 . . . . 0.0 110.286 -178.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.704 ' HG3' HD11 ' A' ' 69' ' ' ILE . 10.9 mttp -82.59 177.43 8.71 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.407 -0.808 . . . . 0.0 110.358 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.043 HG23 ' CE2' ' A' ' 18' ' ' PHE . 14.2 mm -121.51 127.88 25.89 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.102 -0.999 . . . . 0.0 111.92 -178.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.619 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 35.1 Cg_exo -63.06 143.72 91.23 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.881 1.464 . . . . 0.0 110.627 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.756 ' CD1' HD21 ' A' ' 63' ' ' LEU . 5.6 t80 -155.53 132.28 10.55 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.335 -0.853 . . . . 0.0 110.021 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.588 ' O ' HD12 ' A' ' 91' ' ' ILE . 0.8 OUTLIER -144.1 97.68 3.09 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.03 -1.044 . . . . 0.0 110.305 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.719 HD11 ' HB1' ' A' ' 81' ' ' ALA . 11.9 mt . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.274 -0.891 . . . . 0.0 110.184 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.525 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.512 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -130.78 166.95 19.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.268 -1.136 . . . . 0.0 110.157 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.758 HD22 ' CB ' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -128.42 111.22 13.08 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.346 -0.847 . . . . 0.0 109.934 179.701 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.915 ' CG1' HG21 ' A' ' 31' ' ' THR . 5.6 mm -71.08 -25.45 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 122.148 0.975 . . . . 0.0 108.525 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.641 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.253 0.7 OUTLIER -111.87 31.46 6.19 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.718 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 63' ' ' LEU . 32.6 t -13.83 112.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.186 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.539 ' ND2' ' HD3' ' A' ' 46' ' ' LYS . 12.5 t-20 43.78 68.66 2.87 Favored Pre-proline 0 C--N 1.298 -1.66 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.295 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.667 ' HG3' HG23 ' A' ' 79' ' ' ILE . 2.1 Cg_endo -51.41 -174.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.982 1.517 . . . . 0.0 109.142 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.704 HD11 ' HG3' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -142.28 144.41 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 119.088 -1.045 . . . . 0.0 112.488 -178.914 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.007 ' CG2' HD11 ' A' ' 47' ' ' ILE . 26.5 t -98.62 166.87 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 176.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.411 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 3.3 m -123.62 -18.9 5.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.842 -1.161 . . . . 0.0 111.12 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.539 ' O ' ' CD ' ' A' ' 73' ' ' LYS . 8.0 mt-10 -138.0 15.37 2.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.926 -1.109 . . . . 0.0 110.685 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.539 ' CD ' ' O ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER 75.05 -13.39 0.85 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.773 -0.579 . . . . 0.0 111.224 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.47 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 6.3 t70 -131.83 -0.07 3.87 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.89 -1.131 . . . . 0.0 110.163 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 77' ' ' VAL . 8.9 t -72.04 108.36 4.05 Favored Pre-proline 0 C--N 1.304 -1.372 0 O-C-N 121.257 -0.902 . . . . 0.0 108.707 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.639 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 2.0 Cg_endo -46.92 131.03 16.51 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.77 1.405 . . . . 0.0 110.297 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.627 HG21 HG22 ' A' ' 70' ' ' VAL . 63.2 t -118.39 144.81 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.099 -1.001 . . . . 0.0 111.296 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.682 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 4.9 m-80 -105.51 134.82 47.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.431 -0.793 . . . . 0.0 109.574 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.725 HG21 ' CD2' ' A' ' 49' ' ' PHE . 5.2 mt -118.37 119.05 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 119.957 -1.715 . . . . 0.0 111.344 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.951 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.7 tp10 -93.19 114.12 26.52 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.634 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.926 ' C ' HG22 ' A' ' 31' ' ' THR . . . -131.0 150.43 52.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.048 -1.033 . . . . 0.0 110.873 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 4.4 tt0 -101.09 100.2 12.56 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.34 -0.85 . . . . 0.0 110.084 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.539 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 32.4 Cg_endo -69.05 144.64 58.52 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.102 1.58 . . . . 0.0 110.58 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.525 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 19.0 Cg_endo . . . . . 0 C--N 1.306 -1.679 0 O-C-N 124.034 1.544 . . . . 0.0 110.229 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 21.6 m-85 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.227 0.537 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.779 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.8 mp -73.9 113.45 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.213 -0.93 . . . . 0.0 109.394 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.588 HD12 ' O ' ' A' ' 50' ' ' GLU . 9.5 mt -94.1 144.56 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.144 -0.972 . . . . 0.0 110.282 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.0 HD11 HG21 ' A' ' 34' ' ' ILE . 1.8 mt -128.65 141.25 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.406 -0.808 . . . . 0.0 109.697 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.546 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 82.2 -160.36 40.24 Favored Glycine 0 N--CA 1.483 1.786 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.563 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -122.58 148.24 26.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 O-C-N 121.218 -1.166 . . . . 0.0 109.918 -179.73 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.571 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.4 OUTLIER -16.38 -58.56 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.173 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.776 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 7.3 Cg_endo -51.01 73.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 124.131 1.595 . . . . 0.0 112.067 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 88.39 -0.27 83.14 Favored Glycine 0 N--CA 1.495 2.581 0 O-C-N 121.02 -1.05 . . . . 0.0 110.9 178.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.507 ' HB3' ' C ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -47.04 160.52 0.09 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.967 -1.314 . . . . 0.0 110.325 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.596 HD13 HG22 ' A' ' 20' ' ' VAL . 10.6 mt -96.9 177.69 5.54 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.218 -0.926 . . . . 0.0 110.363 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.486 ' HG3' HG12 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -158.72 136.25 10.16 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.297 -0.877 . . . . 0.0 110.104 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.779 HD12 ' O ' ' A' ' 90' ' ' ILE . 2.6 mp -141.48 121.5 13.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.148 -0.97 . . . . 0.0 110.393 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 1.2 p-10 -87.44 129.65 34.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.257 -0.902 . . . . 0.0 110.336 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 110.202 179.837 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 21.5 m . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.525 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 1.2 t -114.82 2.6 14.41 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.932 -1.105 . . . . 0.0 111.974 -178.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.573 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -65.07 -100.03 0.01 OUTLIER Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.104 -1.522 . . . . 0.0 109.437 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.585 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 1.1 tmpt? -141.1 161.86 36.85 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.077 -1.249 . . . . 0.0 109.807 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.995 ' CE2' HG23 ' A' ' 47' ' ' ILE . 18.7 m-85 -126.11 134.92 51.21 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.763 -1.211 . . . . 0.0 111.93 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.516 ' HE2' ' NE2' ' A' ' 37' ' ' GLN . 3.9 ttpt -109.4 120.04 41.3 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.566 -0.709 . . . . 0.0 109.652 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.748 ' CG2' HD13 ' A' ' 99' ' ' LEU . 49.0 t -60.08 131.9 25.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.866 -1.147 . . . . 0.0 108.927 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.602 HG23 ' HA ' ' A' ' 36' ' ' VAL . 72.4 t -105.55 -27.3 3.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.558 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 5.9 tttp -156.04 133.23 10.7 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 177.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -51.84 156.38 1.48 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.555 0.693 . . . . 0.0 111.284 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.692 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -52.88 132.61 15.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.527 -0.733 . . . . 0.0 109.991 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.824 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -109.5 170.87 7.78 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 0.7 OUTLIER -115.78 134.29 55.17 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.73 -1.231 . . . . 0.0 110.552 -179.735 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.955 HG21 ' CD ' ' A' ' 80' ' ' GLU . 14.5 p -93.46 172.33 8.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.502 -0.749 . . . . 0.0 110.372 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -88.6 29.89 0.96 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.328 -0.857 . . . . 0.0 110.191 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.76 5.48 4.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.278 -0.889 . . . . 0.0 110.104 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.06 14.01 52.97 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.942 HG21 ' CG1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -110.87 -178.82 3.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.397 -1.061 . . . . 0.0 110.292 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.824 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -137.44 152.69 27.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 178.605 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.661 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 52.9 t -118.15 130.92 72.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 121.051 -1.031 . . . . 0.0 112.357 -177.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.086 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -114.59 120.21 63.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.557 -0.715 . . . . 0.0 109.423 178.734 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.558 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -105.7 115.78 30.82 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.614 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.802 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.8 m -134.48 -170.74 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 C-N-CA 119.564 -0.854 . . . . 0.0 109.322 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.516 ' NE2' ' HE2' ' A' ' 19' ' ' LYS . 1.9 tt0 -132.42 127.32 35.11 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 1.024 ' HB2' HG21 ' A' ' 70' ' ' VAL . 1.5 t80 -60.63 122.49 14.84 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 118.703 -1.199 . . . . 0.0 110.113 -178.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 17' ' ' LYS . 4.0 mt-10 -112.29 38.62 2.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -0.867 . . . . 0.0 109.193 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.573 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -125.16 -160.68 10.79 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 37.3 p-10 -135.1 85.59 2.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.516 -0.991 . . . . 0.0 110.277 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 43' ' ' SER . . . -147.83 10.04 1.21 Allowed Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.725 -1.226 . . . . 0.0 110.307 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.605 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER 46.67 -158.61 0.01 OUTLIER Pre-proline 0 N--CA 1.487 1.42 0 O-C-N 120.834 -1.392 . . . . 0.0 108.951 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.605 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 87.9 Cg_exo -43.49 95.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 122.72 0.853 . . . . 0.0 110.54 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.693 ' O ' HG23 ' A' ' 69' ' ' ILE . 8.0 p -141.52 171.19 14.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.491 -0.756 . . . . 0.0 110.607 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.771 ' HG3' HD11 ' A' ' 69' ' ' ILE . 33.3 mttt -84.69 169.41 14.33 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.685 0.755 . . . . 0.0 111.627 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.043 HD11 ' CG2' ' A' ' 70' ' ' VAL . 12.7 mm -111.33 124.7 32.06 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.269 -0.894 . . . . 0.0 112.234 -177.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.64 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 34.5 Cg_exo -63.12 144.09 91.62 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.974 1.513 . . . . 0.0 110.815 178.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.894 ' CZ ' HG23 ' A' ' 90' ' ' ILE . 7.6 t80 -154.97 158.88 39.89 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.299 -0.876 . . . . 0.0 110.142 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.478 ' HB3' ' HB ' ' A' ' 91' ' ' ILE . 23.9 tp10 -172.91 107.21 0.16 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.092 -1.005 . . . . 0.0 110.493 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.805 HD11 ' HB1' ' A' ' 81' ' ' ALA . 54.1 mt . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.885 . . . . 0.0 110.222 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.511 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.518 ' CB ' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -135.35 161.3 35.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.349 -1.089 . . . . 0.0 110.165 179.9 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.77 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -123.4 111.46 16.39 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.365 -0.835 . . . . 0.0 109.864 179.698 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.942 ' CG1' HG21 ' A' ' 31' ' ' THR . 6.5 mm -70.55 -29.23 37.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 122.272 1.034 . . . . 0.0 108.297 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.632 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.257 0.7 OUTLIER -106.81 30.56 6.0 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.708 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 63' ' ' LEU . 39.3 t -13.04 111.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.281 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.537 ' ND2' ' HD3' ' A' ' 46' ' ' LYS . 12.6 t-20 43.43 69.32 2.39 Favored Pre-proline 0 C--N 1.298 -1.647 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.274 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.571 ' O ' ' HA ' ' A' ' 46' ' ' LYS . 1.6 Cg_endo -52.19 -175.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.962 1.506 . . . . 0.0 109.319 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.771 HD11 ' HG3' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -142.7 142.67 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.961 -179.316 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.043 ' CG2' HD11 ' A' ' 47' ' ' ILE . 30.8 t -99.76 161.11 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.409 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 5.6 m -115.65 -16.81 11.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.988 -1.07 . . . . 0.0 111.853 -178.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.522 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 14.1 mt-10 -141.3 19.42 2.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.665 -1.272 . . . . 0.0 111.687 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.586 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 0.0 OUTLIER 72.04 -6.37 1.52 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.15 -0.969 . . . . 0.0 111.103 179.73 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.477 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 4.9 t70 -137.8 -0.93 2.07 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.847 -1.158 . . . . 0.0 110.373 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.539 ' O ' HG23 ' A' ' 77' ' ' VAL . 40.2 t -72.37 112.3 14.26 Favored Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 121.17 -0.956 . . . . 0.0 109.027 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.605 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 45.7 Cg_exo -49.22 126.69 16.03 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.885 1.466 . . . . 0.0 110.002 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.99 HG21 HG22 ' A' ' 70' ' ' VAL . 76.3 t -112.66 140.34 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.031 -1.043 . . . . 0.0 111.606 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.682 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 6.4 m-20 -105.38 133.82 49.51 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.455 -0.778 . . . . 0.0 109.377 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.667 ' HB ' HG22 ' A' ' 34' ' ' ILE . 4.4 mt -118.15 119.97 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 119.984 -1.697 . . . . 0.0 111.609 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.955 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.6 tp10 -94.07 110.16 21.88 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.896 ' C ' HG22 ' A' ' 31' ' ' THR . . . -125.4 147.37 49.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.986 -1.071 . . . . 0.0 111.041 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.518 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 3.0 tt0 -99.53 101.89 14.83 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 109.916 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.532 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 12.4 Cg_endo -61.11 143.83 99.01 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.012 1.533 . . . . 0.0 110.504 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.511 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 19.4 Cg_endo . . . . . 0 C--N 1.305 -1.759 0 O-C-N 124.051 1.553 . . . . 0.0 110.334 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 12.3 m-85 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.233 0.54 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.894 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 1.4 mp -74.27 110.97 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.222 -0.924 . . . . 0.0 109.748 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 87.1 mt -92.1 142.18 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 110.152 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.086 HD11 HG21 ' A' ' 34' ' ' ILE . 3.6 mt -132.51 141.27 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.386 -0.821 . . . . 0.0 109.983 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.543 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 80.95 -156.7 38.41 Favored Glycine 0 N--CA 1.484 1.868 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 98' ' ' GLN . 0.2 OUTLIER -130.59 156.52 42.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.129 -1.218 . . . . 0.0 110.338 -179.548 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.528 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 3.0 mt-10 -30.33 -55.81 0.35 Allowed Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.849 -0.532 . . . . 0.0 110.848 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 73.4 Cg_exo -40.56 -36.98 1.97 Allowed 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.052 1.553 . . . . 0.0 110.686 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.585 ' HA3' ' CG ' ' A' ' 17' ' ' LYS . . . -164.71 49.04 0.29 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.557 ' N ' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -93.85 151.9 19.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.204 -1.174 . . . . 0.0 111.08 -178.57 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.748 HD13 ' CG2' ' A' ' 20' ' ' VAL . 13.6 mt -100.54 179.7 4.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.492 -0.755 . . . . 0.0 110.089 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.575 ' C ' HD12 ' A' ' 101' ' ' LEU . 1.6 mtpt -152.8 135.79 15.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.43 -0.794 . . . . 0.0 110.334 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.654 HD22 HG12 ' A' ' 24' ' ' ILE . 5.2 mp -140.33 116.91 10.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.213 -0.93 . . . . 0.0 110.199 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 3.3 p-10 -87.82 120.26 28.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 0.0 110.318 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.655 ' CE3' HG22 ' A' ' 24' ' ' ILE . 50.7 t-105 . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.922 . . . . 0.0 110.227 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 20.3 m . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.527 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 0.5 OUTLIER -99.75 -1.14 38.5 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.021 -1.049 . . . . 0.0 112.363 -178.028 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.592 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -66.46 -108.12 0.01 OUTLIER Glycine 0 N--CA 1.493 2.44 0 C-N-CA 118.942 -1.599 . . . . 0.0 109.301 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.537 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -136.98 177.79 7.59 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.958 -1.319 . . . . 0.0 110.22 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.007 ' CE2' HG23 ' A' ' 47' ' ' ILE . 26.7 m-85 -137.57 144.62 42.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.012 -1.055 . . . . 0.0 111.826 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.459 ' HB2' ' CG ' ' A' ' 39' ' ' GLU . 11.5 ttpt -114.54 117.84 32.05 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.702 -0.624 . . . . 0.0 109.411 179.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.564 ' CG2' HD13 ' A' ' 99' ' ' LEU . 46.1 t -59.66 132.45 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.78 -1.2 . . . . 0.0 108.958 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.592 HG23 ' HA ' ' A' ' 36' ' ' VAL . 73.6 t -106.84 -26.24 3.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.561 ' HB3' ' CG ' ' A' ' 35' ' ' ARG . 3.4 tttt -156.87 133.15 9.81 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -52.12 156.49 1.6 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.65 0.738 . . . . 0.0 111.374 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.804 HG13 HD13 ' A' ' 90' ' ' ILE . 0.6 OUTLIER -52.99 132.79 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.505 -0.747 . . . . 0.0 109.944 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.788 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -109.62 170.9 7.77 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.5 pm0 -115.93 134.5 54.91 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.78 -1.2 . . . . 0.0 110.37 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.94 HG21 ' CD ' ' A' ' 80' ' ' GLU . 16.0 p -92.4 175.55 6.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.474 -0.766 . . . . 0.0 110.387 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -88.96 27.34 1.36 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.466 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -130.89 6.68 4.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.201 -0.937 . . . . 0.0 110.194 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.59 3.03 61.3 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.92 HG22 ' C ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -96.65 -177.59 3.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.335 -1.097 . . . . 0.0 110.31 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.788 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -138.88 153.84 25.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.668 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.702 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 55.5 t -119.78 130.68 73.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 O-C-N 121.003 -1.061 . . . . 0.0 112.41 -177.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.002 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -114.61 120.84 65.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 121.408 -0.807 . . . . 0.0 109.412 178.51 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.561 ' CG ' ' HB3' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -106.52 113.59 27.2 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.865 HG11 HD13 ' A' ' 92' ' ' ILE . 1.7 m -132.05 -169.78 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 C-N-CA 119.689 -0.805 . . . . 0.0 109.283 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.529 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 9.9 tt0 -134.83 127.66 31.23 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.962 ' HB2' HG21 ' A' ' 70' ' ' VAL . 1.6 t80 -60.46 124.02 19.07 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 118.796 -1.161 . . . . 0.0 110.033 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.459 ' CG ' ' HB2' ' A' ' 19' ' ' LYS . 22.6 mm-40 -103.5 -22.23 13.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.243 -0.911 . . . . 0.0 109.25 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.592 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -64.94 -161.2 0.57 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.557 ' HA ' ' CD ' ' A' ' 73' ' ' LYS . 3.3 p-10 -143.21 93.98 2.56 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.598 -0.943 . . . . 0.0 110.054 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -150.92 15.24 0.9 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.606 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER 48.39 -160.0 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.366 0 O-C-N 121.033 -1.274 . . . . 0.0 109.298 179.422 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 85.7 Cg_exo -43.19 95.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 122.946 0.971 . . . . 0.0 110.622 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.674 ' O ' HG23 ' A' ' 69' ' ' ILE . 11.6 p -140.94 170.92 14.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.536 -0.728 . . . . 0.0 110.637 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.769 ' HG3' HD11 ' A' ' 69' ' ' ILE . 20.7 mttt -87.32 165.71 15.42 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.438 -0.789 . . . . 0.0 111.413 -178.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.051 HD11 ' CG2' ' A' ' 70' ' ' VAL . 12.6 mm -108.64 124.87 33.12 Favored Pre-proline 0 C--N 1.303 -1.415 0 O-C-N 121.18 -0.95 . . . . 0.0 112.643 -177.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.639 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 34.7 Cg_exo -63.24 146.17 93.72 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 124.023 1.538 . . . . 0.0 110.436 178.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.914 ' CZ ' HG23 ' A' ' 90' ' ' ILE . 10.2 t80 -155.22 160.22 40.69 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.147 -0.971 . . . . 0.0 110.6 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.938 ' O ' HD12 ' A' ' 91' ' ' ILE . 19.2 tp10 -177.69 115.49 0.09 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.307 -0.87 . . . . 0.0 110.212 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.639 HD11 ' HB1' ' A' ' 81' ' ' ALA . 43.4 mt . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.205 -0.934 . . . . 0.0 110.372 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.511 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -115.33 167.4 10.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -1.182 . . . . 0.0 110.039 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.756 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -130.93 110.76 11.5 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.387 -0.821 . . . . 0.0 109.916 179.672 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.911 ' CG1' HG21 ' A' ' 31' ' ' THR . 4.9 mm -69.98 -25.6 28.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-O 122.15 0.976 . . . . 0.0 108.53 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.627 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.251 0.6 OUTLIER -110.95 30.1 7.17 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.658 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 63' ' ' LEU . 40.3 t -11.9 112.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.394 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.534 ' ND2' ' HD3' ' A' ' 46' ' ' LYS . 13.7 t-20 41.63 69.63 1.99 Allowed Pre-proline 0 C--N 1.299 -1.598 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.463 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.554 ' O ' ' HA ' ' A' ' 46' ' ' LYS . 1.4 Cg_endo -51.88 -174.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.886 1.466 . . . . 0.0 109.456 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.769 HD11 ' HG3' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -142.81 143.58 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 119.148 -1.021 . . . . 0.0 112.06 -179.136 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.051 ' CG2' HD11 ' A' ' 47' ' ' ILE . 22.2 t -101.91 159.6 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 176.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.3 m -116.67 -14.53 10.82 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.046 -1.062 . . . . 0.0 111.853 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 73' ' ' LYS . 19.6 mt-10 -142.0 22.51 2.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.619 -1.301 . . . . 0.0 111.756 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.598 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 0.8 OUTLIER 66.7 -1.57 1.29 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.095 -1.003 . . . . 0.0 111.087 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.465 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 9.7 t0 -142.47 -0.35 1.24 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.944 -1.098 . . . . 0.0 110.574 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.613 ' O ' HG23 ' A' ' 77' ' ' VAL . 39.4 t -72.76 108.43 4.41 Favored Pre-proline 0 N--CA 1.486 1.344 0 O-C-N 120.977 -1.077 . . . . 0.0 109.218 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.596 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 2.3 Cg_endo -47.25 127.41 13.01 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.743 1.391 . . . . 0.0 109.684 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.943 HG21 HG22 ' A' ' 70' ' ' VAL . 58.7 t -115.46 143.43 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.954 -1.091 . . . . 0.0 111.611 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.679 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 4.0 m120 -106.18 134.12 49.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.551 -0.718 . . . . 0.0 109.525 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.67 ' HB ' HG22 ' A' ' 34' ' ' ILE . 4.2 mt -117.5 119.75 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 119.988 -1.695 . . . . 0.0 111.402 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.94 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.8 tp10 -95.24 110.74 22.68 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.92 ' C ' HG22 ' A' ' 31' ' ' THR . . . -126.46 150.1 48.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.077 -1.014 . . . . 0.0 111.004 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.511 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 9.6 tp10 -101.83 101.68 19.45 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.354 -0.841 . . . . 0.0 110.127 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.533 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 20.3 Cg_endo -66.71 144.56 72.28 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.08 1.568 . . . . 0.0 110.427 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo . . . . . 0 C--N 1.303 -1.837 0 O-C-N 124.052 1.554 . . . . 0.0 110.327 179.908 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.521 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 8.1 m-85 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.231 0.539 . . . . 0.0 110.153 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.914 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 1.3 mp -74.16 108.39 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -0.906 . . . . 0.0 109.482 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.938 HD12 ' O ' ' A' ' 50' ' ' GLU . 7.0 mt -92.09 142.37 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.131 -0.98 . . . . 0.0 110.42 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.002 HD11 HG21 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -129.61 138.26 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.545 -0.722 . . . . 0.0 109.521 -179.905 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.524 ' O ' ' HB2' ' A' ' 48' ' ' PRO . . . 86.06 -161.87 34.9 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.554 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -121.89 148.38 25.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 O-C-N 121.264 -1.139 . . . . 0.0 110.129 -179.721 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.581 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.2 OUTLIER -18.07 -58.02 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.145 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 9.3 Cg_endo -52.62 70.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 124.198 1.631 . . . . 0.0 112.148 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 91.34 2.89 70.08 Favored Glycine 0 N--CA 1.495 2.584 0 O-C-N 120.875 -1.141 . . . . 0.0 110.912 178.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.521 ' HB2' ' N ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -51.64 159.12 0.82 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.965 -1.315 . . . . 0.0 110.229 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.564 HD13 ' CG2' ' A' ' 20' ' ' VAL . 5.7 mt -96.24 174.68 6.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.224 -0.922 . . . . 0.0 110.297 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.909 ' C ' HD12 ' A' ' 101' ' ' LEU . 3.8 ttmt -152.71 143.09 22.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.34 -0.85 . . . . 0.0 110.328 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.909 HD12 ' C ' ' A' ' 100' ' ' LYS . 5.6 mp -144.59 113.45 6.79 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.168 -0.957 . . . . 0.0 110.222 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 9.8 t-20 -79.64 131.18 35.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.243 -0.91 . . . . 0.0 110.334 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 0.0 110.196 179.941 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.587 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 35.8 m . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 121.355 0.598 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.534 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 39.6 p -95.79 -5.8 41.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 111.652 -178.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.598 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -61.21 -117.65 0.01 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.54 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -138.51 173.08 11.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.956 -1.32 . . . . 0.0 110.139 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.999 ' CE2' HG23 ' A' ' 47' ' ' ILE . 30.8 m-85 -132.69 141.51 48.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.012 -1.055 . . . . 0.0 111.693 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.474 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 14.9 ttpt -110.51 119.84 40.47 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.627 -0.67 . . . . 0.0 109.444 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.475 HG22 HD13 ' A' ' 99' ' ' LEU . 31.4 t -60.23 132.74 25.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 120.91 -1.119 . . . . 0.0 109.205 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.637 HG23 ' HA ' ' A' ' 36' ' ' VAL . 90.1 t -106.04 -27.12 3.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.582 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 14.1 tttt -156.96 133.45 9.95 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -51.26 160.17 0.57 Allowed 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.702 0.763 . . . . 0.0 111.72 -178.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.695 HG23 HG22 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -57.93 133.45 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 CA-C-O 121.579 0.704 . . . . 0.0 110.248 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.599 ' HB3' ' HB ' ' A' ' 33' ' ' VAL . . . -112.05 158.35 19.68 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.6 pm0 -110.67 132.77 53.91 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 120.295 -1.503 . . . . 0.0 110.27 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.938 HG21 ' OE2' ' A' ' 80' ' ' GLU . 1.8 p -91.21 175.44 6.94 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.163 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -80.8 -16.7 53.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.238 -0.914 . . . . 0.0 110.495 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -80.6 1.53 29.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 0.0 110.292 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.92 9.33 61.03 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.894 HG21 ' CG1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -98.31 174.8 6.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -1.097 . . . . 0.0 110.395 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.876 HD11 ' CG ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -129.22 142.96 42.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.621 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 26.7 t -110.91 131.1 63.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 O-C-N 121.388 -0.82 . . . . 0.0 111.775 -177.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.027 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -119.34 121.3 66.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.456 -0.777 . . . . 0.0 109.349 178.809 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.582 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -106.14 111.62 24.31 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.737 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.86 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.5 m -131.44 -167.92 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.175 -178.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.471 ' N ' HG23 ' A' ' 36' ' ' VAL . 10.6 tt0 -135.59 129.25 32.63 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.938 ' HB2' HG21 ' A' ' 70' ' ' VAL . 1.7 t80 -60.2 122.33 14.19 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 118.544 -1.262 . . . . 0.0 110.361 -178.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.474 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 4.6 mt-10 -112.05 39.26 2.45 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.453 -0.779 . . . . 0.0 108.973 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.598 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -133.06 -160.64 9.56 Favored Glycine 0 N--CA 1.484 1.894 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.451 ' HA ' ' HD2' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -121.98 141.9 50.86 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.537 -0.978 . . . . 0.0 110.267 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 154.92 -11.43 0.43 Allowed Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.857 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.607 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.7 OUTLIER 54.88 -153.29 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 120.542 -1.563 . . . . 0.0 108.119 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.607 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 83.1 Cg_exo -41.83 97.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.322 -0.864 0 N-CA-C 108.904 -1.229 . . . . 0.0 108.904 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.733 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -145.89 170.82 15.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.794 -0.567 . . . . 0.0 109.958 -177.647 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.682 ' HG3' HD11 ' A' ' 69' ' ' ILE . 33.8 mttm -87.29 176.11 7.7 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.417 -0.802 . . . . 0.0 111.653 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.085 HD11 ' CG2' ' A' ' 70' ' ' VAL . 16.2 mm -122.47 129.05 25.21 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.305 -0.872 . . . . 0.0 112.405 -178.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.622 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 24.8 Cg_exo -67.47 146.55 74.82 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.689 1.593 . . . . 0.0 111.246 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.728 ' CD2' HD21 ' A' ' 63' ' ' LEU . 9.7 t80 -155.53 154.55 31.93 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.419 -0.8 . . . . 0.0 109.741 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.888 ' HG2' HD12 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -164.14 125.26 2.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.842 -1.161 . . . . 0.0 110.661 179.666 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.979 HG21 ' HB3' ' A' ' 83' ' ' PRO . 11.1 mt . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.493 -0.754 . . . . 0.0 109.842 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 83' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.525 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -122.85 165.99 15.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.174 -1.192 . . . . 0.0 110.433 -179.866 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.819 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -131.8 111.27 11.48 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.701 179.269 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.894 ' CG1' HG21 ' A' ' 31' ' ' THR . 5.2 mm -69.13 -30.26 45.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-O 122.126 0.965 . . . . 0.0 108.576 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.612 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.253 0.6 OUTLIER -104.98 29.92 5.94 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.554 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 63' ' ' LEU . 48.0 t -12.65 110.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.247 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 19.6 t-20 44.23 69.1 2.62 Favored Pre-proline 0 C--N 1.299 -1.612 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.048 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.553 ' O ' ' HA ' ' A' ' 46' ' ' LYS . 2.3 Cg_endo -50.18 -178.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 124.033 1.544 . . . . 0.0 109.474 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.733 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.8 OUTLIER -140.71 143.93 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 119.183 -1.007 . . . . 0.0 112.104 -178.89 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.085 ' CG2' HD11 ' A' ' 47' ' ' ILE . 20.2 t -99.78 170.33 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.425 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 5.2 m -126.73 -17.2 5.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.959 -1.088 . . . . 0.0 111.173 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 7.4 mt-10 -140.01 15.67 2.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.944 -1.097 . . . . 0.0 110.918 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 11.4 ttpp 73.59 -7.11 1.63 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.307 -0.871 . . . . 0.0 110.781 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.466 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 5.3 t70 -137.68 1.46 2.34 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.024 -1.048 . . . . 0.0 110.096 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.576 ' O ' HG23 ' A' ' 77' ' ' VAL . 12.4 t -72.74 108.28 4.21 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 121.128 -0.982 . . . . 0.0 108.921 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.629 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 1.9 Cg_endo -47.52 130.19 17.7 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.801 1.421 . . . . 0.0 110.071 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.682 HG21 HG22 ' A' ' 70' ' ' VAL . 60.1 t -118.01 145.43 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.022 -1.049 . . . . 0.0 111.415 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.697 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 3.9 m120 -105.6 134.53 48.56 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.511 -0.743 . . . . 0.0 109.537 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.652 ' HB ' HG22 ' A' ' 34' ' ' ILE . 3.4 mt -117.88 119.89 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 119.953 -1.717 . . . . 0.0 111.358 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.938 ' OE2' HG21 ' A' ' 27' ' ' THR . 2.4 tp10 -95.45 106.86 18.97 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.861 ' C ' HG22 ' A' ' 31' ' ' THR . . . -112.19 147.39 36.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.09 -1.006 . . . . 0.0 110.655 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 3.0 tt0 -113.2 53.89 0.53 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.408 -0.807 . . . . 0.0 110.932 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.979 ' HB3' HG21 ' A' ' 51' ' ' ILE . 23.1 Cg_endo -66.16 159.74 48.21 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 123.675 1.355 . . . . 0.0 110.402 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.44 ' HD3' ' HA2' ' A' ' 61' ' ' GLY . 11.5 Cg_endo . . . . . 0 C--N 1.305 -1.716 0 O-C-N 123.948 1.499 . . . . 0.0 109.827 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.526 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 24.6 m-85 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.228 0.537 . . . . 0.0 111.853 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.805 HG22 ' HB2' ' A' ' 101' ' ' LEU . 0.7 OUTLIER -74.46 168.25 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.017 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.888 HD12 ' HG2' ' A' ' 50' ' ' GLU . 94.7 mt -131.21 143.36 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.318 -1.489 . . . . 0.0 111.868 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.027 HD11 HG21 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -133.96 138.06 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.502 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.536 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 86.18 -158.96 32.07 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.541 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -123.89 149.53 28.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 O-C-N 121.061 -1.258 . . . . 0.0 110.411 -179.462 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.587 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 5.4 mt-10 -20.35 -57.39 0.07 OUTLIER Pre-proline 0 N--CA 1.501 2.078 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.563 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 9.7 Cg_endo -53.9 70.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 124.108 1.583 . . . . 0.0 111.898 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 91.42 6.75 65.9 Favored Glycine 0 N--CA 1.494 2.512 0 O-C-N 120.967 -1.083 . . . . 0.0 110.896 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.503 ' HB3' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -52.42 161.21 0.71 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.972 -1.31 . . . . 0.0 110.019 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.527 ' CD1' ' O ' ' A' ' 18' ' ' PHE . 4.9 mt -95.77 170.06 9.58 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.189 -0.944 . . . . 0.0 110.773 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -152.61 142.74 22.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.5 -0.75 . . . . 0.0 109.722 179.573 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.805 ' HB2' HG22 ' A' ' 90' ' ' ILE . 4.0 mp -138.89 117.68 12.32 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.98 -1.075 . . . . 0.0 110.878 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -59.92 146.26 42.93 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.283 -0.886 . . . . 0.0 110.201 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.438 ' NE1' HG21 ' A' ' 32' ' ' ILE . 9.1 t-105 . . . . . 0 N--CA 1.488 1.438 0 O-C-N 121.212 -0.93 . . . . 0.0 110.417 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 mtt . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.255 0.55 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -115.19 24.7 11.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -0.894 . . . . 0.0 110.177 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.572 ' C ' HD23 ' A' ' 4' ' ' LEU . 1.0 OUTLIER -117.02 151.66 36.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.227 -0.921 . . . . 0.0 110.279 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.572 HD23 ' C ' ' A' ' 3' ' ' LYS . 0.3 OUTLIER -166.74 62.08 0.09 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.181 -0.95 . . . . 0.0 110.15 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.477 ' CG ' ' C ' ' A' ' 4' ' ' LEU . 59.4 mt-30 -153.45 -46.26 0.09 Allowed 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.294 -0.879 . . . . 0.0 110.259 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.54 78.69 3.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.21 -0.931 . . . . 0.0 110.234 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.33 101.75 13.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 110.169 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 132.34 131.77 3.25 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 47.49 53.37 11.14 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.223 -1.163 . . . . 0.0 110.125 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.7 p -130.02 160.49 33.5 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.306 -0.871 . . . . 0.0 110.253 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.573 ' CZ ' ' HB2' ' A' ' 44' ' ' PRO . 1.3 t80 -149.16 -74.48 0.17 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.351 -0.843 . . . . 0.0 109.613 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.505 ' HB3' ' HA ' ' A' ' 45' ' ' CYS . 3.6 t -142.84 -122.29 0.09 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.174 -0.954 . . . . 0.0 109.199 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.432 ' O ' ' CG ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -176.91 98.24 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.724 -1.235 . . . . 0.0 110.075 179.529 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 20.7 m -62.85 93.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.386 -0.821 . . . . 0.0 109.002 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.471 ' O ' ' O ' ' A' ' 16' ' ' GLY . 5.9 t -88.79 -6.82 57.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.138 -0.976 . . . . 0.0 111.755 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.518 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -61.2 -129.74 0.01 OUTLIER Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.531 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -125.09 177.99 5.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.228 -1.16 . . . . 0.0 110.008 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.04 ' CE2' HG23 ' A' ' 47' ' ' ILE . 33.0 m-85 -135.36 142.85 45.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.925 -1.11 . . . . 0.0 111.638 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.478 ' HE2' ' HB3' ' A' ' 37' ' ' GLN . 37.6 ttpt -113.43 117.68 32.4 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.644 ' CG2' HD13 ' A' ' 99' ' ' LEU . 54.9 t -59.3 124.54 13.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 120.659 -1.276 . . . . 0.0 109.501 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.633 HG23 ' HA ' ' A' ' 36' ' ' VAL . 70.3 t -98.07 -29.62 3.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.647 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 0.5 OUTLIER -150.46 138.05 19.78 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.391 0.615 . . . . 0.0 109.887 177.619 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -56.15 153.43 9.22 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.297 0.57 . . . . 0.0 110.261 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.722 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -49.35 131.3 7.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.109 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.878 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -108.47 172.1 7.04 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 16.8 pt-20 -113.0 130.67 56.05 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.881 -1.137 . . . . 0.0 110.335 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.51 ' O ' ' CB ' ' A' ' 28' ' ' GLN . 17.5 p -74.99 0.41 15.96 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.461 -0.774 . . . . 0.0 110.292 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.51 ' CB ' ' O ' ' A' ' 27' ' ' THR . 0.5 OUTLIER 70.03 10.69 7.49 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.302 -0.874 . . . . 0.0 110.131 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.42 11.55 6.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.918 . . . . 0.0 110.292 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.456 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 110.17 -20.19 26.33 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.912 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -92.1 -174.27 3.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.224 -1.162 . . . . 0.0 110.476 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.878 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -148.38 160.24 6.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.745 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.698 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 99.0 t -123.58 131.54 72.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 C-N-CA 118.982 -1.087 . . . . 0.0 111.752 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.141 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -114.91 114.29 46.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.431 -0.793 . . . . 0.0 109.741 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.647 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -95.27 125.79 40.15 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.058 -1.026 . . . . 0.0 108.467 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.698 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.8 m -150.13 159.11 5.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.274 -0.891 . . . . 0.0 108.609 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.485 ' N ' HG23 ' A' ' 21' ' ' VAL 0.26 25.6 tt0 -103.85 124.7 49.43 Favored 'General case' 0 C--N 1.27 -2.872 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -179.165 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 1.02 ' HB2' HG21 ' A' ' 70' ' ' VAL . 1.2 t80 -60.75 122.35 14.58 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 119.016 -1.074 . . . . 0.0 110.509 -178.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 17' ' ' LYS . 23.1 mm-40 -106.87 152.06 24.4 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.374 -0.829 . . . . 0.0 108.921 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.519 ' O ' ' CE ' ' A' ' 73' ' ' LYS . . . 105.7 -145.75 15.97 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.455 ' O ' ' OH ' ' A' ' 38' ' ' TYR . 0.5 OUTLIER -130.4 127.95 40.38 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.525 -0.986 . . . . 0.0 109.942 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.04 -29.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.331 -1.414 . . . . 0.0 110.854 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.632 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.4 OUTLIER 56.39 -154.09 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 120.621 -1.517 . . . . 0.0 108.224 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.632 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 44.9 Cg_exo -52.23 89.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 N-CA-C 109.811 -0.88 . . . . 0.0 109.811 179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.748 ' O ' HG23 ' A' ' 69' ' ' ILE . 10.0 p -142.12 174.57 10.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.928 . . . . 0.0 110.636 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.632 ' HG3' ' CD1' ' A' ' 69' ' ' ILE . 2.3 mtpt -87.73 162.49 17.02 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.041 0.924 . . . . 0.0 111.915 -178.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.04 HG23 ' CE2' ' A' ' 18' ' ' PHE . 14.9 mm -105.44 124.24 36.97 Favored Pre-proline 0 C--N 1.3 -1.546 0 O-C-N 121.635 -0.665 . . . . 0.0 111.487 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.626 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 31.4 Cg_exo -62.14 145.12 96.48 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.064 1.56 . . . . 0.0 110.746 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.939 ' CD2' HG21 ' A' ' 79' ' ' ILE . 5.0 t80 -153.76 154.26 33.7 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.495 -0.753 . . . . 0.0 109.187 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.624 ' O ' HG23 ' A' ' 51' ' ' ILE . 18.3 tt0 -157.51 115.4 3.11 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.884 -1.135 . . . . 0.0 110.335 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.687 HG22 ' HA ' ' A' ' 90' ' ' ILE . 19.4 pt -159.64 70.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.471 ' O ' ' HB3' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -129.08 -67.65 0.77 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.1 -1.0 . . . . 0.0 110.777 -179.49 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' A' ' 52' ' ' MET . 1.2 p-10 172.67 -161.39 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.306 -0.871 . . . . 0.0 110.333 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' A' ' 53' ' ' ASP . 11.1 tp 58.59 -105.36 0.25 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 0.0 110.044 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.14 18.83 4.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.923 -1.111 . . . . 0.0 109.658 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.538 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 8.5 mptt -98.93 -10.33 22.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.431 -0.793 . . . . 0.0 110.221 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.432 ' CB ' ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER 66.19 18.29 10.92 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.226 -0.921 . . . . 0.0 110.086 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.594 ' CE1' ' HG2' ' A' ' 84' ' ' PRO . 0.5 OUTLIER -125.72 -140.0 0.28 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.887 . . . . 0.0 110.253 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.575 HG23 ' N ' ' A' ' 60' ' ' LEU . 3.7 m -141.0 -42.98 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.188 -0.945 . . . . 0.0 110.376 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.575 ' N ' HG23 ' A' ' 59' ' ' VAL . 0.1 OUTLIER 176.88 81.77 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.098 -1.001 . . . . 0.0 110.757 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.537 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . -97.4 168.96 24.48 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.53 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -131.49 166.89 20.34 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.18 -1.188 . . . . 0.0 110.515 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.676 HD12 ' N ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -121.87 121.02 36.2 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.301 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.912 HG12 HG21 ' A' ' 31' ' ' THR . 1.6 mp -85.98 -27.42 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 106.706 -1.591 . . . . 0.0 106.706 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.843 HG22 ' O ' ' A' ' 65' ' ' THR 0.255 3.0 m -110.75 42.8 1.53 Allowed 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.338 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.676 ' N ' HD12 ' A' ' 63' ' ' LEU . 6.7 t -30.94 133.06 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 121.275 0.56 . . . . 0.0 111.021 -178.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.673 ' CG ' HG12 ' A' ' 66' ' ' VAL . 0.4 OUTLIER 27.52 74.92 0.35 Allowed Pre-proline 0 N--CA 1.488 1.458 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.575 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.546 ' O ' ' HA ' ' A' ' 46' ' ' LYS . 8.4 Cg_endo -60.8 -171.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.707 1.372 . . . . 0.0 108.851 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.748 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.8 OUTLIER -142.79 144.49 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.816 -1.177 . . . . 0.0 112.227 -179.157 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.02 HG21 ' HB2' ' A' ' 38' ' ' TYR . 43.7 t -100.66 156.76 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 175.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.8 m -111.28 -20.8 12.17 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.791 -1.164 . . . . 0.0 111.224 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 7.4 mt-10 -132.25 15.9 4.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.842 -1.161 . . . . 0.0 111.244 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.522 ' O ' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER 71.63 -4.18 1.96 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.259 -0.901 . . . . 0.0 110.87 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.482 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 5.5 t70 -137.31 -0.04 2.26 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.885 -1.134 . . . . 0.0 110.26 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.685 ' O ' HG23 ' A' ' 77' ' ' VAL . 33.9 t -73.07 112.24 14.74 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.244 -0.91 . . . . 0.0 109.248 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 74' ' ' ASP . 33.2 Cg_exo -51.38 112.87 0.91 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.783 1.412 . . . . 0.0 109.738 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.944 HG21 HG22 ' A' ' 70' ' ' VAL . 59.9 t -102.1 130.74 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.322 -0.861 . . . . 0.0 111.516 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.649 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 12.0 m-80 -93.12 135.26 34.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.401 -0.812 . . . . 0.0 108.972 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.939 HG21 ' CD2' ' A' ' 49' ' ' PHE . 6.1 mt -114.53 117.26 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 117.69 -1.604 . . . . 0.0 111.979 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.685 ' HG3' HG22 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -86.03 114.14 22.67 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.333 179.362 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.693 ' C ' HG22 ' A' ' 31' ' ' THR . . . -133.45 153.28 51.74 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.024 -1.048 . . . . 0.0 110.505 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 0.8 OUTLIER -101.56 101.95 19.91 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.186 -0.946 . . . . 0.0 110.425 -179.611 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.587 ' HG2' ' CD2' ' A' ' 104' ' ' PHE . 33.7 Cg_endo -70.57 142.41 44.31 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.127 1.593 . . . . 0.0 110.325 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.594 ' HG2' ' CE1' ' A' ' 58' ' ' HIS . 32.3 Cg_endo -71.97 -75.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.09 1.574 . . . . 0.0 110.348 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.61 ' CD1' ' N ' ' A' ' 86' ' ' GLY . 50.5 t80 -179.43 168.45 1.45 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.243 -0.91 . . . . 0.0 110.18 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.61 ' N ' ' CD1' ' A' ' 85' ' ' PHE . . . 64.56 -176.13 11.18 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 89' ' ' TYR . 6.1 m-20 -46.06 114.1 0.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -1.15 . . . . 0.0 109.999 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.586 ' CB ' ' NE2' ' A' ' 58' ' ' HIS . 34.9 m -117.17 93.17 4.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.185 -0.947 . . . . 0.0 110.567 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.591 ' CZ ' ' HB3' ' A' ' 87' ' ' ASP . 19.9 m-85 -85.15 100.97 12.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.225 -0.922 . . . . 0.0 109.963 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.687 ' HA ' HG22 ' A' ' 51' ' ' ILE . 2.2 mt -73.9 133.74 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 109.544 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.588 HD12 ' HG2' ' A' ' 50' ' ' GLU . 84.6 mt -106.2 134.62 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.908 -1.12 . . . . 0.0 110.583 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.141 HD11 HG21 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -124.21 144.87 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.492 -0.755 . . . . 0.0 109.569 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.547 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 82.68 -162.67 41.56 Favored Glycine 0 N--CA 1.482 1.714 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.555 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -119.78 146.88 23.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 O-C-N 121.257 -1.143 . . . . 0.0 109.932 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.569 ' O ' ' N ' ' A' ' 97' ' ' GLY . 3.9 mt-10 -17.85 -58.22 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.181 0 N-CA-C 111.655 0.242 . . . . 0.0 111.655 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 10.0 Cg_endo -53.17 71.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 124.112 1.585 . . . . 0.0 111.962 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 92.73 1.59 67.96 Favored Glycine 0 N--CA 1.495 2.605 0 O-C-N 120.97 -1.082 . . . . 0.0 111.04 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.499 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -50.04 160.81 0.31 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.895 -1.356 . . . . 0.0 109.839 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.644 HD13 ' CG2' ' A' ' 20' ' ' VAL . 8.7 mt -98.96 175.78 5.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.102 -0.999 . . . . 0.0 111.053 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.695 ' C ' HD12 ' A' ' 101' ' ' LEU . 0.8 OUTLIER -154.72 137.5 15.3 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.559 -0.713 . . . . 0.0 109.811 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.801 ' N ' HD12 ' A' ' 101' ' ' LEU . 2.0 mp -143.33 125.54 15.5 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.094 -1.004 . . . . 0.0 110.527 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.506 ' HB2' ' CD1' ' A' ' 89' ' ' TYR . 32.4 t30 -90.35 133.79 34.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.286 -0.884 . . . . 0.0 110.403 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.648 ' CE3' HG22 ' A' ' 24' ' ' ILE . 60.5 t-105 -145.88 173.04 12.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.353 -0.842 . . . . 0.0 110.31 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.587 ' CD2' ' HG2' ' A' ' 83' ' ' PRO . 0.2 OUTLIER 67.67 -74.97 0.07 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.319 -0.863 . . . . 0.0 110.44 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.502 ' HA ' ' N ' ' A' ' 87' ' ' ASP . 1.6 tttp 64.79 -155.52 0.29 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.943 . . . . 0.0 110.154 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.422 ' CG ' ' N ' ' A' ' 107' ' ' GLY . 0.0 OUTLIER -76.4 -89.67 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.308 -0.87 . . . . 0.0 110.214 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.422 ' N ' ' CG ' ' A' ' 106' ' ' LYS . . . -127.36 -38.06 0.43 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.11 164.82 21.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.216 -1.167 . . . . 0.0 110.139 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.55 139.36 35.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.326 -0.859 . . . . 0.0 110.174 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.466 ' O ' ' N ' ' A' ' 112' ' ' HIS . 28.8 tp 53.38 81.76 0.09 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 110.233 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -61.21 80.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.247 -0.908 . . . . 0.0 110.248 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.466 ' N ' ' O ' ' A' ' 110' ' ' LEU . 1.6 t-80 -84.07 93.82 8.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -0.895 . . . . 0.0 110.262 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 12.1 m80 -157.85 135.99 10.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.313 -0.867 . . . . 0.0 110.184 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -167.33 133.06 2.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.18 -0.95 . . . . 0.0 110.226 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -92.85 160.02 15.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.907 . . . . 0.0 110.169 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -160.25 -49.34 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 110.213 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 10.5 t60 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.267 179.977 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mtm . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.267 0.556 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.93 60.87 1.0 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.915 . . . . 0.0 110.162 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.77 29.58 7.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.913 . . . . 0.0 110.209 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.442 ' O ' ' CB ' ' A' ' 5' ' ' GLN . 6.4 tp -51.73 120.3 5.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.279 -0.888 . . . . 0.0 110.169 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.442 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER 171.49 87.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.171 -0.955 . . . . 0.0 110.217 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.619 HD21 ' HE2' ' A' ' 46' ' ' LYS . 1.4 tp -85.22 60.58 6.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.2 -0.938 . . . . 0.0 110.242 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.62 -82.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.294 -0.879 . . . . 0.0 110.194 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 6' ' ' LEU . . . -166.44 -40.09 0.02 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.8 ttm -135.14 -69.42 0.51 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.172 -1.193 . . . . 0.0 110.281 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.47 144.74 17.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.179 -0.951 . . . . 0.0 110.319 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -87.83 -74.09 0.46 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.297 -0.877 . . . . 0.0 109.698 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.568 ' HB3' ' CB ' ' A' ' 45' ' ' CYS . 3.3 t -145.61 -27.09 0.45 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.267 -0.896 . . . . 0.0 111.135 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.489 ' HB3' ' O ' ' A' ' 12' ' ' SER . 8.3 ttt 60.16 91.1 0.05 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.361 -0.837 . . . . 0.0 109.471 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.633 ' SG ' HD13 ' A' ' 47' ' ' ILE . 32.7 m -49.14 138.57 12.0 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.469 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 0.9 OUTLIER -126.6 -17.08 5.14 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.528 -1.357 . . . . 0.0 111.965 -178.468 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.573 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -59.77 -117.1 0.01 OUTLIER Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.4 -1.381 . . . . 0.0 109.786 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.535 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -135.35 -179.9 5.92 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.963 -1.316 . . . . 0.0 110.324 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.977 ' CE1' HG23 ' A' ' 47' ' ' ILE . 31.0 m-85 -136.57 149.67 48.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.04 -1.038 . . . . 0.0 111.851 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.455 ' HB2' ' CG ' ' A' ' 39' ' ' GLU . 17.6 ttpt -116.6 118.76 33.49 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.655 -0.653 . . . . 0.0 109.557 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.5 ' CG2' HD13 ' A' ' 99' ' ' LEU . 51.3 t -59.63 131.52 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.784 -1.198 . . . . 0.0 108.772 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.605 HG23 ' HA ' ' A' ' 36' ' ' VAL . 76.8 t -105.62 -26.44 3.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.562 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 12.5 tttt -157.53 133.34 9.3 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -52.47 155.39 2.15 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.535 0.683 . . . . 0.0 111.243 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.679 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -49.76 133.22 8.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 C-N-CA 119.996 -0.681 . . . . 0.0 109.957 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.867 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -108.24 171.52 7.36 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.2 pm0 -116.91 132.62 56.65 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.87 -1.144 . . . . 0.0 110.454 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.861 HG21 ' CD ' ' A' ' 80' ' ' GLU . 13.7 p -90.57 179.61 5.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.334 -0.854 . . . . 0.0 110.127 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -93.25 29.86 1.81 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -0.93 . . . . 0.0 110.379 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.53 6.89 3.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 110.357 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.427 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 95.64 5.56 60.04 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.89 HG22 ' C ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -98.86 -173.1 2.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.316 -1.108 . . . . 0.0 110.135 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.867 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -144.33 159.42 15.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.629 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.8 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 85.5 t -125.28 128.72 72.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 O-C-N 120.864 -1.148 . . . . 0.0 112.457 -177.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.986 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -110.81 118.16 56.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.379 -0.826 . . . . 0.0 109.476 178.672 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -103.77 114.76 29.26 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.806 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.8 m -133.95 -172.15 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.223 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.535 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 10.9 tt0 -132.37 126.79 34.05 Favored 'General case' 0 C--N 1.276 -2.615 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 1.021 ' HB2' HG21 ' A' ' 70' ' ' VAL . 1.5 t80 -60.55 123.99 19.03 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 118.716 -1.194 . . . . 0.0 109.92 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.455 ' CG ' ' HB2' ' A' ' 19' ' ' LYS . 43.4 mm-40 -103.65 -21.95 13.65 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.124 -0.985 . . . . 0.0 109.156 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.573 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -67.17 -164.85 2.25 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.511 ' HA ' ' HG3' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -137.63 94.04 2.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.578 -0.954 . . . . 0.0 109.976 179.716 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 43' ' ' SER . . . -149.12 12.19 1.06 Allowed Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.348 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.606 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.3 OUTLIER 47.31 -158.65 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.352 0 O-C-N 120.788 -1.419 . . . . 0.0 109.127 179.491 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.606 ' HD2' ' CB ' ' A' ' 43' ' ' SER . 89.2 Cg_exo -42.86 94.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 122.87 0.931 . . . . 0.0 110.186 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.889 ' O ' HG23 ' A' ' 69' ' ' ILE . 25.7 p -143.13 163.77 31.96 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.742 -0.599 . . . . 0.0 109.566 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.619 ' HE2' HD21 ' A' ' 6' ' ' LEU . 1.6 mttt -86.65 156.9 19.81 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.027 -1.046 . . . . 0.0 111.428 -178.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.01 ' CD1' HG23 ' A' ' 70' ' ' VAL . 11.3 mm -99.72 125.07 41.85 Favored Pre-proline 0 C--N 1.294 -1.83 0 O-C-N 121.474 -0.766 . . . . 0.0 111.808 -177.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.618 ' HD2' ' CE2' ' A' ' 18' ' ' PHE . 33.2 Cg_exo -60.85 148.17 93.08 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.223 1.644 . . . . 0.0 111.046 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.928 ' CD2' HG21 ' A' ' 79' ' ' ILE . 4.9 t80 -154.22 151.54 29.28 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.487 -0.758 . . . . 0.0 109.582 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.493 ' HB3' ' HB ' ' A' ' 91' ' ' ILE . 3.8 tp10 -162.76 113.59 1.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.806 -1.184 . . . . 0.0 110.761 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.572 HD11 ' HE1' ' A' ' 49' ' ' PHE . 31.9 mt -112.24 128.04 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.388 -0.82 . . . . 0.0 109.744 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.499 ' HG2' ' CG ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -153.7 -49.87 0.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.047 -1.033 . . . . 0.0 110.69 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.573 ' OD2' ' CE2' ' A' ' 89' ' ' TYR . 16.3 t70 45.21 80.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.023 -1.048 . . . . 0.0 110.11 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.509 ' CB ' ' O ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER 69.49 4.53 4.71 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.171 -0.955 . . . . 0.0 110.267 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.534 ' CD ' HD13 ' A' ' 60' ' ' LEU . 1.4 tm-20 -136.36 52.11 1.98 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.286 -0.884 . . . . 0.0 110.002 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.499 ' CG ' ' HG2' ' A' ' 52' ' ' MET . 0.0 OUTLIER -97.85 25.65 5.77 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.403 -0.811 . . . . 0.0 110.209 -179.834 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.84 -10.69 14.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -0.899 . . . . 0.0 109.891 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -141.7 -143.48 0.15 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.401 -0.812 . . . . 0.0 110.064 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.6 t -121.91 124.24 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.225 -0.922 . . . . 0.0 110.343 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.534 HD13 ' CD ' ' A' ' 55' ' ' GLU . 0.6 OUTLIER -134.32 -76.6 0.47 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.905 . . . . 0.0 110.19 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.522 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . -67.1 164.24 44.18 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.529 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -131.3 170.51 14.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -1.148 . . . . 0.0 110.465 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.87 HD21 ' CD1' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -124.19 121.63 35.61 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.553 -0.717 . . . . 0.0 109.678 179.314 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.822 HG12 HG21 ' A' ' 31' ' ' THR . 1.5 mp -85.11 -24.47 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.801 HG22 ' O ' ' A' ' 65' ' ' THR 0.258 2.9 m -115.29 38.43 3.23 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.855 HG12 ' ND2' ' A' ' 67' ' ' ASN . 10.5 t -25.41 132.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 121.347 0.594 . . . . 0.0 111.5 -178.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.855 ' ND2' HG12 ' A' ' 66' ' ' VAL . 25.4 p30 30.47 70.23 0.63 Allowed Pre-proline 0 C--N 1.303 -1.446 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.745 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.605 ' HG3' HG23 ' A' ' 79' ' ' ILE . 1.2 Cg_endo -55.74 -175.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.644 0 N-CA-C 107.977 -1.586 . . . . 0.0 107.977 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.889 HG23 ' O ' ' A' ' 45' ' ' CYS . 1.1 mt -144.93 146.12 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 C-N-CA 118.56 -1.256 . . . . 0.0 112.174 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.021 HG21 ' HB2' ' A' ' 38' ' ' TYR . 22.0 t -102.26 157.82 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.1 m -114.26 -16.12 12.07 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 118.973 -1.091 . . . . 0.0 111.656 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.527 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 12.4 mt-10 -136.75 16.55 3.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.574 -1.329 . . . . 0.0 111.619 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.576 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 2.4 ttpt 71.57 -5.08 1.71 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.149 -0.969 . . . . 0.0 110.994 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.478 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 5.1 t70 -137.86 -1.51 2.0 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.969 -1.082 . . . . 0.0 110.32 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.606 ' O ' HG23 ' A' ' 77' ' ' VAL . 39.2 t -72.36 112.24 14.01 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.209 -0.932 . . . . 0.0 109.259 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.602 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 49.7 Cg_exo -48.51 126.51 14.29 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.828 1.436 . . . . 0.0 109.744 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.999 HG21 HG22 ' A' ' 70' ' ' VAL . 74.8 t -114.31 133.41 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.015 -1.053 . . . . 0.0 111.45 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.681 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 5.3 m-80 -99.65 131.8 45.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.493 -0.754 . . . . 0.0 109.12 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.928 HG21 ' CD2' ' A' ' 49' ' ' PHE . 10.9 mt -114.17 119.62 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.099 -1.626 . . . . 0.0 111.636 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.861 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.7 tp10 -92.4 118.59 31.09 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.94 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.89 ' C ' HG22 ' A' ' 31' ' ' THR . . . -135.93 152.55 51.1 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.006 -1.059 . . . . 0.0 110.78 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.529 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 2.0 tt0 -102.36 102.63 26.32 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.367 -0.833 . . . . 0.0 110.266 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.54 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 35.7 Cg_endo -71.96 151.56 56.45 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.086 1.571 . . . . 0.0 110.564 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.575 ' O ' ' CG ' ' A' ' 85' ' ' PHE . 15.5 Cg_endo -62.74 -79.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.081 1.569 . . . . 0.0 110.249 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.575 ' CG ' ' O ' ' A' ' 84' ' ' PRO . 2.6 m-85 -173.32 151.57 2.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.915 . . . . 0.0 110.214 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 104' ' ' PHE . . . 74.44 -162.72 54.22 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 103' ' ' TRP . 51.7 p-10 -55.96 176.69 0.07 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.298 -1.119 . . . . 0.0 110.126 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.493 ' HA ' ' HB2' ' A' ' 53' ' ' ASP . 0.5 OUTLIER 173.91 131.37 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.194 -0.941 . . . . 0.0 110.325 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.573 ' CE2' ' OD2' ' A' ' 53' ' ' ASP . 15.4 m-85 -105.02 100.01 9.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.137 -0.977 . . . . 0.0 110.085 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.606 ' CG2' ' CZ ' ' A' ' 49' ' ' PHE . 1.3 mp -73.94 125.03 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.21 -0.931 . . . . 0.0 109.447 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.498 ' CG2' ' CD ' ' A' ' 98' ' ' GLN . 81.0 mt -96.5 144.14 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.156 -0.965 . . . . 0.0 110.503 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.986 HD11 HG21 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -129.76 137.87 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.502 -0.749 . . . . 0.0 109.596 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.562 ' O ' ' HB2' ' A' ' 48' ' ' PRO . . . 86.7 -163.78 35.43 Favored Glycine 0 N--CA 1.481 1.681 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.57 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -118.15 143.92 27.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 O-C-N 121.049 -1.265 . . . . 0.0 110.32 -179.478 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.576 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -14.54 -59.26 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.139 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -179.692 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 5.9 Cg_endo -49.86 74.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 124.235 1.65 . . . . 0.0 111.752 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 86.68 -2.37 87.25 Favored Glycine 0 N--CA 1.494 2.519 0 O-C-N 121.045 -1.034 . . . . 0.0 111.096 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.511 ' HB3' ' C ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -43.41 162.73 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.812 -1.405 . . . . 0.0 109.897 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.603 HD11 ' O ' ' A' ' 18' ' ' PHE . 10.5 mt -98.91 174.88 6.15 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.069 -1.019 . . . . 0.0 110.889 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.494 ' HG3' HG12 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -152.1 130.32 11.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.603 -0.686 . . . . 0.0 109.871 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' A' ' 89' ' ' TYR . 4.2 mp -131.73 123.9 28.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.145 -0.972 . . . . 0.0 110.394 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -86.96 128.98 35.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.325 -0.859 . . . . 0.0 110.207 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.61 ' CE3' HG22 ' A' ' 24' ' ' ILE . 61.7 t-105 -136.69 169.07 18.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.16 -0.963 . . . . 0.0 110.275 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 104' ' ' PHE . 16.9 p90 -137.7 149.59 46.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.286 -0.883 . . . . 0.0 110.261 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.0 138.63 28.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -0.925 . . . . 0.0 110.198 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.2 pttm -158.58 152.31 23.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.908 . . . . 0.0 110.162 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 162.37 -147.0 12.62 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.9 t -57.01 134.53 55.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -1.103 . . . . 0.0 110.219 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 54.5 p -172.99 95.7 0.12 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.315 -0.865 . . . . 0.0 110.149 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.93 -65.77 0.64 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.231 -0.918 . . . . 0.0 110.256 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 55.98 83.04 0.1 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 110.18 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -135.35 -44.57 0.69 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.224 -0.923 . . . . 0.0 110.239 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -62.7 176.21 0.7 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.268 -0.895 . . . . 0.0 110.095 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.418 ' ND1' ' O ' ' A' ' 114' ' ' HIS . 21.3 t-80 -98.93 90.53 4.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.296 -0.878 . . . . 0.0 110.363 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -86.36 129.04 34.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 110.155 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -129.84 40.9 3.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.279 -0.888 . . . . 0.0 110.276 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.207 179.978 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.28 0.562 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 4' ' ' LEU . 2.9 p-10 -165.82 171.39 12.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 110.255 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 53.18 -88.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.283 -0.886 . . . . 0.0 110.248 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 2' ' ' ASP . 0.7 OUTLIER -72.16 -151.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.239 -0.913 . . . . 0.0 110.137 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.445 ' CG ' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER 172.23 -84.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.203 -0.936 . . . . 0.0 110.114 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.826 HD11 HG11 ' A' ' 66' ' ' VAL . 11.3 mp 43.79 -163.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.311 -0.868 . . . . 0.0 110.215 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER 178.03 37.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.238 -0.914 . . . . 0.0 110.185 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.3 49.76 3.39 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -112.93 18.05 18.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -1.18 . . . . 0.0 110.262 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.533 ' HA ' ' CE ' ' A' ' 46' ' ' LYS . 19.5 t -81.84 162.34 22.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 110.238 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -137.29 -74.05 0.42 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.283 -0.886 . . . . 0.0 110.373 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 13' ' ' MET . 3.2 t -136.94 -5.0 1.92 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.998 -1.064 . . . . 0.0 111.258 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.882 ' HG2' HG23 ' A' ' 15' ' ' THR . 21.7 ttm 56.6 85.42 0.08 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.946 -1.096 . . . . 0.0 108.923 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.596 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 39.6 m -57.57 98.04 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.449 -0.782 . . . . 0.0 109.31 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.882 HG23 ' HG2' ' A' ' 13' ' ' MET . 3.7 p -95.52 -1.98 49.53 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.18 -0.95 . . . . 0.0 112.07 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.594 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -66.84 -110.59 0.01 OUTLIER Glycine 0 N--CA 1.49 2.295 0 C-N-CA 118.844 -1.645 . . . . 0.0 109.048 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.529 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -143.47 173.62 11.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.985 -1.303 . . . . 0.0 110.103 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.863 ' CE2' HG23 ' A' ' 47' ' ' ILE . 33.6 m-85 -133.66 151.12 51.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.993 -1.067 . . . . 0.0 111.631 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.44 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 5.2 ttpt -117.75 115.95 26.04 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.61 -0.681 . . . . 0.0 109.239 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.64 ' CG2' HD13 ' A' ' 99' ' ' LEU . 40.6 t -59.67 124.7 14.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 120.655 -1.278 . . . . 0.0 109.131 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.569 HG23 ' HA ' ' A' ' 36' ' ' VAL . 60.6 t -98.25 -26.37 3.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.614 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 7.7 tttt -158.06 133.6 8.95 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -50.58 160.22 0.44 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.618 0.723 . . . . 0.0 111.465 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.679 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.7 OUTLIER -55.24 132.88 18.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 121.545 0.688 . . . . 0.0 110.277 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.74 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -108.94 168.19 9.54 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 4.2 pm0 -114.77 134.65 54.94 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.613 -1.304 . . . . 0.0 110.695 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.66 HG21 ' CD ' ' A' ' 80' ' ' GLU . 9.5 p -91.79 172.06 8.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.521 -0.737 . . . . 0.0 110.041 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -87.85 31.03 0.79 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.234 -0.916 . . . . 0.0 110.378 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.95 6.38 3.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.244 -0.91 . . . . 0.0 110.249 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.473 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 94.73 10.32 57.9 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.863 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -106.08 -178.21 3.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.392 -1.064 . . . . 0.0 110.273 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.74 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -139.51 150.63 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.595 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 54.1 t -117.45 134.2 61.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 O-C-N 121.184 -0.947 . . . . 0.0 112.126 -177.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.015 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -116.85 119.88 63.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.366 -0.834 . . . . 0.0 109.761 178.944 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.614 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 1.1 ttm180 -101.12 123.66 45.62 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.798 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.4 m -149.2 161.56 4.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.148 -0.97 . . . . 0.0 108.766 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 74' ' ' ASP 0.262 1.9 tt0 -107.35 125.62 51.43 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.859 ' HB2' HG21 ' A' ' 70' ' ' VAL . 3.3 t80 -59.87 122.94 15.5 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 118.909 -1.117 . . . . 0.0 110.126 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.44 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 1.3 mm-40 -98.57 -23.89 15.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.319 -0.863 . . . . 0.0 109.168 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.594 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -65.59 -161.6 0.82 Allowed Glycine 0 N--CA 1.484 1.89 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.448 ' HA ' ' HD2' ' A' ' 73' ' ' LYS . 30.9 t0 -128.23 146.46 50.73 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.468 -1.019 . . . . 0.0 110.185 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.402 ' O ' ' CB ' ' A' ' 43' ' ' SER . . . 156.69 -14.39 0.35 Allowed Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.59 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.606 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.8 OUTLIER 60.49 -152.95 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 120.639 -1.506 . . . . 0.0 108.16 -179.723 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 88.5 Cg_exo -42.39 97.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.32 -0.959 0 N-CA-C 108.819 -1.262 . . . . 0.0 108.819 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.708 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -146.77 171.28 15.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.767 -0.583 . . . . 0.0 110.02 -177.714 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.699 ' HG3' HD11 ' A' ' 69' ' ' ILE . 16.6 mtmt -85.79 175.01 8.93 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.35 -0.844 . . . . 0.0 111.664 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.067 HD11 ' CG2' ' A' ' 70' ' ' VAL . 15.7 mm -123.05 125.78 26.17 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.401 -0.812 . . . . 0.0 112.299 -178.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.625 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 30.2 Cg_exo -65.42 146.8 86.3 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.963 1.507 . . . . 0.0 110.686 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.709 ' CD2' HD11 ' A' ' 63' ' ' LEU . 11.4 t80 -155.88 159.9 39.71 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.255 -0.903 . . . . 0.0 110.422 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.511 ' OE2' ' HA ' ' A' ' 57' ' ' ARG . 5.9 tp10 -176.29 114.38 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.067 -1.021 . . . . 0.0 110.554 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.643 HD11 ' HE2' ' A' ' 49' ' ' PHE . 55.9 mt -106.89 97.7 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 110.094 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.469 ' SD ' ' HD2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -129.57 -67.04 0.78 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 110.317 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 54' ' ' LEU . 5.5 p30 174.06 -36.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.241 -0.912 . . . . 0.0 110.347 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.508 ' N ' ' OD1' ' A' ' 53' ' ' ASP . 1.0 OUTLIER -128.91 -89.56 0.51 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 0.0 110.288 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.477 ' OE2' ' HA ' ' A' ' 95' ' ' GLU . 11.5 tt0 -153.93 52.05 0.69 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.939 . . . . 0.0 110.271 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.469 ' HD2' ' SD ' ' A' ' 52' ' ' MET . 0.1 OUTLIER -119.74 139.25 52.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 0.0 110.156 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.575 ' O ' ' CG ' ' A' ' 58' ' ' HIS . 8.1 mtp180 -97.81 124.96 42.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.232 -0.918 . . . . 0.0 110.303 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 57' ' ' ARG . 15.8 m80 -162.22 -91.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 110.267 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.534 ' O ' HD22 ' A' ' 60' ' ' LEU . 1.9 p 175.88 100.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.187 -0.946 . . . . 0.0 110.133 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.534 HD22 ' O ' ' A' ' 59' ' ' VAL . 0.5 OUTLIER -126.86 -50.63 1.46 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -0.923 . . . . 0.0 110.25 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.471 ' HA2' ' HD3' ' A' ' 84' ' ' PRO . . . -106.35 -174.37 23.31 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.559 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -120.6 149.96 41.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.18 -1.188 . . . . 0.0 110.113 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.726 ' O ' HG23 ' A' ' 66' ' ' VAL . 3.2 mt -110.15 118.15 35.61 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.197 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.863 HG12 HG21 ' A' ' 31' ' ' THR . 1.5 mp -77.49 -22.97 14.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.669 HG22 ' O ' ' A' ' 65' ' ' THR 0.272 1.0 OUTLIER -113.69 29.77 7.75 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.439 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.826 HG11 HD11 ' A' ' 6' ' ' LEU . 52.0 t -12.47 112.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.534 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.494 ' OD1' ' HB3' ' A' ' 46' ' ' LYS . 20.8 t-20 41.24 70.0 1.79 Allowed Pre-proline 0 C--N 1.302 -1.488 0 O-C-N 121.647 -0.658 . . . . 0.0 110.4 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.525 ' CG ' HG12 ' A' ' 79' ' ' ILE . 1.7 Cg_endo -51.85 -176.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.01 1.532 . . . . 0.0 109.723 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.708 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.9 OUTLIER -140.7 142.07 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.947 -178.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.067 ' CG2' HD11 ' A' ' 47' ' ' ILE . 24.8 t -93.39 169.51 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.2 m -124.15 -20.73 5.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.883 -1.136 . . . . 0.0 110.929 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.531 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 6.9 mt-10 -135.87 14.44 3.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.026 -1.046 . . . . 0.0 110.754 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.531 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 10.6 ttpt 73.81 -7.52 1.58 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.422 -0.798 . . . . 0.0 110.818 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.487 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 5.7 t70 -136.78 -1.15 2.26 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.965 -1.085 . . . . 0.0 110.23 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.564 ' O ' HG23 ' A' ' 77' ' ' VAL . 36.2 t -73.19 112.46 15.78 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.194 -0.941 . . . . 0.0 109.44 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 35.0 Cg_exo -50.93 113.52 1.12 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.806 1.424 . . . . 0.0 109.912 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.719 HG21 HG22 ' A' ' 70' ' ' VAL . 74.0 t -99.13 155.19 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.318 -0.864 . . . . 0.0 110.714 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.654 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -111.77 134.86 53.06 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.465 -0.772 . . . . 0.0 109.96 179.667 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.688 ' HB ' HG22 ' A' ' 34' ' ' ILE . 3.8 mt -115.35 114.23 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 117.731 -1.588 . . . . 0.0 111.289 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.66 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.1 tt0 -90.78 115.0 27.52 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.983 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.818 ' C ' HG22 ' A' ' 31' ' ' THR . . . -131.61 149.16 52.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.908 -1.12 . . . . 0.0 110.768 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' A' ' 62' ' ' ARG . 2.2 tt0 -98.82 104.99 28.23 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 110.337 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.526 ' CB ' ' OD2' ' A' ' 87' ' ' ASP . 30.8 Cg_endo -70.32 131.97 21.49 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.001 1.527 . . . . 0.0 110.298 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.471 ' HD3' ' HA2' ' A' ' 61' ' ' GLY . 23.0 Cg_endo -67.38 -70.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.933 1.491 . . . . 0.0 110.398 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -165.63 70.4 0.14 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.295 -0.878 . . . . 0.0 110.293 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 105' ' ' LYS . . . 140.75 -94.17 0.19 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.526 ' OD2' ' CB ' ' A' ' 83' ' ' PRO . 12.9 m-20 63.5 -70.39 0.07 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.479 -1.012 . . . . 0.0 110.307 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.543 ' O ' ' N ' ' A' ' 103' ' ' TRP . 0.8 OUTLIER 64.71 -73.09 0.06 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.151 -0.968 . . . . 0.0 110.777 179.795 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.536 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 9.7 m-85 -97.11 90.9 5.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.75 -1.219 . . . . 0.0 111.231 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.528 HD11 HD12 ' A' ' 32' ' ' ILE . 20.6 mt -73.81 163.63 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.49 ' CG2' ' CD ' ' A' ' 98' ' ' GLN . 80.2 mt -126.25 139.54 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.496 -1.377 . . . . 0.0 112.04 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.015 HD11 HG21 ' A' ' 34' ' ' ILE . 0.5 OUTLIER -128.44 136.12 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.242 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.533 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 87.71 -161.17 31.97 Favored Glycine 0 N--CA 1.481 1.649 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.563 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -121.18 146.84 25.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 121.04 -1.27 . . . . 0.0 110.154 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.581 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.3 OUTLIER -17.03 -58.6 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.203 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 7.1 Cg_endo -51.18 75.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 124.216 1.64 . . . . 0.0 111.735 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 87.02 -0.27 86.02 Favored Glycine 0 N--CA 1.494 2.501 0 O-C-N 120.96 -1.087 . . . . 0.0 111.043 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.51 ' HB3' ' C ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -44.65 164.48 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.744 -1.445 . . . . 0.0 109.807 179.864 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.64 HD13 ' CG2' ' A' ' 20' ' ' VAL . 7.2 mt -102.35 170.67 7.93 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.104 -0.998 . . . . 0.0 111.263 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -146.41 132.84 19.65 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.602 -0.687 . . . . 0.0 109.478 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.944 HD11 HD12 ' A' ' 92' ' ' ILE . 1.0 OUTLIER -122.99 135.41 54.46 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.002 -1.061 . . . . 0.0 110.744 -179.534 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.527 ' HA ' ' O ' ' A' ' 88' ' ' SER . 2.6 p-10 -84.74 130.63 34.66 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.372 -0.83 . . . . 0.0 110.657 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.543 ' N ' ' O ' ' A' ' 88' ' ' SER . 26.2 t-105 -161.07 97.52 1.14 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.325 -0.86 . . . . 0.0 109.965 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -73.36 105.99 4.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.21 -0.931 . . . . 0.0 110.241 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -111.37 65.17 0.62 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.201 -0.937 . . . . 0.0 110.202 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.52 -42.17 0.45 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 110.278 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.88 -147.2 18.43 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 47.69 75.41 0.13 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.233 -1.157 . . . . 0.0 110.13 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.28 94.8 4.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -0.899 . . . . 0.0 110.269 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.88 50.13 1.27 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.284 -0.885 . . . . 0.0 110.184 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.88 -43.42 1.36 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 110.243 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.52 -171.49 3.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.907 . . . . 0.0 110.243 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -95.41 121.24 36.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 110.199 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -99.24 84.37 3.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 0.0 110.26 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.445 ' O ' ' HB3' ' A' ' 116' ' ' HIS . 0.4 OUTLIER -167.78 -62.14 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.328 -0.858 . . . . 0.0 110.163 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.445 ' HB3' ' O ' ' A' ' 115' ' ' HIS . 13.0 t-160 57.28 102.64 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.235 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.486 ' CG ' ' OXT' ' A' ' 117' ' ' HIS . 11.6 t-160 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.087 -0.958 . . . . 0.0 110.249 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.226 0.536 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.405 ' OD1' ' C ' ' A' ' 2' ' ' ASP . 2.6 p30 -156.29 177.52 11.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 110.216 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -109.7 -61.46 1.64 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.288 -0.883 . . . . 0.0 110.139 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.645 HD23 ' H ' ' A' ' 4' ' ' LEU . 0.5 OUTLIER -85.56 -154.24 0.19 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.241 -0.912 . . . . 0.0 110.149 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER 172.25 -71.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.295 -0.878 . . . . 0.0 110.129 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 8' ' ' GLY . 0.1 OUTLIER 66.25 -64.4 0.22 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.255 -0.903 . . . . 0.0 110.262 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 5' ' ' GLN . 3.0 mtpp 52.53 -89.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.247 -0.908 . . . . 0.0 110.205 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 6' ' ' LEU . . . -118.49 -88.62 1.23 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.518 ' O ' ' ND2' ' A' ' 67' ' ' ASN . 0.0 OUTLIER 65.43 128.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -1.162 . . . . 0.0 110.229 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.563 ' HA ' ' CD ' ' A' ' 46' ' ' LYS . 43.6 t -141.77 145.74 35.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.927 . . . . 0.0 110.125 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -93.31 -73.59 0.56 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.164 -0.96 . . . . 0.0 110.216 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.445 ' O ' ' HB3' ' A' ' 13' ' ' MET . 3.3 t -135.93 -6.44 2.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.117 -0.989 . . . . 0.0 110.925 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.485 ' HG2' HG23 ' A' ' 15' ' ' THR . 5.4 ttm 56.13 80.42 0.15 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.001 -1.062 . . . . 0.0 108.756 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.587 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 42.9 m -55.27 92.87 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.413 -0.805 . . . . 0.0 109.2 -178.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.534 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -88.8 -7.36 56.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.385 -0.822 . . . . 0.0 111.766 -178.375 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.581 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -61.55 -110.83 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 C-N-CA 118.775 -1.679 . . . . 0.0 108.966 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.538 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -145.99 171.8 14.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.98 -1.306 . . . . 0.0 110.253 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.087 ' CE2' HG23 ' A' ' 47' ' ' ILE . 38.1 m-85 -130.49 148.69 52.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.062 -1.024 . . . . 0.0 111.48 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.498 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 4.2 ttpp -114.13 114.68 26.4 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.481 -0.762 . . . . 0.0 109.131 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.73 HG22 HD13 ' A' ' 99' ' ' LEU . 21.5 t -59.49 124.15 13.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 120.606 -1.309 . . . . 0.0 109.015 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.68 HG21 ' HB3' ' A' ' 76' ' ' PRO . 64.4 t -97.56 -25.54 4.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.602 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 3.8 tttp -158.68 133.54 8.27 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 177.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -51.68 163.27 0.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.671 0.748 . . . . 0.0 111.305 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.676 HG12 HD22 ' A' ' 101' ' ' LEU . 0.7 OUTLIER -57.09 132.81 21.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 121.647 0.736 . . . . 0.0 110.2 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.81 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -108.05 169.83 8.38 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 2.9 pm0 -116.01 132.94 56.51 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.784 -1.197 . . . . 0.0 110.425 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.925 HG21 ' CD ' ' A' ' 80' ' ' GLU . 16.5 p -91.17 -179.32 5.4 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.659 -0.817 . . . . 0.0 110.103 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -94.16 17.22 12.97 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.184 -0.947 . . . . 0.0 110.373 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.28 8.09 12.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.293 -0.879 . . . . 0.0 110.062 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.34 11.33 59.82 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.846 HG22 ' C ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -104.91 -174.38 2.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.39 -1.064 . . . . 0.0 110.345 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.81 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -141.13 155.67 21.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.795 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 76.7 t -120.76 129.95 75.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 119.101 -1.04 . . . . 0.0 112.231 -178.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.056 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -113.7 117.65 56.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 121.399 -0.813 . . . . 0.0 109.79 178.89 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.602 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 3.1 ttm180 -100.77 119.91 39.33 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.796 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.4 m -146.87 158.72 10.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.2 -0.937 . . . . 0.0 109.014 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.468 ' N ' HG23 ' A' ' 21' ' ' VAL 0.252 11.9 tt0 -106.08 125.57 51.15 Favored 'General case' 0 C--N 1.271 -2.817 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.393 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.935 ' HB2' HG21 ' A' ' 70' ' ' VAL . 3.7 t80 -59.78 123.04 15.73 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 119.003 -1.079 . . . . 0.0 110.079 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.498 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 8.3 mt-10 -98.86 -23.54 15.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.359 -0.838 . . . . 0.0 109.206 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.581 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -65.01 -162.12 0.68 Allowed Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.472 ' OD1' ' HE2' ' A' ' 73' ' ' LYS . 17.7 m-20 -129.15 146.52 51.06 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.457 -1.025 . . . . 0.0 110.307 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 43' ' ' SER . . . 155.37 -12.8 0.43 Allowed Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.597 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.608 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.7 OUTLIER 61.08 -153.29 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 120.661 -1.493 . . . . 0.0 108.32 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.608 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 88.4 Cg_exo -42.16 97.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.32 -0.958 0 N-CA-C 108.964 -1.206 . . . . 0.0 108.964 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.883 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -146.66 170.19 17.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.829 -0.545 . . . . 0.0 110.143 -177.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.639 ' CG ' HD11 ' A' ' 69' ' ' ILE . 1.2 mtpm? -84.67 175.09 9.44 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.173 -0.955 . . . . 0.0 112.033 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.087 HG23 ' CE2' ' A' ' 18' ' ' PHE . 15.5 mm -123.65 124.2 26.22 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.68 -0.638 . . . . 0.0 111.539 -178.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.618 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 31.7 Cg_exo -61.92 144.71 96.83 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.06 1.558 . . . . 0.0 110.384 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 1.005 ' CE1' HG21 ' A' ' 79' ' ' ILE . 4.8 t80 -151.69 156.21 39.89 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.203 -0.935 . . . . 0.0 110.324 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.535 ' HG3' HD12 ' A' ' 91' ' ' ILE . 23.1 tp10 -173.76 95.6 0.1 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.073 -1.017 . . . . 0.0 110.184 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.503 HD11 ' CB ' ' A' ' 81' ' ' ALA . 97.2 mt -85.48 88.05 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.302 -0.874 . . . . 0.0 110.265 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.472 ' HB3' ' HG3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -148.97 -65.47 0.23 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.198 -0.939 . . . . 0.0 110.228 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.513 ' O ' ' NZ ' ' A' ' 100' ' ' LYS . 9.5 t70 -168.02 -55.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.176 -0.953 . . . . 0.0 110.188 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.877 HD12 ' CD ' ' A' ' 100' ' ' LYS . 4.5 tp -169.4 -38.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -0.915 . . . . 0.0 110.146 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.456 ' OE2' ' OE1' ' A' ' 95' ' ' GLU . 15.8 tt0 -161.03 61.99 0.29 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.379 -0.826 . . . . 0.0 109.991 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.472 ' HG3' ' HB3' ' A' ' 52' ' ' MET . 1.1 mtpt -108.49 138.74 44.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.281 -0.887 . . . . 0.0 110.239 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.5 ttm180 -62.76 -63.68 1.14 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.217 -0.927 . . . . 0.0 110.105 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -51.88 147.68 6.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.253 -0.905 . . . . 0.0 110.136 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.672 ' O ' ' CB ' ' A' ' 60' ' ' LEU . 55.4 t -91.12 -71.24 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.963 . . . . 0.0 110.336 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.672 ' CB ' ' O ' ' A' ' 59' ' ' VAL . 13.3 tp 96.82 -63.6 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.522 0 CA-C-O 121.245 0.545 . . . . 0.0 109.646 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.528 ' N ' ' HG3' ' A' ' 84' ' ' PRO . . . -73.21 -160.45 5.89 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.555 ' O ' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -150.54 163.93 37.25 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.267 -1.137 . . . . 0.0 109.525 179.846 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.103 HD23 ' HB2' ' A' ' 81' ' ' ALA . 11.8 mt -122.01 121.41 36.96 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 118.837 -1.145 . . . . 0.0 110.539 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.828 HG12 HG21 ' A' ' 31' ' ' THR . 1.4 mp -82.54 -27.62 8.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.728 HG22 ' O ' ' A' ' 65' ' ' THR 0.26 1.1 m -96.78 32.61 2.04 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 122.781 1.277 . . . . 0.0 107.673 178.726 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 1.008 HG23 ' O ' ' A' ' 63' ' ' LEU . 16.3 t -34.74 140.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.25 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.57 ' N ' ' CD ' ' A' ' 68' ' ' PRO . 38.9 t-20 56.55 46.4 2.24 Favored Pre-proline 0 C--N 1.302 -1.493 0 O-C-N 121.577 -0.702 . . . . 0.0 110.585 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.596 ' CB ' ' CD1' ' A' ' 79' ' ' ILE . 8.1 Cg_endo -59.15 146.36 94.71 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.673 1.354 . . . . 0.0 109.043 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.883 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.7 OUTLIER -141.3 149.86 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 119.127 -1.029 . . . . 0.0 112.915 -177.652 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.016 ' CG2' HD11 ' A' ' 47' ' ' ILE . 41.9 t -97.28 168.86 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.412 ' N ' HG12 ' A' ' 70' ' ' VAL . 4.8 m -122.78 -21.25 5.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.857 -1.152 . . . . 0.0 111.201 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.535 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 15.6 mt-10 -136.51 17.23 3.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.816 -1.177 . . . . 0.0 111.192 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER 72.54 -5.63 1.79 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.281 -0.887 . . . . 0.0 110.981 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.477 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 5.8 t70 -138.81 0.27 1.98 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.923 -1.111 . . . . 0.0 110.429 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.508 ' O ' HG23 ' A' ' 77' ' ' VAL . 22.8 t -73.09 108.59 4.76 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.15 -0.969 . . . . 0.0 109.476 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.68 ' HB3' HG21 ' A' ' 21' ' ' VAL . 1.6 Cg_endo -50.22 110.66 0.41 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.697 1.367 . . . . 0.0 109.736 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.551 HG21 HG22 ' A' ' 70' ' ' VAL . 82.0 t -94.34 146.0 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.269 -0.894 . . . . 0.0 111.044 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.639 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.1 m120 -106.64 131.09 54.18 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 1.005 HG21 ' CE1' ' A' ' 49' ' ' PHE . 3.9 mm -112.2 117.46 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.079 -1.638 . . . . 0.0 111.803 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.925 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.6 tp10 -93.57 106.97 18.89 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.302 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 1.103 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -130.24 153.86 48.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.88 -1.137 . . . . 0.0 111.308 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 62' ' ' ARG . 24.6 tt0 -97.82 103.55 17.47 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.647 -0.658 . . . . 0.0 110.409 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.541 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 37.4 Cg_endo -70.77 144.56 49.02 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.984 1.518 . . . . 0.0 110.539 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.528 ' HG3' ' N ' ' A' ' 61' ' ' GLY . 23.7 Cg_exo -59.91 -142.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.095 1.577 . . . . 0.0 110.155 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.575 ' CD2' ' HD3' ' A' ' 106' ' ' LYS . 1.4 m-30 -108.75 155.62 20.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 110.245 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.521 ' CA ' ' O ' ' A' ' 105' ' ' LYS . . . 72.12 -165.19 54.19 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -54.2 171.69 0.1 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.258 -1.142 . . . . 0.0 110.196 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.439 ' OG ' ' HD2' ' A' ' 84' ' ' PRO . 0.6 OUTLIER -174.41 122.98 0.29 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.881 . . . . 0.0 110.346 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 17.9 m-85 -99.9 103.44 15.03 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.182 -0.949 . . . . 0.0 110.259 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.753 HD11 HD13 ' A' ' 32' ' ' ILE . 4.1 mt -74.14 116.94 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 109.469 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.606 HD11 ' N ' ' A' ' 54' ' ' LEU . 37.9 mt -94.62 147.44 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.177 -0.952 . . . . 0.0 110.395 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.056 HD11 HG21 ' A' ' 34' ' ' ILE . 1.6 mt -133.36 139.66 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.464 -0.772 . . . . 0.0 109.478 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.532 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 83.13 -161.17 39.28 Favored Glycine 0 N--CA 1.481 1.651 0 N-CA-C 108.624 -1.791 . . . . 0.0 108.624 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.554 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -122.12 149.1 25.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 121.213 -1.169 . . . . 0.0 110.169 -179.745 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.577 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.6 OUTLIER -17.15 -58.42 0.04 OUTLIER Pre-proline 0 N--CA 1.501 2.117 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 8.6 Cg_endo -51.87 71.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 124.279 1.673 . . . . 0.0 112.116 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 90.6 0.57 75.58 Favored Glycine 0 N--CA 1.494 2.537 0 O-C-N 120.941 -1.1 . . . . 0.0 110.943 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.507 ' HB3' ' C ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -48.38 159.97 0.18 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.952 -1.322 . . . . 0.0 110.199 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.73 HD13 HG22 ' A' ' 20' ' ' VAL . 12.2 mt -96.87 177.84 5.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.239 -0.913 . . . . 0.0 110.623 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.877 ' CD ' HD12 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -157.62 137.28 12.16 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.477 -0.765 . . . . 0.0 110.16 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.676 HD22 HG12 ' A' ' 24' ' ' ILE . 2.8 mp -138.21 116.94 12.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.207 -0.933 . . . . 0.0 110.373 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 9.1 p-10 -83.31 128.06 34.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 110.405 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.425 ' N ' ' O ' ' A' ' 88' ' ' SER . 10.6 t-105 -120.4 141.28 50.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.243 -0.911 . . . . 0.0 110.155 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -98.52 100.33 11.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -0.926 . . . . 0.0 110.116 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.521 ' O ' ' CA ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -108.2 120.85 43.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 110.288 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.575 ' HD3' ' CD2' ' A' ' 85' ' ' PHE . 1.2 ttpp 62.55 102.06 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.215 -0.928 . . . . 0.0 110.209 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.11 -149.19 25.37 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.74 -163.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.155 -1.203 . . . . 0.0 110.134 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 110' ' ' LEU . 7.6 t -92.67 55.26 2.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 110.249 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 109' ' ' SER . 5.3 mp 58.67 -89.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 110.169 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 109' ' ' SER . 1.4 tp10 60.39 116.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.305 -0.872 . . . . 0.0 110.288 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.43 -63.01 0.56 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 110.186 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.406 ' O ' ' CB ' ' A' ' 114' ' ' HIS . 0.5 OUTLIER -104.64 14.72 29.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.277 -0.889 . . . . 0.0 110.182 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.406 ' CB ' ' O ' ' A' ' 113' ' ' HIS . 19.0 t60 62.97 59.55 1.33 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.277 -0.889 . . . . 0.0 110.221 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -99.12 90.54 4.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -0.929 . . . . 0.0 110.202 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 22.6 m170 -107.32 -26.6 10.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 110.169 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.215 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mtt . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.21 0.529 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 4' ' ' LEU . 2.0 p30 -137.52 144.28 42.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.891 . . . . 0.0 110.202 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 2' ' ' ASP . 0.0 OUTLIER 62.32 -75.24 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.32 -0.863 . . . . 0.0 110.205 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 2' ' ' ASP . 1.1 mp -74.12 119.65 18.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 110.171 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.454 ' HB3' ' O ' ' A' ' 4' ' ' LEU . 3.1 pt20 175.65 137.54 0.05 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.893 . . . . 0.0 110.152 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.414 HD12 ' C ' ' A' ' 6' ' ' LEU . 3.5 pp -165.09 156.91 15.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 110.262 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -134.19 24.44 3.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.24 -0.913 . . . . 0.0 110.222 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.76 11.65 66.3 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.28 55.64 1.36 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.339 -1.095 . . . . 0.0 110.221 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.94 -34.42 11.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 0.0 110.241 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.581 ' CE2' ' O ' ' A' ' 44' ' ' PRO . 2.2 t80 -145.19 -74.56 0.23 Allowed 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.175 -0.953 . . . . 0.0 110.237 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.556 ' HB3' ' CB ' ' A' ' 45' ' ' CYS . 3.3 t -137.16 -36.18 0.67 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.166 -0.959 . . . . 0.0 110.474 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.477 ' HB3' ' O ' ' A' ' 12' ' ' SER . 1.1 ttt 57.87 92.41 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.452 -0.78 . . . . 0.0 109.303 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.587 ' HB3' ' CE1' ' A' ' 38' ' ' TYR . 1.3 m -72.66 126.64 30.37 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.209 -0.932 . . . . 0.0 109.65 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.538 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 1.2 p -116.39 4.95 13.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.132 -0.98 . . . . 0.0 111.716 -178.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.582 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -62.02 -115.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.531 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -136.49 174.06 11.03 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.989 -1.3 . . . . 0.0 109.946 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.997 ' CE2' HG23 ' A' ' 47' ' ' ILE . 42.8 m-85 -133.02 140.84 47.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.965 -1.084 . . . . 0.0 111.814 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.538 ' HB2' ' CG ' ' A' ' 39' ' ' GLU . 7.9 ttpt -107.67 117.65 34.67 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.633 -0.667 . . . . 0.0 109.277 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.735 HG22 HD13 ' A' ' 99' ' ' LEU . 21.2 t -59.64 132.91 25.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 120.835 -1.166 . . . . 0.0 109.042 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.644 HG23 ' HA ' ' A' ' 36' ' ' VAL . 92.1 t -105.78 -24.12 4.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.593 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 16.2 tttt -161.64 134.48 6.11 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -53.23 158.84 1.46 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.699 0.761 . . . . 0.0 111.421 -178.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.584 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -52.86 133.08 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-O 121.587 0.708 . . . . 0.0 110.202 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.848 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -109.64 171.73 7.27 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 5.3 pm0 -116.65 134.68 54.53 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.833 -1.167 . . . . 0.0 110.56 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.926 HG21 ' CD ' ' A' ' 80' ' ' GLU . 14.0 p -92.8 175.03 6.96 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.255 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -88.62 31.25 0.84 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.905 . . . . 0.0 110.234 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.3 m170 -133.87 5.78 3.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.894 . . . . 0.0 110.183 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.85 1.23 61.74 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.161 -1.575 . . . . 0.0 109.161 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.889 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -95.32 -176.73 3.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -1.144 . . . . 0.0 110.355 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.848 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -140.21 153.34 22.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.763 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.678 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 55.1 t -118.97 132.24 69.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 119.113 -1.035 . . . . 0.0 112.351 -177.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.059 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -113.55 120.54 63.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 O-C-N 121.355 -0.841 . . . . 0.0 109.61 178.601 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.593 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 2.9 ttm180 -105.19 110.85 23.39 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.842 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.5 m -132.59 -169.91 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.438 -0.789 . . . . 0.0 109.312 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.448 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 17.1 tt0 -136.58 128.19 28.77 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.841 ' HB2' HG21 ' A' ' 70' ' ' VAL . 16.1 t80 -61.02 118.66 7.04 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 117.983 -1.487 . . . . 0.0 110.633 -178.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.538 ' CG ' ' HB2' ' A' ' 19' ' ' LYS . 7.5 mm-40 -97.25 -0.79 46.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.503 -0.748 . . . . 0.0 109.327 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.582 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -93.57 -161.77 35.81 Favored Glycine 0 N--CA 1.484 1.855 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 41' ' ' ASP . 2.0 p30 -127.52 134.77 49.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.461 -1.023 . . . . 0.0 109.929 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' ' 43' ' ' SER . . . 171.92 -23.03 0.08 OUTLIER Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.483 -1.342 . . . . 0.0 110.664 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.611 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.5 OUTLIER 64.12 -154.95 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 120.602 -1.529 . . . . 0.0 108.073 -179.563 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.611 ' HD2' ' CB ' ' A' ' 43' ' ' SER . 88.2 Cg_exo -42.54 94.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -0.993 0 N-CA-C 109.059 -1.169 . . . . 0.0 109.059 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.95 ' O ' HG23 ' A' ' 69' ' ' ILE . 31.6 p -148.02 178.36 8.59 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.792 -0.568 . . . . 0.0 109.576 -178.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 68' ' ' PRO . 1.0 OUTLIER -96.05 175.04 6.62 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.943 -1.098 . . . . 0.0 111.412 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.038 HD11 ' CG2' ' A' ' 70' ' ' VAL . 17.7 mm -121.94 131.75 24.36 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.346 -0.846 . . . . 0.0 112.591 -177.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.62 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 26.1 Cg_exo -66.94 143.52 66.61 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 124.115 1.587 . . . . 0.0 110.768 178.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.961 ' CE2' HG21 ' A' ' 79' ' ' ILE . 9.2 t80 -152.96 158.65 42.39 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.313 -0.867 . . . . 0.0 110.248 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 1.036 ' HG2' HD12 ' A' ' 91' ' ' ILE . 5.3 tt0 -173.29 111.49 0.2 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.067 -1.02 . . . . 0.0 110.324 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.931 HD11 ' HB1' ' A' ' 81' ' ' ALA . 68.5 mt -95.78 69.94 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 110.34 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.664 ' HB3' HG21 ' A' ' 59' ' ' VAL . 23.5 mtt -149.93 -67.36 0.21 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.121 -0.987 . . . . 0.0 110.318 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.532 ' HB3' ' CG ' ' A' ' 56' ' ' LYS . 6.3 t70 174.93 171.37 0.26 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.321 -0.862 . . . . 0.0 110.082 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.626 HD12 ' CD ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -82.05 -0.35 44.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.203 -0.935 . . . . 0.0 110.489 -179.866 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -163.17 63.46 0.18 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 110.238 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.532 ' CG ' ' HB3' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -118.84 -172.2 2.24 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.326 -0.859 . . . . 0.0 110.276 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -127.89 -51.57 1.34 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 110.203 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 17.9 t60 -146.99 107.19 4.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.187 -0.946 . . . . 0.0 110.24 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.664 HG21 ' HB3' ' A' ' 52' ' ' MET . 11.1 t -119.01 -120.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.153 -0.967 . . . . 0.0 110.012 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.496 ' HB3' ' HB3' ' A' ' 84' ' ' PRO . 1.4 mt -161.01 -158.66 0.6 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.851 -1.156 . . . . 0.0 110.353 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.503 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . 100.16 174.3 30.2 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.526 ' CB ' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -158.93 166.69 31.24 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.073 -1.251 . . . . 0.0 109.596 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.038 HD23 ' HB2' ' A' ' 81' ' ' ALA . 10.5 mt -124.17 122.75 38.65 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 118.804 -1.158 . . . . 0.0 111.077 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.889 HG12 HG21 ' A' ' 31' ' ' THR . 1.5 mp -84.82 -23.35 7.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 178.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 65' ' ' THR 0.28 2.0 m -108.26 37.17 2.55 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 122.476 1.132 . . . . 0.0 108.096 179.514 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' ' 63' ' ' LEU . 37.3 t -38.22 152.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-O 121.504 0.668 . . . . 0.0 111.077 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.651 ' OD1' HG12 ' A' ' 66' ' ' VAL . 5.3 p-10 37.53 59.36 4.32 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.851 -0.53 . . . . 0.0 111.253 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.94 ' CG ' HD12 ' A' ' 79' ' ' ILE . 19.3 Cg_exo -58.64 164.8 8.86 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 N-CA-C 108.325 -1.452 . . . . 0.0 108.325 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.95 HG23 ' O ' ' A' ' 45' ' ' CYS . 1.1 mt -143.45 146.22 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 118.418 -1.313 . . . . 0.0 113.001 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.038 ' CG2' HD11 ' A' ' 47' ' ' ILE . 15.3 t -103.77 163.33 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 176.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.481 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 3.1 m -124.85 -12.04 7.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.823 -1.173 . . . . 0.0 111.654 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 4.4 mt-10 -140.88 10.52 2.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.719 -1.238 . . . . 0.0 111.311 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 15.8 mtmt 78.16 -16.75 0.63 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.744 -0.597 . . . . 0.0 111.036 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.492 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 6.2 t70 -132.52 0.52 3.65 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.071 -1.018 . . . . 0.0 109.801 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.7 t -71.71 111.53 10.8 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.643 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 38.2 Cg_exo -49.76 131.51 29.3 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.901 1.474 . . . . 0.0 110.332 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.776 HG21 HG22 ' A' ' 70' ' ' VAL . 89.2 t -110.36 154.52 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.172 -0.955 . . . . 0.0 110.515 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.659 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 0.9 OUTLIER -116.63 132.42 56.69 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.525 -0.735 . . . . 0.0 109.289 179.627 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.961 HG21 ' CE2' ' A' ' 49' ' ' PHE . 25.2 mm -117.76 117.05 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 117.497 -1.681 . . . . 0.0 112.105 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.926 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.6 tp10 -94.76 110.72 22.55 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.418 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 1.038 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -131.15 155.94 46.15 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.781 -1.199 . . . . 0.0 111.386 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.526 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 35.3 tp10 -99.79 102.36 16.93 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.593 -0.692 . . . . 0.0 110.418 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.544 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 56.9 Cg_endo -75.23 148.42 34.39 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.997 1.525 . . . . 0.0 110.747 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.503 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 12.2 Cg_endo -61.84 -157.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.099 1.579 . . . . 0.0 110.108 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.548 ' CD1' ' O ' ' A' ' 85' ' ' PHE . 24.0 p90 -104.17 135.67 45.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.193 -0.942 . . . . 0.0 110.067 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 99.01 -147.94 18.65 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.9 p30 -69.49 156.56 38.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.2 -1.177 . . . . 0.0 110.185 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.5 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 0.4 OUTLIER -163.71 135.44 4.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.179 -0.95 . . . . 0.0 110.354 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.546 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 2.0 m-85 -114.19 105.45 13.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.184 -0.948 . . . . 0.0 110.092 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.806 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 1.6 mp -74.01 118.44 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.203 -0.936 . . . . 0.0 109.522 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 1.036 HD12 ' HG2' ' A' ' 50' ' ' GLU . 70.9 mt -98.68 148.16 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 110.643 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.059 HD11 HG21 ' A' ' 34' ' ' ILE . 1.7 mt -135.88 138.2 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.643 -0.661 . . . . 0.0 109.333 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.54 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 83.9 -159.39 36.03 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.558 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -124.22 149.96 28.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 O-C-N 121.198 -1.178 . . . . 0.0 110.18 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.578 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 2.3 mt-10 -17.97 -57.88 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.121 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 9.0 Cg_endo -52.08 71.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 124.157 1.609 . . . . 0.0 112.177 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 89.81 2.74 74.9 Favored Glycine 0 N--CA 1.494 2.526 0 O-C-N 120.935 -1.103 . . . . 0.0 110.898 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.507 ' HB3' ' C ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -49.75 159.5 0.37 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.958 -1.319 . . . . 0.0 110.161 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.735 HD13 HG22 ' A' ' 20' ' ' VAL . 10.4 mt -94.91 172.66 8.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 110.445 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.626 ' CD ' HD12 ' A' ' 54' ' ' LEU . 4.5 ttpt -156.15 133.28 10.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.392 -0.817 . . . . 0.0 110.201 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.581 HD13 HG13 ' A' ' 34' ' ' ILE . 2.2 mp -134.11 122.72 23.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.257 -0.902 . . . . 0.0 110.058 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.403 ' OD1' ' CG ' ' A' ' 117' ' ' HIS . 0.9 OUTLIER -87.25 134.85 33.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.19 -0.944 . . . . 0.0 110.366 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.445 ' N ' ' O ' ' A' ' 88' ' ' SER . 22.3 t-105 -130.65 143.81 51.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.364 -0.835 . . . . 0.0 110.185 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -103.62 133.63 48.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.194 -0.941 . . . . 0.0 110.109 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -134.97 127.49 30.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.273 -0.892 . . . . 0.0 110.242 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 51.98 -167.62 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.292 -0.88 . . . . 0.0 110.26 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 162.13 102.45 0.17 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.5 m -69.88 -52.86 21.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.231 -1.159 . . . . 0.0 110.236 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.4 m -147.91 42.23 1.03 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.898 . . . . 0.0 110.165 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.553 HD12 ' C ' ' A' ' 110' ' ' LEU . 4.3 pp -50.93 167.0 0.08 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 110.119 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -119.57 159.94 23.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.934 . . . . 0.0 110.275 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -84.1 92.66 7.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.233 -0.917 . . . . 0.0 110.251 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 14.9 t-160 -80.87 125.59 30.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.895 . . . . 0.0 110.262 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.07 61.46 4.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 110.191 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -175.69 -47.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.243 -0.911 . . . . 0.0 110.268 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 58.67 -166.01 0.17 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.878 . . . . 0.0 110.276 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.403 ' CG ' ' OD1' ' A' ' 102' ' ' ASN . 3.1 t60 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.894 -1.05 . . . . 0.0 110.288 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.407 ' O ' ' HB2' ' A' ' 2' ' ' ASP . 5.9 tpp . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.26 0.553 . . . . 0.0 110.264 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 1' ' ' MET . 77.4 m-20 54.06 51.43 14.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 110.169 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.7 57.02 0.83 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.318 -0.864 . . . . 0.0 110.252 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.442 ' O ' ' HB3' ' A' ' 5' ' ' GLN . 0.5 OUTLIER -146.4 125.65 13.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.229 -0.919 . . . . 0.0 110.189 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.442 ' HB3' ' O ' ' A' ' 4' ' ' LEU . 0.8 OUTLIER 178.77 97.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.284 -0.885 . . . . 0.0 110.222 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.75 97.01 3.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.177 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.52 -15.4 20.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.281 -0.887 . . . . 0.0 110.236 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 129.69 135.3 3.87 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.452 ' O ' ' O ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -174.42 -54.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.239 -1.154 . . . . 0.0 110.289 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.551 ' HA ' ' CD ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER 57.94 156.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -0.921 . . . . 0.0 110.15 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.451 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 4.2 t80 -90.91 -72.85 0.56 Allowed 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.207 -0.933 . . . . 0.0 110.08 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' A' ' 13' ' ' MET . 3.3 t -135.08 -6.83 2.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.052 -1.03 . . . . 0.0 110.946 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.735 ' O ' HG23 ' A' ' 15' ' ' THR . 1.5 ttt 55.69 81.99 0.11 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.873 -1.142 . . . . 0.0 108.659 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.579 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 33.5 m -56.43 100.44 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.388 -0.82 . . . . 0.0 109.764 -178.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.735 HG23 ' O ' ' A' ' 13' ' ' MET . 71.2 p -97.53 -5.05 36.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 111.081 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.549 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -59.32 -110.37 0.01 OUTLIER Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.116 -1.516 . . . . 0.0 109.381 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.591 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 1.1 ttpt -142.95 162.56 35.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.039 -1.271 . . . . 0.0 109.924 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.024 ' CE2' HG23 ' A' ' 47' ' ' ILE . 21.0 m-85 -126.82 136.37 52.27 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.939 -1.101 . . . . 0.0 111.224 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.489 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 10.9 ttpp -108.0 119.24 38.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.418 -0.802 . . . . 0.0 109.678 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.834 ' CG2' HD13 ' A' ' 99' ' ' LEU . 48.3 t -59.93 130.76 24.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.829 -1.17 . . . . 0.0 108.995 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.615 HG23 ' HA ' ' A' ' 36' ' ' VAL . 61.3 t -102.98 -24.81 3.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.573 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 1.5 tttt -161.98 133.71 5.46 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -52.34 156.67 1.65 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.611 0.719 . . . . 0.0 111.193 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.577 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -49.94 132.66 9.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-O 121.616 0.722 . . . . 0.0 109.843 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.873 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -108.32 172.32 6.91 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.4 pm0 -115.23 130.58 56.95 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.834 -1.166 . . . . 0.0 110.516 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.945 HG21 ' CD ' ' A' ' 80' ' ' GLU . 26.4 p -84.57 177.22 8.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.439 -0.788 . . . . 0.0 109.967 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -92.24 28.61 1.86 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.882 . . . . 0.0 110.158 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -133.65 5.19 3.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.242 -0.911 . . . . 0.0 110.312 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.462 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 101.35 -3.3 54.32 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.873 HG22 ' C ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -92.19 -175.73 4.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.205 -1.174 . . . . 0.0 110.478 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.873 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -139.15 156.88 27.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.627 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.706 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 59.4 t -122.06 132.03 71.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 119.079 -1.049 . . . . 0.0 112.322 -177.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.026 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -112.2 120.16 61.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 O-C-N 121.197 -0.94 . . . . 0.0 109.7 178.767 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.573 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -104.47 114.96 29.54 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.638 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.834 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.3 m -137.27 -176.35 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.336 -0.853 . . . . 0.0 109.125 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.494 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 4.2 tt0 -129.36 131.47 46.86 Favored 'General case' 0 C--N 1.276 -2.613 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.929 ' HB2' HG21 ' A' ' 70' ' ' VAL . 6.2 t80 -60.88 122.54 15.12 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 118.724 -1.191 . . . . 0.0 110.731 -178.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 6.8 mt-10 -111.57 26.14 10.95 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.062 -1.024 . . . . 0.0 108.869 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.549 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -121.22 -161.07 11.25 Favored Glycine 0 N--CA 1.484 1.863 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 40.8 p-10 -125.0 149.18 48.01 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.384 -1.068 . . . . 0.0 110.392 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.48 -2.51 1.1 Allowed Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.555 -1.307 . . . . 0.0 110.958 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.612 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.6 OUTLIER 49.48 -153.57 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 120.534 -1.568 . . . . 0.0 108.353 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.612 ' HD2' ' CB ' ' A' ' 43' ' ' SER . 86.1 Cg_exo -41.46 97.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.321 -0.906 0 N-CA-C 109.121 -1.146 . . . . 0.0 109.121 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.896 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -143.65 169.66 17.31 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.192 0.52 . . . . 0.0 109.648 -178.095 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.592 ' O ' HD13 ' A' ' 47' ' ' ILE . 6.1 mtpm? -83.53 175.46 9.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.155 -0.966 . . . . 0.0 112.163 -178.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.097 ' CD1' HG23 ' A' ' 70' ' ' VAL . 15.4 mm -124.55 123.64 25.75 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.696 -0.627 . . . . 0.0 111.373 -178.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.627 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 31.7 Cg_exo -62.33 144.97 95.95 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.097 1.577 . . . . 0.0 110.901 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.999 ' CE1' HG21 ' A' ' 79' ' ' ILE . 5.8 t80 -152.97 155.71 37.48 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.374 -0.829 . . . . 0.0 110.033 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.742 ' HG2' HD12 ' A' ' 91' ' ' ILE . 21.7 tt0 -171.42 103.05 0.2 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.092 -1.005 . . . . 0.0 110.382 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.53 HD11 ' HB1' ' A' ' 81' ' ' ALA . 79.3 mt -94.56 86.63 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.295 -0.878 . . . . 0.0 110.134 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.754 ' HG3' HD13 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -153.91 -65.78 0.14 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.135 -0.978 . . . . 0.0 110.276 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.429 ' C ' HD11 ' A' ' 91' ' ' ILE . 5.5 t0 -157.98 -71.93 0.09 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.875 . . . . 0.0 110.236 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -149.7 -39.24 0.15 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.883 . . . . 0.0 110.298 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.432 ' HG3' ' HG3' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -164.85 55.68 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -0.955 . . . . 0.0 110.266 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.449 ' O ' ' SD ' ' A' ' 52' ' ' MET . 0.1 OUTLIER -131.89 89.62 2.71 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -0.891 . . . . 0.0 110.24 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.59 137.35 58.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 110.26 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -173.65 -153.22 0.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.349 -0.844 . . . . 0.0 110.158 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.7 t -106.53 77.96 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.217 -0.927 . . . . 0.0 110.278 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.754 HD13 ' HG3' ' A' ' 52' ' ' MET . 0.4 OUTLIER -137.23 143.97 42.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.26 -0.9 . . . . 0.0 110.184 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.428 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . 51.08 -171.35 0.21 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.6 ' O ' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -158.3 167.08 30.73 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.211 -1.17 . . . . 0.0 109.381 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.058 HD23 ' HB2' ' A' ' 81' ' ' ALA . 11.6 mt -122.69 122.08 37.92 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 118.916 -1.114 . . . . 0.0 110.814 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.848 HG12 HG21 ' A' ' 31' ' ' THR . 1.4 mp -83.44 -28.16 7.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.741 HG22 ' O ' ' A' ' 65' ' ' THR 0.27 1.3 m -96.98 34.57 1.7 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.447 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 1.0 HG23 ' O ' ' A' ' 63' ' ' LEU . 13.9 t -36.81 142.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.713 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.56 ' N ' ' HD3' ' A' ' 68' ' ' PRO . 46.5 t-20 49.62 59.77 16.3 Favored Pre-proline 0 C--N 1.299 -1.604 0 O-C-N 121.485 -0.759 . . . . 0.0 110.096 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.638 ' CG ' HD12 ' A' ' 79' ' ' ILE . 3.0 Cg_exo -68.91 154.89 70.14 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.719 1.378 . . . . 0.0 108.703 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.896 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.8 OUTLIER -142.91 146.5 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.13 -1.028 . . . . 0.0 112.247 -178.63 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.097 HG23 ' CD1' ' A' ' 47' ' ' ILE . 54.5 t -96.86 154.28 3.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.43 -21.89 12.28 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 120.913 -1.117 . . . . 0.0 108.714 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.539 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 32.1 mt-10 -139.22 146.47 40.53 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.545 ' O ' ' O ' ' A' ' 38' ' ' TYR . 0.5 OUTLIER -53.61 -13.9 0.75 Allowed 'General case' 0 C--N 1.296 -1.756 0 O-C-N 120.808 -1.182 . . . . 0.0 110.948 -178.873 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.471 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 15.7 t0 -126.91 6.99 6.65 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.58 -1.325 . . . . 0.0 110.671 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.499 ' CB ' ' HB2' ' A' ' 72' ' ' GLU . 0.1 OUTLIER -72.73 112.23 14.35 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.035 -1.041 . . . . 0.0 108.618 178.803 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.635 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 31.5 Cg_exo -56.34 126.71 23.23 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 O-C-N 124.008 1.531 . . . . 0.0 110.68 -178.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.774 HG21 HG22 ' A' ' 70' ' ' VAL . 53.9 t -105.56 158.62 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.097 -1.002 . . . . 0.0 110.448 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.648 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -121.13 131.21 54.12 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.417 -0.802 . . . . 0.0 109.484 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.999 HG21 ' CE1' ' A' ' 49' ' ' PHE . 15.4 mm -114.86 115.13 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 117.598 -1.641 . . . . 0.0 111.674 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.945 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.5 tp10 -94.23 108.06 19.96 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 1.058 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -129.4 155.7 45.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.874 -1.141 . . . . 0.0 111.093 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.539 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 1.2 tp10 -95.97 110.72 53.29 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.577 -0.702 . . . . 0.0 110.165 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.531 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 38.1 Cg_endo -71.41 144.84 46.49 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.027 1.541 . . . . 0.0 110.501 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 85' ' ' PHE . 13.4 Cg_endo -61.71 -72.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.006 1.529 . . . . 0.0 110.081 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.483 ' CB ' ' O ' ' A' ' 84' ' ' PRO . 0.1 OUTLIER 170.44 142.31 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.163 -0.961 . . . . 0.0 110.237 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.12 -145.57 27.08 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.62 126.58 30.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -1.137 . . . . 0.0 110.175 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 5.4 m -139.98 128.79 23.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.908 . . . . 0.0 110.259 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.583 ' CE2' ' ND2' ' A' ' 102' ' ' ASN . 11.6 m-85 -104.08 103.48 13.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -0.961 . . . . 0.0 110.256 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.719 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.5 mp -74.26 121.78 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.908 . . . . 0.0 109.752 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.742 HD12 ' HG2' ' A' ' 50' ' ' GLU . 14.2 mt -96.13 146.93 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -0.946 . . . . 0.0 110.176 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.026 HD11 HG21 ' A' ' 34' ' ' ILE . 1.7 mt -135.3 140.82 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.307 -0.87 . . . . 0.0 110.073 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 48' ' ' PRO . . . 80.22 -156.77 39.98 Favored Glycine 0 N--CA 1.484 1.881 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.596 HG21 ' HA ' ' A' ' 15' ' ' THR . 0.4 OUTLIER -130.99 156.83 43.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 O-C-N 121.055 -1.262 . . . . 0.0 110.685 -179.511 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.642 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 2.3 mt-10 -30.44 -54.08 0.37 Allowed Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.861 -0.524 . . . . 0.0 111.569 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 3.3 Cg_endo -48.43 -20.67 2.65 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.506 1.267 . . . . 0.0 111.125 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.591 ' HA3' ' CG ' ' A' ' 17' ' ' LYS . . . -176.81 46.42 0.11 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 94' ' ' VAL . 1.2 tt0 -95.21 153.72 17.53 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.88 -1.365 . . . . 0.0 111.138 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.834 HD13 ' CG2' ' A' ' 20' ' ' VAL . 24.2 mt -103.71 -177.52 3.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.547 -0.721 . . . . 0.0 110.268 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.413 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 0.7 OUTLIER -156.48 137.06 13.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.526 -0.734 . . . . 0.0 110.117 179.671 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.719 HD12 ' O ' ' A' ' 90' ' ' ILE . 2.5 mp -139.59 119.98 13.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.102 -0.999 . . . . 0.0 110.338 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.583 ' ND2' ' CE2' ' A' ' 89' ' ' TYR . 16.6 t-20 -87.26 130.22 34.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.314 -0.866 . . . . 0.0 110.314 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.533 ' CE3' HG22 ' A' ' 24' ' ' ILE . 21.9 t-105 -119.62 120.76 37.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 110.066 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.528 ' CE2' ' HD3' ' A' ' 106' ' ' LYS . 35.8 t80 -88.05 80.71 7.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.24 -0.912 . . . . 0.0 110.24 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.92 105.76 9.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.259 -0.9 . . . . 0.0 110.211 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.528 ' HD3' ' CE2' ' A' ' 104' ' ' PHE . 6.0 pttt -112.11 120.38 41.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.31 -0.869 . . . . 0.0 110.284 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 108' ' ' SER . . . 49.69 -126.24 20.38 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 0.3 OUTLIER 173.19 -30.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -1.132 . . . . 0.0 110.146 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.85 115.96 26.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.28 -0.887 . . . . 0.0 110.232 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.406 ' O ' ' HB2' ' A' ' 111' ' ' GLU . 0.8 OUTLIER -102.74 44.65 1.0 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.168 -0.957 . . . . 0.0 110.224 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 27.6 tt0 -177.52 84.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 110.169 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.444 ' CD2' ' O ' ' A' ' 112' ' ' HIS . 50.8 p-80 -112.45 44.15 1.5 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 110.194 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -109.21 86.55 2.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 110.189 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.81 -58.74 1.87 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -0.918 . . . . 0.0 110.213 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 38.1 m170 -73.53 -8.64 56.76 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.258 -0.901 . . . . 0.0 110.242 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -131.01 175.43 9.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.91 . . . . 0.0 110.223 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.482 ' N ' ' ND1' ' A' ' 117' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.28 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.422 ' O ' ' HG3' ' A' ' 3' ' ' LYS . 1.2 tpt . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.243 0.544 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.428 ' O ' ' C ' ' A' ' 3' ' ' LYS . 4.7 p-10 -55.89 -20.32 15.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 110.264 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 2' ' ' ASP . 0.7 OUTLIER 42.88 -146.49 0.06 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.933 . . . . 0.0 110.229 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.472 ' O ' ' CB ' ' A' ' 5' ' ' GLN . 0.4 OUTLIER -66.16 124.16 21.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 110.196 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.472 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER 170.87 95.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.261 -0.899 . . . . 0.0 110.051 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.0 mp -124.98 76.01 1.49 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 110.201 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.16 20.7 0.25 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.207 -0.933 . . . . 0.0 110.163 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -154.97 -40.89 0.02 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 42.9 mtp -80.65 -29.84 36.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.287 -1.125 . . . . 0.0 110.219 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.522 ' HB2' ' NZ ' ' A' ' 46' ' ' LYS . 24.6 p -45.65 139.95 3.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.208 -0.933 . . . . 0.0 110.077 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.86 -74.12 0.56 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.138 -0.976 . . . . 0.0 110.312 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 13' ' ' MET . 3.1 t -141.09 -2.9 1.25 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.006 -1.059 . . . . 0.0 111.219 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.453 ' HB3' ' O ' ' A' ' 12' ' ' SER . 1.7 ttm 56.22 84.4 0.08 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.908 -1.12 . . . . 0.0 108.536 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.591 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 32.5 m -54.81 106.27 0.21 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.375 -0.828 . . . . 0.0 109.65 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 16' ' ' GLY . 4.3 t -94.0 -9.52 36.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.336 -0.852 . . . . 0.0 111.722 -178.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.57 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -59.86 -123.56 0.01 OUTLIER Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.543 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -135.19 174.98 10.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.011 -1.288 . . . . 0.0 109.909 -179.749 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.076 ' CE2' HG23 ' A' ' 47' ' ' ILE . 35.0 m-85 -133.81 140.33 46.84 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.92 -1.112 . . . . 0.0 111.311 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.488 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 4.0 ttpt -109.89 117.18 33.12 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.584 -0.698 . . . . 0.0 109.366 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.735 ' CG2' HD13 ' A' ' 99' ' ' LEU . 46.9 t -59.76 123.07 11.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 120.688 -1.258 . . . . 0.0 109.013 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.946 HG21 ' HB3' ' A' ' 76' ' ' PRO . 53.2 t -96.95 -25.08 4.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.603 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 4.9 tttt -158.93 133.9 8.26 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -52.33 159.55 0.96 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.645 0.736 . . . . 0.0 111.186 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.597 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -51.82 133.24 13.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.514 0.673 . . . . 0.0 110.202 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 1.001 ' HB3' ' HB ' ' A' ' 33' ' ' VAL . . . -105.74 169.91 8.2 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 0.4 OUTLIER -117.32 123.17 45.87 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.883 -1.135 . . . . 0.0 110.55 -179.677 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.4 ' H ' HG23 ' A' ' 27' ' ' THR . 5.1 p -78.47 -175.71 4.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.402 -0.811 . . . . 0.0 109.808 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -100.25 34.54 2.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.186 -0.946 . . . . 0.0 110.058 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -140.64 8.57 2.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.247 -0.908 . . . . 0.0 110.434 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.38 -3.5 58.01 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.948 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -91.74 -176.39 4.45 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -1.167 . . . . 0.0 110.262 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.87 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -142.23 168.53 14.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.591 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.001 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 93.4 t -131.83 126.17 56.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 C-N-CA 118.71 -1.196 . . . . 0.0 111.995 -178.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.014 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -109.27 115.84 50.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.309 -0.869 . . . . 0.0 109.852 178.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.603 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 1.4 ttm180 -99.13 120.48 39.56 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.798 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.4 m -147.38 158.14 9.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.326 -0.859 . . . . 0.0 108.919 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 74' ' ' ASP 0.252 0.8 OUTLIER -105.65 125.22 50.74 Favored 'General case' 0 C--N 1.272 -2.796 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.291 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.905 ' HB2' HG21 ' A' ' 70' ' ' VAL . 2.1 t80 -60.1 124.12 19.27 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 119.07 -1.052 . . . . 0.0 110.289 -178.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.499 ' O ' ' N ' ' A' ' 17' ' ' LYS . 21.4 mm-40 -112.23 92.05 3.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.874 . . . . 0.0 109.872 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.57 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 164.47 -151.05 19.98 Favored Glycine 0 N--CA 1.486 1.97 0 C-N-CA 119.404 -1.379 . . . . 0.0 109.858 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.449 ' O ' ' OH ' ' A' ' 38' ' ' TYR . 4.4 m-20 -112.4 125.07 53.8 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.5 -1.0 . . . . 0.0 110.48 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 43' ' ' SER . . . 177.66 -27.92 0.06 OUTLIER Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.504 -1.332 . . . . 0.0 110.614 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.609 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.7 OUTLIER 48.56 -153.92 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 120.723 -1.457 . . . . 0.0 107.594 -179.421 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.609 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 53.6 Cg_exo -46.81 94.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.198 0 N-CA-C 108.385 -1.429 . . . . 0.0 108.385 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.858 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -150.47 172.67 15.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.582 -0.699 . . . . 0.0 110.063 -177.696 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.579 ' HG3' HD11 ' A' ' 69' ' ' ILE . 22.0 mtmt -81.09 175.71 10.43 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.236 -0.915 . . . . 0.0 112.102 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.076 HG23 ' CE2' ' A' ' 18' ' ' PHE . 15.7 mm -124.26 127.48 25.3 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.62 -0.675 . . . . 0.0 111.427 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.629 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 38.3 Cg_exo -63.86 144.13 87.64 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.048 1.551 . . . . 0.0 110.42 178.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.711 ' CZ ' HG23 ' A' ' 90' ' ' ILE . 9.6 t80 -151.83 160.28 43.6 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.259 -0.901 . . . . 0.0 110.286 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.678 ' O ' HD12 ' A' ' 91' ' ' ILE . 0.9 OUTLIER -175.2 98.78 0.08 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.214 -0.929 . . . . 0.0 109.532 179.569 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.923 HD11 ' HB1' ' A' ' 81' ' ' ALA . 64.0 mt -83.7 23.26 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.15 -0.969 . . . . 0.0 111.37 -178.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.595 ' HA ' ' CG ' ' A' ' 56' ' ' LYS . 11.2 ptt? -154.8 -49.55 0.09 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.935 -1.103 . . . . 0.0 110.701 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.706 ' HB2' HD13 ' A' ' 91' ' ' ILE . 0.4 OUTLIER 49.3 -153.9 0.11 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.071 -1.018 . . . . 0.0 110.333 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.73 0.11 53.72 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.375 -0.828 . . . . 0.0 110.335 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.439 ' O ' ' HD3' ' A' ' 56' ' ' LYS . 1.3 mm-40 -86.96 -11.57 50.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.269 -0.894 . . . . 0.0 109.725 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.595 ' CG ' ' HA ' ' A' ' 52' ' ' MET . 1.6 mmtp -120.08 -42.06 2.61 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.273 -0.892 . . . . 0.0 110.235 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 56' ' ' LYS . 6.1 ttt85 42.91 79.76 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.141 -0.974 . . . . 0.0 110.182 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 174.92 -67.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.291 -0.881 . . . . 0.0 110.137 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 59' ' ' VAL . 10.6 p -132.57 131.04 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.898 . . . . 0.0 110.202 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.515 ' CA ' ' SD ' ' A' ' 52' ' ' MET . 0.6 OUTLIER -91.2 29.98 1.33 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 110.187 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 60' ' ' LEU . . . 43.7 -164.52 0.04 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.51 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -131.57 155.46 47.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -1.156 . . . . 0.0 110.36 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.907 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -115.1 116.33 28.24 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.221 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.948 HG12 HG21 ' A' ' 31' ' ' THR . 1.7 mp -80.07 -27.35 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.756 HG22 ' O ' ' A' ' 65' ' ' THR 0.259 1.2 m -98.47 34.08 2.09 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.062 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.907 HG23 ' O ' ' A' ' 63' ' ' LEU . 40.6 t -26.62 145.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.526 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.642 ' ND2' ' O ' ' A' ' 67' ' ' ASN . 1.2 p-10 39.81 53.12 5.06 Favored Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 121.778 -0.576 . . . . 0.0 111.475 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.543 ' O ' HG12 ' A' ' 69' ' ' ILE . 1.8 Cg_endo -55.41 154.69 23.18 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 N-CA-C 108.758 -1.285 . . . . 0.0 108.758 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.858 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.7 OUTLIER -141.45 146.47 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 119.049 -1.061 . . . . 0.0 112.819 -177.667 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.033 HG23 ' CD1' ' A' ' 47' ' ' ILE . 95.7 t -92.75 167.63 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.466 ' N ' HG12 ' A' ' 70' ' ' VAL . 3.1 m -118.74 -21.93 7.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.735 -1.228 . . . . 0.0 111.033 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.522 ' O ' ' HB3' ' A' ' 73' ' ' LYS . 4.0 mt-10 -138.06 19.19 2.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.956 -1.09 . . . . 0.0 110.991 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.523 ' CD ' ' O ' ' A' ' 40' ' ' GLY . 0.3 OUTLIER 72.64 -7.34 1.44 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.398 -0.814 . . . . 0.0 111.11 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.5 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 6.1 t0 -137.43 0.33 2.28 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.864 -1.147 . . . . 0.0 110.451 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.611 ' O ' HG23 ' A' ' 77' ' ' VAL . 32.9 t -73.06 108.39 4.49 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.166 -0.959 . . . . 0.0 109.613 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.946 ' HB3' HG21 ' A' ' 21' ' ' VAL . 3.4 Cg_endo -51.57 110.51 0.43 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.735 1.387 . . . . 0.0 109.672 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 75' ' ' SER . 88.8 t -99.41 143.45 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.326 -0.859 . . . . 0.0 111.741 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.645 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 3.6 m-80 -98.17 130.97 44.91 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.726 ' HB ' HG22 ' A' ' 34' ' ' ILE . 5.8 mt -108.81 114.33 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.067 -1.646 . . . . 0.0 111.71 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 3.4 tt0 -84.23 115.29 22.37 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.676 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.923 ' HB1' HD11 ' A' ' 51' ' ' ILE . . . -137.85 152.61 49.24 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.987 -1.071 . . . . 0.0 110.919 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.51 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 34.9 tt0 -100.82 101.24 14.98 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.366 -0.834 . . . . 0.0 110.308 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.548 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 43.2 Cg_endo -73.23 134.08 20.48 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.036 1.545 . . . . 0.0 110.381 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 83' ' ' PRO . 34.3 Cg_exo -53.51 -165.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.923 1.486 . . . . 0.0 110.101 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -91.86 138.87 31.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.149 -0.97 . . . . 0.0 110.361 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.66 -170.02 25.06 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -60.69 158.53 12.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.283 -1.127 . . . . 0.0 110.081 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.424 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 0.4 OUTLIER -163.81 134.04 4.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.218 -0.926 . . . . 0.0 110.469 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.586 ' CD2' ' HE2' ' A' ' 56' ' ' LYS . 2.0 m-30 -107.48 103.73 13.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.212 -0.93 . . . . 0.0 110.009 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.711 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 1.6 mp -74.32 121.87 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.141 -0.975 . . . . 0.0 109.346 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.706 HD13 ' HB2' ' A' ' 53' ' ' ASP . 1.9 mp -100.03 148.25 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.047 -1.033 . . . . 0.0 110.143 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.014 HD11 HG21 ' A' ' 34' ' ' ILE . 1.6 mt -134.05 145.54 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.454 -0.779 . . . . 0.0 109.907 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.555 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 80.04 -161.03 45.15 Favored Glycine 0 N--CA 1.481 1.642 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.547 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -122.15 150.48 25.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 O-C-N 121.366 -1.079 . . . . 0.0 110.064 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.576 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 5.4 mt-10 -20.68 -56.95 0.07 OUTLIER Pre-proline 0 N--CA 1.5 2.04 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 9.2 Cg_endo -54.71 68.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 124.066 1.561 . . . . 0.0 111.963 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 94.33 6.57 61.26 Favored Glycine 0 N--CA 1.495 2.612 0 O-C-N 120.951 -1.093 . . . . 0.0 111.026 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.506 ' HB3' ' C ' ' A' ' 94' ' ' VAL . 0.3 OUTLIER -55.64 161.58 2.02 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.933 -1.334 . . . . 0.0 109.993 179.811 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.735 HD13 ' CG2' ' A' ' 20' ' ' VAL . 12.8 mt -99.26 177.43 5.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.234 -0.916 . . . . 0.0 110.963 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.561 ' C ' HD12 ' A' ' 101' ' ' LEU . 4.3 ttpt -154.8 138.51 16.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.57 -0.706 . . . . 0.0 109.953 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.561 HD12 ' C ' ' A' ' 100' ' ' LYS . 4.9 mp -143.43 124.58 14.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.136 -0.978 . . . . 0.0 110.36 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 8.7 p-10 -92.12 130.61 37.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.357 -0.839 . . . . 0.0 110.596 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.563 ' CZ3' HG22 ' A' ' 24' ' ' ILE . 38.2 t-105 -126.08 148.99 49.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.884 . . . . 0.0 109.998 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.63 123.48 44.9 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -0.892 . . . . 0.0 110.229 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -115.32 60.4 0.7 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -0.932 . . . . 0.0 110.227 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' A' ' 105' ' ' LYS . 0.1 OUTLIER 173.9 119.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.22 -0.925 . . . . 0.0 110.244 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.63 -158.85 16.54 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.4 m -69.35 119.7 14.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.22 -1.165 . . . . 0.0 110.298 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 111' ' ' GLU . 0.3 OUTLIER -170.06 137.98 1.64 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.254 -0.904 . . . . 0.0 110.22 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.2 mt -53.84 88.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.321 -0.862 . . . . 0.0 110.178 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -138.55 67.6 1.4 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -0.933 . . . . 0.0 110.259 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -61.78 113.07 2.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.258 -0.901 . . . . 0.0 110.214 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 24.5 m170 52.97 -155.65 0.19 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.351 -0.843 . . . . 0.0 110.16 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.443 ' CD2' ' OE2' ' A' ' 111' ' ' GLU . 0.3 OUTLIER -152.31 162.74 40.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.298 -0.876 . . . . 0.0 110.196 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.93 64.17 1.28 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 0.0 110.159 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -119.13 173.74 6.74 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.336 -0.853 . . . . 0.0 110.17 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.164 -179.975 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 ttp . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.229 0.538 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.424 ' O ' ' CB ' ' A' ' 3' ' ' LYS . 32.6 m-20 -139.71 90.83 2.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 0.0 110.193 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 2' ' ' ASP . 0.3 OUTLIER 173.64 125.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 110.256 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.454 ' O ' ' HB3' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -171.72 150.21 2.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.282 -0.886 . . . . 0.0 110.252 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.454 ' HB3' ' O ' ' A' ' 4' ' ' LEU . 2.5 pm0 179.45 59.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.288 -0.882 . . . . 0.0 110.06 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -166.0 -43.45 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.298 -0.876 . . . . 0.0 110.196 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.1 mttt 47.26 47.05 16.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.913 . . . . 0.0 110.157 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 9' ' ' MET . . . -149.22 16.12 1.15 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.456 ' O ' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER 48.77 -178.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -1.147 . . . . 0.0 110.208 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.565 ' HA ' ' CD ' ' A' ' 46' ' ' LYS . 80.3 p -139.81 -173.56 3.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.251 -0.906 . . . . 0.0 110.105 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -143.46 -74.16 0.27 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.183 -0.948 . . . . 0.0 110.396 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.481 ' HB3' ' HB2' ' A' ' 45' ' ' CYS . 2.9 t -139.23 1.96 2.04 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.966 -1.083 . . . . 0.0 110.832 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.429 ' C ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER 45.95 83.23 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.042 -1.036 . . . . 0.0 108.386 -179.528 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.58 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 30.8 m -54.0 102.4 0.06 Allowed 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.575 -178.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.491 ' O ' ' O ' ' A' ' 16' ' ' GLY . 3.4 p -87.84 -8.08 56.37 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.375 -0.828 . . . . 0.0 111.711 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.579 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -60.33 -131.55 0.01 OUTLIER Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.518 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -134.37 -178.91 5.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.02 -1.282 . . . . 0.0 109.822 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.946 ' CZ ' HG23 ' A' ' 47' ' ' ILE . 44.1 m-85 -138.01 142.62 40.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.894 -1.129 . . . . 0.0 111.851 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.51 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 31.9 ttpt -110.4 117.92 34.89 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.695 ' CG2' HD13 ' A' ' 99' ' ' LEU . 60.6 t -59.56 124.23 13.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 120.666 -1.271 . . . . 0.0 109.459 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.717 HG23 ' HA ' ' A' ' 36' ' ' VAL . 83.3 t -96.27 -27.09 4.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.637 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 0.2 OUTLIER -154.31 138.06 16.16 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.332 177.11 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.54 158.43 4.45 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.383 0.611 . . . . 0.0 110.364 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.691 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.7 OUTLIER -55.4 130.64 17.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.051 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.782 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -108.65 168.74 9.12 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 12.9 pt-20 -113.87 134.94 54.49 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.786 -1.196 . . . . 0.0 110.479 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.915 HG21 ' CD ' ' A' ' 80' ' ' GLU . 16.5 p -90.52 -172.67 3.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.5 -0.75 . . . . 0.0 110.278 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -95.91 4.41 52.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.269 -0.895 . . . . 0.0 110.419 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -106.67 6.82 30.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.201 -0.937 . . . . 0.0 110.223 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.53 7.64 61.62 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.968 HG22 ' C ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -97.48 -171.95 2.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -1.092 . . . . 0.0 110.457 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.782 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -142.69 147.21 21.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.777 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.671 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 66.8 t -111.64 134.79 52.91 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 O-C-N 121.346 -0.846 . . . . 0.0 112.08 -177.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.082 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -120.95 118.76 57.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 121.409 -0.807 . . . . 0.0 109.988 179.11 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.637 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -100.07 122.99 43.8 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 119.026 -1.07 . . . . 0.0 108.34 179.23 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.799 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.3 m -149.0 158.52 6.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.175 -0.953 . . . . 0.0 109.053 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 74' ' ' ASP 0.256 1.8 tt0 -107.61 126.74 52.94 Favored 'General case' 0 C--N 1.27 -2.848 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.503 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.961 ' HB2' HG21 ' A' ' 70' ' ' VAL . 1.9 t80 -59.18 125.46 23.68 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.182 -178.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.51 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 5.2 mm-40 -111.85 87.96 2.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.18 -0.95 . . . . 0.0 109.715 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.579 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 164.65 -150.58 18.85 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.456 ' O ' ' OH ' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -117.82 137.02 53.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.594 -0.945 . . . . 0.0 110.496 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 43' ' ' SER . . . 173.32 -24.76 0.08 OUTLIER Glycine 0 N--CA 1.488 2.109 0 C-N-CA 119.649 -1.262 . . . . 0.0 110.641 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.599 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.4 OUTLIER 49.36 -156.54 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 120.732 -1.452 . . . . 0.0 107.813 -179.501 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.599 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 50.8 Cg_exo -48.15 94.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.318 0 N-CA-C 107.951 -1.596 . . . . 0.0 107.951 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.919 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -148.06 173.62 12.74 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.633 -0.667 . . . . 0.0 109.333 -177.584 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 68' ' ' PRO . 0.3 OUTLIER -88.6 173.84 8.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.0 -1.062 . . . . 0.0 111.78 -178.73 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.06 ' CD1' HG23 ' A' ' 70' ' ' VAL . 19.2 mm -124.18 129.64 24.65 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.64 -0.662 . . . . 0.0 112.033 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.613 ' HD2' ' CE2' ' A' ' 18' ' ' PHE . 36.8 Cg_exo -63.71 147.82 92.42 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 124.05 1.552 . . . . 0.0 111.034 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.912 ' CE2' HG21 ' A' ' 79' ' ' ILE . 11.0 t80 -155.51 157.6 37.16 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.324 -0.86 . . . . 0.0 110.552 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.889 ' HG2' HD12 ' A' ' 91' ' ' ILE . 22.4 tt0 -175.72 95.91 0.07 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.147 -0.971 . . . . 0.0 110.306 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.75 HD11 ' HB1' ' A' ' 81' ' ' ALA . 0.5 OUTLIER -58.65 -35.58 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.313 -0.867 . . . . 0.0 109.74 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.471 ' SD ' ' HB2' ' A' ' 56' ' ' LYS . 1.0 OUTLIER -154.71 -67.74 0.13 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.126 -0.984 . . . . 0.0 110.189 179.587 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 55' ' ' GLU . 5.8 t0 37.44 -150.29 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.553 -0.717 . . . . 0.0 110.677 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.68 HD13 ' OE2' ' A' ' 50' ' ' GLU . 6.3 mp 43.98 -92.12 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.415 -0.803 . . . . 0.0 110.517 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 53' ' ' ASP . 3.4 pt-20 -166.41 64.44 0.1 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.062 -1.024 . . . . 0.0 110.248 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.471 ' HB2' ' SD ' ' A' ' 52' ' ' MET . 39.7 mmtt -98.59 -175.63 3.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.26 -0.9 . . . . 0.0 110.077 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -43.16 -26.71 0.18 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.907 . . . . 0.0 110.06 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.418 ' N ' ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -172.45 -177.09 1.69 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.288 -0.883 . . . . 0.0 110.119 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 59' ' ' VAL . 4.9 p -148.96 80.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.951 . . . . 0.0 110.289 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.55 4.68 2.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 110.317 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.534 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . -59.07 174.7 3.26 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.54 ' CB ' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -150.34 163.49 38.21 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.271 -1.134 . . . . 0.0 109.496 179.749 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.034 HD23 ' HB2' ' A' ' 81' ' ' ALA . 11.1 mt -123.6 121.2 34.96 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 118.639 -1.224 . . . . 0.0 110.408 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.804 ' CG1' HG21 ' A' ' 31' ' ' THR . 4.1 mm -83.34 -29.32 7.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.776 HG22 ' O ' ' A' ' 65' ' ' THR 0.267 1.9 m -99.37 35.87 1.86 Allowed 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.868 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.947 HG23 ' O ' ' A' ' 63' ' ' LEU . 44.7 t -37.79 155.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-O 121.489 0.662 . . . . 0.0 110.995 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.623 ' ND2' ' O ' ' A' ' 66' ' ' VAL . 0.4 OUTLIER 36.46 53.97 2.56 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 122.065 -0.397 . . . . 0.0 111.378 179.302 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.826 ' CG ' HD12 ' A' ' 79' ' ' ILE . 15.7 Cg_exo -55.05 161.56 6.44 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 N-CA-C 108.472 -1.395 . . . . 0.0 108.472 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.919 HG23 ' O ' ' A' ' 45' ' ' CYS . 1.0 OUTLIER -142.79 145.8 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 118.844 -1.143 . . . . 0.0 112.813 -178.431 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.06 HG23 ' CD1' ' A' ' 47' ' ' ILE . 55.8 t -101.38 160.59 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 176.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.452 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 2.8 m -116.09 -19.48 10.28 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.653 -1.279 . . . . 0.0 111.326 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 3.2 mt-10 -137.61 14.71 2.94 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.831 -1.168 . . . . 0.0 111.272 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.529 ' O ' ' O ' ' A' ' 38' ' ' TYR . 3.2 mtmt 75.11 -11.3 1.09 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.517 -0.739 . . . . 0.0 111.03 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.489 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 6.4 t0 -133.67 0.92 3.32 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.979 -1.076 . . . . 0.0 110.204 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.561 ' O ' HG23 ' A' ' 77' ' ' VAL . 25.1 t -72.83 108.76 4.87 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.202 -0.937 . . . . 0.0 109.528 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.717 ' HB3' HG21 ' A' ' 21' ' ' VAL . 4.2 Cg_endo -52.16 113.59 1.26 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.766 1.403 . . . . 0.0 109.921 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 75' ' ' SER . 62.0 t -99.35 153.67 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.268 -0.895 . . . . 0.0 110.982 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.652 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.3 m-20 -112.39 133.11 54.66 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.912 HG21 ' CE2' ' A' ' 49' ' ' PHE . 7.2 mm -115.47 121.86 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.1 -1.625 . . . . 0.0 111.588 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.915 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.0 OUTLIER -99.15 106.59 18.79 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.681 -0.637 . . . . 0.0 109.815 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 1.034 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -123.2 156.25 35.49 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.989 -1.069 . . . . 0.0 111.178 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.54 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 4.7 tt0 -101.64 101.03 15.83 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.632 -0.668 . . . . 0.0 110.283 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.555 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 23.3 Cg_endo -67.82 151.22 78.72 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 124.045 1.55 . . . . 0.0 110.467 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.534 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 15.2 Cg_endo -62.16 -74.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.047 1.551 . . . . 0.0 110.337 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -175.84 160.56 2.39 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.288 -0.882 . . . . 0.0 110.214 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.506 ' CA ' ' O ' ' A' ' 105' ' ' LYS . . . 62.63 -143.43 48.65 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -67.86 152.44 45.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -1.129 . . . . 0.0 110.256 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 103' ' ' TRP . 2.6 t -155.76 125.53 6.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.308 -0.87 . . . . 0.0 110.167 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 10.2 m-85 -100.43 100.25 10.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.938 . . . . 0.0 110.163 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.809 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 1.6 mp -74.16 111.47 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.152 -0.968 . . . . 0.0 109.381 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.889 HD12 ' HG2' ' A' ' 50' ' ' GLU . 33.7 mt -92.23 146.8 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.243 -0.911 . . . . 0.0 110.435 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.082 HD11 HG21 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -134.71 137.1 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.617 -0.677 . . . . 0.0 109.54 -179.843 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 48' ' ' PRO . . . 85.91 -162.6 35.77 Favored Glycine 0 N--CA 1.482 1.735 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.56 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -120.27 147.92 23.71 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 O-C-N 121.146 -1.208 . . . . 0.0 110.179 -179.637 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.579 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.8 mt-10 -16.86 -58.31 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.149 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 6.9 Cg_endo -51.07 72.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 124.164 1.613 . . . . 0.0 111.992 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 89.36 -1.78 82.53 Favored Glycine 0 N--CA 1.494 2.551 0 O-C-N 121.032 -1.042 . . . . 0.0 110.809 178.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.51 ' HB3' ' C ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -45.83 159.3 0.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.986 -1.302 . . . . 0.0 110.042 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.695 HD13 ' CG2' ' A' ' 20' ' ' VAL . 10.2 mt -96.06 173.26 7.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 110.6 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.61 ' C ' HD12 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -154.57 131.03 10.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.388 -0.82 . . . . 0.0 110.007 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.61 HD12 ' C ' ' A' ' 100' ' ' LYS . 5.5 mp -134.33 121.46 21.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 0.0 110.432 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 10.8 t30 -89.78 130.94 35.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.285 -0.884 . . . . 0.0 110.141 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.469 ' N ' ' O ' ' A' ' 88' ' ' SER . 10.7 t-105 -113.72 135.29 54.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.227 -0.921 . . . . 0.0 110.205 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.38 77.21 5.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.373 -0.829 . . . . 0.0 110.135 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.506 ' O ' ' CA ' ' A' ' 86' ' ' GLY . 0.1 OUTLIER -94.0 93.23 7.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.287 -0.883 . . . . 0.0 110.261 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -100.06 -81.74 0.46 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.28 -0.888 . . . . 0.0 110.173 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 108' ' ' SER . . . -98.1 -114.06 3.3 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 107' ' ' GLY . 1.1 m 44.13 57.22 4.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -1.152 . . . . 0.0 110.206 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.6 t -104.43 164.4 11.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 110.163 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.13 123.78 5.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 0.0 110.222 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -174.72 172.13 3.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.914 . . . . 0.0 110.234 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 59.55 91.4 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -0.906 . . . . 0.0 110.258 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.482 ' CG ' ' N ' ' A' ' 114' ' ' HIS . 7.3 p-80 -172.16 -142.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.268 -0.895 . . . . 0.0 110.132 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.482 ' N ' ' CG ' ' A' ' 113' ' ' HIS . 7.4 p-80 -153.37 115.73 4.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 110.164 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -94.75 -172.06 2.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 0.0 110.231 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 3.7 m80 -97.9 78.84 2.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.171 -0.956 . . . . 0.0 110.247 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.546 ' O ' ' CG ' ' A' ' 117' ' ' HIS . 11.8 p80 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.158 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.199 0.524 . . . . 0.0 110.289 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -110.03 -47.86 3.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.262 -0.899 . . . . 0.0 110.152 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.46 ' O ' ' O ' ' A' ' 4' ' ' LEU . 60.7 mttt -69.23 -172.96 0.48 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 110.282 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.473 ' O ' ' HG3' ' A' ' 5' ' ' GLN . 14.5 tp 60.8 131.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 110.052 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -179.49 -72.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.127 -0.983 . . . . 0.0 110.28 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 62.13 106.67 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 0.0 110.18 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.11 133.04 36.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.296 -0.877 . . . . 0.0 110.207 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.92 -113.26 0.01 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.36 -158.38 0.24 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.282 -1.128 . . . . 0.0 110.225 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 10' ' ' SER . 1.9 t -89.95 59.35 4.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.268 -0.895 . . . . 0.0 110.063 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.65 ' CE1' HD12 ' A' ' 69' ' ' ILE . 0.8 OUTLIER -165.13 23.96 0.05 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.248 -0.908 . . . . 0.0 109.463 -179.789 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.577 ' HA ' ' HD3' ' A' ' 46' ' ' LYS . 3.2 t -135.76 -21.73 1.47 Allowed 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.622 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.591 ' O ' ' CG ' ' A' ' 13' ' ' MET . 0.3 OUTLIER -174.8 75.83 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.018 -1.051 . . . . 0.0 111.194 -179.109 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.579 ' HB3' ' CE1' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -45.03 103.83 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.714 -1.241 . . . . 0.0 109.127 179.365 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.653 ' HA ' HG21 ' A' ' 94' ' ' VAL . 1.2 p -68.74 -5.65 21.78 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.479 -0.763 . . . . 0.0 111.755 -178.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.549 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -59.3 -149.74 0.01 OUTLIER Glycine 0 N--CA 1.48 1.623 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.572 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 1.4 tmpt? -123.61 160.77 26.38 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.37 -1.076 . . . . 0.0 108.929 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.065 ' CE2' HG23 ' A' ' 47' ' ' ILE . 34.5 m-85 -118.76 137.55 53.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.497 -1.377 . . . . 0.0 112.144 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.511 ' HE2' ' NE2' ' A' ' 37' ' ' GLN . 7.7 ttpp -109.21 119.33 39.2 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.703 -0.623 . . . . 0.0 109.435 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.425 ' HA ' HG12 ' A' ' 36' ' ' VAL . 27.4 t -59.46 129.54 21.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 120.709 -1.244 . . . . 0.0 108.836 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.635 HG23 ' HA ' ' A' ' 36' ' ' VAL . 64.3 t -104.75 -24.75 3.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.562 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 15.3 tttt -159.91 134.6 7.76 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 177.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -52.6 155.02 2.36 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.6 0.714 . . . . 0.0 111.094 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.609 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -47.87 133.85 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.967 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.921 ' HB3' ' HB ' ' A' ' 33' ' ' VAL . . . -106.84 173.33 6.37 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.5 pm0 -116.98 126.11 52.41 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.905 -1.122 . . . . 0.0 110.582 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.443 HG21 ' HG2' ' A' ' 80' ' ' GLU . 11.9 p -79.85 -163.74 0.57 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.355 -0.841 . . . . 0.0 110.035 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -110.44 31.56 5.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 109.874 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -139.84 10.36 2.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.344 -0.848 . . . . 0.0 110.447 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.85 -1.44 59.65 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.915 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -91.81 -175.46 4.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -1.117 . . . . 0.0 110.269 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.872 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -142.93 165.98 15.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.842 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.921 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 93.7 t -130.26 125.87 60.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 120.724 -1.235 . . . . 0.0 112.44 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.082 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -106.51 116.68 50.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.363 -0.836 . . . . 0.0 109.566 178.803 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 3.4 ttm180 -101.49 120.07 39.74 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.744 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.8 m -140.69 -173.68 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.536 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 1.9 tt0 -133.89 124.57 26.66 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.85 ' HB2' HG21 ' A' ' 70' ' ' VAL . 89.3 t80 -61.32 140.64 57.95 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.368 -1.333 . . . . 0.0 110.527 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 17' ' ' LYS . 3.3 mm-40 -134.74 83.34 2.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.491 -0.756 . . . . 0.0 109.805 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.549 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 174.0 -147.07 9.09 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.543 ' HA ' ' HD2' ' A' ' 73' ' ' LYS . 50.0 t0 -113.93 132.79 55.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.627 -0.925 . . . . 0.0 110.38 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.458 ' O ' ' OG ' ' A' ' 10' ' ' SER . . . 165.01 -24.7 0.17 Allowed Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.726 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.608 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.5 OUTLIER 49.24 -156.13 0.01 OUTLIER Pre-proline 0 N--CA 1.487 1.395 0 O-C-N 120.598 -1.531 . . . . 0.0 108.105 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.608 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 74.6 Cg_exo -44.02 96.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.35 0 N-CA-C 109.283 -1.083 . . . . 0.0 109.283 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.726 ' O ' HG23 ' A' ' 69' ' ' ILE . 24.5 p -143.34 169.31 17.89 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.634 -0.666 . . . . 0.0 110.134 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.692 ' CG ' HD11 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -83.86 172.74 11.86 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.411 -0.806 . . . . 0.0 110.358 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.065 HG23 ' CE2' ' A' ' 18' ' ' PHE . 15.8 mm -114.76 126.6 27.71 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 111.957 -177.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.62 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 33.8 Cg_exo -63.02 144.6 93.23 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.993 1.523 . . . . 0.0 110.846 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.923 ' CD2' HG21 ' A' ' 79' ' ' ILE . 3.9 t80 -154.29 153.11 31.13 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.537 -0.727 . . . . 0.0 109.678 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.616 ' HG3' HD12 ' A' ' 91' ' ' ILE . 19.3 tp10 -166.37 98.06 0.59 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.928 -1.107 . . . . 0.0 110.546 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.719 HD11 ' HB1' ' A' ' 81' ' ' ALA . 4.8 mt -92.07 136.08 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.29 -0.881 . . . . 0.0 109.821 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.569 ' O ' HD22 ' A' ' 60' ' ' LEU . 3.7 ptt? -136.19 -49.6 0.68 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.08 -1.013 . . . . 0.0 110.548 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' A' ' 52' ' ' MET . 12.4 t0 68.28 -58.76 0.46 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.1 -1.0 . . . . 0.0 110.202 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 52' ' ' MET . 11.7 mt -83.02 -75.62 0.31 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.923 . . . . 0.0 110.2 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 56' ' ' LYS . 8.0 mm-40 -124.86 -76.9 0.59 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.154 -0.966 . . . . 0.0 110.202 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.465 ' HA ' ' HB3' ' A' ' 52' ' ' MET . 0.1 OUTLIER 179.1 67.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.193 -0.942 . . . . 0.0 110.239 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.466 ' HB3' HG22 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -121.22 174.99 6.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 0.0 110.146 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.529 ' O ' ' CG ' ' A' ' 58' ' ' HIS . 47.1 t-80 -101.49 25.32 8.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 110.159 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.513 HG23 HD12 ' A' ' 60' ' ' LEU . 9.0 m -117.43 3.22 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 110.228 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.571 HD23 ' HG3' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -117.88 119.2 34.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.192 -0.943 . . . . 0.0 110.257 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.521 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . 84.04 162.76 34.53 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.523 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -143.25 169.35 17.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -1.143 . . . . 0.0 110.373 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.751 HD21 ' CD1' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -120.89 121.26 37.68 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.479 179.39 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.915 HG12 HG21 ' A' ' 31' ' ' THR . 1.4 mp -85.53 -27.79 6.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 106.735 -1.579 . . . . 0.0 106.735 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.799 HG22 ' O ' ' A' ' 65' ' ' THR 0.254 2.3 m -110.93 39.79 2.17 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.283 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.738 ' N ' HD12 ' A' ' 63' ' ' LEU . 6.8 t -25.9 121.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 CA-C-O 121.711 0.767 . . . . 0.0 111.813 -178.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 7.2 t-20 41.8 69.96 1.88 Allowed Pre-proline 0 C--N 1.297 -1.696 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.77 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.726 ' HG3' HG23 ' A' ' 79' ' ' ILE . 1.2 Cg_endo -55.6 -171.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.725 1.382 . . . . 0.0 108.826 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.726 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.7 OUTLIER -143.53 145.62 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 118.926 -1.109 . . . . 0.0 112.44 -179.409 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.949 ' CG2' HD11 ' A' ' 47' ' ' ILE . 60.1 t -97.86 162.12 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 176.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.6 m -117.26 -17.21 10.24 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.666 -1.213 . . . . 0.0 111.351 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.54 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 15.4 mt-10 -142.03 16.87 2.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.875 -1.141 . . . . 0.0 111.054 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.543 ' HD2' ' HA ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER 75.71 -12.71 0.96 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.48 -0.763 . . . . 0.0 110.97 179.745 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.472 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 12.5 t70 -133.41 -1.94 3.13 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.051 -1.031 . . . . 0.0 110.234 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.608 ' O ' HG23 ' A' ' 77' ' ' VAL . 8.2 t -71.97 112.27 13.77 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.246 -0.909 . . . . 0.0 108.69 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.631 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 42.7 Cg_exo -49.03 126.29 14.89 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.9 1.473 . . . . 0.0 110.387 -178.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.705 HG21 HG22 ' A' ' 70' ' ' VAL . 58.2 t -115.65 143.37 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.072 -1.018 . . . . 0.0 111.254 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.672 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 1.5 m-20 -104.74 136.18 44.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.412 -0.805 . . . . 0.0 109.562 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.923 HG21 ' CD2' ' A' ' 49' ' ' PHE . 7.3 mt -115.41 116.94 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.134 -1.604 . . . . 0.0 111.552 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.712 ' HG3' HG22 ' A' ' 33' ' ' VAL . 3.8 tt0 -88.06 114.0 24.25 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.455 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.809 ' C ' HG22 ' A' ' 31' ' ' THR . . . -132.77 149.32 52.29 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.943 -1.098 . . . . 0.0 110.915 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.523 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 2.8 tp10 -99.99 99.15 8.6 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.305 -0.872 . . . . 0.0 110.196 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.541 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 21.9 Cg_endo -66.21 152.6 80.73 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.064 1.56 . . . . 0.0 110.494 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.571 ' HG3' HD23 ' A' ' 60' ' ' LEU . 17.8 Cg_endo -65.1 -74.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.993 1.522 . . . . 0.0 110.241 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.508 ' CD1' ' O ' ' A' ' 85' ' ' PHE . 10.2 p90 -179.07 151.73 0.52 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.88 . . . . 0.0 110.187 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.06 -166.09 52.68 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 53' ' ' ASP . 2.6 p30 -61.43 146.22 49.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.238 -1.154 . . . . 0.0 110.118 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -157.86 120.72 3.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.294 -0.879 . . . . 0.0 110.231 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.42 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 2.9 m-85 -90.36 98.31 11.7 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.19 -0.944 . . . . 0.0 110.167 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.643 HG21 ' CZ ' ' A' ' 49' ' ' PHE . 11.0 mt -74.33 138.7 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.267 -0.896 . . . . 0.0 109.67 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.616 HD12 ' HG3' ' A' ' 50' ' ' GLU . 14.6 mt -98.83 150.11 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.051 -1.031 . . . . 0.0 110.216 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.082 HD11 HG21 ' A' ' 34' ' ' ILE . 0.6 OUTLIER -138.61 142.73 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.49 -0.756 . . . . 0.0 109.928 -179.506 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.557 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 80.03 -157.15 40.84 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.653 HG21 ' HA ' ' A' ' 15' ' ' THR . 0.8 OUTLIER -129.08 157.33 41.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 121.077 -1.249 . . . . 0.0 110.023 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.537 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 4.0 mt-10 -33.05 -54.62 0.63 Allowed Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.635 -0.666 . . . . 0.0 110.442 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 62.0 Cg_exo -44.31 -37.94 10.82 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.154 1.607 . . . . 0.0 110.458 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.572 ' HA3' ' CG ' ' A' ' 17' ' ' LYS . . . -157.17 53.22 0.4 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.598 ' HB2' ' N ' ' A' ' 94' ' ' VAL . 0.6 OUTLIER -109.62 149.39 29.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.04 -1.271 . . . . 0.0 111.0 -178.678 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.898 HD21 ' O ' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -119.88 -163.05 0.96 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.197 -0.94 . . . . 0.0 109.869 178.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -146.49 153.72 40.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.519 -0.738 . . . . 0.0 110.284 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.813 HD13 HG13 ' A' ' 34' ' ' ILE . 1.1 mt -138.26 113.12 9.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.922 . . . . 0.0 110.162 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 88' ' ' SER . 4.8 p-10 -87.36 130.5 34.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.869 . . . . 0.0 110.459 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.558 ' CE3' HG22 ' A' ' 24' ' ' ILE . 53.2 t-105 -133.58 144.84 49.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.336 -0.852 . . . . 0.0 110.073 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -104.0 110.4 22.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 110.188 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -111.75 73.17 0.8 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.939 . . . . 0.0 110.229 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.53 -175.24 4.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.277 -0.89 . . . . 0.0 110.11 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.91 60.54 0.33 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.6 t -83.77 -39.19 20.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -1.16 . . . . 0.0 110.098 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 45.7 t -176.56 139.48 0.32 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.269 -0.894 . . . . 0.0 110.161 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.617 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.8 OUTLIER -147.85 68.0 1.11 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.227 -0.921 . . . . 0.0 110.209 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -173.6 152.42 2.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.315 -0.865 . . . . 0.0 110.173 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -151.21 64.9 0.89 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.284 -0.885 . . . . 0.0 110.277 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.486 ' O ' ' CG ' ' A' ' 114' ' ' HIS . 43.2 p-80 -127.51 143.97 51.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.216 -0.927 . . . . 0.0 110.238 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.486 ' CG ' ' O ' ' A' ' 113' ' ' HIS . 42.4 m80 -156.2 -69.88 0.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.894 . . . . 0.0 110.262 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.48 ' O ' ' N ' ' A' ' 117' ' ' HIS . 0.0 OUTLIER -61.64 145.26 52.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 110.196 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 59.29 -82.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.303 -0.873 . . . . 0.0 110.23 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.48 ' N ' ' O ' ' A' ' 115' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.198 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttm . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.317 0.579 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.423 ' C ' ' HD3' ' A' ' 3' ' ' LYS . 17.3 m-20 -134.61 43.63 2.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.302 -0.874 . . . . 0.0 110.156 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.423 ' HD3' ' C ' ' A' ' 2' ' ' ASP . 4.1 mppt? -135.15 47.05 2.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.229 -0.919 . . . . 0.0 110.221 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.427 ' O ' ' CG ' ' A' ' 5' ' ' GLN . 1.8 mt -97.47 -137.73 0.27 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.334 -0.854 . . . . 0.0 110.137 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.427 ' CG ' ' O ' ' A' ' 4' ' ' LEU . 0.7 OUTLIER -176.91 -40.53 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.112 -0.993 . . . . 0.0 110.192 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.05 161.98 16.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.294 -0.879 . . . . 0.0 110.132 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -120.22 -6.42 9.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.168 -0.957 . . . . 0.0 110.203 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 9' ' ' MET . . . -156.34 53.57 0.41 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.411 ' O ' ' O ' ' A' ' 8' ' ' GLY . 15.7 mmt 47.88 -173.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -1.155 . . . . 0.0 110.206 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.54 ' CA ' ' HD2' ' A' ' 46' ' ' LYS . 1.4 m -115.03 -177.12 3.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.187 -0.946 . . . . 0.0 110.15 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -91.47 -73.14 0.55 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.164 -0.96 . . . . 0.0 110.184 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.454 ' O ' ' HB3' ' A' ' 13' ' ' MET . 3.4 t -133.56 -5.83 2.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.121 -0.987 . . . . 0.0 110.778 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.718 ' O ' HG23 ' A' ' 15' ' ' THR . 3.8 ttp 56.35 79.08 0.18 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.067 -1.021 . . . . 0.0 108.976 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.577 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 31.1 m -54.6 109.02 0.44 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.417 -0.802 . . . . 0.0 109.398 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 13' ' ' MET . 77.6 p -101.14 -4.72 26.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.159 -0.963 . . . . 0.0 111.764 -178.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.573 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -60.13 -124.14 0.01 OUTLIER Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.567 ' HE3' ' N ' ' A' ' 18' ' ' PHE . 1.5 ttpt -134.74 154.7 51.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.043 -1.269 . . . . 0.0 109.774 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.074 ' CE2' HG23 ' A' ' 47' ' ' ILE . 37.2 m-85 -118.25 137.84 52.76 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.805 -1.185 . . . . 0.0 111.768 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.444 ' HE2' ' HB3' ' A' ' 37' ' ' GLN . 35.2 ttpt -107.95 119.53 39.71 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.548 -0.72 . . . . 0.0 109.274 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.824 ' CG2' HD13 ' A' ' 99' ' ' LEU . 43.4 t -60.12 124.76 15.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 120.736 -1.228 . . . . 0.0 109.364 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.78 HG23 ' HA ' ' A' ' 36' ' ' VAL . 88.6 t -95.35 -27.02 4.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.678 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 5.1 tttp -159.26 133.51 7.69 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -48.59 160.31 0.18 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.569 0.699 . . . . 0.0 111.367 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.704 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -56.53 133.13 20.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-O 121.662 0.744 . . . . 0.0 110.193 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.773 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -108.58 169.72 8.47 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.7 pm0 -115.09 134.37 55.23 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.556 -1.34 . . . . 0.0 110.591 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.942 HG21 ' CD ' ' A' ' 80' ' ' GLU . 16.1 p -92.42 171.92 8.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.44 -0.788 . . . . 0.0 110.255 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -86.98 26.78 1.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.213 -0.929 . . . . 0.0 110.529 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.93 6.82 5.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.237 -0.915 . . . . 0.0 110.192 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.93 5.81 59.54 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.902 HG22 ' C ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -101.78 178.42 4.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -1.124 . . . . 0.0 110.427 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.811 HD11 ' HG3' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -134.76 153.02 34.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.481 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.685 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 48.5 t -117.96 132.13 68.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 C-N-CA 119.167 -1.013 . . . . 0.0 112.076 -177.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.108 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -117.76 119.98 63.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.327 -0.858 . . . . 0.0 110.009 179.128 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.678 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -102.45 124.04 47.29 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.241 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.78 ' HA ' HG23 ' A' ' 21' ' ' VAL . 1.2 m -147.7 161.93 7.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.157 -0.964 . . . . 0.0 108.834 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.635 HE21 ' HD3' ' A' ' 76' ' ' PRO 0.271 11.6 tt0 -107.37 122.93 47.59 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -178.588 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.876 ' HB2' HG21 ' A' ' 70' ' ' VAL . 12.9 t80 -62.71 122.12 15.1 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 118.814 -1.154 . . . . 0.0 110.282 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.498 ' HB2' ' HE2' ' A' ' 17' ' ' LYS . 2.7 mm-40 -115.87 98.61 6.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 110.019 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.573 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 160.16 -151.97 22.69 Favored Glycine 0 N--CA 1.486 2.005 0 C-N-CA 119.282 -1.437 . . . . 0.0 110.074 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 1.5 m-20 -105.85 106.37 16.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.704 -0.88 . . . . 0.0 109.954 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 43' ' ' SER . . . -165.32 -41.51 0.02 OUTLIER Glycine 0 N--CA 1.489 2.175 0 C-N-CA 119.539 -1.315 . . . . 0.0 110.394 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.63 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 1.0 OUTLIER 49.3 -150.23 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.366 0 O-C-N 120.869 -1.371 . . . . 0.0 107.485 -179.442 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.63 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 51.7 Cg_exo -47.83 92.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -1.022 0 N-CA-C 108.431 -1.411 . . . . 0.0 108.431 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.709 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -153.91 173.98 15.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.683 -0.636 . . . . 0.0 109.396 -177.78 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.68 ' CG ' HD11 ' A' ' 69' ' ' ILE . 14.9 mttp -85.18 174.94 9.27 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.287 -0.883 . . . . 0.0 111.594 -178.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.074 HG23 ' CE2' ' A' ' 18' ' ' PHE . 14.5 mm -123.06 128.72 25.23 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.401 -0.812 . . . . 0.0 111.936 -178.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.622 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 37.7 Cg_exo -63.68 145.03 90.83 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.58 1.52 . . . . 0.0 111.24 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.733 ' CD2' HD21 ' A' ' 63' ' ' LEU . 10.6 t80 -155.46 146.1 22.14 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.407 -0.808 . . . . 0.0 110.434 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.584 ' CG ' ' CG2' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -156.84 111.22 2.73 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.006 -1.059 . . . . 0.0 110.367 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.829 HD11 ' HB1' ' A' ' 81' ' ' ALA . 5.7 mt -98.69 56.65 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.184 -0.947 . . . . 0.0 110.296 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.764 ' CE ' HD22 ' A' ' 60' ' ' LEU . 2.4 mmt -154.68 -58.04 0.11 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.21 -0.931 . . . . 0.0 110.263 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.618 ' HB2' HD11 ' A' ' 91' ' ' ILE . 26.1 t0 66.29 -58.35 0.35 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.352 -0.842 . . . . 0.0 110.563 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 52' ' ' MET . 1.7 mt -86.94 1.88 51.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 110.696 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -171.56 69.82 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.166 -0.959 . . . . 0.0 110.205 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.452 ' HG2' ' CB ' ' A' ' 52' ' ' MET . 24.1 mtmt -97.86 46.01 1.02 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.409 -0.807 . . . . 0.0 110.201 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.473 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 1.6 tpm_? -121.54 -15.5 8.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.312 -0.867 . . . . 0.0 110.077 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -107.15 -158.15 0.64 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.311 -0.868 . . . . 0.0 110.094 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.1 t -109.94 82.23 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.307 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.764 HD22 ' CE ' ' A' ' 52' ' ' MET . 0.2 OUTLIER -112.29 146.86 37.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.855 . . . . 0.0 110.179 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.55 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . 57.19 160.36 0.02 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.512 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -129.13 162.34 27.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -1.138 . . . . 0.0 110.408 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.742 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -124.51 112.7 17.18 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.45 -0.781 . . . . 0.0 109.609 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.899 ' CG1' HG21 ' A' ' 31' ' ' THR . 7.2 mm -72.23 -27.38 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 122.351 1.072 . . . . 0.0 108.287 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.647 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.258 0.8 OUTLIER -109.13 32.2 5.12 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.534 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 63' ' ' LEU . 33.6 t -14.99 112.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.817 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.541 ' ND2' ' HD3' ' A' ' 46' ' ' LYS . 14.5 t-20 44.71 69.13 2.67 Favored Pre-proline 0 C--N 1.297 -1.688 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.699 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.62 ' HG3' HG23 ' A' ' 79' ' ' ILE . 6.3 Cg_exo -48.95 -178.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 124.246 1.656 . . . . 0.0 109.484 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.709 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.9 OUTLIER -140.7 139.37 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 118.971 -1.092 . . . . 0.0 112.241 -178.831 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.014 ' CG2' HD11 ' A' ' 47' ' ' ILE . 47.3 t -92.23 172.53 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 176.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.481 ' N ' HG12 ' A' ' 70' ' ' VAL . 22.9 m -122.13 -24.04 5.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.769 -1.207 . . . . 0.0 110.968 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.592 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 3.9 mm-40 -130.09 -46.78 1.12 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.015 -1.053 . . . . 0.0 110.032 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.592 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.1 OUTLIER 155.59 -61.46 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.621 ' O ' ' NE2' ' A' ' 37' ' ' GLN . 2.4 t0 -89.65 12.9 15.5 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.207 -0.933 . . . . 0.0 110.371 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 77' ' ' VAL . 48.0 t -72.65 108.95 5.03 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.149 -0.969 . . . . 0.0 108.821 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.635 ' HD3' HE21 ' A' ' 37' ' ' GLN . 9.7 Cg_endo -56.95 113.8 1.63 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.829 1.436 . . . . 0.0 110.469 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.557 HG21 HG22 ' A' ' 70' ' ' VAL . 57.7 t -102.8 148.14 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.377 -0.827 . . . . 0.0 110.937 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.658 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 1.9 m-20 -106.22 138.2 42.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.322 -0.861 . . . . 0.0 109.981 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.686 HG21 ' CD1' ' A' ' 49' ' ' PHE . 4.5 mt -118.09 119.51 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 117.778 -1.569 . . . . 0.0 111.41 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.942 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.7 tp10 -94.01 110.2 21.9 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.902 ' C ' HG22 ' A' ' 31' ' ' THR . . . -124.31 147.49 48.11 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.069 -1.019 . . . . 0.0 111.011 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.644 ' HB2' HG23 ' A' ' 31' ' ' THR . 23.6 tt0 -107.61 94.7 12.47 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.597 -0.689 . . . . 0.0 110.617 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.811 ' HG3' HD11 ' A' ' 32' ' ' ILE . 40.3 Cg_endo -72.51 153.88 55.16 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.971 1.511 . . . . 0.0 110.219 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.685 ' HG3' HD23 ' A' ' 60' ' ' LEU . 10.8 Cg_endo -59.11 -74.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.963 1.507 . . . . 0.0 110.159 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -120.6 176.23 5.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.244 -0.91 . . . . 0.0 109.896 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.516 ' HA3' ' N ' ' A' ' 105' ' ' LYS . . . -76.83 74.93 1.75 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.416 ' HB3' ' O ' ' A' ' 86' ' ' GLY . 19.1 p30 179.68 63.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -1.103 . . . . 0.0 109.847 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 0.4 OUTLIER -141.74 174.37 10.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 0.0 110.3 -179.649 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.558 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 4.1 m-85 -118.11 108.65 15.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.91 . . . . 0.0 110.145 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.543 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 12.7 mm -74.74 108.87 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.159 -0.963 . . . . 0.0 109.477 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.618 HD11 ' HB2' ' A' ' 53' ' ' ASP . 32.5 mt -100.98 154.22 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.92 -1.112 . . . . 0.0 110.004 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.108 HD11 HG21 ' A' ' 34' ' ' ILE . 2.7 mt -140.28 150.61 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.258 -0.901 . . . . 0.0 110.447 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.546 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 77.65 -157.1 45.34 Favored Glycine 0 N--CA 1.485 1.9 0 C-N-CA 119.319 -1.42 . . . . 0.0 109.658 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.559 ' O ' ' N ' ' A' ' 98' ' ' GLN . 0.2 OUTLIER -130.36 157.08 42.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.116 -1.226 . . . . 0.0 110.318 -179.596 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.524 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 1.0 OUTLIER -30.47 -55.71 0.36 Allowed Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.847 -0.533 . . . . 0.0 110.723 -179.739 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 76.4 Cg_exo -41.02 -40.58 3.88 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 124.055 1.555 . . . . 0.0 110.615 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 17' ' ' LYS . . . -160.76 50.95 0.35 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.559 ' N ' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -94.56 149.5 21.18 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.976 -1.308 . . . . 0.0 110.903 -178.734 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.824 HD13 ' CG2' ' A' ' 20' ' ' VAL . 13.7 mt -94.44 177.74 5.84 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.553 -0.717 . . . . 0.0 109.941 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.742 ' C ' HD12 ' A' ' 101' ' ' LEU . 0.4 OUTLIER -148.21 119.91 8.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.396 -0.815 . . . . 0.0 111.123 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.742 HD12 ' C ' ' A' ' 100' ' ' LYS . 7.3 mp -128.81 -164.52 1.4 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 102' ' ' ASN . 14.5 p-10 -179.05 151.11 0.49 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.843 -1.161 . . . . 0.0 110.931 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.467 ' HA ' ' CE3' ' A' ' 103' ' ' TRP . 0.5 OUTLIER -120.59 135.75 55.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 110.047 179.702 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.486 ' O ' ' HB2' ' A' ' 105' ' ' LYS . 19.1 p90 -121.69 135.91 54.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.34 -0.85 . . . . 0.0 110.253 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.516 ' N ' ' HA3' ' A' ' 86' ' ' GLY . 13.5 ttpt 171.36 121.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.378 -0.827 . . . . 0.0 109.994 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.5 ptmt -93.47 -141.45 0.22 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.244 -0.91 . . . . 0.0 110.168 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.78 -126.05 0.56 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.3 t -150.68 72.37 1.08 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.295 -1.121 . . . . 0.0 110.167 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.8 t -169.48 96.5 0.32 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 110.249 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.6 pp -135.84 4.7 3.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 110.243 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.18 37.41 3.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.264 -0.897 . . . . 0.0 110.223 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.514 ' O ' ' CG ' ' A' ' 113' ' ' HIS . 0.9 OUTLIER -154.77 125.07 6.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.91 . . . . 0.0 110.144 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.514 ' CG ' ' O ' ' A' ' 112' ' ' HIS . 0.3 OUTLIER 178.45 -44.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.269 -0.894 . . . . 0.0 110.275 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 113' ' ' HIS . 1.4 m170 57.67 167.71 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -0.947 . . . . 0.0 110.169 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 32.6 p80 -108.04 41.79 1.48 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.932 . . . . 0.0 110.19 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 4.2 m170 -86.25 -173.85 4.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.269 -0.894 . . . . 0.0 110.177 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.195 -179.982 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.27 0.557 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.44 77.0 9.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.288 -0.883 . . . . 0.0 110.21 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.6 tptt -54.83 -25.98 32.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.295 -0.878 . . . . 0.0 110.234 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.47 ' O ' ' CG ' ' A' ' 5' ' ' GLN . 3.0 tt -58.09 92.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.276 -0.89 . . . . 0.0 110.128 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.47 ' CG ' ' O ' ' A' ' 4' ' ' LEU . 0.6 OUTLIER 171.61 83.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.206 -0.933 . . . . 0.0 110.191 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.41 -19.48 10.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.891 . . . . 0.0 110.171 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 61.79 32.21 18.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.229 -0.92 . . . . 0.0 110.161 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -166.13 174.06 41.69 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.412 ' O ' ' C ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -131.22 -169.68 2.22 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.327 -1.102 . . . . 0.0 110.087 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 9' ' ' MET . 1.5 p -44.16 147.75 0.5 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.239 -0.913 . . . . 0.0 110.153 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.545 ' HB2' ' CD1' ' A' ' 69' ' ' ILE . 0.6 OUTLIER -90.72 -72.37 0.58 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.192 -0.942 . . . . 0.0 110.083 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.464 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 3.2 t -133.52 -4.38 2.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.159 -0.963 . . . . 0.0 110.578 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.499 ' O ' ' CG ' ' A' ' 13' ' ' MET . 5.6 ttm 56.34 76.15 0.31 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.078 -1.013 . . . . 0.0 108.986 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.581 ' HB3' ' CE1' ' A' ' 38' ' ' TYR . 22.9 m -51.76 100.96 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.424 -0.798 . . . . 0.0 109.572 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.5 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 10.6 t -92.36 -7.95 46.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.357 -0.84 . . . . 0.0 111.564 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.56 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -60.52 -118.19 0.01 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.543 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -140.15 174.75 10.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.952 -1.323 . . . . 0.0 110.235 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.02 ' CE2' HG23 ' A' ' 47' ' ' ILE . 37.7 m-85 -134.84 138.59 44.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.038 -1.039 . . . . 0.0 111.406 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.496 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 2.9 ttpt -106.53 116.92 32.76 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.425 -0.797 . . . . 0.0 109.175 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.742 HG22 HD13 ' A' ' 99' ' ' LEU . 46.3 t -59.58 125.12 15.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 120.625 -1.297 . . . . 0.0 109.647 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.726 HG23 ' HA ' ' A' ' 36' ' ' VAL . 80.3 t -97.03 -28.23 3.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.627 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -153.38 137.72 16.64 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.236 177.178 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -56.08 158.77 3.74 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.3 0.572 . . . . 0.0 110.285 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.999 HG12 HD22 ' A' ' 101' ' ' LEU . 0.7 OUTLIER -55.6 130.35 17.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.274 -0.971 . . . . 0.0 109.795 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.804 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -108.18 168.11 9.53 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 12.3 pt-20 -112.69 132.43 55.2 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.782 -1.199 . . . . 0.0 110.423 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.956 HG21 ' CD ' ' A' ' 80' ' ' GLU . 21.5 p -86.91 175.75 8.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.526 -0.734 . . . . 0.0 110.238 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -89.16 29.1 1.11 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.299 -0.876 . . . . 0.0 110.203 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -133.6 5.55 3.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.23 -0.919 . . . . 0.0 110.326 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.34 -0.3 58.45 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.876 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -95.02 -175.94 3.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.208 -1.172 . . . . 0.0 110.472 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.804 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -139.46 153.41 23.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.648 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.621 HG23 ' CG2' ' A' ' 27' ' ' THR . 70.0 t -118.51 135.31 59.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 O-C-N 121.192 -0.943 . . . . 0.0 111.765 -178.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.077 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -119.97 118.75 58.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 O-C-N 121.382 -0.824 . . . . 0.0 110.049 179.2 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.627 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.6 OUTLIER -100.19 123.51 44.5 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.123 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.812 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.3 m -147.85 162.86 6.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 121.082 -1.011 . . . . 0.0 108.819 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 74' ' ' ASP 0.254 10.2 tt0 -109.75 130.67 55.49 Favored 'General case' 0 C--N 1.27 -2.867 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.631 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.924 ' HB2' HG21 ' A' ' 70' ' ' VAL . 9.6 t80 -59.06 121.11 10.44 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.412 -178.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.496 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 5.8 mt-10 -106.86 21.18 17.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.107 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.56 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -115.84 -161.48 12.86 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.516 ' N ' ' OH ' ' A' ' 38' ' ' TYR . 13.5 t0 -125.66 145.19 50.27 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.455 -1.026 . . . . 0.0 110.245 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.21 -5.91 0.67 Allowed Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.421 -1.371 . . . . 0.0 111.02 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.615 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.7 OUTLIER 51.33 -153.06 0.01 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 120.436 -1.626 . . . . 0.0 108.198 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.615 ' HD2' ' CB ' ' A' ' 43' ' ' SER . 83.1 Cg_exo -41.47 96.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.321 -0.9 0 N-CA-C 109.241 -1.1 . . . . 0.0 109.241 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.867 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -145.59 169.29 18.71 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.339 0.59 . . . . 0.0 109.701 -178.162 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.63 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -82.74 174.85 10.61 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.223 -0.923 . . . . 0.0 111.829 -178.9 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.096 ' CD1' HG23 ' A' ' 70' ' ' VAL . 13.3 mm -123.64 123.74 26.3 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.835 -0.541 . . . . 0.0 111.396 -178.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.619 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 31.7 Cg_exo -61.47 143.89 97.68 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.109 1.584 . . . . 0.0 110.368 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.991 ' CE1' HG21 ' A' ' 79' ' ' ILE . 5.3 t80 -152.06 159.83 43.6 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 110.469 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.488 ' HB3' ' HB ' ' A' ' 91' ' ' ILE . 32.0 tp10 -178.74 100.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 110.037 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.656 HD11 ' HB1' ' A' ' 81' ' ' ALA . 36.0 mt -87.7 71.29 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.179 -0.951 . . . . 0.0 110.245 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.795 ' HE3' HD13 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -154.56 -66.33 0.13 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 0.0 110.278 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.547 ' CA ' HD11 ' A' ' 91' ' ' ILE . 0.4 OUTLIER 176.86 109.68 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.194 -0.941 . . . . 0.0 110.245 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.638 ' N ' HD11 ' A' ' 91' ' ' ILE . 0.2 OUTLIER 56.05 -84.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.236 -0.915 . . . . 0.0 110.146 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 53' ' ' ASP . 9.8 tt0 -165.6 63.8 0.11 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.172 -0.955 . . . . 0.0 110.127 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -119.64 125.76 49.51 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.222 -0.924 . . . . 0.0 110.392 -179.816 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 56' ' ' LYS . 1.7 mmt85 41.81 -164.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.36 -0.838 . . . . 0.0 110.376 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.421 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 11.1 t-80 -176.23 36.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.32 -0.863 . . . . 0.0 110.222 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 59' ' ' VAL . 16.3 t -107.28 46.02 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.251 -0.905 . . . . 0.0 110.283 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.795 HD13 ' HE3' ' A' ' 52' ' ' MET . 0.5 OUTLIER -125.7 -74.12 0.61 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.295 -0.878 . . . . 0.0 110.158 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.473 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . -84.46 -162.11 34.16 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.587 ' O ' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -154.69 167.64 29.5 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.273 -1.133 . . . . 0.0 109.297 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.058 HD23 ' HB2' ' A' ' 81' ' ' ALA . 11.7 mt -121.52 121.88 38.47 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 118.746 -1.182 . . . . 0.0 110.737 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.876 HG12 HG21 ' A' ' 31' ' ' THR . 1.4 mp -82.09 -26.8 9.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.708 HG22 ' O ' ' A' ' 65' ' ' THR 0.256 1.0 OUTLIER -96.67 33.19 1.89 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.241 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 1.048 HG23 ' O ' ' A' ' 63' ' ' LEU . 8.9 t -34.72 140.97 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.032 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.621 ' ND2' ' O ' ' A' ' 67' ' ' ASN . 1.3 t30 56.99 46.34 2.07 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.608 -0.682 . . . . 0.0 110.422 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.582 ' CB ' ' CD1' ' A' ' 79' ' ' ILE . 9.2 Cg_endo -58.93 148.22 85.63 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.611 1.322 . . . . 0.0 108.979 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.867 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.7 OUTLIER -142.69 144.65 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 119.255 -0.978 . . . . 0.0 112.111 -178.151 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.096 HG23 ' CD1' ' A' ' 47' ' ' ILE . 54.4 t -94.2 153.02 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.94 -21.4 12.35 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 120.932 -1.105 . . . . 0.0 108.57 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.535 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 2.3 mt-10 -138.45 145.8 41.32 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.54 ' O ' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -54.23 -14.15 1.07 Allowed 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.989 -1.069 . . . . 0.0 110.773 -178.939 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.497 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 7.1 t70 -126.31 9.21 7.26 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.589 -1.32 . . . . 0.0 110.578 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.488 ' CB ' ' HB2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -73.18 111.86 13.35 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.119 -0.988 . . . . 0.0 108.776 178.945 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 22.2 Cg_exo -59.91 114.45 2.08 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.864 1.455 . . . . 0.0 110.536 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.678 HG21 HG22 ' A' ' 70' ' ' VAL . 53.0 t -95.79 150.99 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.23 -0.919 . . . . 0.0 110.54 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.656 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 11.2 m-80 -114.4 130.05 56.68 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.991 HG21 ' CE1' ' A' ' 49' ' ' PHE . 9.5 mm -112.73 118.28 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 117.638 -1.625 . . . . 0.0 111.934 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.956 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.7 tp10 -95.79 107.44 19.67 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 1.058 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -129.3 155.47 45.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.797 -1.19 . . . . 0.0 111.287 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 62' ' ' ARG . 43.8 tp10 -100.8 103.25 23.39 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.531 -0.731 . . . . 0.0 110.466 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.531 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 60.7 Cg_endo -77.68 152.44 29.26 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.958 1.504 . . . . 0.0 110.484 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.549 ' HG3' HD23 ' A' ' 60' ' ' LEU . 28.2 Cg_endo -70.0 123.74 10.31 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.993 1.523 . . . . 0.0 109.888 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.435 ' C ' ' O ' ' A' ' 84' ' ' PRO . 0.6 OUTLIER -41.42 113.06 0.37 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.264 -0.898 . . . . 0.0 110.498 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.479 ' N ' ' HA ' ' A' ' 105' ' ' LYS . . . 131.97 -150.64 19.62 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -76.26 137.51 39.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.236 -1.155 . . . . 0.0 110.049 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 4.3 m -158.49 149.93 20.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.168 -0.957 . . . . 0.0 110.538 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.553 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 6.1 m-85 -124.43 104.46 8.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.915 . . . . 0.0 109.992 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.792 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 2.0 mp -73.87 107.96 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.312 -0.868 . . . . 0.0 109.578 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.638 HD11 ' N ' ' A' ' 54' ' ' LEU . 30.7 mt -91.97 148.29 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.264 -0.898 . . . . 0.0 110.468 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.077 HD11 HG21 ' A' ' 34' ' ' ILE . 1.8 mt -133.28 140.64 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.565 -0.709 . . . . 0.0 109.606 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.54 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 82.13 -161.4 41.46 Favored Glycine 0 N--CA 1.481 1.655 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.54 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -122.61 149.84 26.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 O-C-N 121.225 -1.162 . . . . 0.0 110.181 -179.627 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.578 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.9 OUTLIER -17.03 -58.24 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.189 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 8.2 Cg_endo -51.65 71.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 124.219 1.641 . . . . 0.0 112.171 179.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 89.51 1.23 78.24 Favored Glycine 0 N--CA 1.494 2.511 0 O-C-N 120.943 -1.098 . . . . 0.0 110.878 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.513 ' HB3' ' C ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -48.63 159.68 0.22 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.975 -1.309 . . . . 0.0 110.27 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.742 HD13 HG22 ' A' ' 20' ' ' VAL . 13.0 mt -96.14 176.91 5.91 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.296 -0.877 . . . . 0.0 110.418 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.509 ' HG3' HG12 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -157.19 138.8 14.02 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.309 -0.869 . . . . 0.0 110.408 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.999 HD22 HG12 ' A' ' 24' ' ' ILE . 3.5 mp -141.06 118.1 11.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.247 -0.908 . . . . 0.0 110.026 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' A' ' 88' ' ' SER . 1.9 t-20 -87.44 129.74 34.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 110.759 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 8.5 t-105 -119.51 129.19 54.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 0.0 109.739 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.51 ' O ' ' N ' ' A' ' 106' ' ' LYS . 1.0 OUTLIER -91.02 138.49 31.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.938 . . . . 0.0 110.507 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.479 ' HA ' ' N ' ' A' ' 86' ' ' GLY . 19.3 mttt 44.38 -92.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.292 -0.88 . . . . 0.0 110.355 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -151.94 16.87 0.67 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.205 -0.935 . . . . 0.0 110.123 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.81 179.33 43.57 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -102.88 -68.27 0.84 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.311 -1.111 . . . . 0.0 110.215 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 108' ' ' SER . 48.0 t 43.61 77.37 0.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 0.0 110.187 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.3 -33.61 23.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.312 -0.868 . . . . 0.0 110.175 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -134.96 115.99 14.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.16 -0.963 . . . . 0.0 110.257 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -60.25 178.54 0.19 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.204 -0.935 . . . . 0.0 110.227 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 13.3 p-80 -161.4 134.16 6.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.212 -0.93 . . . . 0.0 110.22 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -56.44 153.7 9.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.244 -0.91 . . . . 0.0 110.223 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -169.3 153.74 5.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -0.926 . . . . 0.0 110.237 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 -166.7 42.31 0.05 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 110.218 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.234 180.0 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.281 0.563 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 2' ' ' ASP . 14.7 p30 -159.55 158.6 32.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 110.208 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -114.77 20.06 15.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 0.0 110.175 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.463 ' O ' ' HB3' ' A' ' 5' ' ' GLN . 8.5 mp -77.9 140.64 39.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.2 -0.938 . . . . 0.0 110.251 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' A' ' 4' ' ' LEU . 1.7 pt20 -178.04 50.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.314 -0.866 . . . . 0.0 110.119 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' A' ' 6' ' ' LEU . 2.6 mt -155.8 145.9 21.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.142 -0.974 . . . . 0.0 110.225 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.27 148.29 26.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.23 -0.919 . . . . 0.0 110.219 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.11 175.57 34.73 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.457 ' O ' ' HE2' ' A' ' 46' ' ' LYS . 10.9 mtt -61.58 149.96 37.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -1.164 . . . . 0.0 110.196 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.49 161.23 15.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.919 . . . . 0.0 110.182 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -143.0 -74.89 0.27 Allowed 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.273 -0.892 . . . . 0.0 110.169 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.566 ' HB3' ' CB ' ' A' ' 45' ' ' CYS . 3.6 t -136.97 -25.82 1.06 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.321 -0.862 . . . . 0.0 110.902 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.521 ' O ' ' N ' ' A' ' 15' ' ' THR . 0.4 OUTLIER 59.23 93.24 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.28 -0.887 . . . . 0.0 109.525 -179.609 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.734 ' SG ' HD13 ' A' ' 47' ' ' ILE . 56.2 m -50.55 90.28 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.445 -0.784 . . . . 0.0 109.558 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 13' ' ' MET . 3.2 t -79.13 -11.34 59.98 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.067 -1.02 . . . . 0.0 111.419 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.531 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -60.93 -131.76 0.01 OUTLIER Glycine 0 N--CA 1.485 1.944 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.539 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -130.1 -177.88 4.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -1.167 . . . . 0.0 109.809 -179.73 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.995 ' CE2' HG23 ' A' ' 47' ' ' ILE . 32.5 m-85 -137.6 141.87 41.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.741 -1.224 . . . . 0.0 111.968 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.485 ' HB2' ' OE2' ' A' ' 39' ' ' GLU . 33.3 ttpt -113.44 118.28 34.06 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.607 ' CG2' HD13 ' A' ' 99' ' ' LEU . 40.9 t -59.47 125.01 14.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 120.576 -1.328 . . . . 0.0 109.036 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.565 ' HB ' ' CG ' ' A' ' 35' ' ' ARG . 62.8 t -98.26 -27.16 3.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.608 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 3.0 tttp -156.77 133.12 9.9 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -50.87 162.13 0.3 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.716 0.769 . . . . 0.0 111.411 -178.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.656 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.7 OUTLIER -57.73 132.22 22.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 121.584 0.707 . . . . 0.0 110.289 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.603 ' HB3' ' HB ' ' A' ' 33' ' ' VAL . . . -109.17 163.17 13.59 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 5.3 pm0 -112.46 134.11 54.17 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.344 -1.472 . . . . 0.0 110.553 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.908 HG21 ' CD ' ' A' ' 80' ' ' GLU . 4.7 p -94.22 165.21 12.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.524 -0.735 . . . . 0.0 110.336 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -78.58 -1.02 32.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.42 -0.8 . . . . 0.0 110.123 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.06 3.51 55.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.9 . . . . 0.0 110.34 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.491 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 88.88 25.81 28.48 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.866 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -121.77 -177.17 3.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.54 -0.976 . . . . 0.0 110.363 -179.779 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.747 HD12 HD11 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -136.34 142.73 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.638 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.629 HG23 ' CG2' ' A' ' 27' ' ' THR . 43.0 t -110.26 133.81 54.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 O-C-N 121.47 -0.768 . . . . 0.0 112.279 -177.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.093 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -118.74 119.54 61.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 O-C-N 121.339 -0.85 . . . . 0.0 109.865 178.738 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.608 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 1.0 OUTLIER -101.86 123.34 45.62 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 179.428 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.781 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.5 m -148.79 161.45 5.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 108.773 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.488 ' N ' HG23 ' A' ' 21' ' ' VAL 0.254 1.0 OUTLIER -106.75 124.6 49.85 Favored 'General case' 0 C--N 1.273 -2.757 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -179.43 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.981 ' HB2' HG21 ' A' ' 70' ' ' VAL . 2.1 t80 -61.15 125.52 24.03 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.017 -1.073 . . . . 0.0 110.425 -178.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.485 ' OE2' ' HB2' ' A' ' 19' ' ' LYS . 22.2 mm-40 -98.08 -148.91 0.33 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.022 -1.049 . . . . 0.0 109.19 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.531 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 44.24 -145.5 1.77 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.471 ' HA ' ' HD2' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -134.52 143.62 47.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.679 -0.895 . . . . 0.0 110.139 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.94 -25.32 0.04 OUTLIER Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.42 -1.372 . . . . 0.0 110.95 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.617 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.4 OUTLIER 56.24 -156.1 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 120.726 -1.455 . . . . 0.0 108.267 -179.545 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.617 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 50.9 Cg_exo -48.45 92.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.506 0 N-CA-C 109.61 -0.958 . . . . 0.0 109.61 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.789 ' O ' HG23 ' A' ' 69' ' ' ILE . 21.8 p -143.32 167.75 21.43 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.422 -0.799 . . . . 0.0 110.389 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.699 ' CG ' HD11 ' A' ' 69' ' ' ILE . 47.0 mttp -85.38 154.99 21.5 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 122.142 0.972 . . . . 0.0 111.176 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.053 ' CD1' HG23 ' A' ' 70' ' ' VAL . 12.4 mm -101.92 123.32 44.14 Favored Pre-proline 0 C--N 1.297 -1.699 0 O-C-N 121.591 -0.693 . . . . 0.0 111.782 -177.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.626 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 32.2 Cg_exo -61.59 149.32 90.3 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.181 1.621 . . . . 0.0 110.457 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.999 ' CD1' HD11 ' A' ' 63' ' ' LEU . 5.9 t80 -159.4 155.25 26.34 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.389 -0.82 . . . . 0.0 110.165 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.772 ' O ' HD12 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -177.67 106.62 0.05 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.277 -0.889 . . . . 0.0 109.873 179.721 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 51' ' ' ILE . 3.0 mt -81.16 10.65 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.349 -0.844 . . . . 0.0 110.126 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.57 ' CB ' ' HB3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -145.97 -66.87 0.29 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.121 -0.987 . . . . 0.0 110.468 179.443 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.544 ' CB ' ' HG2' ' A' ' 50' ' ' GLU . 0.4 OUTLIER 71.24 52.94 0.25 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.045 -1.034 . . . . 0.0 110.623 179.762 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.54 ' O ' ' CB ' ' A' ' 55' ' ' GLU . 33.5 mt 59.69 142.35 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.156 -0.965 . . . . 0.0 110.356 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.54 ' CB ' ' O ' ' A' ' 54' ' ' LEU . 0.1 OUTLIER 73.65 13.87 4.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.473 -0.767 . . . . 0.0 109.089 -179.416 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.57 ' HB3' ' CB ' ' A' ' 52' ' ' MET . 0.1 OUTLIER -125.57 18.63 8.09 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.026 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.509 ' HG3' ' N ' ' A' ' 58' ' ' HIS . 11.3 ptt180 -52.89 -30.97 37.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.299 -0.875 . . . . 0.0 110.341 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.509 ' N ' ' HG3' ' A' ' 57' ' ' ARG . 4.7 m170 -57.71 -15.68 8.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.913 . . . . 0.0 110.146 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.666 HG11 ' O ' ' A' ' 87' ' ' ASP . 6.0 m -144.58 87.4 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.922 . . . . 0.0 110.156 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.401 ' O ' ' HB3' ' A' ' 84' ' ' PRO . 6.5 mt -84.38 108.12 17.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 110.189 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.446 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . -94.94 -163.87 35.13 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.623 ' O ' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -159.19 166.57 31.14 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.256 -1.143 . . . . 0.0 109.617 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.018 HD23 ' HB2' ' A' ' 81' ' ' ALA . 11.3 mt -122.77 123.92 42.16 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 118.819 -1.152 . . . . 0.0 111.077 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.866 HG12 HG21 ' A' ' 31' ' ' THR . 1.5 mp -85.22 -28.45 6.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.774 HG22 ' O ' ' A' ' 65' ' ' THR 0.257 1.8 m -99.32 35.69 1.89 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.662 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.925 HG23 ' O ' ' A' ' 63' ' ' LEU . 43.0 t -37.85 152.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.667 0.746 . . . . 0.0 111.231 -178.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.619 ' ND2' ' O ' ' A' ' 66' ' ' VAL . 0.4 OUTLIER 37.22 52.35 2.46 Favored Pre-proline 0 C--N 1.302 -1.47 0 O-C-N 121.968 -0.458 . . . . 0.0 111.568 179.526 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.927 ' CG ' HD12 ' A' ' 79' ' ' ILE . 1.9 Cg_endo -59.85 162.98 14.55 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 N-CA-C 108.363 -1.437 . . . . 0.0 108.363 178.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.789 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.8 OUTLIER -143.94 148.66 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 C-N-CA 118.817 -1.153 . . . . 0.0 112.744 -178.471 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.053 HG23 ' CD1' ' A' ' 47' ' ' ILE . 44.0 t -102.46 159.43 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 175.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.3 m -112.89 -19.85 11.8 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.809 -1.156 . . . . 0.0 111.448 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 16.3 mt-10 -131.38 15.14 5.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.777 -1.202 . . . . 0.0 111.502 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.535 ' O ' ' O ' ' A' ' 38' ' ' TYR . 2.3 ttpt 71.56 -5.58 1.6 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.221 -0.925 . . . . 0.0 111.034 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.477 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 7.8 t0 -137.76 -1.2 2.05 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.877 -1.14 . . . . 0.0 110.257 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.481 ' O ' HG23 ' A' ' 77' ' ' VAL . 47.7 t -72.6 112.26 14.32 Favored Pre-proline 0 N--CA 1.486 1.363 0 O-C-N 121.208 -0.932 . . . . 0.0 109.362 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 32.6 Cg_exo -51.56 111.8 0.67 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.82 1.431 . . . . 0.0 109.915 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.889 HG21 HG22 ' A' ' 70' ' ' VAL . 92.5 t -95.15 143.46 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.325 -0.859 . . . . 0.0 110.997 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.643 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 8.2 m-20 -105.9 131.25 53.45 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.945 HG21 ' CD2' ' A' ' 49' ' ' PHE . 10.5 mm -116.35 119.89 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 117.567 -1.653 . . . . 0.0 111.767 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.908 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.1 tp10 -94.44 110.79 22.55 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.16 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 1.018 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -125.28 159.9 30.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.926 -1.109 . . . . 0.0 110.752 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.555 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -93.68 113.9 61.57 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.527 -0.733 . . . . 0.0 110.323 -179.284 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.683 ' HB3' HD11 ' A' ' 32' ' ' ILE . 46.4 Cg_endo -73.3 133.03 18.64 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.853 1.449 . . . . 0.0 110.525 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.446 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 19.4 Cg_endo -64.38 -158.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.925 1.487 . . . . 0.0 109.928 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -105.39 103.88 13.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.141 -0.975 . . . . 0.0 110.129 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 121.49 -153.75 16.66 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.666 ' O ' HG11 ' A' ' 59' ' ' VAL . 5.8 t70 -71.63 161.34 31.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.288 -1.125 . . . . 0.0 110.212 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -170.46 147.17 2.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.212 -0.93 . . . . 0.0 110.294 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.587 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 3.2 m-85 -118.5 104.8 11.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 110.174 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.799 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 5.2 mt -74.08 111.34 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.164 -0.96 . . . . 0.0 109.442 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.772 HD12 ' O ' ' A' ' 50' ' ' GLU . 2.1 mp -90.99 140.23 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.949 . . . . 0.0 110.178 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.093 HD11 HG21 ' A' ' 34' ' ' ILE . 1.4 mt -126.44 138.03 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.423 -0.798 . . . . 0.0 109.83 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.578 ' O ' ' HB2' ' A' ' 48' ' ' PRO . . . 85.99 -163.71 36.56 Favored Glycine 0 N--CA 1.482 1.754 0 C-N-CA 119.112 -1.518 . . . . 0.0 109.488 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.547 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -118.62 146.95 22.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 O-C-N 121.135 -1.215 . . . . 0.0 110.16 -179.623 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.578 ' O ' ' N ' ' A' ' 97' ' ' GLY . 3.9 mt-10 -16.89 -58.47 0.04 OUTLIER Pre-proline 0 N--CA 1.501 2.103 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 6.8 Cg_endo -51.08 72.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 124.219 1.641 . . . . 0.0 112.034 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 89.42 -1.35 81.92 Favored Glycine 0 N--CA 1.494 2.538 0 O-C-N 120.995 -1.065 . . . . 0.0 110.865 178.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.503 ' HB3' ' C ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -45.79 159.19 0.07 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.891 -1.358 . . . . 0.0 109.932 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.607 HD13 ' CG2' ' A' ' 20' ' ' VAL . 10.9 mt -96.68 177.44 5.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.245 -0.91 . . . . 0.0 110.645 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.428 ' C ' HD12 ' A' ' 101' ' ' LEU . 3.3 tttt -154.59 135.49 13.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.415 -0.803 . . . . 0.0 110.115 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.617 HD22 HG12 ' A' ' 24' ' ' ILE . 4.8 mp -137.16 122.44 19.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.181 -0.949 . . . . 0.0 110.328 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 88' ' ' SER . 3.7 t-20 -87.92 125.25 34.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 110.277 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.485 ' CD1' HD13 ' A' ' 32' ' ' ILE . 20.7 t-105 -123.98 154.21 40.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.905 . . . . 0.0 110.075 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.441 ' CD1' ' C ' ' A' ' 104' ' ' PHE . 27.6 p90 -119.43 146.12 45.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.229 -0.919 . . . . 0.0 110.308 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -138.84 101.95 4.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 110.175 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -133.04 42.01 3.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.211 -0.931 . . . . 0.0 110.255 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -137.9 124.0 2.86 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.56 128.6 53.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -1.158 . . . . 0.0 110.189 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -50.34 141.3 11.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.893 . . . . 0.0 110.252 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.89 -53.83 53.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.196 -0.94 . . . . 0.0 110.14 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -70.29 137.56 50.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.921 . . . . 0.0 110.196 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -107.66 17.81 22.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.908 . . . . 0.0 110.217 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -52.71 -22.13 4.84 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.259 -0.901 . . . . 0.0 110.176 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -86.81 83.54 7.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 0.0 110.21 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -106.55 165.05 11.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.3 -0.875 . . . . 0.0 110.261 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -170.18 68.98 0.05 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.312 -0.867 . . . . 0.0 110.199 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.223 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.209 0.528 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -54.79 -84.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 0.0 110.219 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 4' ' ' LEU . 1.3 ttpp -87.13 176.19 7.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.896 . . . . 0.0 110.336 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.451 ' O ' ' HB3' ' A' ' 5' ' ' GLN . 0.0 OUTLIER 63.75 133.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.253 -0.905 . . . . 0.0 110.32 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.468 ' CD ' ' N ' ' A' ' 5' ' ' GLN . 0.4 OUTLIER -179.37 31.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.325 -0.859 . . . . 0.0 110.093 179.889 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 tp -145.6 171.53 14.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.293 -0.879 . . . . 0.0 110.208 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.406 ' HD3' ' O ' ' A' ' 7' ' ' LYS . 2.8 tmtt? -95.34 26.84 3.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 110.255 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.34 146.88 6.41 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.44 27.71 1.22 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -1.141 . . . . 0.0 110.204 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.64 157.04 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.192 -0.943 . . . . 0.0 110.184 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -146.09 -74.2 0.22 Allowed 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.135 -0.978 . . . . 0.0 110.131 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.521 ' O ' ' CE ' ' A' ' 46' ' ' LYS . 2.8 t -139.33 -128.35 0.12 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.049 -1.032 . . . . 0.0 109.938 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.92 100.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.992 -1.067 . . . . 0.0 109.62 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.592 ' HB3' ' CE1' ' A' ' 38' ' ' TYR . 1.7 m -86.22 126.04 33.98 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.224 -0.923 . . . . 0.0 110.035 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.539 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 0.6 OUTLIER -126.85 15.28 7.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -0.909 . . . . 0.0 111.129 -179.227 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.596 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -69.94 -96.04 0.05 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.56 ' CD ' ' HA3' ' A' ' 97' ' ' GLY . 1.1 ttmt -149.4 161.27 42.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.04 -1.271 . . . . 0.0 109.833 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.002 ' CE2' HG23 ' A' ' 47' ' ' ILE . 50.3 m-85 -126.36 147.82 49.69 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.866 -1.146 . . . . 0.0 111.584 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.481 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 15.0 ttpp -114.15 115.88 28.21 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.595 -0.69 . . . . 0.0 109.161 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.717 ' CG2' HD13 ' A' ' 99' ' ' LEU . 43.5 t -59.63 123.03 11.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 120.541 -1.349 . . . . 0.0 109.049 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.839 HG21 ' HB3' ' A' ' 76' ' ' PRO . 53.2 t -96.82 -26.02 4.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.584 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 4.0 tttp -158.63 133.56 8.34 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -52.17 157.82 1.28 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.524 0.678 . . . . 0.0 111.063 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.798 HG13 HD13 ' A' ' 90' ' ' ILE . 0.6 OUTLIER -48.85 132.72 6.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.132 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 1.046 ' HB3' ' HB ' ' A' ' 33' ' ' VAL . . . -102.8 169.86 8.35 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 7.0 pm0 -113.54 132.24 55.78 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.924 -1.11 . . . . 0.0 110.519 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.547 HG21 ' CD ' ' A' ' 80' ' ' GLU . 11.1 p -90.1 178.76 6.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.408 -0.807 . . . . 0.0 109.865 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -95.62 31.87 1.94 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.168 -0.957 . . . . 0.0 110.183 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.88 10.42 2.41 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.256 -0.902 . . . . 0.0 110.315 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.35 -0.86 60.17 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.922 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -96.04 -177.17 3.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.274 -1.133 . . . . 0.0 110.291 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.81 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -140.22 178.95 2.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.616 -1.254 . . . . 0.0 107.616 178.175 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.046 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 64.8 t -138.92 124.01 21.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 118.909 -1.117 . . . . 0.0 111.838 -178.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.107 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -106.69 115.16 47.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.203 -0.936 . . . . 0.0 109.974 179.132 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.584 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -98.94 118.17 35.11 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.815 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.5 m -145.04 155.31 13.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.342 -0.848 . . . . 0.0 109.032 -178.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.523 ' CG ' ' O ' ' A' ' 74' ' ' ASP 0.252 0.2 OUTLIER -103.5 123.41 46.84 Favored 'General case' 0 C--N 1.272 -2.776 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.277 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.75 ' HB2' HG21 ' A' ' 70' ' ' VAL . 23.8 t80 -60.37 120.57 10.13 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 118.783 -1.167 . . . . 0.0 110.481 -178.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 17' ' ' LYS . 4.1 mt-10 -91.56 -26.09 18.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.466 -0.771 . . . . 0.0 109.321 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.596 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -63.75 -161.3 0.38 Allowed Glycine 0 N--CA 1.484 1.834 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.52 ' N ' ' OH ' ' A' ' 38' ' ' TYR . 15.8 p-10 -127.55 134.76 49.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.511 -0.994 . . . . 0.0 110.162 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 43' ' ' SER . . . 171.83 -23.4 0.08 OUTLIER Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.458 -1.353 . . . . 0.0 110.575 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.612 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.6 OUTLIER 61.42 -154.38 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.688 -1.478 . . . . 0.0 108.096 -179.541 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.612 ' HD2' ' CB ' ' A' ' 43' ' ' SER . 87.6 Cg_exo -42.24 96.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -0.994 0 N-CA-C 109.042 -1.176 . . . . 0.0 109.042 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.959 ' O ' HG23 ' A' ' 69' ' ' ILE . 31.5 p -151.47 -178.8 6.89 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.919 -0.488 . . . . 0.0 109.864 -177.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.635 ' O ' HD13 ' A' ' 47' ' ' ILE . 12.0 mtpt -94.57 170.17 9.67 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.975 -1.078 . . . . 0.0 111.305 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.07 ' CD1' HG23 ' A' ' 70' ' ' VAL . 11.6 mm -122.84 130.41 24.63 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.444 -0.785 . . . . 0.0 112.384 -177.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.623 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 38.1 Cg_exo -64.16 143.01 82.76 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 124.197 1.63 . . . . 0.0 110.793 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 1.006 ' CZ ' HG23 ' A' ' 90' ' ' ILE . 16.5 t80 -152.99 162.17 41.65 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.288 -0.883 . . . . 0.0 110.501 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.822 ' HG2' HD12 ' A' ' 91' ' ' ILE . 37.2 tt0 178.61 89.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.131 -0.981 . . . . 0.0 110.459 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 1.06 HD11 ' HB1' ' A' ' 81' ' ' ALA . 6.7 mt -61.14 -51.36 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.175 -0.953 . . . . 0.0 109.958 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.562 ' HA ' ' CG ' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -136.41 -66.98 0.52 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.891 . . . . 0.0 110.05 179.845 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.493 ' HB2' ' HG3' ' A' ' 50' ' ' GLU . 0.4 OUTLIER 61.76 -158.77 0.32 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.389 179.784 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.7 mt -75.12 0.2 17.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.379 -0.826 . . . . 0.0 110.329 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.401 ' C ' ' HD3' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -83.7 -18.02 39.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.357 -0.839 . . . . 0.0 109.486 179.814 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.562 ' CG ' ' HA ' ' A' ' 52' ' ' MET . 3.6 mmtm -117.31 -45.74 2.72 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.413 -0.804 . . . . 0.0 110.014 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 3.6 tpp180 -179.75 -142.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.305 -0.872 . . . . 0.0 109.978 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -70.17 -162.92 0.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.288 -0.883 . . . . 0.0 110.085 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.484 ' O ' HG23 ' A' ' 59' ' ' VAL . 27.7 m -91.48 123.16 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.155 -0.966 . . . . 0.0 110.157 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.478 HD23 ' HA ' ' A' ' 60' ' ' LEU . 18.9 mt -140.02 -56.28 0.55 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.209 -0.932 . . . . 0.0 110.348 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 83' ' ' PRO . . . -70.13 157.39 53.52 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -140.35 167.45 22.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -1.052 . . . . 0.0 109.985 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.884 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -117.28 120.68 38.98 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.382 -0.824 . . . . 0.0 108.928 179.414 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.922 HG12 HG21 ' A' ' 31' ' ' THR . 1.4 mp -81.6 -29.88 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.814 ' C ' HD12 ' A' ' 63' ' ' LEU 0.266 1.5 m -97.74 36.79 1.47 Allowed 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.807 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.884 HG23 ' O ' ' A' ' 63' ' ' LEU . 24.2 t -29.16 119.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.279 -178.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.502 ' OD1' ' HE3' ' A' ' 46' ' ' LYS . 3.8 t-20 59.62 69.1 1.34 Allowed Pre-proline 0 C--N 1.298 -1.632 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.969 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.676 ' HG3' HG23 ' A' ' 79' ' ' ILE . 5.3 Cg_exo -65.41 171.27 9.57 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.044 1.549 . . . . 0.0 109.575 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.959 HG23 ' O ' ' A' ' 45' ' ' CYS . 1.1 mt -145.56 141.22 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 118.99 -1.084 . . . . 0.0 112.264 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.07 HG23 ' CD1' ' A' ' 47' ' ' ILE . 46.2 t -93.07 165.54 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.438 ' O ' ' HD3' ' A' ' 44' ' ' PRO . 2.2 m -118.44 -24.34 6.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.782 -1.199 . . . . 0.0 111.113 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.526 ' O ' ' HB3' ' A' ' 73' ' ' LYS . 2.5 mt-10 -131.37 13.84 5.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.941 -1.099 . . . . 0.0 110.711 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.526 ' HB3' ' O ' ' A' ' 72' ' ' GLU . 14.3 ttpt 74.78 -10.69 1.15 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.657 -0.652 . . . . 0.0 111.074 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.523 ' O ' ' CG ' ' A' ' 37' ' ' GLN . 8.2 t0 -134.07 -3.24 2.82 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.971 -1.081 . . . . 0.0 110.359 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 77' ' ' VAL . 12.7 t -72.83 112.51 15.54 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.179 -0.951 . . . . 0.0 109.286 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.839 ' HB3' HG21 ' A' ' 21' ' ' VAL . 34.3 Cg_exo -51.04 111.41 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.858 1.452 . . . . 0.0 109.899 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 75' ' ' SER . 98.5 t -96.01 144.34 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.353 -0.842 . . . . 0.0 111.166 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.625 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.9 m120 -100.04 130.51 46.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.534 -0.729 . . . . 0.0 109.5 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.707 HG21 ' CD1' ' A' ' 49' ' ' PHE . 5.5 mt -109.66 116.21 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 117.902 -1.519 . . . . 0.0 110.912 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.778 ' OE1' HG22 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -84.08 117.25 23.32 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.812 179.476 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 1.06 ' HB1' HD11 ' A' ' 51' ' ' ILE . . . -135.92 146.85 47.78 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.959 -1.088 . . . . 0.0 111.248 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.629 ' HB2' HG23 ' A' ' 31' ' ' THR . 29.2 tt0 -106.09 86.93 2.19 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.452 -0.78 . . . . 0.0 110.727 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.672 ' HG3' HD11 ' A' ' 32' ' ' ILE . 56.8 Cg_endo -75.12 160.57 39.6 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.812 1.428 . . . . 0.0 110.348 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 85' ' ' PHE . 12.5 Cg_endo -61.32 -157.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.963 1.507 . . . . 0.0 110.0 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.459 ' O ' ' N ' ' A' ' 87' ' ' ASP . 1.9 m-85 -45.41 170.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.992 -1.067 . . . . 0.0 109.95 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.552 ' HA3' ' CB ' ' A' ' 105' ' ' LYS . . . -63.2 80.87 0.04 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.46 ' O ' ' OD1' ' A' ' 87' ' ' ASP . 10.7 p30 176.44 81.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.393 -1.063 . . . . 0.0 109.537 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.559 ' O ' ' CD1' ' A' ' 89' ' ' TYR . 0.6 OUTLIER -151.6 -162.22 1.49 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.35 -0.844 . . . . 0.0 110.6 -179.237 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.559 ' CD1' ' O ' ' A' ' 88' ' ' SER . 15.8 m-85 -151.64 104.49 3.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.681 -0.637 . . . . 0.0 109.716 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.006 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 2.1 mp -74.09 108.29 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.926 . . . . 0.0 109.907 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.822 HD12 ' HG2' ' A' ' 50' ' ' GLU . 94.9 mt -89.17 142.53 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -0.899 . . . . 0.0 110.045 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.107 HD11 HG21 ' A' ' 34' ' ' ILE . 1.5 mt -133.24 141.0 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.4 -0.812 . . . . 0.0 110.111 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' A' ' 48' ' ' PRO . . . 80.59 -155.99 38.19 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' ' 15' ' ' THR . 0.1 OUTLIER -130.45 154.75 41.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.062 -1.258 . . . . 0.0 111.226 -179.394 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.568 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 1.7 mm-40 -28.44 -55.12 0.25 Allowed Pre-proline 0 N--CA 1.499 2.02 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.635 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 86.8 Cg_exo -34.02 -30.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.993 1.522 . . . . 0.0 111.011 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.56 ' HA3' ' CD ' ' A' ' 17' ' ' LYS . . . 179.34 37.83 0.07 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.371 -1.892 . . . . 0.0 108.371 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.524 ' HB2' ' N ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -72.15 160.3 32.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.807 -0.819 . . . . 0.0 110.881 -179.05 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.717 HD13 ' CG2' ' A' ' 20' ' ' VAL . 9.4 mt -101.16 179.29 4.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.392 -0.818 . . . . 0.0 110.139 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.706 ' C ' HD12 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -156.8 135.48 11.6 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.337 -0.852 . . . . 0.0 110.456 179.833 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.706 HD12 ' C ' ' A' ' 100' ' ' LYS . 5.7 mp -137.17 118.8 14.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.371 -0.831 . . . . 0.0 109.737 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.548 ' HA ' ' O ' ' A' ' 88' ' ' SER . 4.7 p-10 -88.25 131.94 34.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.853 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.457 ' HA ' ' CE3' ' A' ' 103' ' ' TRP . 3.5 t-105 -110.9 126.29 54.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.101 -1.0 . . . . 0.0 110.265 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.506 ' O ' ' CG ' ' A' ' 105' ' ' LYS . 0.1 OUTLIER -115.09 152.31 32.75 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.263 -0.898 . . . . 0.0 110.241 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.552 ' CB ' ' HA3' ' A' ' 86' ' ' GLY . 0.0 OUTLIER 169.03 105.22 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.302 -0.873 . . . . 0.0 110.247 -179.871 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.453 ' O ' ' O ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -58.47 -152.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.271 -0.893 . . . . 0.0 110.218 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -114.05 53.75 0.59 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.3 m 52.64 -144.19 0.65 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.246 -1.149 . . . . 0.0 110.225 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.1 m -163.14 70.28 0.24 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.176 -0.953 . . . . 0.0 110.198 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.23 -34.27 3.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.339 -0.85 . . . . 0.0 110.172 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -45.57 147.02 0.94 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.26 -0.9 . . . . 0.0 110.253 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.79 -160.6 0.75 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 0.0 110.233 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -150.1 -162.12 1.49 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.212 -0.93 . . . . 0.0 110.12 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -164.72 58.05 0.13 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 110.31 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -76.05 -163.5 0.3 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.26 -0.9 . . . . 0.0 110.183 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -111.81 -179.74 3.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.222 -0.924 . . . . 0.0 110.206 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.193 -179.976 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.194 0.521 . . . . 0.0 110.179 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.16 -13.14 61.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 0.0 110.187 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -80.02 66.44 5.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 110.236 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.42 ' O ' ' HB2' ' A' ' 5' ' ' GLN . 1.6 pp -46.43 157.86 0.12 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -0.887 . . . . 0.0 110.288 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.42 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 0.4 OUTLIER 174.97 52.89 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 110.182 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.99 150.12 21.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 0.0 110.246 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.0 tttt -110.98 -32.47 6.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.93 . . . . 0.0 110.196 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.66 8.97 73.13 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 56.65 175.73 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.197 -1.179 . . . . 0.0 110.18 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.557 ' HA ' ' CE ' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -136.43 169.36 17.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.916 . . . . 0.0 110.205 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.07 -72.69 0.54 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.22 -0.925 . . . . 0.0 109.868 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.431 ' O ' ' HB3' ' A' ' 13' ' ' MET . 3.2 t -137.24 -2.31 2.05 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.158 -0.964 . . . . 0.0 110.721 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.512 ' HG2' HG23 ' A' ' 15' ' ' THR . 0.9 OUTLIER 55.45 79.98 0.14 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.97 -1.081 . . . . 0.0 108.575 -179.333 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.574 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 22.6 m -52.55 98.07 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.377 -0.827 . . . . 0.0 109.435 -178.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.512 HG23 ' HG2' ' A' ' 13' ' ' MET . 0.9 OUTLIER -86.65 -9.1 56.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.464 -0.773 . . . . 0.0 111.935 -178.359 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.584 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -59.55 -124.46 0.01 OUTLIER Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.489 -1.339 . . . . 0.0 109.84 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.552 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -135.75 173.86 11.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.018 -1.283 . . . . 0.0 109.99 -179.568 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.017 ' CE2' HG23 ' A' ' 47' ' ' ILE . 34.6 m-85 -133.44 136.89 45.47 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.969 -1.082 . . . . 0.0 111.51 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.467 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 23.4 ttpt -108.21 120.54 42.66 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.627 -0.671 . . . . 0.0 109.366 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.484 HG22 HD13 ' A' ' 99' ' ' LEU . 34.5 t -59.76 131.49 24.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.85 -1.156 . . . . 0.0 109.043 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.641 HG23 ' HA ' ' A' ' 36' ' ' VAL . 92.3 t -105.28 -26.39 3.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 1.8 tttp -157.37 133.61 9.65 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -51.94 159.58 0.84 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.723 0.773 . . . . 0.0 111.327 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.832 HG12 HD22 ' A' ' 101' ' ' LEU . 0.7 OUTLIER -55.79 132.04 19.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-O 121.577 0.703 . . . . 0.0 110.476 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' A' ' 33' ' ' VAL . . . -109.57 158.95 17.51 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.498 ' N ' ' OE1' ' A' ' 26' ' ' GLU . 7.0 pm0 -110.43 133.35 53.36 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 120.166 -1.584 . . . . 0.0 110.494 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.893 HG21 ' OE2' ' A' ' 80' ' ' GLU . 2.8 p -92.14 169.5 10.57 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.567 -0.708 . . . . 0.0 110.216 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.88 -16.34 60.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 110.538 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -80.41 0.47 33.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.085 -1.009 . . . . 0.0 110.34 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.73 8.1 60.99 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.888 HG22 ' C ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -98.39 175.34 6.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.314 -1.11 . . . . 0.0 110.381 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 1.008 HD13 ' CD1' ' A' ' 103' ' ' TRP . 0.0 OUTLIER -129.17 141.86 45.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.764 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.57 ' N ' ' O ' ' A' ' 25' ' ' ALA . 24.6 t -109.6 132.53 57.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 O-C-N 121.441 -0.787 . . . . 0.0 111.847 -177.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.081 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -118.28 121.29 66.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.435 -0.791 . . . . 0.0 109.413 178.799 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.574 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -105.67 111.19 23.78 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.866 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.5 m -131.09 -168.12 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.474 ' N ' HG23 ' A' ' 36' ' ' VAL . 4.2 tt0 -135.86 128.2 30.22 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.896 ' HB2' HG21 ' A' ' 70' ' ' VAL . 1.7 t80 -60.25 124.01 18.96 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 118.633 -1.227 . . . . 0.0 110.032 -178.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 17' ' ' LYS . 2.4 mm-40 -116.61 86.19 2.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -0.887 . . . . 0.0 110.09 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.584 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 165.0 -150.38 18.24 Favored Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.425 -1.369 . . . . 0.0 109.986 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.462 ' O ' ' OH ' ' A' ' 38' ' ' TYR . 0.5 OUTLIER -113.24 128.62 56.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.665 -0.903 . . . . 0.0 110.408 -179.75 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 43' ' ' SER . . . 177.77 -26.71 0.06 OUTLIER Glycine 0 N--CA 1.487 2.087 0 C-N-CA 119.555 -1.307 . . . . 0.0 110.57 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.599 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.5 OUTLIER 48.94 -154.89 0.01 OUTLIER Pre-proline 0 N--CA 1.487 1.378 0 O-C-N 120.706 -1.467 . . . . 0.0 107.779 -179.58 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.599 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 53.3 Cg_exo -46.84 94.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.259 0 N-CA-C 108.241 -1.484 . . . . 0.0 108.241 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.719 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -148.97 173.15 13.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.615 -0.678 . . . . 0.0 109.853 -177.681 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.704 ' HG3' HD11 ' A' ' 69' ' ' ILE . 28.5 mttm -87.82 175.13 7.97 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.309 -0.87 . . . . 0.0 111.61 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.07 HD11 ' CG2' ' A' ' 70' ' ' VAL . 16.0 mm -119.92 128.82 25.66 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.499 -0.75 . . . . 0.0 112.237 -177.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.62 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 29.8 Cg_exo -65.31 144.75 81.61 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 121.593 1.529 . . . . 0.0 110.993 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.638 ' CD1' HG21 ' A' ' 79' ' ' ILE . 10.9 t80 -155.69 159.01 39.19 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.226 -0.921 . . . . 0.0 110.088 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.758 ' HG2' HD12 ' A' ' 91' ' ' ILE . 21.3 tt0 -175.17 114.54 0.15 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.981 -1.074 . . . . 0.0 110.496 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.995 HG21 ' HB3' ' A' ' 83' ' ' PRO . 10.0 mt -107.46 103.29 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.28 -0.887 . . . . 0.0 110.057 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.535 ' O ' HG21 ' A' ' 59' ' ' VAL . 1.8 mtt -141.48 -66.68 0.41 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.24 -0.913 . . . . 0.0 110.209 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 52' ' ' MET . 0.1 OUTLIER 172.95 -160.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.257 -0.902 . . . . 0.0 110.236 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -45.32 -73.19 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.313 -0.867 . . . . 0.0 110.246 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.462 ' O ' ' CG ' ' A' ' 56' ' ' LYS . 3.4 mm-40 -93.6 -64.97 1.03 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.344 -0.847 . . . . 0.0 110.221 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.462 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 2.9 mtpp 173.36 85.37 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.315 -0.865 . . . . 0.0 110.174 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.95 18.21 6.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.232 -0.918 . . . . 0.0 110.183 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.449 ' HA ' ' SD ' ' A' ' 52' ' ' MET . 34.4 m80 49.32 89.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.906 . . . . 0.0 110.162 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.695 ' O ' HD12 ' A' ' 60' ' ' LEU . 24.8 t -101.06 -113.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.314 -0.866 . . . . 0.0 110.077 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.695 HD12 ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER 174.23 65.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.887 -1.133 . . . . 0.0 110.186 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.534 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -103.32 170.68 19.74 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.493 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -122.91 164.27 18.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.13 -1.217 . . . . 0.0 110.65 -179.65 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.821 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -129.73 110.84 12.09 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.569 -0.707 . . . . 0.0 109.529 179.109 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.873 ' CG1' HG21 ' A' ' 31' ' ' THR . 5.5 mm -69.02 -33.34 58.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 122.342 1.068 . . . . 0.0 108.328 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.638 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.259 0.7 OUTLIER -100.99 31.33 3.65 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.375 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 63' ' ' LEU . 42.7 t -15.03 109.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.927 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.524 ' ND2' ' HD3' ' A' ' 46' ' ' LYS . 19.2 t-20 47.12 69.25 2.8 Favored Pre-proline 0 C--N 1.3 -1.58 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.785 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.561 ' O ' ' HA ' ' A' ' 46' ' ' LYS . 3.0 Cg_endo -50.06 -176.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.074 1.565 . . . . 0.0 109.538 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.719 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.7 OUTLIER -141.96 144.09 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 119.171 -1.012 . . . . 0.0 112.171 -178.869 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.07 ' CG2' HD11 ' A' ' 47' ' ' ILE . 21.5 t -100.97 166.29 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.9 m -123.84 -15.41 6.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.745 -1.222 . . . . 0.0 111.166 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 26.1 mt-10 -140.03 14.48 2.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.929 -1.107 . . . . 0.0 111.016 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.1 OUTLIER 74.34 -9.83 1.23 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.42 -0.8 . . . . 0.0 111.006 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.476 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 6.9 t70 -135.96 0.18 2.61 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.932 -1.105 . . . . 0.0 110.059 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.499 ' O ' HG23 ' A' ' 77' ' ' VAL . 22.0 t -72.54 108.21 4.05 Favored Pre-proline 0 N--CA 1.486 1.344 0 O-C-N 121.201 -0.937 . . . . 0.0 108.826 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.624 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 5.6 Cg_exo -45.07 130.71 10.72 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.757 1.398 . . . . 0.0 110.117 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.889 HG21 HG22 ' A' ' 70' ' ' VAL . 74.8 t -115.35 145.03 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.041 -1.037 . . . . 0.0 111.351 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.694 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.0 m-20 -106.52 133.25 51.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.516 -0.74 . . . . 0.0 109.597 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.663 ' HB ' HG22 ' A' ' 34' ' ' ILE . 3.6 mt -118.15 118.86 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 117.65 -1.62 . . . . 0.0 111.364 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.893 ' OE2' HG21 ' A' ' 27' ' ' THR . 1.7 tp10 -94.45 109.77 21.62 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.888 ' C ' HG22 ' A' ' 31' ' ' THR . . . -118.24 147.34 43.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.041 -1.037 . . . . 0.0 110.774 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.583 ' HB2' HG23 ' A' ' 31' ' ' THR . 4.6 tt0 -112.37 58.64 0.55 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.45 -0.781 . . . . 0.0 111.051 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.995 ' HB3' HG21 ' A' ' 51' ' ' ILE . 37.1 Cg_endo -69.73 162.02 43.66 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.727 1.383 . . . . 0.0 110.63 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.503 ' HD3' ' HA2' ' A' ' 61' ' ' GLY . 23.4 Cg_exo -59.19 -145.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.096 1.577 . . . . 0.0 110.594 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -145.81 176.86 9.34 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.198 -0.939 . . . . 0.0 110.345 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.56 ' O ' ' CA ' ' A' ' 105' ' ' LYS . . . 113.6 -83.4 0.33 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.556 ' N ' ' HB3' ' A' ' 104' ' ' PHE . 11.5 t0 -170.81 119.83 0.53 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.04 -1.271 . . . . 0.0 109.549 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.616 ' HB2' ' CG ' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -155.68 -155.34 0.55 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.968 -1.083 . . . . 0.0 111.384 -179.387 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.72 ' CE1' ' ND2' ' A' ' 102' ' ' ASN . 85.3 m-85 -156.09 110.91 2.88 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.131 0.491 . . . . 0.0 109.842 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.855 HD11 HD12 ' A' ' 32' ' ' ILE . 88.1 mt -73.71 134.16 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.179 -0.951 . . . . 0.0 109.475 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.758 HD12 ' HG2' ' A' ' 50' ' ' GLU . 57.5 mt -106.42 145.71 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.122 -0.987 . . . . 0.0 110.981 -179.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.081 HD11 HG21 ' A' ' 34' ' ' ILE . 1.9 mt -132.77 139.21 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.538 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 83.22 -159.52 37.35 Favored Glycine 0 N--CA 1.481 1.665 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.55 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -123.86 150.08 28.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 121.183 -1.187 . . . . 0.0 110.194 -179.568 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.574 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.7 OUTLIER -19.1 -57.47 0.05 OUTLIER Pre-proline 0 N--CA 1.5 2.045 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 10.3 Cg_endo -53.18 70.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 124.214 1.639 . . . . 0.0 111.952 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 90.76 5.11 69.0 Favored Glycine 0 N--CA 1.494 2.531 0 O-C-N 121.012 -1.055 . . . . 0.0 110.985 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.503 ' HB3' ' C ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -51.46 160.77 0.55 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.998 -1.295 . . . . 0.0 110.187 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' A' ' 18' ' ' PHE . 8.4 mt -97.52 177.4 5.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.214 -0.929 . . . . 0.0 110.35 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -159.14 141.35 13.77 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.266 -0.896 . . . . 0.0 110.456 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.832 HD22 HG12 ' A' ' 24' ' ' ILE . 3.0 mp -141.11 120.82 13.4 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.242 -0.911 . . . . 0.0 110.239 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.72 ' ND2' ' CE1' ' A' ' 89' ' ' TYR . 20.3 t-20 -72.13 131.2 42.49 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.292 -0.88 . . . . 0.0 110.7 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 1.008 ' CD1' HD13 ' A' ' 32' ' ' ILE . 6.9 t-105 -141.22 -143.94 0.16 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.823 -1.173 . . . . 0.0 111.193 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.616 ' CG ' ' HB2' ' A' ' 88' ' ' SER . 7.5 m-85 67.64 -82.43 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -178.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.56 ' CA ' ' O ' ' A' ' 86' ' ' GLY . 5.9 mtmt 63.02 170.49 0.15 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.86 -1.15 . . . . 0.0 110.295 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.58 125.34 30.27 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.913 . . . . 0.0 110.188 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -161.78 83.29 0.12 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 98.6 p -67.37 129.39 39.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.275 -1.132 . . . . 0.0 110.167 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.14 -36.54 3.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.317 -0.865 . . . . 0.0 110.11 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 110' ' ' LEU . 0.7 OUTLIER -134.01 37.32 3.22 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.339 -0.85 . . . . 0.0 110.179 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -139.41 114.42 9.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.255 -0.903 . . . . 0.0 110.251 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.8 26.85 0.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.899 . . . . 0.0 110.167 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -140.8 179.16 6.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 0.0 110.236 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.38 136.67 46.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.906 . . . . 0.0 110.219 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 48.3 m170 -94.15 155.82 16.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 110.134 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 58.09 -179.33 0.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 110.077 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 23.5 m170 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.188 -179.982 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.416 ' O ' ' OD1' ' A' ' 2' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.226 0.536 . . . . 0.0 110.205 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 1' ' ' MET . 0.6 OUTLIER -149.74 -60.91 0.21 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.278 -0.889 . . . . 0.0 110.191 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.3 mmtm -120.58 -24.67 5.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.256 -0.903 . . . . 0.0 110.201 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.451 ' O ' ' HB3' ' A' ' 5' ' ' GLN . 0.9 OUTLIER -139.02 -171.33 3.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 110.238 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.463 ' O ' ' O ' ' A' ' 6' ' ' LEU . 3.5 pt20 178.54 42.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.314 -0.867 . . . . 0.0 110.218 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.524 HD22 HD22 ' A' ' 67' ' ' ASN . 1.1 mp 46.19 97.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.358 -0.839 . . . . 0.0 110.387 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -109.73 124.29 50.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -0.889 . . . . 0.0 110.25 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.89 156.12 8.39 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.63 -10.61 19.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.206 -1.173 . . . . 0.0 110.223 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 44' ' ' PRO . 61.4 p -143.23 37.97 1.4 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.266 -0.896 . . . . 0.0 110.122 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.605 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 0.3 OUTLIER -171.75 35.12 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.236 -0.915 . . . . 0.0 109.366 -179.699 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.554 ' HA ' ' HD3' ' A' ' 46' ' ' LYS . 2.7 t -147.33 -35.99 0.23 Allowed 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.843 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.44 ' O ' ' N ' ' A' ' 15' ' ' THR . 7.7 tmm? -160.95 87.54 0.73 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.141 -0.974 . . . . 0.0 111.137 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 4.0 m -52.3 96.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.043 -1.036 . . . . 0.0 109.003 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 16' ' ' GLY . 49.4 p -64.56 -11.31 33.24 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.491 -0.756 . . . . 0.0 111.33 -178.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.537 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -60.08 -145.97 0.01 OUTLIER Glycine 0 N--CA 1.481 1.675 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.546 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -127.91 174.42 9.18 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.299 -1.118 . . . . 0.0 109.345 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.075 ' CE2' HG23 ' A' ' 47' ' ' ILE . 46.9 m-85 -131.24 133.62 45.63 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.743 -1.223 . . . . 0.0 112.099 -179.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -108.01 121.62 45.17 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.575 ' CG2' HD13 ' A' ' 99' ' ' LEU . 48.0 t -59.66 130.39 23.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.196 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.626 HG23 ' HA ' ' A' ' 36' ' ' VAL . 69.7 t -105.21 -26.91 3.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.566 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 19.6 tttt -156.32 133.06 10.3 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.15 155.95 1.77 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.542 0.687 . . . . 0.0 111.215 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.69 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -50.98 132.51 12.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.536 -0.727 . . . . 0.0 109.862 179.839 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.83 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -107.23 170.58 7.87 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 5.2 pm0 -116.36 130.58 56.84 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.809 -1.182 . . . . 0.0 110.569 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.94 HG21 ' OE2' ' A' ' 80' ' ' GLU . 14.5 p -89.2 173.93 8.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.361 -0.837 . . . . 0.0 110.056 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -88.07 29.2 0.96 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.154 -0.966 . . . . 0.0 110.472 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -132.25 6.19 4.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.16 -0.962 . . . . 0.0 110.291 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.77 -2.46 60.3 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.996 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -92.54 -178.14 4.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.303 -1.116 . . . . 0.0 110.384 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.83 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -139.18 158.46 28.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.568 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.81 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 73.6 t -123.08 128.15 74.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 C-N-CA 118.933 -1.107 . . . . 0.0 112.372 -177.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.054 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -111.24 118.47 57.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 121.357 -0.84 . . . . 0.0 109.716 178.895 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.566 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 2.9 ttm180 -104.71 114.65 29.0 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.765 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.6 m -133.46 -168.46 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 O-C-N 121.469 -0.769 . . . . 0.0 109.31 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.478 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 9.8 tt0 -135.14 126.25 27.93 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.94 ' HB2' HG21 ' A' ' 70' ' ' VAL . 1.5 t80 -61.04 127.32 30.95 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.975 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 17' ' ' LYS . 3.5 mt-10 -125.28 89.63 3.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.044 -1.035 . . . . 0.0 110.172 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.537 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 162.45 -151.69 21.69 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.51 ' HA ' ' HD2' ' A' ' 73' ' ' LYS . 11.1 t0 -107.48 118.23 36.18 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.565 -0.962 . . . . 0.0 110.217 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.06 -36.48 0.04 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.601 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER 52.43 -158.15 0.01 OUTLIER Pre-proline 0 C--N 1.305 -1.346 0 O-C-N 120.945 -1.327 . . . . 0.0 108.665 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.601 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 76.2 Cg_exo -45.21 93.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.229 0 N-CA-C 109.376 -1.048 . . . . 0.0 109.376 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.735 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -154.92 175.65 13.52 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.611 -0.681 . . . . 0.0 109.811 -179.093 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.625 ' HG3' ' CD1' ' A' ' 69' ' ' ILE . 2.6 mttp -82.01 175.37 10.42 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.393 -0.817 . . . . 0.0 112.07 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.075 HG23 ' CE2' ' A' ' 18' ' ' PHE . 16.8 mm -120.03 128.01 26.07 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.636 -0.665 . . . . 0.0 111.672 -178.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.632 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 34.2 Cg_exo -63.06 145.1 93.84 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 124.043 1.549 . . . . 0.0 110.495 178.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.874 ' CD2' HG21 ' A' ' 79' ' ' ILE . 5.4 t80 -154.11 162.45 41.18 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.268 -0.895 . . . . 0.0 110.101 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.878 ' O ' HD12 ' A' ' 91' ' ' ILE . 7.0 tp10 -179.19 97.88 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.192 -0.943 . . . . 0.0 110.03 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 1.079 HD11 ' HB1' ' A' ' 81' ' ' ALA . 16.1 mt -77.99 6.05 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.161 -0.962 . . . . 0.0 110.575 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.575 ' HA ' ' CG ' ' A' ' 56' ' ' LYS . 2.2 mpp? -142.88 -55.16 0.41 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.089 -1.007 . . . . 0.0 110.182 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.663 ' HB2' HD13 ' A' ' 91' ' ' ILE . 22.1 t0 70.85 20.55 5.43 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.27 -0.894 . . . . 0.0 110.373 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.515 ' CB ' ' O ' ' A' ' 53' ' ' ASP . 0.9 OUTLIER 71.63 -0.62 3.09 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.272 -0.893 . . . . 0.0 110.746 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -98.32 -0.61 43.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.15 -0.969 . . . . 0.0 110.237 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.608 ' HE3' ' CD1' ' A' ' 89' ' ' TYR . 0.6 OUTLIER -111.1 58.98 0.61 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.178 -0.951 . . . . 0.0 110.184 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.415 ' O ' ' HB2' ' A' ' 58' ' ' HIS . 0.3 OUTLIER -60.4 96.63 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 110.265 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.415 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 2.1 t60 178.26 -48.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.256 -0.902 . . . . 0.0 110.202 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.2 m -139.65 -155.56 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.285 -0.884 . . . . 0.0 110.176 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -158.88 117.31 2.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.302 -0.874 . . . . 0.0 110.237 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.51 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . -83.67 179.39 52.33 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.528 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -137.75 168.29 19.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.197 -1.178 . . . . 0.0 110.416 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.843 HD12 ' N ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -122.59 122.68 39.43 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.581 -0.699 . . . . 0.0 109.295 179.161 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.996 HG12 HG21 ' A' ' 31' ' ' THR . 1.4 mp -85.3 -30.73 6.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.825 HG22 ' O ' ' A' ' 65' ' ' THR 0.262 2.9 m -107.75 42.87 1.27 Allowed 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.258 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.843 ' N ' HD12 ' A' ' 63' ' ' LEU . 18.7 t -30.07 121.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-O 121.604 0.716 . . . . 0.0 111.503 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.524 HD22 HD22 ' A' ' 6' ' ' LEU . 12.9 t-20 43.09 71.91 1.31 Allowed Pre-proline 0 C--N 1.297 -1.683 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.617 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.796 ' HG3' HG23 ' A' ' 79' ' ' ILE . 1.1 Cg_endo -56.0 -171.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.909 1.479 . . . . 0.0 108.967 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.735 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.8 OUTLIER -143.6 148.01 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 119.041 -1.064 . . . . 0.0 112.285 -179.241 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.004 ' CG2' HD11 ' A' ' 47' ' ' ILE . 54.3 t -104.79 164.69 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 176.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.3 m -118.89 -19.39 8.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.878 -1.139 . . . . 0.0 111.5 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.528 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 19.0 mt-10 -140.2 18.78 2.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.76 -1.213 . . . . 0.0 111.386 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.548 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 9.0 ttpt 72.61 -6.7 1.56 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.247 -0.908 . . . . 0.0 110.949 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.468 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 18.1 t0 -137.94 -2.2 1.92 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.0 -1.062 . . . . 0.0 110.33 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.553 ' O ' HG23 ' A' ' 77' ' ' VAL . 10.2 t -72.64 112.42 15.01 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.071 -1.018 . . . . 0.0 108.939 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.625 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 50.5 Cg_exo -47.82 128.2 15.64 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.9 1.474 . . . . 0.0 110.067 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.95 HG21 HG22 ' A' ' 70' ' ' VAL . 66.3 t -114.94 142.32 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.04 -1.038 . . . . 0.0 111.534 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.679 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.1 m-20 -104.99 133.43 49.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.468 -0.77 . . . . 0.0 109.312 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.874 HG21 ' CD2' ' A' ' 49' ' ' PHE . 5.5 mt -117.39 119.66 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.075 -1.641 . . . . 0.0 111.582 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.94 ' OE2' HG21 ' A' ' 27' ' ' THR . 1.9 tp10 -91.84 115.92 28.46 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.229 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 1.079 ' HB1' HD11 ' A' ' 51' ' ' ILE . . . -131.85 151.7 51.52 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.982 -1.074 . . . . 0.0 110.775 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.528 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 35.2 tt0 -100.76 103.09 22.18 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.234 -0.916 . . . . 0.0 110.247 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.536 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 42.8 Cg_endo -73.6 145.85 37.98 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.032 1.543 . . . . 0.0 110.655 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.51 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 43.8 Cg_endo -75.72 -160.17 0.1 Allowed 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.154 1.607 . . . . 0.0 110.256 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -97.52 149.21 22.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 110.069 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 105' ' ' LYS . . . 95.69 -159.73 22.4 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.88 137.24 36.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -1.162 . . . . 0.0 110.005 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 0.4 OUTLIER -141.41 150.83 42.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.218 -0.926 . . . . 0.0 110.534 -179.821 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.61 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 8.5 m-85 -129.88 108.49 10.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.348 -0.845 . . . . 0.0 110.044 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.734 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 1.7 mp -74.32 121.94 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.194 -0.941 . . . . 0.0 109.81 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.878 HD12 ' O ' ' A' ' 50' ' ' GLU . 3.2 mt -101.06 145.88 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.17 -0.956 . . . . 0.0 110.04 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.054 HD11 HG21 ' A' ' 34' ' ' ILE . 4.0 mt -132.73 146.18 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.465 -0.772 . . . . 0.0 110.359 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.544 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 78.74 -161.05 47.59 Favored Glycine 0 N--CA 1.484 1.896 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.528 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.1 OUTLIER -124.19 140.98 45.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.187 -1.184 . . . . 0.0 110.866 -179.632 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.559 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.8 OUTLIER -16.6 -58.97 0.04 OUTLIER Pre-proline 0 N--CA 1.505 2.309 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.876 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 24.4 Cg_exo -32.32 -32.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 124.013 1.533 . . . . 0.0 110.956 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.546 ' HA3' ' CG ' ' A' ' 17' ' ' LYS . . . -175.67 35.98 0.1 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.58 ' HG3' HG23 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -71.43 164.69 25.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.697 -0.884 . . . . 0.0 110.74 -179.247 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.575 HD13 ' CG2' ' A' ' 20' ' ' VAL . 8.2 mt -100.99 176.95 5.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.432 -0.793 . . . . 0.0 110.128 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.469 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -154.84 135.59 13.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.318 -0.864 . . . . 0.0 110.259 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.643 HD12 ' O ' ' A' ' 90' ' ' ILE . 2.4 mp -142.02 122.87 14.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.267 -0.895 . . . . 0.0 110.231 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.482 ' HA ' ' O ' ' A' ' 88' ' ' SER . 7.4 p-10 -86.02 131.31 34.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.15 -0.969 . . . . 0.0 110.241 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.4 ' O ' ' CB ' ' A' ' 104' ' ' PHE . 49.4 t-105 -141.48 169.68 17.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.949 . . . . 0.0 110.317 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.498 ' O ' ' CB ' ' A' ' 105' ' ' LYS . 0.2 OUTLIER 63.63 -163.14 0.27 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.301 -0.875 . . . . 0.0 110.235 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 86' ' ' GLY . 0.1 OUTLIER 169.42 -175.86 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.273 -0.892 . . . . 0.0 110.172 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.47 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 25.5 mtpt -58.23 -29.52 65.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.306 -0.871 . . . . 0.0 110.327 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -168.97 -169.72 32.7 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.67 -173.22 2.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -1.152 . . . . 0.0 110.171 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.5 m 50.25 -168.52 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.192 -0.942 . . . . 0.0 110.19 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.441 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -48.67 139.78 9.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 110.191 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -105.56 -62.79 1.31 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 110.324 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 57.99 69.53 0.73 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 110.19 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -168.23 -50.19 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.268 -0.895 . . . . 0.0 110.197 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -108.15 6.66 27.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.208 -0.932 . . . . 0.0 110.195 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.4 ' O ' ' CB ' ' A' ' 116' ' ' HIS . 0.0 OUTLIER -90.22 -4.21 57.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.864 . . . . 0.0 110.203 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.4 ' CB ' ' O ' ' A' ' 115' ' ' HIS . 4.4 t-160 63.03 86.3 0.12 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.292 -0.88 . . . . 0.0 110.15 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.201 179.904 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.433 ' O ' ' CB ' ' A' ' 2' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.211 0.529 . . . . 0.0 110.193 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.433 ' CB ' ' O ' ' A' ' 1' ' ' MET . 6.4 t0 64.62 -179.9 0.18 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.869 . . . . 0.0 110.233 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 2' ' ' ASP . 10.8 mttt 54.86 95.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.9 . . . . 0.0 110.329 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.747 ' O ' HD12 ' A' ' 4' ' ' LEU . 1.1 pp -132.09 53.93 1.97 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.306 -0.871 . . . . 0.0 110.135 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.9 35.17 3.57 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.304 -0.872 . . . . 0.0 110.231 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.1 mt -128.4 96.77 4.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 110.239 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.402 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -121.79 86.66 2.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 110.271 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.42 155.14 25.07 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.514 ' O ' ' N ' ' A' ' 11' ' ' TYR . 1.5 ttt -90.29 -44.53 9.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.223 -1.163 . . . . 0.0 110.327 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.9 t 46.46 -92.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.279 -0.888 . . . . 0.0 110.104 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.571 ' CZ ' ' HB2' ' A' ' 44' ' ' PRO . 1.1 t80 -148.88 -74.88 0.17 Allowed 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.144 -0.973 . . . . 0.0 110.143 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.529 ' HB3' ' CB ' ' A' ' 45' ' ' CYS . 2.4 t -145.85 -127.89 0.07 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.201 -0.937 . . . . 0.0 109.509 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.522 ' O ' ' N ' ' A' ' 15' ' ' THR . 1.5 ptt? -178.55 97.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.94 -1.1 . . . . 0.0 110.394 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 56.4 m -60.44 80.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.884 . . . . 0.0 108.999 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 13' ' ' MET . 0.1 OUTLIER -83.35 -4.6 58.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.302 -0.874 . . . . 0.0 111.656 -178.553 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -61.23 -128.75 0.01 OUTLIER Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.544 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -123.24 176.29 6.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.235 -1.156 . . . . 0.0 109.971 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.98 ' CE2' HG23 ' A' ' 47' ' ' ILE . 34.4 m-85 -135.93 141.38 44.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.879 -1.138 . . . . 0.0 111.704 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -112.33 117.62 32.99 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.638 ' CG2' HD13 ' A' ' 99' ' ' LEU . 44.2 t -59.67 123.94 13.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 120.586 -1.321 . . . . 0.0 108.94 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.744 HG21 ' HB3' ' A' ' 76' ' ' PRO . 53.9 t -97.62 -26.63 3.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.605 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 18.8 tttt -157.17 133.21 9.56 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -50.62 161.69 0.31 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.694 0.759 . . . . 0.0 111.325 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.716 HG13 HD13 ' A' ' 90' ' ' ILE . 0.7 OUTLIER -55.83 132.64 19.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-O 121.716 0.769 . . . . 0.0 110.311 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.724 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -109.5 167.22 10.29 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 6.9 pm0 -113.91 130.37 56.51 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 120.595 -1.316 . . . . 0.0 110.681 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.534 HG22 HG23 ' A' ' 33' ' ' VAL . 8.4 p -81.72 -167.59 1.57 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.455 -0.778 . . . . 0.0 110.005 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -103.94 23.02 13.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 110.281 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -128.48 7.08 5.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.204 -0.935 . . . . 0.0 110.178 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.479 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 97.95 0.94 58.61 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.975 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -91.93 -177.28 4.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.285 -1.127 . . . . 0.0 110.254 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.824 HD12 HD11 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -140.69 150.4 20.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.611 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.703 HG22 ' HG3' ' A' ' 80' ' ' GLU . 69.7 t -116.5 131.71 68.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 O-C-N 121.151 -0.968 . . . . 0.0 111.875 -178.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.075 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -114.72 117.06 54.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.401 -0.812 . . . . 0.0 109.694 179.056 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.605 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -98.65 122.41 41.84 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.864 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.777 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.7 m -149.25 158.17 6.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.942 0.877 . . . . 0.0 109.022 -178.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.503 ' NE2' ' HD3' ' A' ' 76' ' ' PRO 0.256 2.7 tt0 -104.43 122.33 45.28 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.318 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.894 ' HB2' HG21 ' A' ' 70' ' ' VAL . 7.6 t80 -61.47 144.98 53.29 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.081 -1.047 . . . . 0.0 110.148 -178.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 17' ' ' LYS . 45.3 mm-40 -119.19 -143.8 0.36 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.276 -0.89 . . . . 0.0 108.848 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 43.86 -139.77 3.62 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.445 ' HA ' ' HD2' ' A' ' 73' ' ' LYS . 1.3 m-20 -135.18 143.35 46.4 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.737 -0.861 . . . . 0.0 110.001 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.02 -27.17 0.05 OUTLIER Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.475 -1.345 . . . . 0.0 110.626 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.643 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.4 OUTLIER 56.31 -153.88 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 120.637 -1.508 . . . . 0.0 108.324 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.643 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 38.9 Cg_exo -53.5 90.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 N-CA-C 109.981 -0.815 . . . . 0.0 109.981 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.703 ' O ' HG23 ' A' ' 69' ' ' ILE . 6.6 p -142.46 173.68 11.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.137 -0.977 . . . . 0.0 110.541 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.774 ' HG3' HD11 ' A' ' 69' ' ' ILE . 12.1 mtmm -84.42 168.97 15.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.411 -0.806 . . . . 0.0 111.347 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.031 HD11 ' CG2' ' A' ' 70' ' ' VAL . 13.3 mm -112.06 127.18 27.21 Favored Pre-proline 0 C--N 1.304 -1.391 0 O-C-N 121.241 -0.912 . . . . 0.0 112.31 -177.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.635 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 34.6 Cg_exo -63.71 144.17 88.55 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 124.055 1.555 . . . . 0.0 110.258 178.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.863 ' CD2' HG21 ' A' ' 79' ' ' ILE . 7.1 t80 -153.05 162.01 41.83 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.259 -0.9 . . . . 0.0 110.603 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.63 ' O ' HD12 ' A' ' 91' ' ' ILE . 9.4 tp10 -179.83 108.7 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.345 -0.847 . . . . 0.0 109.729 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 1.057 HD11 ' HB1' ' A' ' 81' ' ' ALA . 5.0 mt -86.52 25.08 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.064 -1.023 . . . . 0.0 110.547 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.543 ' HA ' ' HG3' ' A' ' 56' ' ' LYS . 39.6 mtm -148.57 -67.54 0.23 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.233 -0.917 . . . . 0.0 110.277 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.916 ' HB2' HD13 ' A' ' 91' ' ' ILE . 6.7 t0 40.47 -163.96 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.331 -0.855 . . . . 0.0 110.686 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 45.05 -92.47 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.39 -0.819 . . . . 0.0 110.319 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 53' ' ' ASP . 19.1 pt-20 -163.12 61.77 0.18 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.175 -0.953 . . . . 0.0 110.066 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.543 ' HG3' ' HA ' ' A' ' 52' ' ' MET . 43.9 mmtt -98.64 81.55 2.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -0.883 . . . . 0.0 109.948 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' A' ' 56' ' ' LYS . 1.3 mtt180 -50.21 -177.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.403 -0.811 . . . . 0.0 110.389 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 55.27 85.84 0.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.322 -0.861 . . . . 0.0 110.075 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.2 t -76.88 127.23 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 110.265 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.474 ' HB3' ' HB3' ' A' ' 84' ' ' PRO . 3.7 mt -150.86 -45.07 0.12 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.273 -0.892 . . . . 0.0 110.254 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.541 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . -45.08 160.09 0.14 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -149.43 170.16 19.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.216 -1.167 . . . . 0.0 110.812 -179.682 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.827 HD12 ' N ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -119.7 121.99 40.46 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.422 179.302 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.975 HG12 HG21 ' A' ' 31' ' ' THR . 1.3 mp -84.69 -30.86 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.83 HG22 ' O ' ' A' ' 65' ' ' THR 0.259 1.9 m -108.52 43.84 1.19 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.159 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.827 ' N ' HD12 ' A' ' 63' ' ' LEU . 9.0 t -29.52 135.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 CA-C-O 121.33 0.586 . . . . 0.0 111.396 -178.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.782 ' ND2' HG12 ' A' ' 66' ' ' VAL . 23.6 p30 26.52 73.14 0.37 Allowed Pre-proline 0 N--CA 1.49 1.538 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.753 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.581 ' O ' ' HA ' ' A' ' 46' ' ' LYS . 3.2 Cg_endo -57.1 -174.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.902 1.475 . . . . 0.0 108.821 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.774 HD11 ' HG3' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -140.83 142.57 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 C-N-CA 118.847 -1.141 . . . . 0.0 112.346 -179.071 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.031 ' CG2' HD11 ' A' ' 47' ' ' ILE . 46.6 t -98.63 160.05 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 176.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.5 m -113.8 -21.65 10.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.954 -1.092 . . . . 0.0 110.964 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.512 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 6.6 mt-10 -132.02 15.62 4.7 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.963 -1.086 . . . . 0.0 111.05 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.53 ' O ' ' O ' ' A' ' 38' ' ' TYR . 0.2 OUTLIER 72.37 -4.36 2.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.353 -0.842 . . . . 0.0 110.984 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.47 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 12.6 t70 -137.38 1.87 2.44 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.06 -1.025 . . . . 0.0 110.188 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.739 ' O ' HG23 ' A' ' 77' ' ' VAL . 40.3 t -73.0 109.28 5.87 Favored Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.192 -0.943 . . . . 0.0 109.454 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.744 ' HB3' HG21 ' A' ' 21' ' ' VAL . 3.7 Cg_endo -52.59 111.15 0.57 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.817 1.43 . . . . 0.0 109.713 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 75' ' ' SER . 48.7 t -102.65 145.49 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.331 -0.856 . . . . 0.0 111.712 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.652 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 1.5 m120 -101.93 134.12 45.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.488 -0.757 . . . . 0.0 109.207 179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.863 HG21 ' CD2' ' A' ' 49' ' ' PHE . 6.6 mt -114.85 117.42 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.21 -1.556 . . . . 0.0 111.626 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.703 ' HG3' HG22 ' A' ' 33' ' ' VAL . 2.6 tt0 -88.18 111.52 21.71 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.59 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 1.057 ' HB1' HD11 ' A' ' 51' ' ' ILE . . . -127.23 149.39 50.02 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.032 -1.043 . . . . 0.0 110.836 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -99.47 104.15 25.41 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.243 -0.91 . . . . 0.0 110.51 -179.692 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.537 ' HG3' ' CD1' ' A' ' 32' ' ' ILE . 74.6 Cg_endo -81.15 147.58 16.46 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.004 1.528 . . . . 0.0 110.609 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.541 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 9.7 Cg_endo -58.32 -52.46 5.6 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.872 1.459 . . . . 0.0 109.769 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.48 ' HB3' ' OD1' ' A' ' 87' ' ' ASP . 1.0 OUTLIER -151.98 176.43 11.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.401 -0.812 . . . . 0.0 109.657 179.682 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.554 ' HA3' ' CB ' ' A' ' 105' ' ' LYS . . . -74.17 76.24 1.09 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 87' ' ' ASP . 5.7 p-10 175.11 81.38 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.491 -1.005 . . . . 0.0 109.339 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.544 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -158.67 -159.05 0.75 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 110.651 -179.081 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.52 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 3.4 m-85 -151.13 100.72 2.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.69 -0.631 . . . . 0.0 109.728 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.824 HD11 HD12 ' A' ' 32' ' ' ILE . 3.4 mt -73.91 120.04 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.148 -0.97 . . . . 0.0 109.575 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.916 HD13 ' HB2' ' A' ' 53' ' ' ASP . 1.9 mp -98.53 140.16 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.046 -1.034 . . . . 0.0 110.048 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.075 HD11 HG21 ' A' ' 34' ' ' ILE . 1.2 mt -126.14 142.22 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.452 -0.78 . . . . 0.0 109.994 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.534 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 82.59 -160.36 39.48 Favored Glycine 0 N--CA 1.481 1.65 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.553 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -122.77 149.82 26.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 O-C-N 121.307 -1.113 . . . . 0.0 110.091 -179.652 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.569 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -19.19 -57.56 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.109 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 9.7 Cg_endo -53.84 69.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 124.137 1.598 . . . . 0.0 112.145 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 93.57 4.61 63.82 Favored Glycine 0 N--CA 1.495 2.6 0 O-C-N 120.876 -1.14 . . . . 0.0 111.033 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.505 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -53.87 159.78 1.61 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.046 -1.267 . . . . 0.0 110.193 179.873 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.638 HD13 ' CG2' ' A' ' 20' ' ' VAL . 9.1 mt -97.91 177.4 5.45 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.215 -0.928 . . . . 0.0 110.758 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.467 ' HG3' HG13 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -157.07 128.37 6.89 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.47 -0.769 . . . . 0.0 110.094 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 89' ' ' TYR . 4.7 mp -130.5 124.98 33.2 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.279 -0.888 . . . . 0.0 109.972 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.544 ' HA ' ' O ' ' A' ' 88' ' ' SER . 10.1 t-20 -90.91 132.21 36.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 110.89 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.505 ' O ' ' N ' ' A' ' 87' ' ' ASP . 3.4 t-105 -113.22 122.57 47.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.049 -1.032 . . . . 0.0 110.243 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' A' ' 86' ' ' GLY . 1.3 t80 -117.52 145.5 44.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.187 -0.946 . . . . 0.0 110.326 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.554 ' CB ' ' HA3' ' A' ' 86' ' ' GLY . 0.0 OUTLIER 168.22 117.19 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.271 -0.893 . . . . 0.0 110.293 -179.952 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.57 -20.97 14.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 110.136 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 60.41 51.43 58.82 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 60.4 p -66.8 -74.55 0.11 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -1.146 . . . . 0.0 110.217 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 35.5 m -156.19 104.49 2.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.186 -0.946 . . . . 0.0 110.245 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.698 HD12 ' N ' ' A' ' 110' ' ' LEU . 7.4 mp -78.4 -80.01 0.12 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 110.184 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 110' ' ' LEU . 1.1 mt-10 43.57 69.73 0.38 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.293 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -145.62 -62.77 0.33 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.337 -0.852 . . . . 0.0 110.112 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -92.81 77.01 4.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 110.125 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.481 ' O ' ' CD2' ' A' ' 114' ' ' HIS . 22.4 p-80 -136.67 93.32 2.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 110.18 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -63.44 155.47 29.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.917 . . . . 0.0 110.204 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.404 ' O ' ' CB ' ' A' ' 117' ' ' HIS . 0.1 OUTLIER -137.78 174.97 10.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.282 -0.886 . . . . 0.0 110.213 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.404 ' CB ' ' O ' ' A' ' 116' ' ' HIS . 1.9 t-160 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.232 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.247 0.546 . . . . 0.0 110.185 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.413 ' O ' ' CG ' ' A' ' 2' ' ' ASP . 11.0 p-10 -165.08 117.72 1.2 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.896 . . . . 0.0 110.203 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.7 mttm -144.59 23.86 1.58 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.912 . . . . 0.0 110.215 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.484 ' HA ' HD13 ' A' ' 4' ' ' LEU . 3.5 mm? -80.52 82.46 6.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.32 -0.863 . . . . 0.0 110.239 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.464 ' O ' ' O ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -179.38 41.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.266 -0.896 . . . . 0.0 110.23 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 5' ' ' GLN . 4.7 mp 50.75 176.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 110.201 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.1 mtmt -80.46 -9.49 59.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 0.0 110.107 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 9' ' ' MET . . . -170.94 -58.21 0.04 OUTLIER Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.431 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER 177.34 163.92 0.55 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -1.169 . . . . 0.0 110.229 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.6 m -57.99 124.49 19.47 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.225 -0.922 . . . . 0.0 110.141 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.54 ' CE2' ' O ' ' A' ' 44' ' ' PRO . 1.8 t80 -88.66 -74.0 0.48 Allowed 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.257 -0.902 . . . . 0.0 110.166 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 13' ' ' MET . 3.4 t -133.13 -28.25 1.54 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.363 -0.835 . . . . 0.0 110.645 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.48 ' HB3' ' O ' ' A' ' 12' ' ' SER . 2.7 ttm 58.28 95.52 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.309 -0.869 . . . . 0.0 108.972 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.592 ' HB3' ' CE1' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -71.61 126.55 29.97 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.889 -179.183 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 16' ' ' GLY . 14.8 t -107.71 -2.37 20.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.267 -0.895 . . . . 0.0 111.385 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.575 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -60.8 -125.08 0.01 OUTLIER Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.543 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -132.49 178.12 7.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.028 -1.278 . . . . 0.0 110.029 -179.793 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.043 ' CE2' HG23 ' A' ' 47' ' ' ILE . 34.1 m-85 -136.12 133.92 37.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.948 -1.095 . . . . 0.0 111.63 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.555 ' CE ' ' HB3' ' A' ' 37' ' ' GLN . 0.3 OUTLIER -104.26 119.71 39.56 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.622 -0.674 . . . . 0.0 109.444 179.2 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.596 HG22 HD13 ' A' ' 99' ' ' LEU . 41.6 t -59.72 131.12 24.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 118.588 -1.245 . . . . 0.0 108.275 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.624 HG23 ' HA ' ' A' ' 36' ' ' VAL . 75.9 t -105.27 -26.15 3.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.562 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 2.2 tttt -157.11 133.08 9.53 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -52.3 158.86 1.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.523 0.677 . . . . 0.0 111.304 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.68 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -54.39 132.38 17.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.588 0.708 . . . . 0.0 109.903 -179.964 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.848 ' HB3' ' HB ' ' A' ' 33' ' ' VAL . . . -107.29 169.7 8.41 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.5 pm0 -115.85 133.54 55.92 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.65 -1.281 . . . . 0.0 110.406 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.951 HG21 ' CD ' ' A' ' 80' ' ' GLU . 13.2 p -93.13 172.45 8.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.393 -0.817 . . . . 0.0 110.181 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -87.73 29.23 0.92 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.266 -0.896 . . . . 0.0 110.328 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.87 5.82 4.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.924 . . . . 0.0 110.179 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.88 8.06 59.47 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.926 HG22 ' C ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -102.66 -174.84 2.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -1.08 . . . . 0.0 110.081 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.773 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -141.91 156.91 20.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 178.632 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.848 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 76.3 t -121.69 128.18 75.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 O-C-N 120.974 -1.079 . . . . 0.0 112.222 -177.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.0 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -112.89 118.97 59.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 O-C-N 121.437 -0.789 . . . . 0.0 109.685 178.832 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 3.4 ttm180 -105.67 112.81 26.03 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.791 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.7 m -132.34 -168.01 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.476 -0.765 . . . . 0.0 109.422 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.555 ' HB3' ' CE ' ' A' ' 19' ' ' LYS . 33.0 tt0 -138.26 127.06 23.76 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.874 ' HB2' HG21 ' A' ' 70' ' ' VAL . 75.5 t80 -60.31 128.34 36.25 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 118.29 -1.364 . . . . 0.0 110.579 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.498 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 61.8 mm-40 -116.01 82.85 1.84 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.484 -0.76 . . . . 0.0 109.62 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.575 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 171.62 -145.01 8.48 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.472 ' O ' ' OH ' ' A' ' 38' ' ' TYR . 7.5 m-20 -128.54 140.83 51.6 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.637 -0.919 . . . . 0.0 110.56 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 166.9 -20.61 0.1 OUTLIER Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.689 -1.243 . . . . 0.0 110.66 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.606 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER 56.03 -157.98 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 120.705 -1.468 . . . . 0.0 108.413 -179.702 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 72.9 Cg_exo -44.35 94.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.262 0 N-CA-C 108.944 -1.214 . . . . 0.0 108.944 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.698 ' O ' HG23 ' A' ' 69' ' ' ILE . 26.3 p -141.17 165.88 26.31 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.746 -0.596 . . . . 0.0 110.286 -178.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.704 ' HG3' HD11 ' A' ' 69' ' ' ILE . 10.9 mttp -82.59 177.43 8.71 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.407 -0.808 . . . . 0.0 110.358 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.043 HG23 ' CE2' ' A' ' 18' ' ' PHE . 14.2 mm -121.51 127.88 25.89 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.102 -0.999 . . . . 0.0 111.92 -178.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.619 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 35.1 Cg_exo -63.06 143.72 91.23 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.881 1.464 . . . . 0.0 110.627 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.756 ' CD1' HD21 ' A' ' 63' ' ' LEU . 5.6 t80 -155.53 132.28 10.55 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.335 -0.853 . . . . 0.0 110.021 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.588 ' O ' HD12 ' A' ' 91' ' ' ILE . 0.8 OUTLIER -144.1 97.68 3.09 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.03 -1.044 . . . . 0.0 110.305 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.719 HD11 ' HB1' ' A' ' 81' ' ' ALA . 11.9 mt -86.02 61.53 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.274 -0.891 . . . . 0.0 110.184 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.501 ' HB2' ' HG2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -142.93 -65.1 0.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.312 -0.868 . . . . 0.0 110.345 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.661 ' OD2' HD11 ' A' ' 91' ' ' ILE . 0.6 OUTLIER 58.42 106.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.121 -0.987 . . . . 0.0 110.002 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.525 ' CB ' ' O ' ' A' ' 53' ' ' ASP . 2.4 tp 72.7 -1.08 3.11 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.34 -0.85 . . . . 0.0 110.514 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -142.65 52.62 1.41 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.905 . . . . 0.0 110.106 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.501 ' HG2' ' HB2' ' A' ' 52' ' ' MET . 18.4 mtmt -98.69 102.66 14.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.3 -0.875 . . . . 0.0 110.235 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -165.67 -56.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.0 110.28 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.3 -156.47 0.5 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.23 -0.919 . . . . 0.0 110.149 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.4 t -101.32 99.39 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.341 -0.849 . . . . 0.0 110.261 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.09 132.07 56.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.194 -0.941 . . . . 0.0 110.226 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.525 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . 68.33 161.5 2.06 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.512 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -130.78 166.95 19.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.268 -1.136 . . . . 0.0 110.157 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.758 HD22 ' CB ' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -128.42 111.22 13.08 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.346 -0.847 . . . . 0.0 109.934 179.701 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.915 ' CG1' HG21 ' A' ' 31' ' ' THR . 5.6 mm -71.08 -25.45 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 122.148 0.975 . . . . 0.0 108.525 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.641 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.253 0.7 OUTLIER -111.87 31.46 6.19 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.718 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 63' ' ' LEU . 32.6 t -13.83 112.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.186 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.539 ' ND2' ' HD3' ' A' ' 46' ' ' LYS . 12.5 t-20 43.78 68.66 2.87 Favored Pre-proline 0 C--N 1.298 -1.66 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.295 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.667 ' HG3' HG23 ' A' ' 79' ' ' ILE . 2.1 Cg_endo -51.41 -174.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.982 1.517 . . . . 0.0 109.142 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.704 HD11 ' HG3' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -142.28 144.41 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 119.088 -1.045 . . . . 0.0 112.488 -178.914 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.007 ' CG2' HD11 ' A' ' 47' ' ' ILE . 26.5 t -98.62 166.87 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 176.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.411 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 3.3 m -123.62 -18.9 5.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.842 -1.161 . . . . 0.0 111.12 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.539 ' O ' ' CD ' ' A' ' 73' ' ' LYS . 8.0 mt-10 -138.0 15.37 2.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.926 -1.109 . . . . 0.0 110.685 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.539 ' CD ' ' O ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER 75.05 -13.39 0.85 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.773 -0.579 . . . . 0.0 111.224 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.47 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 6.3 t70 -131.83 -0.07 3.87 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.89 -1.131 . . . . 0.0 110.163 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 77' ' ' VAL . 8.9 t -72.04 108.36 4.05 Favored Pre-proline 0 C--N 1.304 -1.372 0 O-C-N 121.257 -0.902 . . . . 0.0 108.707 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.639 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 2.0 Cg_endo -46.92 131.03 16.51 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.77 1.405 . . . . 0.0 110.297 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.627 HG21 HG22 ' A' ' 70' ' ' VAL . 63.2 t -118.39 144.81 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.099 -1.001 . . . . 0.0 111.296 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.682 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 4.9 m-80 -105.51 134.82 47.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.431 -0.793 . . . . 0.0 109.574 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.725 HG21 ' CD2' ' A' ' 49' ' ' PHE . 5.2 mt -118.37 119.05 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 119.957 -1.715 . . . . 0.0 111.344 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.951 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.7 tp10 -93.19 114.12 26.52 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.634 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.926 ' C ' HG22 ' A' ' 31' ' ' THR . . . -131.0 150.43 52.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.048 -1.033 . . . . 0.0 110.873 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 4.4 tt0 -101.09 100.2 12.56 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.34 -0.85 . . . . 0.0 110.084 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.539 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 32.4 Cg_endo -69.05 144.64 58.52 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.102 1.58 . . . . 0.0 110.58 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.525 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 19.0 Cg_endo -63.62 -163.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.034 1.544 . . . . 0.0 110.229 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.57 ' O ' ' CD2' ' A' ' 85' ' ' PHE . 37.4 p90 -91.19 125.49 35.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.918 . . . . 0.0 110.243 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.24 -173.23 17.82 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -57.72 167.5 1.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -1.167 . . . . 0.0 110.194 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 0.6 OUTLIER -172.95 130.05 0.49 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 110.266 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 21.6 m-85 -100.9 102.66 13.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.913 . . . . 0.0 110.16 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.779 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.8 mp -73.9 113.45 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.213 -0.93 . . . . 0.0 109.394 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.661 HD11 ' OD2' ' A' ' 53' ' ' ASP . 9.5 mt -94.1 144.56 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.144 -0.972 . . . . 0.0 110.282 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.0 HD11 HG21 ' A' ' 34' ' ' ILE . 1.8 mt -128.65 141.25 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.406 -0.808 . . . . 0.0 109.697 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.546 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 82.2 -160.36 40.24 Favored Glycine 0 N--CA 1.483 1.786 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.563 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -122.58 148.24 26.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 O-C-N 121.218 -1.166 . . . . 0.0 109.918 -179.73 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.571 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.4 OUTLIER -16.38 -58.56 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.173 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.776 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 7.3 Cg_endo -51.01 73.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 124.131 1.595 . . . . 0.0 112.067 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 88.39 -0.27 83.14 Favored Glycine 0 N--CA 1.495 2.581 0 O-C-N 121.02 -1.05 . . . . 0.0 110.9 178.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.507 ' HB3' ' C ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -47.04 160.52 0.09 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.967 -1.314 . . . . 0.0 110.325 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.596 HD13 HG22 ' A' ' 20' ' ' VAL . 10.6 mt -96.9 177.69 5.54 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.218 -0.926 . . . . 0.0 110.363 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.486 ' HG3' HG12 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -158.72 136.25 10.16 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.297 -0.877 . . . . 0.0 110.104 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.779 HD12 ' O ' ' A' ' 90' ' ' ILE . 2.6 mp -141.48 121.5 13.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.148 -0.97 . . . . 0.0 110.393 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 1.2 p-10 -87.44 129.65 34.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.257 -0.902 . . . . 0.0 110.336 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 -126.09 152.94 45.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 110.202 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -109.95 118.35 36.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.274 -0.891 . . . . 0.0 110.217 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -116.91 57.6 0.78 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 110.221 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -78.62 -173.67 3.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 0.0 110.163 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 140.28 167.0 10.88 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.492 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.8 OUTLIER -130.7 -145.84 0.29 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.283 -1.128 . . . . 0.0 110.188 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 111' ' ' GLU . 1.5 m -48.71 -36.77 16.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.169 -0.957 . . . . 0.0 110.32 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 108' ' ' SER . 0.6 OUTLIER 52.62 -88.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.955 . . . . 0.0 110.14 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 109' ' ' SER . 11.8 tt0 -167.68 40.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.94 . . . . 0.0 110.217 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -165.79 107.9 0.76 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 110.19 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.42 ' O ' ' CG ' ' A' ' 114' ' ' HIS . 20.0 p80 -165.69 -179.55 5.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.259 -0.9 . . . . 0.0 110.211 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.42 ' CG ' ' O ' ' A' ' 113' ' ' HIS . 2.3 m-70 -166.15 90.04 0.42 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.175 -0.953 . . . . 0.0 110.237 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -178.81 -161.41 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 110.205 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -164.05 168.14 19.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.207 -0.933 . . . . 0.0 110.262 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 6.8 t60 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.265 179.99 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 mtp . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.208 0.528 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.3 t0 62.76 65.42 0.82 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 110.212 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -85.53 163.03 18.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.221 -0.925 . . . . 0.0 110.258 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.74 112.39 3.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.322 -0.861 . . . . 0.0 110.147 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -110.1 6.42 22.85 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.316 -0.865 . . . . 0.0 110.266 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.644 HD22 HG11 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -156.48 -161.28 1.09 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.925 . . . . 0.0 110.174 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.17 -73.12 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.934 . . . . 0.0 110.283 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.422 ' O ' ' CB ' ' A' ' 9' ' ' MET . . . -166.88 -122.08 0.59 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.422 ' CB ' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER 64.32 138.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.287 -1.125 . . . . 0.0 110.152 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.0 p -175.46 135.27 0.32 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.264 -0.898 . . . . 0.0 110.158 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.623 ' CZ ' ' HB2' ' A' ' 44' ' ' PRO . 1.2 t80 -149.26 -75.0 0.17 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.206 -0.933 . . . . 0.0 109.994 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.512 ' HB3' ' HA ' ' A' ' 45' ' ' CYS . 2.1 t -148.4 -126.21 0.05 Allowed 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.112 -0.993 . . . . 0.0 109.054 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.456 ' HB3' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -178.3 98.41 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.741 -1.224 . . . . 0.0 110.66 179.429 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 21.5 m -61.85 104.87 0.49 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.066 -1.022 . . . . 0.0 108.401 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.525 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 1.2 t -114.82 2.6 14.41 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.932 -1.105 . . . . 0.0 111.974 -178.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.573 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -65.07 -100.03 0.01 OUTLIER Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.104 -1.522 . . . . 0.0 109.437 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.585 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 1.1 tmpt? -141.1 161.86 36.85 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.077 -1.249 . . . . 0.0 109.807 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.995 ' CE2' HG23 ' A' ' 47' ' ' ILE . 18.7 m-85 -126.11 134.92 51.21 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.763 -1.211 . . . . 0.0 111.93 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.516 ' HE2' ' NE2' ' A' ' 37' ' ' GLN . 3.9 ttpt -109.4 120.04 41.3 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.566 -0.709 . . . . 0.0 109.652 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.748 ' CG2' HD13 ' A' ' 99' ' ' LEU . 49.0 t -60.08 131.9 25.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.866 -1.147 . . . . 0.0 108.927 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.602 HG23 ' HA ' ' A' ' 36' ' ' VAL . 72.4 t -105.55 -27.3 3.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.558 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 5.9 tttp -156.04 133.23 10.7 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 177.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -51.84 156.38 1.48 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.555 0.693 . . . . 0.0 111.284 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.692 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -52.88 132.61 15.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.527 -0.733 . . . . 0.0 109.991 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.824 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -109.5 170.87 7.78 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 0.7 OUTLIER -115.78 134.29 55.17 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.73 -1.231 . . . . 0.0 110.552 -179.735 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.955 HG21 ' CD ' ' A' ' 80' ' ' GLU . 14.5 p -93.46 172.33 8.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.502 -0.749 . . . . 0.0 110.372 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -88.6 29.89 0.96 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.328 -0.857 . . . . 0.0 110.191 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.76 5.48 4.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.278 -0.889 . . . . 0.0 110.104 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.06 14.01 52.97 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.942 HG21 ' CG1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -110.87 -178.82 3.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.397 -1.061 . . . . 0.0 110.292 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.824 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -137.44 152.69 27.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 178.605 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.661 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 52.9 t -118.15 130.92 72.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 121.051 -1.031 . . . . 0.0 112.357 -177.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.086 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -114.59 120.21 63.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.557 -0.715 . . . . 0.0 109.423 178.734 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.558 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -105.7 115.78 30.82 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.614 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.802 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.8 m -134.48 -170.74 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 C-N-CA 119.564 -0.854 . . . . 0.0 109.322 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.516 ' NE2' ' HE2' ' A' ' 19' ' ' LYS . 1.9 tt0 -132.42 127.32 35.11 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 1.024 ' HB2' HG21 ' A' ' 70' ' ' VAL . 1.5 t80 -60.63 122.49 14.84 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 118.703 -1.199 . . . . 0.0 110.113 -178.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 17' ' ' LYS . 4.0 mt-10 -112.29 38.62 2.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -0.867 . . . . 0.0 109.193 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.573 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -125.16 -160.68 10.79 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 37.3 p-10 -135.1 85.59 2.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.516 -0.991 . . . . 0.0 110.277 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 43' ' ' SER . . . -147.83 10.04 1.21 Allowed Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.725 -1.226 . . . . 0.0 110.307 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.605 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER 46.67 -158.61 0.01 OUTLIER Pre-proline 0 N--CA 1.487 1.42 0 O-C-N 120.834 -1.392 . . . . 0.0 108.951 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.623 ' HB2' ' CZ ' ' A' ' 11' ' ' TYR . 87.9 Cg_exo -43.49 95.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 122.72 0.853 . . . . 0.0 110.54 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.693 ' O ' HG23 ' A' ' 69' ' ' ILE . 8.0 p -141.52 171.19 14.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.491 -0.756 . . . . 0.0 110.607 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.771 ' HG3' HD11 ' A' ' 69' ' ' ILE . 33.3 mttt -84.69 169.41 14.33 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.685 0.755 . . . . 0.0 111.627 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.043 HD11 ' CG2' ' A' ' 70' ' ' VAL . 12.7 mm -111.33 124.7 32.06 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.269 -0.894 . . . . 0.0 112.234 -177.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.64 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 34.5 Cg_exo -63.12 144.09 91.62 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.974 1.513 . . . . 0.0 110.815 178.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.894 ' CZ ' HG23 ' A' ' 90' ' ' ILE . 7.6 t80 -154.97 158.88 39.89 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.299 -0.876 . . . . 0.0 110.142 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.478 ' HB3' ' HB ' ' A' ' 91' ' ' ILE . 23.9 tp10 -172.91 107.21 0.16 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.092 -1.005 . . . . 0.0 110.493 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.805 HD11 ' HB1' ' A' ' 81' ' ' ALA . 54.1 mt -99.11 94.78 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.885 . . . . 0.0 110.222 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.488 ' SD ' ' N ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -150.93 -66.78 0.19 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.207 -0.933 . . . . 0.0 110.181 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.465 ' O ' HD11 ' A' ' 91' ' ' ILE . 0.4 OUTLIER -177.53 -144.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.294 -0.879 . . . . 0.0 110.22 -179.94 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.79 -60.34 3.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.887 . . . . 0.0 110.192 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.504 ' O ' ' CG ' ' A' ' 56' ' ' LYS . 17.6 mt-10 -103.58 -77.14 0.57 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.0 110.212 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.504 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER 176.37 159.84 0.32 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.19 -0.944 . . . . 0.0 110.245 -179.956 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.488 ' N ' ' SD ' ' A' ' 52' ' ' MET . 0.4 OUTLIER 174.58 119.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.25 -0.906 . . . . 0.0 110.159 179.93 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.432 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 29.6 t60 63.53 152.54 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.925 . . . . 0.0 110.179 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.629 ' O ' HG23 ' A' ' 59' ' ' VAL . 14.1 m -90.83 121.41 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 110.163 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 59' ' ' VAL . 24.6 mt -147.86 155.59 41.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -0.89 . . . . 0.0 110.262 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.511 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . 80.12 162.26 25.63 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.518 ' CB ' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -135.35 161.3 35.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.349 -1.089 . . . . 0.0 110.165 179.9 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.77 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -123.4 111.46 16.39 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.365 -0.835 . . . . 0.0 109.864 179.698 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.942 ' CG1' HG21 ' A' ' 31' ' ' THR . 6.5 mm -70.55 -29.23 37.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 122.272 1.034 . . . . 0.0 108.297 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.632 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.257 0.7 OUTLIER -106.81 30.56 6.0 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.708 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 63' ' ' LEU . 39.3 t -13.04 111.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.281 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.537 ' ND2' ' HD3' ' A' ' 46' ' ' LYS . 12.6 t-20 43.43 69.32 2.39 Favored Pre-proline 0 C--N 1.298 -1.647 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.274 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.571 ' O ' ' HA ' ' A' ' 46' ' ' LYS . 1.6 Cg_endo -52.19 -175.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.962 1.506 . . . . 0.0 109.319 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.771 HD11 ' HG3' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -142.7 142.67 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.961 -179.316 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.043 ' CG2' HD11 ' A' ' 47' ' ' ILE . 30.8 t -99.76 161.11 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.409 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 5.6 m -115.65 -16.81 11.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.988 -1.07 . . . . 0.0 111.853 -178.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.522 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 14.1 mt-10 -141.3 19.42 2.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.665 -1.272 . . . . 0.0 111.687 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.586 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 0.0 OUTLIER 72.04 -6.37 1.52 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.15 -0.969 . . . . 0.0 111.103 179.73 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.477 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 4.9 t70 -137.8 -0.93 2.07 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.847 -1.158 . . . . 0.0 110.373 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.539 ' O ' HG23 ' A' ' 77' ' ' VAL . 40.2 t -72.37 112.3 14.26 Favored Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 121.17 -0.956 . . . . 0.0 109.027 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.605 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 45.7 Cg_exo -49.22 126.69 16.03 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.885 1.466 . . . . 0.0 110.002 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.99 HG21 HG22 ' A' ' 70' ' ' VAL . 76.3 t -112.66 140.34 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.031 -1.043 . . . . 0.0 111.606 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.682 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 6.4 m-20 -105.38 133.82 49.51 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.455 -0.778 . . . . 0.0 109.377 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.667 ' HB ' HG22 ' A' ' 34' ' ' ILE . 4.4 mt -118.15 119.97 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 119.984 -1.697 . . . . 0.0 111.609 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.955 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.6 tp10 -94.07 110.16 21.88 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.896 ' C ' HG22 ' A' ' 31' ' ' THR . . . -125.4 147.37 49.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.986 -1.071 . . . . 0.0 111.041 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.518 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 3.0 tt0 -99.53 101.89 14.83 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 109.916 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.532 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 12.4 Cg_endo -61.11 143.83 99.01 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.012 1.533 . . . . 0.0 110.504 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.511 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 19.4 Cg_endo -64.14 -71.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.051 1.553 . . . . 0.0 110.334 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -177.89 151.23 0.68 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.164 -0.96 . . . . 0.0 110.281 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.08 -161.0 54.14 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -61.21 132.38 53.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -1.132 . . . . 0.0 110.23 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.24 122.89 22.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 110.244 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 12.3 m-85 -95.96 105.14 17.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.179 -0.951 . . . . 0.0 110.199 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.894 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 1.4 mp -74.27 110.97 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.222 -0.924 . . . . 0.0 109.748 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 87.1 mt -92.1 142.18 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 110.152 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.086 HD11 HG21 ' A' ' 34' ' ' ILE . 3.6 mt -132.51 141.27 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.386 -0.821 . . . . 0.0 109.983 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.543 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 80.95 -156.7 38.41 Favored Glycine 0 N--CA 1.484 1.868 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 98' ' ' GLN . 0.2 OUTLIER -130.59 156.52 42.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.129 -1.218 . . . . 0.0 110.338 -179.548 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.528 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 3.0 mt-10 -30.33 -55.81 0.35 Allowed Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.849 -0.532 . . . . 0.0 110.848 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 73.4 Cg_exo -40.56 -36.98 1.97 Allowed 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.052 1.553 . . . . 0.0 110.686 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.585 ' HA3' ' CG ' ' A' ' 17' ' ' LYS . . . -164.71 49.04 0.29 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.557 ' N ' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -93.85 151.9 19.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.204 -1.174 . . . . 0.0 111.08 -178.57 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.748 HD13 ' CG2' ' A' ' 20' ' ' VAL . 13.6 mt -100.54 179.7 4.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.492 -0.755 . . . . 0.0 110.089 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.575 ' C ' HD12 ' A' ' 101' ' ' LEU . 1.6 mtpt -152.8 135.79 15.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.43 -0.794 . . . . 0.0 110.334 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.654 HD22 HG12 ' A' ' 24' ' ' ILE . 5.2 mp -140.33 116.91 10.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.213 -0.93 . . . . 0.0 110.199 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 3.3 p-10 -87.82 120.26 28.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 0.0 110.318 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.655 ' CE3' HG22 ' A' ' 24' ' ' ILE . 50.7 t-105 -117.52 124.32 48.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.922 . . . . 0.0 110.227 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -72.35 123.14 22.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 110.176 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.43 ' HG2' ' HG2' ' A' ' 83' ' ' PRO . 0.1 OUTLIER -131.43 47.12 2.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 0.0 110.216 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.12 -60.34 2.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.293 -0.88 . . . . 0.0 110.163 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 149.68 -82.72 0.18 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.33 65.95 1.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -1.111 . . . . 0.0 110.208 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.5 p -144.81 -158.3 0.87 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.292 -0.88 . . . . 0.0 110.187 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 53.81 58.27 5.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.893 . . . . 0.0 110.238 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -97.13 56.74 1.41 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 0.0 110.246 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -75.25 -6.37 49.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.17 -0.956 . . . . 0.0 110.152 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -61.04 -63.66 1.22 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 110.228 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 62.7 22.8 13.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 110.176 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -92.56 127.66 38.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.869 . . . . 0.0 110.26 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -83.82 174.84 10.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.163 -0.96 . . . . 0.0 110.215 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.205 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ttm . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.258 0.552 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 47.37 61.0 3.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.205 -0.935 . . . . 0.0 110.17 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 4' ' ' LEU . 0.9 OUTLIER -140.61 110.94 6.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -0.883 . . . . 0.0 110.254 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.467 ' HA ' HD13 ' A' ' 4' ' ' LEU . 3.4 mm? 50.92 101.85 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.326 -0.859 . . . . 0.0 110.213 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.408 ' HG2' ' C ' ' A' ' 4' ' ' LEU . 83.3 mm-40 -139.91 -45.17 0.43 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.238 -0.914 . . . . 0.0 110.285 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.55 128.28 35.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.897 . . . . 0.0 110.152 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.88 97.61 4.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.894 . . . . 0.0 110.257 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 10' ' ' SER . . . 179.96 94.72 0.1 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.439 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER 57.09 -82.02 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.385 -1.068 . . . . 0.0 110.298 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 8' ' ' GLY . 0.2 OUTLIER 60.62 158.3 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.268 -0.895 . . . . 0.0 110.168 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.634 ' CZ ' ' HB2' ' A' ' 44' ' ' PRO . 1.4 t80 -150.37 -74.74 0.16 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.166 -0.959 . . . . 0.0 109.905 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.509 ' HB3' ' HA ' ' A' ' 45' ' ' CYS . 3.9 t -142.15 -119.23 0.1 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.215 -0.928 . . . . 0.0 109.056 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.453 ' HG3' ' O ' ' A' ' 13' ' ' MET . 2.2 ptt? -179.6 95.56 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.569 -1.332 . . . . 0.0 110.655 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 20.3 m -60.49 94.17 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.527 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 0.5 OUTLIER -99.75 -1.14 38.5 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.021 -1.049 . . . . 0.0 112.363 -178.028 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.592 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -66.46 -108.12 0.01 OUTLIER Glycine 0 N--CA 1.493 2.44 0 C-N-CA 118.942 -1.599 . . . . 0.0 109.301 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.537 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -136.98 177.79 7.59 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.958 -1.319 . . . . 0.0 110.22 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.007 ' CE2' HG23 ' A' ' 47' ' ' ILE . 26.7 m-85 -137.57 144.62 42.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.012 -1.055 . . . . 0.0 111.826 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.459 ' HB2' ' CG ' ' A' ' 39' ' ' GLU . 11.5 ttpt -114.54 117.84 32.05 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.702 -0.624 . . . . 0.0 109.411 179.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.564 ' CG2' HD13 ' A' ' 99' ' ' LEU . 46.1 t -59.66 132.45 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.78 -1.2 . . . . 0.0 108.958 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.592 HG23 ' HA ' ' A' ' 36' ' ' VAL . 73.6 t -106.84 -26.24 3.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.561 ' HB3' ' CG ' ' A' ' 35' ' ' ARG . 3.4 tttt -156.87 133.15 9.81 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -52.12 156.49 1.6 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.65 0.738 . . . . 0.0 111.374 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.804 HG13 HD13 ' A' ' 90' ' ' ILE . 0.6 OUTLIER -52.99 132.79 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.505 -0.747 . . . . 0.0 109.944 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.788 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -109.62 170.9 7.77 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.5 pm0 -115.93 134.5 54.91 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.78 -1.2 . . . . 0.0 110.37 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.94 HG21 ' CD ' ' A' ' 80' ' ' GLU . 16.0 p -92.4 175.55 6.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.474 -0.766 . . . . 0.0 110.387 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -88.96 27.34 1.36 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.466 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -130.89 6.68 4.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.201 -0.937 . . . . 0.0 110.194 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.59 3.03 61.3 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.92 HG22 ' C ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -96.65 -177.59 3.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.335 -1.097 . . . . 0.0 110.31 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.788 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -138.88 153.84 25.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.668 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.702 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 55.5 t -119.78 130.68 73.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 O-C-N 121.003 -1.061 . . . . 0.0 112.41 -177.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.002 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -114.61 120.84 65.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 121.408 -0.807 . . . . 0.0 109.412 178.51 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.561 ' CG ' ' HB3' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -106.52 113.59 27.2 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.865 HG11 HD13 ' A' ' 92' ' ' ILE . 1.7 m -132.05 -169.78 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 C-N-CA 119.689 -0.805 . . . . 0.0 109.283 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.529 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 9.9 tt0 -134.83 127.66 31.23 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.962 ' HB2' HG21 ' A' ' 70' ' ' VAL . 1.6 t80 -60.46 124.02 19.07 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 118.796 -1.161 . . . . 0.0 110.033 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.459 ' CG ' ' HB2' ' A' ' 19' ' ' LYS . 22.6 mm-40 -103.5 -22.23 13.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.243 -0.911 . . . . 0.0 109.25 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.592 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -64.94 -161.2 0.57 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.557 ' HA ' ' CD ' ' A' ' 73' ' ' LYS . 3.3 p-10 -143.21 93.98 2.56 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.598 -0.943 . . . . 0.0 110.054 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -150.92 15.24 0.9 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.606 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER 48.39 -160.0 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.366 0 O-C-N 121.033 -1.274 . . . . 0.0 109.298 179.422 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.634 ' HB2' ' CZ ' ' A' ' 11' ' ' TYR . 85.7 Cg_exo -43.19 95.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 122.946 0.971 . . . . 0.0 110.622 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.674 ' O ' HG23 ' A' ' 69' ' ' ILE . 11.6 p -140.94 170.92 14.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.536 -0.728 . . . . 0.0 110.637 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.769 ' HG3' HD11 ' A' ' 69' ' ' ILE . 20.7 mttt -87.32 165.71 15.42 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.438 -0.789 . . . . 0.0 111.413 -178.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.051 HD11 ' CG2' ' A' ' 70' ' ' VAL . 12.6 mm -108.64 124.87 33.12 Favored Pre-proline 0 C--N 1.303 -1.415 0 O-C-N 121.18 -0.95 . . . . 0.0 112.643 -177.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.639 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 34.7 Cg_exo -63.24 146.17 93.72 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 124.023 1.538 . . . . 0.0 110.436 178.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.914 ' CZ ' HG23 ' A' ' 90' ' ' ILE . 10.2 t80 -155.22 160.22 40.69 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.147 -0.971 . . . . 0.0 110.6 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.938 ' O ' HD12 ' A' ' 91' ' ' ILE . 19.2 tp10 -177.69 115.49 0.09 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.307 -0.87 . . . . 0.0 110.212 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.639 HD11 ' HB1' ' A' ' 81' ' ' ALA . 43.4 mt -105.94 63.6 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.205 -0.934 . . . . 0.0 110.372 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.504 ' O ' ' N ' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -154.63 -67.17 0.13 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.14 -0.975 . . . . 0.0 110.262 179.831 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.473 ' HB2' HD11 ' A' ' 91' ' ' ILE . 0.6 OUTLIER 61.59 -73.83 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.296 -0.878 . . . . 0.0 110.595 179.815 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 52' ' ' MET . 0.3 OUTLIER -67.92 -7.46 28.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.206 -0.934 . . . . 0.0 110.427 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 52' ' ' MET . 1.5 tt0 -149.8 55.74 0.96 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.189 -0.944 . . . . 0.0 110.268 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.478 ' HG2' ' OE2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -98.76 77.87 2.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.935 . . . . 0.0 110.301 -179.938 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 58' ' ' HIS . 5.9 ttt180 -109.92 -29.74 8.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.215 -0.928 . . . . 0.0 110.136 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 44.4 t-80 -177.54 -60.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.251 -0.906 . . . . 0.0 110.369 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.409 HG22 ' H ' ' A' ' 59' ' ' VAL . 34.4 m -86.78 159.61 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.195 -0.941 . . . . 0.0 110.394 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 61' ' ' GLY . 0.9 OUTLIER -178.47 -173.68 0.35 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -0.867 . . . . 0.0 110.17 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 60' ' ' LEU . . . -51.39 -176.45 0.03 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.511 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -115.33 167.4 10.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -1.182 . . . . 0.0 110.039 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.756 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -130.93 110.76 11.5 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.387 -0.821 . . . . 0.0 109.916 179.672 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.911 ' CG1' HG21 ' A' ' 31' ' ' THR . 4.9 mm -69.98 -25.6 28.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-O 122.15 0.976 . . . . 0.0 108.53 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.627 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.251 0.6 OUTLIER -110.95 30.1 7.17 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.658 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 63' ' ' LEU . 40.3 t -11.9 112.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.394 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.534 ' ND2' ' HD3' ' A' ' 46' ' ' LYS . 13.7 t-20 41.63 69.63 1.99 Allowed Pre-proline 0 C--N 1.299 -1.598 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.463 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.554 ' O ' ' HA ' ' A' ' 46' ' ' LYS . 1.4 Cg_endo -51.88 -174.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.886 1.466 . . . . 0.0 109.456 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.769 HD11 ' HG3' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -142.81 143.58 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 119.148 -1.021 . . . . 0.0 112.06 -179.136 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.051 ' CG2' HD11 ' A' ' 47' ' ' ILE . 22.2 t -101.91 159.6 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 176.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.3 m -116.67 -14.53 10.82 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.046 -1.062 . . . . 0.0 111.853 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 73' ' ' LYS . 19.6 mt-10 -142.0 22.51 2.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.619 -1.301 . . . . 0.0 111.756 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.598 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 0.8 OUTLIER 66.7 -1.57 1.29 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.095 -1.003 . . . . 0.0 111.087 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.465 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 9.7 t0 -142.47 -0.35 1.24 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.944 -1.098 . . . . 0.0 110.574 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.613 ' O ' HG23 ' A' ' 77' ' ' VAL . 39.4 t -72.76 108.43 4.41 Favored Pre-proline 0 N--CA 1.486 1.344 0 O-C-N 120.977 -1.077 . . . . 0.0 109.218 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.596 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 2.3 Cg_endo -47.25 127.41 13.01 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.743 1.391 . . . . 0.0 109.684 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.943 HG21 HG22 ' A' ' 70' ' ' VAL . 58.7 t -115.46 143.43 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.954 -1.091 . . . . 0.0 111.611 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.679 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 4.0 m120 -106.18 134.12 49.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.551 -0.718 . . . . 0.0 109.525 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.67 ' HB ' HG22 ' A' ' 34' ' ' ILE . 4.2 mt -117.5 119.75 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 119.988 -1.695 . . . . 0.0 111.402 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.94 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.8 tp10 -95.24 110.74 22.68 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.92 ' C ' HG22 ' A' ' 31' ' ' THR . . . -126.46 150.1 48.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.077 -1.014 . . . . 0.0 111.004 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.511 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 9.6 tp10 -101.83 101.68 19.45 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.354 -0.841 . . . . 0.0 110.127 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.533 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 20.3 Cg_endo -66.71 144.56 72.28 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.08 1.568 . . . . 0.0 110.427 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.438 ' O ' ' HB3' ' A' ' 85' ' ' PHE . 15.1 Cg_endo -62.8 -74.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 124.052 1.554 . . . . 0.0 110.327 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.438 ' HB3' ' O ' ' A' ' 84' ' ' PRO . 17.5 p90 177.21 154.42 0.26 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.913 . . . . 0.0 110.282 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.429 ' HA2' ' HB2' ' A' ' 106' ' ' LYS . . . 78.24 -161.68 49.04 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -64.77 140.92 58.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -1.147 . . . . 0.0 110.12 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -149.31 159.0 44.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.352 -0.842 . . . . 0.0 110.243 -179.842 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.521 ' N ' ' CD1' ' A' ' 89' ' ' TYR . 8.1 m-85 -132.2 108.14 9.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.325 -0.859 . . . . 0.0 110.153 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.914 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 1.3 mp -74.16 108.39 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -0.906 . . . . 0.0 109.482 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.938 HD12 ' O ' ' A' ' 50' ' ' GLU . 7.0 mt -92.09 142.37 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.131 -0.98 . . . . 0.0 110.42 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.002 HD11 HG21 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -129.61 138.26 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.545 -0.722 . . . . 0.0 109.521 -179.905 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.524 ' O ' ' HB2' ' A' ' 48' ' ' PRO . . . 86.06 -161.87 34.9 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.554 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -121.89 148.38 25.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 O-C-N 121.264 -1.139 . . . . 0.0 110.129 -179.721 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.581 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.2 OUTLIER -18.07 -58.02 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.145 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 9.3 Cg_endo -52.62 70.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 124.198 1.631 . . . . 0.0 112.148 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 91.34 2.89 70.08 Favored Glycine 0 N--CA 1.495 2.584 0 O-C-N 120.875 -1.141 . . . . 0.0 110.912 178.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.521 ' HB2' ' N ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -51.64 159.12 0.82 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.965 -1.315 . . . . 0.0 110.229 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.564 HD13 ' CG2' ' A' ' 20' ' ' VAL . 5.7 mt -96.24 174.68 6.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.224 -0.922 . . . . 0.0 110.297 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.909 ' C ' HD12 ' A' ' 101' ' ' LEU . 3.8 ttmt -152.71 143.09 22.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.34 -0.85 . . . . 0.0 110.328 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.909 HD12 ' C ' ' A' ' 100' ' ' LYS . 5.6 mp -144.59 113.45 6.79 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.168 -0.957 . . . . 0.0 110.222 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.491 ' HA ' ' O ' ' A' ' 88' ' ' SER . 9.8 t-20 -79.64 131.18 35.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.243 -0.91 . . . . 0.0 110.334 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 -127.73 123.87 36.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 0.0 110.196 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -82.9 128.02 34.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 0.0 110.285 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.15 47.88 1.6 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.138 -0.976 . . . . 0.0 110.232 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.429 ' HB2' ' HA2' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -115.67 138.41 51.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.256 -0.902 . . . . 0.0 110.179 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.28 -149.82 16.97 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.39 -46.54 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.27 -1.135 . . . . 0.0 110.221 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.9 t -171.68 29.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.169 -0.957 . . . . 0.0 110.247 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.41 35.25 2.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.905 . . . . 0.0 110.167 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.46 161.18 16.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 110.267 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 47.5 87.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 110.24 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.97 -179.94 4.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.925 . . . . 0.0 110.141 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -143.94 -73.5 0.27 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.237 -0.915 . . . . 0.0 110.135 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 62.09 -150.39 0.37 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 110.254 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.427 ' O ' ' O ' ' A' ' 117' ' ' HIS . 9.3 t60 -85.83 -15.7 41.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.321 -0.862 . . . . 0.0 110.219 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.427 ' O ' ' O ' ' A' ' 116' ' ' HIS . 36.7 t-80 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.146 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.4 mtm . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.272 0.558 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 36.7 p-10 -82.58 -165.84 1.14 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.208 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER -119.8 22.17 11.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.302 -0.874 . . . . 0.0 110.229 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.477 ' O ' ' CB ' ' A' ' 5' ' ' GLN . 0.5 OUTLIER -43.17 146.78 0.4 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.231 -0.918 . . . . 0.0 110.244 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.477 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER 171.28 56.4 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -0.923 . . . . 0.0 110.197 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.429 ' O ' ' HB2' ' A' ' 10' ' ' SER . 0.7 OUTLIER -54.24 -57.69 10.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.217 -0.927 . . . . 0.0 110.098 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -6.14 47.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.9 . . . . 0.0 110.062 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.67 -25.97 63.97 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.469 ' O ' ' O ' ' A' ' 10' ' ' SER . 13.4 mtm -140.15 -91.43 0.17 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -1.169 . . . . 0.0 110.23 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.51 ' HA ' ' CE ' ' A' ' 46' ' ' LYS . 8.1 t 56.09 161.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.2 -0.938 . . . . 0.0 110.147 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -92.37 -72.89 0.57 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.137 -0.977 . . . . 0.0 110.137 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.45 ' O ' ' HB3' ' A' ' 13' ' ' MET . 3.1 t -136.28 -6.89 2.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.086 -1.009 . . . . 0.0 111.067 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.654 ' O ' HG23 ' A' ' 15' ' ' THR . 4.2 ttp 55.98 81.59 0.12 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.952 -1.093 . . . . 0.0 108.683 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.587 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 35.8 m -56.39 101.54 0.06 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.483 -0.761 . . . . 0.0 109.491 -178.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.654 HG23 ' O ' ' A' ' 13' ' ' MET . 39.6 p -95.79 -5.8 41.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 111.652 -178.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.598 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -61.21 -117.65 0.01 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.54 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -138.51 173.08 11.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.956 -1.32 . . . . 0.0 110.139 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.999 ' CE2' HG23 ' A' ' 47' ' ' ILE . 30.8 m-85 -132.69 141.51 48.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.012 -1.055 . . . . 0.0 111.693 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.474 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 14.9 ttpt -110.51 119.84 40.47 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.627 -0.67 . . . . 0.0 109.444 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.475 HG22 HD13 ' A' ' 99' ' ' LEU . 31.4 t -60.23 132.74 25.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 120.91 -1.119 . . . . 0.0 109.205 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.637 HG23 ' HA ' ' A' ' 36' ' ' VAL . 90.1 t -106.04 -27.12 3.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.582 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 14.1 tttt -156.96 133.45 9.95 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -51.26 160.17 0.57 Allowed 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.702 0.763 . . . . 0.0 111.72 -178.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.695 HG23 HG22 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -57.93 133.45 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 CA-C-O 121.579 0.704 . . . . 0.0 110.248 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.599 ' HB3' ' HB ' ' A' ' 33' ' ' VAL . . . -112.05 158.35 19.68 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.6 pm0 -110.67 132.77 53.91 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 120.295 -1.503 . . . . 0.0 110.27 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.938 HG21 ' OE2' ' A' ' 80' ' ' GLU . 1.8 p -91.21 175.44 6.94 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.163 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -80.8 -16.7 53.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.238 -0.914 . . . . 0.0 110.495 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -80.6 1.53 29.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 0.0 110.292 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.92 9.33 61.03 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.894 HG21 ' CG1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -98.31 174.8 6.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -1.097 . . . . 0.0 110.395 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.876 HD11 ' CG ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -129.22 142.96 42.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.621 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 26.7 t -110.91 131.1 63.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 O-C-N 121.388 -0.82 . . . . 0.0 111.775 -177.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.027 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -119.34 121.3 66.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.456 -0.777 . . . . 0.0 109.349 178.809 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.582 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -106.14 111.62 24.31 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.737 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.86 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.5 m -131.44 -167.92 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.175 -178.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.471 ' N ' HG23 ' A' ' 36' ' ' VAL . 10.6 tt0 -135.59 129.25 32.63 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.938 ' HB2' HG21 ' A' ' 70' ' ' VAL . 1.7 t80 -60.2 122.33 14.19 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 118.544 -1.262 . . . . 0.0 110.361 -178.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.474 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 4.6 mt-10 -112.05 39.26 2.45 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.453 -0.779 . . . . 0.0 108.973 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.598 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -133.06 -160.64 9.56 Favored Glycine 0 N--CA 1.484 1.894 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.451 ' HA ' ' HD2' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -121.98 141.9 50.86 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.537 -0.978 . . . . 0.0 110.267 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 154.92 -11.43 0.43 Allowed Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.857 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.607 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.7 OUTLIER 54.88 -153.29 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 120.542 -1.563 . . . . 0.0 108.119 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.607 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 83.1 Cg_exo -41.83 97.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.322 -0.864 0 N-CA-C 108.904 -1.229 . . . . 0.0 108.904 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.733 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -145.89 170.82 15.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.794 -0.567 . . . . 0.0 109.958 -177.647 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.682 ' HG3' HD11 ' A' ' 69' ' ' ILE . 33.8 mttm -87.29 176.11 7.7 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.417 -0.802 . . . . 0.0 111.653 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.085 HD11 ' CG2' ' A' ' 70' ' ' VAL . 16.2 mm -122.47 129.05 25.21 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.305 -0.872 . . . . 0.0 112.405 -178.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.622 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 24.8 Cg_exo -67.47 146.55 74.82 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.689 1.593 . . . . 0.0 111.246 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.728 ' CD2' HD21 ' A' ' 63' ' ' LEU . 9.7 t80 -155.53 154.55 31.93 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.419 -0.8 . . . . 0.0 109.741 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.888 ' HG2' HD12 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -164.14 125.26 2.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.842 -1.161 . . . . 0.0 110.661 179.666 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.979 HG21 ' HB3' ' A' ' 83' ' ' PRO . 11.1 mt -123.91 123.3 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.493 -0.754 . . . . 0.0 109.842 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.484 ' O ' ' N ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -129.41 -58.31 1.12 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.187 -0.946 . . . . 0.0 110.379 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.511 ' OD2' ' HA ' ' A' ' 87' ' ' ASP . 25.5 t0 66.56 -67.48 0.16 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.254 -0.904 . . . . 0.0 110.12 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 52' ' ' MET . 1.7 tt -44.66 -69.19 0.14 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 110.073 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.535 ' O ' ' CB ' ' A' ' 56' ' ' LYS . 13.2 tt0 -142.11 -81.63 0.21 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.261 -0.899 . . . . 0.0 109.965 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER 166.3 35.97 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.38 -0.825 . . . . 0.0 110.134 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.574 ' O ' ' CG ' ' A' ' 58' ' ' HIS . 6.2 mtp85 -146.58 26.75 1.14 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.201 -0.937 . . . . 0.0 110.418 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.574 ' CG ' ' O ' ' A' ' 57' ' ' ARG . 4.4 m-70 -165.8 105.65 0.71 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.938 . . . . 0.0 110.408 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 59' ' ' VAL . 6.3 p -76.88 97.81 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.317 -0.864 . . . . 0.0 110.022 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.537 HD23 ' HG3' ' A' ' 84' ' ' PRO . 0.6 OUTLIER -103.07 16.84 25.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 110.387 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 83' ' ' PRO . . . -110.5 172.68 15.64 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.525 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -122.85 165.99 15.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.174 -1.192 . . . . 0.0 110.433 -179.866 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.819 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -131.8 111.27 11.48 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.701 179.269 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.894 ' CG1' HG21 ' A' ' 31' ' ' THR . 5.2 mm -69.13 -30.26 45.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-O 122.126 0.965 . . . . 0.0 108.576 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.612 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.253 0.6 OUTLIER -104.98 29.92 5.94 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.554 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 63' ' ' LEU . 48.0 t -12.65 110.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.247 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 19.6 t-20 44.23 69.1 2.62 Favored Pre-proline 0 C--N 1.299 -1.612 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.048 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.553 ' O ' ' HA ' ' A' ' 46' ' ' LYS . 2.3 Cg_endo -50.18 -178.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 124.033 1.544 . . . . 0.0 109.474 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.733 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.8 OUTLIER -140.71 143.93 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 119.183 -1.007 . . . . 0.0 112.104 -178.89 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.085 ' CG2' HD11 ' A' ' 47' ' ' ILE . 20.2 t -99.78 170.33 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.425 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 5.2 m -126.73 -17.2 5.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.959 -1.088 . . . . 0.0 111.173 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 7.4 mt-10 -140.01 15.67 2.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.944 -1.097 . . . . 0.0 110.918 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 11.4 ttpp 73.59 -7.11 1.63 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.307 -0.871 . . . . 0.0 110.781 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.466 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 5.3 t70 -137.68 1.46 2.34 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.024 -1.048 . . . . 0.0 110.096 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.576 ' O ' HG23 ' A' ' 77' ' ' VAL . 12.4 t -72.74 108.28 4.21 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 121.128 -0.982 . . . . 0.0 108.921 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.629 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 1.9 Cg_endo -47.52 130.19 17.7 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.801 1.421 . . . . 0.0 110.071 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.682 HG21 HG22 ' A' ' 70' ' ' VAL . 60.1 t -118.01 145.43 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.022 -1.049 . . . . 0.0 111.415 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.697 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 3.9 m120 -105.6 134.53 48.56 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.511 -0.743 . . . . 0.0 109.537 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.652 ' HB ' HG22 ' A' ' 34' ' ' ILE . 3.4 mt -117.88 119.89 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 119.953 -1.717 . . . . 0.0 111.358 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.938 ' OE2' HG21 ' A' ' 27' ' ' THR . 2.4 tp10 -95.45 106.86 18.97 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.861 ' C ' HG22 ' A' ' 31' ' ' THR . . . -112.19 147.39 36.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.09 -1.006 . . . . 0.0 110.655 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 3.0 tt0 -113.2 53.89 0.53 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.408 -0.807 . . . . 0.0 110.932 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.979 ' HB3' HG21 ' A' ' 51' ' ' ILE . 23.1 Cg_endo -66.16 159.74 48.21 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 123.675 1.355 . . . . 0.0 110.402 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.537 ' HG3' HD23 ' A' ' 60' ' ' LEU . 11.5 Cg_endo -60.58 84.6 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.948 1.499 . . . . 0.0 109.827 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.423 ' HB2' ' O ' ' A' ' 84' ' ' PRO . 0.2 OUTLIER 65.19 -168.58 0.21 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.273 -0.892 . . . . 0.0 109.856 -179.495 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 105' ' ' LYS . . . -54.64 109.27 1.16 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.73 ' CG ' HD12 ' A' ' 90' ' ' ILE . 7.6 p-10 -84.32 41.48 0.83 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.359 -1.083 . . . . 0.0 110.216 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.532 ' O ' ' N ' ' A' ' 103' ' ' TRP . 31.3 p 39.68 -121.06 0.34 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.409 -0.807 . . . . 0.0 111.089 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.526 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 24.6 m-85 -78.19 100.75 6.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.877 -1.14 . . . . 0.0 111.853 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.805 HG22 ' HB2' ' A' ' 101' ' ' LEU . 0.7 OUTLIER -74.46 168.25 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.017 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.888 HD12 ' HG2' ' A' ' 50' ' ' GLU . 94.7 mt -131.21 143.36 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.318 -1.489 . . . . 0.0 111.868 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.027 HD11 HG21 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -133.96 138.06 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.502 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.536 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 86.18 -158.96 32.07 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.541 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -123.89 149.53 28.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 O-C-N 121.061 -1.258 . . . . 0.0 110.411 -179.462 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.587 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 5.4 mt-10 -20.35 -57.39 0.07 OUTLIER Pre-proline 0 N--CA 1.501 2.078 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.563 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 9.7 Cg_endo -53.9 70.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 124.108 1.583 . . . . 0.0 111.898 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 91.42 6.75 65.9 Favored Glycine 0 N--CA 1.494 2.512 0 O-C-N 120.967 -1.083 . . . . 0.0 110.896 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.503 ' HB3' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -52.42 161.21 0.71 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.972 -1.31 . . . . 0.0 110.019 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.527 ' CD1' ' O ' ' A' ' 18' ' ' PHE . 4.9 mt -95.77 170.06 9.58 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.189 -0.944 . . . . 0.0 110.773 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -152.61 142.74 22.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.5 -0.75 . . . . 0.0 109.722 179.573 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.805 ' HB2' HG22 ' A' ' 90' ' ' ILE . 4.0 mp -138.89 117.68 12.32 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.98 -1.075 . . . . 0.0 110.878 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -59.92 146.26 42.93 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.283 -0.886 . . . . 0.0 110.201 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.532 ' N ' ' O ' ' A' ' 88' ' ' SER . 9.1 t-105 -167.84 58.64 0.07 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.212 -0.93 . . . . 0.0 110.417 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.521 ' O ' ' N ' ' A' ' 106' ' ' LYS . 6.9 t80 -63.28 110.05 1.76 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.119 -0.988 . . . . 0.0 110.535 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.486 ' O ' ' HA3' ' A' ' 86' ' ' GLY . 0.9 OUTLIER 56.39 -81.83 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.416 -0.803 . . . . 0.0 110.616 179.72 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 104' ' ' PHE . 0.5 OUTLIER -169.41 -65.34 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.149 -0.969 . . . . 0.0 110.227 -179.827 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 160.63 -92.26 0.11 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 38.0 p -107.62 94.28 5.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.234 -1.157 . . . . 0.0 110.247 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.63 108.47 10.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.892 . . . . 0.0 110.206 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.11 30.27 6.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 110.177 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.18 -39.86 0.09 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 110.208 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.418 ' O ' ' HB3' ' A' ' 113' ' ' HIS . 1.3 t60 -95.54 122.02 37.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.878 . . . . 0.0 110.196 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.425 ' O ' ' HB3' ' A' ' 114' ' ' HIS . 16.7 p80 -176.37 -151.36 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.202 -0.936 . . . . 0.0 110.2 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.425 ' HB3' ' O ' ' A' ' 113' ' ' HIS . 8.6 p-80 179.39 -173.94 0.2 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.277 -0.889 . . . . 0.0 110.189 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.403 ' O ' ' CB ' ' A' ' 116' ' ' HIS . 43.9 m-70 -145.59 -89.54 0.1 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.195 -0.941 . . . . 0.0 110.258 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.403 ' CB ' ' O ' ' A' ' 115' ' ' HIS . 0.2 OUTLIER 173.73 134.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.931 . . . . 0.0 110.186 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.231 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 20.7 m . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.471 ' O ' ' O ' ' A' ' 16' ' ' GLY . 5.9 t -88.79 -6.82 57.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.138 -0.976 . . . . 0.0 111.755 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.518 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -61.2 -129.74 0.01 OUTLIER Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.531 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -125.09 177.99 5.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.228 -1.16 . . . . 0.0 110.008 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.04 ' CE2' HG23 ' A' ' 47' ' ' ILE . 33.0 m-85 -135.36 142.85 45.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.925 -1.11 . . . . 0.0 111.638 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.478 ' HE2' ' HB3' ' A' ' 37' ' ' GLN . 37.6 ttpt -113.43 117.68 32.4 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.644 ' CG2' HD13 ' A' ' 99' ' ' LEU . 54.9 t -59.3 124.54 13.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 120.659 -1.276 . . . . 0.0 109.501 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.633 HG23 ' HA ' ' A' ' 36' ' ' VAL . 70.3 t -98.07 -29.62 3.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.647 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 0.5 OUTLIER -150.46 138.05 19.78 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.391 0.615 . . . . 0.0 109.887 177.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -56.15 153.43 9.22 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.297 0.57 . . . . 0.0 110.261 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.722 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -49.35 131.3 7.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.109 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.878 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -108.47 172.1 7.04 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 16.8 pt-20 -113.0 130.67 56.05 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.881 -1.137 . . . . 0.0 110.335 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.51 ' O ' ' CB ' ' A' ' 28' ' ' GLN . 17.5 p -74.99 0.41 15.96 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.461 -0.774 . . . . 0.0 110.292 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.51 ' CB ' ' O ' ' A' ' 27' ' ' THR . 0.5 OUTLIER 70.03 10.69 7.49 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.302 -0.874 . . . . 0.0 110.131 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.42 11.55 6.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.918 . . . . 0.0 110.292 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.456 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 110.17 -20.19 26.33 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.912 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -92.1 -174.27 3.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.224 -1.162 . . . . 0.0 110.476 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.878 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -148.38 160.24 6.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.698 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 99.0 t -123.58 131.54 72.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 C-N-CA 118.982 -1.087 . . . . 0.0 111.752 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.141 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -114.91 114.29 46.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.431 -0.793 . . . . 0.0 109.741 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.647 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -95.27 125.79 40.15 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.058 -1.026 . . . . 0.0 108.467 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.698 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.8 m -150.13 159.11 5.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.274 -0.891 . . . . 0.0 108.609 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.485 ' N ' HG23 ' A' ' 21' ' ' VAL 0.26 25.6 tt0 -103.85 124.7 49.43 Favored 'General case' 0 C--N 1.27 -2.872 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -179.165 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 1.02 ' HB2' HG21 ' A' ' 70' ' ' VAL . 1.2 t80 -60.75 122.35 14.58 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 119.016 -1.074 . . . . 0.0 110.509 -178.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 17' ' ' LYS . 23.1 mm-40 -106.87 152.06 24.4 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.374 -0.829 . . . . 0.0 108.921 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.519 ' O ' ' CE ' ' A' ' 73' ' ' LYS . . . 105.7 -145.75 15.97 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.455 ' O ' ' OH ' ' A' ' 38' ' ' TYR . 0.5 OUTLIER -130.4 127.95 40.38 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.525 -0.986 . . . . 0.0 109.942 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.04 -29.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.331 -1.414 . . . . 0.0 110.854 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.632 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.4 OUTLIER 56.39 -154.09 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 120.621 -1.517 . . . . 0.0 108.224 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.632 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 44.9 Cg_exo -52.23 89.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 N-CA-C 109.811 -0.88 . . . . 0.0 109.811 179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.748 ' O ' HG23 ' A' ' 69' ' ' ILE . 10.0 p -142.12 174.57 10.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.928 . . . . 0.0 110.636 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.632 ' HG3' ' CD1' ' A' ' 69' ' ' ILE . 2.3 mtpt -87.73 162.49 17.02 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.041 0.924 . . . . 0.0 111.915 -178.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.04 HG23 ' CE2' ' A' ' 18' ' ' PHE . 14.9 mm -105.44 124.24 36.97 Favored Pre-proline 0 C--N 1.3 -1.546 0 O-C-N 121.635 -0.665 . . . . 0.0 111.487 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.626 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 31.4 Cg_exo -62.14 145.12 96.48 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.064 1.56 . . . . 0.0 110.746 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.939 ' CD2' HG21 ' A' ' 79' ' ' ILE . 5.0 t80 -153.76 154.26 33.7 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.495 -0.753 . . . . 0.0 109.187 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.624 ' O ' HG23 ' A' ' 51' ' ' ILE . 18.3 tt0 -157.51 115.4 3.11 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.884 -1.135 . . . . 0.0 110.335 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.687 HG22 ' HA ' ' A' ' 90' ' ' ILE . 19.4 pt . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.537 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.493 2.471 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.53 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -131.49 166.89 20.34 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.18 -1.188 . . . . 0.0 110.515 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.676 HD12 ' N ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -121.87 121.02 36.2 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.301 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.912 HG12 HG21 ' A' ' 31' ' ' THR . 1.6 mp -85.98 -27.42 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 106.706 -1.591 . . . . 0.0 106.706 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.843 HG22 ' O ' ' A' ' 65' ' ' THR 0.255 3.0 m -110.75 42.8 1.53 Allowed 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.338 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.774 HG12 ' ND2' ' A' ' 67' ' ' ASN . 6.7 t -30.94 133.06 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 121.275 0.56 . . . . 0.0 111.021 -178.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.774 ' ND2' HG12 ' A' ' 66' ' ' VAL . 23.0 p30 27.52 74.92 0.35 Allowed Pre-proline 0 N--CA 1.488 1.458 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.575 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.546 ' O ' ' HA ' ' A' ' 46' ' ' LYS . 8.4 Cg_endo -60.8 -171.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.707 1.372 . . . . 0.0 108.851 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.748 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.8 OUTLIER -142.79 144.49 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.816 -1.177 . . . . 0.0 112.227 -179.157 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.02 HG21 ' HB2' ' A' ' 38' ' ' TYR . 43.7 t -100.66 156.76 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 175.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.8 m -111.28 -20.8 12.17 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.791 -1.164 . . . . 0.0 111.224 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 7.4 mt-10 -132.25 15.9 4.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.842 -1.161 . . . . 0.0 111.244 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.522 ' O ' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER 71.63 -4.18 1.96 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.259 -0.901 . . . . 0.0 110.87 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.482 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 5.5 t70 -137.31 -0.04 2.26 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.885 -1.134 . . . . 0.0 110.26 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.685 ' O ' HG23 ' A' ' 77' ' ' VAL . 33.9 t -73.07 112.24 14.74 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.244 -0.91 . . . . 0.0 109.248 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 74' ' ' ASP . 33.2 Cg_exo -51.38 112.87 0.91 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.783 1.412 . . . . 0.0 109.738 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.944 HG21 HG22 ' A' ' 70' ' ' VAL . 59.9 t -102.1 130.74 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.322 -0.861 . . . . 0.0 111.516 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.649 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 12.0 m-80 -93.12 135.26 34.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.401 -0.812 . . . . 0.0 108.972 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.939 HG21 ' CD2' ' A' ' 49' ' ' PHE . 6.1 mt -114.53 117.26 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 117.69 -1.604 . . . . 0.0 111.979 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.685 ' HG3' HG22 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -86.03 114.14 22.67 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.333 179.362 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.693 ' C ' HG22 ' A' ' 31' ' ' THR . . . -133.45 153.28 51.74 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.024 -1.048 . . . . 0.0 110.505 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 0.8 OUTLIER -101.56 101.95 19.91 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.186 -0.946 . . . . 0.0 110.425 -179.611 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.562 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 33.7 Cg_endo -70.57 142.41 44.31 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.127 1.593 . . . . 0.0 110.325 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.537 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 32.3 Cg_endo . . . . . 0 C--N 1.304 -1.796 0 O-C-N 124.09 1.574 . . . . 0.0 110.348 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 19.9 m-85 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.097 0.475 . . . . 0.0 109.963 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.687 ' HA ' HG22 ' A' ' 51' ' ' ILE . 2.2 mt -73.9 133.74 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 109.544 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.588 HD12 ' HG2' ' A' ' 50' ' ' GLU . 84.6 mt -106.2 134.62 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.908 -1.12 . . . . 0.0 110.583 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.141 HD11 HG21 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -124.21 144.87 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.492 -0.755 . . . . 0.0 109.569 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.547 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 82.68 -162.67 41.56 Favored Glycine 0 N--CA 1.482 1.714 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.555 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -119.78 146.88 23.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 O-C-N 121.257 -1.143 . . . . 0.0 109.932 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.569 ' O ' ' N ' ' A' ' 97' ' ' GLY . 3.9 mt-10 -17.85 -58.22 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.181 0 N-CA-C 111.655 0.242 . . . . 0.0 111.655 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 10.0 Cg_endo -53.17 71.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 124.112 1.585 . . . . 0.0 111.962 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 92.73 1.59 67.96 Favored Glycine 0 N--CA 1.495 2.605 0 O-C-N 120.97 -1.082 . . . . 0.0 111.04 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.499 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -50.04 160.81 0.31 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.895 -1.356 . . . . 0.0 109.839 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.644 HD13 ' CG2' ' A' ' 20' ' ' VAL . 8.7 mt -98.96 175.78 5.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.102 -0.999 . . . . 0.0 111.053 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.695 ' C ' HD12 ' A' ' 101' ' ' LEU . 0.8 OUTLIER -154.72 137.5 15.3 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.559 -0.713 . . . . 0.0 109.811 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.801 ' N ' HD12 ' A' ' 101' ' ' LEU . 2.0 mp -143.33 125.54 15.5 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.094 -1.004 . . . . 0.0 110.527 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.506 ' HB2' ' CD1' ' A' ' 89' ' ' TYR . 32.4 t30 -90.35 133.79 34.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.286 -0.884 . . . . 0.0 110.403 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.648 ' CE3' HG22 ' A' ' 24' ' ' ILE . 60.5 t-105 . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.353 -0.842 . . . . 0.0 110.31 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.633 ' SG ' HD13 ' A' ' 47' ' ' ILE . 32.7 m . . . . . 0 N--CA 1.486 1.331 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.469 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 0.9 OUTLIER -126.6 -17.08 5.14 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.528 -1.357 . . . . 0.0 111.965 -178.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.573 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -59.77 -117.1 0.01 OUTLIER Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.4 -1.381 . . . . 0.0 109.786 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.535 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -135.35 -179.9 5.92 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.963 -1.316 . . . . 0.0 110.324 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.977 ' CE1' HG23 ' A' ' 47' ' ' ILE . 31.0 m-85 -136.57 149.67 48.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.04 -1.038 . . . . 0.0 111.851 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.455 ' HB2' ' CG ' ' A' ' 39' ' ' GLU . 17.6 ttpt -116.6 118.76 33.49 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.655 -0.653 . . . . 0.0 109.557 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.5 ' CG2' HD13 ' A' ' 99' ' ' LEU . 51.3 t -59.63 131.52 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.784 -1.198 . . . . 0.0 108.772 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.605 HG23 ' HA ' ' A' ' 36' ' ' VAL . 76.8 t -105.62 -26.44 3.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.562 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 12.5 tttt -157.53 133.34 9.3 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -52.47 155.39 2.15 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.535 0.683 . . . . 0.0 111.243 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.679 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -49.76 133.22 8.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 C-N-CA 119.996 -0.681 . . . . 0.0 109.957 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.867 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -108.24 171.52 7.36 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.2 pm0 -116.91 132.62 56.65 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.87 -1.144 . . . . 0.0 110.454 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.861 HG21 ' CD ' ' A' ' 80' ' ' GLU . 13.7 p -90.57 179.61 5.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.334 -0.854 . . . . 0.0 110.127 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -93.25 29.86 1.81 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -0.93 . . . . 0.0 110.379 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.53 6.89 3.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 110.357 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.427 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 95.64 5.56 60.04 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.89 HG22 ' C ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -98.86 -173.1 2.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.316 -1.108 . . . . 0.0 110.135 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.867 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -144.33 159.42 15.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.8 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 85.5 t -125.28 128.72 72.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 O-C-N 120.864 -1.148 . . . . 0.0 112.457 -177.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.986 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -110.81 118.16 56.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.379 -0.826 . . . . 0.0 109.476 178.672 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -103.77 114.76 29.26 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.806 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.8 m -133.95 -172.15 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.223 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.535 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 10.9 tt0 -132.37 126.79 34.05 Favored 'General case' 0 C--N 1.276 -2.615 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 1.021 ' HB2' HG21 ' A' ' 70' ' ' VAL . 1.5 t80 -60.55 123.99 19.03 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 118.716 -1.194 . . . . 0.0 109.92 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.455 ' CG ' ' HB2' ' A' ' 19' ' ' LYS . 43.4 mm-40 -103.65 -21.95 13.65 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.124 -0.985 . . . . 0.0 109.156 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.573 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -67.17 -164.85 2.25 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.511 ' HA ' ' HG3' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -137.63 94.04 2.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.578 -0.954 . . . . 0.0 109.976 179.716 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 43' ' ' SER . . . -149.12 12.19 1.06 Allowed Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.348 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.606 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.3 OUTLIER 47.31 -158.65 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.352 0 O-C-N 120.788 -1.419 . . . . 0.0 109.127 179.491 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.606 ' HD2' ' CB ' ' A' ' 43' ' ' SER . 89.2 Cg_exo -42.86 94.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 122.87 0.931 . . . . 0.0 110.186 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.889 ' O ' HG23 ' A' ' 69' ' ' ILE . 25.7 p -143.13 163.77 31.96 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.742 -0.599 . . . . 0.0 109.566 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.594 ' HA ' ' O ' ' A' ' 68' ' ' PRO . 1.6 mttt -86.65 156.9 19.81 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.027 -1.046 . . . . 0.0 111.428 -178.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.01 ' CD1' HG23 ' A' ' 70' ' ' VAL . 11.3 mm -99.72 125.07 41.85 Favored Pre-proline 0 C--N 1.294 -1.83 0 O-C-N 121.474 -0.766 . . . . 0.0 111.808 -177.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.618 ' HD2' ' CE2' ' A' ' 18' ' ' PHE . 33.2 Cg_exo -60.85 148.17 93.08 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.223 1.644 . . . . 0.0 111.046 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.928 ' CD2' HG21 ' A' ' 79' ' ' ILE . 4.9 t80 -154.22 151.54 29.28 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.487 -0.758 . . . . 0.0 109.582 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.493 ' HB3' ' HB ' ' A' ' 91' ' ' ILE . 3.8 tp10 -162.76 113.59 1.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.806 -1.184 . . . . 0.0 110.761 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.572 HD11 ' HE1' ' A' ' 49' ' ' PHE . 31.9 mt . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.388 -0.82 . . . . 0.0 109.744 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.522 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.529 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -131.3 170.51 14.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -1.148 . . . . 0.0 110.465 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.87 HD21 ' CD1' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -124.19 121.63 35.61 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.553 -0.717 . . . . 0.0 109.678 179.314 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.822 HG12 HG21 ' A' ' 31' ' ' THR . 1.5 mp -85.11 -24.47 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.801 HG22 ' O ' ' A' ' 65' ' ' THR 0.258 2.9 m -115.29 38.43 3.23 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.855 HG12 ' ND2' ' A' ' 67' ' ' ASN . 10.5 t -25.41 132.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 121.347 0.594 . . . . 0.0 111.5 -178.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.855 ' ND2' HG12 ' A' ' 66' ' ' VAL . 25.4 p30 30.47 70.23 0.63 Allowed Pre-proline 0 C--N 1.303 -1.446 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.745 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.605 ' HG3' HG23 ' A' ' 79' ' ' ILE . 1.2 Cg_endo -55.74 -175.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.644 0 N-CA-C 107.977 -1.586 . . . . 0.0 107.977 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.889 HG23 ' O ' ' A' ' 45' ' ' CYS . 1.1 mt -144.93 146.12 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 C-N-CA 118.56 -1.256 . . . . 0.0 112.174 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.021 HG21 ' HB2' ' A' ' 38' ' ' TYR . 22.0 t -102.26 157.82 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.1 m -114.26 -16.12 12.07 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 118.973 -1.091 . . . . 0.0 111.656 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.527 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 12.4 mt-10 -136.75 16.55 3.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.574 -1.329 . . . . 0.0 111.619 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.576 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 2.4 ttpt 71.57 -5.08 1.71 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.149 -0.969 . . . . 0.0 110.994 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.478 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 5.1 t70 -137.86 -1.51 2.0 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.969 -1.082 . . . . 0.0 110.32 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.606 ' O ' HG23 ' A' ' 77' ' ' VAL . 39.2 t -72.36 112.24 14.01 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.209 -0.932 . . . . 0.0 109.259 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.602 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 49.7 Cg_exo -48.51 126.51 14.29 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.828 1.436 . . . . 0.0 109.744 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.999 HG21 HG22 ' A' ' 70' ' ' VAL . 74.8 t -114.31 133.41 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.015 -1.053 . . . . 0.0 111.45 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.681 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 5.3 m-80 -99.65 131.8 45.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.493 -0.754 . . . . 0.0 109.12 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.928 HG21 ' CD2' ' A' ' 49' ' ' PHE . 10.9 mt -114.17 119.62 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.099 -1.626 . . . . 0.0 111.636 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.861 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.7 tp10 -92.4 118.59 31.09 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.94 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.89 ' C ' HG22 ' A' ' 31' ' ' THR . . . -135.93 152.55 51.1 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.006 -1.059 . . . . 0.0 110.78 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.529 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 2.0 tt0 -102.36 102.63 26.32 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.367 -0.833 . . . . 0.0 110.266 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.54 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 35.7 Cg_endo -71.96 151.56 56.45 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.086 1.571 . . . . 0.0 110.564 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.522 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 15.5 Cg_endo . . . . . 0 C--N 1.304 -1.771 0 O-C-N 124.081 1.569 . . . . 0.0 110.249 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.505 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 15.4 m-85 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.186 0.517 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.606 ' CG2' ' CZ ' ' A' ' 49' ' ' PHE . 1.3 mp -73.94 125.03 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.21 -0.931 . . . . 0.0 109.447 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.498 ' CG2' ' CD ' ' A' ' 98' ' ' GLN . 81.0 mt -96.5 144.14 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.156 -0.965 . . . . 0.0 110.503 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.986 HD11 HG21 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -129.76 137.87 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.502 -0.749 . . . . 0.0 109.596 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.562 ' O ' ' HB2' ' A' ' 48' ' ' PRO . . . 86.7 -163.78 35.43 Favored Glycine 0 N--CA 1.481 1.681 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.57 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -118.15 143.92 27.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 O-C-N 121.049 -1.265 . . . . 0.0 110.32 -179.478 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.576 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -14.54 -59.26 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.139 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -179.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 5.9 Cg_endo -49.86 74.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 124.235 1.65 . . . . 0.0 111.752 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 86.68 -2.37 87.25 Favored Glycine 0 N--CA 1.494 2.519 0 O-C-N 121.045 -1.034 . . . . 0.0 111.096 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.511 ' HB3' ' C ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -43.41 162.73 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.812 -1.405 . . . . 0.0 109.897 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.603 HD11 ' O ' ' A' ' 18' ' ' PHE . 10.5 mt -98.91 174.88 6.15 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.069 -1.019 . . . . 0.0 110.889 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.494 ' HG3' HG12 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -152.1 130.32 11.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.603 -0.686 . . . . 0.0 109.871 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' A' ' 89' ' ' TYR . 4.2 mp -131.73 123.9 28.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.145 -0.972 . . . . 0.0 110.394 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -86.96 128.98 35.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.325 -0.859 . . . . 0.0 110.207 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.61 ' CE3' HG22 ' A' ' 24' ' ' ILE . 61.7 t-105 . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.16 -0.963 . . . . 0.0 110.275 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.596 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 39.6 m . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.539 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 3.7 p -95.52 -1.98 49.53 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.18 -0.95 . . . . 0.0 112.07 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.594 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -66.84 -110.59 0.01 OUTLIER Glycine 0 N--CA 1.49 2.295 0 C-N-CA 118.844 -1.645 . . . . 0.0 109.048 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.529 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -143.47 173.62 11.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.985 -1.303 . . . . 0.0 110.103 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.863 ' CE2' HG23 ' A' ' 47' ' ' ILE . 33.6 m-85 -133.66 151.12 51.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.993 -1.067 . . . . 0.0 111.631 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.491 ' HE2' ' NE2' ' A' ' 37' ' ' GLN . 5.2 ttpt -117.75 115.95 26.04 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.61 -0.681 . . . . 0.0 109.239 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.64 ' CG2' HD13 ' A' ' 99' ' ' LEU . 40.6 t -59.67 124.7 14.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 120.655 -1.278 . . . . 0.0 109.131 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.569 HG23 ' HA ' ' A' ' 36' ' ' VAL . 60.6 t -98.25 -26.37 3.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.614 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 7.7 tttt -158.06 133.6 8.95 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -50.58 160.22 0.44 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.618 0.723 . . . . 0.0 111.465 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.679 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.7 OUTLIER -55.24 132.88 18.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 121.545 0.688 . . . . 0.0 110.277 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.74 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -108.94 168.19 9.54 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 4.2 pm0 -114.77 134.65 54.94 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.613 -1.304 . . . . 0.0 110.695 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.66 HG21 ' CD ' ' A' ' 80' ' ' GLU . 9.5 p -91.79 172.06 8.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.521 -0.737 . . . . 0.0 110.041 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -87.85 31.03 0.79 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.234 -0.916 . . . . 0.0 110.378 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.95 6.38 3.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.244 -0.91 . . . . 0.0 110.249 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.473 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 94.73 10.32 57.9 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.863 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -106.08 -178.21 3.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.392 -1.064 . . . . 0.0 110.273 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.74 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -139.51 150.63 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 54.1 t -117.45 134.2 61.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 O-C-N 121.184 -0.947 . . . . 0.0 112.126 -177.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.015 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -116.85 119.88 63.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.366 -0.834 . . . . 0.0 109.761 178.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.614 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 1.1 ttm180 -101.12 123.66 45.62 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.798 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.4 m -149.2 161.56 4.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.148 -0.97 . . . . 0.0 108.766 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.491 ' NE2' ' HE2' ' A' ' 19' ' ' LYS 0.262 1.6 tt0 -107.35 125.62 51.43 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.859 ' HB2' HG21 ' A' ' 70' ' ' VAL . 3.3 t80 -59.87 122.94 15.5 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 118.909 -1.117 . . . . 0.0 110.126 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.44 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 1.3 mm-40 -98.57 -23.89 15.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.319 -0.863 . . . . 0.0 109.168 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.594 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -65.59 -161.6 0.82 Allowed Glycine 0 N--CA 1.484 1.89 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.448 ' HA ' ' HD2' ' A' ' 73' ' ' LYS . 30.9 t0 -128.23 146.46 50.73 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.468 -1.019 . . . . 0.0 110.185 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.402 ' O ' ' CB ' ' A' ' 43' ' ' SER . . . 156.69 -14.39 0.35 Allowed Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.59 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.606 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.8 OUTLIER 60.49 -152.95 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 120.639 -1.506 . . . . 0.0 108.16 -179.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 88.5 Cg_exo -42.39 97.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.32 -0.959 0 N-CA-C 108.819 -1.262 . . . . 0.0 108.819 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.708 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -146.77 171.28 15.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.767 -0.583 . . . . 0.0 110.02 -177.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.699 ' HG3' HD11 ' A' ' 69' ' ' ILE . 16.6 mtmt -85.79 175.01 8.93 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.35 -0.844 . . . . 0.0 111.664 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.067 HD11 ' CG2' ' A' ' 70' ' ' VAL . 15.7 mm -123.05 125.78 26.17 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.401 -0.812 . . . . 0.0 112.299 -178.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.625 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 30.2 Cg_exo -65.42 146.8 86.3 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.963 1.507 . . . . 0.0 110.686 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.709 ' CD2' HD11 ' A' ' 63' ' ' LEU . 11.4 t80 -155.88 159.9 39.71 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.255 -0.903 . . . . 0.0 110.422 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.506 ' OE1' ' N ' ' A' ' 51' ' ' ILE . 5.9 tp10 -176.29 114.38 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.067 -1.021 . . . . 0.0 110.554 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.643 HD11 ' HE2' ' A' ' 49' ' ' PHE . 55.9 mt . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 110.094 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.471 ' HA2' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.559 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -120.6 149.96 41.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.18 -1.188 . . . . 0.0 110.113 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.726 ' O ' HG23 ' A' ' 66' ' ' VAL . 3.2 mt -110.15 118.15 35.61 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.197 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.863 HG12 HG21 ' A' ' 31' ' ' THR . 1.5 mp -77.49 -22.97 14.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.669 HG22 ' O ' ' A' ' 65' ' ' THR 0.272 1.0 OUTLIER -113.69 29.77 7.75 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.439 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 63' ' ' LEU . 52.0 t -12.47 112.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.534 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.494 ' OD1' ' HB3' ' A' ' 46' ' ' LYS . 20.8 t-20 41.24 70.0 1.79 Allowed Pre-proline 0 C--N 1.302 -1.488 0 O-C-N 121.647 -0.658 . . . . 0.0 110.4 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.525 ' CG ' HG12 ' A' ' 79' ' ' ILE . 1.7 Cg_endo -51.85 -176.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.01 1.532 . . . . 0.0 109.723 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.708 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.9 OUTLIER -140.7 142.07 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.947 -178.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.067 ' CG2' HD11 ' A' ' 47' ' ' ILE . 24.8 t -93.39 169.51 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.2 m -124.15 -20.73 5.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.883 -1.136 . . . . 0.0 110.929 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.531 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 6.9 mt-10 -135.87 14.44 3.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.026 -1.046 . . . . 0.0 110.754 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.531 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 10.6 ttpt 73.81 -7.52 1.58 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.422 -0.798 . . . . 0.0 110.818 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.487 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 5.7 t70 -136.78 -1.15 2.26 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.965 -1.085 . . . . 0.0 110.23 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.564 ' O ' HG23 ' A' ' 77' ' ' VAL . 36.2 t -73.19 112.46 15.78 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.194 -0.941 . . . . 0.0 109.44 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 35.0 Cg_exo -50.93 113.52 1.12 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.806 1.424 . . . . 0.0 109.912 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.719 HG21 HG22 ' A' ' 70' ' ' VAL . 74.0 t -99.13 155.19 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.318 -0.864 . . . . 0.0 110.714 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.654 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -111.77 134.86 53.06 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.465 -0.772 . . . . 0.0 109.96 179.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.688 ' HB ' HG22 ' A' ' 34' ' ' ILE . 3.8 mt -115.35 114.23 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 117.731 -1.588 . . . . 0.0 111.289 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.66 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.1 tt0 -90.78 115.0 27.52 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.983 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.818 ' C ' HG22 ' A' ' 31' ' ' THR . . . -131.61 149.16 52.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.908 -1.12 . . . . 0.0 110.768 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' A' ' 62' ' ' ARG . 2.2 tt0 -98.82 104.99 28.23 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 110.337 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.508 ' HD3' HG13 ' A' ' 32' ' ' ILE . 30.8 Cg_endo -70.32 131.97 21.49 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.001 1.527 . . . . 0.0 110.298 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.471 ' HD3' ' HA2' ' A' ' 61' ' ' GLY . 23.0 Cg_endo . . . . . 0 C--N 1.305 -1.72 0 O-C-N 123.933 1.491 . . . . 0.0 110.398 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.536 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 9.7 m-85 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.124 0.488 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.528 HD11 HD12 ' A' ' 32' ' ' ILE . 20.6 mt -73.81 163.63 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.49 ' CG2' ' CD ' ' A' ' 98' ' ' GLN . 80.2 mt -126.25 139.54 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.496 -1.377 . . . . 0.0 112.04 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.015 HD11 HG21 ' A' ' 34' ' ' ILE . 0.5 OUTLIER -128.44 136.12 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.242 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.533 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 87.71 -161.17 31.97 Favored Glycine 0 N--CA 1.481 1.649 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.563 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -121.18 146.84 25.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 121.04 -1.27 . . . . 0.0 110.154 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.581 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.3 OUTLIER -17.03 -58.6 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.203 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 7.1 Cg_endo -51.18 75.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 124.216 1.64 . . . . 0.0 111.735 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 87.02 -0.27 86.02 Favored Glycine 0 N--CA 1.494 2.501 0 O-C-N 120.96 -1.087 . . . . 0.0 111.043 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.51 ' HB3' ' C ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -44.65 164.48 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.744 -1.445 . . . . 0.0 109.807 179.864 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.64 HD13 ' CG2' ' A' ' 20' ' ' VAL . 7.2 mt -102.35 170.67 7.93 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.104 -0.998 . . . . 0.0 111.263 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -146.41 132.84 19.65 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.602 -0.687 . . . . 0.0 109.478 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.944 HD11 HD12 ' A' ' 92' ' ' ILE . 1.0 OUTLIER -122.99 135.41 54.46 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.002 -1.061 . . . . 0.0 110.744 -179.534 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -84.74 130.63 34.66 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.372 -0.83 . . . . 0.0 110.657 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.476 ' NE1' HG21 ' A' ' 32' ' ' ILE . 26.2 t-105 . . . . . 0 N--CA 1.487 1.416 0 O-C-N 121.325 -0.86 . . . . 0.0 109.965 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.587 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 42.9 m . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.534 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -88.8 -7.36 56.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.385 -0.822 . . . . 0.0 111.766 -178.375 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.581 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -61.55 -110.83 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 C-N-CA 118.775 -1.679 . . . . 0.0 108.966 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.538 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -145.99 171.8 14.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.98 -1.306 . . . . 0.0 110.253 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.087 ' CE2' HG23 ' A' ' 47' ' ' ILE . 38.1 m-85 -130.49 148.69 52.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.062 -1.024 . . . . 0.0 111.48 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.498 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 4.2 ttpp -114.13 114.68 26.4 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.481 -0.762 . . . . 0.0 109.131 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.73 HG22 HD13 ' A' ' 99' ' ' LEU . 21.5 t -59.49 124.15 13.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 120.606 -1.309 . . . . 0.0 109.015 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.68 HG21 ' HB3' ' A' ' 76' ' ' PRO . 64.4 t -97.56 -25.54 4.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.602 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 3.8 tttp -158.68 133.54 8.27 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 177.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -51.68 163.27 0.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.671 0.748 . . . . 0.0 111.305 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.676 HG12 HD22 ' A' ' 101' ' ' LEU . 0.7 OUTLIER -57.09 132.81 21.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 121.647 0.736 . . . . 0.0 110.2 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.81 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -108.05 169.83 8.38 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 2.9 pm0 -116.01 132.94 56.51 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.784 -1.197 . . . . 0.0 110.425 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.925 HG21 ' CD ' ' A' ' 80' ' ' GLU . 16.5 p -91.17 -179.32 5.4 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.659 -0.817 . . . . 0.0 110.103 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -94.16 17.22 12.97 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.184 -0.947 . . . . 0.0 110.373 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.28 8.09 12.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.293 -0.879 . . . . 0.0 110.062 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.34 11.33 59.82 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.846 HG22 ' C ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -104.91 -174.38 2.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.39 -1.064 . . . . 0.0 110.345 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.81 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -141.13 155.67 21.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.795 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 76.7 t -120.76 129.95 75.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 119.101 -1.04 . . . . 0.0 112.231 -178.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.056 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -113.7 117.65 56.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 121.399 -0.813 . . . . 0.0 109.79 178.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.602 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 3.1 ttm180 -100.77 119.91 39.33 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.796 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.4 m -146.87 158.72 10.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.2 -0.937 . . . . 0.0 109.014 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.468 ' N ' HG23 ' A' ' 21' ' ' VAL 0.252 11.9 tt0 -106.08 125.57 51.15 Favored 'General case' 0 C--N 1.271 -2.817 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.393 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.935 ' HB2' HG21 ' A' ' 70' ' ' VAL . 3.7 t80 -59.78 123.04 15.73 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 119.003 -1.079 . . . . 0.0 110.079 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.498 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 8.3 mt-10 -98.86 -23.54 15.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.359 -0.838 . . . . 0.0 109.206 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.581 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -65.01 -162.12 0.68 Allowed Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.472 ' OD1' ' HE2' ' A' ' 73' ' ' LYS . 17.7 m-20 -129.15 146.52 51.06 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.457 -1.025 . . . . 0.0 110.307 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 43' ' ' SER . . . 155.37 -12.8 0.43 Allowed Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.597 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.608 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.7 OUTLIER 61.08 -153.29 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 120.661 -1.493 . . . . 0.0 108.32 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.608 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 88.4 Cg_exo -42.16 97.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.32 -0.958 0 N-CA-C 108.964 -1.206 . . . . 0.0 108.964 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.883 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -146.66 170.19 17.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.829 -0.545 . . . . 0.0 110.143 -177.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.639 ' CG ' HD11 ' A' ' 69' ' ' ILE . 1.2 mtpm? -84.67 175.09 9.44 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.173 -0.955 . . . . 0.0 112.033 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.087 HG23 ' CE2' ' A' ' 18' ' ' PHE . 15.5 mm -123.65 124.2 26.22 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.68 -0.638 . . . . 0.0 111.539 -178.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.618 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 31.7 Cg_exo -61.92 144.71 96.83 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.06 1.558 . . . . 0.0 110.384 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 1.005 ' CE1' HG21 ' A' ' 79' ' ' ILE . 4.8 t80 -151.69 156.21 39.89 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.203 -0.935 . . . . 0.0 110.324 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.535 ' HG3' HD12 ' A' ' 91' ' ' ILE . 23.1 tp10 -173.76 95.6 0.1 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.073 -1.017 . . . . 0.0 110.184 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.503 HD11 ' CB ' ' A' ' 81' ' ' ALA . 97.2 mt . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.302 -0.874 . . . . 0.0 110.265 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.528 ' N ' ' HG3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.555 ' O ' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -150.54 163.93 37.25 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.267 -1.137 . . . . 0.0 109.525 179.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.103 HD23 ' HB2' ' A' ' 81' ' ' ALA . 11.8 mt -122.01 121.41 36.96 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 118.837 -1.145 . . . . 0.0 110.539 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.828 HG12 HG21 ' A' ' 31' ' ' THR . 1.4 mp -82.54 -27.62 8.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.728 HG22 ' O ' ' A' ' 65' ' ' THR 0.26 1.1 m -96.78 32.61 2.04 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 122.781 1.277 . . . . 0.0 107.673 178.726 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 1.008 HG23 ' O ' ' A' ' 63' ' ' LEU . 16.3 t -34.74 140.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.25 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.57 ' N ' ' CD ' ' A' ' 68' ' ' PRO . 38.9 t-20 56.55 46.4 2.24 Favored Pre-proline 0 C--N 1.302 -1.493 0 O-C-N 121.577 -0.702 . . . . 0.0 110.585 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.596 ' CB ' ' CD1' ' A' ' 79' ' ' ILE . 8.1 Cg_endo -59.15 146.36 94.71 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.673 1.354 . . . . 0.0 109.043 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.883 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.7 OUTLIER -141.3 149.86 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 119.127 -1.029 . . . . 0.0 112.915 -177.652 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.016 ' CG2' HD11 ' A' ' 47' ' ' ILE . 41.9 t -97.28 168.86 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.412 ' N ' HG12 ' A' ' 70' ' ' VAL . 4.8 m -122.78 -21.25 5.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.857 -1.152 . . . . 0.0 111.201 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.535 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 15.6 mt-10 -136.51 17.23 3.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.816 -1.177 . . . . 0.0 111.192 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER 72.54 -5.63 1.79 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.281 -0.887 . . . . 0.0 110.981 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.477 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 5.8 t70 -138.81 0.27 1.98 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.923 -1.111 . . . . 0.0 110.429 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.508 ' O ' HG23 ' A' ' 77' ' ' VAL . 22.8 t -73.09 108.59 4.76 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.15 -0.969 . . . . 0.0 109.476 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.68 ' HB3' HG21 ' A' ' 21' ' ' VAL . 1.6 Cg_endo -50.22 110.66 0.41 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.697 1.367 . . . . 0.0 109.736 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.551 HG21 HG22 ' A' ' 70' ' ' VAL . 82.0 t -94.34 146.0 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.269 -0.894 . . . . 0.0 111.044 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.639 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.1 m120 -106.64 131.09 54.18 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 1.005 HG21 ' CE1' ' A' ' 49' ' ' PHE . 3.9 mm -112.2 117.46 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.079 -1.638 . . . . 0.0 111.803 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.925 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.6 tp10 -93.57 106.97 18.89 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.302 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 1.103 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -130.24 153.86 48.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.88 -1.137 . . . . 0.0 111.308 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 62' ' ' ARG . 24.6 tt0 -97.82 103.55 17.47 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.647 -0.658 . . . . 0.0 110.409 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.541 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 37.4 Cg_endo -70.77 144.56 49.02 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.984 1.518 . . . . 0.0 110.539 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.528 ' HG3' ' N ' ' A' ' 61' ' ' GLY . 23.7 Cg_exo . . . . . 0 C--N 1.305 -1.761 0 O-C-N 124.095 1.577 . . . . 0.0 110.155 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 17.9 m-85 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.213 0.53 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.753 HD11 HD13 ' A' ' 32' ' ' ILE . 4.1 mt -74.14 116.94 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 109.469 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.535 HD12 ' HG3' ' A' ' 50' ' ' GLU . 37.9 mt -94.62 147.44 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.177 -0.952 . . . . 0.0 110.395 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.056 HD11 HG21 ' A' ' 34' ' ' ILE . 1.6 mt -133.36 139.66 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.464 -0.772 . . . . 0.0 109.478 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.532 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 83.13 -161.17 39.28 Favored Glycine 0 N--CA 1.481 1.651 0 N-CA-C 108.624 -1.791 . . . . 0.0 108.624 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.554 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -122.12 149.1 25.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 121.213 -1.169 . . . . 0.0 110.169 -179.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.577 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.6 OUTLIER -17.15 -58.42 0.04 OUTLIER Pre-proline 0 N--CA 1.501 2.117 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 8.6 Cg_endo -51.87 71.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 124.279 1.673 . . . . 0.0 112.116 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 90.6 0.57 75.58 Favored Glycine 0 N--CA 1.494 2.537 0 O-C-N 120.941 -1.1 . . . . 0.0 110.943 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.507 ' HB3' ' C ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -48.38 159.97 0.18 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.952 -1.322 . . . . 0.0 110.199 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.73 HD13 HG22 ' A' ' 20' ' ' VAL . 12.2 mt -96.87 177.84 5.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.239 -0.913 . . . . 0.0 110.623 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.459 ' HG3' HG12 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -157.62 137.28 12.16 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.477 -0.765 . . . . 0.0 110.16 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.676 HD22 HG12 ' A' ' 24' ' ' ILE . 2.8 mp -138.21 116.94 12.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.207 -0.933 . . . . 0.0 110.373 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 9.1 p-10 -83.31 128.06 34.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 110.405 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 10.6 t-105 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.243 -0.911 . . . . 0.0 110.155 179.921 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.587 ' HB3' ' CE1' ' A' ' 38' ' ' TYR . 1.3 m . . . . . 0 N--CA 1.485 1.314 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.538 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 1.2 p -116.39 4.95 13.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.132 -0.98 . . . . 0.0 111.716 -178.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.582 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -62.02 -115.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.531 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -136.49 174.06 11.03 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.989 -1.3 . . . . 0.0 109.946 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.997 ' CE2' HG23 ' A' ' 47' ' ' ILE . 42.8 m-85 -133.02 140.84 47.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.965 -1.084 . . . . 0.0 111.814 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.538 ' HB2' ' CG ' ' A' ' 39' ' ' GLU . 7.9 ttpt -107.67 117.65 34.67 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.633 -0.667 . . . . 0.0 109.277 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.735 HG22 HD13 ' A' ' 99' ' ' LEU . 21.2 t -59.64 132.91 25.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 120.835 -1.166 . . . . 0.0 109.042 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.644 HG23 ' HA ' ' A' ' 36' ' ' VAL . 92.1 t -105.78 -24.12 4.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.593 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 16.2 tttt -161.64 134.48 6.11 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -53.23 158.84 1.46 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.699 0.761 . . . . 0.0 111.421 -178.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.584 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -52.86 133.08 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-O 121.587 0.708 . . . . 0.0 110.202 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.848 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -109.64 171.73 7.27 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 5.3 pm0 -116.65 134.68 54.53 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.833 -1.167 . . . . 0.0 110.56 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.926 HG21 ' CD ' ' A' ' 80' ' ' GLU . 14.0 p -92.8 175.03 6.96 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.255 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -88.62 31.25 0.84 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.905 . . . . 0.0 110.234 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.3 m170 -133.87 5.78 3.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.894 . . . . 0.0 110.183 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.85 1.23 61.74 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.161 -1.575 . . . . 0.0 109.161 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.889 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -95.32 -176.73 3.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -1.144 . . . . 0.0 110.355 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.848 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -140.21 153.34 22.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.678 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 55.1 t -118.97 132.24 69.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 119.113 -1.035 . . . . 0.0 112.351 -177.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.059 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -113.55 120.54 63.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 O-C-N 121.355 -0.841 . . . . 0.0 109.61 178.601 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.593 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 2.9 ttm180 -105.19 110.85 23.39 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.842 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.5 m -132.59 -169.91 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.438 -0.789 . . . . 0.0 109.312 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.448 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 17.1 tt0 -136.58 128.19 28.77 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.841 ' HB2' HG21 ' A' ' 70' ' ' VAL . 16.1 t80 -61.02 118.66 7.04 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 117.983 -1.487 . . . . 0.0 110.633 -178.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.538 ' CG ' ' HB2' ' A' ' 19' ' ' LYS . 7.5 mm-40 -97.25 -0.79 46.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.503 -0.748 . . . . 0.0 109.327 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.582 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -93.57 -161.77 35.81 Favored Glycine 0 N--CA 1.484 1.855 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 41' ' ' ASP . 2.0 p30 -127.52 134.77 49.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.461 -1.023 . . . . 0.0 109.929 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' ' 43' ' ' SER . . . 171.92 -23.03 0.08 OUTLIER Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.483 -1.342 . . . . 0.0 110.664 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.611 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.5 OUTLIER 64.12 -154.95 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 120.602 -1.529 . . . . 0.0 108.073 -179.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.611 ' HD2' ' CB ' ' A' ' 43' ' ' SER . 88.2 Cg_exo -42.54 94.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -0.993 0 N-CA-C 109.059 -1.169 . . . . 0.0 109.059 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.95 ' O ' HG23 ' A' ' 69' ' ' ILE . 31.6 p -148.02 178.36 8.59 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.792 -0.568 . . . . 0.0 109.576 -178.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 68' ' ' PRO . 1.0 OUTLIER -96.05 175.04 6.62 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.943 -1.098 . . . . 0.0 111.412 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.038 HD11 ' CG2' ' A' ' 70' ' ' VAL . 17.7 mm -121.94 131.75 24.36 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.346 -0.846 . . . . 0.0 112.591 -177.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.62 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 26.1 Cg_exo -66.94 143.52 66.61 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 124.115 1.587 . . . . 0.0 110.768 178.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.961 ' CE2' HG21 ' A' ' 79' ' ' ILE . 9.2 t80 -152.96 158.65 42.39 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.313 -0.867 . . . . 0.0 110.248 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 1.036 ' HG2' HD12 ' A' ' 91' ' ' ILE . 5.3 tt0 -173.29 111.49 0.2 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.067 -1.02 . . . . 0.0 110.324 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.931 HD11 ' HB1' ' A' ' 81' ' ' ALA . 68.5 mt . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 110.34 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.503 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.492 2.382 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.526 ' CB ' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -158.93 166.69 31.24 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.073 -1.251 . . . . 0.0 109.596 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.038 HD23 ' HB2' ' A' ' 81' ' ' ALA . 10.5 mt -124.17 122.75 38.65 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 118.804 -1.158 . . . . 0.0 111.077 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.889 HG12 HG21 ' A' ' 31' ' ' THR . 1.5 mp -84.82 -23.35 7.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 178.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 65' ' ' THR 0.28 2.0 m -108.26 37.17 2.55 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 122.476 1.132 . . . . 0.0 108.096 179.514 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' ' 63' ' ' LEU . 37.3 t -38.22 152.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-O 121.504 0.668 . . . . 0.0 111.077 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.651 ' OD1' HG12 ' A' ' 66' ' ' VAL . 5.3 p-10 37.53 59.36 4.32 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.851 -0.53 . . . . 0.0 111.253 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.94 ' CG ' HD12 ' A' ' 79' ' ' ILE . 19.3 Cg_exo -58.64 164.8 8.86 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 N-CA-C 108.325 -1.452 . . . . 0.0 108.325 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.95 HG23 ' O ' ' A' ' 45' ' ' CYS . 1.1 mt -143.45 146.22 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 118.418 -1.313 . . . . 0.0 113.001 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.038 ' CG2' HD11 ' A' ' 47' ' ' ILE . 15.3 t -103.77 163.33 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 176.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.481 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 3.1 m -124.85 -12.04 7.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.823 -1.173 . . . . 0.0 111.654 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 4.4 mt-10 -140.88 10.52 2.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.719 -1.238 . . . . 0.0 111.311 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 15.8 mtmt 78.16 -16.75 0.63 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.744 -0.597 . . . . 0.0 111.036 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.492 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 6.2 t70 -132.52 0.52 3.65 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.071 -1.018 . . . . 0.0 109.801 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.7 t -71.71 111.53 10.8 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.643 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 38.2 Cg_exo -49.76 131.51 29.3 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.901 1.474 . . . . 0.0 110.332 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.776 HG21 HG22 ' A' ' 70' ' ' VAL . 89.2 t -110.36 154.52 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.172 -0.955 . . . . 0.0 110.515 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.659 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 0.4 OUTLIER -116.63 132.42 56.69 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.525 -0.735 . . . . 0.0 109.289 179.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.961 HG21 ' CE2' ' A' ' 49' ' ' PHE . 25.2 mm -117.76 117.05 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 117.497 -1.681 . . . . 0.0 112.105 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.926 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.6 tp10 -94.76 110.72 22.55 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.418 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 1.038 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -131.15 155.94 46.15 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.781 -1.199 . . . . 0.0 111.386 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.526 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 35.3 tp10 -99.79 102.36 16.93 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.593 -0.692 . . . . 0.0 110.418 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.544 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 56.9 Cg_endo -75.23 148.42 34.39 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.997 1.525 . . . . 0.0 110.747 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.503 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 12.2 Cg_endo . . . . . 0 C--N 1.305 -1.739 0 O-C-N 124.099 1.579 . . . . 0.0 110.108 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.546 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 2.0 m-85 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.158 0.504 . . . . 0.0 110.092 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.806 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 1.6 mp -74.01 118.44 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.203 -0.936 . . . . 0.0 109.522 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 1.036 HD12 ' HG2' ' A' ' 50' ' ' GLU . 70.9 mt -98.68 148.16 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 110.643 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.059 HD11 HG21 ' A' ' 34' ' ' ILE . 1.7 mt -135.88 138.2 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.643 -0.661 . . . . 0.0 109.333 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.54 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 83.9 -159.39 36.03 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.558 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -124.22 149.96 28.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 O-C-N 121.198 -1.178 . . . . 0.0 110.18 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.578 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 2.3 mt-10 -17.97 -57.88 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.121 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 9.0 Cg_endo -52.08 71.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 124.157 1.609 . . . . 0.0 112.177 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 89.81 2.74 74.9 Favored Glycine 0 N--CA 1.494 2.526 0 O-C-N 120.935 -1.103 . . . . 0.0 110.898 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.507 ' HB3' ' C ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -49.75 159.5 0.37 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.958 -1.319 . . . . 0.0 110.161 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.735 HD13 HG22 ' A' ' 20' ' ' VAL . 10.4 mt -94.91 172.66 8.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 110.445 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -156.15 133.28 10.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.392 -0.817 . . . . 0.0 110.201 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.581 HD13 HG13 ' A' ' 34' ' ' ILE . 2.2 mp -134.11 122.72 23.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.257 -0.902 . . . . 0.0 110.058 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.25 134.85 33.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.19 -0.944 . . . . 0.0 110.366 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 22.3 t-105 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.364 -0.835 . . . . 0.0 110.185 179.919 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.579 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 33.5 m . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 121.312 0.577 . . . . 0.0 109.764 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.596 ' HA ' HG21 ' A' ' 94' ' ' VAL . 71.2 p -97.53 -5.05 36.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 111.081 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.549 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -59.32 -110.37 0.01 OUTLIER Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.116 -1.516 . . . . 0.0 109.381 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.591 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 1.1 ttpt -142.95 162.56 35.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.039 -1.271 . . . . 0.0 109.924 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.024 ' CE2' HG23 ' A' ' 47' ' ' ILE . 21.0 m-85 -126.82 136.37 52.27 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.939 -1.101 . . . . 0.0 111.224 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.489 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 10.9 ttpp -108.0 119.24 38.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.418 -0.802 . . . . 0.0 109.678 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.834 ' CG2' HD13 ' A' ' 99' ' ' LEU . 48.3 t -59.93 130.76 24.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.829 -1.17 . . . . 0.0 108.995 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.615 HG23 ' HA ' ' A' ' 36' ' ' VAL . 61.3 t -102.98 -24.81 3.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.573 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 1.5 tttt -161.98 133.71 5.46 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -52.34 156.67 1.65 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.611 0.719 . . . . 0.0 111.193 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.577 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -49.94 132.66 9.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-O 121.616 0.722 . . . . 0.0 109.843 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.873 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -108.32 172.32 6.91 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.4 pm0 -115.23 130.58 56.95 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.834 -1.166 . . . . 0.0 110.516 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.945 HG21 ' CD ' ' A' ' 80' ' ' GLU . 26.4 p -84.57 177.22 8.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.439 -0.788 . . . . 0.0 109.967 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -92.24 28.61 1.86 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.882 . . . . 0.0 110.158 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -133.65 5.19 3.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.242 -0.911 . . . . 0.0 110.312 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.462 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 101.35 -3.3 54.32 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.873 HG22 ' C ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -92.19 -175.73 4.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.205 -1.174 . . . . 0.0 110.478 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.873 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -139.15 156.88 27.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.706 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 59.4 t -122.06 132.03 71.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 119.079 -1.049 . . . . 0.0 112.322 -177.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.026 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -112.2 120.16 61.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 O-C-N 121.197 -0.94 . . . . 0.0 109.7 178.767 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.573 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -104.47 114.96 29.54 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.834 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.3 m -137.27 -176.35 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.336 -0.853 . . . . 0.0 109.125 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.494 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 4.2 tt0 -129.36 131.47 46.86 Favored 'General case' 0 C--N 1.276 -2.613 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.929 ' HB2' HG21 ' A' ' 70' ' ' VAL . 6.2 t80 -60.88 122.54 15.12 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 118.724 -1.191 . . . . 0.0 110.731 -178.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 6.8 mt-10 -111.57 26.14 10.95 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.062 -1.024 . . . . 0.0 108.869 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.549 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -121.22 -161.07 11.25 Favored Glycine 0 N--CA 1.484 1.863 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 40.8 p-10 -125.0 149.18 48.01 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.384 -1.068 . . . . 0.0 110.392 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.48 -2.51 1.1 Allowed Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.555 -1.307 . . . . 0.0 110.958 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.612 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.6 OUTLIER 49.48 -153.57 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 120.534 -1.568 . . . . 0.0 108.353 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.612 ' HD2' ' CB ' ' A' ' 43' ' ' SER . 86.1 Cg_exo -41.46 97.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.321 -0.906 0 N-CA-C 109.121 -1.146 . . . . 0.0 109.121 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.896 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -143.65 169.66 17.31 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.192 0.52 . . . . 0.0 109.648 -178.095 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.592 ' O ' HD13 ' A' ' 47' ' ' ILE . 6.1 mtpm? -83.53 175.46 9.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.155 -0.966 . . . . 0.0 112.163 -178.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.097 ' CD1' HG23 ' A' ' 70' ' ' VAL . 15.4 mm -124.55 123.64 25.75 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.696 -0.627 . . . . 0.0 111.373 -178.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.627 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 31.7 Cg_exo -62.33 144.97 95.95 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.097 1.577 . . . . 0.0 110.901 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.999 ' CE1' HG21 ' A' ' 79' ' ' ILE . 5.8 t80 -152.97 155.71 37.48 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.374 -0.829 . . . . 0.0 110.033 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.742 ' HG2' HD12 ' A' ' 91' ' ' ILE . 21.7 tt0 -171.42 103.05 0.2 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.092 -1.005 . . . . 0.0 110.382 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.53 HD11 ' HB1' ' A' ' 81' ' ' ALA . 79.3 mt . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.295 -0.878 . . . . 0.0 110.134 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.428 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.6 ' O ' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -158.3 167.08 30.73 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.211 -1.17 . . . . 0.0 109.381 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.058 HD23 ' HB2' ' A' ' 81' ' ' ALA . 11.6 mt -122.69 122.08 37.92 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 118.916 -1.114 . . . . 0.0 110.814 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.848 HG12 HG21 ' A' ' 31' ' ' THR . 1.4 mp -83.44 -28.16 7.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.741 HG22 ' O ' ' A' ' 65' ' ' THR 0.27 1.3 m -96.98 34.57 1.7 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.447 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 1.0 HG23 ' O ' ' A' ' 63' ' ' LEU . 13.9 t -36.81 142.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.713 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.56 ' N ' ' HD3' ' A' ' 68' ' ' PRO . 46.5 t-20 49.62 59.77 16.3 Favored Pre-proline 0 C--N 1.299 -1.604 0 O-C-N 121.485 -0.759 . . . . 0.0 110.096 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.638 ' CG ' HD12 ' A' ' 79' ' ' ILE . 3.0 Cg_exo -68.91 154.89 70.14 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.719 1.378 . . . . 0.0 108.703 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.896 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.8 OUTLIER -142.91 146.5 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.13 -1.028 . . . . 0.0 112.247 -178.63 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.097 HG23 ' CD1' ' A' ' 47' ' ' ILE . 54.5 t -96.86 154.28 3.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.43 -21.89 12.28 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 120.913 -1.117 . . . . 0.0 108.714 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.539 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 32.1 mt-10 -139.22 146.47 40.53 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.545 ' O ' ' O ' ' A' ' 38' ' ' TYR . 0.5 OUTLIER -53.61 -13.9 0.75 Allowed 'General case' 0 C--N 1.296 -1.756 0 O-C-N 120.808 -1.182 . . . . 0.0 110.948 -178.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.471 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 15.7 t0 -126.91 6.99 6.65 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.58 -1.325 . . . . 0.0 110.671 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.499 ' CB ' ' HB2' ' A' ' 72' ' ' GLU . 0.1 OUTLIER -72.73 112.23 14.35 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.035 -1.041 . . . . 0.0 108.618 178.803 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.635 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 31.5 Cg_exo -56.34 126.71 23.23 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 O-C-N 124.008 1.531 . . . . 0.0 110.68 -178.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.774 HG21 HG22 ' A' ' 70' ' ' VAL . 53.9 t -105.56 158.62 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.097 -1.002 . . . . 0.0 110.448 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.648 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -121.13 131.21 54.12 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.417 -0.802 . . . . 0.0 109.484 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.999 HG21 ' CE1' ' A' ' 49' ' ' PHE . 15.4 mm -114.86 115.13 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 117.598 -1.641 . . . . 0.0 111.674 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.945 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.5 tp10 -94.23 108.06 19.96 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 1.058 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -129.4 155.7 45.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.874 -1.141 . . . . 0.0 111.093 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.539 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 1.2 tp10 -95.97 110.72 53.29 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.577 -0.702 . . . . 0.0 110.165 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.531 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 38.1 Cg_endo -71.41 144.84 46.49 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.027 1.541 . . . . 0.0 110.501 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.428 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 13.4 Cg_endo . . . . . 0 C--N 1.304 -1.815 0 O-C-N 124.006 1.529 . . . . 0.0 110.081 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.583 ' CE2' ' ND2' ' A' ' 102' ' ' ASN . 11.6 m-85 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.198 0.523 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.719 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.5 mp -74.26 121.78 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.908 . . . . 0.0 109.752 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.742 HD12 ' HG2' ' A' ' 50' ' ' GLU . 14.2 mt -96.13 146.93 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -0.946 . . . . 0.0 110.176 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.026 HD11 HG21 ' A' ' 34' ' ' ILE . 1.7 mt -135.3 140.82 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.307 -0.87 . . . . 0.0 110.073 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 48' ' ' PRO . . . 80.22 -156.77 39.98 Favored Glycine 0 N--CA 1.484 1.881 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.596 HG21 ' HA ' ' A' ' 15' ' ' THR . 0.4 OUTLIER -130.99 156.83 43.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 O-C-N 121.055 -1.262 . . . . 0.0 110.685 -179.511 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.642 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 2.3 mt-10 -30.44 -54.08 0.37 Allowed Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.861 -0.524 . . . . 0.0 111.569 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 3.3 Cg_endo -48.43 -20.67 2.65 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.506 1.267 . . . . 0.0 111.125 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.591 ' HA3' ' CG ' ' A' ' 17' ' ' LYS . . . -176.81 46.42 0.11 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -95.21 153.72 17.53 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.88 -1.365 . . . . 0.0 111.138 -178.591 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.834 HD13 ' CG2' ' A' ' 20' ' ' VAL . 24.2 mt -103.71 -177.52 3.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.547 -0.721 . . . . 0.0 110.268 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.413 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 0.7 OUTLIER -156.48 137.06 13.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.526 -0.734 . . . . 0.0 110.117 179.671 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.719 HD12 ' O ' ' A' ' 90' ' ' ILE . 2.5 mp -139.59 119.98 13.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.102 -0.999 . . . . 0.0 110.338 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.583 ' ND2' ' CE2' ' A' ' 89' ' ' TYR . 16.6 t-20 -87.26 130.22 34.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.314 -0.866 . . . . 0.0 110.314 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.533 ' CE3' HG22 ' A' ' 24' ' ' ILE . 21.9 t-105 . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 110.066 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.591 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 32.5 m . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 121.423 0.63 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 16' ' ' GLY . 4.3 t -94.0 -9.52 36.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.336 -0.852 . . . . 0.0 111.722 -178.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.57 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -59.86 -123.56 0.01 OUTLIER Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.543 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -135.19 174.98 10.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.011 -1.288 . . . . 0.0 109.909 -179.749 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.076 ' CE2' HG23 ' A' ' 47' ' ' ILE . 35.0 m-85 -133.81 140.33 46.84 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.92 -1.112 . . . . 0.0 111.311 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.488 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 4.0 ttpt -109.89 117.18 33.12 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.584 -0.698 . . . . 0.0 109.366 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.735 ' CG2' HD13 ' A' ' 99' ' ' LEU . 46.9 t -59.76 123.07 11.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 120.688 -1.258 . . . . 0.0 109.013 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.946 HG21 ' HB3' ' A' ' 76' ' ' PRO . 53.2 t -96.95 -25.08 4.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.603 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 4.9 tttt -158.93 133.9 8.26 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -52.33 159.55 0.96 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.645 0.736 . . . . 0.0 111.186 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.597 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -51.82 133.24 13.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.514 0.673 . . . . 0.0 110.202 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 1.001 ' HB3' ' HB ' ' A' ' 33' ' ' VAL . . . -105.74 169.91 8.2 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 0.4 OUTLIER -117.32 123.17 45.87 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.883 -1.135 . . . . 0.0 110.55 -179.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.4 ' H ' HG23 ' A' ' 27' ' ' THR . 5.1 p -78.47 -175.71 4.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.402 -0.811 . . . . 0.0 109.808 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -100.25 34.54 2.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.186 -0.946 . . . . 0.0 110.058 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -140.64 8.57 2.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.247 -0.908 . . . . 0.0 110.434 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.38 -3.5 58.01 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.948 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -91.74 -176.39 4.45 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -1.167 . . . . 0.0 110.262 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.87 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -142.23 168.53 14.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.591 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.001 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 93.4 t -131.83 126.17 56.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 C-N-CA 118.71 -1.196 . . . . 0.0 111.995 -178.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.014 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -109.27 115.84 50.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.309 -0.869 . . . . 0.0 109.852 178.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.603 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 1.4 ttm180 -99.13 120.48 39.56 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.798 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.4 m -147.38 158.14 9.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.326 -0.859 . . . . 0.0 108.919 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 74' ' ' ASP 0.252 0.3 OUTLIER -105.65 125.22 50.74 Favored 'General case' 0 C--N 1.272 -2.796 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.291 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.905 ' HB2' HG21 ' A' ' 70' ' ' VAL . 2.1 t80 -60.1 124.12 19.27 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 119.07 -1.052 . . . . 0.0 110.289 -178.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.499 ' O ' ' N ' ' A' ' 17' ' ' LYS . 21.4 mm-40 -112.23 92.05 3.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.874 . . . . 0.0 109.872 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.57 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 164.47 -151.05 19.98 Favored Glycine 0 N--CA 1.486 1.97 0 C-N-CA 119.404 -1.379 . . . . 0.0 109.858 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.449 ' O ' ' OH ' ' A' ' 38' ' ' TYR . 4.4 m-20 -112.4 125.07 53.8 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.5 -1.0 . . . . 0.0 110.48 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 43' ' ' SER . . . 177.66 -27.92 0.06 OUTLIER Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.504 -1.332 . . . . 0.0 110.614 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.609 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.7 OUTLIER 48.56 -153.92 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 120.723 -1.457 . . . . 0.0 107.594 -179.421 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.609 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 53.6 Cg_exo -46.81 94.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.198 0 N-CA-C 108.385 -1.429 . . . . 0.0 108.385 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.858 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -150.47 172.67 15.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.582 -0.699 . . . . 0.0 110.063 -177.696 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.579 ' HG3' HD11 ' A' ' 69' ' ' ILE . 22.0 mtmt -81.09 175.71 10.43 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.236 -0.915 . . . . 0.0 112.102 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.076 HG23 ' CE2' ' A' ' 18' ' ' PHE . 15.7 mm -124.26 127.48 25.3 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.62 -0.675 . . . . 0.0 111.427 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.629 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 38.3 Cg_exo -63.86 144.13 87.64 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.048 1.551 . . . . 0.0 110.42 178.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.711 ' CZ ' HG23 ' A' ' 90' ' ' ILE . 9.6 t80 -151.83 160.28 43.6 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.259 -0.901 . . . . 0.0 110.286 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.678 ' O ' HD12 ' A' ' 91' ' ' ILE . 0.9 OUTLIER -175.2 98.78 0.08 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.214 -0.929 . . . . 0.0 109.532 179.569 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.923 HD11 ' HB1' ' A' ' 81' ' ' ALA . 64.0 mt . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.15 -0.969 . . . . 0.0 111.37 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.51 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -131.57 155.46 47.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -1.156 . . . . 0.0 110.36 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.907 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -115.1 116.33 28.24 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.221 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.948 HG12 HG21 ' A' ' 31' ' ' THR . 1.7 mp -80.07 -27.35 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.756 HG22 ' O ' ' A' ' 65' ' ' THR 0.259 1.2 m -98.47 34.08 2.09 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.062 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.907 HG23 ' O ' ' A' ' 63' ' ' LEU . 40.6 t -26.62 145.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.526 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.838 HD22 HG12 ' A' ' 66' ' ' VAL . 4.0 p30 39.81 53.12 5.06 Favored Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 121.778 -0.576 . . . . 0.0 111.475 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.543 ' O ' HG12 ' A' ' 69' ' ' ILE . 1.8 Cg_endo -55.41 154.69 23.18 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 N-CA-C 108.758 -1.285 . . . . 0.0 108.758 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.858 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.7 OUTLIER -141.45 146.47 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 119.049 -1.061 . . . . 0.0 112.819 -177.667 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.033 HG23 ' CD1' ' A' ' 47' ' ' ILE . 95.7 t -92.75 167.63 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.466 ' N ' HG12 ' A' ' 70' ' ' VAL . 3.1 m -118.74 -21.93 7.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.735 -1.228 . . . . 0.0 111.033 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.522 ' O ' ' HB3' ' A' ' 73' ' ' LYS . 4.0 mt-10 -138.06 19.19 2.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.956 -1.09 . . . . 0.0 110.991 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.523 ' CD ' ' O ' ' A' ' 40' ' ' GLY . 0.3 OUTLIER 72.64 -7.34 1.44 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.398 -0.814 . . . . 0.0 111.11 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.5 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 6.1 t0 -137.43 0.33 2.28 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.864 -1.147 . . . . 0.0 110.451 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.611 ' O ' HG23 ' A' ' 77' ' ' VAL . 32.9 t -73.06 108.39 4.49 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.166 -0.959 . . . . 0.0 109.613 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.946 ' HB3' HG21 ' A' ' 21' ' ' VAL . 3.4 Cg_endo -51.57 110.51 0.43 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.735 1.387 . . . . 0.0 109.672 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 75' ' ' SER . 88.8 t -99.41 143.45 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.326 -0.859 . . . . 0.0 111.741 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.645 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 3.6 m-80 -98.17 130.97 44.91 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.726 ' HB ' HG22 ' A' ' 34' ' ' ILE . 5.8 mt -108.81 114.33 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.067 -1.646 . . . . 0.0 111.71 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 3.4 tt0 -84.23 115.29 22.37 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.676 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.923 ' HB1' HD11 ' A' ' 51' ' ' ILE . . . -137.85 152.61 49.24 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.987 -1.071 . . . . 0.0 110.919 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.51 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 34.9 tt0 -100.82 101.24 14.98 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.366 -0.834 . . . . 0.0 110.308 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.548 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 43.2 Cg_endo -73.23 134.08 20.48 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.036 1.545 . . . . 0.0 110.381 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 83' ' ' PRO . 34.3 Cg_exo . . . . . 0 C--N 1.306 -1.71 0 O-C-N 123.923 1.486 . . . . 0.0 110.101 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.564 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 2.0 m-30 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.181 0.515 . . . . 0.0 110.009 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.711 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 1.6 mp -74.32 121.87 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.141 -0.975 . . . . 0.0 109.346 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.678 HD12 ' O ' ' A' ' 50' ' ' GLU . 1.9 mp -100.03 148.25 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.047 -1.033 . . . . 0.0 110.143 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.014 HD11 HG21 ' A' ' 34' ' ' ILE . 1.6 mt -134.05 145.54 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.454 -0.779 . . . . 0.0 109.907 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.555 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 80.04 -161.03 45.15 Favored Glycine 0 N--CA 1.481 1.642 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.547 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -122.15 150.48 25.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 O-C-N 121.366 -1.079 . . . . 0.0 110.064 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.576 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 5.4 mt-10 -20.68 -56.95 0.07 OUTLIER Pre-proline 0 N--CA 1.5 2.04 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 9.2 Cg_endo -54.71 68.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 124.066 1.561 . . . . 0.0 111.963 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 94.33 6.57 61.26 Favored Glycine 0 N--CA 1.495 2.612 0 O-C-N 120.951 -1.093 . . . . 0.0 111.026 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.506 ' HB3' ' C ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -55.64 161.58 2.02 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.933 -1.334 . . . . 0.0 109.993 179.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.735 HD13 ' CG2' ' A' ' 20' ' ' VAL . 12.8 mt -99.26 177.43 5.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.234 -0.916 . . . . 0.0 110.963 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.561 ' C ' HD12 ' A' ' 101' ' ' LEU . 4.3 ttpt -154.8 138.51 16.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.57 -0.706 . . . . 0.0 109.953 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.561 HD12 ' C ' ' A' ' 100' ' ' LYS . 4.9 mp -143.43 124.58 14.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.136 -0.978 . . . . 0.0 110.36 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 8.7 p-10 -92.12 130.61 37.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.357 -0.839 . . . . 0.0 110.596 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.563 ' CZ3' HG22 ' A' ' 24' ' ' ILE . 38.2 t-105 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.884 . . . . 0.0 109.998 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.58 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 30.8 m . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 121.337 0.589 . . . . 0.0 109.575 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.491 ' O ' ' O ' ' A' ' 16' ' ' GLY . 3.4 p -87.84 -8.08 56.37 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.375 -0.828 . . . . 0.0 111.711 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.579 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -60.33 -131.55 0.01 OUTLIER Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.518 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -134.37 -178.91 5.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.02 -1.282 . . . . 0.0 109.822 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.946 ' CZ ' HG23 ' A' ' 47' ' ' ILE . 44.1 m-85 -138.01 142.62 40.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.894 -1.129 . . . . 0.0 111.851 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.51 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 31.9 ttpt -110.4 117.92 34.89 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.695 ' CG2' HD13 ' A' ' 99' ' ' LEU . 60.6 t -59.56 124.23 13.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 120.666 -1.271 . . . . 0.0 109.459 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.717 HG23 ' HA ' ' A' ' 36' ' ' VAL . 83.3 t -96.27 -27.09 4.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.637 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 0.2 OUTLIER -154.31 138.06 16.16 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.332 177.11 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.54 158.43 4.45 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.383 0.611 . . . . 0.0 110.364 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.691 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.7 OUTLIER -55.4 130.64 17.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.051 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.782 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -108.65 168.74 9.12 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 12.9 pt-20 -113.87 134.94 54.49 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.786 -1.196 . . . . 0.0 110.479 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.915 HG21 ' CD ' ' A' ' 80' ' ' GLU . 16.5 p -90.52 -172.67 3.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.5 -0.75 . . . . 0.0 110.278 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -95.91 4.41 52.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.269 -0.895 . . . . 0.0 110.419 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -106.67 6.82 30.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.201 -0.937 . . . . 0.0 110.223 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.53 7.64 61.62 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.968 HG22 ' C ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -97.48 -171.95 2.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -1.092 . . . . 0.0 110.457 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.782 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -142.69 147.21 21.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.671 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 66.8 t -111.64 134.79 52.91 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 O-C-N 121.346 -0.846 . . . . 0.0 112.08 -177.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.082 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -120.95 118.76 57.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 121.409 -0.807 . . . . 0.0 109.988 179.11 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.637 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -100.07 122.99 43.8 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 119.026 -1.07 . . . . 0.0 108.34 179.23 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.799 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.3 m -149.0 158.52 6.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.175 -0.953 . . . . 0.0 109.053 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 74' ' ' ASP 0.256 1.8 tt0 -107.61 126.74 52.94 Favored 'General case' 0 C--N 1.27 -2.848 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.503 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.961 ' HB2' HG21 ' A' ' 70' ' ' VAL . 1.9 t80 -59.18 125.46 23.68 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.182 -178.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.51 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 5.2 mm-40 -111.85 87.96 2.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.18 -0.95 . . . . 0.0 109.715 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.579 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 164.65 -150.58 18.85 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.456 ' O ' ' OH ' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -117.82 137.02 53.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.594 -0.945 . . . . 0.0 110.496 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 43' ' ' SER . . . 173.32 -24.76 0.08 OUTLIER Glycine 0 N--CA 1.488 2.109 0 C-N-CA 119.649 -1.262 . . . . 0.0 110.641 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.599 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.4 OUTLIER 49.36 -156.54 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 120.732 -1.452 . . . . 0.0 107.813 -179.501 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.599 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 50.8 Cg_exo -48.15 94.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.318 0 N-CA-C 107.951 -1.596 . . . . 0.0 107.951 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.919 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -148.06 173.62 12.74 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.633 -0.667 . . . . 0.0 109.333 -177.584 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 68' ' ' PRO . 0.3 OUTLIER -88.6 173.84 8.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.0 -1.062 . . . . 0.0 111.78 -178.73 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.06 ' CD1' HG23 ' A' ' 70' ' ' VAL . 19.2 mm -124.18 129.64 24.65 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.64 -0.662 . . . . 0.0 112.033 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.613 ' HD2' ' CE2' ' A' ' 18' ' ' PHE . 36.8 Cg_exo -63.71 147.82 92.42 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 124.05 1.552 . . . . 0.0 111.034 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.912 ' CE2' HG21 ' A' ' 79' ' ' ILE . 11.0 t80 -155.51 157.6 37.16 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.324 -0.86 . . . . 0.0 110.552 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.889 ' HG2' HD12 ' A' ' 91' ' ' ILE . 22.4 tt0 -175.72 95.91 0.07 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.147 -0.971 . . . . 0.0 110.306 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.75 HD11 ' HB1' ' A' ' 81' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.313 -0.867 . . . . 0.0 109.74 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.534 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.54 ' CB ' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -150.34 163.49 38.21 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.271 -1.134 . . . . 0.0 109.496 179.749 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.034 HD23 ' HB2' ' A' ' 81' ' ' ALA . 11.1 mt -123.6 121.2 34.96 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 118.639 -1.224 . . . . 0.0 110.408 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.804 ' CG1' HG21 ' A' ' 31' ' ' THR . 4.1 mm -83.34 -29.32 7.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.776 HG22 ' O ' ' A' ' 65' ' ' THR 0.267 1.9 m -99.37 35.87 1.86 Allowed 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.947 HG23 ' O ' ' A' ' 63' ' ' LEU . 44.7 t -37.79 155.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-O 121.489 0.662 . . . . 0.0 110.995 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.668 ' ND2' HG12 ' A' ' 66' ' ' VAL . 24.3 p30 36.46 53.97 2.56 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 122.065 -0.397 . . . . 0.0 111.378 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.826 ' CG ' HD12 ' A' ' 79' ' ' ILE . 15.7 Cg_exo -55.05 161.56 6.44 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 N-CA-C 108.472 -1.395 . . . . 0.0 108.472 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.919 HG23 ' O ' ' A' ' 45' ' ' CYS . 1.0 OUTLIER -142.79 145.8 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 118.844 -1.143 . . . . 0.0 112.813 -178.431 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.06 HG23 ' CD1' ' A' ' 47' ' ' ILE . 55.8 t -101.38 160.59 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 176.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.452 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 2.8 m -116.09 -19.48 10.28 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.653 -1.279 . . . . 0.0 111.326 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 3.2 mt-10 -137.61 14.71 2.94 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.831 -1.168 . . . . 0.0 111.272 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.529 ' O ' ' O ' ' A' ' 38' ' ' TYR . 3.2 mtmt 75.11 -11.3 1.09 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.517 -0.739 . . . . 0.0 111.03 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.489 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 6.4 t0 -133.67 0.92 3.32 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.979 -1.076 . . . . 0.0 110.204 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.561 ' O ' HG23 ' A' ' 77' ' ' VAL . 25.1 t -72.83 108.76 4.87 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.202 -0.937 . . . . 0.0 109.528 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.717 ' HB3' HG21 ' A' ' 21' ' ' VAL . 4.2 Cg_endo -52.16 113.59 1.26 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.766 1.403 . . . . 0.0 109.921 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 75' ' ' SER . 62.0 t -99.35 153.67 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.268 -0.895 . . . . 0.0 110.982 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.652 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.3 m-20 -112.39 133.11 54.66 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.912 HG21 ' CE2' ' A' ' 49' ' ' PHE . 7.2 mm -115.47 121.86 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.1 -1.625 . . . . 0.0 111.588 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.915 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.0 OUTLIER -99.15 106.59 18.79 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.681 -0.637 . . . . 0.0 109.815 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 1.034 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -123.2 156.25 35.49 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.989 -1.069 . . . . 0.0 111.178 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.54 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 4.7 tt0 -101.64 101.03 15.83 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.632 -0.668 . . . . 0.0 110.283 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.555 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 23.3 Cg_endo -67.82 151.22 78.72 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 124.045 1.55 . . . . 0.0 110.467 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.534 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 15.2 Cg_endo . . . . . 0 C--N 1.305 -1.716 0 O-C-N 124.047 1.551 . . . . 0.0 110.337 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 10.2 m-85 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.222 0.534 . . . . 0.0 110.163 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.809 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 1.6 mp -74.16 111.47 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.152 -0.968 . . . . 0.0 109.381 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.889 HD12 ' HG2' ' A' ' 50' ' ' GLU . 33.7 mt -92.23 146.8 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.243 -0.911 . . . . 0.0 110.435 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.082 HD11 HG21 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -134.71 137.1 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.617 -0.677 . . . . 0.0 109.54 -179.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 48' ' ' PRO . . . 85.91 -162.6 35.77 Favored Glycine 0 N--CA 1.482 1.735 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.56 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -120.27 147.92 23.71 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 O-C-N 121.146 -1.208 . . . . 0.0 110.179 -179.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.579 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.8 mt-10 -16.86 -58.31 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.149 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 6.9 Cg_endo -51.07 72.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 124.164 1.613 . . . . 0.0 111.992 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 89.36 -1.78 82.53 Favored Glycine 0 N--CA 1.494 2.551 0 O-C-N 121.032 -1.042 . . . . 0.0 110.809 178.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.51 ' HB3' ' C ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -45.83 159.3 0.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.986 -1.302 . . . . 0.0 110.042 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.695 HD13 ' CG2' ' A' ' 20' ' ' VAL . 10.2 mt -96.06 173.26 7.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 110.6 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.61 ' C ' HD12 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -154.57 131.03 10.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.388 -0.82 . . . . 0.0 110.007 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.61 HD12 ' C ' ' A' ' 100' ' ' LYS . 5.5 mp -134.33 121.46 21.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 0.0 110.432 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.486 ' ND2' ' CE1' ' A' ' 89' ' ' TYR . 5.6 t-20 -89.78 130.94 35.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.285 -0.884 . . . . 0.0 110.141 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.428 ' CD1' HG21 ' A' ' 32' ' ' ILE . 10.7 t-105 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.227 -0.921 . . . . 0.0 110.205 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.579 ' HB3' ' CE1' ' A' ' 38' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.653 ' HA ' HG21 ' A' ' 94' ' ' VAL . 1.2 p -68.74 -5.65 21.78 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.479 -0.763 . . . . 0.0 111.755 -178.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.549 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -59.3 -149.74 0.01 OUTLIER Glycine 0 N--CA 1.48 1.623 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.572 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 1.4 tmpt? -123.61 160.77 26.38 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.37 -1.076 . . . . 0.0 108.929 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.065 ' CE2' HG23 ' A' ' 47' ' ' ILE . 34.5 m-85 -118.76 137.55 53.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.497 -1.377 . . . . 0.0 112.144 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.511 ' HE2' ' NE2' ' A' ' 37' ' ' GLN . 7.7 ttpp -109.21 119.33 39.2 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.703 -0.623 . . . . 0.0 109.435 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.425 ' HA ' HG12 ' A' ' 36' ' ' VAL . 27.4 t -59.46 129.54 21.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 120.709 -1.244 . . . . 0.0 108.836 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.635 HG23 ' HA ' ' A' ' 36' ' ' VAL . 64.3 t -104.75 -24.75 3.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.562 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 15.3 tttt -159.91 134.6 7.76 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 177.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -52.6 155.02 2.36 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.6 0.714 . . . . 0.0 111.094 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.609 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -47.87 133.85 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.967 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.921 ' HB3' ' HB ' ' A' ' 33' ' ' VAL . . . -106.84 173.33 6.37 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.5 pm0 -116.98 126.11 52.41 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.905 -1.122 . . . . 0.0 110.582 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.443 HG21 ' HG2' ' A' ' 80' ' ' GLU . 11.9 p -79.85 -163.74 0.57 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.355 -0.841 . . . . 0.0 110.035 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -110.44 31.56 5.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 109.874 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -139.84 10.36 2.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.344 -0.848 . . . . 0.0 110.447 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.85 -1.44 59.65 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.915 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -91.81 -175.46 4.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -1.117 . . . . 0.0 110.269 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.872 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -142.93 165.98 15.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.921 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 93.7 t -130.26 125.87 60.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 120.724 -1.235 . . . . 0.0 112.44 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.082 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -106.51 116.68 50.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.363 -0.836 . . . . 0.0 109.566 178.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 3.4 ttm180 -101.49 120.07 39.74 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.744 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.8 m -140.69 -173.68 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.536 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 1.9 tt0 -133.89 124.57 26.66 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.85 ' HB2' HG21 ' A' ' 70' ' ' VAL . 89.3 t80 -61.32 140.64 57.95 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.368 -1.333 . . . . 0.0 110.527 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 17' ' ' LYS . 3.3 mm-40 -134.74 83.34 2.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.491 -0.756 . . . . 0.0 109.805 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.549 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 174.0 -147.07 9.09 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.543 ' HA ' ' HD2' ' A' ' 73' ' ' LYS . 50.0 t0 -113.93 132.79 55.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.627 -0.925 . . . . 0.0 110.38 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.457 ' HA3' ' SG ' ' A' ' 14' ' ' CYS . . . 165.01 -24.7 0.17 Allowed Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.726 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.608 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.5 OUTLIER 49.24 -156.13 0.01 OUTLIER Pre-proline 0 N--CA 1.487 1.395 0 O-C-N 120.598 -1.531 . . . . 0.0 108.105 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.608 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 74.6 Cg_exo -44.02 96.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.35 0 N-CA-C 109.283 -1.083 . . . . 0.0 109.283 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.726 ' O ' HG23 ' A' ' 69' ' ' ILE . 24.5 p -143.34 169.31 17.89 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.634 -0.666 . . . . 0.0 110.134 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.692 ' CG ' HD11 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -83.86 172.74 11.86 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.411 -0.806 . . . . 0.0 110.358 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.065 HG23 ' CE2' ' A' ' 18' ' ' PHE . 15.8 mm -114.76 126.6 27.71 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 111.957 -177.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.62 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 33.8 Cg_exo -63.02 144.6 93.23 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.993 1.523 . . . . 0.0 110.846 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.923 ' CD2' HG21 ' A' ' 79' ' ' ILE . 3.9 t80 -154.29 153.11 31.13 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.537 -0.727 . . . . 0.0 109.678 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.616 ' HG3' HD12 ' A' ' 91' ' ' ILE . 19.3 tp10 -166.37 98.06 0.59 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.928 -1.107 . . . . 0.0 110.546 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.719 HD11 ' HB1' ' A' ' 81' ' ' ALA . 4.8 mt . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.29 -0.881 . . . . 0.0 109.821 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.521 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.523 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -143.25 169.35 17.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -1.143 . . . . 0.0 110.373 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.751 HD21 ' CD1' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -120.89 121.26 37.68 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.479 179.39 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.915 HG12 HG21 ' A' ' 31' ' ' THR . 1.4 mp -85.53 -27.79 6.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 106.735 -1.579 . . . . 0.0 106.735 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.799 HG22 ' O ' ' A' ' 65' ' ' THR 0.254 2.3 m -110.93 39.79 2.17 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.283 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.738 ' N ' HD12 ' A' ' 63' ' ' LEU . 6.8 t -25.9 121.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 CA-C-O 121.711 0.767 . . . . 0.0 111.813 -178.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.579 ' ND2' ' HB3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER 41.8 69.96 1.88 Allowed Pre-proline 0 C--N 1.297 -1.696 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.77 178.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.726 ' HG3' HG23 ' A' ' 79' ' ' ILE . 1.2 Cg_endo -55.6 -171.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.725 1.382 . . . . 0.0 108.826 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.726 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.7 OUTLIER -143.53 145.62 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 118.926 -1.109 . . . . 0.0 112.44 -179.409 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.949 ' CG2' HD11 ' A' ' 47' ' ' ILE . 60.1 t -97.86 162.12 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 176.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.6 m -117.26 -17.21 10.24 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.666 -1.213 . . . . 0.0 111.351 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.54 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 15.4 mt-10 -142.03 16.87 2.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.875 -1.141 . . . . 0.0 111.054 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.543 ' HD2' ' HA ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER 75.71 -12.71 0.96 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.48 -0.763 . . . . 0.0 110.97 179.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.472 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 12.5 t70 -133.41 -1.94 3.13 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.051 -1.031 . . . . 0.0 110.234 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.608 ' O ' HG23 ' A' ' 77' ' ' VAL . 8.2 t -71.97 112.27 13.77 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.246 -0.909 . . . . 0.0 108.69 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.631 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 42.7 Cg_exo -49.03 126.29 14.89 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.9 1.473 . . . . 0.0 110.387 -178.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.705 HG21 HG22 ' A' ' 70' ' ' VAL . 58.2 t -115.65 143.37 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.072 -1.018 . . . . 0.0 111.254 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.672 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 1.5 m-20 -104.74 136.18 44.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.412 -0.805 . . . . 0.0 109.562 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.923 HG21 ' CD2' ' A' ' 49' ' ' PHE . 7.3 mt -115.41 116.94 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.134 -1.604 . . . . 0.0 111.552 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.712 ' HG3' HG22 ' A' ' 33' ' ' VAL . 3.8 tt0 -88.06 114.0 24.25 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.455 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.809 ' C ' HG22 ' A' ' 31' ' ' THR . . . -132.77 149.32 52.29 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.943 -1.098 . . . . 0.0 110.915 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.523 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 2.8 tp10 -99.99 99.15 8.6 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.305 -0.872 . . . . 0.0 110.196 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.541 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 21.9 Cg_endo -66.21 152.6 80.73 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.064 1.56 . . . . 0.0 110.494 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.521 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 17.8 Cg_endo . . . . . 0 C--N 1.305 -1.716 0 O-C-N 123.993 1.522 . . . . 0.0 110.241 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 2.9 m-85 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.154 0.502 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.643 HG21 ' CZ ' ' A' ' 49' ' ' PHE . 11.0 mt -74.33 138.7 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.267 -0.896 . . . . 0.0 109.67 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.616 HD12 ' HG3' ' A' ' 50' ' ' GLU . 14.6 mt -98.83 150.11 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.051 -1.031 . . . . 0.0 110.216 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.082 HD11 HG21 ' A' ' 34' ' ' ILE . 0.6 OUTLIER -138.61 142.73 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.49 -0.756 . . . . 0.0 109.928 -179.506 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.557 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 80.03 -157.15 40.84 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.653 HG21 ' HA ' ' A' ' 15' ' ' THR . 0.8 OUTLIER -129.08 157.33 41.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 121.077 -1.249 . . . . 0.0 110.023 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.537 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 4.0 mt-10 -33.05 -54.62 0.63 Allowed Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.635 -0.666 . . . . 0.0 110.442 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 62.0 Cg_exo -44.31 -37.94 10.82 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.154 1.607 . . . . 0.0 110.458 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.572 ' HA3' ' CG ' ' A' ' 17' ' ' LYS . . . -157.17 53.22 0.4 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.598 ' HB2' ' N ' ' A' ' 94' ' ' VAL . 0.6 OUTLIER -109.62 149.39 29.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.04 -1.271 . . . . 0.0 111.0 -178.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.898 HD21 ' O ' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -119.88 -163.05 0.96 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.197 -0.94 . . . . 0.0 109.869 178.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -146.49 153.72 40.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.519 -0.738 . . . . 0.0 110.284 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.813 HD13 HG13 ' A' ' 34' ' ' ILE . 1.1 mt -138.26 113.12 9.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.922 . . . . 0.0 110.162 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -87.36 130.5 34.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.869 . . . . 0.0 110.459 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.558 ' CE3' HG22 ' A' ' 24' ' ' ILE . 53.2 t-105 . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.336 -0.852 . . . . 0.0 110.073 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.577 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 31.1 m . . . . . 0 N--CA 1.488 1.452 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.511 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 77.6 p -101.14 -4.72 26.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.159 -0.963 . . . . 0.0 111.764 -178.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.573 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -60.13 -124.14 0.01 OUTLIER Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.567 ' HE3' ' N ' ' A' ' 18' ' ' PHE . 1.5 ttpt -134.74 154.7 51.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.043 -1.269 . . . . 0.0 109.774 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.074 ' CE2' HG23 ' A' ' 47' ' ' ILE . 37.2 m-85 -118.25 137.84 52.76 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.805 -1.185 . . . . 0.0 111.768 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.444 ' HE2' ' HB3' ' A' ' 37' ' ' GLN . 35.2 ttpt -107.95 119.53 39.71 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.548 -0.72 . . . . 0.0 109.274 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.824 ' CG2' HD13 ' A' ' 99' ' ' LEU . 43.4 t -60.12 124.76 15.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 120.736 -1.228 . . . . 0.0 109.364 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.78 HG23 ' HA ' ' A' ' 36' ' ' VAL . 88.6 t -95.35 -27.02 4.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.678 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 5.1 tttp -159.26 133.51 7.69 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -48.59 160.31 0.18 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.569 0.699 . . . . 0.0 111.367 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.704 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -56.53 133.13 20.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-O 121.662 0.744 . . . . 0.0 110.193 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.773 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -108.58 169.72 8.47 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.7 pm0 -115.09 134.37 55.23 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.556 -1.34 . . . . 0.0 110.591 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.942 HG21 ' CD ' ' A' ' 80' ' ' GLU . 16.1 p -92.42 171.92 8.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.44 -0.788 . . . . 0.0 110.255 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -86.98 26.78 1.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.213 -0.929 . . . . 0.0 110.529 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.93 6.82 5.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.237 -0.915 . . . . 0.0 110.192 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.93 5.81 59.54 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.902 HG22 ' C ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -101.78 178.42 4.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -1.124 . . . . 0.0 110.427 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.811 HD11 ' HG3' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -134.76 153.02 34.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.481 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.685 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 48.5 t -117.96 132.13 68.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 C-N-CA 119.167 -1.013 . . . . 0.0 112.076 -177.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.108 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -117.76 119.98 63.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.327 -0.858 . . . . 0.0 110.009 179.128 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.678 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -102.45 124.04 47.29 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.241 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.78 ' HA ' HG23 ' A' ' 21' ' ' VAL . 1.2 m -147.7 161.93 7.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.157 -0.964 . . . . 0.0 108.834 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.513 ' NE2' ' OD2' ' A' ' 74' ' ' ASP 0.271 12.5 tt0 -107.37 122.93 47.59 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -178.588 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.876 ' HB2' HG21 ' A' ' 70' ' ' VAL . 12.9 t80 -62.71 122.12 15.1 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 118.814 -1.154 . . . . 0.0 110.282 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.498 ' HB2' ' HE2' ' A' ' 17' ' ' LYS . 2.7 mm-40 -115.87 98.61 6.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 110.019 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.573 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 160.16 -151.97 22.69 Favored Glycine 0 N--CA 1.486 2.005 0 C-N-CA 119.282 -1.437 . . . . 0.0 110.074 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 1.5 m-20 -105.85 106.37 16.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.704 -0.88 . . . . 0.0 109.954 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 43' ' ' SER . . . -165.32 -41.51 0.02 OUTLIER Glycine 0 N--CA 1.489 2.175 0 C-N-CA 119.539 -1.315 . . . . 0.0 110.394 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.63 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 1.0 OUTLIER 49.3 -150.23 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.366 0 O-C-N 120.869 -1.371 . . . . 0.0 107.485 -179.442 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.63 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 51.7 Cg_exo -47.83 92.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -1.022 0 N-CA-C 108.431 -1.411 . . . . 0.0 108.431 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.709 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -153.91 173.98 15.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.683 -0.636 . . . . 0.0 109.396 -177.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.68 ' CG ' HD11 ' A' ' 69' ' ' ILE . 14.9 mttp -85.18 174.94 9.27 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.287 -0.883 . . . . 0.0 111.594 -178.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.074 HG23 ' CE2' ' A' ' 18' ' ' PHE . 14.5 mm -123.06 128.72 25.23 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.401 -0.812 . . . . 0.0 111.936 -178.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.622 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 37.7 Cg_exo -63.68 145.03 90.83 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.58 1.52 . . . . 0.0 111.24 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.733 ' CD2' HD21 ' A' ' 63' ' ' LEU . 10.6 t80 -155.46 146.1 22.14 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.407 -0.808 . . . . 0.0 110.434 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.584 ' CG ' ' CG2' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -156.84 111.22 2.73 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.006 -1.059 . . . . 0.0 110.367 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.829 HD11 ' HB1' ' A' ' 81' ' ' ALA . 5.7 mt . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.184 -0.947 . . . . 0.0 110.296 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.55 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.512 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -129.13 162.34 27.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -1.138 . . . . 0.0 110.408 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.742 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -124.51 112.7 17.18 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.45 -0.781 . . . . 0.0 109.609 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.899 ' CG1' HG21 ' A' ' 31' ' ' THR . 7.2 mm -72.23 -27.38 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 122.351 1.072 . . . . 0.0 108.287 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.647 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.258 0.8 OUTLIER -109.13 32.2 5.12 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.534 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 63' ' ' LEU . 33.6 t -14.99 112.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.817 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.541 ' ND2' ' HD3' ' A' ' 46' ' ' LYS . 14.5 t-20 44.71 69.13 2.67 Favored Pre-proline 0 C--N 1.297 -1.688 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.699 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.62 ' HG3' HG23 ' A' ' 79' ' ' ILE . 6.3 Cg_exo -48.95 -178.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 124.246 1.656 . . . . 0.0 109.484 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.709 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.9 OUTLIER -140.7 139.37 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 118.971 -1.092 . . . . 0.0 112.241 -178.831 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.014 ' CG2' HD11 ' A' ' 47' ' ' ILE . 47.3 t -92.23 172.53 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 176.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.481 ' N ' HG12 ' A' ' 70' ' ' VAL . 22.9 m -122.13 -24.04 5.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.769 -1.207 . . . . 0.0 110.968 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.592 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 3.9 mm-40 -130.09 -46.78 1.12 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.015 -1.053 . . . . 0.0 110.032 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.592 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.1 OUTLIER 155.59 -61.46 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.513 ' OD2' ' NE2' ' A' ' 37' ' ' GLN . 2.4 t0 -89.65 12.9 15.5 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.207 -0.933 . . . . 0.0 110.371 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 77' ' ' VAL . 48.0 t -72.65 108.95 5.03 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.149 -0.969 . . . . 0.0 108.821 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.609 ' HB3' HG21 ' A' ' 21' ' ' VAL . 9.7 Cg_endo -56.95 113.8 1.63 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.829 1.436 . . . . 0.0 110.469 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.557 HG21 HG22 ' A' ' 70' ' ' VAL . 57.7 t -102.8 148.14 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.377 -0.827 . . . . 0.0 110.937 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.658 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 1.9 m-20 -106.22 138.2 42.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.322 -0.861 . . . . 0.0 109.981 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.686 HG21 ' CD1' ' A' ' 49' ' ' PHE . 4.5 mt -118.09 119.51 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 117.778 -1.569 . . . . 0.0 111.41 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.942 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.7 tp10 -94.01 110.2 21.9 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.902 ' C ' HG22 ' A' ' 31' ' ' THR . . . -124.31 147.49 48.11 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.069 -1.019 . . . . 0.0 111.011 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.644 ' HB2' HG23 ' A' ' 31' ' ' THR . 23.6 tt0 -107.61 94.7 12.47 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.597 -0.689 . . . . 0.0 110.617 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.811 ' HG3' HD11 ' A' ' 32' ' ' ILE . 40.3 Cg_endo -72.51 153.88 55.16 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.971 1.511 . . . . 0.0 110.219 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.55 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 10.8 Cg_endo . . . . . 0 C--N 1.305 -1.727 0 O-C-N 123.963 1.507 . . . . 0.0 110.159 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.558 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 4.1 m-85 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.197 0.522 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.543 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 12.7 mm -74.74 108.87 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.159 -0.963 . . . . 0.0 109.477 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.584 ' CG2' ' CG ' ' A' ' 50' ' ' GLU . 32.5 mt -100.98 154.22 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.92 -1.112 . . . . 0.0 110.004 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.108 HD11 HG21 ' A' ' 34' ' ' ILE . 2.7 mt -140.28 150.61 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.258 -0.901 . . . . 0.0 110.447 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.546 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 77.65 -157.1 45.34 Favored Glycine 0 N--CA 1.485 1.9 0 C-N-CA 119.319 -1.42 . . . . 0.0 109.658 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.559 ' O ' ' N ' ' A' ' 98' ' ' GLN . 0.2 OUTLIER -130.36 157.08 42.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.116 -1.226 . . . . 0.0 110.318 -179.596 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.524 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 1.0 OUTLIER -30.47 -55.71 0.36 Allowed Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.847 -0.533 . . . . 0.0 110.723 -179.739 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 76.4 Cg_exo -41.02 -40.58 3.88 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 124.055 1.555 . . . . 0.0 110.615 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 17' ' ' LYS . . . -160.76 50.95 0.35 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.559 ' N ' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -94.56 149.5 21.18 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.976 -1.308 . . . . 0.0 110.903 -178.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.824 HD13 ' CG2' ' A' ' 20' ' ' VAL . 13.7 mt -94.44 177.74 5.84 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.553 -0.717 . . . . 0.0 109.941 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.742 ' C ' HD12 ' A' ' 101' ' ' LEU . 0.4 OUTLIER -148.21 119.91 8.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.396 -0.815 . . . . 0.0 111.123 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.742 HD12 ' C ' ' A' ' 100' ' ' LYS . 7.3 mp -128.81 -164.52 1.4 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 102' ' ' ASN . 14.5 p-10 -179.05 151.11 0.49 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.843 -1.161 . . . . 0.0 110.931 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.467 ' HA ' ' CE3' ' A' ' 103' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 110.047 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.581 ' HB3' ' CE1' ' A' ' 38' ' ' TYR . 22.9 m . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 121.336 0.589 . . . . 0.0 109.572 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.5 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 10.6 t -92.36 -7.95 46.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.357 -0.84 . . . . 0.0 111.564 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.56 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -60.52 -118.19 0.01 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.543 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -140.15 174.75 10.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.952 -1.323 . . . . 0.0 110.235 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.02 ' CE2' HG23 ' A' ' 47' ' ' ILE . 37.7 m-85 -134.84 138.59 44.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.038 -1.039 . . . . 0.0 111.406 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.496 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 2.9 ttpt -106.53 116.92 32.76 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.425 -0.797 . . . . 0.0 109.175 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.742 HG22 HD13 ' A' ' 99' ' ' LEU . 46.3 t -59.58 125.12 15.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 120.625 -1.297 . . . . 0.0 109.647 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.726 HG23 ' HA ' ' A' ' 36' ' ' VAL . 80.3 t -97.03 -28.23 3.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.627 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -153.38 137.72 16.64 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.236 177.178 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -56.08 158.77 3.74 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.3 0.572 . . . . 0.0 110.285 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.999 HG12 HD22 ' A' ' 101' ' ' LEU . 0.7 OUTLIER -55.6 130.35 17.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.274 -0.971 . . . . 0.0 109.795 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.804 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -108.18 168.11 9.53 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 12.3 pt-20 -112.69 132.43 55.2 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.782 -1.199 . . . . 0.0 110.423 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.956 HG21 ' CD ' ' A' ' 80' ' ' GLU . 21.5 p -86.91 175.75 8.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.526 -0.734 . . . . 0.0 110.238 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -89.16 29.1 1.11 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.299 -0.876 . . . . 0.0 110.203 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -133.6 5.55 3.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.23 -0.919 . . . . 0.0 110.326 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.34 -0.3 58.45 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.876 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -95.02 -175.94 3.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.208 -1.172 . . . . 0.0 110.472 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.804 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -139.46 153.41 23.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.621 HG23 ' CG2' ' A' ' 27' ' ' THR . 70.0 t -118.51 135.31 59.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 O-C-N 121.192 -0.943 . . . . 0.0 111.765 -178.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.077 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -119.97 118.75 58.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 O-C-N 121.382 -0.824 . . . . 0.0 110.049 179.2 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.627 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.6 OUTLIER -100.19 123.51 44.5 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.123 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.812 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.3 m -147.85 162.86 6.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 121.082 -1.011 . . . . 0.0 108.819 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 74' ' ' ASP 0.254 10.2 tt0 -109.75 130.67 55.49 Favored 'General case' 0 C--N 1.27 -2.867 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.631 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.924 ' HB2' HG21 ' A' ' 70' ' ' VAL . 9.6 t80 -59.06 121.11 10.44 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.412 -178.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.496 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 5.8 mt-10 -106.86 21.18 17.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.107 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.56 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -115.84 -161.48 12.86 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.516 ' N ' ' OH ' ' A' ' 38' ' ' TYR . 13.5 t0 -125.66 145.19 50.27 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.455 -1.026 . . . . 0.0 110.245 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.21 -5.91 0.67 Allowed Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.421 -1.371 . . . . 0.0 111.02 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.615 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.7 OUTLIER 51.33 -153.06 0.01 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 120.436 -1.626 . . . . 0.0 108.198 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.615 ' HD2' ' CB ' ' A' ' 43' ' ' SER . 83.1 Cg_exo -41.47 96.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.321 -0.9 0 N-CA-C 109.241 -1.1 . . . . 0.0 109.241 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.867 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -145.59 169.29 18.71 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.339 0.59 . . . . 0.0 109.701 -178.162 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.63 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -82.74 174.85 10.61 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.223 -0.923 . . . . 0.0 111.829 -178.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.096 ' CD1' HG23 ' A' ' 70' ' ' VAL . 13.3 mm -123.64 123.74 26.3 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.835 -0.541 . . . . 0.0 111.396 -178.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.619 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 31.7 Cg_exo -61.47 143.89 97.68 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.109 1.584 . . . . 0.0 110.368 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.991 ' CE1' HG21 ' A' ' 79' ' ' ILE . 5.3 t80 -152.06 159.83 43.6 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 110.469 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.488 ' HB3' ' HB ' ' A' ' 91' ' ' ILE . 32.0 tp10 -178.74 100.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 110.037 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.656 HD11 ' HB1' ' A' ' 81' ' ' ALA . 36.0 mt . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.179 -0.951 . . . . 0.0 110.245 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.473 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.587 ' O ' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -154.69 167.64 29.5 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.273 -1.133 . . . . 0.0 109.297 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.058 HD23 ' HB2' ' A' ' 81' ' ' ALA . 11.7 mt -121.52 121.88 38.47 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 118.746 -1.182 . . . . 0.0 110.737 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.876 HG12 HG21 ' A' ' 31' ' ' THR . 1.4 mp -82.09 -26.8 9.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.708 HG22 ' O ' ' A' ' 65' ' ' THR 0.256 1.0 OUTLIER -96.67 33.19 1.89 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.241 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 1.048 HG23 ' O ' ' A' ' 63' ' ' LEU . 8.9 t -34.72 140.97 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.032 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.57 ' N ' ' CD ' ' A' ' 68' ' ' PRO . 22.1 t-20 56.99 46.34 2.07 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.608 -0.682 . . . . 0.0 110.422 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.582 ' CB ' ' CD1' ' A' ' 79' ' ' ILE . 9.2 Cg_endo -58.93 148.22 85.63 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.611 1.322 . . . . 0.0 108.979 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.867 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.7 OUTLIER -142.69 144.65 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 119.255 -0.978 . . . . 0.0 112.111 -178.151 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.096 HG23 ' CD1' ' A' ' 47' ' ' ILE . 54.4 t -94.2 153.02 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.94 -21.4 12.35 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 120.932 -1.105 . . . . 0.0 108.57 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.535 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 2.3 mt-10 -138.45 145.8 41.32 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.54 ' O ' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -54.23 -14.15 1.07 Allowed 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.989 -1.069 . . . . 0.0 110.773 -178.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.497 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 7.1 t70 -126.31 9.21 7.26 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.589 -1.32 . . . . 0.0 110.578 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.488 ' CB ' ' HB2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -73.18 111.86 13.35 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.119 -0.988 . . . . 0.0 108.776 178.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 22.2 Cg_exo -59.91 114.45 2.08 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.864 1.455 . . . . 0.0 110.536 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.678 HG21 HG22 ' A' ' 70' ' ' VAL . 53.0 t -95.79 150.99 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.23 -0.919 . . . . 0.0 110.54 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.656 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 11.2 m-80 -114.4 130.05 56.68 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.991 HG21 ' CE1' ' A' ' 49' ' ' PHE . 9.5 mm -112.73 118.28 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 117.638 -1.625 . . . . 0.0 111.934 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.956 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.7 tp10 -95.79 107.44 19.67 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 1.058 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -129.3 155.47 45.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.797 -1.19 . . . . 0.0 111.287 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 62' ' ' ARG . 43.8 tp10 -100.8 103.25 23.39 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.531 -0.731 . . . . 0.0 110.466 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.531 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 60.7 Cg_endo -77.68 152.44 29.26 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.958 1.504 . . . . 0.0 110.484 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.473 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 28.2 Cg_endo . . . . . 0 C--N 1.305 -1.738 0 O-C-N 123.993 1.523 . . . . 0.0 109.888 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.553 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 6.1 m-85 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.135 0.493 . . . . 0.0 109.992 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.792 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 2.0 mp -73.87 107.96 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.312 -0.868 . . . . 0.0 109.578 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.509 HG12 ' HG3' ' A' ' 100' ' ' LYS . 30.7 mt -91.97 148.29 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.264 -0.898 . . . . 0.0 110.468 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.077 HD11 HG21 ' A' ' 34' ' ' ILE . 1.8 mt -133.28 140.64 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.565 -0.709 . . . . 0.0 109.606 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.54 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 82.13 -161.4 41.46 Favored Glycine 0 N--CA 1.481 1.655 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.54 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -122.61 149.84 26.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 O-C-N 121.225 -1.162 . . . . 0.0 110.181 -179.627 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.578 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.9 OUTLIER -17.03 -58.24 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.189 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 8.2 Cg_endo -51.65 71.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 124.219 1.641 . . . . 0.0 112.171 179.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 89.51 1.23 78.24 Favored Glycine 0 N--CA 1.494 2.511 0 O-C-N 120.943 -1.098 . . . . 0.0 110.878 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.513 ' HB3' ' C ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -48.63 159.68 0.22 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.975 -1.309 . . . . 0.0 110.27 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.742 HD13 HG22 ' A' ' 20' ' ' VAL . 13.0 mt -96.14 176.91 5.91 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.296 -0.877 . . . . 0.0 110.418 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.509 ' HG3' HG12 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -157.19 138.8 14.02 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.309 -0.869 . . . . 0.0 110.408 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.999 HD22 HG12 ' A' ' 24' ' ' ILE . 3.5 mp -141.06 118.1 11.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.247 -0.908 . . . . 0.0 110.026 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 1.9 t-20 -87.44 129.74 34.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 110.759 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 8.5 t-105 . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 0.0 109.739 179.596 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.734 ' SG ' HD13 ' A' ' 47' ' ' ILE . 56.2 m . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 16' ' ' GLY . 3.2 t -79.13 -11.34 59.98 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.067 -1.02 . . . . 0.0 111.419 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.531 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -60.93 -131.76 0.01 OUTLIER Glycine 0 N--CA 1.485 1.944 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.539 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -130.1 -177.88 4.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -1.167 . . . . 0.0 109.809 -179.73 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.995 ' CE2' HG23 ' A' ' 47' ' ' ILE . 32.5 m-85 -137.6 141.87 41.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.741 -1.224 . . . . 0.0 111.968 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.485 ' HB2' ' OE2' ' A' ' 39' ' ' GLU . 33.3 ttpt -113.44 118.28 34.06 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.607 ' CG2' HD13 ' A' ' 99' ' ' LEU . 40.9 t -59.47 125.01 14.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 120.576 -1.328 . . . . 0.0 109.036 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.565 ' HB ' ' CG ' ' A' ' 35' ' ' ARG . 62.8 t -98.26 -27.16 3.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.608 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 3.0 tttp -156.77 133.12 9.9 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -50.87 162.13 0.3 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.716 0.769 . . . . 0.0 111.411 -178.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.656 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.7 OUTLIER -57.73 132.22 22.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 121.584 0.707 . . . . 0.0 110.289 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.603 ' HB3' ' HB ' ' A' ' 33' ' ' VAL . . . -109.17 163.17 13.59 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 5.3 pm0 -112.46 134.11 54.17 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.344 -1.472 . . . . 0.0 110.553 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.908 HG21 ' CD ' ' A' ' 80' ' ' GLU . 4.7 p -94.22 165.21 12.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.524 -0.735 . . . . 0.0 110.336 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -78.58 -1.02 32.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.42 -0.8 . . . . 0.0 110.123 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.06 3.51 55.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.9 . . . . 0.0 110.34 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.491 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 88.88 25.81 28.48 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.866 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -121.77 -177.17 3.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.54 -0.976 . . . . 0.0 110.363 -179.779 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.747 HD12 HD11 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -136.34 142.73 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.638 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.629 HG23 ' CG2' ' A' ' 27' ' ' THR . 43.0 t -110.26 133.81 54.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 O-C-N 121.47 -0.768 . . . . 0.0 112.279 -177.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.093 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -118.74 119.54 61.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 O-C-N 121.339 -0.85 . . . . 0.0 109.865 178.738 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.608 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 1.0 OUTLIER -101.86 123.34 45.62 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 179.428 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.781 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.5 m -148.79 161.45 5.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 108.773 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.488 ' N ' HG23 ' A' ' 21' ' ' VAL 0.254 0.1 OUTLIER -106.75 124.6 49.85 Favored 'General case' 0 C--N 1.273 -2.757 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -179.43 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.981 ' HB2' HG21 ' A' ' 70' ' ' VAL . 2.1 t80 -61.15 125.52 24.03 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.017 -1.073 . . . . 0.0 110.425 -178.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.485 ' OE2' ' HB2' ' A' ' 19' ' ' LYS . 22.2 mm-40 -98.08 -148.91 0.33 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.022 -1.049 . . . . 0.0 109.19 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.531 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 44.24 -145.5 1.77 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.471 ' HA ' ' HD2' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -134.52 143.62 47.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.679 -0.895 . . . . 0.0 110.139 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.94 -25.32 0.04 OUTLIER Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.42 -1.372 . . . . 0.0 110.95 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.617 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.4 OUTLIER 56.24 -156.1 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 120.726 -1.455 . . . . 0.0 108.267 -179.545 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.617 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 50.9 Cg_exo -48.45 92.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.506 0 N-CA-C 109.61 -0.958 . . . . 0.0 109.61 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.789 ' O ' HG23 ' A' ' 69' ' ' ILE . 21.8 p -143.32 167.75 21.43 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.422 -0.799 . . . . 0.0 110.389 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.699 ' CG ' HD11 ' A' ' 69' ' ' ILE . 47.0 mttp -85.38 154.99 21.5 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 122.142 0.972 . . . . 0.0 111.176 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.053 ' CD1' HG23 ' A' ' 70' ' ' VAL . 12.4 mm -101.92 123.32 44.14 Favored Pre-proline 0 C--N 1.297 -1.699 0 O-C-N 121.591 -0.693 . . . . 0.0 111.782 -177.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.626 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 32.2 Cg_exo -61.59 149.32 90.3 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.181 1.621 . . . . 0.0 110.457 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.999 ' CD1' HD11 ' A' ' 63' ' ' LEU . 5.9 t80 -159.4 155.25 26.34 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.389 -0.82 . . . . 0.0 110.165 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.772 ' O ' HD12 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -177.67 106.62 0.05 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.277 -0.889 . . . . 0.0 109.873 179.721 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 51' ' ' ILE . 3.0 mt . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.349 -0.844 . . . . 0.0 110.126 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.446 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.623 ' O ' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -159.19 166.57 31.14 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.256 -1.143 . . . . 0.0 109.617 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.018 HD23 ' HB2' ' A' ' 81' ' ' ALA . 11.3 mt -122.77 123.92 42.16 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 118.819 -1.152 . . . . 0.0 111.077 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.866 HG12 HG21 ' A' ' 31' ' ' THR . 1.5 mp -85.22 -28.45 6.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.774 HG22 ' O ' ' A' ' 65' ' ' THR 0.257 1.8 m -99.32 35.69 1.89 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.925 HG23 ' O ' ' A' ' 63' ' ' LEU . 43.0 t -37.85 152.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.667 0.746 . . . . 0.0 111.231 -178.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.685 ' ND2' HG12 ' A' ' 66' ' ' VAL . 24.5 p30 37.22 52.35 2.46 Favored Pre-proline 0 C--N 1.302 -1.47 0 O-C-N 121.968 -0.458 . . . . 0.0 111.568 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.927 ' CG ' HD12 ' A' ' 79' ' ' ILE . 1.9 Cg_endo -59.85 162.98 14.55 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 N-CA-C 108.363 -1.437 . . . . 0.0 108.363 178.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.789 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.8 OUTLIER -143.94 148.66 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 C-N-CA 118.817 -1.153 . . . . 0.0 112.744 -178.471 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.053 HG23 ' CD1' ' A' ' 47' ' ' ILE . 44.0 t -102.46 159.43 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 175.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.3 m -112.89 -19.85 11.8 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.809 -1.156 . . . . 0.0 111.448 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 16.3 mt-10 -131.38 15.14 5.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.777 -1.202 . . . . 0.0 111.502 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.535 ' O ' ' O ' ' A' ' 38' ' ' TYR . 2.3 ttpt 71.56 -5.58 1.6 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.221 -0.925 . . . . 0.0 111.034 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.477 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 7.8 t0 -137.76 -1.2 2.05 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.877 -1.14 . . . . 0.0 110.257 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.481 ' O ' HG23 ' A' ' 77' ' ' VAL . 47.7 t -72.6 112.26 14.32 Favored Pre-proline 0 N--CA 1.486 1.363 0 O-C-N 121.208 -0.932 . . . . 0.0 109.362 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 32.6 Cg_exo -51.56 111.8 0.67 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.82 1.431 . . . . 0.0 109.915 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.889 HG21 HG22 ' A' ' 70' ' ' VAL . 92.5 t -95.15 143.46 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.325 -0.859 . . . . 0.0 110.997 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.643 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.9 m120 -105.9 131.25 53.45 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.945 HG21 ' CD2' ' A' ' 49' ' ' PHE . 10.5 mm -116.35 119.89 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 117.567 -1.653 . . . . 0.0 111.767 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.908 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.1 tp10 -94.44 110.79 22.55 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.16 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 1.018 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -125.28 159.9 30.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.926 -1.109 . . . . 0.0 110.752 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.555 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -93.68 113.9 61.57 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.527 -0.733 . . . . 0.0 110.323 -179.284 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.683 ' HB3' HD11 ' A' ' 32' ' ' ILE . 46.4 Cg_endo -73.3 133.03 18.64 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.853 1.449 . . . . 0.0 110.525 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.446 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 19.4 Cg_endo . . . . . 0 C--N 1.306 -1.706 0 O-C-N 123.925 1.487 . . . . 0.0 109.928 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.587 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 3.2 m-85 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.215 0.531 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.799 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 5.2 mt -74.08 111.34 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.164 -0.96 . . . . 0.0 109.442 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.772 HD12 ' O ' ' A' ' 50' ' ' GLU . 2.1 mp -90.99 140.23 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.949 . . . . 0.0 110.178 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.093 HD11 HG21 ' A' ' 34' ' ' ILE . 1.4 mt -126.44 138.03 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.423 -0.798 . . . . 0.0 109.83 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.578 ' O ' ' HB2' ' A' ' 48' ' ' PRO . . . 85.99 -163.71 36.56 Favored Glycine 0 N--CA 1.482 1.754 0 C-N-CA 119.112 -1.518 . . . . 0.0 109.488 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.547 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -118.62 146.95 22.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 O-C-N 121.135 -1.215 . . . . 0.0 110.16 -179.623 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.578 ' O ' ' N ' ' A' ' 97' ' ' GLY . 3.9 mt-10 -16.89 -58.47 0.04 OUTLIER Pre-proline 0 N--CA 1.501 2.103 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 6.8 Cg_endo -51.08 72.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 124.219 1.641 . . . . 0.0 112.034 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 89.42 -1.35 81.92 Favored Glycine 0 N--CA 1.494 2.538 0 O-C-N 120.995 -1.065 . . . . 0.0 110.865 178.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.503 ' HB3' ' C ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -45.79 159.19 0.07 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.891 -1.358 . . . . 0.0 109.932 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.607 HD13 ' CG2' ' A' ' 20' ' ' VAL . 10.9 mt -96.68 177.44 5.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.245 -0.91 . . . . 0.0 110.645 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.428 ' C ' HD12 ' A' ' 101' ' ' LEU . 3.3 tttt -154.59 135.49 13.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.415 -0.803 . . . . 0.0 110.115 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.617 HD22 HG12 ' A' ' 24' ' ' ILE . 4.8 mp -137.16 122.44 19.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.181 -0.949 . . . . 0.0 110.328 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 3.7 t-20 -87.92 125.25 34.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 110.277 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.485 ' CD1' HD13 ' A' ' 32' ' ' ILE . 20.7 t-105 . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.905 . . . . 0.0 110.075 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.592 ' HB3' ' CE1' ' A' ' 38' ' ' TYR . 1.7 m . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 121.155 0.502 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.539 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 0.6 OUTLIER -126.85 15.28 7.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -0.909 . . . . 0.0 111.129 -179.227 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.596 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -69.94 -96.04 0.05 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.56 ' CD ' ' HA3' ' A' ' 97' ' ' GLY . 1.1 ttmt -149.4 161.27 42.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.04 -1.271 . . . . 0.0 109.833 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.002 ' CE2' HG23 ' A' ' 47' ' ' ILE . 50.3 m-85 -126.36 147.82 49.69 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.866 -1.146 . . . . 0.0 111.584 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.481 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 15.0 ttpp -114.15 115.88 28.21 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.595 -0.69 . . . . 0.0 109.161 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.717 ' CG2' HD13 ' A' ' 99' ' ' LEU . 43.5 t -59.63 123.03 11.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 120.541 -1.349 . . . . 0.0 109.049 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.839 HG21 ' HB3' ' A' ' 76' ' ' PRO . 53.2 t -96.82 -26.02 4.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.584 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 4.0 tttp -158.63 133.56 8.34 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -52.17 157.82 1.28 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.524 0.678 . . . . 0.0 111.063 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.798 HG13 HD13 ' A' ' 90' ' ' ILE . 0.6 OUTLIER -48.85 132.72 6.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.132 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 1.046 ' HB3' ' HB ' ' A' ' 33' ' ' VAL . . . -102.8 169.86 8.35 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 7.0 pm0 -113.54 132.24 55.78 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.924 -1.11 . . . . 0.0 110.519 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.547 HG21 ' CD ' ' A' ' 80' ' ' GLU . 11.1 p -90.1 178.76 6.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.408 -0.807 . . . . 0.0 109.865 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -95.62 31.87 1.94 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.168 -0.957 . . . . 0.0 110.183 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.88 10.42 2.41 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.256 -0.902 . . . . 0.0 110.315 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.35 -0.86 60.17 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.922 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -96.04 -177.17 3.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.274 -1.133 . . . . 0.0 110.291 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.81 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -140.22 178.95 2.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.616 -1.254 . . . . 0.0 107.616 178.175 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.046 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 64.8 t -138.92 124.01 21.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 118.909 -1.117 . . . . 0.0 111.838 -178.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.107 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -106.69 115.16 47.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.203 -0.936 . . . . 0.0 109.974 179.132 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.584 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -98.94 118.17 35.11 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.815 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.5 m -145.04 155.31 13.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.342 -0.848 . . . . 0.0 109.032 -178.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.523 ' CG ' ' O ' ' A' ' 74' ' ' ASP 0.252 0.2 OUTLIER -103.5 123.41 46.84 Favored 'General case' 0 C--N 1.272 -2.776 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.277 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.75 ' HB2' HG21 ' A' ' 70' ' ' VAL . 23.8 t80 -60.37 120.57 10.13 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 118.783 -1.167 . . . . 0.0 110.481 -178.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 17' ' ' LYS . 4.1 mt-10 -91.56 -26.09 18.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.466 -0.771 . . . . 0.0 109.321 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.596 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -63.75 -161.3 0.38 Allowed Glycine 0 N--CA 1.484 1.834 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.52 ' N ' ' OH ' ' A' ' 38' ' ' TYR . 15.8 p-10 -127.55 134.76 49.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.511 -0.994 . . . . 0.0 110.162 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 43' ' ' SER . . . 171.83 -23.4 0.08 OUTLIER Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.458 -1.353 . . . . 0.0 110.575 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.612 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.6 OUTLIER 61.42 -154.38 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.688 -1.478 . . . . 0.0 108.096 -179.541 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.612 ' HD2' ' CB ' ' A' ' 43' ' ' SER . 87.6 Cg_exo -42.24 96.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -0.994 0 N-CA-C 109.042 -1.176 . . . . 0.0 109.042 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.959 ' O ' HG23 ' A' ' 69' ' ' ILE . 31.5 p -151.47 -178.8 6.89 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.919 -0.488 . . . . 0.0 109.864 -177.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.635 ' O ' HD13 ' A' ' 47' ' ' ILE . 12.0 mtpt -94.57 170.17 9.67 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.975 -1.078 . . . . 0.0 111.305 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.07 ' CD1' HG23 ' A' ' 70' ' ' VAL . 11.6 mm -122.84 130.41 24.63 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.444 -0.785 . . . . 0.0 112.384 -177.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.623 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 38.1 Cg_exo -64.16 143.01 82.76 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 124.197 1.63 . . . . 0.0 110.793 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 1.006 ' CZ ' HG23 ' A' ' 90' ' ' ILE . 16.5 t80 -152.99 162.17 41.65 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.288 -0.883 . . . . 0.0 110.501 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.822 ' HG2' HD12 ' A' ' 91' ' ' ILE . 37.2 tt0 178.61 89.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.131 -0.981 . . . . 0.0 110.459 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 1.06 HD11 ' HB1' ' A' ' 81' ' ' ALA . 6.7 mt . . . . . 0 N--CA 1.493 1.706 0 O-C-N 121.175 -0.953 . . . . 0.0 109.958 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 83' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -140.35 167.45 22.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -1.052 . . . . 0.0 109.985 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.884 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -117.28 120.68 38.98 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.382 -0.824 . . . . 0.0 108.928 179.414 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.922 HG12 HG21 ' A' ' 31' ' ' THR . 1.4 mp -81.6 -29.88 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.814 ' C ' HD12 ' A' ' 63' ' ' LEU 0.266 1.5 m -97.74 36.79 1.47 Allowed 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.807 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.884 HG23 ' O ' ' A' ' 63' ' ' LEU . 24.2 t -29.16 119.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.279 -178.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.502 ' OD1' ' HE3' ' A' ' 46' ' ' LYS . 3.8 t-20 59.62 69.1 1.34 Allowed Pre-proline 0 C--N 1.298 -1.632 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.969 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.676 ' HG3' HG23 ' A' ' 79' ' ' ILE . 5.3 Cg_exo -65.41 171.27 9.57 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.044 1.549 . . . . 0.0 109.575 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.959 HG23 ' O ' ' A' ' 45' ' ' CYS . 1.1 mt -145.56 141.22 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 118.99 -1.084 . . . . 0.0 112.264 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.07 HG23 ' CD1' ' A' ' 47' ' ' ILE . 46.2 t -93.07 165.54 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.438 ' O ' ' HD3' ' A' ' 44' ' ' PRO . 2.2 m -118.44 -24.34 6.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.782 -1.199 . . . . 0.0 111.113 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.526 ' O ' ' HB3' ' A' ' 73' ' ' LYS . 2.5 mt-10 -131.37 13.84 5.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.941 -1.099 . . . . 0.0 110.711 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.526 ' HB3' ' O ' ' A' ' 72' ' ' GLU . 14.3 ttpt 74.78 -10.69 1.15 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.657 -0.652 . . . . 0.0 111.074 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.523 ' O ' ' CG ' ' A' ' 37' ' ' GLN . 8.2 t0 -134.07 -3.24 2.82 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.971 -1.081 . . . . 0.0 110.359 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 77' ' ' VAL . 12.7 t -72.83 112.51 15.54 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.179 -0.951 . . . . 0.0 109.286 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.839 ' HB3' HG21 ' A' ' 21' ' ' VAL . 34.3 Cg_exo -51.04 111.41 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.858 1.452 . . . . 0.0 109.899 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 75' ' ' SER . 98.5 t -96.01 144.34 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.353 -0.842 . . . . 0.0 111.166 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.625 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.9 m120 -100.04 130.51 46.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.534 -0.729 . . . . 0.0 109.5 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.707 HG21 ' CD1' ' A' ' 49' ' ' PHE . 5.5 mt -109.66 116.21 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 117.902 -1.519 . . . . 0.0 110.912 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.778 ' OE1' HG22 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -84.08 117.25 23.32 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.812 179.476 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 1.06 ' HB1' HD11 ' A' ' 51' ' ' ILE . . . -135.92 146.85 47.78 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.959 -1.088 . . . . 0.0 111.248 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.629 ' HB2' HG23 ' A' ' 31' ' ' THR . 29.2 tt0 -106.09 86.93 2.19 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.452 -0.78 . . . . 0.0 110.727 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.672 ' HG3' HD11 ' A' ' 32' ' ' ILE . 56.8 Cg_endo -75.12 160.57 39.6 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.812 1.428 . . . . 0.0 110.348 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' A' ' 61' ' ' GLY . 12.5 Cg_endo . . . . . 0 C--N 1.304 -1.801 0 O-C-N 123.963 1.507 . . . . 0.0 110.0 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 15.8 m-85 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.233 0.54 . . . . 0.0 109.716 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 1.006 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 2.1 mp -74.09 108.29 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.926 . . . . 0.0 109.907 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.822 HD12 ' HG2' ' A' ' 50' ' ' GLU . 94.9 mt -89.17 142.53 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -0.899 . . . . 0.0 110.045 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.107 HD11 HG21 ' A' ' 34' ' ' ILE . 1.5 mt -133.24 141.0 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.4 -0.812 . . . . 0.0 110.111 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' A' ' 48' ' ' PRO . . . 80.59 -155.99 38.19 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' ' 15' ' ' THR . 0.1 OUTLIER -130.45 154.75 41.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.062 -1.258 . . . . 0.0 111.226 -179.394 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.568 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 1.7 mm-40 -28.44 -55.12 0.25 Allowed Pre-proline 0 N--CA 1.499 2.02 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.635 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 86.8 Cg_exo -34.02 -30.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.993 1.522 . . . . 0.0 111.011 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.56 ' HA3' ' CD ' ' A' ' 17' ' ' LYS . . . 179.34 37.83 0.07 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.371 -1.892 . . . . 0.0 108.371 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.524 ' HB2' ' N ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -72.15 160.3 32.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.807 -0.819 . . . . 0.0 110.881 -179.05 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.717 HD13 ' CG2' ' A' ' 20' ' ' VAL . 9.4 mt -101.16 179.29 4.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.392 -0.818 . . . . 0.0 110.139 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.706 ' C ' HD12 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -156.8 135.48 11.6 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.337 -0.852 . . . . 0.0 110.456 179.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.706 HD12 ' C ' ' A' ' 100' ' ' LYS . 5.7 mp -137.17 118.8 14.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.371 -0.831 . . . . 0.0 109.737 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 4.7 p-10 -88.25 131.94 34.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.853 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.457 ' HA ' ' CE3' ' A' ' 103' ' ' TRP . 3.5 t-105 . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.101 -1.0 . . . . 0.0 110.265 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.574 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 22.6 m . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 121.366 0.603 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.489 ' O ' ' O ' ' A' ' 16' ' ' GLY . 0.9 OUTLIER -86.65 -9.1 56.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.464 -0.773 . . . . 0.0 111.935 -178.359 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.584 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -59.55 -124.46 0.01 OUTLIER Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.489 -1.339 . . . . 0.0 109.84 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.552 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -135.75 173.86 11.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.018 -1.283 . . . . 0.0 109.99 -179.568 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.017 ' CE2' HG23 ' A' ' 47' ' ' ILE . 34.6 m-85 -133.44 136.89 45.47 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.969 -1.082 . . . . 0.0 111.51 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.467 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 23.4 ttpt -108.21 120.54 42.66 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.627 -0.671 . . . . 0.0 109.366 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.484 HG22 HD13 ' A' ' 99' ' ' LEU . 34.5 t -59.76 131.49 24.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.85 -1.156 . . . . 0.0 109.043 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.641 HG23 ' HA ' ' A' ' 36' ' ' VAL . 92.3 t -105.28 -26.39 3.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 1.8 tttp -157.37 133.61 9.65 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -51.94 159.58 0.84 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.723 0.773 . . . . 0.0 111.327 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.832 HG12 HD22 ' A' ' 101' ' ' LEU . 0.7 OUTLIER -55.79 132.04 19.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-O 121.577 0.703 . . . . 0.0 110.476 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' A' ' 33' ' ' VAL . . . -109.57 158.95 17.51 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.498 ' N ' ' OE1' ' A' ' 26' ' ' GLU . 7.0 pm0 -110.43 133.35 53.36 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 120.166 -1.584 . . . . 0.0 110.494 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.893 HG21 ' OE2' ' A' ' 80' ' ' GLU . 2.8 p -92.14 169.5 10.57 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.567 -0.708 . . . . 0.0 110.216 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.88 -16.34 60.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 110.538 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -80.41 0.47 33.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.085 -1.009 . . . . 0.0 110.34 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.73 8.1 60.99 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.888 HG22 ' C ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -98.39 175.34 6.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.314 -1.11 . . . . 0.0 110.381 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 1.008 HD13 ' CD1' ' A' ' 103' ' ' TRP . 0.0 OUTLIER -129.17 141.86 45.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.764 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.57 ' N ' ' O ' ' A' ' 25' ' ' ALA . 24.6 t -109.6 132.53 57.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 O-C-N 121.441 -0.787 . . . . 0.0 111.847 -177.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.081 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -118.28 121.29 66.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.435 -0.791 . . . . 0.0 109.413 178.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.574 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -105.67 111.19 23.78 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.866 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.5 m -131.09 -168.12 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.474 ' N ' HG23 ' A' ' 36' ' ' VAL . 4.2 tt0 -135.86 128.2 30.22 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.896 ' HB2' HG21 ' A' ' 70' ' ' VAL . 1.7 t80 -60.25 124.01 18.96 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 118.633 -1.227 . . . . 0.0 110.032 -178.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 17' ' ' LYS . 2.4 mm-40 -116.61 86.19 2.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -0.887 . . . . 0.0 110.09 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.584 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 165.0 -150.38 18.24 Favored Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.425 -1.369 . . . . 0.0 109.986 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.462 ' O ' ' OH ' ' A' ' 38' ' ' TYR . 0.5 OUTLIER -113.24 128.62 56.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.665 -0.903 . . . . 0.0 110.408 -179.75 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 43' ' ' SER . . . 177.77 -26.71 0.06 OUTLIER Glycine 0 N--CA 1.487 2.087 0 C-N-CA 119.555 -1.307 . . . . 0.0 110.57 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.599 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.5 OUTLIER 48.94 -154.89 0.01 OUTLIER Pre-proline 0 N--CA 1.487 1.378 0 O-C-N 120.706 -1.467 . . . . 0.0 107.779 -179.58 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.599 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 53.3 Cg_exo -46.84 94.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.259 0 N-CA-C 108.241 -1.484 . . . . 0.0 108.241 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.719 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -148.97 173.15 13.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.615 -0.678 . . . . 0.0 109.853 -177.681 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.704 ' HG3' HD11 ' A' ' 69' ' ' ILE . 28.5 mttm -87.82 175.13 7.97 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.309 -0.87 . . . . 0.0 111.61 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.07 HD11 ' CG2' ' A' ' 70' ' ' VAL . 16.0 mm -119.92 128.82 25.66 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.499 -0.75 . . . . 0.0 112.237 -177.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.62 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 29.8 Cg_exo -65.31 144.75 81.61 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 121.593 1.529 . . . . 0.0 110.993 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.638 ' CD1' HG21 ' A' ' 79' ' ' ILE . 10.9 t80 -155.69 159.01 39.19 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.226 -0.921 . . . . 0.0 110.088 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.758 ' HG2' HD12 ' A' ' 91' ' ' ILE . 21.3 tt0 -175.17 114.54 0.15 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.981 -1.074 . . . . 0.0 110.496 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.995 HG21 ' HB3' ' A' ' 83' ' ' PRO . 10.0 mt . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.28 -0.887 . . . . 0.0 110.057 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.534 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.493 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -122.91 164.27 18.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.13 -1.217 . . . . 0.0 110.65 -179.65 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.821 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -129.73 110.84 12.09 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.569 -0.707 . . . . 0.0 109.529 179.109 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.873 ' CG1' HG21 ' A' ' 31' ' ' THR . 5.5 mm -69.02 -33.34 58.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 122.342 1.068 . . . . 0.0 108.328 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.638 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.259 0.7 OUTLIER -100.99 31.33 3.65 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.375 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 63' ' ' LEU . 42.7 t -15.03 109.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.927 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.524 ' ND2' ' HD3' ' A' ' 46' ' ' LYS . 19.2 t-20 47.12 69.25 2.8 Favored Pre-proline 0 C--N 1.3 -1.58 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.785 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.561 ' O ' ' HA ' ' A' ' 46' ' ' LYS . 3.0 Cg_endo -50.06 -176.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.074 1.565 . . . . 0.0 109.538 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.719 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.7 OUTLIER -141.96 144.09 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 119.171 -1.012 . . . . 0.0 112.171 -178.869 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.07 ' CG2' HD11 ' A' ' 47' ' ' ILE . 21.5 t -100.97 166.29 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.9 m -123.84 -15.41 6.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.745 -1.222 . . . . 0.0 111.166 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 26.1 mt-10 -140.03 14.48 2.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.929 -1.107 . . . . 0.0 111.016 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.1 OUTLIER 74.34 -9.83 1.23 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.42 -0.8 . . . . 0.0 111.006 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.476 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 6.9 t70 -135.96 0.18 2.61 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.932 -1.105 . . . . 0.0 110.059 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.499 ' O ' HG23 ' A' ' 77' ' ' VAL . 22.0 t -72.54 108.21 4.05 Favored Pre-proline 0 N--CA 1.486 1.344 0 O-C-N 121.201 -0.937 . . . . 0.0 108.826 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.624 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 5.6 Cg_exo -45.07 130.71 10.72 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.757 1.398 . . . . 0.0 110.117 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.889 HG21 HG22 ' A' ' 70' ' ' VAL . 74.8 t -115.35 145.03 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.041 -1.037 . . . . 0.0 111.351 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.694 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.0 m-20 -106.52 133.25 51.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.516 -0.74 . . . . 0.0 109.597 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.663 ' HB ' HG22 ' A' ' 34' ' ' ILE . 3.6 mt -118.15 118.86 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 117.65 -1.62 . . . . 0.0 111.364 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.893 ' OE2' HG21 ' A' ' 27' ' ' THR . 1.7 tp10 -94.45 109.77 21.62 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.888 ' C ' HG22 ' A' ' 31' ' ' THR . . . -118.24 147.34 43.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.041 -1.037 . . . . 0.0 110.774 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.583 ' HB2' HG23 ' A' ' 31' ' ' THR . 4.6 tt0 -112.37 58.64 0.55 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.45 -0.781 . . . . 0.0 111.051 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.995 ' HB3' HG21 ' A' ' 51' ' ' ILE . 37.1 Cg_endo -69.73 162.02 43.66 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.727 1.383 . . . . 0.0 110.63 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.503 ' HD3' ' HA2' ' A' ' 61' ' ' GLY . 23.4 Cg_exo . . . . . 0 C--N 1.305 -1.726 0 O-C-N 124.096 1.577 . . . . 0.0 110.594 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.57 ' CE1' ' OD1' ' A' ' 102' ' ' ASN . 85.3 m-85 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.131 0.491 . . . . 0.0 109.842 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.855 HD11 HD12 ' A' ' 32' ' ' ILE . 88.1 mt -73.71 134.16 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.179 -0.951 . . . . 0.0 109.475 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.758 HD12 ' HG2' ' A' ' 50' ' ' GLU . 57.5 mt -106.42 145.71 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.122 -0.987 . . . . 0.0 110.981 -179.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.081 HD11 HG21 ' A' ' 34' ' ' ILE . 1.9 mt -132.77 139.21 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.538 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 83.22 -159.52 37.35 Favored Glycine 0 N--CA 1.481 1.665 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.55 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -123.86 150.08 28.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 121.183 -1.187 . . . . 0.0 110.194 -179.568 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.574 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.7 OUTLIER -19.1 -57.47 0.05 OUTLIER Pre-proline 0 N--CA 1.5 2.045 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 10.3 Cg_endo -53.18 70.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 124.214 1.639 . . . . 0.0 111.952 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 90.76 5.11 69.0 Favored Glycine 0 N--CA 1.494 2.531 0 O-C-N 121.012 -1.055 . . . . 0.0 110.985 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.503 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -51.46 160.77 0.55 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.998 -1.295 . . . . 0.0 110.187 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' A' ' 18' ' ' PHE . 8.4 mt -97.52 177.4 5.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.214 -0.929 . . . . 0.0 110.35 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -159.14 141.35 13.77 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.266 -0.896 . . . . 0.0 110.456 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.832 HD22 HG12 ' A' ' 24' ' ' ILE . 3.0 mp -141.11 120.82 13.4 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.242 -0.911 . . . . 0.0 110.239 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.57 ' OD1' ' CE1' ' A' ' 89' ' ' TYR . 4.0 t30 -72.13 131.2 42.49 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.292 -0.88 . . . . 0.0 110.7 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 1.008 ' CD1' HD13 ' A' ' 32' ' ' ILE . 6.9 t-105 . . . . . 0 N--CA 1.492 1.63 0 O-C-N 120.823 -1.173 . . . . 0.0 111.193 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 4.0 m . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 16' ' ' GLY . 49.4 p -64.56 -11.31 33.24 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.491 -0.756 . . . . 0.0 111.33 -178.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.537 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -60.08 -145.97 0.01 OUTLIER Glycine 0 N--CA 1.481 1.675 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.546 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -127.91 174.42 9.18 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.299 -1.118 . . . . 0.0 109.345 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.075 ' CE2' HG23 ' A' ' 47' ' ' ILE . 46.9 m-85 -131.24 133.62 45.63 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.743 -1.223 . . . . 0.0 112.099 -179.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -108.01 121.62 45.17 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.575 ' CG2' HD13 ' A' ' 99' ' ' LEU . 48.0 t -59.66 130.39 23.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.196 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.626 HG23 ' HA ' ' A' ' 36' ' ' VAL . 69.7 t -105.21 -26.91 3.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.566 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 19.6 tttt -156.32 133.06 10.3 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.15 155.95 1.77 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.542 0.687 . . . . 0.0 111.215 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.69 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -50.98 132.51 12.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.536 -0.727 . . . . 0.0 109.862 179.839 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.83 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -107.23 170.58 7.87 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 5.2 pm0 -116.36 130.58 56.84 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.809 -1.182 . . . . 0.0 110.569 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.94 HG21 ' OE2' ' A' ' 80' ' ' GLU . 14.5 p -89.2 173.93 8.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.361 -0.837 . . . . 0.0 110.056 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -88.07 29.2 0.96 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.154 -0.966 . . . . 0.0 110.472 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -132.25 6.19 4.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.16 -0.962 . . . . 0.0 110.291 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.77 -2.46 60.3 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.996 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -92.54 -178.14 4.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.303 -1.116 . . . . 0.0 110.384 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.83 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -139.18 158.46 28.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.568 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.81 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 73.6 t -123.08 128.15 74.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 C-N-CA 118.933 -1.107 . . . . 0.0 112.372 -177.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.054 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -111.24 118.47 57.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 121.357 -0.84 . . . . 0.0 109.716 178.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.566 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 2.9 ttm180 -104.71 114.65 29.0 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.765 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.6 m -133.46 -168.46 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 O-C-N 121.469 -0.769 . . . . 0.0 109.31 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.478 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 9.8 tt0 -135.14 126.25 27.93 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.94 ' HB2' HG21 ' A' ' 70' ' ' VAL . 1.5 t80 -61.04 127.32 30.95 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.975 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 17' ' ' LYS . 3.5 mt-10 -125.28 89.63 3.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.044 -1.035 . . . . 0.0 110.172 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.537 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 162.45 -151.69 21.69 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.51 ' HA ' ' HD2' ' A' ' 73' ' ' LYS . 11.1 t0 -107.48 118.23 36.18 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.565 -0.962 . . . . 0.0 110.217 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.06 -36.48 0.04 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.601 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER 52.43 -158.15 0.01 OUTLIER Pre-proline 0 C--N 1.305 -1.346 0 O-C-N 120.945 -1.327 . . . . 0.0 108.665 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.601 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 76.2 Cg_exo -45.21 93.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.229 0 N-CA-C 109.376 -1.048 . . . . 0.0 109.376 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.735 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -154.92 175.65 13.52 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.611 -0.681 . . . . 0.0 109.811 -179.093 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.625 ' HG3' ' CD1' ' A' ' 69' ' ' ILE . 2.6 mttp -82.01 175.37 10.42 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.393 -0.817 . . . . 0.0 112.07 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.075 HG23 ' CE2' ' A' ' 18' ' ' PHE . 16.8 mm -120.03 128.01 26.07 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.636 -0.665 . . . . 0.0 111.672 -178.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.632 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 34.2 Cg_exo -63.06 145.1 93.84 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 124.043 1.549 . . . . 0.0 110.495 178.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.874 ' CD2' HG21 ' A' ' 79' ' ' ILE . 5.4 t80 -154.11 162.45 41.18 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.268 -0.895 . . . . 0.0 110.101 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.878 ' O ' HD12 ' A' ' 91' ' ' ILE . 7.0 tp10 -179.19 97.88 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.192 -0.943 . . . . 0.0 110.03 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 1.079 HD11 ' HB1' ' A' ' 81' ' ' ALA . 16.1 mt . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.161 -0.962 . . . . 0.0 110.575 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.51 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.528 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -137.75 168.29 19.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.197 -1.178 . . . . 0.0 110.416 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.843 HD12 ' N ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -122.59 122.68 39.43 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.581 -0.699 . . . . 0.0 109.295 179.161 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.996 HG12 HG21 ' A' ' 31' ' ' THR . 1.4 mp -85.3 -30.73 6.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.825 HG22 ' O ' ' A' ' 65' ' ' THR 0.262 2.9 m -107.75 42.87 1.27 Allowed 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.258 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.843 ' N ' HD12 ' A' ' 63' ' ' LEU . 18.7 t -30.07 121.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-O 121.604 0.716 . . . . 0.0 111.503 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.497 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 12.9 t-20 43.09 71.91 1.31 Allowed Pre-proline 0 C--N 1.297 -1.683 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.617 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.796 ' HG3' HG23 ' A' ' 79' ' ' ILE . 1.1 Cg_endo -56.0 -171.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.909 1.479 . . . . 0.0 108.967 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.735 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.8 OUTLIER -143.6 148.01 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 119.041 -1.064 . . . . 0.0 112.285 -179.241 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.004 ' CG2' HD11 ' A' ' 47' ' ' ILE . 54.3 t -104.79 164.69 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 176.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.3 m -118.89 -19.39 8.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.878 -1.139 . . . . 0.0 111.5 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.528 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 19.0 mt-10 -140.2 18.78 2.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.76 -1.213 . . . . 0.0 111.386 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.548 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 9.0 ttpt 72.61 -6.7 1.56 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.247 -0.908 . . . . 0.0 110.949 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.468 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 18.1 t0 -137.94 -2.2 1.92 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.0 -1.062 . . . . 0.0 110.33 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.553 ' O ' HG23 ' A' ' 77' ' ' VAL . 10.2 t -72.64 112.42 15.01 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.071 -1.018 . . . . 0.0 108.939 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.625 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 50.5 Cg_exo -47.82 128.2 15.64 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.9 1.474 . . . . 0.0 110.067 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.95 HG21 HG22 ' A' ' 70' ' ' VAL . 66.3 t -114.94 142.32 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.04 -1.038 . . . . 0.0 111.534 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.679 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.1 m-20 -104.99 133.43 49.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.468 -0.77 . . . . 0.0 109.312 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.874 HG21 ' CD2' ' A' ' 49' ' ' PHE . 5.5 mt -117.39 119.66 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.075 -1.641 . . . . 0.0 111.582 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.94 ' OE2' HG21 ' A' ' 27' ' ' THR . 1.9 tp10 -91.84 115.92 28.46 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.229 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 1.079 ' HB1' HD11 ' A' ' 51' ' ' ILE . . . -131.85 151.7 51.52 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.982 -1.074 . . . . 0.0 110.775 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.528 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 35.2 tt0 -100.76 103.09 22.18 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.234 -0.916 . . . . 0.0 110.247 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.536 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 42.8 Cg_endo -73.6 145.85 37.98 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.032 1.543 . . . . 0.0 110.655 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.51 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 43.8 Cg_endo . . . . . 0 C--N 1.304 -1.785 0 O-C-N 124.154 1.607 . . . . 0.0 110.256 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 8.5 m-85 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.242 0.544 . . . . 0.0 110.044 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.734 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 1.7 mp -74.32 121.94 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.194 -0.941 . . . . 0.0 109.81 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.878 HD12 ' O ' ' A' ' 50' ' ' GLU . 3.2 mt -101.06 145.88 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.17 -0.956 . . . . 0.0 110.04 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.054 HD11 HG21 ' A' ' 34' ' ' ILE . 4.0 mt -132.73 146.18 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.465 -0.772 . . . . 0.0 110.359 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.544 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 78.74 -161.05 47.59 Favored Glycine 0 N--CA 1.484 1.896 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.528 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.1 OUTLIER -124.19 140.98 45.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.187 -1.184 . . . . 0.0 110.866 -179.632 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.559 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.8 OUTLIER -16.6 -58.97 0.04 OUTLIER Pre-proline 0 N--CA 1.505 2.309 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 24.4 Cg_exo -32.32 -32.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 124.013 1.533 . . . . 0.0 110.956 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.546 ' HA3' ' CG ' ' A' ' 17' ' ' LYS . . . -175.67 35.98 0.1 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.58 ' HG3' HG23 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -71.43 164.69 25.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.697 -0.884 . . . . 0.0 110.74 -179.247 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.575 HD13 ' CG2' ' A' ' 20' ' ' VAL . 8.2 mt -100.99 176.95 5.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.432 -0.793 . . . . 0.0 110.128 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.469 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -154.84 135.59 13.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.318 -0.864 . . . . 0.0 110.259 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.643 HD12 ' O ' ' A' ' 90' ' ' ILE . 2.4 mp -142.02 122.87 14.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.267 -0.895 . . . . 0.0 110.231 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 7.4 p-10 -86.02 131.31 34.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.15 -0.969 . . . . 0.0 110.241 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 49.4 t-105 . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.949 . . . . 0.0 110.317 -179.991 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 56.4 m . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.515 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -83.35 -4.6 58.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.302 -0.874 . . . . 0.0 111.656 -178.553 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -61.23 -128.75 0.01 OUTLIER Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.544 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -123.24 176.29 6.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.235 -1.156 . . . . 0.0 109.971 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.98 ' CE2' HG23 ' A' ' 47' ' ' ILE . 34.4 m-85 -135.93 141.38 44.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.879 -1.138 . . . . 0.0 111.704 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -112.33 117.62 32.99 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.638 ' CG2' HD13 ' A' ' 99' ' ' LEU . 44.2 t -59.67 123.94 13.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 120.586 -1.321 . . . . 0.0 108.94 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.744 HG21 ' HB3' ' A' ' 76' ' ' PRO . 53.9 t -97.62 -26.63 3.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.605 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 18.8 tttt -157.17 133.21 9.56 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -50.62 161.69 0.31 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.694 0.759 . . . . 0.0 111.325 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.716 HG13 HD13 ' A' ' 90' ' ' ILE . 0.7 OUTLIER -55.83 132.64 19.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-O 121.716 0.769 . . . . 0.0 110.311 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.724 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -109.5 167.22 10.29 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 6.9 pm0 -113.91 130.37 56.51 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 120.595 -1.316 . . . . 0.0 110.681 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.534 HG22 HG23 ' A' ' 33' ' ' VAL . 8.4 p -81.72 -167.59 1.57 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.455 -0.778 . . . . 0.0 110.005 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -103.94 23.02 13.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 110.281 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -128.48 7.08 5.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.204 -0.935 . . . . 0.0 110.178 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.479 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 97.95 0.94 58.61 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.975 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -91.93 -177.28 4.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.285 -1.127 . . . . 0.0 110.254 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.824 HD12 HD11 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -140.69 150.4 20.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.611 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.703 HG22 ' HG3' ' A' ' 80' ' ' GLU . 69.7 t -116.5 131.71 68.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 O-C-N 121.151 -0.968 . . . . 0.0 111.875 -178.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.075 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -114.72 117.06 54.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.401 -0.812 . . . . 0.0 109.694 179.056 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.605 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -98.65 122.41 41.84 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.864 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.777 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.7 m -149.25 158.17 6.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.942 0.877 . . . . 0.0 109.022 -178.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.503 ' NE2' ' HD3' ' A' ' 76' ' ' PRO 0.256 2.7 tt0 -104.43 122.33 45.28 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.318 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.894 ' HB2' HG21 ' A' ' 70' ' ' VAL . 7.6 t80 -61.47 144.98 53.29 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.081 -1.047 . . . . 0.0 110.148 -178.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 17' ' ' LYS . 45.3 mm-40 -119.19 -143.8 0.36 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.276 -0.89 . . . . 0.0 108.848 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 43.86 -139.77 3.62 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.445 ' HA ' ' HD2' ' A' ' 73' ' ' LYS . 1.3 m-20 -135.18 143.35 46.4 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.737 -0.861 . . . . 0.0 110.001 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.02 -27.17 0.05 OUTLIER Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.475 -1.345 . . . . 0.0 110.626 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.643 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.4 OUTLIER 56.31 -153.88 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 120.637 -1.508 . . . . 0.0 108.324 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.643 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 38.9 Cg_exo -53.5 90.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 N-CA-C 109.981 -0.815 . . . . 0.0 109.981 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.703 ' O ' HG23 ' A' ' 69' ' ' ILE . 6.6 p -142.46 173.68 11.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.137 -0.977 . . . . 0.0 110.541 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.774 ' HG3' HD11 ' A' ' 69' ' ' ILE . 12.1 mtmm -84.42 168.97 15.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.411 -0.806 . . . . 0.0 111.347 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.031 HD11 ' CG2' ' A' ' 70' ' ' VAL . 13.3 mm -112.06 127.18 27.21 Favored Pre-proline 0 C--N 1.304 -1.391 0 O-C-N 121.241 -0.912 . . . . 0.0 112.31 -177.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.635 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 34.6 Cg_exo -63.71 144.17 88.55 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 124.055 1.555 . . . . 0.0 110.258 178.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.863 ' CD2' HG21 ' A' ' 79' ' ' ILE . 7.1 t80 -153.05 162.01 41.83 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.259 -0.9 . . . . 0.0 110.603 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.63 ' O ' HD12 ' A' ' 91' ' ' ILE . 9.4 tp10 -179.83 108.7 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.345 -0.847 . . . . 0.0 109.729 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 1.057 HD11 ' HB1' ' A' ' 81' ' ' ALA . 5.0 mt . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.064 -1.023 . . . . 0.0 110.547 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.541 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -149.43 170.16 19.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.216 -1.167 . . . . 0.0 110.812 -179.682 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.827 HD12 ' N ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -119.7 121.99 40.46 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.422 179.302 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.975 HG12 HG21 ' A' ' 31' ' ' THR . 1.3 mp -84.69 -30.86 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.83 HG22 ' O ' ' A' ' 65' ' ' THR 0.259 1.9 m -108.52 43.84 1.19 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.159 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.827 ' N ' HD12 ' A' ' 63' ' ' LEU . 9.0 t -29.52 135.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 CA-C-O 121.33 0.586 . . . . 0.0 111.396 -178.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.782 ' ND2' HG12 ' A' ' 66' ' ' VAL . 23.6 p30 26.52 73.14 0.37 Allowed Pre-proline 0 N--CA 1.49 1.538 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.753 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.581 ' O ' ' HA ' ' A' ' 46' ' ' LYS . 3.2 Cg_endo -57.1 -174.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.902 1.475 . . . . 0.0 108.821 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.774 HD11 ' HG3' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -140.83 142.57 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 C-N-CA 118.847 -1.141 . . . . 0.0 112.346 -179.071 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.031 ' CG2' HD11 ' A' ' 47' ' ' ILE . 46.6 t -98.63 160.05 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 176.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.5 m -113.8 -21.65 10.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.954 -1.092 . . . . 0.0 110.964 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.512 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 6.6 mt-10 -132.02 15.62 4.7 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.963 -1.086 . . . . 0.0 111.05 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.53 ' O ' ' O ' ' A' ' 38' ' ' TYR . 0.2 OUTLIER 72.37 -4.36 2.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.353 -0.842 . . . . 0.0 110.984 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.47 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 12.6 t70 -137.38 1.87 2.44 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.06 -1.025 . . . . 0.0 110.188 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.739 ' O ' HG23 ' A' ' 77' ' ' VAL . 40.3 t -73.0 109.28 5.87 Favored Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.192 -0.943 . . . . 0.0 109.454 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.744 ' HB3' HG21 ' A' ' 21' ' ' VAL . 3.7 Cg_endo -52.59 111.15 0.57 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.817 1.43 . . . . 0.0 109.713 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 75' ' ' SER . 48.7 t -102.65 145.49 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.331 -0.856 . . . . 0.0 111.712 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.652 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 1.5 m120 -101.93 134.12 45.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.488 -0.757 . . . . 0.0 109.207 179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.863 HG21 ' CD2' ' A' ' 49' ' ' PHE . 6.6 mt -114.85 117.42 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.21 -1.556 . . . . 0.0 111.626 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.703 ' HG3' HG22 ' A' ' 33' ' ' VAL . 2.6 tt0 -88.18 111.52 21.71 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.59 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 1.057 ' HB1' HD11 ' A' ' 51' ' ' ILE . . . -127.23 149.39 50.02 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.032 -1.043 . . . . 0.0 110.836 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -99.47 104.15 25.41 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.243 -0.91 . . . . 0.0 110.51 -179.692 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.537 ' HG3' ' CD1' ' A' ' 32' ' ' ILE . 74.6 Cg_endo -81.15 147.58 16.46 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.004 1.528 . . . . 0.0 110.609 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.541 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 9.7 Cg_endo . . . . . 0 C--N 1.305 -1.73 0 O-C-N 123.872 1.459 . . . . 0.0 109.769 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 3.4 m-85 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.133 0.492 . . . . 0.0 109.728 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.824 HD11 HD12 ' A' ' 32' ' ' ILE . 3.4 mt -73.91 120.04 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.148 -0.97 . . . . 0.0 109.575 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.63 HD12 ' O ' ' A' ' 50' ' ' GLU . 1.9 mp -98.53 140.16 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.046 -1.034 . . . . 0.0 110.048 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.075 HD11 HG21 ' A' ' 34' ' ' ILE . 1.2 mt -126.14 142.22 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.452 -0.78 . . . . 0.0 109.994 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.534 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 82.59 -160.36 39.48 Favored Glycine 0 N--CA 1.481 1.65 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.553 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -122.77 149.82 26.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 O-C-N 121.307 -1.113 . . . . 0.0 110.091 -179.652 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.569 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -19.19 -57.56 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.109 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 9.7 Cg_endo -53.84 69.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 124.137 1.598 . . . . 0.0 112.145 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 93.57 4.61 63.82 Favored Glycine 0 N--CA 1.495 2.6 0 O-C-N 120.876 -1.14 . . . . 0.0 111.033 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.505 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -53.87 159.78 1.61 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.046 -1.267 . . . . 0.0 110.193 179.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.638 HD13 ' CG2' ' A' ' 20' ' ' VAL . 9.1 mt -97.91 177.4 5.45 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.215 -0.928 . . . . 0.0 110.758 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.467 ' HG3' HG13 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -157.07 128.37 6.89 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.47 -0.769 . . . . 0.0 110.094 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 89' ' ' TYR . 4.7 mp -130.5 124.98 33.2 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.279 -0.888 . . . . 0.0 109.972 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.485 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 10.1 t-20 -90.91 132.21 36.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 110.89 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.466 ' HA ' ' CE3' ' A' ' 103' ' ' TRP . 3.4 t-105 . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.049 -1.032 . . . . 0.0 110.243 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.592 ' HB3' ' CE1' ' A' ' 38' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 121.209 0.528 . . . . 0.0 109.889 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 16' ' ' GLY . 14.8 t -107.71 -2.37 20.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.267 -0.895 . . . . 0.0 111.385 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.575 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -60.8 -125.08 0.01 OUTLIER Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.543 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -132.49 178.12 7.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.028 -1.278 . . . . 0.0 110.029 -179.793 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.043 ' CE2' HG23 ' A' ' 47' ' ' ILE . 34.1 m-85 -136.12 133.92 37.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.948 -1.095 . . . . 0.0 111.63 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.555 ' CE ' ' HB3' ' A' ' 37' ' ' GLN . 0.3 OUTLIER -104.26 119.71 39.56 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.622 -0.674 . . . . 0.0 109.444 179.2 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.596 HG22 HD13 ' A' ' 99' ' ' LEU . 41.6 t -59.72 131.12 24.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 118.588 -1.245 . . . . 0.0 108.275 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.624 HG23 ' HA ' ' A' ' 36' ' ' VAL . 75.9 t -105.27 -26.15 3.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.562 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 2.2 tttt -157.11 133.08 9.53 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -52.3 158.86 1.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.523 0.677 . . . . 0.0 111.304 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.68 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -54.39 132.38 17.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.588 0.708 . . . . 0.0 109.903 -179.964 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.848 ' HB3' ' HB ' ' A' ' 33' ' ' VAL . . . -107.29 169.7 8.41 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.5 pm0 -115.85 133.54 55.92 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.65 -1.281 . . . . 0.0 110.406 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.951 HG21 ' CD ' ' A' ' 80' ' ' GLU . 13.2 p -93.13 172.45 8.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.393 -0.817 . . . . 0.0 110.181 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -87.73 29.23 0.92 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.266 -0.896 . . . . 0.0 110.328 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.87 5.82 4.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.924 . . . . 0.0 110.179 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.88 8.06 59.47 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.926 HG22 ' C ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -102.66 -174.84 2.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -1.08 . . . . 0.0 110.081 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.773 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -141.91 156.91 20.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 178.632 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.848 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 76.3 t -121.69 128.18 75.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 O-C-N 120.974 -1.079 . . . . 0.0 112.222 -177.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.0 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -112.89 118.97 59.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 O-C-N 121.437 -0.789 . . . . 0.0 109.685 178.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 3.4 ttm180 -105.67 112.81 26.03 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.791 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.7 m -132.34 -168.01 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.476 -0.765 . . . . 0.0 109.422 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.555 ' HB3' ' CE ' ' A' ' 19' ' ' LYS . 21.6 tt0 -138.26 127.06 23.76 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.874 ' HB2' HG21 ' A' ' 70' ' ' VAL . 75.5 t80 -60.31 128.34 36.25 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 118.29 -1.364 . . . . 0.0 110.579 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.498 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 61.8 mm-40 -116.01 82.85 1.84 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.484 -0.76 . . . . 0.0 109.62 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.575 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 171.62 -145.01 8.48 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.472 ' O ' ' OH ' ' A' ' 38' ' ' TYR . 7.5 m-20 -128.54 140.83 51.6 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.637 -0.919 . . . . 0.0 110.56 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 166.9 -20.61 0.1 OUTLIER Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.689 -1.243 . . . . 0.0 110.66 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.606 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER 56.03 -157.98 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 120.705 -1.468 . . . . 0.0 108.413 -179.702 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 72.9 Cg_exo -44.35 94.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.262 0 N-CA-C 108.944 -1.214 . . . . 0.0 108.944 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.698 ' O ' HG23 ' A' ' 69' ' ' ILE . 26.3 p -141.17 165.88 26.31 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.746 -0.596 . . . . 0.0 110.286 -178.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.704 ' HG3' HD11 ' A' ' 69' ' ' ILE . 10.9 mttp -82.59 177.43 8.71 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.407 -0.808 . . . . 0.0 110.358 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.043 HG23 ' CE2' ' A' ' 18' ' ' PHE . 14.2 mm -121.51 127.88 25.89 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.102 -0.999 . . . . 0.0 111.92 -178.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.619 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 35.1 Cg_exo -63.06 143.72 91.23 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.881 1.464 . . . . 0.0 110.627 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.756 ' CD1' HD21 ' A' ' 63' ' ' LEU . 5.6 t80 -155.53 132.28 10.55 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.335 -0.853 . . . . 0.0 110.021 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.588 ' O ' HD12 ' A' ' 91' ' ' ILE . 0.8 OUTLIER -144.1 97.68 3.09 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.03 -1.044 . . . . 0.0 110.305 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.719 HD11 ' HB1' ' A' ' 81' ' ' ALA . 11.9 mt . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.274 -0.891 . . . . 0.0 110.184 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.525 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.512 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -130.78 166.95 19.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.268 -1.136 . . . . 0.0 110.157 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.758 HD22 ' CB ' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -128.42 111.22 13.08 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.346 -0.847 . . . . 0.0 109.934 179.701 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.915 ' CG1' HG21 ' A' ' 31' ' ' THR . 5.6 mm -71.08 -25.45 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 122.148 0.975 . . . . 0.0 108.525 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.641 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.253 0.7 OUTLIER -111.87 31.46 6.19 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.718 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 63' ' ' LEU . 32.6 t -13.83 112.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.186 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.539 ' ND2' ' HD3' ' A' ' 46' ' ' LYS . 12.5 t-20 43.78 68.66 2.87 Favored Pre-proline 0 C--N 1.298 -1.66 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.295 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.667 ' HG3' HG23 ' A' ' 79' ' ' ILE . 2.1 Cg_endo -51.41 -174.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.982 1.517 . . . . 0.0 109.142 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.704 HD11 ' HG3' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -142.28 144.41 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 119.088 -1.045 . . . . 0.0 112.488 -178.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.007 ' CG2' HD11 ' A' ' 47' ' ' ILE . 26.5 t -98.62 166.87 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 176.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.411 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 3.3 m -123.62 -18.9 5.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.842 -1.161 . . . . 0.0 111.12 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.539 ' O ' ' CD ' ' A' ' 73' ' ' LYS . 8.0 mt-10 -138.0 15.37 2.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.926 -1.109 . . . . 0.0 110.685 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.539 ' CD ' ' O ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER 75.05 -13.39 0.85 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.773 -0.579 . . . . 0.0 111.224 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.47 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 6.3 t70 -131.83 -0.07 3.87 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.89 -1.131 . . . . 0.0 110.163 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 77' ' ' VAL . 8.9 t -72.04 108.36 4.05 Favored Pre-proline 0 C--N 1.304 -1.372 0 O-C-N 121.257 -0.902 . . . . 0.0 108.707 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.639 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 2.0 Cg_endo -46.92 131.03 16.51 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.77 1.405 . . . . 0.0 110.297 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.627 HG21 HG22 ' A' ' 70' ' ' VAL . 63.2 t -118.39 144.81 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.099 -1.001 . . . . 0.0 111.296 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.682 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 4.9 m-80 -105.51 134.82 47.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.431 -0.793 . . . . 0.0 109.574 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.725 HG21 ' CD2' ' A' ' 49' ' ' PHE . 5.2 mt -118.37 119.05 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 119.957 -1.715 . . . . 0.0 111.344 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.951 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.7 tp10 -93.19 114.12 26.52 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.634 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.926 ' C ' HG22 ' A' ' 31' ' ' THR . . . -131.0 150.43 52.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.048 -1.033 . . . . 0.0 110.873 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 4.4 tt0 -101.09 100.2 12.56 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.34 -0.85 . . . . 0.0 110.084 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.539 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 32.4 Cg_endo -69.05 144.64 58.52 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.102 1.58 . . . . 0.0 110.58 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.525 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 19.0 Cg_endo . . . . . 0 C--N 1.306 -1.679 0 O-C-N 124.034 1.544 . . . . 0.0 110.229 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 21.6 m-85 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.227 0.537 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.779 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.8 mp -73.9 113.45 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.213 -0.93 . . . . 0.0 109.394 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.588 HD12 ' O ' ' A' ' 50' ' ' GLU . 9.5 mt -94.1 144.56 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.144 -0.972 . . . . 0.0 110.282 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.0 HD11 HG21 ' A' ' 34' ' ' ILE . 1.8 mt -128.65 141.25 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.406 -0.808 . . . . 0.0 109.697 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.546 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 82.2 -160.36 40.24 Favored Glycine 0 N--CA 1.483 1.786 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.563 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -122.58 148.24 26.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 O-C-N 121.218 -1.166 . . . . 0.0 109.918 -179.73 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.571 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.4 OUTLIER -16.38 -58.56 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.173 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.776 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 7.3 Cg_endo -51.01 73.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 124.131 1.595 . . . . 0.0 112.067 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 88.39 -0.27 83.14 Favored Glycine 0 N--CA 1.495 2.581 0 O-C-N 121.02 -1.05 . . . . 0.0 110.9 178.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.507 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -47.04 160.52 0.09 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.967 -1.314 . . . . 0.0 110.325 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.596 HD13 HG22 ' A' ' 20' ' ' VAL . 10.6 mt -96.9 177.69 5.54 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.218 -0.926 . . . . 0.0 110.363 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.486 ' HG3' HG12 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -158.72 136.25 10.16 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.297 -0.877 . . . . 0.0 110.104 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.779 HD12 ' O ' ' A' ' 90' ' ' ILE . 2.6 mp -141.48 121.5 13.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.148 -0.97 . . . . 0.0 110.393 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -87.44 129.65 34.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.257 -0.902 . . . . 0.0 110.336 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 110.202 179.837 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 21.5 m . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.525 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 1.2 t -114.82 2.6 14.41 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.932 -1.105 . . . . 0.0 111.974 -178.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.573 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -65.07 -100.03 0.01 OUTLIER Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.104 -1.522 . . . . 0.0 109.437 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.585 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 1.1 tmpt? -141.1 161.86 36.85 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.077 -1.249 . . . . 0.0 109.807 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.995 ' CE2' HG23 ' A' ' 47' ' ' ILE . 18.7 m-85 -126.11 134.92 51.21 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.763 -1.211 . . . . 0.0 111.93 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.516 ' HE2' ' NE2' ' A' ' 37' ' ' GLN . 3.9 ttpt -109.4 120.04 41.3 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.566 -0.709 . . . . 0.0 109.652 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.748 ' CG2' HD13 ' A' ' 99' ' ' LEU . 49.0 t -60.08 131.9 25.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.866 -1.147 . . . . 0.0 108.927 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.602 HG23 ' HA ' ' A' ' 36' ' ' VAL . 72.4 t -105.55 -27.3 3.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.558 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 5.9 tttp -156.04 133.23 10.7 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 177.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -51.84 156.38 1.48 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.555 0.693 . . . . 0.0 111.284 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.692 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -52.88 132.61 15.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.527 -0.733 . . . . 0.0 109.991 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.824 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -109.5 170.87 7.78 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 0.7 OUTLIER -115.78 134.29 55.17 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.73 -1.231 . . . . 0.0 110.552 -179.735 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.955 HG21 ' CD ' ' A' ' 80' ' ' GLU . 14.5 p -93.46 172.33 8.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.502 -0.749 . . . . 0.0 110.372 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -88.6 29.89 0.96 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.328 -0.857 . . . . 0.0 110.191 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.76 5.48 4.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.278 -0.889 . . . . 0.0 110.104 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.06 14.01 52.97 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.942 HG21 ' CG1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -110.87 -178.82 3.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.397 -1.061 . . . . 0.0 110.292 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.824 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -137.44 152.69 27.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 178.605 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.661 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 52.9 t -118.15 130.92 72.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 121.051 -1.031 . . . . 0.0 112.357 -177.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.086 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -114.59 120.21 63.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.557 -0.715 . . . . 0.0 109.423 178.734 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.558 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -105.7 115.78 30.82 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.614 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.802 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.8 m -134.48 -170.74 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 C-N-CA 119.564 -0.854 . . . . 0.0 109.322 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.516 ' NE2' ' HE2' ' A' ' 19' ' ' LYS . 1.9 tt0 -132.42 127.32 35.11 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 1.024 ' HB2' HG21 ' A' ' 70' ' ' VAL . 1.5 t80 -60.63 122.49 14.84 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 118.703 -1.199 . . . . 0.0 110.113 -178.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 17' ' ' LYS . 4.0 mt-10 -112.29 38.62 2.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -0.867 . . . . 0.0 109.193 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.573 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -125.16 -160.68 10.79 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 37.3 p-10 -135.1 85.59 2.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.516 -0.991 . . . . 0.0 110.277 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 43' ' ' SER . . . -147.83 10.04 1.21 Allowed Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.725 -1.226 . . . . 0.0 110.307 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.605 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER 46.67 -158.61 0.01 OUTLIER Pre-proline 0 N--CA 1.487 1.42 0 O-C-N 120.834 -1.392 . . . . 0.0 108.951 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.605 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 87.9 Cg_exo -43.49 95.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 122.72 0.853 . . . . 0.0 110.54 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.693 ' O ' HG23 ' A' ' 69' ' ' ILE . 8.0 p -141.52 171.19 14.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.491 -0.756 . . . . 0.0 110.607 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.771 ' HG3' HD11 ' A' ' 69' ' ' ILE . 33.3 mttt -84.69 169.41 14.33 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.685 0.755 . . . . 0.0 111.627 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.043 HD11 ' CG2' ' A' ' 70' ' ' VAL . 12.7 mm -111.33 124.7 32.06 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.269 -0.894 . . . . 0.0 112.234 -177.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.64 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 34.5 Cg_exo -63.12 144.09 91.62 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.974 1.513 . . . . 0.0 110.815 178.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.894 ' CZ ' HG23 ' A' ' 90' ' ' ILE . 7.6 t80 -154.97 158.88 39.89 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.299 -0.876 . . . . 0.0 110.142 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.478 ' HB3' ' HB ' ' A' ' 91' ' ' ILE . 23.9 tp10 -172.91 107.21 0.16 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.092 -1.005 . . . . 0.0 110.493 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.805 HD11 ' HB1' ' A' ' 81' ' ' ALA . 54.1 mt . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.885 . . . . 0.0 110.222 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.511 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.518 ' CB ' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -135.35 161.3 35.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.349 -1.089 . . . . 0.0 110.165 179.9 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.77 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -123.4 111.46 16.39 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.365 -0.835 . . . . 0.0 109.864 179.698 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.942 ' CG1' HG21 ' A' ' 31' ' ' THR . 6.5 mm -70.55 -29.23 37.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 122.272 1.034 . . . . 0.0 108.297 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.632 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.257 0.7 OUTLIER -106.81 30.56 6.0 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.708 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 63' ' ' LEU . 39.3 t -13.04 111.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.281 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.537 ' ND2' ' HD3' ' A' ' 46' ' ' LYS . 12.6 t-20 43.43 69.32 2.39 Favored Pre-proline 0 C--N 1.298 -1.647 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.274 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.571 ' O ' ' HA ' ' A' ' 46' ' ' LYS . 1.6 Cg_endo -52.19 -175.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.962 1.506 . . . . 0.0 109.319 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.771 HD11 ' HG3' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -142.7 142.67 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.961 -179.316 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.043 ' CG2' HD11 ' A' ' 47' ' ' ILE . 30.8 t -99.76 161.11 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.409 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 5.6 m -115.65 -16.81 11.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.988 -1.07 . . . . 0.0 111.853 -178.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.522 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 14.1 mt-10 -141.3 19.42 2.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.665 -1.272 . . . . 0.0 111.687 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.586 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 0.0 OUTLIER 72.04 -6.37 1.52 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.15 -0.969 . . . . 0.0 111.103 179.73 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.477 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 4.9 t70 -137.8 -0.93 2.07 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.847 -1.158 . . . . 0.0 110.373 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.539 ' O ' HG23 ' A' ' 77' ' ' VAL . 40.2 t -72.37 112.3 14.26 Favored Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 121.17 -0.956 . . . . 0.0 109.027 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.605 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 45.7 Cg_exo -49.22 126.69 16.03 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.885 1.466 . . . . 0.0 110.002 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.99 HG21 HG22 ' A' ' 70' ' ' VAL . 76.3 t -112.66 140.34 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.031 -1.043 . . . . 0.0 111.606 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.682 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.3 m120 -105.38 133.82 49.51 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.455 -0.778 . . . . 0.0 109.377 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.667 ' HB ' HG22 ' A' ' 34' ' ' ILE . 4.4 mt -118.15 119.97 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 119.984 -1.697 . . . . 0.0 111.609 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.955 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.6 tp10 -94.07 110.16 21.88 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.896 ' C ' HG22 ' A' ' 31' ' ' THR . . . -125.4 147.37 49.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.986 -1.071 . . . . 0.0 111.041 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.518 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 3.0 tt0 -99.53 101.89 14.83 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 109.916 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.532 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 12.4 Cg_endo -61.11 143.83 99.01 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.012 1.533 . . . . 0.0 110.504 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.511 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 19.4 Cg_endo . . . . . 0 C--N 1.305 -1.759 0 O-C-N 124.051 1.553 . . . . 0.0 110.334 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 12.3 m-85 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.233 0.54 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.894 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 1.4 mp -74.27 110.97 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.222 -0.924 . . . . 0.0 109.748 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 87.1 mt -92.1 142.18 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 110.152 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.086 HD11 HG21 ' A' ' 34' ' ' ILE . 3.6 mt -132.51 141.27 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.386 -0.821 . . . . 0.0 109.983 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.543 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 80.95 -156.7 38.41 Favored Glycine 0 N--CA 1.484 1.868 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 98' ' ' GLN . 0.2 OUTLIER -130.59 156.52 42.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.129 -1.218 . . . . 0.0 110.338 -179.548 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.528 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 3.0 mt-10 -30.33 -55.81 0.35 Allowed Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.849 -0.532 . . . . 0.0 110.848 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 73.4 Cg_exo -40.56 -36.98 1.97 Allowed 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.052 1.553 . . . . 0.0 110.686 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.585 ' HA3' ' CG ' ' A' ' 17' ' ' LYS . . . -164.71 49.04 0.29 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.557 ' N ' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -93.85 151.9 19.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.204 -1.174 . . . . 0.0 111.08 -178.57 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.748 HD13 ' CG2' ' A' ' 20' ' ' VAL . 13.6 mt -100.54 179.7 4.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.492 -0.755 . . . . 0.0 110.089 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.575 ' C ' HD12 ' A' ' 101' ' ' LEU . 1.6 mtpt -152.8 135.79 15.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.43 -0.794 . . . . 0.0 110.334 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.654 HD22 HG12 ' A' ' 24' ' ' ILE . 5.2 mp -140.33 116.91 10.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.213 -0.93 . . . . 0.0 110.199 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 3.3 p-10 -87.82 120.26 28.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 0.0 110.318 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.655 ' CE3' HG22 ' A' ' 24' ' ' ILE . 50.7 t-105 . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.922 . . . . 0.0 110.227 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 20.3 m . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.527 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 0.5 OUTLIER -99.75 -1.14 38.5 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.021 -1.049 . . . . 0.0 112.363 -178.028 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.592 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -66.46 -108.12 0.01 OUTLIER Glycine 0 N--CA 1.493 2.44 0 C-N-CA 118.942 -1.599 . . . . 0.0 109.301 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.537 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -136.98 177.79 7.59 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.958 -1.319 . . . . 0.0 110.22 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.007 ' CE2' HG23 ' A' ' 47' ' ' ILE . 26.7 m-85 -137.57 144.62 42.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.012 -1.055 . . . . 0.0 111.826 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.459 ' HB2' ' CG ' ' A' ' 39' ' ' GLU . 11.5 ttpt -114.54 117.84 32.05 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.702 -0.624 . . . . 0.0 109.411 179.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.564 ' CG2' HD13 ' A' ' 99' ' ' LEU . 46.1 t -59.66 132.45 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.78 -1.2 . . . . 0.0 108.958 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.592 HG23 ' HA ' ' A' ' 36' ' ' VAL . 73.6 t -106.84 -26.24 3.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.561 ' HB3' ' CG ' ' A' ' 35' ' ' ARG . 3.4 tttt -156.87 133.15 9.81 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -52.12 156.49 1.6 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.65 0.738 . . . . 0.0 111.374 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.804 HG13 HD13 ' A' ' 90' ' ' ILE . 0.6 OUTLIER -52.99 132.79 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.505 -0.747 . . . . 0.0 109.944 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.788 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -109.62 170.9 7.77 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.5 pm0 -115.93 134.5 54.91 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.78 -1.2 . . . . 0.0 110.37 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.94 HG21 ' CD ' ' A' ' 80' ' ' GLU . 16.0 p -92.4 175.55 6.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.474 -0.766 . . . . 0.0 110.387 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -88.96 27.34 1.36 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.466 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -130.89 6.68 4.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.201 -0.937 . . . . 0.0 110.194 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.59 3.03 61.3 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.92 HG22 ' C ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -96.65 -177.59 3.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.335 -1.097 . . . . 0.0 110.31 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.788 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -138.88 153.84 25.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.668 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.702 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 55.5 t -119.78 130.68 73.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 O-C-N 121.003 -1.061 . . . . 0.0 112.41 -177.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.002 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -114.61 120.84 65.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 121.408 -0.807 . . . . 0.0 109.412 178.51 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.561 ' CG ' ' HB3' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -106.52 113.59 27.2 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.865 HG11 HD13 ' A' ' 92' ' ' ILE . 1.7 m -132.05 -169.78 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 C-N-CA 119.689 -0.805 . . . . 0.0 109.283 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.529 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 9.9 tt0 -134.83 127.66 31.23 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.962 ' HB2' HG21 ' A' ' 70' ' ' VAL . 1.6 t80 -60.46 124.02 19.07 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 118.796 -1.161 . . . . 0.0 110.033 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.459 ' CG ' ' HB2' ' A' ' 19' ' ' LYS . 22.6 mm-40 -103.5 -22.23 13.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.243 -0.911 . . . . 0.0 109.25 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.592 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -64.94 -161.2 0.57 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.557 ' HA ' ' CD ' ' A' ' 73' ' ' LYS . 3.3 p-10 -143.21 93.98 2.56 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.598 -0.943 . . . . 0.0 110.054 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -150.92 15.24 0.9 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.606 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER 48.39 -160.0 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.366 0 O-C-N 121.033 -1.274 . . . . 0.0 109.298 179.422 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 85.7 Cg_exo -43.19 95.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 122.946 0.971 . . . . 0.0 110.622 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.674 ' O ' HG23 ' A' ' 69' ' ' ILE . 11.6 p -140.94 170.92 14.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.536 -0.728 . . . . 0.0 110.637 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.769 ' HG3' HD11 ' A' ' 69' ' ' ILE . 20.7 mttt -87.32 165.71 15.42 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.438 -0.789 . . . . 0.0 111.413 -178.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.051 HD11 ' CG2' ' A' ' 70' ' ' VAL . 12.6 mm -108.64 124.87 33.12 Favored Pre-proline 0 C--N 1.303 -1.415 0 O-C-N 121.18 -0.95 . . . . 0.0 112.643 -177.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.639 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 34.7 Cg_exo -63.24 146.17 93.72 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 124.023 1.538 . . . . 0.0 110.436 178.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.914 ' CZ ' HG23 ' A' ' 90' ' ' ILE . 10.2 t80 -155.22 160.22 40.69 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.147 -0.971 . . . . 0.0 110.6 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.938 ' O ' HD12 ' A' ' 91' ' ' ILE . 19.2 tp10 -177.69 115.49 0.09 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.307 -0.87 . . . . 0.0 110.212 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.639 HD11 ' HB1' ' A' ' 81' ' ' ALA . 43.4 mt . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.205 -0.934 . . . . 0.0 110.372 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.511 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -115.33 167.4 10.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -1.182 . . . . 0.0 110.039 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.756 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -130.93 110.76 11.5 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.387 -0.821 . . . . 0.0 109.916 179.672 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.911 ' CG1' HG21 ' A' ' 31' ' ' THR . 4.9 mm -69.98 -25.6 28.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-O 122.15 0.976 . . . . 0.0 108.53 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.627 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.251 0.6 OUTLIER -110.95 30.1 7.17 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.658 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 63' ' ' LEU . 40.3 t -11.9 112.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.394 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.534 ' ND2' ' HD3' ' A' ' 46' ' ' LYS . 13.7 t-20 41.63 69.63 1.99 Allowed Pre-proline 0 C--N 1.299 -1.598 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.463 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.554 ' O ' ' HA ' ' A' ' 46' ' ' LYS . 1.4 Cg_endo -51.88 -174.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.886 1.466 . . . . 0.0 109.456 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.769 HD11 ' HG3' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -142.81 143.58 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 119.148 -1.021 . . . . 0.0 112.06 -179.136 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.051 ' CG2' HD11 ' A' ' 47' ' ' ILE . 22.2 t -101.91 159.6 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 176.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.3 m -116.67 -14.53 10.82 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.046 -1.062 . . . . 0.0 111.853 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 73' ' ' LYS . 19.6 mt-10 -142.0 22.51 2.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.619 -1.301 . . . . 0.0 111.756 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.598 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 0.8 OUTLIER 66.7 -1.57 1.29 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.095 -1.003 . . . . 0.0 111.087 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.465 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 9.7 t0 -142.47 -0.35 1.24 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.944 -1.098 . . . . 0.0 110.574 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.613 ' O ' HG23 ' A' ' 77' ' ' VAL . 39.4 t -72.76 108.43 4.41 Favored Pre-proline 0 N--CA 1.486 1.344 0 O-C-N 120.977 -1.077 . . . . 0.0 109.218 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.596 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 2.3 Cg_endo -47.25 127.41 13.01 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.743 1.391 . . . . 0.0 109.684 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.943 HG21 HG22 ' A' ' 70' ' ' VAL . 58.7 t -115.46 143.43 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.954 -1.091 . . . . 0.0 111.611 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.679 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 4.0 m120 -106.18 134.12 49.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.551 -0.718 . . . . 0.0 109.525 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.67 ' HB ' HG22 ' A' ' 34' ' ' ILE . 4.2 mt -117.5 119.75 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 119.988 -1.695 . . . . 0.0 111.402 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.94 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.8 tp10 -95.24 110.74 22.68 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.92 ' C ' HG22 ' A' ' 31' ' ' THR . . . -126.46 150.1 48.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.077 -1.014 . . . . 0.0 111.004 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.511 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 9.6 tp10 -101.83 101.68 19.45 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.354 -0.841 . . . . 0.0 110.127 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.533 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 20.3 Cg_endo -66.71 144.56 72.28 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.08 1.568 . . . . 0.0 110.427 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo . . . . . 0 C--N 1.303 -1.837 0 O-C-N 124.052 1.554 . . . . 0.0 110.327 179.908 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 8.1 m-85 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.231 0.539 . . . . 0.0 110.153 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.914 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 1.3 mp -74.16 108.39 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -0.906 . . . . 0.0 109.482 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.938 HD12 ' O ' ' A' ' 50' ' ' GLU . 7.0 mt -92.09 142.37 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.131 -0.98 . . . . 0.0 110.42 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.002 HD11 HG21 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -129.61 138.26 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.545 -0.722 . . . . 0.0 109.521 -179.905 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.524 ' O ' ' HB2' ' A' ' 48' ' ' PRO . . . 86.06 -161.87 34.9 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.554 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -121.89 148.38 25.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 O-C-N 121.264 -1.139 . . . . 0.0 110.129 -179.721 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.581 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.2 OUTLIER -18.07 -58.02 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.145 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 9.3 Cg_endo -52.62 70.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 124.198 1.631 . . . . 0.0 112.148 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 91.34 2.89 70.08 Favored Glycine 0 N--CA 1.495 2.584 0 O-C-N 120.875 -1.141 . . . . 0.0 110.912 178.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.521 ' HB2' ' N ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -51.64 159.12 0.82 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.965 -1.315 . . . . 0.0 110.229 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.564 HD13 ' CG2' ' A' ' 20' ' ' VAL . 5.7 mt -96.24 174.68 6.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.224 -0.922 . . . . 0.0 110.297 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.909 ' C ' HD12 ' A' ' 101' ' ' LEU . 3.8 ttmt -152.71 143.09 22.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.34 -0.85 . . . . 0.0 110.328 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.909 HD12 ' C ' ' A' ' 100' ' ' LYS . 5.6 mp -144.59 113.45 6.79 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.168 -0.957 . . . . 0.0 110.222 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 9.8 t-20 -79.64 131.18 35.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.243 -0.91 . . . . 0.0 110.334 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 0.0 110.196 179.941 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.587 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 35.8 m . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 121.355 0.598 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.534 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 39.6 p -95.79 -5.8 41.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 111.652 -178.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.598 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -61.21 -117.65 0.01 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.54 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -138.51 173.08 11.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.956 -1.32 . . . . 0.0 110.139 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.999 ' CE2' HG23 ' A' ' 47' ' ' ILE . 30.8 m-85 -132.69 141.51 48.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.012 -1.055 . . . . 0.0 111.693 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.474 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 14.9 ttpt -110.51 119.84 40.47 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.627 -0.67 . . . . 0.0 109.444 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.475 HG22 HD13 ' A' ' 99' ' ' LEU . 31.4 t -60.23 132.74 25.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 120.91 -1.119 . . . . 0.0 109.205 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.637 HG23 ' HA ' ' A' ' 36' ' ' VAL . 90.1 t -106.04 -27.12 3.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.582 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 14.1 tttt -156.96 133.45 9.95 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -51.26 160.17 0.57 Allowed 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.702 0.763 . . . . 0.0 111.72 -178.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.695 HG23 HG22 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -57.93 133.45 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 CA-C-O 121.579 0.704 . . . . 0.0 110.248 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.599 ' HB3' ' HB ' ' A' ' 33' ' ' VAL . . . -112.05 158.35 19.68 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.6 pm0 -110.67 132.77 53.91 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 120.295 -1.503 . . . . 0.0 110.27 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.938 HG21 ' OE2' ' A' ' 80' ' ' GLU . 1.8 p -91.21 175.44 6.94 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.163 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -80.8 -16.7 53.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.238 -0.914 . . . . 0.0 110.495 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -80.6 1.53 29.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 0.0 110.292 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.92 9.33 61.03 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.894 HG21 ' CG1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -98.31 174.8 6.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -1.097 . . . . 0.0 110.395 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.876 HD11 ' CG ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -129.22 142.96 42.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.621 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 26.7 t -110.91 131.1 63.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 O-C-N 121.388 -0.82 . . . . 0.0 111.775 -177.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.027 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -119.34 121.3 66.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.456 -0.777 . . . . 0.0 109.349 178.809 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.582 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -106.14 111.62 24.31 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.737 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.86 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.5 m -131.44 -167.92 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.175 -178.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.471 ' N ' HG23 ' A' ' 36' ' ' VAL . 10.6 tt0 -135.59 129.25 32.63 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.938 ' HB2' HG21 ' A' ' 70' ' ' VAL . 1.7 t80 -60.2 122.33 14.19 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 118.544 -1.262 . . . . 0.0 110.361 -178.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.474 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 4.6 mt-10 -112.05 39.26 2.45 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.453 -0.779 . . . . 0.0 108.973 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.598 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -133.06 -160.64 9.56 Favored Glycine 0 N--CA 1.484 1.894 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.451 ' HA ' ' HD2' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -121.98 141.9 50.86 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.537 -0.978 . . . . 0.0 110.267 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 154.92 -11.43 0.43 Allowed Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.857 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.607 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.7 OUTLIER 54.88 -153.29 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 120.542 -1.563 . . . . 0.0 108.119 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.607 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 83.1 Cg_exo -41.83 97.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.322 -0.864 0 N-CA-C 108.904 -1.229 . . . . 0.0 108.904 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.733 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -145.89 170.82 15.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.794 -0.567 . . . . 0.0 109.958 -177.647 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.682 ' HG3' HD11 ' A' ' 69' ' ' ILE . 33.8 mttm -87.29 176.11 7.7 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.417 -0.802 . . . . 0.0 111.653 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.085 HD11 ' CG2' ' A' ' 70' ' ' VAL . 16.2 mm -122.47 129.05 25.21 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.305 -0.872 . . . . 0.0 112.405 -178.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.622 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 24.8 Cg_exo -67.47 146.55 74.82 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.689 1.593 . . . . 0.0 111.246 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.728 ' CD2' HD21 ' A' ' 63' ' ' LEU . 9.7 t80 -155.53 154.55 31.93 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.419 -0.8 . . . . 0.0 109.741 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.888 ' HG2' HD12 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -164.14 125.26 2.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.842 -1.161 . . . . 0.0 110.661 179.666 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.979 HG21 ' HB3' ' A' ' 83' ' ' PRO . 11.1 mt . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.493 -0.754 . . . . 0.0 109.842 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 83' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.525 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -122.85 165.99 15.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.174 -1.192 . . . . 0.0 110.433 -179.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.819 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -131.8 111.27 11.48 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.701 179.269 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.894 ' CG1' HG21 ' A' ' 31' ' ' THR . 5.2 mm -69.13 -30.26 45.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-O 122.126 0.965 . . . . 0.0 108.576 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.612 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.253 0.6 OUTLIER -104.98 29.92 5.94 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.554 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 63' ' ' LEU . 48.0 t -12.65 110.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.247 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 19.6 t-20 44.23 69.1 2.62 Favored Pre-proline 0 C--N 1.299 -1.612 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.048 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.553 ' O ' ' HA ' ' A' ' 46' ' ' LYS . 2.3 Cg_endo -50.18 -178.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 124.033 1.544 . . . . 0.0 109.474 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.733 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.8 OUTLIER -140.71 143.93 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 119.183 -1.007 . . . . 0.0 112.104 -178.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.085 ' CG2' HD11 ' A' ' 47' ' ' ILE . 20.2 t -99.78 170.33 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.425 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 5.2 m -126.73 -17.2 5.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.959 -1.088 . . . . 0.0 111.173 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 7.4 mt-10 -140.01 15.67 2.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.944 -1.097 . . . . 0.0 110.918 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 11.4 ttpp 73.59 -7.11 1.63 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.307 -0.871 . . . . 0.0 110.781 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.466 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 5.3 t70 -137.68 1.46 2.34 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.024 -1.048 . . . . 0.0 110.096 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.576 ' O ' HG23 ' A' ' 77' ' ' VAL . 12.4 t -72.74 108.28 4.21 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 121.128 -0.982 . . . . 0.0 108.921 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.629 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 1.9 Cg_endo -47.52 130.19 17.7 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.801 1.421 . . . . 0.0 110.071 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.682 HG21 HG22 ' A' ' 70' ' ' VAL . 60.1 t -118.01 145.43 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.022 -1.049 . . . . 0.0 111.415 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.697 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 3.9 m120 -105.6 134.53 48.56 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.511 -0.743 . . . . 0.0 109.537 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.652 ' HB ' HG22 ' A' ' 34' ' ' ILE . 3.4 mt -117.88 119.89 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 119.953 -1.717 . . . . 0.0 111.358 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.938 ' OE2' HG21 ' A' ' 27' ' ' THR . 2.4 tp10 -95.45 106.86 18.97 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.861 ' C ' HG22 ' A' ' 31' ' ' THR . . . -112.19 147.39 36.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.09 -1.006 . . . . 0.0 110.655 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 3.0 tt0 -113.2 53.89 0.53 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.408 -0.807 . . . . 0.0 110.932 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.979 ' HB3' HG21 ' A' ' 51' ' ' ILE . 23.1 Cg_endo -66.16 159.74 48.21 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 123.675 1.355 . . . . 0.0 110.402 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.44 ' HD3' ' HA2' ' A' ' 61' ' ' GLY . 11.5 Cg_endo . . . . . 0 C--N 1.305 -1.716 0 O-C-N 123.948 1.499 . . . . 0.0 109.827 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.526 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 24.6 m-85 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.228 0.537 . . . . 0.0 111.853 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.805 HG22 ' HB2' ' A' ' 101' ' ' LEU . 0.7 OUTLIER -74.46 168.25 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.017 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.888 HD12 ' HG2' ' A' ' 50' ' ' GLU . 94.7 mt -131.21 143.36 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.318 -1.489 . . . . 0.0 111.868 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.027 HD11 HG21 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -133.96 138.06 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.502 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.536 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 86.18 -158.96 32.07 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.541 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -123.89 149.53 28.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 O-C-N 121.061 -1.258 . . . . 0.0 110.411 -179.462 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.587 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 5.4 mt-10 -20.35 -57.39 0.07 OUTLIER Pre-proline 0 N--CA 1.501 2.078 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.563 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 9.7 Cg_endo -53.9 70.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 124.108 1.583 . . . . 0.0 111.898 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 91.42 6.75 65.9 Favored Glycine 0 N--CA 1.494 2.512 0 O-C-N 120.967 -1.083 . . . . 0.0 110.896 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.503 ' HB3' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -52.42 161.21 0.71 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.972 -1.31 . . . . 0.0 110.019 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.527 ' CD1' ' O ' ' A' ' 18' ' ' PHE . 4.9 mt -95.77 170.06 9.58 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.189 -0.944 . . . . 0.0 110.773 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -152.61 142.74 22.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.5 -0.75 . . . . 0.0 109.722 179.573 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.805 ' HB2' HG22 ' A' ' 90' ' ' ILE . 4.0 mp -138.89 117.68 12.32 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.98 -1.075 . . . . 0.0 110.878 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -59.92 146.26 42.93 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.283 -0.886 . . . . 0.0 110.201 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.438 ' NE1' HG21 ' A' ' 32' ' ' ILE . 9.1 t-105 . . . . . 0 N--CA 1.488 1.438 0 O-C-N 121.212 -0.93 . . . . 0.0 110.417 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 mtt . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.255 0.55 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -115.19 24.7 11.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -0.894 . . . . 0.0 110.177 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.572 ' C ' HD23 ' A' ' 4' ' ' LEU . 1.0 OUTLIER -117.02 151.66 36.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.227 -0.921 . . . . 0.0 110.279 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.572 HD23 ' C ' ' A' ' 3' ' ' LYS . 0.3 OUTLIER -166.74 62.08 0.09 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.181 -0.95 . . . . 0.0 110.15 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.477 ' CG ' ' C ' ' A' ' 4' ' ' LEU . 59.4 mt-30 -153.45 -46.26 0.09 Allowed 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.294 -0.879 . . . . 0.0 110.259 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.54 78.69 3.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.21 -0.931 . . . . 0.0 110.234 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.33 101.75 13.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 110.169 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 132.34 131.77 3.25 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 47.49 53.37 11.14 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.223 -1.163 . . . . 0.0 110.125 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.7 p -130.02 160.49 33.5 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.306 -0.871 . . . . 0.0 110.253 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.573 ' CZ ' ' HB2' ' A' ' 44' ' ' PRO . 1.3 t80 -149.16 -74.48 0.17 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.351 -0.843 . . . . 0.0 109.613 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.505 ' HB3' ' HA ' ' A' ' 45' ' ' CYS . 3.6 t -142.84 -122.29 0.09 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.174 -0.954 . . . . 0.0 109.199 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.432 ' CG ' ' O ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -176.91 98.24 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.724 -1.235 . . . . 0.0 110.075 179.529 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 20.7 m -62.85 93.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.386 -0.821 . . . . 0.0 109.002 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.471 ' O ' ' O ' ' A' ' 16' ' ' GLY . 5.9 t -88.79 -6.82 57.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.138 -0.976 . . . . 0.0 111.755 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.518 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -61.2 -129.74 0.01 OUTLIER Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.531 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -125.09 177.99 5.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.228 -1.16 . . . . 0.0 110.008 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.04 ' CE2' HG23 ' A' ' 47' ' ' ILE . 33.0 m-85 -135.36 142.85 45.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.925 -1.11 . . . . 0.0 111.638 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.478 ' HE2' ' HB3' ' A' ' 37' ' ' GLN . 37.6 ttpt -113.43 117.68 32.4 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.644 ' CG2' HD13 ' A' ' 99' ' ' LEU . 54.9 t -59.3 124.54 13.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 120.659 -1.276 . . . . 0.0 109.501 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.633 HG23 ' HA ' ' A' ' 36' ' ' VAL . 70.3 t -98.07 -29.62 3.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.647 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 0.5 OUTLIER -150.46 138.05 19.78 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.391 0.615 . . . . 0.0 109.887 177.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -56.15 153.43 9.22 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.297 0.57 . . . . 0.0 110.261 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.722 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -49.35 131.3 7.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.109 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.878 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -108.47 172.1 7.04 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 16.8 pt-20 -113.0 130.67 56.05 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.881 -1.137 . . . . 0.0 110.335 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.51 ' O ' ' CB ' ' A' ' 28' ' ' GLN . 17.5 p -74.99 0.41 15.96 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.461 -0.774 . . . . 0.0 110.292 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.51 ' CB ' ' O ' ' A' ' 27' ' ' THR . 0.5 OUTLIER 70.03 10.69 7.49 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.302 -0.874 . . . . 0.0 110.131 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.42 11.55 6.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.918 . . . . 0.0 110.292 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.456 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 110.17 -20.19 26.33 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.912 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -92.1 -174.27 3.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.224 -1.162 . . . . 0.0 110.476 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.878 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -148.38 160.24 6.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.698 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 99.0 t -123.58 131.54 72.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 C-N-CA 118.982 -1.087 . . . . 0.0 111.752 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.141 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -114.91 114.29 46.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.431 -0.793 . . . . 0.0 109.741 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.647 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -95.27 125.79 40.15 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.058 -1.026 . . . . 0.0 108.467 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.698 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.8 m -150.13 159.11 5.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.274 -0.891 . . . . 0.0 108.609 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.485 ' N ' HG23 ' A' ' 21' ' ' VAL 0.26 25.6 tt0 -103.85 124.7 49.43 Favored 'General case' 0 C--N 1.27 -2.872 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -179.165 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 1.02 ' HB2' HG21 ' A' ' 70' ' ' VAL . 1.2 t80 -60.75 122.35 14.58 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 119.016 -1.074 . . . . 0.0 110.509 -178.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 17' ' ' LYS . 23.1 mm-40 -106.87 152.06 24.4 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.374 -0.829 . . . . 0.0 108.921 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.519 ' O ' ' CE ' ' A' ' 73' ' ' LYS . . . 105.7 -145.75 15.97 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.455 ' O ' ' OH ' ' A' ' 38' ' ' TYR . 0.5 OUTLIER -130.4 127.95 40.38 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.525 -0.986 . . . . 0.0 109.942 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.04 -29.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.331 -1.414 . . . . 0.0 110.854 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.632 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.4 OUTLIER 56.39 -154.09 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 120.621 -1.517 . . . . 0.0 108.224 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.632 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 44.9 Cg_exo -52.23 89.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 N-CA-C 109.811 -0.88 . . . . 0.0 109.811 179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.748 ' O ' HG23 ' A' ' 69' ' ' ILE . 10.0 p -142.12 174.57 10.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.928 . . . . 0.0 110.636 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.632 ' HG3' ' CD1' ' A' ' 69' ' ' ILE . 2.3 mtpt -87.73 162.49 17.02 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.041 0.924 . . . . 0.0 111.915 -178.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.04 HG23 ' CE2' ' A' ' 18' ' ' PHE . 14.9 mm -105.44 124.24 36.97 Favored Pre-proline 0 C--N 1.3 -1.546 0 O-C-N 121.635 -0.665 . . . . 0.0 111.487 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.626 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 31.4 Cg_exo -62.14 145.12 96.48 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.064 1.56 . . . . 0.0 110.746 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.939 ' CD2' HG21 ' A' ' 79' ' ' ILE . 5.0 t80 -153.76 154.26 33.7 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.495 -0.753 . . . . 0.0 109.187 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.624 ' O ' HG23 ' A' ' 51' ' ' ILE . 18.3 tt0 -157.51 115.4 3.11 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.884 -1.135 . . . . 0.0 110.335 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.687 HG22 ' HA ' ' A' ' 90' ' ' ILE . 19.4 pt -159.64 70.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.471 ' O ' ' HB3' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -129.08 -67.65 0.77 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.1 -1.0 . . . . 0.0 110.777 -179.49 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' A' ' 52' ' ' MET . 1.2 p-10 172.67 -161.39 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.306 -0.871 . . . . 0.0 110.333 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' A' ' 53' ' ' ASP . 11.1 tp 58.59 -105.36 0.25 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 0.0 110.044 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.14 18.83 4.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.923 -1.111 . . . . 0.0 109.658 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.538 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 8.5 mptt -98.93 -10.33 22.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.431 -0.793 . . . . 0.0 110.221 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.432 ' CB ' ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER 66.19 18.29 10.92 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.226 -0.921 . . . . 0.0 110.086 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.594 ' CE1' ' HG2' ' A' ' 84' ' ' PRO . 0.5 OUTLIER -125.72 -140.0 0.28 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.887 . . . . 0.0 110.253 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.575 HG23 ' N ' ' A' ' 60' ' ' LEU . 3.7 m -141.0 -42.98 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.188 -0.945 . . . . 0.0 110.376 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.575 ' N ' HG23 ' A' ' 59' ' ' VAL . 0.1 OUTLIER 176.88 81.77 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.098 -1.001 . . . . 0.0 110.757 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.537 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . -97.4 168.96 24.48 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.53 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -131.49 166.89 20.34 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.18 -1.188 . . . . 0.0 110.515 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.676 HD12 ' N ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -121.87 121.02 36.2 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.301 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.912 HG12 HG21 ' A' ' 31' ' ' THR . 1.6 mp -85.98 -27.42 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 106.706 -1.591 . . . . 0.0 106.706 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.843 HG22 ' O ' ' A' ' 65' ' ' THR 0.255 3.0 m -110.75 42.8 1.53 Allowed 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.338 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.774 HG12 ' ND2' ' A' ' 67' ' ' ASN . 6.7 t -30.94 133.06 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 121.275 0.56 . . . . 0.0 111.021 -178.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.774 ' ND2' HG12 ' A' ' 66' ' ' VAL . 23.0 p30 27.52 74.92 0.35 Allowed Pre-proline 0 N--CA 1.488 1.458 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.575 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.546 ' O ' ' HA ' ' A' ' 46' ' ' LYS . 8.4 Cg_endo -60.8 -171.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.707 1.372 . . . . 0.0 108.851 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.748 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.8 OUTLIER -142.79 144.49 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.816 -1.177 . . . . 0.0 112.227 -179.157 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.02 HG21 ' HB2' ' A' ' 38' ' ' TYR . 43.7 t -100.66 156.76 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 175.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.8 m -111.28 -20.8 12.17 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.791 -1.164 . . . . 0.0 111.224 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 7.4 mt-10 -132.25 15.9 4.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.842 -1.161 . . . . 0.0 111.244 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.522 ' O ' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER 71.63 -4.18 1.96 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.259 -0.901 . . . . 0.0 110.87 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.482 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 5.5 t70 -137.31 -0.04 2.26 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.885 -1.134 . . . . 0.0 110.26 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.685 ' O ' HG23 ' A' ' 77' ' ' VAL . 33.9 t -73.07 112.24 14.74 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.244 -0.91 . . . . 0.0 109.248 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 74' ' ' ASP . 33.2 Cg_exo -51.38 112.87 0.91 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.783 1.412 . . . . 0.0 109.738 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.944 HG21 HG22 ' A' ' 70' ' ' VAL . 59.9 t -102.1 130.74 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.322 -0.861 . . . . 0.0 111.516 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.649 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 12.0 m-80 -93.12 135.26 34.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.401 -0.812 . . . . 0.0 108.972 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.939 HG21 ' CD2' ' A' ' 49' ' ' PHE . 6.1 mt -114.53 117.26 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 117.69 -1.604 . . . . 0.0 111.979 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.685 ' HG3' HG22 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -86.03 114.14 22.67 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.333 179.362 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.693 ' C ' HG22 ' A' ' 31' ' ' THR . . . -133.45 153.28 51.74 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.024 -1.048 . . . . 0.0 110.505 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 0.8 OUTLIER -101.56 101.95 19.91 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.186 -0.946 . . . . 0.0 110.425 -179.611 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.587 ' HG2' ' CD2' ' A' ' 104' ' ' PHE . 33.7 Cg_endo -70.57 142.41 44.31 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.127 1.593 . . . . 0.0 110.325 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.594 ' HG2' ' CE1' ' A' ' 58' ' ' HIS . 32.3 Cg_endo -71.97 -75.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.09 1.574 . . . . 0.0 110.348 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.61 ' CD1' ' N ' ' A' ' 86' ' ' GLY . 50.5 t80 -179.43 168.45 1.45 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.243 -0.91 . . . . 0.0 110.18 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.61 ' N ' ' CD1' ' A' ' 85' ' ' PHE . . . 64.56 -176.13 11.18 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 89' ' ' TYR . 6.1 m-20 -46.06 114.1 0.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -1.15 . . . . 0.0 109.999 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.586 ' CB ' ' NE2' ' A' ' 58' ' ' HIS . 34.9 m -117.17 93.17 4.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.185 -0.947 . . . . 0.0 110.567 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.591 ' CZ ' ' HB3' ' A' ' 87' ' ' ASP . 19.9 m-85 -85.15 100.97 12.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.225 -0.922 . . . . 0.0 109.963 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.687 ' HA ' HG22 ' A' ' 51' ' ' ILE . 2.2 mt -73.9 133.74 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 109.544 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.588 HD12 ' HG2' ' A' ' 50' ' ' GLU . 84.6 mt -106.2 134.62 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.908 -1.12 . . . . 0.0 110.583 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.141 HD11 HG21 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -124.21 144.87 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.492 -0.755 . . . . 0.0 109.569 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.547 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 82.68 -162.67 41.56 Favored Glycine 0 N--CA 1.482 1.714 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.555 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -119.78 146.88 23.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 O-C-N 121.257 -1.143 . . . . 0.0 109.932 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.569 ' O ' ' N ' ' A' ' 97' ' ' GLY . 3.9 mt-10 -17.85 -58.22 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.181 0 N-CA-C 111.655 0.242 . . . . 0.0 111.655 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 10.0 Cg_endo -53.17 71.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 124.112 1.585 . . . . 0.0 111.962 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 92.73 1.59 67.96 Favored Glycine 0 N--CA 1.495 2.605 0 O-C-N 120.97 -1.082 . . . . 0.0 111.04 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.499 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -50.04 160.81 0.31 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.895 -1.356 . . . . 0.0 109.839 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.644 HD13 ' CG2' ' A' ' 20' ' ' VAL . 8.7 mt -98.96 175.78 5.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.102 -0.999 . . . . 0.0 111.053 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.695 ' C ' HD12 ' A' ' 101' ' ' LEU . 0.8 OUTLIER -154.72 137.5 15.3 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.559 -0.713 . . . . 0.0 109.811 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.801 ' N ' HD12 ' A' ' 101' ' ' LEU . 2.0 mp -143.33 125.54 15.5 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.094 -1.004 . . . . 0.0 110.527 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.506 ' HB2' ' CD1' ' A' ' 89' ' ' TYR . 32.4 t30 -90.35 133.79 34.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.286 -0.884 . . . . 0.0 110.403 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.648 ' CE3' HG22 ' A' ' 24' ' ' ILE . 60.5 t-105 -145.88 173.04 12.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.353 -0.842 . . . . 0.0 110.31 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.587 ' CD2' ' HG2' ' A' ' 83' ' ' PRO . 0.2 OUTLIER 67.67 -74.97 0.07 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.319 -0.863 . . . . 0.0 110.44 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.502 ' HA ' ' N ' ' A' ' 87' ' ' ASP . 1.6 tttp 64.79 -155.52 0.29 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.943 . . . . 0.0 110.154 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.422 ' CG ' ' N ' ' A' ' 107' ' ' GLY . 0.0 OUTLIER -76.4 -89.67 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.308 -0.87 . . . . 0.0 110.214 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.422 ' N ' ' CG ' ' A' ' 106' ' ' LYS . . . -127.36 -38.06 0.43 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.11 164.82 21.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.216 -1.167 . . . . 0.0 110.139 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.55 139.36 35.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.326 -0.859 . . . . 0.0 110.174 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.466 ' O ' ' N ' ' A' ' 112' ' ' HIS . 28.8 tp 53.38 81.76 0.09 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 110.233 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -61.21 80.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.247 -0.908 . . . . 0.0 110.248 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.466 ' N ' ' O ' ' A' ' 110' ' ' LEU . 1.6 t-80 -84.07 93.82 8.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -0.895 . . . . 0.0 110.262 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 30.0 m-70 -157.85 135.99 10.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.313 -0.867 . . . . 0.0 110.184 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -167.33 133.06 2.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.18 -0.95 . . . . 0.0 110.226 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -92.85 160.02 15.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.907 . . . . 0.0 110.169 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -160.25 -49.34 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 110.213 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 10.5 t60 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.267 179.977 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mtm . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.267 0.556 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.93 60.87 1.0 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.915 . . . . 0.0 110.162 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.77 29.58 7.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.913 . . . . 0.0 110.209 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.442 ' O ' ' CB ' ' A' ' 5' ' ' GLN . 6.4 tp -51.73 120.3 5.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.279 -0.888 . . . . 0.0 110.169 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.442 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER 171.49 87.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.171 -0.955 . . . . 0.0 110.217 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.619 HD21 ' HE2' ' A' ' 46' ' ' LYS . 1.4 tp -85.22 60.58 6.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.2 -0.938 . . . . 0.0 110.242 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.62 -82.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.294 -0.879 . . . . 0.0 110.194 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 6' ' ' LEU . . . -166.44 -40.09 0.02 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.8 ttm -135.14 -69.42 0.51 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.172 -1.193 . . . . 0.0 110.281 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.47 144.74 17.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.179 -0.951 . . . . 0.0 110.319 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -87.83 -74.09 0.46 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.297 -0.877 . . . . 0.0 109.698 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.568 ' HB3' ' CB ' ' A' ' 45' ' ' CYS . 3.3 t -145.61 -27.09 0.45 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.267 -0.896 . . . . 0.0 111.135 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.489 ' HB3' ' O ' ' A' ' 12' ' ' SER . 8.3 ttt 60.16 91.1 0.05 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.361 -0.837 . . . . 0.0 109.471 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.633 ' SG ' HD13 ' A' ' 47' ' ' ILE . 32.7 m -49.14 138.57 12.0 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.469 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 0.9 OUTLIER -126.6 -17.08 5.14 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.528 -1.357 . . . . 0.0 111.965 -178.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.573 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -59.77 -117.1 0.01 OUTLIER Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.4 -1.381 . . . . 0.0 109.786 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.535 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -135.35 -179.9 5.92 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.963 -1.316 . . . . 0.0 110.324 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.977 ' CE1' HG23 ' A' ' 47' ' ' ILE . 31.0 m-85 -136.57 149.67 48.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.04 -1.038 . . . . 0.0 111.851 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.455 ' HB2' ' CG ' ' A' ' 39' ' ' GLU . 17.6 ttpt -116.6 118.76 33.49 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.655 -0.653 . . . . 0.0 109.557 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.5 ' CG2' HD13 ' A' ' 99' ' ' LEU . 51.3 t -59.63 131.52 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.784 -1.198 . . . . 0.0 108.772 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.605 HG23 ' HA ' ' A' ' 36' ' ' VAL . 76.8 t -105.62 -26.44 3.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.562 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 12.5 tttt -157.53 133.34 9.3 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -52.47 155.39 2.15 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.535 0.683 . . . . 0.0 111.243 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.679 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -49.76 133.22 8.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 C-N-CA 119.996 -0.681 . . . . 0.0 109.957 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.867 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -108.24 171.52 7.36 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.2 pm0 -116.91 132.62 56.65 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.87 -1.144 . . . . 0.0 110.454 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.861 HG21 ' CD ' ' A' ' 80' ' ' GLU . 13.7 p -90.57 179.61 5.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.334 -0.854 . . . . 0.0 110.127 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -93.25 29.86 1.81 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -0.93 . . . . 0.0 110.379 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.53 6.89 3.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 110.357 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.427 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 95.64 5.56 60.04 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.89 HG22 ' C ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -98.86 -173.1 2.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.316 -1.108 . . . . 0.0 110.135 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.867 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -144.33 159.42 15.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.8 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 85.5 t -125.28 128.72 72.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 O-C-N 120.864 -1.148 . . . . 0.0 112.457 -177.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.986 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -110.81 118.16 56.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.379 -0.826 . . . . 0.0 109.476 178.672 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -103.77 114.76 29.26 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.806 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.8 m -133.95 -172.15 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.223 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.535 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 10.9 tt0 -132.37 126.79 34.05 Favored 'General case' 0 C--N 1.276 -2.615 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 1.021 ' HB2' HG21 ' A' ' 70' ' ' VAL . 1.5 t80 -60.55 123.99 19.03 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 118.716 -1.194 . . . . 0.0 109.92 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.455 ' CG ' ' HB2' ' A' ' 19' ' ' LYS . 43.4 mm-40 -103.65 -21.95 13.65 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.124 -0.985 . . . . 0.0 109.156 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.573 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -67.17 -164.85 2.25 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.511 ' HA ' ' HG3' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -137.63 94.04 2.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.578 -0.954 . . . . 0.0 109.976 179.716 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 43' ' ' SER . . . -149.12 12.19 1.06 Allowed Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.348 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.606 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.3 OUTLIER 47.31 -158.65 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.352 0 O-C-N 120.788 -1.419 . . . . 0.0 109.127 179.491 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.606 ' HD2' ' CB ' ' A' ' 43' ' ' SER . 89.2 Cg_exo -42.86 94.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 122.87 0.931 . . . . 0.0 110.186 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.889 ' O ' HG23 ' A' ' 69' ' ' ILE . 25.7 p -143.13 163.77 31.96 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.742 -0.599 . . . . 0.0 109.566 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.619 ' HE2' HD21 ' A' ' 6' ' ' LEU . 1.6 mttt -86.65 156.9 19.81 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.027 -1.046 . . . . 0.0 111.428 -178.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.01 ' CD1' HG23 ' A' ' 70' ' ' VAL . 11.3 mm -99.72 125.07 41.85 Favored Pre-proline 0 C--N 1.294 -1.83 0 O-C-N 121.474 -0.766 . . . . 0.0 111.808 -177.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.618 ' HD2' ' CE2' ' A' ' 18' ' ' PHE . 33.2 Cg_exo -60.85 148.17 93.08 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.223 1.644 . . . . 0.0 111.046 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.928 ' CD2' HG21 ' A' ' 79' ' ' ILE . 4.9 t80 -154.22 151.54 29.28 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.487 -0.758 . . . . 0.0 109.582 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.493 ' HB3' ' HB ' ' A' ' 91' ' ' ILE . 3.8 tp10 -162.76 113.59 1.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.806 -1.184 . . . . 0.0 110.761 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.572 HD11 ' HE1' ' A' ' 49' ' ' PHE . 31.9 mt -112.24 128.04 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.388 -0.82 . . . . 0.0 109.744 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.499 ' HG2' ' CG ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -153.7 -49.87 0.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.047 -1.033 . . . . 0.0 110.69 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.573 ' OD2' ' CE2' ' A' ' 89' ' ' TYR . 16.3 t70 45.21 80.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.023 -1.048 . . . . 0.0 110.11 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.509 ' CB ' ' O ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER 69.49 4.53 4.71 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.171 -0.955 . . . . 0.0 110.267 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.534 ' CD ' HD13 ' A' ' 60' ' ' LEU . 1.4 tm-20 -136.36 52.11 1.98 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.286 -0.884 . . . . 0.0 110.002 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.499 ' CG ' ' HG2' ' A' ' 52' ' ' MET . 0.0 OUTLIER -97.85 25.65 5.77 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.403 -0.811 . . . . 0.0 110.209 -179.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.84 -10.69 14.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -0.899 . . . . 0.0 109.891 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -141.7 -143.48 0.15 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.401 -0.812 . . . . 0.0 110.064 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.6 t -121.91 124.24 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.225 -0.922 . . . . 0.0 110.343 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.534 HD13 ' CD ' ' A' ' 55' ' ' GLU . 0.6 OUTLIER -134.32 -76.6 0.47 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.905 . . . . 0.0 110.19 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.522 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . -67.1 164.24 44.18 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.529 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -131.3 170.51 14.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -1.148 . . . . 0.0 110.465 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.87 HD21 ' CD1' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -124.19 121.63 35.61 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.553 -0.717 . . . . 0.0 109.678 179.314 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.822 HG12 HG21 ' A' ' 31' ' ' THR . 1.5 mp -85.11 -24.47 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.801 HG22 ' O ' ' A' ' 65' ' ' THR 0.258 2.9 m -115.29 38.43 3.23 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.855 HG12 ' ND2' ' A' ' 67' ' ' ASN . 10.5 t -25.41 132.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 121.347 0.594 . . . . 0.0 111.5 -178.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.855 ' ND2' HG12 ' A' ' 66' ' ' VAL . 25.4 p30 30.47 70.23 0.63 Allowed Pre-proline 0 C--N 1.303 -1.446 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.745 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.605 ' HG3' HG23 ' A' ' 79' ' ' ILE . 1.2 Cg_endo -55.74 -175.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.644 0 N-CA-C 107.977 -1.586 . . . . 0.0 107.977 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.889 HG23 ' O ' ' A' ' 45' ' ' CYS . 1.1 mt -144.93 146.12 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 C-N-CA 118.56 -1.256 . . . . 0.0 112.174 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.021 HG21 ' HB2' ' A' ' 38' ' ' TYR . 22.0 t -102.26 157.82 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.1 m -114.26 -16.12 12.07 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 118.973 -1.091 . . . . 0.0 111.656 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.527 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 12.4 mt-10 -136.75 16.55 3.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.574 -1.329 . . . . 0.0 111.619 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.576 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 2.4 ttpt 71.57 -5.08 1.71 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.149 -0.969 . . . . 0.0 110.994 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.478 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 5.1 t70 -137.86 -1.51 2.0 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.969 -1.082 . . . . 0.0 110.32 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.606 ' O ' HG23 ' A' ' 77' ' ' VAL . 39.2 t -72.36 112.24 14.01 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.209 -0.932 . . . . 0.0 109.259 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.602 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 49.7 Cg_exo -48.51 126.51 14.29 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.828 1.436 . . . . 0.0 109.744 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.999 HG21 HG22 ' A' ' 70' ' ' VAL . 74.8 t -114.31 133.41 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.015 -1.053 . . . . 0.0 111.45 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.681 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 5.3 m-80 -99.65 131.8 45.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.493 -0.754 . . . . 0.0 109.12 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.928 HG21 ' CD2' ' A' ' 49' ' ' PHE . 10.9 mt -114.17 119.62 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.099 -1.626 . . . . 0.0 111.636 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.861 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.7 tp10 -92.4 118.59 31.09 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.94 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.89 ' C ' HG22 ' A' ' 31' ' ' THR . . . -135.93 152.55 51.1 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.006 -1.059 . . . . 0.0 110.78 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.529 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 2.0 tt0 -102.36 102.63 26.32 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.367 -0.833 . . . . 0.0 110.266 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.54 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 35.7 Cg_endo -71.96 151.56 56.45 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.086 1.571 . . . . 0.0 110.564 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.575 ' O ' ' CG ' ' A' ' 85' ' ' PHE . 15.5 Cg_endo -62.74 -79.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.081 1.569 . . . . 0.0 110.249 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.575 ' CG ' ' O ' ' A' ' 84' ' ' PRO . 2.6 m-85 -173.32 151.57 2.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.915 . . . . 0.0 110.214 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 104' ' ' PHE . . . 74.44 -162.72 54.22 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 103' ' ' TRP . 51.7 p-10 -55.96 176.69 0.07 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.298 -1.119 . . . . 0.0 110.126 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.493 ' HA ' ' HB2' ' A' ' 53' ' ' ASP . 0.5 OUTLIER 173.91 131.37 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.194 -0.941 . . . . 0.0 110.325 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.573 ' CE2' ' OD2' ' A' ' 53' ' ' ASP . 15.4 m-85 -105.02 100.01 9.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.137 -0.977 . . . . 0.0 110.085 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.606 ' CG2' ' CZ ' ' A' ' 49' ' ' PHE . 1.3 mp -73.94 125.03 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.21 -0.931 . . . . 0.0 109.447 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.498 ' CG2' ' CD ' ' A' ' 98' ' ' GLN . 81.0 mt -96.5 144.14 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.156 -0.965 . . . . 0.0 110.503 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.986 HD11 HG21 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -129.76 137.87 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.502 -0.749 . . . . 0.0 109.596 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.562 ' O ' ' HB2' ' A' ' 48' ' ' PRO . . . 86.7 -163.78 35.43 Favored Glycine 0 N--CA 1.481 1.681 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.57 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -118.15 143.92 27.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 O-C-N 121.049 -1.265 . . . . 0.0 110.32 -179.478 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.576 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -14.54 -59.26 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.139 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -179.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 5.9 Cg_endo -49.86 74.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 124.235 1.65 . . . . 0.0 111.752 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 86.68 -2.37 87.25 Favored Glycine 0 N--CA 1.494 2.519 0 O-C-N 121.045 -1.034 . . . . 0.0 111.096 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.511 ' HB3' ' C ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -43.41 162.73 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.812 -1.405 . . . . 0.0 109.897 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.603 HD11 ' O ' ' A' ' 18' ' ' PHE . 10.5 mt -98.91 174.88 6.15 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.069 -1.019 . . . . 0.0 110.889 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.494 ' HG3' HG12 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -152.1 130.32 11.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.603 -0.686 . . . . 0.0 109.871 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' A' ' 89' ' ' TYR . 4.2 mp -131.73 123.9 28.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.145 -0.972 . . . . 0.0 110.394 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -86.96 128.98 35.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.325 -0.859 . . . . 0.0 110.207 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.61 ' CE3' HG22 ' A' ' 24' ' ' ILE . 61.7 t-105 -136.69 169.07 18.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.16 -0.963 . . . . 0.0 110.275 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 104' ' ' PHE . 16.9 p90 -137.7 149.59 46.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.286 -0.883 . . . . 0.0 110.261 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.0 138.63 28.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -0.925 . . . . 0.0 110.198 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.2 pttm -158.58 152.31 23.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.908 . . . . 0.0 110.162 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 162.37 -147.0 12.62 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.9 t -57.01 134.53 55.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -1.103 . . . . 0.0 110.219 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 54.5 p -172.99 95.7 0.12 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.315 -0.865 . . . . 0.0 110.149 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.93 -65.77 0.64 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.231 -0.918 . . . . 0.0 110.256 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 55.98 83.04 0.1 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 110.18 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -135.35 -44.57 0.69 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.224 -0.923 . . . . 0.0 110.239 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -62.7 176.21 0.7 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.268 -0.895 . . . . 0.0 110.095 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.418 ' O ' ' ND1' ' A' ' 114' ' ' HIS . 21.3 t-80 -98.93 90.53 4.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.296 -0.878 . . . . 0.0 110.363 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -86.36 129.04 34.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 110.155 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.419 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 15.2 t-160 -129.84 40.9 3.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.279 -0.888 . . . . 0.0 110.276 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.207 179.978 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.28 0.562 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 4' ' ' LEU . 2.9 p-10 -165.82 171.39 12.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 110.255 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 53.18 -88.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.283 -0.886 . . . . 0.0 110.248 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 2' ' ' ASP . 0.7 OUTLIER -72.16 -151.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.239 -0.913 . . . . 0.0 110.137 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.445 ' CG ' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER 172.23 -84.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.203 -0.936 . . . . 0.0 110.114 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.826 HD11 HG11 ' A' ' 66' ' ' VAL . 11.3 mp 43.79 -163.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.311 -0.868 . . . . 0.0 110.215 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER 178.03 37.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.238 -0.914 . . . . 0.0 110.185 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.3 49.76 3.39 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -112.93 18.05 18.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -1.18 . . . . 0.0 110.262 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.533 ' HA ' ' CE ' ' A' ' 46' ' ' LYS . 19.5 t -81.84 162.34 22.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 110.238 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -137.29 -74.05 0.42 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.283 -0.886 . . . . 0.0 110.373 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 13' ' ' MET . 3.2 t -136.94 -5.0 1.92 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.998 -1.064 . . . . 0.0 111.258 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.882 ' HG2' HG23 ' A' ' 15' ' ' THR . 21.7 ttm 56.6 85.42 0.08 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.946 -1.096 . . . . 0.0 108.923 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.596 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 39.6 m -57.57 98.04 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.449 -0.782 . . . . 0.0 109.31 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.882 HG23 ' HG2' ' A' ' 13' ' ' MET . 3.7 p -95.52 -1.98 49.53 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.18 -0.95 . . . . 0.0 112.07 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.594 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -66.84 -110.59 0.01 OUTLIER Glycine 0 N--CA 1.49 2.295 0 C-N-CA 118.844 -1.645 . . . . 0.0 109.048 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.529 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -143.47 173.62 11.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.985 -1.303 . . . . 0.0 110.103 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.863 ' CE2' HG23 ' A' ' 47' ' ' ILE . 33.6 m-85 -133.66 151.12 51.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.993 -1.067 . . . . 0.0 111.631 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.491 ' HE2' ' NE2' ' A' ' 37' ' ' GLN . 5.2 ttpt -117.75 115.95 26.04 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.61 -0.681 . . . . 0.0 109.239 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.64 ' CG2' HD13 ' A' ' 99' ' ' LEU . 40.6 t -59.67 124.7 14.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 120.655 -1.278 . . . . 0.0 109.131 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.569 HG23 ' HA ' ' A' ' 36' ' ' VAL . 60.6 t -98.25 -26.37 3.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.614 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 7.7 tttt -158.06 133.6 8.95 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -50.58 160.22 0.44 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.618 0.723 . . . . 0.0 111.465 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.679 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.7 OUTLIER -55.24 132.88 18.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 121.545 0.688 . . . . 0.0 110.277 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.74 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -108.94 168.19 9.54 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 4.2 pm0 -114.77 134.65 54.94 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.613 -1.304 . . . . 0.0 110.695 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.66 HG21 ' CD ' ' A' ' 80' ' ' GLU . 9.5 p -91.79 172.06 8.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.521 -0.737 . . . . 0.0 110.041 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -87.85 31.03 0.79 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.234 -0.916 . . . . 0.0 110.378 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.95 6.38 3.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.244 -0.91 . . . . 0.0 110.249 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.473 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 94.73 10.32 57.9 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.863 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -106.08 -178.21 3.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.392 -1.064 . . . . 0.0 110.273 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.74 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -139.51 150.63 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 54.1 t -117.45 134.2 61.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 O-C-N 121.184 -0.947 . . . . 0.0 112.126 -177.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.015 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -116.85 119.88 63.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.366 -0.834 . . . . 0.0 109.761 178.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.614 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 1.1 ttm180 -101.12 123.66 45.62 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.798 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.4 m -149.2 161.56 4.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.148 -0.97 . . . . 0.0 108.766 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.491 ' NE2' ' HE2' ' A' ' 19' ' ' LYS 0.262 1.6 tt0 -107.35 125.62 51.43 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.859 ' HB2' HG21 ' A' ' 70' ' ' VAL . 3.3 t80 -59.87 122.94 15.5 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 118.909 -1.117 . . . . 0.0 110.126 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.44 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 1.3 mm-40 -98.57 -23.89 15.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.319 -0.863 . . . . 0.0 109.168 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.594 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -65.59 -161.6 0.82 Allowed Glycine 0 N--CA 1.484 1.89 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.448 ' HA ' ' HD2' ' A' ' 73' ' ' LYS . 30.9 t0 -128.23 146.46 50.73 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.468 -1.019 . . . . 0.0 110.185 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.402 ' O ' ' CB ' ' A' ' 43' ' ' SER . . . 156.69 -14.39 0.35 Allowed Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.59 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.606 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.8 OUTLIER 60.49 -152.95 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 120.639 -1.506 . . . . 0.0 108.16 -179.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 88.5 Cg_exo -42.39 97.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.32 -0.959 0 N-CA-C 108.819 -1.262 . . . . 0.0 108.819 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.708 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -146.77 171.28 15.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.767 -0.583 . . . . 0.0 110.02 -177.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.699 ' HG3' HD11 ' A' ' 69' ' ' ILE . 16.6 mtmt -85.79 175.01 8.93 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.35 -0.844 . . . . 0.0 111.664 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.067 HD11 ' CG2' ' A' ' 70' ' ' VAL . 15.7 mm -123.05 125.78 26.17 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.401 -0.812 . . . . 0.0 112.299 -178.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.625 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 30.2 Cg_exo -65.42 146.8 86.3 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.963 1.507 . . . . 0.0 110.686 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.709 ' CD2' HD11 ' A' ' 63' ' ' LEU . 11.4 t80 -155.88 159.9 39.71 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.255 -0.903 . . . . 0.0 110.422 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.511 ' OE2' ' HA ' ' A' ' 57' ' ' ARG . 5.9 tp10 -176.29 114.38 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.067 -1.021 . . . . 0.0 110.554 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.643 HD11 ' HE2' ' A' ' 49' ' ' PHE . 55.9 mt -106.89 97.7 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 110.094 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.469 ' SD ' ' HD2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -129.57 -67.04 0.78 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 110.317 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 54' ' ' LEU . 5.5 p30 174.06 -36.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.241 -0.912 . . . . 0.0 110.347 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.508 ' N ' ' OD1' ' A' ' 53' ' ' ASP . 1.0 OUTLIER -128.91 -89.56 0.51 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 0.0 110.288 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.477 ' OE2' ' HA ' ' A' ' 95' ' ' GLU . 11.5 tt0 -153.93 52.05 0.69 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.939 . . . . 0.0 110.271 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.469 ' HD2' ' SD ' ' A' ' 52' ' ' MET . 0.1 OUTLIER -119.74 139.25 52.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 0.0 110.156 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.575 ' O ' ' CG ' ' A' ' 58' ' ' HIS . 8.1 mtp180 -97.81 124.96 42.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.232 -0.918 . . . . 0.0 110.303 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 57' ' ' ARG . 15.8 m80 -162.22 -91.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 110.267 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.534 ' O ' HD22 ' A' ' 60' ' ' LEU . 1.9 p 175.88 100.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.187 -0.946 . . . . 0.0 110.133 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.534 HD22 ' O ' ' A' ' 59' ' ' VAL . 0.5 OUTLIER -126.86 -50.63 1.46 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -0.923 . . . . 0.0 110.25 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.471 ' HA2' ' HD3' ' A' ' 84' ' ' PRO . . . -106.35 -174.37 23.31 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.559 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -120.6 149.96 41.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.18 -1.188 . . . . 0.0 110.113 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.726 ' O ' HG23 ' A' ' 66' ' ' VAL . 3.2 mt -110.15 118.15 35.61 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.197 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.863 HG12 HG21 ' A' ' 31' ' ' THR . 1.5 mp -77.49 -22.97 14.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.669 HG22 ' O ' ' A' ' 65' ' ' THR 0.272 1.0 OUTLIER -113.69 29.77 7.75 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.439 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.826 HG11 HD11 ' A' ' 6' ' ' LEU . 52.0 t -12.47 112.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.534 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.494 ' OD1' ' HB3' ' A' ' 46' ' ' LYS . 20.8 t-20 41.24 70.0 1.79 Allowed Pre-proline 0 C--N 1.302 -1.488 0 O-C-N 121.647 -0.658 . . . . 0.0 110.4 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.525 ' CG ' HG12 ' A' ' 79' ' ' ILE . 1.7 Cg_endo -51.85 -176.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.01 1.532 . . . . 0.0 109.723 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.708 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.9 OUTLIER -140.7 142.07 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.947 -178.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.067 ' CG2' HD11 ' A' ' 47' ' ' ILE . 24.8 t -93.39 169.51 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.2 m -124.15 -20.73 5.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.883 -1.136 . . . . 0.0 110.929 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.531 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 6.9 mt-10 -135.87 14.44 3.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.026 -1.046 . . . . 0.0 110.754 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.531 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 10.6 ttpt 73.81 -7.52 1.58 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.422 -0.798 . . . . 0.0 110.818 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.487 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 5.7 t70 -136.78 -1.15 2.26 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.965 -1.085 . . . . 0.0 110.23 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.564 ' O ' HG23 ' A' ' 77' ' ' VAL . 36.2 t -73.19 112.46 15.78 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.194 -0.941 . . . . 0.0 109.44 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 35.0 Cg_exo -50.93 113.52 1.12 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.806 1.424 . . . . 0.0 109.912 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.719 HG21 HG22 ' A' ' 70' ' ' VAL . 74.0 t -99.13 155.19 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.318 -0.864 . . . . 0.0 110.714 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.654 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -111.77 134.86 53.06 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.465 -0.772 . . . . 0.0 109.96 179.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.688 ' HB ' HG22 ' A' ' 34' ' ' ILE . 3.8 mt -115.35 114.23 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 117.731 -1.588 . . . . 0.0 111.289 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.66 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.1 tt0 -90.78 115.0 27.52 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.983 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.818 ' C ' HG22 ' A' ' 31' ' ' THR . . . -131.61 149.16 52.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.908 -1.12 . . . . 0.0 110.768 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' A' ' 62' ' ' ARG . 2.2 tt0 -98.82 104.99 28.23 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 110.337 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.526 ' CB ' ' OD2' ' A' ' 87' ' ' ASP . 30.8 Cg_endo -70.32 131.97 21.49 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.001 1.527 . . . . 0.0 110.298 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.471 ' HD3' ' HA2' ' A' ' 61' ' ' GLY . 23.0 Cg_endo -67.38 -70.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.933 1.491 . . . . 0.0 110.398 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -165.63 70.4 0.14 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.295 -0.878 . . . . 0.0 110.293 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 105' ' ' LYS . . . 140.75 -94.17 0.19 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.526 ' OD2' ' CB ' ' A' ' 83' ' ' PRO . 12.9 m-20 63.5 -70.39 0.07 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.479 -1.012 . . . . 0.0 110.307 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.543 ' O ' ' N ' ' A' ' 103' ' ' TRP . 0.8 OUTLIER 64.71 -73.09 0.06 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.151 -0.968 . . . . 0.0 110.777 179.795 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.536 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 9.7 m-85 -97.11 90.9 5.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.75 -1.219 . . . . 0.0 111.231 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.528 HD11 HD12 ' A' ' 32' ' ' ILE . 20.6 mt -73.81 163.63 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.49 ' CG2' ' CD ' ' A' ' 98' ' ' GLN . 80.2 mt -126.25 139.54 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.496 -1.377 . . . . 0.0 112.04 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.015 HD11 HG21 ' A' ' 34' ' ' ILE . 0.5 OUTLIER -128.44 136.12 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.242 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.533 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 87.71 -161.17 31.97 Favored Glycine 0 N--CA 1.481 1.649 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.563 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -121.18 146.84 25.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 121.04 -1.27 . . . . 0.0 110.154 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.581 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.3 OUTLIER -17.03 -58.6 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.203 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 7.1 Cg_endo -51.18 75.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 124.216 1.64 . . . . 0.0 111.735 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 87.02 -0.27 86.02 Favored Glycine 0 N--CA 1.494 2.501 0 O-C-N 120.96 -1.087 . . . . 0.0 111.043 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.51 ' HB3' ' C ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -44.65 164.48 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.744 -1.445 . . . . 0.0 109.807 179.864 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.64 HD13 ' CG2' ' A' ' 20' ' ' VAL . 7.2 mt -102.35 170.67 7.93 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.104 -0.998 . . . . 0.0 111.263 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -146.41 132.84 19.65 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.602 -0.687 . . . . 0.0 109.478 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.944 HD11 HD12 ' A' ' 92' ' ' ILE . 1.0 OUTLIER -122.99 135.41 54.46 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.002 -1.061 . . . . 0.0 110.744 -179.534 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.527 ' HA ' ' O ' ' A' ' 88' ' ' SER . 2.6 p-10 -84.74 130.63 34.66 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.372 -0.83 . . . . 0.0 110.657 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.543 ' N ' ' O ' ' A' ' 88' ' ' SER . 26.2 t-105 -161.07 97.52 1.14 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.325 -0.86 . . . . 0.0 109.965 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -73.36 105.99 4.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.21 -0.931 . . . . 0.0 110.241 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -111.37 65.17 0.62 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.201 -0.937 . . . . 0.0 110.202 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.52 -42.17 0.45 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 110.278 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.88 -147.2 18.43 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 47.69 75.41 0.13 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.233 -1.157 . . . . 0.0 110.13 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.28 94.8 4.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -0.899 . . . . 0.0 110.269 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.88 50.13 1.27 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.284 -0.885 . . . . 0.0 110.184 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.88 -43.42 1.36 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 110.243 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.52 -171.49 3.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.907 . . . . 0.0 110.243 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -95.41 121.24 36.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 110.199 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -99.24 84.37 3.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 0.0 110.26 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.445 ' O ' ' HB3' ' A' ' 116' ' ' HIS . 0.4 OUTLIER -167.78 -62.14 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.328 -0.858 . . . . 0.0 110.163 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.445 ' HB3' ' O ' ' A' ' 115' ' ' HIS . 13.0 t-160 57.28 102.64 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.235 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.486 ' OXT' ' CG ' ' A' ' 117' ' ' HIS . 11.6 t-160 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.087 -0.958 . . . . 0.0 110.249 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.226 0.536 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.405 ' OD1' ' C ' ' A' ' 2' ' ' ASP . 2.6 p30 -156.29 177.52 11.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 110.216 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -109.7 -61.46 1.64 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.288 -0.883 . . . . 0.0 110.139 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.645 HD23 ' H ' ' A' ' 4' ' ' LEU . 0.5 OUTLIER -85.56 -154.24 0.19 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.241 -0.912 . . . . 0.0 110.149 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER 172.25 -71.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.295 -0.878 . . . . 0.0 110.129 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 8' ' ' GLY . 0.1 OUTLIER 66.25 -64.4 0.22 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.255 -0.903 . . . . 0.0 110.262 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 5' ' ' GLN . 3.0 mtpp 52.53 -89.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.247 -0.908 . . . . 0.0 110.205 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 6' ' ' LEU . . . -118.49 -88.62 1.23 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.518 ' O ' ' ND2' ' A' ' 67' ' ' ASN . 0.0 OUTLIER 65.43 128.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -1.162 . . . . 0.0 110.229 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.563 ' HA ' ' CD ' ' A' ' 46' ' ' LYS . 43.6 t -141.77 145.74 35.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.927 . . . . 0.0 110.125 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -93.31 -73.59 0.56 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.164 -0.96 . . . . 0.0 110.216 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.445 ' O ' ' HB3' ' A' ' 13' ' ' MET . 3.3 t -135.93 -6.44 2.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.117 -0.989 . . . . 0.0 110.925 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.485 ' HG2' HG23 ' A' ' 15' ' ' THR . 5.4 ttm 56.13 80.42 0.15 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.001 -1.062 . . . . 0.0 108.756 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.587 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 42.9 m -55.27 92.87 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.413 -0.805 . . . . 0.0 109.2 -178.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.534 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -88.8 -7.36 56.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.385 -0.822 . . . . 0.0 111.766 -178.375 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.581 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -61.55 -110.83 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 C-N-CA 118.775 -1.679 . . . . 0.0 108.966 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.538 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -145.99 171.8 14.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.98 -1.306 . . . . 0.0 110.253 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.087 ' CE2' HG23 ' A' ' 47' ' ' ILE . 38.1 m-85 -130.49 148.69 52.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.062 -1.024 . . . . 0.0 111.48 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.498 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 4.2 ttpp -114.13 114.68 26.4 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.481 -0.762 . . . . 0.0 109.131 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.73 HG22 HD13 ' A' ' 99' ' ' LEU . 21.5 t -59.49 124.15 13.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 120.606 -1.309 . . . . 0.0 109.015 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.68 HG21 ' HB3' ' A' ' 76' ' ' PRO . 64.4 t -97.56 -25.54 4.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.602 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 3.8 tttp -158.68 133.54 8.27 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 177.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -51.68 163.27 0.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.671 0.748 . . . . 0.0 111.305 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.676 HG12 HD22 ' A' ' 101' ' ' LEU . 0.7 OUTLIER -57.09 132.81 21.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 121.647 0.736 . . . . 0.0 110.2 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.81 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -108.05 169.83 8.38 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 2.9 pm0 -116.01 132.94 56.51 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.784 -1.197 . . . . 0.0 110.425 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.925 HG21 ' CD ' ' A' ' 80' ' ' GLU . 16.5 p -91.17 -179.32 5.4 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.659 -0.817 . . . . 0.0 110.103 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -94.16 17.22 12.97 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.184 -0.947 . . . . 0.0 110.373 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.28 8.09 12.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.293 -0.879 . . . . 0.0 110.062 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.34 11.33 59.82 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.846 HG22 ' C ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -104.91 -174.38 2.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.39 -1.064 . . . . 0.0 110.345 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.81 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -141.13 155.67 21.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.795 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 76.7 t -120.76 129.95 75.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 119.101 -1.04 . . . . 0.0 112.231 -178.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.056 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -113.7 117.65 56.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 121.399 -0.813 . . . . 0.0 109.79 178.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.602 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 3.1 ttm180 -100.77 119.91 39.33 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.796 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.4 m -146.87 158.72 10.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.2 -0.937 . . . . 0.0 109.014 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.468 ' N ' HG23 ' A' ' 21' ' ' VAL 0.252 11.9 tt0 -106.08 125.57 51.15 Favored 'General case' 0 C--N 1.271 -2.817 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.393 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.935 ' HB2' HG21 ' A' ' 70' ' ' VAL . 3.7 t80 -59.78 123.04 15.73 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 119.003 -1.079 . . . . 0.0 110.079 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.498 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 8.3 mt-10 -98.86 -23.54 15.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.359 -0.838 . . . . 0.0 109.206 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.581 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -65.01 -162.12 0.68 Allowed Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.472 ' OD1' ' HE2' ' A' ' 73' ' ' LYS . 17.7 m-20 -129.15 146.52 51.06 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.457 -1.025 . . . . 0.0 110.307 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 43' ' ' SER . . . 155.37 -12.8 0.43 Allowed Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.597 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.608 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.7 OUTLIER 61.08 -153.29 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 120.661 -1.493 . . . . 0.0 108.32 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.608 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 88.4 Cg_exo -42.16 97.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.32 -0.958 0 N-CA-C 108.964 -1.206 . . . . 0.0 108.964 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.883 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -146.66 170.19 17.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.829 -0.545 . . . . 0.0 110.143 -177.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.639 ' CG ' HD11 ' A' ' 69' ' ' ILE . 1.2 mtpm? -84.67 175.09 9.44 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.173 -0.955 . . . . 0.0 112.033 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.087 HG23 ' CE2' ' A' ' 18' ' ' PHE . 15.5 mm -123.65 124.2 26.22 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.68 -0.638 . . . . 0.0 111.539 -178.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.618 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 31.7 Cg_exo -61.92 144.71 96.83 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.06 1.558 . . . . 0.0 110.384 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 1.005 ' CE1' HG21 ' A' ' 79' ' ' ILE . 4.8 t80 -151.69 156.21 39.89 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.203 -0.935 . . . . 0.0 110.324 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.535 ' HG3' HD12 ' A' ' 91' ' ' ILE . 23.1 tp10 -173.76 95.6 0.1 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.073 -1.017 . . . . 0.0 110.184 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.503 HD11 ' CB ' ' A' ' 81' ' ' ALA . 97.2 mt -85.48 88.05 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.302 -0.874 . . . . 0.0 110.265 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.472 ' HB3' ' HG3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -148.97 -65.47 0.23 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.198 -0.939 . . . . 0.0 110.228 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.513 ' O ' ' NZ ' ' A' ' 100' ' ' LYS . 9.5 t70 -168.02 -55.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.176 -0.953 . . . . 0.0 110.188 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.877 HD12 ' CD ' ' A' ' 100' ' ' LYS . 4.5 tp -169.4 -38.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -0.915 . . . . 0.0 110.146 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.456 ' OE2' ' OE1' ' A' ' 95' ' ' GLU . 15.8 tt0 -161.03 61.99 0.29 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.379 -0.826 . . . . 0.0 109.991 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.472 ' HG3' ' HB3' ' A' ' 52' ' ' MET . 1.1 mtpt -108.49 138.74 44.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.281 -0.887 . . . . 0.0 110.239 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.5 ttm180 -62.76 -63.68 1.14 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.217 -0.927 . . . . 0.0 110.105 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -51.88 147.68 6.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.253 -0.905 . . . . 0.0 110.136 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.672 ' O ' ' CB ' ' A' ' 60' ' ' LEU . 55.4 t -91.12 -71.24 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.963 . . . . 0.0 110.336 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.672 ' CB ' ' O ' ' A' ' 59' ' ' VAL . 13.3 tp 96.82 -63.6 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.522 0 CA-C-O 121.245 0.545 . . . . 0.0 109.646 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.528 ' N ' ' HG3' ' A' ' 84' ' ' PRO . . . -73.21 -160.45 5.89 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.555 ' O ' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -150.54 163.93 37.25 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.267 -1.137 . . . . 0.0 109.525 179.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.103 HD23 ' HB2' ' A' ' 81' ' ' ALA . 11.8 mt -122.01 121.41 36.96 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 118.837 -1.145 . . . . 0.0 110.539 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.828 HG12 HG21 ' A' ' 31' ' ' THR . 1.4 mp -82.54 -27.62 8.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.728 HG22 ' O ' ' A' ' 65' ' ' THR 0.26 1.1 m -96.78 32.61 2.04 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 122.781 1.277 . . . . 0.0 107.673 178.726 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 1.008 HG23 ' O ' ' A' ' 63' ' ' LEU . 16.3 t -34.74 140.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.25 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.57 ' N ' ' CD ' ' A' ' 68' ' ' PRO . 38.9 t-20 56.55 46.4 2.24 Favored Pre-proline 0 C--N 1.302 -1.493 0 O-C-N 121.577 -0.702 . . . . 0.0 110.585 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.596 ' CB ' ' CD1' ' A' ' 79' ' ' ILE . 8.1 Cg_endo -59.15 146.36 94.71 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.673 1.354 . . . . 0.0 109.043 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.883 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.7 OUTLIER -141.3 149.86 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 119.127 -1.029 . . . . 0.0 112.915 -177.652 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.016 ' CG2' HD11 ' A' ' 47' ' ' ILE . 41.9 t -97.28 168.86 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.412 ' N ' HG12 ' A' ' 70' ' ' VAL . 4.8 m -122.78 -21.25 5.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.857 -1.152 . . . . 0.0 111.201 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.535 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 15.6 mt-10 -136.51 17.23 3.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.816 -1.177 . . . . 0.0 111.192 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER 72.54 -5.63 1.79 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.281 -0.887 . . . . 0.0 110.981 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.477 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 5.8 t70 -138.81 0.27 1.98 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.923 -1.111 . . . . 0.0 110.429 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.508 ' O ' HG23 ' A' ' 77' ' ' VAL . 22.8 t -73.09 108.59 4.76 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.15 -0.969 . . . . 0.0 109.476 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.68 ' HB3' HG21 ' A' ' 21' ' ' VAL . 1.6 Cg_endo -50.22 110.66 0.41 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.697 1.367 . . . . 0.0 109.736 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.551 HG21 HG22 ' A' ' 70' ' ' VAL . 82.0 t -94.34 146.0 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.269 -0.894 . . . . 0.0 111.044 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.639 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.1 m120 -106.64 131.09 54.18 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 1.005 HG21 ' CE1' ' A' ' 49' ' ' PHE . 3.9 mm -112.2 117.46 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.079 -1.638 . . . . 0.0 111.803 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.925 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.6 tp10 -93.57 106.97 18.89 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.302 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 1.103 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -130.24 153.86 48.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.88 -1.137 . . . . 0.0 111.308 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 62' ' ' ARG . 24.6 tt0 -97.82 103.55 17.47 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.647 -0.658 . . . . 0.0 110.409 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.541 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 37.4 Cg_endo -70.77 144.56 49.02 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.984 1.518 . . . . 0.0 110.539 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.528 ' HG3' ' N ' ' A' ' 61' ' ' GLY . 23.7 Cg_exo -59.91 -142.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.095 1.577 . . . . 0.0 110.155 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.575 ' CD2' ' HD3' ' A' ' 106' ' ' LYS . 1.4 m-30 -108.75 155.62 20.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 110.245 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.521 ' CA ' ' O ' ' A' ' 105' ' ' LYS . . . 72.12 -165.19 54.19 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -54.2 171.69 0.1 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.258 -1.142 . . . . 0.0 110.196 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.439 ' OG ' ' HD2' ' A' ' 84' ' ' PRO . 0.6 OUTLIER -174.41 122.98 0.29 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.881 . . . . 0.0 110.346 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 17.9 m-85 -99.9 103.44 15.03 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.182 -0.949 . . . . 0.0 110.259 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.753 HD11 HD13 ' A' ' 32' ' ' ILE . 4.1 mt -74.14 116.94 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 109.469 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.606 HD11 ' N ' ' A' ' 54' ' ' LEU . 37.9 mt -94.62 147.44 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.177 -0.952 . . . . 0.0 110.395 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.056 HD11 HG21 ' A' ' 34' ' ' ILE . 1.6 mt -133.36 139.66 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.464 -0.772 . . . . 0.0 109.478 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.532 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 83.13 -161.17 39.28 Favored Glycine 0 N--CA 1.481 1.651 0 N-CA-C 108.624 -1.791 . . . . 0.0 108.624 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.554 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -122.12 149.1 25.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 121.213 -1.169 . . . . 0.0 110.169 -179.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.577 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.6 OUTLIER -17.15 -58.42 0.04 OUTLIER Pre-proline 0 N--CA 1.501 2.117 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 8.6 Cg_endo -51.87 71.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 124.279 1.673 . . . . 0.0 112.116 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 90.6 0.57 75.58 Favored Glycine 0 N--CA 1.494 2.537 0 O-C-N 120.941 -1.1 . . . . 0.0 110.943 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.507 ' HB3' ' C ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -48.38 159.97 0.18 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.952 -1.322 . . . . 0.0 110.199 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.73 HD13 HG22 ' A' ' 20' ' ' VAL . 12.2 mt -96.87 177.84 5.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.239 -0.913 . . . . 0.0 110.623 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.877 ' CD ' HD12 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -157.62 137.28 12.16 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.477 -0.765 . . . . 0.0 110.16 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.676 HD22 HG12 ' A' ' 24' ' ' ILE . 2.8 mp -138.21 116.94 12.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.207 -0.933 . . . . 0.0 110.373 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 9.1 p-10 -83.31 128.06 34.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 110.405 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.425 ' N ' ' O ' ' A' ' 88' ' ' SER . 10.6 t-105 -120.4 141.28 50.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.243 -0.911 . . . . 0.0 110.155 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -98.52 100.33 11.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -0.926 . . . . 0.0 110.116 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.521 ' O ' ' CA ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -108.2 120.85 43.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 110.288 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.575 ' HD3' ' CD2' ' A' ' 85' ' ' PHE . 1.2 ttpp 62.55 102.06 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.215 -0.928 . . . . 0.0 110.209 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.11 -149.19 25.37 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.74 -163.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.155 -1.203 . . . . 0.0 110.134 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 110' ' ' LEU . 7.6 t -92.67 55.26 2.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 110.249 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 109' ' ' SER . 5.3 mp 58.67 -89.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 110.169 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 109' ' ' SER . 1.4 tp10 60.39 116.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.305 -0.872 . . . . 0.0 110.288 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.43 -63.01 0.56 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 110.186 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.406 ' O ' ' CB ' ' A' ' 114' ' ' HIS . 0.5 OUTLIER -104.64 14.72 29.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.277 -0.889 . . . . 0.0 110.182 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.406 ' CB ' ' O ' ' A' ' 113' ' ' HIS . 19.0 t60 62.97 59.55 1.33 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.277 -0.889 . . . . 0.0 110.221 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -99.12 90.54 4.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -0.929 . . . . 0.0 110.202 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 22.6 m170 -107.32 -26.6 10.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 110.169 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.215 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mtt . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.21 0.529 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 4' ' ' LEU . 2.0 p30 -137.52 144.28 42.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.891 . . . . 0.0 110.202 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 2' ' ' ASP . 0.0 OUTLIER 62.32 -75.24 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.32 -0.863 . . . . 0.0 110.205 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 2' ' ' ASP . 1.1 mp -74.12 119.65 18.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 110.171 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.454 ' HB3' ' O ' ' A' ' 4' ' ' LEU . 3.1 pt20 175.65 137.54 0.05 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.893 . . . . 0.0 110.152 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.414 ' C ' HD12 ' A' ' 6' ' ' LEU . 3.5 pp -165.09 156.91 15.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 110.262 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -134.19 24.44 3.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.24 -0.913 . . . . 0.0 110.222 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.76 11.65 66.3 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.28 55.64 1.36 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.339 -1.095 . . . . 0.0 110.221 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.94 -34.42 11.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 0.0 110.241 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.581 ' CE2' ' O ' ' A' ' 44' ' ' PRO . 2.2 t80 -145.19 -74.56 0.23 Allowed 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.175 -0.953 . . . . 0.0 110.237 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.556 ' HB3' ' CB ' ' A' ' 45' ' ' CYS . 3.3 t -137.16 -36.18 0.67 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.166 -0.959 . . . . 0.0 110.474 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.477 ' HB3' ' O ' ' A' ' 12' ' ' SER . 1.1 ttt 57.87 92.41 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.452 -0.78 . . . . 0.0 109.303 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.587 ' HB3' ' CE1' ' A' ' 38' ' ' TYR . 1.3 m -72.66 126.64 30.37 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.209 -0.932 . . . . 0.0 109.65 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.538 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 1.2 p -116.39 4.95 13.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.132 -0.98 . . . . 0.0 111.716 -178.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.582 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -62.02 -115.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.531 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -136.49 174.06 11.03 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.989 -1.3 . . . . 0.0 109.946 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.997 ' CE2' HG23 ' A' ' 47' ' ' ILE . 42.8 m-85 -133.02 140.84 47.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.965 -1.084 . . . . 0.0 111.814 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.538 ' HB2' ' CG ' ' A' ' 39' ' ' GLU . 7.9 ttpt -107.67 117.65 34.67 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.633 -0.667 . . . . 0.0 109.277 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.735 HG22 HD13 ' A' ' 99' ' ' LEU . 21.2 t -59.64 132.91 25.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 120.835 -1.166 . . . . 0.0 109.042 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.644 HG23 ' HA ' ' A' ' 36' ' ' VAL . 92.1 t -105.78 -24.12 4.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.593 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 16.2 tttt -161.64 134.48 6.11 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -53.23 158.84 1.46 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.699 0.761 . . . . 0.0 111.421 -178.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.584 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -52.86 133.08 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-O 121.587 0.708 . . . . 0.0 110.202 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.848 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -109.64 171.73 7.27 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 5.3 pm0 -116.65 134.68 54.53 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.833 -1.167 . . . . 0.0 110.56 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.926 HG21 ' CD ' ' A' ' 80' ' ' GLU . 14.0 p -92.8 175.03 6.96 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.255 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -88.62 31.25 0.84 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.905 . . . . 0.0 110.234 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.3 m170 -133.87 5.78 3.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.894 . . . . 0.0 110.183 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.85 1.23 61.74 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.161 -1.575 . . . . 0.0 109.161 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.889 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -95.32 -176.73 3.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -1.144 . . . . 0.0 110.355 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.848 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -140.21 153.34 22.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.678 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 55.1 t -118.97 132.24 69.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 119.113 -1.035 . . . . 0.0 112.351 -177.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.059 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -113.55 120.54 63.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 O-C-N 121.355 -0.841 . . . . 0.0 109.61 178.601 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.593 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 2.9 ttm180 -105.19 110.85 23.39 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.842 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.5 m -132.59 -169.91 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.438 -0.789 . . . . 0.0 109.312 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.448 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 17.1 tt0 -136.58 128.19 28.77 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.841 ' HB2' HG21 ' A' ' 70' ' ' VAL . 16.1 t80 -61.02 118.66 7.04 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 117.983 -1.487 . . . . 0.0 110.633 -178.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.538 ' CG ' ' HB2' ' A' ' 19' ' ' LYS . 7.5 mm-40 -97.25 -0.79 46.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.503 -0.748 . . . . 0.0 109.327 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.582 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -93.57 -161.77 35.81 Favored Glycine 0 N--CA 1.484 1.855 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 41' ' ' ASP . 2.0 p30 -127.52 134.77 49.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.461 -1.023 . . . . 0.0 109.929 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' ' 43' ' ' SER . . . 171.92 -23.03 0.08 OUTLIER Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.483 -1.342 . . . . 0.0 110.664 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.611 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.5 OUTLIER 64.12 -154.95 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 120.602 -1.529 . . . . 0.0 108.073 -179.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.611 ' HD2' ' CB ' ' A' ' 43' ' ' SER . 88.2 Cg_exo -42.54 94.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -0.993 0 N-CA-C 109.059 -1.169 . . . . 0.0 109.059 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.95 ' O ' HG23 ' A' ' 69' ' ' ILE . 31.6 p -148.02 178.36 8.59 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.792 -0.568 . . . . 0.0 109.576 -178.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 68' ' ' PRO . 1.0 OUTLIER -96.05 175.04 6.62 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.943 -1.098 . . . . 0.0 111.412 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.038 HD11 ' CG2' ' A' ' 70' ' ' VAL . 17.7 mm -121.94 131.75 24.36 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.346 -0.846 . . . . 0.0 112.591 -177.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.62 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 26.1 Cg_exo -66.94 143.52 66.61 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 124.115 1.587 . . . . 0.0 110.768 178.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.961 ' CE2' HG21 ' A' ' 79' ' ' ILE . 9.2 t80 -152.96 158.65 42.39 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.313 -0.867 . . . . 0.0 110.248 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 1.036 ' HG2' HD12 ' A' ' 91' ' ' ILE . 5.3 tt0 -173.29 111.49 0.2 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.067 -1.02 . . . . 0.0 110.324 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.931 HD11 ' HB1' ' A' ' 81' ' ' ALA . 68.5 mt -95.78 69.94 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 110.34 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.664 ' HB3' HG21 ' A' ' 59' ' ' VAL . 23.5 mtt -149.93 -67.36 0.21 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.121 -0.987 . . . . 0.0 110.318 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.532 ' HB3' ' CG ' ' A' ' 56' ' ' LYS . 6.3 t70 174.93 171.37 0.26 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.321 -0.862 . . . . 0.0 110.082 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.626 HD12 ' CD ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -82.05 -0.35 44.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.203 -0.935 . . . . 0.0 110.489 -179.866 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -163.17 63.46 0.18 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 110.238 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.532 ' CG ' ' HB3' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -118.84 -172.2 2.24 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.326 -0.859 . . . . 0.0 110.276 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -127.89 -51.57 1.34 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 110.203 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 17.9 t60 -146.99 107.19 4.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.187 -0.946 . . . . 0.0 110.24 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.664 HG21 ' HB3' ' A' ' 52' ' ' MET . 11.1 t -119.01 -120.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.153 -0.967 . . . . 0.0 110.012 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.496 ' HB3' ' HB3' ' A' ' 84' ' ' PRO . 1.4 mt -161.01 -158.66 0.6 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.851 -1.156 . . . . 0.0 110.353 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.503 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . 100.16 174.3 30.2 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.526 ' CB ' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -158.93 166.69 31.24 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.073 -1.251 . . . . 0.0 109.596 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.038 HD23 ' HB2' ' A' ' 81' ' ' ALA . 10.5 mt -124.17 122.75 38.65 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 118.804 -1.158 . . . . 0.0 111.077 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.889 HG12 HG21 ' A' ' 31' ' ' THR . 1.5 mp -84.82 -23.35 7.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 178.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 65' ' ' THR 0.28 2.0 m -108.26 37.17 2.55 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 122.476 1.132 . . . . 0.0 108.096 179.514 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' ' 63' ' ' LEU . 37.3 t -38.22 152.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-O 121.504 0.668 . . . . 0.0 111.077 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.651 ' OD1' HG12 ' A' ' 66' ' ' VAL . 5.3 p-10 37.53 59.36 4.32 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.851 -0.53 . . . . 0.0 111.253 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.94 ' CG ' HD12 ' A' ' 79' ' ' ILE . 19.3 Cg_exo -58.64 164.8 8.86 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 N-CA-C 108.325 -1.452 . . . . 0.0 108.325 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.95 HG23 ' O ' ' A' ' 45' ' ' CYS . 1.1 mt -143.45 146.22 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 118.418 -1.313 . . . . 0.0 113.001 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.038 ' CG2' HD11 ' A' ' 47' ' ' ILE . 15.3 t -103.77 163.33 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 176.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.481 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 3.1 m -124.85 -12.04 7.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.823 -1.173 . . . . 0.0 111.654 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 4.4 mt-10 -140.88 10.52 2.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.719 -1.238 . . . . 0.0 111.311 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 15.8 mtmt 78.16 -16.75 0.63 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.744 -0.597 . . . . 0.0 111.036 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.492 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 6.2 t70 -132.52 0.52 3.65 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.071 -1.018 . . . . 0.0 109.801 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.7 t -71.71 111.53 10.8 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.643 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 38.2 Cg_exo -49.76 131.51 29.3 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.901 1.474 . . . . 0.0 110.332 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.776 HG21 HG22 ' A' ' 70' ' ' VAL . 89.2 t -110.36 154.52 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.172 -0.955 . . . . 0.0 110.515 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.659 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 0.4 OUTLIER -116.63 132.42 56.69 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.525 -0.735 . . . . 0.0 109.289 179.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.961 HG21 ' CE2' ' A' ' 49' ' ' PHE . 25.2 mm -117.76 117.05 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 117.497 -1.681 . . . . 0.0 112.105 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.926 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.6 tp10 -94.76 110.72 22.55 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.418 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 1.038 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -131.15 155.94 46.15 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.781 -1.199 . . . . 0.0 111.386 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.526 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 35.3 tp10 -99.79 102.36 16.93 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.593 -0.692 . . . . 0.0 110.418 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.544 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 56.9 Cg_endo -75.23 148.42 34.39 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.997 1.525 . . . . 0.0 110.747 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.503 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 12.2 Cg_endo -61.84 -157.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.099 1.579 . . . . 0.0 110.108 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.548 ' CD1' ' O ' ' A' ' 85' ' ' PHE . 24.0 p90 -104.17 135.67 45.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.193 -0.942 . . . . 0.0 110.067 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 99.01 -147.94 18.65 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.9 p30 -69.49 156.56 38.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.2 -1.177 . . . . 0.0 110.185 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.5 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 0.4 OUTLIER -163.71 135.44 4.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.179 -0.95 . . . . 0.0 110.354 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.546 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 2.0 m-85 -114.19 105.45 13.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.184 -0.948 . . . . 0.0 110.092 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.806 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 1.6 mp -74.01 118.44 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.203 -0.936 . . . . 0.0 109.522 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 1.036 HD12 ' HG2' ' A' ' 50' ' ' GLU . 70.9 mt -98.68 148.16 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 110.643 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.059 HD11 HG21 ' A' ' 34' ' ' ILE . 1.7 mt -135.88 138.2 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.643 -0.661 . . . . 0.0 109.333 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.54 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 83.9 -159.39 36.03 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.558 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -124.22 149.96 28.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 O-C-N 121.198 -1.178 . . . . 0.0 110.18 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.578 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 2.3 mt-10 -17.97 -57.88 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.121 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 9.0 Cg_endo -52.08 71.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 124.157 1.609 . . . . 0.0 112.177 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 89.81 2.74 74.9 Favored Glycine 0 N--CA 1.494 2.526 0 O-C-N 120.935 -1.103 . . . . 0.0 110.898 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.507 ' HB3' ' C ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -49.75 159.5 0.37 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.958 -1.319 . . . . 0.0 110.161 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.735 HD13 HG22 ' A' ' 20' ' ' VAL . 10.4 mt -94.91 172.66 8.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 110.445 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.626 ' CD ' HD12 ' A' ' 54' ' ' LEU . 4.5 ttpt -156.15 133.28 10.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.392 -0.817 . . . . 0.0 110.201 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.581 HD13 HG13 ' A' ' 34' ' ' ILE . 2.2 mp -134.11 122.72 23.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.257 -0.902 . . . . 0.0 110.058 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.403 ' OD1' ' CG ' ' A' ' 117' ' ' HIS . 0.9 OUTLIER -87.25 134.85 33.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.19 -0.944 . . . . 0.0 110.366 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.445 ' N ' ' O ' ' A' ' 88' ' ' SER . 22.3 t-105 -130.65 143.81 51.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.364 -0.835 . . . . 0.0 110.185 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -103.62 133.63 48.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.194 -0.941 . . . . 0.0 110.109 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -134.97 127.49 30.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.273 -0.892 . . . . 0.0 110.242 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 51.98 -167.62 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.292 -0.88 . . . . 0.0 110.26 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 162.13 102.45 0.17 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.5 m -69.88 -52.86 21.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.231 -1.159 . . . . 0.0 110.236 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.4 m -147.91 42.23 1.03 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.898 . . . . 0.0 110.165 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.553 ' C ' HD12 ' A' ' 110' ' ' LEU . 4.3 pp -50.93 167.0 0.08 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 110.119 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -119.57 159.94 23.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.934 . . . . 0.0 110.275 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -84.1 92.66 7.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.233 -0.917 . . . . 0.0 110.251 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 14.9 t-160 -80.87 125.59 30.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.895 . . . . 0.0 110.262 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.07 61.46 4.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 110.191 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -175.69 -47.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.243 -0.911 . . . . 0.0 110.268 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 58.67 -166.01 0.17 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.878 . . . . 0.0 110.276 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.403 ' CG ' ' OD1' ' A' ' 102' ' ' ASN . 3.1 t60 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.894 -1.05 . . . . 0.0 110.288 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.407 ' O ' ' HB2' ' A' ' 2' ' ' ASP . 5.9 tpp . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.26 0.553 . . . . 0.0 110.264 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 1' ' ' MET . 77.4 m-20 54.06 51.43 14.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 110.169 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.7 57.02 0.83 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.318 -0.864 . . . . 0.0 110.252 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.442 ' O ' ' HB3' ' A' ' 5' ' ' GLN . 0.5 OUTLIER -146.4 125.65 13.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.229 -0.919 . . . . 0.0 110.189 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.442 ' HB3' ' O ' ' A' ' 4' ' ' LEU . 0.8 OUTLIER 178.77 97.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.284 -0.885 . . . . 0.0 110.222 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.75 97.01 3.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.177 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.52 -15.4 20.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.281 -0.887 . . . . 0.0 110.236 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 129.69 135.3 3.87 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.452 ' O ' ' O ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -174.42 -54.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.239 -1.154 . . . . 0.0 110.289 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.551 ' HA ' ' CD ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER 57.94 156.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -0.921 . . . . 0.0 110.15 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.451 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 4.2 t80 -90.91 -72.85 0.56 Allowed 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.207 -0.933 . . . . 0.0 110.08 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' A' ' 13' ' ' MET . 3.3 t -135.08 -6.83 2.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.052 -1.03 . . . . 0.0 110.946 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.735 ' O ' HG23 ' A' ' 15' ' ' THR . 1.5 ttt 55.69 81.99 0.11 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.873 -1.142 . . . . 0.0 108.659 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.579 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 33.5 m -56.43 100.44 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.388 -0.82 . . . . 0.0 109.764 -178.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.735 HG23 ' O ' ' A' ' 13' ' ' MET . 71.2 p -97.53 -5.05 36.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 111.081 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.549 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -59.32 -110.37 0.01 OUTLIER Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.116 -1.516 . . . . 0.0 109.381 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.591 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 1.1 ttpt -142.95 162.56 35.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.039 -1.271 . . . . 0.0 109.924 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.024 ' CE2' HG23 ' A' ' 47' ' ' ILE . 21.0 m-85 -126.82 136.37 52.27 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.939 -1.101 . . . . 0.0 111.224 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.489 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 10.9 ttpp -108.0 119.24 38.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.418 -0.802 . . . . 0.0 109.678 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.834 ' CG2' HD13 ' A' ' 99' ' ' LEU . 48.3 t -59.93 130.76 24.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.829 -1.17 . . . . 0.0 108.995 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.615 HG23 ' HA ' ' A' ' 36' ' ' VAL . 61.3 t -102.98 -24.81 3.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.573 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 1.5 tttt -161.98 133.71 5.46 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -52.34 156.67 1.65 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.611 0.719 . . . . 0.0 111.193 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.577 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -49.94 132.66 9.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-O 121.616 0.722 . . . . 0.0 109.843 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.873 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -108.32 172.32 6.91 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.4 pm0 -115.23 130.58 56.95 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.834 -1.166 . . . . 0.0 110.516 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.945 HG21 ' CD ' ' A' ' 80' ' ' GLU . 26.4 p -84.57 177.22 8.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.439 -0.788 . . . . 0.0 109.967 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -92.24 28.61 1.86 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.882 . . . . 0.0 110.158 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -133.65 5.19 3.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.242 -0.911 . . . . 0.0 110.312 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.462 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 101.35 -3.3 54.32 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.873 HG22 ' C ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -92.19 -175.73 4.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.205 -1.174 . . . . 0.0 110.478 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.873 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -139.15 156.88 27.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.706 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 59.4 t -122.06 132.03 71.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 119.079 -1.049 . . . . 0.0 112.322 -177.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.026 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -112.2 120.16 61.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 O-C-N 121.197 -0.94 . . . . 0.0 109.7 178.767 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.573 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -104.47 114.96 29.54 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.834 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.3 m -137.27 -176.35 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.336 -0.853 . . . . 0.0 109.125 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.494 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 4.2 tt0 -129.36 131.47 46.86 Favored 'General case' 0 C--N 1.276 -2.613 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.929 ' HB2' HG21 ' A' ' 70' ' ' VAL . 6.2 t80 -60.88 122.54 15.12 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 118.724 -1.191 . . . . 0.0 110.731 -178.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 6.8 mt-10 -111.57 26.14 10.95 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.062 -1.024 . . . . 0.0 108.869 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.549 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -121.22 -161.07 11.25 Favored Glycine 0 N--CA 1.484 1.863 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 40.8 p-10 -125.0 149.18 48.01 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.384 -1.068 . . . . 0.0 110.392 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.48 -2.51 1.1 Allowed Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.555 -1.307 . . . . 0.0 110.958 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.612 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.6 OUTLIER 49.48 -153.57 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 120.534 -1.568 . . . . 0.0 108.353 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.612 ' HD2' ' CB ' ' A' ' 43' ' ' SER . 86.1 Cg_exo -41.46 97.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.321 -0.906 0 N-CA-C 109.121 -1.146 . . . . 0.0 109.121 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.896 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -143.65 169.66 17.31 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.192 0.52 . . . . 0.0 109.648 -178.095 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.592 ' O ' HD13 ' A' ' 47' ' ' ILE . 6.1 mtpm? -83.53 175.46 9.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.155 -0.966 . . . . 0.0 112.163 -178.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.097 ' CD1' HG23 ' A' ' 70' ' ' VAL . 15.4 mm -124.55 123.64 25.75 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.696 -0.627 . . . . 0.0 111.373 -178.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.627 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 31.7 Cg_exo -62.33 144.97 95.95 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.097 1.577 . . . . 0.0 110.901 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.999 ' CE1' HG21 ' A' ' 79' ' ' ILE . 5.8 t80 -152.97 155.71 37.48 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.374 -0.829 . . . . 0.0 110.033 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.742 ' HG2' HD12 ' A' ' 91' ' ' ILE . 21.7 tt0 -171.42 103.05 0.2 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.092 -1.005 . . . . 0.0 110.382 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.53 HD11 ' HB1' ' A' ' 81' ' ' ALA . 79.3 mt -94.56 86.63 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.295 -0.878 . . . . 0.0 110.134 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.754 ' HG3' HD13 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -153.91 -65.78 0.14 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.135 -0.978 . . . . 0.0 110.276 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.429 ' C ' HD11 ' A' ' 91' ' ' ILE . 5.5 t0 -157.98 -71.93 0.09 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.875 . . . . 0.0 110.236 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -149.7 -39.24 0.15 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.883 . . . . 0.0 110.298 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.432 ' HG3' ' HG3' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -164.85 55.68 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -0.955 . . . . 0.0 110.266 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.449 ' O ' ' SD ' ' A' ' 52' ' ' MET . 0.1 OUTLIER -131.89 89.62 2.71 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -0.891 . . . . 0.0 110.24 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.59 137.35 58.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 110.26 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -173.65 -153.22 0.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.349 -0.844 . . . . 0.0 110.158 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.7 t -106.53 77.96 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.217 -0.927 . . . . 0.0 110.278 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.754 HD13 ' HG3' ' A' ' 52' ' ' MET . 0.4 OUTLIER -137.23 143.97 42.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.26 -0.9 . . . . 0.0 110.184 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.428 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . 51.08 -171.35 0.21 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.6 ' O ' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -158.3 167.08 30.73 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.211 -1.17 . . . . 0.0 109.381 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.058 HD23 ' HB2' ' A' ' 81' ' ' ALA . 11.6 mt -122.69 122.08 37.92 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 118.916 -1.114 . . . . 0.0 110.814 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.848 HG12 HG21 ' A' ' 31' ' ' THR . 1.4 mp -83.44 -28.16 7.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.741 HG22 ' O ' ' A' ' 65' ' ' THR 0.27 1.3 m -96.98 34.57 1.7 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.447 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 1.0 HG23 ' O ' ' A' ' 63' ' ' LEU . 13.9 t -36.81 142.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.713 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.56 ' N ' ' HD3' ' A' ' 68' ' ' PRO . 46.5 t-20 49.62 59.77 16.3 Favored Pre-proline 0 C--N 1.299 -1.604 0 O-C-N 121.485 -0.759 . . . . 0.0 110.096 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.638 ' CG ' HD12 ' A' ' 79' ' ' ILE . 3.0 Cg_exo -68.91 154.89 70.14 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.719 1.378 . . . . 0.0 108.703 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.896 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.8 OUTLIER -142.91 146.5 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.13 -1.028 . . . . 0.0 112.247 -178.63 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.097 HG23 ' CD1' ' A' ' 47' ' ' ILE . 54.5 t -96.86 154.28 3.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.43 -21.89 12.28 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 120.913 -1.117 . . . . 0.0 108.714 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.539 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 32.1 mt-10 -139.22 146.47 40.53 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.545 ' O ' ' O ' ' A' ' 38' ' ' TYR . 0.5 OUTLIER -53.61 -13.9 0.75 Allowed 'General case' 0 C--N 1.296 -1.756 0 O-C-N 120.808 -1.182 . . . . 0.0 110.948 -178.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.471 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 15.7 t0 -126.91 6.99 6.65 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.58 -1.325 . . . . 0.0 110.671 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.499 ' CB ' ' HB2' ' A' ' 72' ' ' GLU . 0.1 OUTLIER -72.73 112.23 14.35 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.035 -1.041 . . . . 0.0 108.618 178.803 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.635 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 31.5 Cg_exo -56.34 126.71 23.23 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 O-C-N 124.008 1.531 . . . . 0.0 110.68 -178.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.774 HG21 HG22 ' A' ' 70' ' ' VAL . 53.9 t -105.56 158.62 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.097 -1.002 . . . . 0.0 110.448 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.648 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -121.13 131.21 54.12 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.417 -0.802 . . . . 0.0 109.484 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.999 HG21 ' CE1' ' A' ' 49' ' ' PHE . 15.4 mm -114.86 115.13 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 117.598 -1.641 . . . . 0.0 111.674 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.945 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.5 tp10 -94.23 108.06 19.96 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 1.058 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -129.4 155.7 45.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.874 -1.141 . . . . 0.0 111.093 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.539 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 1.2 tp10 -95.97 110.72 53.29 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.577 -0.702 . . . . 0.0 110.165 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.531 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 38.1 Cg_endo -71.41 144.84 46.49 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.027 1.541 . . . . 0.0 110.501 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 85' ' ' PHE . 13.4 Cg_endo -61.71 -72.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.006 1.529 . . . . 0.0 110.081 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.483 ' CB ' ' O ' ' A' ' 84' ' ' PRO . 0.1 OUTLIER 170.44 142.31 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.163 -0.961 . . . . 0.0 110.237 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.12 -145.57 27.08 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.62 126.58 30.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -1.137 . . . . 0.0 110.175 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 5.4 m -139.98 128.79 23.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.908 . . . . 0.0 110.259 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.583 ' CE2' ' ND2' ' A' ' 102' ' ' ASN . 11.6 m-85 -104.08 103.48 13.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -0.961 . . . . 0.0 110.256 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.719 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.5 mp -74.26 121.78 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.908 . . . . 0.0 109.752 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.742 HD12 ' HG2' ' A' ' 50' ' ' GLU . 14.2 mt -96.13 146.93 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -0.946 . . . . 0.0 110.176 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.026 HD11 HG21 ' A' ' 34' ' ' ILE . 1.7 mt -135.3 140.82 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.307 -0.87 . . . . 0.0 110.073 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 48' ' ' PRO . . . 80.22 -156.77 39.98 Favored Glycine 0 N--CA 1.484 1.881 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.596 HG21 ' HA ' ' A' ' 15' ' ' THR . 0.4 OUTLIER -130.99 156.83 43.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 O-C-N 121.055 -1.262 . . . . 0.0 110.685 -179.511 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.642 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 2.3 mt-10 -30.44 -54.08 0.37 Allowed Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.861 -0.524 . . . . 0.0 111.569 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 3.3 Cg_endo -48.43 -20.67 2.65 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.506 1.267 . . . . 0.0 111.125 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.591 ' HA3' ' CG ' ' A' ' 17' ' ' LYS . . . -176.81 46.42 0.11 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -95.21 153.72 17.53 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.88 -1.365 . . . . 0.0 111.138 -178.591 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.834 HD13 ' CG2' ' A' ' 20' ' ' VAL . 24.2 mt -103.71 -177.52 3.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.547 -0.721 . . . . 0.0 110.268 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.413 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 0.7 OUTLIER -156.48 137.06 13.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.526 -0.734 . . . . 0.0 110.117 179.671 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.719 HD12 ' O ' ' A' ' 90' ' ' ILE . 2.5 mp -139.59 119.98 13.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.102 -0.999 . . . . 0.0 110.338 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.583 ' ND2' ' CE2' ' A' ' 89' ' ' TYR . 16.6 t-20 -87.26 130.22 34.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.314 -0.866 . . . . 0.0 110.314 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.533 ' CE3' HG22 ' A' ' 24' ' ' ILE . 21.9 t-105 -119.62 120.76 37.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 110.066 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.528 ' CE2' ' HD3' ' A' ' 106' ' ' LYS . 35.8 t80 -88.05 80.71 7.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.24 -0.912 . . . . 0.0 110.24 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.92 105.76 9.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.259 -0.9 . . . . 0.0 110.211 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.528 ' HD3' ' CE2' ' A' ' 104' ' ' PHE . 6.0 pttt -112.11 120.38 41.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.31 -0.869 . . . . 0.0 110.284 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 108' ' ' SER . . . 49.69 -126.24 20.38 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 107' ' ' GLY . 0.3 OUTLIER 173.19 -30.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -1.132 . . . . 0.0 110.146 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.85 115.96 26.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.28 -0.887 . . . . 0.0 110.232 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.406 ' O ' ' HB2' ' A' ' 111' ' ' GLU . 0.8 OUTLIER -102.74 44.65 1.0 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.168 -0.957 . . . . 0.0 110.224 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 27.6 tt0 -177.52 84.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 110.169 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.444 ' CD2' ' O ' ' A' ' 112' ' ' HIS . 50.8 p-80 -112.45 44.15 1.5 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 110.194 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -109.21 86.55 2.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 110.189 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.81 -58.74 1.87 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -0.918 . . . . 0.0 110.213 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 38.1 m170 -73.53 -8.64 56.76 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.258 -0.901 . . . . 0.0 110.242 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 72.8 m-70 -131.01 175.43 9.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.91 . . . . 0.0 110.223 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.482 ' N ' ' ND1' ' A' ' 117' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.28 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.422 ' O ' ' HG3' ' A' ' 3' ' ' LYS . 1.2 tpt . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.243 0.544 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.428 ' O ' ' C ' ' A' ' 3' ' ' LYS . 4.7 p-10 -55.89 -20.32 15.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 110.264 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 2' ' ' ASP . 0.7 OUTLIER 42.88 -146.49 0.06 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.933 . . . . 0.0 110.229 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.472 ' O ' ' CB ' ' A' ' 5' ' ' GLN . 0.4 OUTLIER -66.16 124.16 21.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 110.196 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.472 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER 170.87 95.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.261 -0.899 . . . . 0.0 110.051 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.0 mp -124.98 76.01 1.49 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 110.201 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.16 20.7 0.25 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.207 -0.933 . . . . 0.0 110.163 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -154.97 -40.89 0.02 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 42.9 mtp -80.65 -29.84 36.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.287 -1.125 . . . . 0.0 110.219 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.522 ' HB2' ' NZ ' ' A' ' 46' ' ' LYS . 24.6 p -45.65 139.95 3.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.208 -0.933 . . . . 0.0 110.077 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.86 -74.12 0.56 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.138 -0.976 . . . . 0.0 110.312 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 13' ' ' MET . 3.1 t -141.09 -2.9 1.25 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.006 -1.059 . . . . 0.0 111.219 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.453 ' HB3' ' O ' ' A' ' 12' ' ' SER . 1.7 ttm 56.22 84.4 0.08 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.908 -1.12 . . . . 0.0 108.536 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.591 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 32.5 m -54.81 106.27 0.21 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.375 -0.828 . . . . 0.0 109.65 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 16' ' ' GLY . 4.3 t -94.0 -9.52 36.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.336 -0.852 . . . . 0.0 111.722 -178.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.57 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -59.86 -123.56 0.01 OUTLIER Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.543 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -135.19 174.98 10.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.011 -1.288 . . . . 0.0 109.909 -179.749 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.076 ' CE2' HG23 ' A' ' 47' ' ' ILE . 35.0 m-85 -133.81 140.33 46.84 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.92 -1.112 . . . . 0.0 111.311 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.488 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 4.0 ttpt -109.89 117.18 33.12 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.584 -0.698 . . . . 0.0 109.366 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.735 ' CG2' HD13 ' A' ' 99' ' ' LEU . 46.9 t -59.76 123.07 11.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 120.688 -1.258 . . . . 0.0 109.013 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.946 HG21 ' HB3' ' A' ' 76' ' ' PRO . 53.2 t -96.95 -25.08 4.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.603 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 4.9 tttt -158.93 133.9 8.26 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -52.33 159.55 0.96 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.645 0.736 . . . . 0.0 111.186 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.597 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -51.82 133.24 13.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.514 0.673 . . . . 0.0 110.202 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 1.001 ' HB3' ' HB ' ' A' ' 33' ' ' VAL . . . -105.74 169.91 8.2 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 0.4 OUTLIER -117.32 123.17 45.87 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.883 -1.135 . . . . 0.0 110.55 -179.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.4 ' H ' HG23 ' A' ' 27' ' ' THR . 5.1 p -78.47 -175.71 4.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.402 -0.811 . . . . 0.0 109.808 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -100.25 34.54 2.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.186 -0.946 . . . . 0.0 110.058 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -140.64 8.57 2.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.247 -0.908 . . . . 0.0 110.434 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.38 -3.5 58.01 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.948 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -91.74 -176.39 4.45 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -1.167 . . . . 0.0 110.262 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.87 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -142.23 168.53 14.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.591 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.001 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 93.4 t -131.83 126.17 56.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 C-N-CA 118.71 -1.196 . . . . 0.0 111.995 -178.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.014 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -109.27 115.84 50.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.309 -0.869 . . . . 0.0 109.852 178.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.603 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 1.4 ttm180 -99.13 120.48 39.56 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.798 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.4 m -147.38 158.14 9.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.326 -0.859 . . . . 0.0 108.919 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 74' ' ' ASP 0.252 0.3 OUTLIER -105.65 125.22 50.74 Favored 'General case' 0 C--N 1.272 -2.796 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.291 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.905 ' HB2' HG21 ' A' ' 70' ' ' VAL . 2.1 t80 -60.1 124.12 19.27 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 119.07 -1.052 . . . . 0.0 110.289 -178.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.499 ' O ' ' N ' ' A' ' 17' ' ' LYS . 21.4 mm-40 -112.23 92.05 3.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.874 . . . . 0.0 109.872 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.57 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 164.47 -151.05 19.98 Favored Glycine 0 N--CA 1.486 1.97 0 C-N-CA 119.404 -1.379 . . . . 0.0 109.858 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.449 ' O ' ' OH ' ' A' ' 38' ' ' TYR . 4.4 m-20 -112.4 125.07 53.8 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.5 -1.0 . . . . 0.0 110.48 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 43' ' ' SER . . . 177.66 -27.92 0.06 OUTLIER Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.504 -1.332 . . . . 0.0 110.614 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.609 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.7 OUTLIER 48.56 -153.92 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 120.723 -1.457 . . . . 0.0 107.594 -179.421 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.609 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 53.6 Cg_exo -46.81 94.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.198 0 N-CA-C 108.385 -1.429 . . . . 0.0 108.385 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.858 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -150.47 172.67 15.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.582 -0.699 . . . . 0.0 110.063 -177.696 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.579 ' HG3' HD11 ' A' ' 69' ' ' ILE . 22.0 mtmt -81.09 175.71 10.43 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.236 -0.915 . . . . 0.0 112.102 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.076 HG23 ' CE2' ' A' ' 18' ' ' PHE . 15.7 mm -124.26 127.48 25.3 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.62 -0.675 . . . . 0.0 111.427 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.629 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 38.3 Cg_exo -63.86 144.13 87.64 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.048 1.551 . . . . 0.0 110.42 178.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.711 ' CZ ' HG23 ' A' ' 90' ' ' ILE . 9.6 t80 -151.83 160.28 43.6 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.259 -0.901 . . . . 0.0 110.286 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.678 ' O ' HD12 ' A' ' 91' ' ' ILE . 0.9 OUTLIER -175.2 98.78 0.08 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.214 -0.929 . . . . 0.0 109.532 179.569 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.923 HD11 ' HB1' ' A' ' 81' ' ' ALA . 64.0 mt -83.7 23.26 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.15 -0.969 . . . . 0.0 111.37 -178.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.595 ' HA ' ' CG ' ' A' ' 56' ' ' LYS . 11.2 ptt? -154.8 -49.55 0.09 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.935 -1.103 . . . . 0.0 110.701 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.706 ' HB2' HD13 ' A' ' 91' ' ' ILE . 0.4 OUTLIER 49.3 -153.9 0.11 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.071 -1.018 . . . . 0.0 110.333 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.73 0.11 53.72 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.375 -0.828 . . . . 0.0 110.335 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.439 ' O ' ' HD3' ' A' ' 56' ' ' LYS . 1.3 mm-40 -86.96 -11.57 50.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.269 -0.894 . . . . 0.0 109.725 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.595 ' CG ' ' HA ' ' A' ' 52' ' ' MET . 1.6 mmtp -120.08 -42.06 2.61 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.273 -0.892 . . . . 0.0 110.235 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 56' ' ' LYS . 6.1 ttt85 42.91 79.76 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.141 -0.974 . . . . 0.0 110.182 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 174.92 -67.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.291 -0.881 . . . . 0.0 110.137 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 59' ' ' VAL . 10.6 p -132.57 131.04 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.898 . . . . 0.0 110.202 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.515 ' CA ' ' SD ' ' A' ' 52' ' ' MET . 0.6 OUTLIER -91.2 29.98 1.33 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 110.187 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 60' ' ' LEU . . . 43.7 -164.52 0.04 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.51 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -131.57 155.46 47.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -1.156 . . . . 0.0 110.36 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.907 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -115.1 116.33 28.24 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.221 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.948 HG12 HG21 ' A' ' 31' ' ' THR . 1.7 mp -80.07 -27.35 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.756 HG22 ' O ' ' A' ' 65' ' ' THR 0.259 1.2 m -98.47 34.08 2.09 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.062 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.907 HG23 ' O ' ' A' ' 63' ' ' LEU . 40.6 t -26.62 145.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.526 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.838 HD22 HG12 ' A' ' 66' ' ' VAL . 4.0 p30 39.81 53.12 5.06 Favored Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 121.778 -0.576 . . . . 0.0 111.475 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.543 ' O ' HG12 ' A' ' 69' ' ' ILE . 1.8 Cg_endo -55.41 154.69 23.18 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 N-CA-C 108.758 -1.285 . . . . 0.0 108.758 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.858 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.7 OUTLIER -141.45 146.47 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 119.049 -1.061 . . . . 0.0 112.819 -177.667 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.033 HG23 ' CD1' ' A' ' 47' ' ' ILE . 95.7 t -92.75 167.63 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.466 ' N ' HG12 ' A' ' 70' ' ' VAL . 3.1 m -118.74 -21.93 7.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.735 -1.228 . . . . 0.0 111.033 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.522 ' O ' ' HB3' ' A' ' 73' ' ' LYS . 4.0 mt-10 -138.06 19.19 2.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.956 -1.09 . . . . 0.0 110.991 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.523 ' CD ' ' O ' ' A' ' 40' ' ' GLY . 0.3 OUTLIER 72.64 -7.34 1.44 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.398 -0.814 . . . . 0.0 111.11 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.5 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 6.1 t0 -137.43 0.33 2.28 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.864 -1.147 . . . . 0.0 110.451 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.611 ' O ' HG23 ' A' ' 77' ' ' VAL . 32.9 t -73.06 108.39 4.49 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.166 -0.959 . . . . 0.0 109.613 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.946 ' HB3' HG21 ' A' ' 21' ' ' VAL . 3.4 Cg_endo -51.57 110.51 0.43 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.735 1.387 . . . . 0.0 109.672 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 75' ' ' SER . 88.8 t -99.41 143.45 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.326 -0.859 . . . . 0.0 111.741 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.645 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 3.6 m-80 -98.17 130.97 44.91 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.726 ' HB ' HG22 ' A' ' 34' ' ' ILE . 5.8 mt -108.81 114.33 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.067 -1.646 . . . . 0.0 111.71 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 3.4 tt0 -84.23 115.29 22.37 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.676 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.923 ' HB1' HD11 ' A' ' 51' ' ' ILE . . . -137.85 152.61 49.24 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.987 -1.071 . . . . 0.0 110.919 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.51 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 34.9 tt0 -100.82 101.24 14.98 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.366 -0.834 . . . . 0.0 110.308 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.548 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 43.2 Cg_endo -73.23 134.08 20.48 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.036 1.545 . . . . 0.0 110.381 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 83' ' ' PRO . 34.3 Cg_exo -53.51 -165.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.923 1.486 . . . . 0.0 110.101 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -91.86 138.87 31.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.149 -0.97 . . . . 0.0 110.361 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.66 -170.02 25.06 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -60.69 158.53 12.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.283 -1.127 . . . . 0.0 110.081 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.424 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 0.4 OUTLIER -163.81 134.04 4.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.218 -0.926 . . . . 0.0 110.469 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.586 ' CD2' ' HE2' ' A' ' 56' ' ' LYS . 2.0 m-30 -107.48 103.73 13.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.212 -0.93 . . . . 0.0 110.009 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.711 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 1.6 mp -74.32 121.87 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.141 -0.975 . . . . 0.0 109.346 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.706 HD13 ' HB2' ' A' ' 53' ' ' ASP . 1.9 mp -100.03 148.25 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.047 -1.033 . . . . 0.0 110.143 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.014 HD11 HG21 ' A' ' 34' ' ' ILE . 1.6 mt -134.05 145.54 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.454 -0.779 . . . . 0.0 109.907 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.555 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 80.04 -161.03 45.15 Favored Glycine 0 N--CA 1.481 1.642 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.547 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -122.15 150.48 25.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 O-C-N 121.366 -1.079 . . . . 0.0 110.064 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.576 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 5.4 mt-10 -20.68 -56.95 0.07 OUTLIER Pre-proline 0 N--CA 1.5 2.04 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 9.2 Cg_endo -54.71 68.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 124.066 1.561 . . . . 0.0 111.963 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 94.33 6.57 61.26 Favored Glycine 0 N--CA 1.495 2.612 0 O-C-N 120.951 -1.093 . . . . 0.0 111.026 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.506 ' HB3' ' C ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -55.64 161.58 2.02 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.933 -1.334 . . . . 0.0 109.993 179.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.735 HD13 ' CG2' ' A' ' 20' ' ' VAL . 12.8 mt -99.26 177.43 5.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.234 -0.916 . . . . 0.0 110.963 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.561 ' C ' HD12 ' A' ' 101' ' ' LEU . 4.3 ttpt -154.8 138.51 16.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.57 -0.706 . . . . 0.0 109.953 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.561 HD12 ' C ' ' A' ' 100' ' ' LYS . 4.9 mp -143.43 124.58 14.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.136 -0.978 . . . . 0.0 110.36 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 8.7 p-10 -92.12 130.61 37.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.357 -0.839 . . . . 0.0 110.596 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.563 ' CZ3' HG22 ' A' ' 24' ' ' ILE . 38.2 t-105 -126.08 148.99 49.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.884 . . . . 0.0 109.998 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.63 123.48 44.9 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -0.892 . . . . 0.0 110.229 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -115.32 60.4 0.7 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -0.932 . . . . 0.0 110.227 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' A' ' 105' ' ' LYS . 0.1 OUTLIER 173.9 119.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.22 -0.925 . . . . 0.0 110.244 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.63 -158.85 16.54 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.4 m -69.35 119.7 14.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.22 -1.165 . . . . 0.0 110.298 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 111' ' ' GLU . 0.3 OUTLIER -170.06 137.98 1.64 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.254 -0.904 . . . . 0.0 110.22 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.2 mt -53.84 88.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.321 -0.862 . . . . 0.0 110.178 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -138.55 67.6 1.4 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -0.933 . . . . 0.0 110.259 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -61.78 113.07 2.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.258 -0.901 . . . . 0.0 110.214 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 24.5 m170 52.97 -155.65 0.19 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.351 -0.843 . . . . 0.0 110.16 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.466 ' CE1' ' OE2' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -152.31 162.74 40.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.298 -0.876 . . . . 0.0 110.196 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.481 ' N ' ' CD2' ' A' ' 115' ' ' HIS . 0.5 OUTLIER -74.93 64.17 1.28 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 0.0 110.159 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -119.13 173.74 6.74 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.336 -0.853 . . . . 0.0 110.17 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.164 -179.975 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 ttp . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.229 0.538 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.424 ' O ' ' CB ' ' A' ' 3' ' ' LYS . 32.6 m-20 -139.71 90.83 2.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 0.0 110.193 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 2' ' ' ASP . 0.3 OUTLIER 173.64 125.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 110.256 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.454 ' O ' ' HB3' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -171.72 150.21 2.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.282 -0.886 . . . . 0.0 110.252 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.454 ' HB3' ' O ' ' A' ' 4' ' ' LEU . 2.5 pm0 179.45 59.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.288 -0.882 . . . . 0.0 110.06 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -166.0 -43.45 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.298 -0.876 . . . . 0.0 110.196 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.1 mttt 47.26 47.05 16.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.913 . . . . 0.0 110.157 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 9' ' ' MET . . . -149.22 16.12 1.15 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.456 ' O ' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER 48.77 -178.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -1.147 . . . . 0.0 110.208 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.565 ' HA ' ' CD ' ' A' ' 46' ' ' LYS . 80.3 p -139.81 -173.56 3.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.251 -0.906 . . . . 0.0 110.105 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -143.46 -74.16 0.27 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.183 -0.948 . . . . 0.0 110.396 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.481 ' HB3' ' HB2' ' A' ' 45' ' ' CYS . 2.9 t -139.23 1.96 2.04 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.966 -1.083 . . . . 0.0 110.832 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.429 ' C ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER 45.95 83.23 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.042 -1.036 . . . . 0.0 108.386 -179.528 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.58 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 30.8 m -54.0 102.4 0.06 Allowed 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.575 -178.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.491 ' O ' ' O ' ' A' ' 16' ' ' GLY . 3.4 p -87.84 -8.08 56.37 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.375 -0.828 . . . . 0.0 111.711 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.579 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -60.33 -131.55 0.01 OUTLIER Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.518 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -134.37 -178.91 5.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.02 -1.282 . . . . 0.0 109.822 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.946 ' CZ ' HG23 ' A' ' 47' ' ' ILE . 44.1 m-85 -138.01 142.62 40.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.894 -1.129 . . . . 0.0 111.851 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.51 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 31.9 ttpt -110.4 117.92 34.89 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.695 ' CG2' HD13 ' A' ' 99' ' ' LEU . 60.6 t -59.56 124.23 13.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 120.666 -1.271 . . . . 0.0 109.459 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.717 HG23 ' HA ' ' A' ' 36' ' ' VAL . 83.3 t -96.27 -27.09 4.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.637 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 0.2 OUTLIER -154.31 138.06 16.16 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.332 177.11 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.54 158.43 4.45 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.383 0.611 . . . . 0.0 110.364 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.691 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.7 OUTLIER -55.4 130.64 17.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.051 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.782 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -108.65 168.74 9.12 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 12.9 pt-20 -113.87 134.94 54.49 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.786 -1.196 . . . . 0.0 110.479 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.915 HG21 ' CD ' ' A' ' 80' ' ' GLU . 16.5 p -90.52 -172.67 3.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.5 -0.75 . . . . 0.0 110.278 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -95.91 4.41 52.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.269 -0.895 . . . . 0.0 110.419 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -106.67 6.82 30.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.201 -0.937 . . . . 0.0 110.223 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.53 7.64 61.62 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.968 HG22 ' C ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -97.48 -171.95 2.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -1.092 . . . . 0.0 110.457 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.782 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -142.69 147.21 21.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.671 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 66.8 t -111.64 134.79 52.91 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 O-C-N 121.346 -0.846 . . . . 0.0 112.08 -177.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.082 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -120.95 118.76 57.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 121.409 -0.807 . . . . 0.0 109.988 179.11 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.637 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -100.07 122.99 43.8 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 119.026 -1.07 . . . . 0.0 108.34 179.23 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.799 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.3 m -149.0 158.52 6.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.175 -0.953 . . . . 0.0 109.053 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 74' ' ' ASP 0.256 1.8 tt0 -107.61 126.74 52.94 Favored 'General case' 0 C--N 1.27 -2.848 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.503 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.961 ' HB2' HG21 ' A' ' 70' ' ' VAL . 1.9 t80 -59.18 125.46 23.68 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.182 -178.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.51 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 5.2 mm-40 -111.85 87.96 2.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.18 -0.95 . . . . 0.0 109.715 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.579 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 164.65 -150.58 18.85 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.456 ' O ' ' OH ' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -117.82 137.02 53.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.594 -0.945 . . . . 0.0 110.496 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 43' ' ' SER . . . 173.32 -24.76 0.08 OUTLIER Glycine 0 N--CA 1.488 2.109 0 C-N-CA 119.649 -1.262 . . . . 0.0 110.641 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.599 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.4 OUTLIER 49.36 -156.54 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 120.732 -1.452 . . . . 0.0 107.813 -179.501 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.599 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 50.8 Cg_exo -48.15 94.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.318 0 N-CA-C 107.951 -1.596 . . . . 0.0 107.951 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.919 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -148.06 173.62 12.74 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.633 -0.667 . . . . 0.0 109.333 -177.584 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 68' ' ' PRO . 0.3 OUTLIER -88.6 173.84 8.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.0 -1.062 . . . . 0.0 111.78 -178.73 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.06 ' CD1' HG23 ' A' ' 70' ' ' VAL . 19.2 mm -124.18 129.64 24.65 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.64 -0.662 . . . . 0.0 112.033 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.613 ' HD2' ' CE2' ' A' ' 18' ' ' PHE . 36.8 Cg_exo -63.71 147.82 92.42 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 124.05 1.552 . . . . 0.0 111.034 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.912 ' CE2' HG21 ' A' ' 79' ' ' ILE . 11.0 t80 -155.51 157.6 37.16 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.324 -0.86 . . . . 0.0 110.552 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.889 ' HG2' HD12 ' A' ' 91' ' ' ILE . 22.4 tt0 -175.72 95.91 0.07 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.147 -0.971 . . . . 0.0 110.306 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.75 HD11 ' HB1' ' A' ' 81' ' ' ALA . 0.5 OUTLIER -58.65 -35.58 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.313 -0.867 . . . . 0.0 109.74 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.471 ' SD ' ' HB2' ' A' ' 56' ' ' LYS . 1.0 OUTLIER -154.71 -67.74 0.13 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.126 -0.984 . . . . 0.0 110.189 179.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 55' ' ' GLU . 5.8 t0 37.44 -150.29 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.553 -0.717 . . . . 0.0 110.677 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.68 HD13 ' OE2' ' A' ' 50' ' ' GLU . 6.3 mp 43.98 -92.12 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.415 -0.803 . . . . 0.0 110.517 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 53' ' ' ASP . 3.4 pt-20 -166.41 64.44 0.1 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.062 -1.024 . . . . 0.0 110.248 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.471 ' HB2' ' SD ' ' A' ' 52' ' ' MET . 39.7 mmtt -98.59 -175.63 3.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.26 -0.9 . . . . 0.0 110.077 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -43.16 -26.71 0.18 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.907 . . . . 0.0 110.06 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.418 ' N ' ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -172.45 -177.09 1.69 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.288 -0.883 . . . . 0.0 110.119 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 59' ' ' VAL . 4.9 p -148.96 80.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.951 . . . . 0.0 110.289 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.55 4.68 2.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 110.317 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.534 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . -59.07 174.7 3.26 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.54 ' CB ' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -150.34 163.49 38.21 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.271 -1.134 . . . . 0.0 109.496 179.749 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.034 HD23 ' HB2' ' A' ' 81' ' ' ALA . 11.1 mt -123.6 121.2 34.96 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 118.639 -1.224 . . . . 0.0 110.408 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.804 ' CG1' HG21 ' A' ' 31' ' ' THR . 4.1 mm -83.34 -29.32 7.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.776 HG22 ' O ' ' A' ' 65' ' ' THR 0.267 1.9 m -99.37 35.87 1.86 Allowed 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.947 HG23 ' O ' ' A' ' 63' ' ' LEU . 44.7 t -37.79 155.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-O 121.489 0.662 . . . . 0.0 110.995 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.668 ' ND2' HG12 ' A' ' 66' ' ' VAL . 24.3 p30 36.46 53.97 2.56 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 122.065 -0.397 . . . . 0.0 111.378 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.826 ' CG ' HD12 ' A' ' 79' ' ' ILE . 15.7 Cg_exo -55.05 161.56 6.44 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 N-CA-C 108.472 -1.395 . . . . 0.0 108.472 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.919 HG23 ' O ' ' A' ' 45' ' ' CYS . 1.0 OUTLIER -142.79 145.8 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 118.844 -1.143 . . . . 0.0 112.813 -178.431 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.06 HG23 ' CD1' ' A' ' 47' ' ' ILE . 55.8 t -101.38 160.59 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 176.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.452 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 2.8 m -116.09 -19.48 10.28 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.653 -1.279 . . . . 0.0 111.326 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 3.2 mt-10 -137.61 14.71 2.94 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.831 -1.168 . . . . 0.0 111.272 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.529 ' O ' ' O ' ' A' ' 38' ' ' TYR . 3.2 mtmt 75.11 -11.3 1.09 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.517 -0.739 . . . . 0.0 111.03 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.489 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 6.4 t0 -133.67 0.92 3.32 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.979 -1.076 . . . . 0.0 110.204 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.561 ' O ' HG23 ' A' ' 77' ' ' VAL . 25.1 t -72.83 108.76 4.87 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.202 -0.937 . . . . 0.0 109.528 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.717 ' HB3' HG21 ' A' ' 21' ' ' VAL . 4.2 Cg_endo -52.16 113.59 1.26 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.766 1.403 . . . . 0.0 109.921 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 75' ' ' SER . 62.0 t -99.35 153.67 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.268 -0.895 . . . . 0.0 110.982 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.652 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.3 m-20 -112.39 133.11 54.66 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.912 HG21 ' CE2' ' A' ' 49' ' ' PHE . 7.2 mm -115.47 121.86 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.1 -1.625 . . . . 0.0 111.588 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.915 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.0 OUTLIER -99.15 106.59 18.79 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.681 -0.637 . . . . 0.0 109.815 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 1.034 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -123.2 156.25 35.49 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.989 -1.069 . . . . 0.0 111.178 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.54 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 4.7 tt0 -101.64 101.03 15.83 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.632 -0.668 . . . . 0.0 110.283 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.555 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 23.3 Cg_endo -67.82 151.22 78.72 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 124.045 1.55 . . . . 0.0 110.467 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.534 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 15.2 Cg_endo -62.16 -74.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.047 1.551 . . . . 0.0 110.337 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -175.84 160.56 2.39 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.288 -0.882 . . . . 0.0 110.214 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.506 ' CA ' ' O ' ' A' ' 105' ' ' LYS . . . 62.63 -143.43 48.65 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -67.86 152.44 45.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -1.129 . . . . 0.0 110.256 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 103' ' ' TRP . 2.6 t -155.76 125.53 6.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.308 -0.87 . . . . 0.0 110.167 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 10.2 m-85 -100.43 100.25 10.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.938 . . . . 0.0 110.163 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.809 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 1.6 mp -74.16 111.47 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.152 -0.968 . . . . 0.0 109.381 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.889 HD12 ' HG2' ' A' ' 50' ' ' GLU . 33.7 mt -92.23 146.8 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.243 -0.911 . . . . 0.0 110.435 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.082 HD11 HG21 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -134.71 137.1 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.617 -0.677 . . . . 0.0 109.54 -179.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 48' ' ' PRO . . . 85.91 -162.6 35.77 Favored Glycine 0 N--CA 1.482 1.735 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.56 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -120.27 147.92 23.71 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 O-C-N 121.146 -1.208 . . . . 0.0 110.179 -179.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.579 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.8 mt-10 -16.86 -58.31 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.149 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 6.9 Cg_endo -51.07 72.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 124.164 1.613 . . . . 0.0 111.992 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 89.36 -1.78 82.53 Favored Glycine 0 N--CA 1.494 2.551 0 O-C-N 121.032 -1.042 . . . . 0.0 110.809 178.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.51 ' HB3' ' C ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -45.83 159.3 0.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.986 -1.302 . . . . 0.0 110.042 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.695 HD13 ' CG2' ' A' ' 20' ' ' VAL . 10.2 mt -96.06 173.26 7.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 110.6 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.61 ' C ' HD12 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -154.57 131.03 10.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.388 -0.82 . . . . 0.0 110.007 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.61 HD12 ' C ' ' A' ' 100' ' ' LYS . 5.5 mp -134.33 121.46 21.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 0.0 110.432 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.486 ' ND2' ' CE1' ' A' ' 89' ' ' TYR . 5.6 t-20 -89.78 130.94 35.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.285 -0.884 . . . . 0.0 110.141 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.469 ' N ' ' O ' ' A' ' 88' ' ' SER . 10.7 t-105 -113.72 135.29 54.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.227 -0.921 . . . . 0.0 110.205 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.38 77.21 5.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.373 -0.829 . . . . 0.0 110.135 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.506 ' O ' ' CA ' ' A' ' 86' ' ' GLY . 0.1 OUTLIER -94.0 93.23 7.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.287 -0.883 . . . . 0.0 110.261 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -100.06 -81.74 0.46 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.28 -0.888 . . . . 0.0 110.173 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 108' ' ' SER . . . -98.1 -114.06 3.3 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 107' ' ' GLY . 1.1 m 44.13 57.22 4.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -1.152 . . . . 0.0 110.206 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.6 t -104.43 164.4 11.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 110.163 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.13 123.78 5.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 0.0 110.222 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -174.72 172.13 3.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.914 . . . . 0.0 110.234 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 59.55 91.4 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -0.906 . . . . 0.0 110.258 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.482 ' CG ' ' N ' ' A' ' 114' ' ' HIS . 7.3 p-80 -172.16 -142.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.268 -0.895 . . . . 0.0 110.132 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.592 ' CD2' ' N ' ' A' ' 114' ' ' HIS . 2.3 p80 -153.37 115.73 4.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 110.164 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -94.75 -172.06 2.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 0.0 110.231 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 3.7 m80 -97.9 78.84 2.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.171 -0.956 . . . . 0.0 110.247 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.546 ' O ' ' CG ' ' A' ' 117' ' ' HIS . 11.8 p80 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.158 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.199 0.524 . . . . 0.0 110.289 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -110.03 -47.86 3.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.262 -0.899 . . . . 0.0 110.152 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.46 ' O ' ' O ' ' A' ' 4' ' ' LEU . 60.7 mttt -69.23 -172.96 0.48 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 110.282 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.473 ' O ' ' HG3' ' A' ' 5' ' ' GLN . 14.5 tp 60.8 131.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 110.052 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -179.49 -72.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.127 -0.983 . . . . 0.0 110.28 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 62.13 106.67 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 0.0 110.18 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.11 133.04 36.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.296 -0.877 . . . . 0.0 110.207 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.92 -113.26 0.01 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.36 -158.38 0.24 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.282 -1.128 . . . . 0.0 110.225 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.464 ' O ' ' OG ' ' A' ' 10' ' ' SER . 1.9 t -89.95 59.35 4.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.268 -0.895 . . . . 0.0 110.063 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.65 ' CE1' HD12 ' A' ' 69' ' ' ILE . 0.8 OUTLIER -165.13 23.96 0.05 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.248 -0.908 . . . . 0.0 109.463 -179.789 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.577 ' HA ' ' HD3' ' A' ' 46' ' ' LYS . 3.2 t -135.76 -21.73 1.47 Allowed 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.622 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.591 ' CG ' ' O ' ' A' ' 13' ' ' MET . 0.3 OUTLIER -174.8 75.83 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.018 -1.051 . . . . 0.0 111.194 -179.109 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.579 ' HB3' ' CE1' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -45.03 103.83 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.714 -1.241 . . . . 0.0 109.127 179.365 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.653 ' HA ' HG21 ' A' ' 94' ' ' VAL . 1.2 p -68.74 -5.65 21.78 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.479 -0.763 . . . . 0.0 111.755 -178.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.549 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -59.3 -149.74 0.01 OUTLIER Glycine 0 N--CA 1.48 1.623 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.572 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 1.4 tmpt? -123.61 160.77 26.38 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.37 -1.076 . . . . 0.0 108.929 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.065 ' CE2' HG23 ' A' ' 47' ' ' ILE . 34.5 m-85 -118.76 137.55 53.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.497 -1.377 . . . . 0.0 112.144 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.511 ' HE2' ' NE2' ' A' ' 37' ' ' GLN . 7.7 ttpp -109.21 119.33 39.2 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.703 -0.623 . . . . 0.0 109.435 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.425 ' HA ' HG12 ' A' ' 36' ' ' VAL . 27.4 t -59.46 129.54 21.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 120.709 -1.244 . . . . 0.0 108.836 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.635 HG23 ' HA ' ' A' ' 36' ' ' VAL . 64.3 t -104.75 -24.75 3.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.562 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 15.3 tttt -159.91 134.6 7.76 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 177.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -52.6 155.02 2.36 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.6 0.714 . . . . 0.0 111.094 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.609 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -47.87 133.85 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.967 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.921 ' HB3' ' HB ' ' A' ' 33' ' ' VAL . . . -106.84 173.33 6.37 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.5 pm0 -116.98 126.11 52.41 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.905 -1.122 . . . . 0.0 110.582 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.443 HG21 ' HG2' ' A' ' 80' ' ' GLU . 11.9 p -79.85 -163.74 0.57 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.355 -0.841 . . . . 0.0 110.035 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -110.44 31.56 5.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 109.874 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -139.84 10.36 2.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.344 -0.848 . . . . 0.0 110.447 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.85 -1.44 59.65 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.915 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -91.81 -175.46 4.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -1.117 . . . . 0.0 110.269 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.872 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -142.93 165.98 15.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.921 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 93.7 t -130.26 125.87 60.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 120.724 -1.235 . . . . 0.0 112.44 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.082 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -106.51 116.68 50.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.363 -0.836 . . . . 0.0 109.566 178.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 3.4 ttm180 -101.49 120.07 39.74 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.744 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.8 m -140.69 -173.68 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.536 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 1.9 tt0 -133.89 124.57 26.66 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.85 ' HB2' HG21 ' A' ' 70' ' ' VAL . 89.3 t80 -61.32 140.64 57.95 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.368 -1.333 . . . . 0.0 110.527 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 17' ' ' LYS . 3.3 mm-40 -134.74 83.34 2.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.491 -0.756 . . . . 0.0 109.805 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.549 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 174.0 -147.07 9.09 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.543 ' HA ' ' HD2' ' A' ' 73' ' ' LYS . 50.0 t0 -113.93 132.79 55.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.627 -0.925 . . . . 0.0 110.38 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.458 ' O ' ' OG ' ' A' ' 10' ' ' SER . . . 165.01 -24.7 0.17 Allowed Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.726 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.608 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.5 OUTLIER 49.24 -156.13 0.01 OUTLIER Pre-proline 0 N--CA 1.487 1.395 0 O-C-N 120.598 -1.531 . . . . 0.0 108.105 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.608 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 74.6 Cg_exo -44.02 96.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.35 0 N-CA-C 109.283 -1.083 . . . . 0.0 109.283 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.726 ' O ' HG23 ' A' ' 69' ' ' ILE . 24.5 p -143.34 169.31 17.89 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.634 -0.666 . . . . 0.0 110.134 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.692 ' CG ' HD11 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -83.86 172.74 11.86 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.411 -0.806 . . . . 0.0 110.358 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.065 HG23 ' CE2' ' A' ' 18' ' ' PHE . 15.8 mm -114.76 126.6 27.71 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 111.957 -177.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.62 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 33.8 Cg_exo -63.02 144.6 93.23 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.993 1.523 . . . . 0.0 110.846 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.923 ' CD2' HG21 ' A' ' 79' ' ' ILE . 3.9 t80 -154.29 153.11 31.13 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.537 -0.727 . . . . 0.0 109.678 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.616 ' HG3' HD12 ' A' ' 91' ' ' ILE . 19.3 tp10 -166.37 98.06 0.59 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.928 -1.107 . . . . 0.0 110.546 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.719 HD11 ' HB1' ' A' ' 81' ' ' ALA . 4.8 mt -92.07 136.08 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.29 -0.881 . . . . 0.0 109.821 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.569 ' O ' HD22 ' A' ' 60' ' ' LEU . 3.7 ptt? -136.19 -49.6 0.68 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.08 -1.013 . . . . 0.0 110.548 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' A' ' 52' ' ' MET . 12.4 t0 68.28 -58.76 0.46 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.1 -1.0 . . . . 0.0 110.202 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 52' ' ' MET . 11.7 mt -83.02 -75.62 0.31 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.923 . . . . 0.0 110.2 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 56' ' ' LYS . 8.0 mm-40 -124.86 -76.9 0.59 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.154 -0.966 . . . . 0.0 110.202 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.465 ' HA ' ' HB3' ' A' ' 52' ' ' MET . 0.1 OUTLIER 179.1 67.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.193 -0.942 . . . . 0.0 110.239 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.466 ' HB3' HG22 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -121.22 174.99 6.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 0.0 110.146 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.529 ' CG ' ' O ' ' A' ' 58' ' ' HIS . 47.1 t-80 -101.49 25.32 8.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 110.159 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.513 HG23 HD12 ' A' ' 60' ' ' LEU . 9.0 m -117.43 3.22 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 110.228 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.571 HD23 ' HG3' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -117.88 119.2 34.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.192 -0.943 . . . . 0.0 110.257 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.521 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . 84.04 162.76 34.53 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.523 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -143.25 169.35 17.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -1.143 . . . . 0.0 110.373 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.751 HD21 ' CD1' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -120.89 121.26 37.68 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.479 179.39 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.915 HG12 HG21 ' A' ' 31' ' ' THR . 1.4 mp -85.53 -27.79 6.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 106.735 -1.579 . . . . 0.0 106.735 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.799 HG22 ' O ' ' A' ' 65' ' ' THR 0.254 2.3 m -110.93 39.79 2.17 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.283 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.738 ' N ' HD12 ' A' ' 63' ' ' LEU . 6.8 t -25.9 121.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 CA-C-O 121.711 0.767 . . . . 0.0 111.813 -178.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.579 ' ND2' ' HB3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER 41.8 69.96 1.88 Allowed Pre-proline 0 C--N 1.297 -1.696 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.77 178.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.726 ' HG3' HG23 ' A' ' 79' ' ' ILE . 1.2 Cg_endo -55.6 -171.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.725 1.382 . . . . 0.0 108.826 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.726 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.7 OUTLIER -143.53 145.62 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 118.926 -1.109 . . . . 0.0 112.44 -179.409 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.949 ' CG2' HD11 ' A' ' 47' ' ' ILE . 60.1 t -97.86 162.12 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 176.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.6 m -117.26 -17.21 10.24 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.666 -1.213 . . . . 0.0 111.351 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.54 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 15.4 mt-10 -142.03 16.87 2.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.875 -1.141 . . . . 0.0 111.054 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.543 ' HD2' ' HA ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER 75.71 -12.71 0.96 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.48 -0.763 . . . . 0.0 110.97 179.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.472 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 12.5 t70 -133.41 -1.94 3.13 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.051 -1.031 . . . . 0.0 110.234 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.608 ' O ' HG23 ' A' ' 77' ' ' VAL . 8.2 t -71.97 112.27 13.77 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.246 -0.909 . . . . 0.0 108.69 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.631 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 42.7 Cg_exo -49.03 126.29 14.89 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.9 1.473 . . . . 0.0 110.387 -178.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.705 HG21 HG22 ' A' ' 70' ' ' VAL . 58.2 t -115.65 143.37 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.072 -1.018 . . . . 0.0 111.254 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.672 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 1.5 m-20 -104.74 136.18 44.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.412 -0.805 . . . . 0.0 109.562 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.923 HG21 ' CD2' ' A' ' 49' ' ' PHE . 7.3 mt -115.41 116.94 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.134 -1.604 . . . . 0.0 111.552 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.712 ' HG3' HG22 ' A' ' 33' ' ' VAL . 3.8 tt0 -88.06 114.0 24.25 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.455 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.809 ' C ' HG22 ' A' ' 31' ' ' THR . . . -132.77 149.32 52.29 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.943 -1.098 . . . . 0.0 110.915 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.523 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 2.8 tp10 -99.99 99.15 8.6 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.305 -0.872 . . . . 0.0 110.196 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.541 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 21.9 Cg_endo -66.21 152.6 80.73 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.064 1.56 . . . . 0.0 110.494 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.571 ' HG3' HD23 ' A' ' 60' ' ' LEU . 17.8 Cg_endo -65.1 -74.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.993 1.522 . . . . 0.0 110.241 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.508 ' CD1' ' O ' ' A' ' 85' ' ' PHE . 10.2 p90 -179.07 151.73 0.52 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.88 . . . . 0.0 110.187 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.06 -166.09 52.68 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 53' ' ' ASP . 2.6 p30 -61.43 146.22 49.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.238 -1.154 . . . . 0.0 110.118 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -157.86 120.72 3.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.294 -0.879 . . . . 0.0 110.231 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 2.9 m-85 -90.36 98.31 11.7 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.19 -0.944 . . . . 0.0 110.167 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.643 HG21 ' CZ ' ' A' ' 49' ' ' PHE . 11.0 mt -74.33 138.7 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.267 -0.896 . . . . 0.0 109.67 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.616 HD12 ' HG3' ' A' ' 50' ' ' GLU . 14.6 mt -98.83 150.11 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.051 -1.031 . . . . 0.0 110.216 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.082 HD11 HG21 ' A' ' 34' ' ' ILE . 0.6 OUTLIER -138.61 142.73 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.49 -0.756 . . . . 0.0 109.928 -179.506 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.557 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 80.03 -157.15 40.84 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.653 HG21 ' HA ' ' A' ' 15' ' ' THR . 0.8 OUTLIER -129.08 157.33 41.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 121.077 -1.249 . . . . 0.0 110.023 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.537 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 4.0 mt-10 -33.05 -54.62 0.63 Allowed Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.635 -0.666 . . . . 0.0 110.442 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 62.0 Cg_exo -44.31 -37.94 10.82 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.154 1.607 . . . . 0.0 110.458 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.572 ' HA3' ' CG ' ' A' ' 17' ' ' LYS . . . -157.17 53.22 0.4 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.598 ' HB2' ' N ' ' A' ' 94' ' ' VAL . 0.6 OUTLIER -109.62 149.39 29.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.04 -1.271 . . . . 0.0 111.0 -178.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.898 HD21 ' O ' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -119.88 -163.05 0.96 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.197 -0.94 . . . . 0.0 109.869 178.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -146.49 153.72 40.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.519 -0.738 . . . . 0.0 110.284 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.813 HD13 HG13 ' A' ' 34' ' ' ILE . 1.1 mt -138.26 113.12 9.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.922 . . . . 0.0 110.162 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 88' ' ' SER . 4.8 p-10 -87.36 130.5 34.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.869 . . . . 0.0 110.459 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.558 ' CE3' HG22 ' A' ' 24' ' ' ILE . 53.2 t-105 -133.58 144.84 49.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.336 -0.852 . . . . 0.0 110.073 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -104.0 110.4 22.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 110.188 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -111.75 73.17 0.8 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.939 . . . . 0.0 110.229 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.53 -175.24 4.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.277 -0.89 . . . . 0.0 110.11 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.91 60.54 0.33 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.6 t -83.77 -39.19 20.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -1.16 . . . . 0.0 110.098 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 45.7 t -176.56 139.48 0.32 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.269 -0.894 . . . . 0.0 110.161 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.617 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.8 OUTLIER -147.85 68.0 1.11 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.227 -0.921 . . . . 0.0 110.209 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -173.6 152.42 2.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.315 -0.865 . . . . 0.0 110.173 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -151.21 64.9 0.89 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.284 -0.885 . . . . 0.0 110.277 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.486 ' O ' ' CG ' ' A' ' 114' ' ' HIS . 43.2 p-80 -127.51 143.97 51.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.216 -0.927 . . . . 0.0 110.238 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.486 ' CG ' ' O ' ' A' ' 113' ' ' HIS . 42.4 m80 -156.2 -69.88 0.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.894 . . . . 0.0 110.262 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.48 ' O ' ' N ' ' A' ' 117' ' ' HIS . 0.0 OUTLIER -61.64 145.26 52.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 110.196 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 59.29 -82.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.303 -0.873 . . . . 0.0 110.23 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.48 ' N ' ' O ' ' A' ' 115' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.198 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttm . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.317 0.579 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.423 ' C ' ' HD3' ' A' ' 3' ' ' LYS . 17.3 m-20 -134.61 43.63 2.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.302 -0.874 . . . . 0.0 110.156 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.423 ' HD3' ' C ' ' A' ' 2' ' ' ASP . 4.1 mppt? -135.15 47.05 2.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.229 -0.919 . . . . 0.0 110.221 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.427 ' O ' ' CG ' ' A' ' 5' ' ' GLN . 1.8 mt -97.47 -137.73 0.27 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.334 -0.854 . . . . 0.0 110.137 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.427 ' CG ' ' O ' ' A' ' 4' ' ' LEU . 0.7 OUTLIER -176.91 -40.53 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.112 -0.993 . . . . 0.0 110.192 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.05 161.98 16.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.294 -0.879 . . . . 0.0 110.132 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -120.22 -6.42 9.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.168 -0.957 . . . . 0.0 110.203 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 9' ' ' MET . . . -156.34 53.57 0.41 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.411 ' O ' ' O ' ' A' ' 8' ' ' GLY . 15.7 mmt 47.88 -173.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -1.155 . . . . 0.0 110.206 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.54 ' CA ' ' HD2' ' A' ' 46' ' ' LYS . 1.4 m -115.03 -177.12 3.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.187 -0.946 . . . . 0.0 110.15 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -91.47 -73.14 0.55 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.164 -0.96 . . . . 0.0 110.184 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.454 ' O ' ' HB3' ' A' ' 13' ' ' MET . 3.4 t -133.56 -5.83 2.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.121 -0.987 . . . . 0.0 110.778 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.718 ' O ' HG23 ' A' ' 15' ' ' THR . 3.8 ttp 56.35 79.08 0.18 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.067 -1.021 . . . . 0.0 108.976 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.577 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 31.1 m -54.6 109.02 0.44 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.417 -0.802 . . . . 0.0 109.398 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 13' ' ' MET . 77.6 p -101.14 -4.72 26.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.159 -0.963 . . . . 0.0 111.764 -178.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.573 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -60.13 -124.14 0.01 OUTLIER Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.567 ' HE3' ' N ' ' A' ' 18' ' ' PHE . 1.5 ttpt -134.74 154.7 51.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.043 -1.269 . . . . 0.0 109.774 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.074 ' CE2' HG23 ' A' ' 47' ' ' ILE . 37.2 m-85 -118.25 137.84 52.76 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.805 -1.185 . . . . 0.0 111.768 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.444 ' HE2' ' HB3' ' A' ' 37' ' ' GLN . 35.2 ttpt -107.95 119.53 39.71 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.548 -0.72 . . . . 0.0 109.274 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.824 ' CG2' HD13 ' A' ' 99' ' ' LEU . 43.4 t -60.12 124.76 15.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 120.736 -1.228 . . . . 0.0 109.364 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.78 HG23 ' HA ' ' A' ' 36' ' ' VAL . 88.6 t -95.35 -27.02 4.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.678 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 5.1 tttp -159.26 133.51 7.69 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -48.59 160.31 0.18 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.569 0.699 . . . . 0.0 111.367 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.704 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -56.53 133.13 20.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-O 121.662 0.744 . . . . 0.0 110.193 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.773 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -108.58 169.72 8.47 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.7 pm0 -115.09 134.37 55.23 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.556 -1.34 . . . . 0.0 110.591 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.942 HG21 ' CD ' ' A' ' 80' ' ' GLU . 16.1 p -92.42 171.92 8.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.44 -0.788 . . . . 0.0 110.255 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -86.98 26.78 1.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.213 -0.929 . . . . 0.0 110.529 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.93 6.82 5.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.237 -0.915 . . . . 0.0 110.192 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.93 5.81 59.54 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.902 HG22 ' C ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -101.78 178.42 4.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -1.124 . . . . 0.0 110.427 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.811 HD11 ' HG3' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -134.76 153.02 34.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.481 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.685 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 48.5 t -117.96 132.13 68.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 C-N-CA 119.167 -1.013 . . . . 0.0 112.076 -177.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.108 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -117.76 119.98 63.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.327 -0.858 . . . . 0.0 110.009 179.128 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.678 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -102.45 124.04 47.29 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.241 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.78 ' HA ' HG23 ' A' ' 21' ' ' VAL . 1.2 m -147.7 161.93 7.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.157 -0.964 . . . . 0.0 108.834 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.513 ' NE2' ' OD2' ' A' ' 74' ' ' ASP 0.271 12.5 tt0 -107.37 122.93 47.59 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -178.588 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.876 ' HB2' HG21 ' A' ' 70' ' ' VAL . 12.9 t80 -62.71 122.12 15.1 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 118.814 -1.154 . . . . 0.0 110.282 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.498 ' HB2' ' HE2' ' A' ' 17' ' ' LYS . 2.7 mm-40 -115.87 98.61 6.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 110.019 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.573 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 160.16 -151.97 22.69 Favored Glycine 0 N--CA 1.486 2.005 0 C-N-CA 119.282 -1.437 . . . . 0.0 110.074 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 1.5 m-20 -105.85 106.37 16.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.704 -0.88 . . . . 0.0 109.954 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 43' ' ' SER . . . -165.32 -41.51 0.02 OUTLIER Glycine 0 N--CA 1.489 2.175 0 C-N-CA 119.539 -1.315 . . . . 0.0 110.394 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.63 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 1.0 OUTLIER 49.3 -150.23 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.366 0 O-C-N 120.869 -1.371 . . . . 0.0 107.485 -179.442 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.63 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 51.7 Cg_exo -47.83 92.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -1.022 0 N-CA-C 108.431 -1.411 . . . . 0.0 108.431 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.709 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -153.91 173.98 15.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.683 -0.636 . . . . 0.0 109.396 -177.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.68 ' CG ' HD11 ' A' ' 69' ' ' ILE . 14.9 mttp -85.18 174.94 9.27 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.287 -0.883 . . . . 0.0 111.594 -178.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.074 HG23 ' CE2' ' A' ' 18' ' ' PHE . 14.5 mm -123.06 128.72 25.23 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.401 -0.812 . . . . 0.0 111.936 -178.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.622 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 37.7 Cg_exo -63.68 145.03 90.83 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.58 1.52 . . . . 0.0 111.24 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.733 ' CD2' HD21 ' A' ' 63' ' ' LEU . 10.6 t80 -155.46 146.1 22.14 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.407 -0.808 . . . . 0.0 110.434 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.584 ' CG ' ' CG2' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -156.84 111.22 2.73 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.006 -1.059 . . . . 0.0 110.367 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.829 HD11 ' HB1' ' A' ' 81' ' ' ALA . 5.7 mt -98.69 56.65 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.184 -0.947 . . . . 0.0 110.296 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.764 ' CE ' HD22 ' A' ' 60' ' ' LEU . 2.4 mmt -154.68 -58.04 0.11 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.21 -0.931 . . . . 0.0 110.263 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.618 ' HB2' HD11 ' A' ' 91' ' ' ILE . 26.1 t0 66.29 -58.35 0.35 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.352 -0.842 . . . . 0.0 110.563 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 52' ' ' MET . 1.7 mt -86.94 1.88 51.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 110.696 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -171.56 69.82 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.166 -0.959 . . . . 0.0 110.205 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.452 ' HG2' ' CB ' ' A' ' 52' ' ' MET . 24.1 mtmt -97.86 46.01 1.02 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.409 -0.807 . . . . 0.0 110.201 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.473 ' HA ' ' NE ' ' A' ' 57' ' ' ARG . 1.6 tpm_? -121.54 -15.5 8.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.312 -0.867 . . . . 0.0 110.077 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -107.15 -158.15 0.64 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.311 -0.868 . . . . 0.0 110.094 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.1 t -109.94 82.23 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.307 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.764 HD22 ' CE ' ' A' ' 52' ' ' MET . 0.2 OUTLIER -112.29 146.86 37.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.855 . . . . 0.0 110.179 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.55 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . 57.19 160.36 0.02 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.512 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -129.13 162.34 27.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -1.138 . . . . 0.0 110.408 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.742 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -124.51 112.7 17.18 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.45 -0.781 . . . . 0.0 109.609 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.899 ' CG1' HG21 ' A' ' 31' ' ' THR . 7.2 mm -72.23 -27.38 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 122.351 1.072 . . . . 0.0 108.287 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.647 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.258 0.8 OUTLIER -109.13 32.2 5.12 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.534 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 63' ' ' LEU . 33.6 t -14.99 112.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.817 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.541 ' ND2' ' HD3' ' A' ' 46' ' ' LYS . 14.5 t-20 44.71 69.13 2.67 Favored Pre-proline 0 C--N 1.297 -1.688 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.699 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.62 ' HG3' HG23 ' A' ' 79' ' ' ILE . 6.3 Cg_exo -48.95 -178.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 124.246 1.656 . . . . 0.0 109.484 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.709 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.9 OUTLIER -140.7 139.37 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 118.971 -1.092 . . . . 0.0 112.241 -178.831 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.014 ' CG2' HD11 ' A' ' 47' ' ' ILE . 47.3 t -92.23 172.53 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 176.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.481 ' N ' HG12 ' A' ' 70' ' ' VAL . 22.9 m -122.13 -24.04 5.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.769 -1.207 . . . . 0.0 110.968 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.592 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 3.9 mm-40 -130.09 -46.78 1.12 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.015 -1.053 . . . . 0.0 110.032 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.592 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.1 OUTLIER 155.59 -61.46 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.513 ' OD2' ' NE2' ' A' ' 37' ' ' GLN . 2.4 t0 -89.65 12.9 15.5 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.207 -0.933 . . . . 0.0 110.371 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 77' ' ' VAL . 48.0 t -72.65 108.95 5.03 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.149 -0.969 . . . . 0.0 108.821 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.609 ' HB3' HG21 ' A' ' 21' ' ' VAL . 9.7 Cg_endo -56.95 113.8 1.63 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.829 1.436 . . . . 0.0 110.469 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.557 HG21 HG22 ' A' ' 70' ' ' VAL . 57.7 t -102.8 148.14 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.377 -0.827 . . . . 0.0 110.937 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.658 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 1.9 m-20 -106.22 138.2 42.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.322 -0.861 . . . . 0.0 109.981 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.686 HG21 ' CD1' ' A' ' 49' ' ' PHE . 4.5 mt -118.09 119.51 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 117.778 -1.569 . . . . 0.0 111.41 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.942 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.7 tp10 -94.01 110.2 21.9 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.902 ' C ' HG22 ' A' ' 31' ' ' THR . . . -124.31 147.49 48.11 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.069 -1.019 . . . . 0.0 111.011 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.644 ' HB2' HG23 ' A' ' 31' ' ' THR . 23.6 tt0 -107.61 94.7 12.47 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.597 -0.689 . . . . 0.0 110.617 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.811 ' HG3' HD11 ' A' ' 32' ' ' ILE . 40.3 Cg_endo -72.51 153.88 55.16 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.971 1.511 . . . . 0.0 110.219 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.685 ' HG3' HD23 ' A' ' 60' ' ' LEU . 10.8 Cg_endo -59.11 -74.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.963 1.507 . . . . 0.0 110.159 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -120.6 176.23 5.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.244 -0.91 . . . . 0.0 109.896 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.516 ' HA3' ' N ' ' A' ' 105' ' ' LYS . . . -76.83 74.93 1.75 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.416 ' HB3' ' O ' ' A' ' 86' ' ' GLY . 19.1 p30 179.68 63.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -1.103 . . . . 0.0 109.847 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 0.4 OUTLIER -141.74 174.37 10.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 0.0 110.3 -179.649 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.558 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 4.1 m-85 -118.11 108.65 15.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.91 . . . . 0.0 110.145 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.543 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 12.7 mm -74.74 108.87 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.159 -0.963 . . . . 0.0 109.477 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.618 HD11 ' HB2' ' A' ' 53' ' ' ASP . 32.5 mt -100.98 154.22 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.92 -1.112 . . . . 0.0 110.004 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.108 HD11 HG21 ' A' ' 34' ' ' ILE . 2.7 mt -140.28 150.61 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.258 -0.901 . . . . 0.0 110.447 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.546 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 77.65 -157.1 45.34 Favored Glycine 0 N--CA 1.485 1.9 0 C-N-CA 119.319 -1.42 . . . . 0.0 109.658 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.559 ' O ' ' N ' ' A' ' 98' ' ' GLN . 0.2 OUTLIER -130.36 157.08 42.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.116 -1.226 . . . . 0.0 110.318 -179.596 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.524 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 1.0 OUTLIER -30.47 -55.71 0.36 Allowed Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.847 -0.533 . . . . 0.0 110.723 -179.739 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 76.4 Cg_exo -41.02 -40.58 3.88 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 124.055 1.555 . . . . 0.0 110.615 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 17' ' ' LYS . . . -160.76 50.95 0.35 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.559 ' N ' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -94.56 149.5 21.18 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.976 -1.308 . . . . 0.0 110.903 -178.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.824 HD13 ' CG2' ' A' ' 20' ' ' VAL . 13.7 mt -94.44 177.74 5.84 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.553 -0.717 . . . . 0.0 109.941 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.742 ' C ' HD12 ' A' ' 101' ' ' LEU . 0.4 OUTLIER -148.21 119.91 8.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.396 -0.815 . . . . 0.0 111.123 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.742 HD12 ' C ' ' A' ' 100' ' ' LYS . 7.3 mp -128.81 -164.52 1.4 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 102' ' ' ASN . 14.5 p-10 -179.05 151.11 0.49 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.843 -1.161 . . . . 0.0 110.931 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.467 ' HA ' ' CE3' ' A' ' 103' ' ' TRP . 0.5 OUTLIER -120.59 135.75 55.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 110.047 179.702 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.486 ' O ' ' HB2' ' A' ' 105' ' ' LYS . 19.1 p90 -121.69 135.91 54.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.34 -0.85 . . . . 0.0 110.253 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.516 ' N ' ' HA3' ' A' ' 86' ' ' GLY . 13.5 ttpt 171.36 121.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.378 -0.827 . . . . 0.0 109.994 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.5 ptmt -93.47 -141.45 0.22 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.244 -0.91 . . . . 0.0 110.168 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.78 -126.05 0.56 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.3 t -150.68 72.37 1.08 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.295 -1.121 . . . . 0.0 110.167 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.8 t -169.48 96.5 0.32 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 110.249 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.6 pp -135.84 4.7 3.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 110.243 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.18 37.41 3.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.264 -0.897 . . . . 0.0 110.223 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.514 ' O ' ' CG ' ' A' ' 113' ' ' HIS . 0.9 OUTLIER -154.77 125.07 6.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.91 . . . . 0.0 110.144 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.514 ' CG ' ' O ' ' A' ' 112' ' ' HIS . 0.3 OUTLIER 178.45 -44.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.269 -0.894 . . . . 0.0 110.275 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 113' ' ' HIS . 1.4 m170 57.67 167.71 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -0.947 . . . . 0.0 110.169 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.48 ' CD2' ' O ' ' A' ' 115' ' ' HIS . 34.6 p-80 -108.04 41.79 1.48 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.932 . . . . 0.0 110.19 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 4.2 m170 -86.25 -173.85 4.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.269 -0.894 . . . . 0.0 110.177 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.195 -179.982 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.27 0.557 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.44 77.0 9.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.288 -0.883 . . . . 0.0 110.21 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.6 tptt -54.83 -25.98 32.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.295 -0.878 . . . . 0.0 110.234 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.47 ' O ' ' CG ' ' A' ' 5' ' ' GLN . 3.0 tt -58.09 92.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.276 -0.89 . . . . 0.0 110.128 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.47 ' CG ' ' O ' ' A' ' 4' ' ' LEU . 0.6 OUTLIER 171.61 83.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.206 -0.933 . . . . 0.0 110.191 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.41 -19.48 10.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.891 . . . . 0.0 110.171 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 61.79 32.21 18.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.229 -0.92 . . . . 0.0 110.161 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -166.13 174.06 41.69 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.412 ' O ' ' C ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -131.22 -169.68 2.22 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.327 -1.102 . . . . 0.0 110.087 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 9' ' ' MET . 1.5 p -44.16 147.75 0.5 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.239 -0.913 . . . . 0.0 110.153 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.545 ' HB2' ' CD1' ' A' ' 69' ' ' ILE . 0.6 OUTLIER -90.72 -72.37 0.58 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.192 -0.942 . . . . 0.0 110.083 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.464 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 3.2 t -133.52 -4.38 2.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.159 -0.963 . . . . 0.0 110.578 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.499 ' CG ' ' O ' ' A' ' 13' ' ' MET . 5.6 ttm 56.34 76.15 0.31 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.078 -1.013 . . . . 0.0 108.986 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.581 ' HB3' ' CE1' ' A' ' 38' ' ' TYR . 22.9 m -51.76 100.96 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.424 -0.798 . . . . 0.0 109.572 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.5 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 10.6 t -92.36 -7.95 46.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.357 -0.84 . . . . 0.0 111.564 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.56 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -60.52 -118.19 0.01 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.543 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -140.15 174.75 10.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.952 -1.323 . . . . 0.0 110.235 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.02 ' CE2' HG23 ' A' ' 47' ' ' ILE . 37.7 m-85 -134.84 138.59 44.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.038 -1.039 . . . . 0.0 111.406 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.496 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 2.9 ttpt -106.53 116.92 32.76 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.425 -0.797 . . . . 0.0 109.175 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.742 HG22 HD13 ' A' ' 99' ' ' LEU . 46.3 t -59.58 125.12 15.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 120.625 -1.297 . . . . 0.0 109.647 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.726 HG23 ' HA ' ' A' ' 36' ' ' VAL . 80.3 t -97.03 -28.23 3.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.627 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -153.38 137.72 16.64 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.236 177.178 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -56.08 158.77 3.74 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.3 0.572 . . . . 0.0 110.285 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.999 HG12 HD22 ' A' ' 101' ' ' LEU . 0.7 OUTLIER -55.6 130.35 17.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.274 -0.971 . . . . 0.0 109.795 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.804 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -108.18 168.11 9.53 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 12.3 pt-20 -112.69 132.43 55.2 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.782 -1.199 . . . . 0.0 110.423 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.956 HG21 ' CD ' ' A' ' 80' ' ' GLU . 21.5 p -86.91 175.75 8.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.526 -0.734 . . . . 0.0 110.238 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -89.16 29.1 1.11 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.299 -0.876 . . . . 0.0 110.203 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -133.6 5.55 3.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.23 -0.919 . . . . 0.0 110.326 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.34 -0.3 58.45 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.876 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -95.02 -175.94 3.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.208 -1.172 . . . . 0.0 110.472 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.804 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -139.46 153.41 23.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.621 HG23 ' CG2' ' A' ' 27' ' ' THR . 70.0 t -118.51 135.31 59.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 O-C-N 121.192 -0.943 . . . . 0.0 111.765 -178.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.077 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -119.97 118.75 58.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 O-C-N 121.382 -0.824 . . . . 0.0 110.049 179.2 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.627 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.6 OUTLIER -100.19 123.51 44.5 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.123 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.812 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.3 m -147.85 162.86 6.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 121.082 -1.011 . . . . 0.0 108.819 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 74' ' ' ASP 0.254 10.2 tt0 -109.75 130.67 55.49 Favored 'General case' 0 C--N 1.27 -2.867 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.631 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.924 ' HB2' HG21 ' A' ' 70' ' ' VAL . 9.6 t80 -59.06 121.11 10.44 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.412 -178.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.496 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 5.8 mt-10 -106.86 21.18 17.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.107 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.56 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -115.84 -161.48 12.86 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.516 ' N ' ' OH ' ' A' ' 38' ' ' TYR . 13.5 t0 -125.66 145.19 50.27 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.455 -1.026 . . . . 0.0 110.245 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.21 -5.91 0.67 Allowed Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.421 -1.371 . . . . 0.0 111.02 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.615 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.7 OUTLIER 51.33 -153.06 0.01 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 120.436 -1.626 . . . . 0.0 108.198 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.615 ' HD2' ' CB ' ' A' ' 43' ' ' SER . 83.1 Cg_exo -41.47 96.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.321 -0.9 0 N-CA-C 109.241 -1.1 . . . . 0.0 109.241 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.867 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -145.59 169.29 18.71 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.339 0.59 . . . . 0.0 109.701 -178.162 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.63 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -82.74 174.85 10.61 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.223 -0.923 . . . . 0.0 111.829 -178.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.096 ' CD1' HG23 ' A' ' 70' ' ' VAL . 13.3 mm -123.64 123.74 26.3 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.835 -0.541 . . . . 0.0 111.396 -178.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.619 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 31.7 Cg_exo -61.47 143.89 97.68 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.109 1.584 . . . . 0.0 110.368 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.991 ' CE1' HG21 ' A' ' 79' ' ' ILE . 5.3 t80 -152.06 159.83 43.6 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 110.469 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.488 ' HB3' ' HB ' ' A' ' 91' ' ' ILE . 32.0 tp10 -178.74 100.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 110.037 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.656 HD11 ' HB1' ' A' ' 81' ' ' ALA . 36.0 mt -87.7 71.29 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.179 -0.951 . . . . 0.0 110.245 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.795 ' HE3' HD13 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -154.56 -66.33 0.13 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 0.0 110.278 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.547 ' CA ' HD11 ' A' ' 91' ' ' ILE . 0.4 OUTLIER 176.86 109.68 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.194 -0.941 . . . . 0.0 110.245 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.638 ' N ' HD11 ' A' ' 91' ' ' ILE . 0.2 OUTLIER 56.05 -84.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.236 -0.915 . . . . 0.0 110.146 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 53' ' ' ASP . 9.8 tt0 -165.6 63.8 0.11 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.172 -0.955 . . . . 0.0 110.127 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -119.64 125.76 49.51 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.222 -0.924 . . . . 0.0 110.392 -179.816 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 56' ' ' LYS . 1.7 mmt85 41.81 -164.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.36 -0.838 . . . . 0.0 110.376 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.421 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 11.1 t-80 -176.23 36.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.32 -0.863 . . . . 0.0 110.222 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 59' ' ' VAL . 16.3 t -107.28 46.02 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.251 -0.905 . . . . 0.0 110.283 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.795 HD13 ' HE3' ' A' ' 52' ' ' MET . 0.5 OUTLIER -125.7 -74.12 0.61 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.295 -0.878 . . . . 0.0 110.158 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.473 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . -84.46 -162.11 34.16 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.587 ' O ' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -154.69 167.64 29.5 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.273 -1.133 . . . . 0.0 109.297 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.058 HD23 ' HB2' ' A' ' 81' ' ' ALA . 11.7 mt -121.52 121.88 38.47 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 118.746 -1.182 . . . . 0.0 110.737 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.876 HG12 HG21 ' A' ' 31' ' ' THR . 1.4 mp -82.09 -26.8 9.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.708 HG22 ' O ' ' A' ' 65' ' ' THR 0.256 1.0 OUTLIER -96.67 33.19 1.89 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.241 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 1.048 HG23 ' O ' ' A' ' 63' ' ' LEU . 8.9 t -34.72 140.97 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.032 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.57 ' N ' ' CD ' ' A' ' 68' ' ' PRO . 22.1 t-20 56.99 46.34 2.07 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.608 -0.682 . . . . 0.0 110.422 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.582 ' CB ' ' CD1' ' A' ' 79' ' ' ILE . 9.2 Cg_endo -58.93 148.22 85.63 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.611 1.322 . . . . 0.0 108.979 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.867 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.7 OUTLIER -142.69 144.65 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 119.255 -0.978 . . . . 0.0 112.111 -178.151 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.096 HG23 ' CD1' ' A' ' 47' ' ' ILE . 54.4 t -94.2 153.02 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.94 -21.4 12.35 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 120.932 -1.105 . . . . 0.0 108.57 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.535 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 2.3 mt-10 -138.45 145.8 41.32 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.54 ' O ' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -54.23 -14.15 1.07 Allowed 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.989 -1.069 . . . . 0.0 110.773 -178.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.497 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 7.1 t70 -126.31 9.21 7.26 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.589 -1.32 . . . . 0.0 110.578 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.488 ' CB ' ' HB2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -73.18 111.86 13.35 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.119 -0.988 . . . . 0.0 108.776 178.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 22.2 Cg_exo -59.91 114.45 2.08 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.864 1.455 . . . . 0.0 110.536 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.678 HG21 HG22 ' A' ' 70' ' ' VAL . 53.0 t -95.79 150.99 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.23 -0.919 . . . . 0.0 110.54 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.656 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 11.2 m-80 -114.4 130.05 56.68 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.991 HG21 ' CE1' ' A' ' 49' ' ' PHE . 9.5 mm -112.73 118.28 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 117.638 -1.625 . . . . 0.0 111.934 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.956 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.7 tp10 -95.79 107.44 19.67 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 1.058 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -129.3 155.47 45.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.797 -1.19 . . . . 0.0 111.287 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 62' ' ' ARG . 43.8 tp10 -100.8 103.25 23.39 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.531 -0.731 . . . . 0.0 110.466 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.531 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 60.7 Cg_endo -77.68 152.44 29.26 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.958 1.504 . . . . 0.0 110.484 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.549 ' HG3' HD23 ' A' ' 60' ' ' LEU . 28.2 Cg_endo -70.0 123.74 10.31 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.993 1.523 . . . . 0.0 109.888 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.435 ' C ' ' O ' ' A' ' 84' ' ' PRO . 0.6 OUTLIER -41.42 113.06 0.37 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.264 -0.898 . . . . 0.0 110.498 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.479 ' N ' ' HA ' ' A' ' 105' ' ' LYS . . . 131.97 -150.64 19.62 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -76.26 137.51 39.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.236 -1.155 . . . . 0.0 110.049 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 4.3 m -158.49 149.93 20.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.168 -0.957 . . . . 0.0 110.538 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.553 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 6.1 m-85 -124.43 104.46 8.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.915 . . . . 0.0 109.992 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.792 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 2.0 mp -73.87 107.96 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.312 -0.868 . . . . 0.0 109.578 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.638 HD11 ' N ' ' A' ' 54' ' ' LEU . 30.7 mt -91.97 148.29 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.264 -0.898 . . . . 0.0 110.468 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.077 HD11 HG21 ' A' ' 34' ' ' ILE . 1.8 mt -133.28 140.64 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.565 -0.709 . . . . 0.0 109.606 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.54 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 82.13 -161.4 41.46 Favored Glycine 0 N--CA 1.481 1.655 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.54 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -122.61 149.84 26.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 O-C-N 121.225 -1.162 . . . . 0.0 110.181 -179.627 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.578 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.9 OUTLIER -17.03 -58.24 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.189 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 8.2 Cg_endo -51.65 71.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 124.219 1.641 . . . . 0.0 112.171 179.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 89.51 1.23 78.24 Favored Glycine 0 N--CA 1.494 2.511 0 O-C-N 120.943 -1.098 . . . . 0.0 110.878 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.513 ' HB3' ' C ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -48.63 159.68 0.22 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.975 -1.309 . . . . 0.0 110.27 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.742 HD13 HG22 ' A' ' 20' ' ' VAL . 13.0 mt -96.14 176.91 5.91 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.296 -0.877 . . . . 0.0 110.418 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.509 ' HG3' HG12 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -157.19 138.8 14.02 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.309 -0.869 . . . . 0.0 110.408 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.999 HD22 HG12 ' A' ' 24' ' ' ILE . 3.5 mp -141.06 118.1 11.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.247 -0.908 . . . . 0.0 110.026 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' A' ' 88' ' ' SER . 1.9 t-20 -87.44 129.74 34.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 110.759 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 8.5 t-105 -119.51 129.19 54.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 0.0 109.739 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.51 ' O ' ' N ' ' A' ' 106' ' ' LYS . 1.0 OUTLIER -91.02 138.49 31.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.938 . . . . 0.0 110.507 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.479 ' HA ' ' N ' ' A' ' 86' ' ' GLY . 19.3 mttt 44.38 -92.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.292 -0.88 . . . . 0.0 110.355 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -151.94 16.87 0.67 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.205 -0.935 . . . . 0.0 110.123 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.81 179.33 43.57 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -102.88 -68.27 0.84 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.311 -1.111 . . . . 0.0 110.215 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 108' ' ' SER . 48.0 t 43.61 77.37 0.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 0.0 110.187 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.3 -33.61 23.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.312 -0.868 . . . . 0.0 110.175 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -134.96 115.99 14.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.16 -0.963 . . . . 0.0 110.257 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -60.25 178.54 0.19 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.204 -0.935 . . . . 0.0 110.227 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 13.3 p-80 -161.4 134.16 6.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.212 -0.93 . . . . 0.0 110.22 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -56.44 153.7 9.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.244 -0.91 . . . . 0.0 110.223 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -169.3 153.74 5.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -0.926 . . . . 0.0 110.237 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.546 ' N ' ' CD2' ' A' ' 116' ' ' HIS . 5.2 p80 -166.7 42.31 0.05 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 110.218 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.234 180.0 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.281 0.563 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 2' ' ' ASP . 14.7 p30 -159.55 158.6 32.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 110.208 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -114.77 20.06 15.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 0.0 110.175 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.463 ' O ' ' HB3' ' A' ' 5' ' ' GLN . 8.5 mp -77.9 140.64 39.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.2 -0.938 . . . . 0.0 110.251 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' A' ' 4' ' ' LEU . 1.7 pt20 -178.04 50.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.314 -0.866 . . . . 0.0 110.119 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' A' ' 6' ' ' LEU . 2.6 mt -155.8 145.9 21.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.142 -0.974 . . . . 0.0 110.225 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.27 148.29 26.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.23 -0.919 . . . . 0.0 110.219 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.11 175.57 34.73 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.457 ' O ' ' HE2' ' A' ' 46' ' ' LYS . 10.9 mtt -61.58 149.96 37.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -1.164 . . . . 0.0 110.196 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.49 161.23 15.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.919 . . . . 0.0 110.182 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -143.0 -74.89 0.27 Allowed 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.273 -0.892 . . . . 0.0 110.169 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.566 ' HB3' ' CB ' ' A' ' 45' ' ' CYS . 3.6 t -136.97 -25.82 1.06 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.321 -0.862 . . . . 0.0 110.902 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.521 ' O ' ' N ' ' A' ' 15' ' ' THR . 0.4 OUTLIER 59.23 93.24 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.28 -0.887 . . . . 0.0 109.525 -179.609 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.734 ' SG ' HD13 ' A' ' 47' ' ' ILE . 56.2 m -50.55 90.28 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.445 -0.784 . . . . 0.0 109.558 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 13' ' ' MET . 3.2 t -79.13 -11.34 59.98 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.067 -1.02 . . . . 0.0 111.419 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.531 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -60.93 -131.76 0.01 OUTLIER Glycine 0 N--CA 1.485 1.944 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.539 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -130.1 -177.88 4.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -1.167 . . . . 0.0 109.809 -179.73 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.995 ' CE2' HG23 ' A' ' 47' ' ' ILE . 32.5 m-85 -137.6 141.87 41.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.741 -1.224 . . . . 0.0 111.968 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.485 ' HB2' ' OE2' ' A' ' 39' ' ' GLU . 33.3 ttpt -113.44 118.28 34.06 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.607 ' CG2' HD13 ' A' ' 99' ' ' LEU . 40.9 t -59.47 125.01 14.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 120.576 -1.328 . . . . 0.0 109.036 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.565 ' HB ' ' CG ' ' A' ' 35' ' ' ARG . 62.8 t -98.26 -27.16 3.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.608 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 3.0 tttp -156.77 133.12 9.9 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -50.87 162.13 0.3 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.716 0.769 . . . . 0.0 111.411 -178.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.656 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.7 OUTLIER -57.73 132.22 22.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 121.584 0.707 . . . . 0.0 110.289 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.603 ' HB3' ' HB ' ' A' ' 33' ' ' VAL . . . -109.17 163.17 13.59 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 5.3 pm0 -112.46 134.11 54.17 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.344 -1.472 . . . . 0.0 110.553 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.908 HG21 ' CD ' ' A' ' 80' ' ' GLU . 4.7 p -94.22 165.21 12.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.524 -0.735 . . . . 0.0 110.336 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -78.58 -1.02 32.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.42 -0.8 . . . . 0.0 110.123 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.06 3.51 55.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.9 . . . . 0.0 110.34 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.491 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 88.88 25.81 28.48 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.866 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -121.77 -177.17 3.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.54 -0.976 . . . . 0.0 110.363 -179.779 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.747 HD12 HD11 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -136.34 142.73 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.638 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.629 HG23 ' CG2' ' A' ' 27' ' ' THR . 43.0 t -110.26 133.81 54.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 O-C-N 121.47 -0.768 . . . . 0.0 112.279 -177.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.093 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -118.74 119.54 61.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 O-C-N 121.339 -0.85 . . . . 0.0 109.865 178.738 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.608 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 1.0 OUTLIER -101.86 123.34 45.62 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 179.428 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.781 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.5 m -148.79 161.45 5.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 108.773 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.488 ' N ' HG23 ' A' ' 21' ' ' VAL 0.254 0.1 OUTLIER -106.75 124.6 49.85 Favored 'General case' 0 C--N 1.273 -2.757 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -179.43 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.981 ' HB2' HG21 ' A' ' 70' ' ' VAL . 2.1 t80 -61.15 125.52 24.03 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.017 -1.073 . . . . 0.0 110.425 -178.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.485 ' OE2' ' HB2' ' A' ' 19' ' ' LYS . 22.2 mm-40 -98.08 -148.91 0.33 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.022 -1.049 . . . . 0.0 109.19 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.531 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 44.24 -145.5 1.77 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.471 ' HA ' ' HD2' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -134.52 143.62 47.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.679 -0.895 . . . . 0.0 110.139 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.94 -25.32 0.04 OUTLIER Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.42 -1.372 . . . . 0.0 110.95 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.617 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.4 OUTLIER 56.24 -156.1 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 120.726 -1.455 . . . . 0.0 108.267 -179.545 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.617 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 50.9 Cg_exo -48.45 92.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.506 0 N-CA-C 109.61 -0.958 . . . . 0.0 109.61 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.789 ' O ' HG23 ' A' ' 69' ' ' ILE . 21.8 p -143.32 167.75 21.43 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.422 -0.799 . . . . 0.0 110.389 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.699 ' CG ' HD11 ' A' ' 69' ' ' ILE . 47.0 mttp -85.38 154.99 21.5 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 122.142 0.972 . . . . 0.0 111.176 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.053 ' CD1' HG23 ' A' ' 70' ' ' VAL . 12.4 mm -101.92 123.32 44.14 Favored Pre-proline 0 C--N 1.297 -1.699 0 O-C-N 121.591 -0.693 . . . . 0.0 111.782 -177.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.626 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 32.2 Cg_exo -61.59 149.32 90.3 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.181 1.621 . . . . 0.0 110.457 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.999 ' CD1' HD11 ' A' ' 63' ' ' LEU . 5.9 t80 -159.4 155.25 26.34 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.389 -0.82 . . . . 0.0 110.165 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.772 ' O ' HD12 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -177.67 106.62 0.05 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.277 -0.889 . . . . 0.0 109.873 179.721 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 51' ' ' ILE . 3.0 mt -81.16 10.65 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.349 -0.844 . . . . 0.0 110.126 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.57 ' CB ' ' HB3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -145.97 -66.87 0.29 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.121 -0.987 . . . . 0.0 110.468 179.443 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.544 ' CB ' ' HG2' ' A' ' 50' ' ' GLU . 0.4 OUTLIER 71.24 52.94 0.25 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.045 -1.034 . . . . 0.0 110.623 179.762 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.54 ' O ' ' CB ' ' A' ' 55' ' ' GLU . 33.5 mt 59.69 142.35 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.156 -0.965 . . . . 0.0 110.356 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.54 ' CB ' ' O ' ' A' ' 54' ' ' LEU . 0.1 OUTLIER 73.65 13.87 4.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.473 -0.767 . . . . 0.0 109.089 -179.416 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.57 ' HB3' ' CB ' ' A' ' 52' ' ' MET . 0.1 OUTLIER -125.57 18.63 8.09 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.026 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.509 ' HG3' ' N ' ' A' ' 58' ' ' HIS . 11.3 ptt180 -52.89 -30.97 37.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.299 -0.875 . . . . 0.0 110.341 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.509 ' N ' ' HG3' ' A' ' 57' ' ' ARG . 4.7 m170 -57.71 -15.68 8.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.913 . . . . 0.0 110.146 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.666 HG11 ' O ' ' A' ' 87' ' ' ASP . 6.0 m -144.58 87.4 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.922 . . . . 0.0 110.156 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.401 ' O ' ' HB3' ' A' ' 84' ' ' PRO . 6.5 mt -84.38 108.12 17.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 110.189 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.446 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . -94.94 -163.87 35.13 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.623 ' O ' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -159.19 166.57 31.14 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.256 -1.143 . . . . 0.0 109.617 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.018 HD23 ' HB2' ' A' ' 81' ' ' ALA . 11.3 mt -122.77 123.92 42.16 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 118.819 -1.152 . . . . 0.0 111.077 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.866 HG12 HG21 ' A' ' 31' ' ' THR . 1.5 mp -85.22 -28.45 6.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.774 HG22 ' O ' ' A' ' 65' ' ' THR 0.257 1.8 m -99.32 35.69 1.89 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.925 HG23 ' O ' ' A' ' 63' ' ' LEU . 43.0 t -37.85 152.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.667 0.746 . . . . 0.0 111.231 -178.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.685 ' ND2' HG12 ' A' ' 66' ' ' VAL . 24.5 p30 37.22 52.35 2.46 Favored Pre-proline 0 C--N 1.302 -1.47 0 O-C-N 121.968 -0.458 . . . . 0.0 111.568 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.927 ' CG ' HD12 ' A' ' 79' ' ' ILE . 1.9 Cg_endo -59.85 162.98 14.55 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 N-CA-C 108.363 -1.437 . . . . 0.0 108.363 178.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.789 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.8 OUTLIER -143.94 148.66 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 C-N-CA 118.817 -1.153 . . . . 0.0 112.744 -178.471 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.053 HG23 ' CD1' ' A' ' 47' ' ' ILE . 44.0 t -102.46 159.43 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 175.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.3 m -112.89 -19.85 11.8 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.809 -1.156 . . . . 0.0 111.448 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 16.3 mt-10 -131.38 15.14 5.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.777 -1.202 . . . . 0.0 111.502 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.535 ' O ' ' O ' ' A' ' 38' ' ' TYR . 2.3 ttpt 71.56 -5.58 1.6 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.221 -0.925 . . . . 0.0 111.034 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.477 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 7.8 t0 -137.76 -1.2 2.05 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.877 -1.14 . . . . 0.0 110.257 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.481 ' O ' HG23 ' A' ' 77' ' ' VAL . 47.7 t -72.6 112.26 14.32 Favored Pre-proline 0 N--CA 1.486 1.363 0 O-C-N 121.208 -0.932 . . . . 0.0 109.362 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 32.6 Cg_exo -51.56 111.8 0.67 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.82 1.431 . . . . 0.0 109.915 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.889 HG21 HG22 ' A' ' 70' ' ' VAL . 92.5 t -95.15 143.46 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.325 -0.859 . . . . 0.0 110.997 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.643 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.9 m120 -105.9 131.25 53.45 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.945 HG21 ' CD2' ' A' ' 49' ' ' PHE . 10.5 mm -116.35 119.89 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 117.567 -1.653 . . . . 0.0 111.767 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.908 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.1 tp10 -94.44 110.79 22.55 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.16 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 1.018 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -125.28 159.9 30.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.926 -1.109 . . . . 0.0 110.752 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.555 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -93.68 113.9 61.57 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.527 -0.733 . . . . 0.0 110.323 -179.284 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.683 ' HB3' HD11 ' A' ' 32' ' ' ILE . 46.4 Cg_endo -73.3 133.03 18.64 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.853 1.449 . . . . 0.0 110.525 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.446 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 19.4 Cg_endo -64.38 -158.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.925 1.487 . . . . 0.0 109.928 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -105.39 103.88 13.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.141 -0.975 . . . . 0.0 110.129 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 121.49 -153.75 16.66 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.666 ' O ' HG11 ' A' ' 59' ' ' VAL . 5.8 t70 -71.63 161.34 31.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.288 -1.125 . . . . 0.0 110.212 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -170.46 147.17 2.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.212 -0.93 . . . . 0.0 110.294 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.587 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 3.2 m-85 -118.5 104.8 11.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 110.174 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.799 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 5.2 mt -74.08 111.34 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.164 -0.96 . . . . 0.0 109.442 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.772 HD12 ' O ' ' A' ' 50' ' ' GLU . 2.1 mp -90.99 140.23 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.949 . . . . 0.0 110.178 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.093 HD11 HG21 ' A' ' 34' ' ' ILE . 1.4 mt -126.44 138.03 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.423 -0.798 . . . . 0.0 109.83 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.578 ' O ' ' HB2' ' A' ' 48' ' ' PRO . . . 85.99 -163.71 36.56 Favored Glycine 0 N--CA 1.482 1.754 0 C-N-CA 119.112 -1.518 . . . . 0.0 109.488 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.547 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -118.62 146.95 22.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 O-C-N 121.135 -1.215 . . . . 0.0 110.16 -179.623 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.578 ' O ' ' N ' ' A' ' 97' ' ' GLY . 3.9 mt-10 -16.89 -58.47 0.04 OUTLIER Pre-proline 0 N--CA 1.501 2.103 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 6.8 Cg_endo -51.08 72.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 124.219 1.641 . . . . 0.0 112.034 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 89.42 -1.35 81.92 Favored Glycine 0 N--CA 1.494 2.538 0 O-C-N 120.995 -1.065 . . . . 0.0 110.865 178.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.503 ' HB3' ' C ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -45.79 159.19 0.07 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.891 -1.358 . . . . 0.0 109.932 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.607 HD13 ' CG2' ' A' ' 20' ' ' VAL . 10.9 mt -96.68 177.44 5.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.245 -0.91 . . . . 0.0 110.645 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.428 ' C ' HD12 ' A' ' 101' ' ' LEU . 3.3 tttt -154.59 135.49 13.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.415 -0.803 . . . . 0.0 110.115 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.617 HD22 HG12 ' A' ' 24' ' ' ILE . 4.8 mp -137.16 122.44 19.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.181 -0.949 . . . . 0.0 110.328 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 88' ' ' SER . 3.7 t-20 -87.92 125.25 34.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 110.277 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.485 ' CD1' HD13 ' A' ' 32' ' ' ILE . 20.7 t-105 -123.98 154.21 40.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.905 . . . . 0.0 110.075 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.441 ' CD1' ' C ' ' A' ' 104' ' ' PHE . 27.6 p90 -119.43 146.12 45.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.229 -0.919 . . . . 0.0 110.308 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -138.84 101.95 4.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 110.175 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -133.04 42.01 3.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.211 -0.931 . . . . 0.0 110.255 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -137.9 124.0 2.86 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.56 128.6 53.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -1.158 . . . . 0.0 110.189 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -50.34 141.3 11.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.893 . . . . 0.0 110.252 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.89 -53.83 53.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.196 -0.94 . . . . 0.0 110.14 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -70.29 137.56 50.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.921 . . . . 0.0 110.196 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -107.66 17.81 22.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.908 . . . . 0.0 110.217 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -52.71 -22.13 4.84 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.259 -0.901 . . . . 0.0 110.176 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -86.81 83.54 7.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 0.0 110.21 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -106.55 165.05 11.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.3 -0.875 . . . . 0.0 110.261 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -170.18 68.98 0.05 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.312 -0.867 . . . . 0.0 110.199 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.223 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.209 0.528 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -54.79 -84.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 0.0 110.219 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 4' ' ' LEU . 1.3 ttpp -87.13 176.19 7.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.896 . . . . 0.0 110.336 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.451 ' O ' ' HB3' ' A' ' 5' ' ' GLN . 0.0 OUTLIER 63.75 133.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.253 -0.905 . . . . 0.0 110.32 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.468 ' N ' ' CD ' ' A' ' 5' ' ' GLN . 0.4 OUTLIER -179.37 31.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.325 -0.859 . . . . 0.0 110.093 179.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 tp -145.6 171.53 14.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.293 -0.879 . . . . 0.0 110.208 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.406 ' HD3' ' O ' ' A' ' 7' ' ' LYS . 2.8 tmtt? -95.34 26.84 3.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 110.255 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.34 146.88 6.41 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.44 27.71 1.22 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -1.141 . . . . 0.0 110.204 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.64 157.04 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.192 -0.943 . . . . 0.0 110.184 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -146.09 -74.2 0.22 Allowed 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.135 -0.978 . . . . 0.0 110.131 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.521 ' O ' ' CE ' ' A' ' 46' ' ' LYS . 2.8 t -139.33 -128.35 0.12 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.049 -1.032 . . . . 0.0 109.938 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.92 100.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.992 -1.067 . . . . 0.0 109.62 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.592 ' HB3' ' CE1' ' A' ' 38' ' ' TYR . 1.7 m -86.22 126.04 33.98 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.224 -0.923 . . . . 0.0 110.035 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.539 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 0.6 OUTLIER -126.85 15.28 7.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -0.909 . . . . 0.0 111.129 -179.227 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.596 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -69.94 -96.04 0.05 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.56 ' CD ' ' HA3' ' A' ' 97' ' ' GLY . 1.1 ttmt -149.4 161.27 42.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.04 -1.271 . . . . 0.0 109.833 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.002 ' CE2' HG23 ' A' ' 47' ' ' ILE . 50.3 m-85 -126.36 147.82 49.69 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.866 -1.146 . . . . 0.0 111.584 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.481 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 15.0 ttpp -114.15 115.88 28.21 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.595 -0.69 . . . . 0.0 109.161 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.717 ' CG2' HD13 ' A' ' 99' ' ' LEU . 43.5 t -59.63 123.03 11.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 120.541 -1.349 . . . . 0.0 109.049 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.839 HG21 ' HB3' ' A' ' 76' ' ' PRO . 53.2 t -96.82 -26.02 4.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.584 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 4.0 tttp -158.63 133.56 8.34 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -52.17 157.82 1.28 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.524 0.678 . . . . 0.0 111.063 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.798 HG13 HD13 ' A' ' 90' ' ' ILE . 0.6 OUTLIER -48.85 132.72 6.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.132 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 1.046 ' HB3' ' HB ' ' A' ' 33' ' ' VAL . . . -102.8 169.86 8.35 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 7.0 pm0 -113.54 132.24 55.78 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.924 -1.11 . . . . 0.0 110.519 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.547 HG21 ' CD ' ' A' ' 80' ' ' GLU . 11.1 p -90.1 178.76 6.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.408 -0.807 . . . . 0.0 109.865 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -95.62 31.87 1.94 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.168 -0.957 . . . . 0.0 110.183 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.88 10.42 2.41 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.256 -0.902 . . . . 0.0 110.315 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.35 -0.86 60.17 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.922 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -96.04 -177.17 3.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.274 -1.133 . . . . 0.0 110.291 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.81 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -140.22 178.95 2.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.616 -1.254 . . . . 0.0 107.616 178.175 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.046 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 64.8 t -138.92 124.01 21.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 118.909 -1.117 . . . . 0.0 111.838 -178.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.107 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -106.69 115.16 47.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.203 -0.936 . . . . 0.0 109.974 179.132 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.584 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -98.94 118.17 35.11 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.815 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.5 m -145.04 155.31 13.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.342 -0.848 . . . . 0.0 109.032 -178.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.523 ' CG ' ' O ' ' A' ' 74' ' ' ASP 0.252 0.2 OUTLIER -103.5 123.41 46.84 Favored 'General case' 0 C--N 1.272 -2.776 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.277 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.75 ' HB2' HG21 ' A' ' 70' ' ' VAL . 23.8 t80 -60.37 120.57 10.13 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 118.783 -1.167 . . . . 0.0 110.481 -178.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 17' ' ' LYS . 4.1 mt-10 -91.56 -26.09 18.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.466 -0.771 . . . . 0.0 109.321 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.596 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -63.75 -161.3 0.38 Allowed Glycine 0 N--CA 1.484 1.834 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.52 ' N ' ' OH ' ' A' ' 38' ' ' TYR . 15.8 p-10 -127.55 134.76 49.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.511 -0.994 . . . . 0.0 110.162 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 43' ' ' SER . . . 171.83 -23.4 0.08 OUTLIER Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.458 -1.353 . . . . 0.0 110.575 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.612 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.6 OUTLIER 61.42 -154.38 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.688 -1.478 . . . . 0.0 108.096 -179.541 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.612 ' HD2' ' CB ' ' A' ' 43' ' ' SER . 87.6 Cg_exo -42.24 96.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -0.994 0 N-CA-C 109.042 -1.176 . . . . 0.0 109.042 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.959 ' O ' HG23 ' A' ' 69' ' ' ILE . 31.5 p -151.47 -178.8 6.89 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.919 -0.488 . . . . 0.0 109.864 -177.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.635 ' O ' HD13 ' A' ' 47' ' ' ILE . 12.0 mtpt -94.57 170.17 9.67 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.975 -1.078 . . . . 0.0 111.305 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.07 ' CD1' HG23 ' A' ' 70' ' ' VAL . 11.6 mm -122.84 130.41 24.63 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.444 -0.785 . . . . 0.0 112.384 -177.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.623 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 38.1 Cg_exo -64.16 143.01 82.76 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 124.197 1.63 . . . . 0.0 110.793 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 1.006 ' CZ ' HG23 ' A' ' 90' ' ' ILE . 16.5 t80 -152.99 162.17 41.65 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.288 -0.883 . . . . 0.0 110.501 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.822 ' HG2' HD12 ' A' ' 91' ' ' ILE . 37.2 tt0 178.61 89.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.131 -0.981 . . . . 0.0 110.459 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 1.06 HD11 ' HB1' ' A' ' 81' ' ' ALA . 6.7 mt -61.14 -51.36 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.175 -0.953 . . . . 0.0 109.958 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.562 ' HA ' ' CG ' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -136.41 -66.98 0.52 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.891 . . . . 0.0 110.05 179.845 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.493 ' HB2' ' HG3' ' A' ' 50' ' ' GLU . 0.4 OUTLIER 61.76 -158.77 0.32 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.389 179.784 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.7 mt -75.12 0.2 17.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.379 -0.826 . . . . 0.0 110.329 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.401 ' C ' ' HD3' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -83.7 -18.02 39.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.357 -0.839 . . . . 0.0 109.486 179.814 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.562 ' CG ' ' HA ' ' A' ' 52' ' ' MET . 3.6 mmtm -117.31 -45.74 2.72 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.413 -0.804 . . . . 0.0 110.014 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 3.6 tpp180 -179.75 -142.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.305 -0.872 . . . . 0.0 109.978 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -70.17 -162.92 0.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.288 -0.883 . . . . 0.0 110.085 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 59' ' ' VAL . 27.7 m -91.48 123.16 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.155 -0.966 . . . . 0.0 110.157 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.478 ' HA ' HD23 ' A' ' 60' ' ' LEU . 18.9 mt -140.02 -56.28 0.55 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.209 -0.932 . . . . 0.0 110.348 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 83' ' ' PRO . . . -70.13 157.39 53.52 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -140.35 167.45 22.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -1.052 . . . . 0.0 109.985 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.884 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -117.28 120.68 38.98 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.382 -0.824 . . . . 0.0 108.928 179.414 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.922 HG12 HG21 ' A' ' 31' ' ' THR . 1.4 mp -81.6 -29.88 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.814 ' C ' HD12 ' A' ' 63' ' ' LEU 0.266 1.5 m -97.74 36.79 1.47 Allowed 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.807 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.884 HG23 ' O ' ' A' ' 63' ' ' LEU . 24.2 t -29.16 119.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.279 -178.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.502 ' OD1' ' HE3' ' A' ' 46' ' ' LYS . 3.8 t-20 59.62 69.1 1.34 Allowed Pre-proline 0 C--N 1.298 -1.632 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.969 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.676 ' HG3' HG23 ' A' ' 79' ' ' ILE . 5.3 Cg_exo -65.41 171.27 9.57 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.044 1.549 . . . . 0.0 109.575 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.959 HG23 ' O ' ' A' ' 45' ' ' CYS . 1.1 mt -145.56 141.22 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 118.99 -1.084 . . . . 0.0 112.264 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.07 HG23 ' CD1' ' A' ' 47' ' ' ILE . 46.2 t -93.07 165.54 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.438 ' O ' ' HD3' ' A' ' 44' ' ' PRO . 2.2 m -118.44 -24.34 6.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.782 -1.199 . . . . 0.0 111.113 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.526 ' O ' ' HB3' ' A' ' 73' ' ' LYS . 2.5 mt-10 -131.37 13.84 5.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.941 -1.099 . . . . 0.0 110.711 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.526 ' HB3' ' O ' ' A' ' 72' ' ' GLU . 14.3 ttpt 74.78 -10.69 1.15 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.657 -0.652 . . . . 0.0 111.074 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.523 ' O ' ' CG ' ' A' ' 37' ' ' GLN . 8.2 t0 -134.07 -3.24 2.82 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.971 -1.081 . . . . 0.0 110.359 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 77' ' ' VAL . 12.7 t -72.83 112.51 15.54 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.179 -0.951 . . . . 0.0 109.286 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.839 ' HB3' HG21 ' A' ' 21' ' ' VAL . 34.3 Cg_exo -51.04 111.41 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.858 1.452 . . . . 0.0 109.899 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 75' ' ' SER . 98.5 t -96.01 144.34 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.353 -0.842 . . . . 0.0 111.166 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.625 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.9 m120 -100.04 130.51 46.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.534 -0.729 . . . . 0.0 109.5 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.707 HG21 ' CD1' ' A' ' 49' ' ' PHE . 5.5 mt -109.66 116.21 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 117.902 -1.519 . . . . 0.0 110.912 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.778 ' OE1' HG22 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -84.08 117.25 23.32 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.812 179.476 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 1.06 ' HB1' HD11 ' A' ' 51' ' ' ILE . . . -135.92 146.85 47.78 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.959 -1.088 . . . . 0.0 111.248 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.629 ' HB2' HG23 ' A' ' 31' ' ' THR . 29.2 tt0 -106.09 86.93 2.19 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.452 -0.78 . . . . 0.0 110.727 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.672 ' HG3' HD11 ' A' ' 32' ' ' ILE . 56.8 Cg_endo -75.12 160.57 39.6 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.812 1.428 . . . . 0.0 110.348 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 85' ' ' PHE . 12.5 Cg_endo -61.32 -157.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.963 1.507 . . . . 0.0 110.0 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.459 ' O ' ' N ' ' A' ' 87' ' ' ASP . 1.9 m-85 -45.41 170.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.992 -1.067 . . . . 0.0 109.95 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.552 ' HA3' ' CB ' ' A' ' 105' ' ' LYS . . . -63.2 80.87 0.04 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.46 ' O ' ' OD1' ' A' ' 87' ' ' ASP . 10.7 p30 176.44 81.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.393 -1.063 . . . . 0.0 109.537 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.559 ' O ' ' CD1' ' A' ' 89' ' ' TYR . 0.6 OUTLIER -151.6 -162.22 1.49 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.35 -0.844 . . . . 0.0 110.6 -179.237 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.559 ' CD1' ' O ' ' A' ' 88' ' ' SER . 15.8 m-85 -151.64 104.49 3.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.681 -0.637 . . . . 0.0 109.716 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.006 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 2.1 mp -74.09 108.29 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.926 . . . . 0.0 109.907 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.822 HD12 ' HG2' ' A' ' 50' ' ' GLU . 94.9 mt -89.17 142.53 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -0.899 . . . . 0.0 110.045 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.107 HD11 HG21 ' A' ' 34' ' ' ILE . 1.5 mt -133.24 141.0 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.4 -0.812 . . . . 0.0 110.111 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' A' ' 48' ' ' PRO . . . 80.59 -155.99 38.19 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' ' 15' ' ' THR . 0.1 OUTLIER -130.45 154.75 41.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.062 -1.258 . . . . 0.0 111.226 -179.394 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.568 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 1.7 mm-40 -28.44 -55.12 0.25 Allowed Pre-proline 0 N--CA 1.499 2.02 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.635 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 86.8 Cg_exo -34.02 -30.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.993 1.522 . . . . 0.0 111.011 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.56 ' HA3' ' CD ' ' A' ' 17' ' ' LYS . . . 179.34 37.83 0.07 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.371 -1.892 . . . . 0.0 108.371 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.524 ' HB2' ' N ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -72.15 160.3 32.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.807 -0.819 . . . . 0.0 110.881 -179.05 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.717 HD13 ' CG2' ' A' ' 20' ' ' VAL . 9.4 mt -101.16 179.29 4.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.392 -0.818 . . . . 0.0 110.139 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.706 ' C ' HD12 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -156.8 135.48 11.6 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.337 -0.852 . . . . 0.0 110.456 179.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.706 HD12 ' C ' ' A' ' 100' ' ' LYS . 5.7 mp -137.17 118.8 14.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.371 -0.831 . . . . 0.0 109.737 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.548 ' HA ' ' O ' ' A' ' 88' ' ' SER . 4.7 p-10 -88.25 131.94 34.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.853 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.457 ' HA ' ' CE3' ' A' ' 103' ' ' TRP . 3.5 t-105 -110.9 126.29 54.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.101 -1.0 . . . . 0.0 110.265 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.506 ' O ' ' CG ' ' A' ' 105' ' ' LYS . 0.1 OUTLIER -115.09 152.31 32.75 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.263 -0.898 . . . . 0.0 110.241 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.552 ' CB ' ' HA3' ' A' ' 86' ' ' GLY . 0.0 OUTLIER 169.03 105.22 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.302 -0.873 . . . . 0.0 110.247 -179.871 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.453 ' O ' ' O ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -58.47 -152.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.271 -0.893 . . . . 0.0 110.218 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -114.05 53.75 0.59 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.3 m 52.64 -144.19 0.65 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.246 -1.149 . . . . 0.0 110.225 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.1 m -163.14 70.28 0.24 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.176 -0.953 . . . . 0.0 110.198 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.23 -34.27 3.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.339 -0.85 . . . . 0.0 110.172 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -45.57 147.02 0.94 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.26 -0.9 . . . . 0.0 110.253 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.79 -160.6 0.75 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 0.0 110.233 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -150.1 -162.12 1.49 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.212 -0.93 . . . . 0.0 110.12 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -164.72 58.05 0.13 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 110.31 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -76.05 -163.5 0.3 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.26 -0.9 . . . . 0.0 110.183 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -111.81 -179.74 3.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.222 -0.924 . . . . 0.0 110.206 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.193 -179.976 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.194 0.521 . . . . 0.0 110.179 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.16 -13.14 61.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 0.0 110.187 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -80.02 66.44 5.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 110.236 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.42 ' O ' ' HB2' ' A' ' 5' ' ' GLN . 1.6 pp -46.43 157.86 0.12 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -0.887 . . . . 0.0 110.288 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.42 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 0.4 OUTLIER 174.97 52.89 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 110.182 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.99 150.12 21.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 0.0 110.246 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.0 tttt -110.98 -32.47 6.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.93 . . . . 0.0 110.196 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.66 8.97 73.13 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 56.65 175.73 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.197 -1.179 . . . . 0.0 110.18 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.557 ' HA ' ' CE ' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -136.43 169.36 17.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.916 . . . . 0.0 110.205 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.07 -72.69 0.54 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.22 -0.925 . . . . 0.0 109.868 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.431 ' O ' ' HB3' ' A' ' 13' ' ' MET . 3.2 t -137.24 -2.31 2.05 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.158 -0.964 . . . . 0.0 110.721 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.512 ' HG2' HG23 ' A' ' 15' ' ' THR . 0.9 OUTLIER 55.45 79.98 0.14 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.97 -1.081 . . . . 0.0 108.575 -179.333 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.574 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 22.6 m -52.55 98.07 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.377 -0.827 . . . . 0.0 109.435 -178.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.512 HG23 ' HG2' ' A' ' 13' ' ' MET . 0.9 OUTLIER -86.65 -9.1 56.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.464 -0.773 . . . . 0.0 111.935 -178.359 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.584 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -59.55 -124.46 0.01 OUTLIER Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.489 -1.339 . . . . 0.0 109.84 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.552 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -135.75 173.86 11.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.018 -1.283 . . . . 0.0 109.99 -179.568 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.017 ' CE2' HG23 ' A' ' 47' ' ' ILE . 34.6 m-85 -133.44 136.89 45.47 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.969 -1.082 . . . . 0.0 111.51 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.467 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 23.4 ttpt -108.21 120.54 42.66 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.627 -0.671 . . . . 0.0 109.366 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.484 HG22 HD13 ' A' ' 99' ' ' LEU . 34.5 t -59.76 131.49 24.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.85 -1.156 . . . . 0.0 109.043 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.641 HG23 ' HA ' ' A' ' 36' ' ' VAL . 92.3 t -105.28 -26.39 3.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 1.8 tttp -157.37 133.61 9.65 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -51.94 159.58 0.84 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.723 0.773 . . . . 0.0 111.327 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.832 HG12 HD22 ' A' ' 101' ' ' LEU . 0.7 OUTLIER -55.79 132.04 19.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-O 121.577 0.703 . . . . 0.0 110.476 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' A' ' 33' ' ' VAL . . . -109.57 158.95 17.51 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.498 ' N ' ' OE1' ' A' ' 26' ' ' GLU . 7.0 pm0 -110.43 133.35 53.36 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 120.166 -1.584 . . . . 0.0 110.494 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.893 HG21 ' OE2' ' A' ' 80' ' ' GLU . 2.8 p -92.14 169.5 10.57 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.567 -0.708 . . . . 0.0 110.216 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.88 -16.34 60.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 110.538 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -80.41 0.47 33.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.085 -1.009 . . . . 0.0 110.34 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.73 8.1 60.99 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.888 HG22 ' C ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -98.39 175.34 6.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.314 -1.11 . . . . 0.0 110.381 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 1.008 HD13 ' CD1' ' A' ' 103' ' ' TRP . 0.0 OUTLIER -129.17 141.86 45.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.764 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.57 ' N ' ' O ' ' A' ' 25' ' ' ALA . 24.6 t -109.6 132.53 57.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 O-C-N 121.441 -0.787 . . . . 0.0 111.847 -177.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.081 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -118.28 121.29 66.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.435 -0.791 . . . . 0.0 109.413 178.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.574 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -105.67 111.19 23.78 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.866 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.5 m -131.09 -168.12 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.474 ' N ' HG23 ' A' ' 36' ' ' VAL . 4.2 tt0 -135.86 128.2 30.22 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.896 ' HB2' HG21 ' A' ' 70' ' ' VAL . 1.7 t80 -60.25 124.01 18.96 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 118.633 -1.227 . . . . 0.0 110.032 -178.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 17' ' ' LYS . 2.4 mm-40 -116.61 86.19 2.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -0.887 . . . . 0.0 110.09 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.584 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 165.0 -150.38 18.24 Favored Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.425 -1.369 . . . . 0.0 109.986 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.462 ' O ' ' OH ' ' A' ' 38' ' ' TYR . 0.5 OUTLIER -113.24 128.62 56.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.665 -0.903 . . . . 0.0 110.408 -179.75 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 43' ' ' SER . . . 177.77 -26.71 0.06 OUTLIER Glycine 0 N--CA 1.487 2.087 0 C-N-CA 119.555 -1.307 . . . . 0.0 110.57 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.599 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.5 OUTLIER 48.94 -154.89 0.01 OUTLIER Pre-proline 0 N--CA 1.487 1.378 0 O-C-N 120.706 -1.467 . . . . 0.0 107.779 -179.58 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.599 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 53.3 Cg_exo -46.84 94.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.259 0 N-CA-C 108.241 -1.484 . . . . 0.0 108.241 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.719 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -148.97 173.15 13.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.615 -0.678 . . . . 0.0 109.853 -177.681 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.704 ' HG3' HD11 ' A' ' 69' ' ' ILE . 28.5 mttm -87.82 175.13 7.97 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.309 -0.87 . . . . 0.0 111.61 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.07 HD11 ' CG2' ' A' ' 70' ' ' VAL . 16.0 mm -119.92 128.82 25.66 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.499 -0.75 . . . . 0.0 112.237 -177.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.62 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 29.8 Cg_exo -65.31 144.75 81.61 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 121.593 1.529 . . . . 0.0 110.993 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.638 ' CD1' HG21 ' A' ' 79' ' ' ILE . 10.9 t80 -155.69 159.01 39.19 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.226 -0.921 . . . . 0.0 110.088 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.758 ' HG2' HD12 ' A' ' 91' ' ' ILE . 21.3 tt0 -175.17 114.54 0.15 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.981 -1.074 . . . . 0.0 110.496 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.995 HG21 ' HB3' ' A' ' 83' ' ' PRO . 10.0 mt -107.46 103.29 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.28 -0.887 . . . . 0.0 110.057 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.535 ' O ' HG21 ' A' ' 59' ' ' VAL . 1.8 mtt -141.48 -66.68 0.41 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.24 -0.913 . . . . 0.0 110.209 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 52' ' ' MET . 0.1 OUTLIER 172.95 -160.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.257 -0.902 . . . . 0.0 110.236 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -45.32 -73.19 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.313 -0.867 . . . . 0.0 110.246 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.462 ' O ' ' CG ' ' A' ' 56' ' ' LYS . 3.4 mm-40 -93.6 -64.97 1.03 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.344 -0.847 . . . . 0.0 110.221 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.462 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 2.9 mtpp 173.36 85.37 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.315 -0.865 . . . . 0.0 110.174 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.95 18.21 6.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.232 -0.918 . . . . 0.0 110.183 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.449 ' HA ' ' SD ' ' A' ' 52' ' ' MET . 34.4 m80 49.32 89.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.906 . . . . 0.0 110.162 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.695 ' O ' HD12 ' A' ' 60' ' ' LEU . 24.8 t -101.06 -113.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.314 -0.866 . . . . 0.0 110.077 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.695 HD12 ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER 174.23 65.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.887 -1.133 . . . . 0.0 110.186 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.534 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -103.32 170.68 19.74 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.493 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -122.91 164.27 18.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.13 -1.217 . . . . 0.0 110.65 -179.65 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.821 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -129.73 110.84 12.09 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.569 -0.707 . . . . 0.0 109.529 179.109 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.873 ' CG1' HG21 ' A' ' 31' ' ' THR . 5.5 mm -69.02 -33.34 58.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 122.342 1.068 . . . . 0.0 108.328 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.638 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.259 0.7 OUTLIER -100.99 31.33 3.65 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.375 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 63' ' ' LEU . 42.7 t -15.03 109.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.927 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.524 ' ND2' ' HD3' ' A' ' 46' ' ' LYS . 19.2 t-20 47.12 69.25 2.8 Favored Pre-proline 0 C--N 1.3 -1.58 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.785 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.561 ' O ' ' HA ' ' A' ' 46' ' ' LYS . 3.0 Cg_endo -50.06 -176.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.074 1.565 . . . . 0.0 109.538 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.719 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.7 OUTLIER -141.96 144.09 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 119.171 -1.012 . . . . 0.0 112.171 -178.869 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.07 ' CG2' HD11 ' A' ' 47' ' ' ILE . 21.5 t -100.97 166.29 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.9 m -123.84 -15.41 6.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.745 -1.222 . . . . 0.0 111.166 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 26.1 mt-10 -140.03 14.48 2.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.929 -1.107 . . . . 0.0 111.016 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.1 OUTLIER 74.34 -9.83 1.23 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.42 -0.8 . . . . 0.0 111.006 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.476 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 6.9 t70 -135.96 0.18 2.61 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.932 -1.105 . . . . 0.0 110.059 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.499 ' O ' HG23 ' A' ' 77' ' ' VAL . 22.0 t -72.54 108.21 4.05 Favored Pre-proline 0 N--CA 1.486 1.344 0 O-C-N 121.201 -0.937 . . . . 0.0 108.826 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.624 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 5.6 Cg_exo -45.07 130.71 10.72 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.757 1.398 . . . . 0.0 110.117 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.889 HG21 HG22 ' A' ' 70' ' ' VAL . 74.8 t -115.35 145.03 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.041 -1.037 . . . . 0.0 111.351 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.694 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.0 m-20 -106.52 133.25 51.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.516 -0.74 . . . . 0.0 109.597 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.663 ' HB ' HG22 ' A' ' 34' ' ' ILE . 3.6 mt -118.15 118.86 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 117.65 -1.62 . . . . 0.0 111.364 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.893 ' OE2' HG21 ' A' ' 27' ' ' THR . 1.7 tp10 -94.45 109.77 21.62 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.888 ' C ' HG22 ' A' ' 31' ' ' THR . . . -118.24 147.34 43.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.041 -1.037 . . . . 0.0 110.774 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.583 ' HB2' HG23 ' A' ' 31' ' ' THR . 4.6 tt0 -112.37 58.64 0.55 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.45 -0.781 . . . . 0.0 111.051 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.995 ' HB3' HG21 ' A' ' 51' ' ' ILE . 37.1 Cg_endo -69.73 162.02 43.66 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.727 1.383 . . . . 0.0 110.63 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.503 ' HD3' ' HA2' ' A' ' 61' ' ' GLY . 23.4 Cg_exo -59.19 -145.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.096 1.577 . . . . 0.0 110.594 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -145.81 176.86 9.34 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.198 -0.939 . . . . 0.0 110.345 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.56 ' O ' ' CA ' ' A' ' 105' ' ' LYS . . . 113.6 -83.4 0.33 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.556 ' N ' ' HB3' ' A' ' 104' ' ' PHE . 11.5 t0 -170.81 119.83 0.53 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.04 -1.271 . . . . 0.0 109.549 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.616 ' HB2' ' CG ' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -155.68 -155.34 0.55 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.968 -1.083 . . . . 0.0 111.384 -179.387 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.57 ' CE1' ' OD1' ' A' ' 102' ' ' ASN . 85.3 m-85 -156.09 110.91 2.88 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.131 0.491 . . . . 0.0 109.842 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.855 HD11 HD12 ' A' ' 32' ' ' ILE . 88.1 mt -73.71 134.16 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.179 -0.951 . . . . 0.0 109.475 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.758 HD12 ' HG2' ' A' ' 50' ' ' GLU . 57.5 mt -106.42 145.71 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.122 -0.987 . . . . 0.0 110.981 -179.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.081 HD11 HG21 ' A' ' 34' ' ' ILE . 1.9 mt -132.77 139.21 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.538 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 83.22 -159.52 37.35 Favored Glycine 0 N--CA 1.481 1.665 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.55 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -123.86 150.08 28.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 121.183 -1.187 . . . . 0.0 110.194 -179.568 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.574 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.7 OUTLIER -19.1 -57.47 0.05 OUTLIER Pre-proline 0 N--CA 1.5 2.045 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 10.3 Cg_endo -53.18 70.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 124.214 1.639 . . . . 0.0 111.952 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 90.76 5.11 69.0 Favored Glycine 0 N--CA 1.494 2.531 0 O-C-N 121.012 -1.055 . . . . 0.0 110.985 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.503 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -51.46 160.77 0.55 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.998 -1.295 . . . . 0.0 110.187 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' A' ' 18' ' ' PHE . 8.4 mt -97.52 177.4 5.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.214 -0.929 . . . . 0.0 110.35 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -159.14 141.35 13.77 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.266 -0.896 . . . . 0.0 110.456 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.832 HD22 HG12 ' A' ' 24' ' ' ILE . 3.0 mp -141.11 120.82 13.4 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.242 -0.911 . . . . 0.0 110.239 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.57 ' OD1' ' CE1' ' A' ' 89' ' ' TYR . 4.0 t30 -72.13 131.2 42.49 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.292 -0.88 . . . . 0.0 110.7 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 1.008 ' CD1' HD13 ' A' ' 32' ' ' ILE . 6.9 t-105 -141.22 -143.94 0.16 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.823 -1.173 . . . . 0.0 111.193 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.616 ' CG ' ' HB2' ' A' ' 88' ' ' SER . 7.5 m-85 67.64 -82.43 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -178.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.56 ' CA ' ' O ' ' A' ' 86' ' ' GLY . 5.9 mtmt 63.02 170.49 0.15 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.86 -1.15 . . . . 0.0 110.295 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.58 125.34 30.27 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.913 . . . . 0.0 110.188 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -161.78 83.29 0.12 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 98.6 p -67.37 129.39 39.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.275 -1.132 . . . . 0.0 110.167 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.14 -36.54 3.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.317 -0.865 . . . . 0.0 110.11 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 110' ' ' LEU . 0.7 OUTLIER -134.01 37.32 3.22 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.339 -0.85 . . . . 0.0 110.179 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -139.41 114.42 9.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.255 -0.903 . . . . 0.0 110.251 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.8 26.85 0.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.899 . . . . 0.0 110.167 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.415 ' CD2' ' NE2' ' A' ' 115' ' ' HIS . 7.3 p-80 -140.8 179.16 6.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 0.0 110.236 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.38 136.67 46.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.906 . . . . 0.0 110.219 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.415 ' NE2' ' CD2' ' A' ' 113' ' ' HIS . 48.3 m170 -94.15 155.82 16.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 110.134 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 58.09 -179.33 0.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 110.077 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 23.5 m170 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.188 -179.982 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.416 ' O ' ' OD1' ' A' ' 2' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.226 0.536 . . . . 0.0 110.205 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 1' ' ' MET . 0.6 OUTLIER -149.74 -60.91 0.21 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.278 -0.889 . . . . 0.0 110.191 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.3 mmtm -120.58 -24.67 5.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.256 -0.903 . . . . 0.0 110.201 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.451 ' O ' ' HB3' ' A' ' 5' ' ' GLN . 0.9 OUTLIER -139.02 -171.33 3.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 110.238 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.463 ' O ' ' O ' ' A' ' 6' ' ' LEU . 3.5 pt20 178.54 42.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.314 -0.867 . . . . 0.0 110.218 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.524 HD22 HD22 ' A' ' 67' ' ' ASN . 1.1 mp 46.19 97.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.358 -0.839 . . . . 0.0 110.387 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -109.73 124.29 50.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -0.889 . . . . 0.0 110.25 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.89 156.12 8.39 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.63 -10.61 19.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.206 -1.173 . . . . 0.0 110.223 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 44' ' ' PRO . 61.4 p -143.23 37.97 1.4 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.266 -0.896 . . . . 0.0 110.122 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.605 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 0.3 OUTLIER -171.75 35.12 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.236 -0.915 . . . . 0.0 109.366 -179.699 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.554 ' HA ' ' HD3' ' A' ' 46' ' ' LYS . 2.7 t -147.33 -35.99 0.23 Allowed 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.843 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.44 ' O ' ' N ' ' A' ' 15' ' ' THR . 7.7 tmm? -160.95 87.54 0.73 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.141 -0.974 . . . . 0.0 111.137 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 4.0 m -52.3 96.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.043 -1.036 . . . . 0.0 109.003 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 16' ' ' GLY . 49.4 p -64.56 -11.31 33.24 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.491 -0.756 . . . . 0.0 111.33 -178.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.537 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -60.08 -145.97 0.01 OUTLIER Glycine 0 N--CA 1.481 1.675 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.546 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -127.91 174.42 9.18 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.299 -1.118 . . . . 0.0 109.345 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.075 ' CE2' HG23 ' A' ' 47' ' ' ILE . 46.9 m-85 -131.24 133.62 45.63 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.743 -1.223 . . . . 0.0 112.099 -179.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -108.01 121.62 45.17 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.575 ' CG2' HD13 ' A' ' 99' ' ' LEU . 48.0 t -59.66 130.39 23.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.196 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.626 HG23 ' HA ' ' A' ' 36' ' ' VAL . 69.7 t -105.21 -26.91 3.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.566 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 19.6 tttt -156.32 133.06 10.3 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.15 155.95 1.77 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.542 0.687 . . . . 0.0 111.215 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.69 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -50.98 132.51 12.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.536 -0.727 . . . . 0.0 109.862 179.839 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.83 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -107.23 170.58 7.87 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 5.2 pm0 -116.36 130.58 56.84 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.809 -1.182 . . . . 0.0 110.569 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.94 HG21 ' OE2' ' A' ' 80' ' ' GLU . 14.5 p -89.2 173.93 8.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.361 -0.837 . . . . 0.0 110.056 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -88.07 29.2 0.96 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.154 -0.966 . . . . 0.0 110.472 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -132.25 6.19 4.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.16 -0.962 . . . . 0.0 110.291 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.77 -2.46 60.3 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.996 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -92.54 -178.14 4.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.303 -1.116 . . . . 0.0 110.384 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.83 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -139.18 158.46 28.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.568 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.81 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 73.6 t -123.08 128.15 74.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 C-N-CA 118.933 -1.107 . . . . 0.0 112.372 -177.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.054 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -111.24 118.47 57.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 121.357 -0.84 . . . . 0.0 109.716 178.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.566 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 2.9 ttm180 -104.71 114.65 29.0 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.765 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.6 m -133.46 -168.46 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 O-C-N 121.469 -0.769 . . . . 0.0 109.31 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.478 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 9.8 tt0 -135.14 126.25 27.93 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.94 ' HB2' HG21 ' A' ' 70' ' ' VAL . 1.5 t80 -61.04 127.32 30.95 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.975 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 17' ' ' LYS . 3.5 mt-10 -125.28 89.63 3.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.044 -1.035 . . . . 0.0 110.172 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.537 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 162.45 -151.69 21.69 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.51 ' HA ' ' HD2' ' A' ' 73' ' ' LYS . 11.1 t0 -107.48 118.23 36.18 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.565 -0.962 . . . . 0.0 110.217 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.06 -36.48 0.04 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.601 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER 52.43 -158.15 0.01 OUTLIER Pre-proline 0 C--N 1.305 -1.346 0 O-C-N 120.945 -1.327 . . . . 0.0 108.665 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.601 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 76.2 Cg_exo -45.21 93.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.229 0 N-CA-C 109.376 -1.048 . . . . 0.0 109.376 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.735 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -154.92 175.65 13.52 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.611 -0.681 . . . . 0.0 109.811 -179.093 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.625 ' HG3' ' CD1' ' A' ' 69' ' ' ILE . 2.6 mttp -82.01 175.37 10.42 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.393 -0.817 . . . . 0.0 112.07 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.075 HG23 ' CE2' ' A' ' 18' ' ' PHE . 16.8 mm -120.03 128.01 26.07 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.636 -0.665 . . . . 0.0 111.672 -178.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.632 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 34.2 Cg_exo -63.06 145.1 93.84 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 124.043 1.549 . . . . 0.0 110.495 178.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.874 ' CD2' HG21 ' A' ' 79' ' ' ILE . 5.4 t80 -154.11 162.45 41.18 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.268 -0.895 . . . . 0.0 110.101 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.878 ' O ' HD12 ' A' ' 91' ' ' ILE . 7.0 tp10 -179.19 97.88 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.192 -0.943 . . . . 0.0 110.03 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 1.079 HD11 ' HB1' ' A' ' 81' ' ' ALA . 16.1 mt -77.99 6.05 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.161 -0.962 . . . . 0.0 110.575 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.575 ' HA ' ' CG ' ' A' ' 56' ' ' LYS . 2.2 mpp? -142.88 -55.16 0.41 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.089 -1.007 . . . . 0.0 110.182 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.663 ' HB2' HD13 ' A' ' 91' ' ' ILE . 22.1 t0 70.85 20.55 5.43 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.27 -0.894 . . . . 0.0 110.373 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.515 ' CB ' ' O ' ' A' ' 53' ' ' ASP . 0.9 OUTLIER 71.63 -0.62 3.09 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.272 -0.893 . . . . 0.0 110.746 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -98.32 -0.61 43.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.15 -0.969 . . . . 0.0 110.237 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.608 ' HE3' ' CD1' ' A' ' 89' ' ' TYR . 0.6 OUTLIER -111.1 58.98 0.61 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.178 -0.951 . . . . 0.0 110.184 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.415 ' O ' ' HB2' ' A' ' 58' ' ' HIS . 0.3 OUTLIER -60.4 96.63 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 110.265 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.415 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 2.1 t60 178.26 -48.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.256 -0.902 . . . . 0.0 110.202 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.2 m -139.65 -155.56 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.285 -0.884 . . . . 0.0 110.176 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -158.88 117.31 2.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.302 -0.874 . . . . 0.0 110.237 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.51 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . -83.67 179.39 52.33 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.528 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -137.75 168.29 19.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.197 -1.178 . . . . 0.0 110.416 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.843 HD12 ' N ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -122.59 122.68 39.43 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.581 -0.699 . . . . 0.0 109.295 179.161 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.996 HG12 HG21 ' A' ' 31' ' ' THR . 1.4 mp -85.3 -30.73 6.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.825 HG22 ' O ' ' A' ' 65' ' ' THR 0.262 2.9 m -107.75 42.87 1.27 Allowed 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.258 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.843 ' N ' HD12 ' A' ' 63' ' ' LEU . 18.7 t -30.07 121.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-O 121.604 0.716 . . . . 0.0 111.503 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.524 HD22 HD22 ' A' ' 6' ' ' LEU . 12.9 t-20 43.09 71.91 1.31 Allowed Pre-proline 0 C--N 1.297 -1.683 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.617 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.796 ' HG3' HG23 ' A' ' 79' ' ' ILE . 1.1 Cg_endo -56.0 -171.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.909 1.479 . . . . 0.0 108.967 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.735 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.8 OUTLIER -143.6 148.01 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 119.041 -1.064 . . . . 0.0 112.285 -179.241 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.004 ' CG2' HD11 ' A' ' 47' ' ' ILE . 54.3 t -104.79 164.69 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 176.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.3 m -118.89 -19.39 8.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.878 -1.139 . . . . 0.0 111.5 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.528 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 19.0 mt-10 -140.2 18.78 2.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.76 -1.213 . . . . 0.0 111.386 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.548 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 9.0 ttpt 72.61 -6.7 1.56 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.247 -0.908 . . . . 0.0 110.949 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.468 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 18.1 t0 -137.94 -2.2 1.92 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.0 -1.062 . . . . 0.0 110.33 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.553 ' O ' HG23 ' A' ' 77' ' ' VAL . 10.2 t -72.64 112.42 15.01 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.071 -1.018 . . . . 0.0 108.939 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.625 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 50.5 Cg_exo -47.82 128.2 15.64 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.9 1.474 . . . . 0.0 110.067 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.95 HG21 HG22 ' A' ' 70' ' ' VAL . 66.3 t -114.94 142.32 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.04 -1.038 . . . . 0.0 111.534 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.679 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.1 m-20 -104.99 133.43 49.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.468 -0.77 . . . . 0.0 109.312 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.874 HG21 ' CD2' ' A' ' 49' ' ' PHE . 5.5 mt -117.39 119.66 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.075 -1.641 . . . . 0.0 111.582 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.94 ' OE2' HG21 ' A' ' 27' ' ' THR . 1.9 tp10 -91.84 115.92 28.46 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.229 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 1.079 ' HB1' HD11 ' A' ' 51' ' ' ILE . . . -131.85 151.7 51.52 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.982 -1.074 . . . . 0.0 110.775 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.528 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 35.2 tt0 -100.76 103.09 22.18 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.234 -0.916 . . . . 0.0 110.247 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.536 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 42.8 Cg_endo -73.6 145.85 37.98 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.032 1.543 . . . . 0.0 110.655 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.51 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 43.8 Cg_endo -75.72 -160.17 0.1 Allowed 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.154 1.607 . . . . 0.0 110.256 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -97.52 149.21 22.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 110.069 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 105' ' ' LYS . . . 95.69 -159.73 22.4 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.88 137.24 36.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -1.162 . . . . 0.0 110.005 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 0.4 OUTLIER -141.41 150.83 42.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.218 -0.926 . . . . 0.0 110.534 -179.821 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 8.5 m-85 -129.88 108.49 10.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.348 -0.845 . . . . 0.0 110.044 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.734 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 1.7 mp -74.32 121.94 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.194 -0.941 . . . . 0.0 109.81 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.878 HD12 ' O ' ' A' ' 50' ' ' GLU . 3.2 mt -101.06 145.88 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.17 -0.956 . . . . 0.0 110.04 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.054 HD11 HG21 ' A' ' 34' ' ' ILE . 4.0 mt -132.73 146.18 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.465 -0.772 . . . . 0.0 110.359 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.544 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 78.74 -161.05 47.59 Favored Glycine 0 N--CA 1.484 1.896 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.528 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.1 OUTLIER -124.19 140.98 45.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.187 -1.184 . . . . 0.0 110.866 -179.632 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.559 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.8 OUTLIER -16.6 -58.97 0.04 OUTLIER Pre-proline 0 N--CA 1.505 2.309 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 24.4 Cg_exo -32.32 -32.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 124.013 1.533 . . . . 0.0 110.956 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.546 ' HA3' ' CG ' ' A' ' 17' ' ' LYS . . . -175.67 35.98 0.1 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.58 ' HG3' HG23 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -71.43 164.69 25.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.697 -0.884 . . . . 0.0 110.74 -179.247 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.575 HD13 ' CG2' ' A' ' 20' ' ' VAL . 8.2 mt -100.99 176.95 5.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.432 -0.793 . . . . 0.0 110.128 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.469 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -154.84 135.59 13.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.318 -0.864 . . . . 0.0 110.259 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.643 HD12 ' O ' ' A' ' 90' ' ' ILE . 2.4 mp -142.02 122.87 14.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.267 -0.895 . . . . 0.0 110.231 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.482 ' HA ' ' O ' ' A' ' 88' ' ' SER . 7.4 p-10 -86.02 131.31 34.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.15 -0.969 . . . . 0.0 110.241 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.4 ' O ' ' CB ' ' A' ' 104' ' ' PHE . 49.4 t-105 -141.48 169.68 17.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.949 . . . . 0.0 110.317 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.498 ' O ' ' CB ' ' A' ' 105' ' ' LYS . 0.2 OUTLIER 63.63 -163.14 0.27 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.301 -0.875 . . . . 0.0 110.235 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 86' ' ' GLY . 0.1 OUTLIER 169.42 -175.86 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.273 -0.892 . . . . 0.0 110.172 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.47 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 25.5 mtpt -58.23 -29.52 65.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.306 -0.871 . . . . 0.0 110.327 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -168.97 -169.72 32.7 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.67 -173.22 2.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -1.152 . . . . 0.0 110.171 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.5 m 50.25 -168.52 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.192 -0.942 . . . . 0.0 110.19 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.441 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -48.67 139.78 9.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 110.191 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -105.56 -62.79 1.31 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 110.324 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 57.99 69.53 0.73 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 110.19 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -168.23 -50.19 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.268 -0.895 . . . . 0.0 110.197 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -108.15 6.66 27.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.208 -0.932 . . . . 0.0 110.195 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.4 ' O ' ' CB ' ' A' ' 116' ' ' HIS . 0.0 OUTLIER -90.22 -4.21 57.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.864 . . . . 0.0 110.203 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.4 ' CB ' ' O ' ' A' ' 115' ' ' HIS . 4.4 t-160 63.03 86.3 0.12 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.292 -0.88 . . . . 0.0 110.15 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.201 179.904 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.433 ' O ' ' CB ' ' A' ' 2' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.211 0.529 . . . . 0.0 110.193 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.433 ' CB ' ' O ' ' A' ' 1' ' ' MET . 6.4 t0 64.62 -179.9 0.18 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.869 . . . . 0.0 110.233 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 2' ' ' ASP . 10.8 mttt 54.86 95.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.9 . . . . 0.0 110.329 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.747 ' O ' HD12 ' A' ' 4' ' ' LEU . 1.1 pp -132.09 53.93 1.97 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.306 -0.871 . . . . 0.0 110.135 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.9 35.17 3.57 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.304 -0.872 . . . . 0.0 110.231 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.1 mt -128.4 96.77 4.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 110.239 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.402 ' HE3' ' HA ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -121.79 86.66 2.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 110.271 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.42 155.14 25.07 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.514 ' O ' ' N ' ' A' ' 11' ' ' TYR . 1.5 ttt -90.29 -44.53 9.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.223 -1.163 . . . . 0.0 110.327 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.9 t 46.46 -92.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.279 -0.888 . . . . 0.0 110.104 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.571 ' CZ ' ' HB2' ' A' ' 44' ' ' PRO . 1.1 t80 -148.88 -74.88 0.17 Allowed 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.144 -0.973 . . . . 0.0 110.143 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.529 ' HB3' ' CB ' ' A' ' 45' ' ' CYS . 2.4 t -145.85 -127.89 0.07 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.201 -0.937 . . . . 0.0 109.509 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.522 ' O ' ' N ' ' A' ' 15' ' ' THR . 1.5 ptt? -178.55 97.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.94 -1.1 . . . . 0.0 110.394 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 56.4 m -60.44 80.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.884 . . . . 0.0 108.999 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 13' ' ' MET . 0.1 OUTLIER -83.35 -4.6 58.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.302 -0.874 . . . . 0.0 111.656 -178.553 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -61.23 -128.75 0.01 OUTLIER Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.544 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -123.24 176.29 6.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.235 -1.156 . . . . 0.0 109.971 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.98 ' CE2' HG23 ' A' ' 47' ' ' ILE . 34.4 m-85 -135.93 141.38 44.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.879 -1.138 . . . . 0.0 111.704 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -112.33 117.62 32.99 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.638 ' CG2' HD13 ' A' ' 99' ' ' LEU . 44.2 t -59.67 123.94 13.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 120.586 -1.321 . . . . 0.0 108.94 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.744 HG21 ' HB3' ' A' ' 76' ' ' PRO . 53.9 t -97.62 -26.63 3.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.605 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 18.8 tttt -157.17 133.21 9.56 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -50.62 161.69 0.31 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.694 0.759 . . . . 0.0 111.325 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.716 HG13 HD13 ' A' ' 90' ' ' ILE . 0.7 OUTLIER -55.83 132.64 19.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-O 121.716 0.769 . . . . 0.0 110.311 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.724 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -109.5 167.22 10.29 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 6.9 pm0 -113.91 130.37 56.51 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 120.595 -1.316 . . . . 0.0 110.681 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.534 HG22 HG23 ' A' ' 33' ' ' VAL . 8.4 p -81.72 -167.59 1.57 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.455 -0.778 . . . . 0.0 110.005 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -103.94 23.02 13.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 110.281 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -128.48 7.08 5.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.204 -0.935 . . . . 0.0 110.178 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.479 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 97.95 0.94 58.61 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.975 HG21 HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -91.93 -177.28 4.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.285 -1.127 . . . . 0.0 110.254 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.824 HD12 HD11 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -140.69 150.4 20.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.611 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.703 HG22 ' HG3' ' A' ' 80' ' ' GLU . 69.7 t -116.5 131.71 68.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 O-C-N 121.151 -0.968 . . . . 0.0 111.875 -178.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.075 HG21 HD11 ' A' ' 92' ' ' ILE . 0.4 OUTLIER -114.72 117.06 54.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.401 -0.812 . . . . 0.0 109.694 179.056 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.605 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -98.65 122.41 41.84 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.864 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.777 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.7 m -149.25 158.17 6.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.942 0.877 . . . . 0.0 109.022 -178.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.503 ' NE2' ' HD3' ' A' ' 76' ' ' PRO 0.256 2.7 tt0 -104.43 122.33 45.28 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.318 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.894 ' HB2' HG21 ' A' ' 70' ' ' VAL . 7.6 t80 -61.47 144.98 53.29 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.081 -1.047 . . . . 0.0 110.148 -178.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 17' ' ' LYS . 45.3 mm-40 -119.19 -143.8 0.36 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.276 -0.89 . . . . 0.0 108.848 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 43.86 -139.77 3.62 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.445 ' HA ' ' HD2' ' A' ' 73' ' ' LYS . 1.3 m-20 -135.18 143.35 46.4 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.737 -0.861 . . . . 0.0 110.001 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.02 -27.17 0.05 OUTLIER Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.475 -1.345 . . . . 0.0 110.626 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.643 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.4 OUTLIER 56.31 -153.88 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 120.637 -1.508 . . . . 0.0 108.324 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.643 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 38.9 Cg_exo -53.5 90.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 N-CA-C 109.981 -0.815 . . . . 0.0 109.981 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.703 ' O ' HG23 ' A' ' 69' ' ' ILE . 6.6 p -142.46 173.68 11.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.137 -0.977 . . . . 0.0 110.541 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.774 ' HG3' HD11 ' A' ' 69' ' ' ILE . 12.1 mtmm -84.42 168.97 15.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.411 -0.806 . . . . 0.0 111.347 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.031 HD11 ' CG2' ' A' ' 70' ' ' VAL . 13.3 mm -112.06 127.18 27.21 Favored Pre-proline 0 C--N 1.304 -1.391 0 O-C-N 121.241 -0.912 . . . . 0.0 112.31 -177.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.635 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 34.6 Cg_exo -63.71 144.17 88.55 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 124.055 1.555 . . . . 0.0 110.258 178.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.863 ' CD2' HG21 ' A' ' 79' ' ' ILE . 7.1 t80 -153.05 162.01 41.83 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.259 -0.9 . . . . 0.0 110.603 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.63 ' O ' HD12 ' A' ' 91' ' ' ILE . 9.4 tp10 -179.83 108.7 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.345 -0.847 . . . . 0.0 109.729 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 1.057 HD11 ' HB1' ' A' ' 81' ' ' ALA . 5.0 mt -86.52 25.08 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.064 -1.023 . . . . 0.0 110.547 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.543 ' HA ' ' HG3' ' A' ' 56' ' ' LYS . 39.6 mtm -148.57 -67.54 0.23 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.233 -0.917 . . . . 0.0 110.277 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.916 ' HB2' HD13 ' A' ' 91' ' ' ILE . 6.7 t0 40.47 -163.96 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.331 -0.855 . . . . 0.0 110.686 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 45.05 -92.47 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.39 -0.819 . . . . 0.0 110.319 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 53' ' ' ASP . 19.1 pt-20 -163.12 61.77 0.18 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.175 -0.953 . . . . 0.0 110.066 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.543 ' HG3' ' HA ' ' A' ' 52' ' ' MET . 43.9 mmtt -98.64 81.55 2.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -0.883 . . . . 0.0 109.948 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' A' ' 56' ' ' LYS . 1.3 mtt180 -50.21 -177.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.403 -0.811 . . . . 0.0 110.389 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 55.27 85.84 0.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.322 -0.861 . . . . 0.0 110.075 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.2 t -76.88 127.23 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 110.265 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.474 ' HB3' ' HB3' ' A' ' 84' ' ' PRO . 3.7 mt -150.86 -45.07 0.12 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.273 -0.892 . . . . 0.0 110.254 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.541 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . -45.08 160.09 0.14 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -149.43 170.16 19.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.216 -1.167 . . . . 0.0 110.812 -179.682 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.827 HD12 ' N ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -119.7 121.99 40.46 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.422 179.302 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.975 HG12 HG21 ' A' ' 31' ' ' THR . 1.3 mp -84.69 -30.86 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.83 HG22 ' O ' ' A' ' 65' ' ' THR 0.259 1.9 m -108.52 43.84 1.19 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.159 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.827 ' N ' HD12 ' A' ' 63' ' ' LEU . 9.0 t -29.52 135.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 CA-C-O 121.33 0.586 . . . . 0.0 111.396 -178.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.782 ' ND2' HG12 ' A' ' 66' ' ' VAL . 23.6 p30 26.52 73.14 0.37 Allowed Pre-proline 0 N--CA 1.49 1.538 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.753 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.581 ' O ' ' HA ' ' A' ' 46' ' ' LYS . 3.2 Cg_endo -57.1 -174.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.902 1.475 . . . . 0.0 108.821 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.774 HD11 ' HG3' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -140.83 142.57 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 C-N-CA 118.847 -1.141 . . . . 0.0 112.346 -179.071 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.031 ' CG2' HD11 ' A' ' 47' ' ' ILE . 46.6 t -98.63 160.05 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 176.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.5 m -113.8 -21.65 10.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.954 -1.092 . . . . 0.0 110.964 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.512 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 6.6 mt-10 -132.02 15.62 4.7 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.963 -1.086 . . . . 0.0 111.05 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.53 ' O ' ' O ' ' A' ' 38' ' ' TYR . 0.2 OUTLIER 72.37 -4.36 2.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.353 -0.842 . . . . 0.0 110.984 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.47 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 12.6 t70 -137.38 1.87 2.44 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.06 -1.025 . . . . 0.0 110.188 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.739 ' O ' HG23 ' A' ' 77' ' ' VAL . 40.3 t -73.0 109.28 5.87 Favored Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.192 -0.943 . . . . 0.0 109.454 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.744 ' HB3' HG21 ' A' ' 21' ' ' VAL . 3.7 Cg_endo -52.59 111.15 0.57 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.817 1.43 . . . . 0.0 109.713 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 75' ' ' SER . 48.7 t -102.65 145.49 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.331 -0.856 . . . . 0.0 111.712 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.652 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 1.5 m120 -101.93 134.12 45.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.488 -0.757 . . . . 0.0 109.207 179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.863 HG21 ' CD2' ' A' ' 49' ' ' PHE . 6.6 mt -114.85 117.42 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.21 -1.556 . . . . 0.0 111.626 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.703 ' HG3' HG22 ' A' ' 33' ' ' VAL . 2.6 tt0 -88.18 111.52 21.71 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.59 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 1.057 ' HB1' HD11 ' A' ' 51' ' ' ILE . . . -127.23 149.39 50.02 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.032 -1.043 . . . . 0.0 110.836 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -99.47 104.15 25.41 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.243 -0.91 . . . . 0.0 110.51 -179.692 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.537 ' HG3' ' CD1' ' A' ' 32' ' ' ILE . 74.6 Cg_endo -81.15 147.58 16.46 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.004 1.528 . . . . 0.0 110.609 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.541 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 9.7 Cg_endo -58.32 -52.46 5.6 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.872 1.459 . . . . 0.0 109.769 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.48 ' HB3' ' OD1' ' A' ' 87' ' ' ASP . 1.0 OUTLIER -151.98 176.43 11.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.401 -0.812 . . . . 0.0 109.657 179.682 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.554 ' HA3' ' CB ' ' A' ' 105' ' ' LYS . . . -74.17 76.24 1.09 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 87' ' ' ASP . 5.7 p-10 175.11 81.38 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.491 -1.005 . . . . 0.0 109.339 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.544 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -158.67 -159.05 0.75 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 110.651 -179.081 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 3.4 m-85 -151.13 100.72 2.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.69 -0.631 . . . . 0.0 109.728 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.824 HD11 HD12 ' A' ' 32' ' ' ILE . 3.4 mt -73.91 120.04 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.148 -0.97 . . . . 0.0 109.575 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.916 HD13 ' HB2' ' A' ' 53' ' ' ASP . 1.9 mp -98.53 140.16 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.046 -1.034 . . . . 0.0 110.048 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.075 HD11 HG21 ' A' ' 34' ' ' ILE . 1.2 mt -126.14 142.22 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.452 -0.78 . . . . 0.0 109.994 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.534 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 82.59 -160.36 39.48 Favored Glycine 0 N--CA 1.481 1.65 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.553 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -122.77 149.82 26.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 O-C-N 121.307 -1.113 . . . . 0.0 110.091 -179.652 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.569 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -19.19 -57.56 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.109 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 9.7 Cg_endo -53.84 69.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 124.137 1.598 . . . . 0.0 112.145 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 93.57 4.61 63.82 Favored Glycine 0 N--CA 1.495 2.6 0 O-C-N 120.876 -1.14 . . . . 0.0 111.033 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.505 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -53.87 159.78 1.61 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.046 -1.267 . . . . 0.0 110.193 179.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.638 HD13 ' CG2' ' A' ' 20' ' ' VAL . 9.1 mt -97.91 177.4 5.45 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.215 -0.928 . . . . 0.0 110.758 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.467 ' HG3' HG13 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -157.07 128.37 6.89 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.47 -0.769 . . . . 0.0 110.094 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 89' ' ' TYR . 4.7 mp -130.5 124.98 33.2 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.279 -0.888 . . . . 0.0 109.972 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.544 ' HA ' ' O ' ' A' ' 88' ' ' SER . 10.1 t-20 -90.91 132.21 36.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 110.89 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.505 ' O ' ' N ' ' A' ' 87' ' ' ASP . 3.4 t-105 -113.22 122.57 47.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.049 -1.032 . . . . 0.0 110.243 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' A' ' 86' ' ' GLY . 1.3 t80 -117.52 145.5 44.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.187 -0.946 . . . . 0.0 110.326 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.554 ' CB ' ' HA3' ' A' ' 86' ' ' GLY . 0.0 OUTLIER 168.22 117.19 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.271 -0.893 . . . . 0.0 110.293 -179.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.57 -20.97 14.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 110.136 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 60.41 51.43 58.82 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 60.4 p -66.8 -74.55 0.11 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -1.146 . . . . 0.0 110.217 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 35.5 m -156.19 104.49 2.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.186 -0.946 . . . . 0.0 110.245 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.698 ' N ' HD12 ' A' ' 110' ' ' LEU . 7.4 mp -78.4 -80.01 0.12 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 110.184 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 110' ' ' LEU . 1.1 mt-10 43.57 69.73 0.38 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.293 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -145.62 -62.77 0.33 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.337 -0.852 . . . . 0.0 110.112 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -92.81 77.01 4.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 110.125 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.481 ' CD2' ' O ' ' A' ' 114' ' ' HIS . 22.4 p-80 -136.67 93.32 2.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 110.18 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -63.44 155.47 29.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.917 . . . . 0.0 110.204 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.404 ' O ' ' CB ' ' A' ' 117' ' ' HIS . 0.1 OUTLIER -137.78 174.97 10.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.282 -0.886 . . . . 0.0 110.213 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.404 ' CB ' ' O ' ' A' ' 116' ' ' HIS . 1.9 t-160 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.232 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.247 0.546 . . . . 0.0 110.185 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.413 ' O ' ' CG ' ' A' ' 2' ' ' ASP . 11.0 p-10 -165.08 117.72 1.2 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.896 . . . . 0.0 110.203 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.7 mttm -144.59 23.86 1.58 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.912 . . . . 0.0 110.215 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.484 HD13 ' HA ' ' A' ' 4' ' ' LEU . 3.5 mm? -80.52 82.46 6.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.32 -0.863 . . . . 0.0 110.239 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.464 ' O ' ' O ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -179.38 41.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.266 -0.896 . . . . 0.0 110.23 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 5' ' ' GLN . 4.7 mp 50.75 176.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 110.201 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.1 mtmt -80.46 -9.49 59.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 0.0 110.107 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 9' ' ' MET . . . -170.94 -58.21 0.04 OUTLIER Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.431 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER 177.34 163.92 0.55 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -1.169 . . . . 0.0 110.229 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.6 m -57.99 124.49 19.47 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.225 -0.922 . . . . 0.0 110.141 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.54 ' CE2' ' O ' ' A' ' 44' ' ' PRO . 1.8 t80 -88.66 -74.0 0.48 Allowed 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.257 -0.902 . . . . 0.0 110.166 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 13' ' ' MET . 3.4 t -133.13 -28.25 1.54 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.363 -0.835 . . . . 0.0 110.645 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.48 ' HB3' ' O ' ' A' ' 12' ' ' SER . 2.7 ttm 58.28 95.52 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.309 -0.869 . . . . 0.0 108.972 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.592 ' HB3' ' CE1' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -71.61 126.55 29.97 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.889 -179.183 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 16' ' ' GLY . 14.8 t -107.71 -2.37 20.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.267 -0.895 . . . . 0.0 111.385 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.575 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -60.8 -125.08 0.01 OUTLIER Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.543 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -132.49 178.12 7.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.028 -1.278 . . . . 0.0 110.029 -179.793 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.043 ' CE2' HG23 ' A' ' 47' ' ' ILE . 34.1 m-85 -136.12 133.92 37.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.948 -1.095 . . . . 0.0 111.63 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.555 ' CE ' ' HB3' ' A' ' 37' ' ' GLN . 0.3 OUTLIER -104.26 119.71 39.56 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.622 -0.674 . . . . 0.0 109.444 179.2 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.596 HG22 HD13 ' A' ' 99' ' ' LEU . 41.6 t -59.72 131.12 24.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 118.588 -1.245 . . . . 0.0 108.275 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.624 HG23 ' HA ' ' A' ' 36' ' ' VAL . 75.9 t -105.27 -26.15 3.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.562 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 2.2 tttt -157.11 133.08 9.53 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -52.3 158.86 1.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.523 0.677 . . . . 0.0 111.304 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.68 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -54.39 132.38 17.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.588 0.708 . . . . 0.0 109.903 -179.964 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.848 ' HB3' ' HB ' ' A' ' 33' ' ' VAL . . . -107.29 169.7 8.41 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.5 pm0 -115.85 133.54 55.92 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.65 -1.281 . . . . 0.0 110.406 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.951 HG21 ' CD ' ' A' ' 80' ' ' GLU . 13.2 p -93.13 172.45 8.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.393 -0.817 . . . . 0.0 110.181 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -87.73 29.23 0.92 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.266 -0.896 . . . . 0.0 110.328 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.87 5.82 4.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.924 . . . . 0.0 110.179 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.88 8.06 59.47 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.926 HG22 ' C ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -102.66 -174.84 2.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -1.08 . . . . 0.0 110.081 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.773 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -141.91 156.91 20.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 178.632 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.848 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 76.3 t -121.69 128.18 75.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 O-C-N 120.974 -1.079 . . . . 0.0 112.222 -177.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.0 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -112.89 118.97 59.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 O-C-N 121.437 -0.789 . . . . 0.0 109.685 178.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 3.4 ttm180 -105.67 112.81 26.03 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.791 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.7 m -132.34 -168.01 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.476 -0.765 . . . . 0.0 109.422 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.555 ' HB3' ' CE ' ' A' ' 19' ' ' LYS . 21.6 tt0 -138.26 127.06 23.76 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.874 ' HB2' HG21 ' A' ' 70' ' ' VAL . 75.5 t80 -60.31 128.34 36.25 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 118.29 -1.364 . . . . 0.0 110.579 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.498 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 61.8 mm-40 -116.01 82.85 1.84 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.484 -0.76 . . . . 0.0 109.62 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.575 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . 171.62 -145.01 8.48 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.472 ' O ' ' OH ' ' A' ' 38' ' ' TYR . 7.5 m-20 -128.54 140.83 51.6 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.637 -0.919 . . . . 0.0 110.56 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 166.9 -20.61 0.1 OUTLIER Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.689 -1.243 . . . . 0.0 110.66 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.606 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER 56.03 -157.98 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 120.705 -1.468 . . . . 0.0 108.413 -179.702 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 72.9 Cg_exo -44.35 94.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.262 0 N-CA-C 108.944 -1.214 . . . . 0.0 108.944 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.698 ' O ' HG23 ' A' ' 69' ' ' ILE . 26.3 p -141.17 165.88 26.31 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.746 -0.596 . . . . 0.0 110.286 -178.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.704 ' HG3' HD11 ' A' ' 69' ' ' ILE . 10.9 mttp -82.59 177.43 8.71 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.407 -0.808 . . . . 0.0 110.358 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.043 HG23 ' CE2' ' A' ' 18' ' ' PHE . 14.2 mm -121.51 127.88 25.89 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.102 -0.999 . . . . 0.0 111.92 -178.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.619 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 35.1 Cg_exo -63.06 143.72 91.23 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.881 1.464 . . . . 0.0 110.627 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.756 ' CD1' HD21 ' A' ' 63' ' ' LEU . 5.6 t80 -155.53 132.28 10.55 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.335 -0.853 . . . . 0.0 110.021 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.588 ' O ' HD12 ' A' ' 91' ' ' ILE . 0.8 OUTLIER -144.1 97.68 3.09 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.03 -1.044 . . . . 0.0 110.305 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.719 HD11 ' HB1' ' A' ' 81' ' ' ALA . 11.9 mt -86.02 61.53 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.274 -0.891 . . . . 0.0 110.184 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.501 ' HB2' ' HG2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -142.93 -65.1 0.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.312 -0.868 . . . . 0.0 110.345 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.661 ' OD2' HD11 ' A' ' 91' ' ' ILE . 0.6 OUTLIER 58.42 106.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.121 -0.987 . . . . 0.0 110.002 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.525 ' CB ' ' O ' ' A' ' 53' ' ' ASP . 2.4 tp 72.7 -1.08 3.11 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.34 -0.85 . . . . 0.0 110.514 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -142.65 52.62 1.41 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.905 . . . . 0.0 110.106 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.501 ' HG2' ' HB2' ' A' ' 52' ' ' MET . 18.4 mtmt -98.69 102.66 14.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.3 -0.875 . . . . 0.0 110.235 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -165.67 -56.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.0 110.28 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.3 -156.47 0.5 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.23 -0.919 . . . . 0.0 110.149 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.4 t -101.32 99.39 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.341 -0.849 . . . . 0.0 110.261 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.09 132.07 56.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.194 -0.941 . . . . 0.0 110.226 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.525 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . 68.33 161.5 2.06 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.512 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -130.78 166.95 19.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.268 -1.136 . . . . 0.0 110.157 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.758 HD22 ' CB ' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -128.42 111.22 13.08 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.346 -0.847 . . . . 0.0 109.934 179.701 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.915 ' CG1' HG21 ' A' ' 31' ' ' THR . 5.6 mm -71.08 -25.45 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 122.148 0.975 . . . . 0.0 108.525 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.641 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.253 0.7 OUTLIER -111.87 31.46 6.19 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.718 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 63' ' ' LEU . 32.6 t -13.83 112.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.186 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.539 ' ND2' ' HD3' ' A' ' 46' ' ' LYS . 12.5 t-20 43.78 68.66 2.87 Favored Pre-proline 0 C--N 1.298 -1.66 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.295 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.667 ' HG3' HG23 ' A' ' 79' ' ' ILE . 2.1 Cg_endo -51.41 -174.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.982 1.517 . . . . 0.0 109.142 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.704 HD11 ' HG3' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -142.28 144.41 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 119.088 -1.045 . . . . 0.0 112.488 -178.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.007 ' CG2' HD11 ' A' ' 47' ' ' ILE . 26.5 t -98.62 166.87 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 176.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.411 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 3.3 m -123.62 -18.9 5.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.842 -1.161 . . . . 0.0 111.12 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.539 ' O ' ' CD ' ' A' ' 73' ' ' LYS . 8.0 mt-10 -138.0 15.37 2.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.926 -1.109 . . . . 0.0 110.685 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.539 ' CD ' ' O ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER 75.05 -13.39 0.85 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.773 -0.579 . . . . 0.0 111.224 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.47 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 6.3 t70 -131.83 -0.07 3.87 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.89 -1.131 . . . . 0.0 110.163 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 77' ' ' VAL . 8.9 t -72.04 108.36 4.05 Favored Pre-proline 0 C--N 1.304 -1.372 0 O-C-N 121.257 -0.902 . . . . 0.0 108.707 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.639 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 2.0 Cg_endo -46.92 131.03 16.51 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.77 1.405 . . . . 0.0 110.297 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.627 HG21 HG22 ' A' ' 70' ' ' VAL . 63.2 t -118.39 144.81 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.099 -1.001 . . . . 0.0 111.296 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.682 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 4.9 m-80 -105.51 134.82 47.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.431 -0.793 . . . . 0.0 109.574 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.725 HG21 ' CD2' ' A' ' 49' ' ' PHE . 5.2 mt -118.37 119.05 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 119.957 -1.715 . . . . 0.0 111.344 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.951 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.7 tp10 -93.19 114.12 26.52 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.634 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.926 ' C ' HG22 ' A' ' 31' ' ' THR . . . -131.0 150.43 52.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.048 -1.033 . . . . 0.0 110.873 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 4.4 tt0 -101.09 100.2 12.56 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.34 -0.85 . . . . 0.0 110.084 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.539 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 32.4 Cg_endo -69.05 144.64 58.52 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.102 1.58 . . . . 0.0 110.58 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.525 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 19.0 Cg_endo -63.62 -163.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.034 1.544 . . . . 0.0 110.229 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.57 ' CD2' ' O ' ' A' ' 85' ' ' PHE . 37.4 p90 -91.19 125.49 35.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.918 . . . . 0.0 110.243 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.24 -173.23 17.82 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -57.72 167.5 1.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -1.167 . . . . 0.0 110.194 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 0.6 OUTLIER -172.95 130.05 0.49 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 110.266 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 21.6 m-85 -100.9 102.66 13.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.913 . . . . 0.0 110.16 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.779 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.8 mp -73.9 113.45 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.213 -0.93 . . . . 0.0 109.394 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.661 HD11 ' OD2' ' A' ' 53' ' ' ASP . 9.5 mt -94.1 144.56 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.144 -0.972 . . . . 0.0 110.282 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.0 HD11 HG21 ' A' ' 34' ' ' ILE . 1.8 mt -128.65 141.25 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.406 -0.808 . . . . 0.0 109.697 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.546 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 82.2 -160.36 40.24 Favored Glycine 0 N--CA 1.483 1.786 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.563 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -122.58 148.24 26.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 O-C-N 121.218 -1.166 . . . . 0.0 109.918 -179.73 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.571 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.4 OUTLIER -16.38 -58.56 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.173 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.776 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 7.3 Cg_endo -51.01 73.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 124.131 1.595 . . . . 0.0 112.067 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 88.39 -0.27 83.14 Favored Glycine 0 N--CA 1.495 2.581 0 O-C-N 121.02 -1.05 . . . . 0.0 110.9 178.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.507 ' CD ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -47.04 160.52 0.09 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.967 -1.314 . . . . 0.0 110.325 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.596 HD13 HG22 ' A' ' 20' ' ' VAL . 10.6 mt -96.9 177.69 5.54 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.218 -0.926 . . . . 0.0 110.363 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.486 ' HG3' HG12 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -158.72 136.25 10.16 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.297 -0.877 . . . . 0.0 110.104 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.779 HD12 ' O ' ' A' ' 90' ' ' ILE . 2.6 mp -141.48 121.5 13.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.148 -0.97 . . . . 0.0 110.393 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -87.44 129.65 34.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.257 -0.902 . . . . 0.0 110.336 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 -126.09 152.94 45.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 110.202 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -109.95 118.35 36.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.274 -0.891 . . . . 0.0 110.217 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -116.91 57.6 0.78 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 110.221 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -78.62 -173.67 3.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 0.0 110.163 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 140.28 167.0 10.88 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.492 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.8 OUTLIER -130.7 -145.84 0.29 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.283 -1.128 . . . . 0.0 110.188 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 111' ' ' GLU . 1.5 m -48.71 -36.77 16.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.169 -0.957 . . . . 0.0 110.32 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 108' ' ' SER . 0.6 OUTLIER 52.62 -88.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.955 . . . . 0.0 110.14 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 109' ' ' SER . 11.8 tt0 -167.68 40.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.94 . . . . 0.0 110.217 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -165.79 107.9 0.76 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 110.19 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.42 ' O ' ' CG ' ' A' ' 114' ' ' HIS . 6.9 p-80 -165.69 -179.55 5.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.259 -0.9 . . . . 0.0 110.211 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.42 ' CG ' ' O ' ' A' ' 113' ' ' HIS . 2.3 m-70 -166.15 90.04 0.42 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.175 -0.953 . . . . 0.0 110.237 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -178.81 -161.41 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 110.205 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -164.05 168.14 19.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.207 -0.933 . . . . 0.0 110.262 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 6.8 t60 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.265 179.99 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 mtp . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.208 0.528 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.3 t0 62.76 65.42 0.82 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 110.212 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -85.53 163.03 18.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.221 -0.925 . . . . 0.0 110.258 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.74 112.39 3.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.322 -0.861 . . . . 0.0 110.147 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -110.1 6.42 22.85 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.316 -0.865 . . . . 0.0 110.266 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.644 HD22 HG11 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -156.48 -161.28 1.09 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.925 . . . . 0.0 110.174 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.17 -73.12 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.934 . . . . 0.0 110.283 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.422 ' O ' ' CB ' ' A' ' 9' ' ' MET . . . -166.88 -122.08 0.59 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.422 ' CB ' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER 64.32 138.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.287 -1.125 . . . . 0.0 110.152 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.0 p -175.46 135.27 0.32 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.264 -0.898 . . . . 0.0 110.158 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.623 ' CZ ' ' HB2' ' A' ' 44' ' ' PRO . 1.2 t80 -149.26 -75.0 0.17 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.206 -0.933 . . . . 0.0 109.994 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.512 ' HB3' ' HA ' ' A' ' 45' ' ' CYS . 2.1 t -148.4 -126.21 0.05 Allowed 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.112 -0.993 . . . . 0.0 109.054 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.456 ' HB3' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -178.3 98.41 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.741 -1.224 . . . . 0.0 110.66 179.429 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 21.5 m -61.85 104.87 0.49 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.066 -1.022 . . . . 0.0 108.401 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.525 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 1.2 t -114.82 2.6 14.41 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.932 -1.105 . . . . 0.0 111.974 -178.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.573 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -65.07 -100.03 0.01 OUTLIER Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.104 -1.522 . . . . 0.0 109.437 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.585 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 1.1 tmpt? -141.1 161.86 36.85 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.077 -1.249 . . . . 0.0 109.807 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.995 ' CE2' HG23 ' A' ' 47' ' ' ILE . 18.7 m-85 -126.11 134.92 51.21 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.763 -1.211 . . . . 0.0 111.93 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.516 ' HE2' ' NE2' ' A' ' 37' ' ' GLN . 3.9 ttpt -109.4 120.04 41.3 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.566 -0.709 . . . . 0.0 109.652 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.748 ' CG2' HD13 ' A' ' 99' ' ' LEU . 49.0 t -60.08 131.9 25.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.866 -1.147 . . . . 0.0 108.927 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.602 HG23 ' HA ' ' A' ' 36' ' ' VAL . 72.4 t -105.55 -27.3 3.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.558 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 5.9 tttp -156.04 133.23 10.7 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 177.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -51.84 156.38 1.48 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.555 0.693 . . . . 0.0 111.284 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.692 HD11 ' HB ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -52.88 132.61 15.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.527 -0.733 . . . . 0.0 109.991 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.824 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -109.5 170.87 7.78 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 0.7 OUTLIER -115.78 134.29 55.17 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.73 -1.231 . . . . 0.0 110.552 -179.735 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.955 HG21 ' CD ' ' A' ' 80' ' ' GLU . 14.5 p -93.46 172.33 8.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.502 -0.749 . . . . 0.0 110.372 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -88.6 29.89 0.96 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.328 -0.857 . . . . 0.0 110.191 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.76 5.48 4.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.278 -0.889 . . . . 0.0 110.104 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.06 14.01 52.97 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.942 HG21 ' CG1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -110.87 -178.82 3.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.397 -1.061 . . . . 0.0 110.292 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.824 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -137.44 152.69 27.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 178.605 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.661 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 52.9 t -118.15 130.92 72.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 121.051 -1.031 . . . . 0.0 112.357 -177.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.086 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -114.59 120.21 63.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.557 -0.715 . . . . 0.0 109.423 178.734 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.558 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -105.7 115.78 30.82 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.614 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.802 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.8 m -134.48 -170.74 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 C-N-CA 119.564 -0.854 . . . . 0.0 109.322 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.516 ' NE2' ' HE2' ' A' ' 19' ' ' LYS . 1.9 tt0 -132.42 127.32 35.11 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 1.024 ' HB2' HG21 ' A' ' 70' ' ' VAL . 1.5 t80 -60.63 122.49 14.84 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 118.703 -1.199 . . . . 0.0 110.113 -178.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 17' ' ' LYS . 4.0 mt-10 -112.29 38.62 2.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -0.867 . . . . 0.0 109.193 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.573 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -125.16 -160.68 10.79 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 37.3 p-10 -135.1 85.59 2.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.516 -0.991 . . . . 0.0 110.277 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 43' ' ' SER . . . -147.83 10.04 1.21 Allowed Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.725 -1.226 . . . . 0.0 110.307 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.605 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER 46.67 -158.61 0.01 OUTLIER Pre-proline 0 N--CA 1.487 1.42 0 O-C-N 120.834 -1.392 . . . . 0.0 108.951 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.623 ' HB2' ' CZ ' ' A' ' 11' ' ' TYR . 87.9 Cg_exo -43.49 95.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 122.72 0.853 . . . . 0.0 110.54 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.693 ' O ' HG23 ' A' ' 69' ' ' ILE . 8.0 p -141.52 171.19 14.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.491 -0.756 . . . . 0.0 110.607 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.771 ' HG3' HD11 ' A' ' 69' ' ' ILE . 33.3 mttt -84.69 169.41 14.33 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.685 0.755 . . . . 0.0 111.627 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.043 HD11 ' CG2' ' A' ' 70' ' ' VAL . 12.7 mm -111.33 124.7 32.06 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.269 -0.894 . . . . 0.0 112.234 -177.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.64 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 34.5 Cg_exo -63.12 144.09 91.62 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.974 1.513 . . . . 0.0 110.815 178.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.894 ' CZ ' HG23 ' A' ' 90' ' ' ILE . 7.6 t80 -154.97 158.88 39.89 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.299 -0.876 . . . . 0.0 110.142 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.478 ' HB3' ' HB ' ' A' ' 91' ' ' ILE . 23.9 tp10 -172.91 107.21 0.16 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.092 -1.005 . . . . 0.0 110.493 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.805 HD11 ' HB1' ' A' ' 81' ' ' ALA . 54.1 mt -99.11 94.78 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.885 . . . . 0.0 110.222 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.488 ' SD ' ' N ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -150.93 -66.78 0.19 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.207 -0.933 . . . . 0.0 110.181 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.465 ' O ' HD11 ' A' ' 91' ' ' ILE . 0.4 OUTLIER -177.53 -144.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.294 -0.879 . . . . 0.0 110.22 -179.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.79 -60.34 3.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.887 . . . . 0.0 110.192 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.504 ' O ' ' CG ' ' A' ' 56' ' ' LYS . 17.6 mt-10 -103.58 -77.14 0.57 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.0 110.212 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.504 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER 176.37 159.84 0.32 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.19 -0.944 . . . . 0.0 110.245 -179.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.488 ' N ' ' SD ' ' A' ' 52' ' ' MET . 0.4 OUTLIER 174.58 119.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.25 -0.906 . . . . 0.0 110.159 179.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.432 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 29.6 t60 63.53 152.54 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.925 . . . . 0.0 110.179 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 59' ' ' VAL . 14.1 m -90.83 121.41 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 110.163 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 59' ' ' VAL . 24.6 mt -147.86 155.59 41.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -0.89 . . . . 0.0 110.262 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.511 ' CA ' ' HD3' ' A' ' 84' ' ' PRO . . . 80.12 162.26 25.63 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.518 ' CB ' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -135.35 161.3 35.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.349 -1.089 . . . . 0.0 110.165 179.9 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.77 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -123.4 111.46 16.39 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.365 -0.835 . . . . 0.0 109.864 179.698 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.942 ' CG1' HG21 ' A' ' 31' ' ' THR . 6.5 mm -70.55 -29.23 37.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 122.272 1.034 . . . . 0.0 108.297 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.632 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.257 0.7 OUTLIER -106.81 30.56 6.0 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.708 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 63' ' ' LEU . 39.3 t -13.04 111.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.281 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.537 ' ND2' ' HD3' ' A' ' 46' ' ' LYS . 12.6 t-20 43.43 69.32 2.39 Favored Pre-proline 0 C--N 1.298 -1.647 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.274 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.571 ' O ' ' HA ' ' A' ' 46' ' ' LYS . 1.6 Cg_endo -52.19 -175.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.962 1.506 . . . . 0.0 109.319 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.771 HD11 ' HG3' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -142.7 142.67 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.961 -179.316 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.043 ' CG2' HD11 ' A' ' 47' ' ' ILE . 30.8 t -99.76 161.11 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.409 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 5.6 m -115.65 -16.81 11.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.988 -1.07 . . . . 0.0 111.853 -178.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.522 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 14.1 mt-10 -141.3 19.42 2.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.665 -1.272 . . . . 0.0 111.687 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.586 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 0.0 OUTLIER 72.04 -6.37 1.52 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.15 -0.969 . . . . 0.0 111.103 179.73 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.477 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 4.9 t70 -137.8 -0.93 2.07 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.847 -1.158 . . . . 0.0 110.373 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.539 ' O ' HG23 ' A' ' 77' ' ' VAL . 40.2 t -72.37 112.3 14.26 Favored Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 121.17 -0.956 . . . . 0.0 109.027 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.605 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 45.7 Cg_exo -49.22 126.69 16.03 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.885 1.466 . . . . 0.0 110.002 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.99 HG21 HG22 ' A' ' 70' ' ' VAL . 76.3 t -112.66 140.34 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.031 -1.043 . . . . 0.0 111.606 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.682 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 2.3 m120 -105.38 133.82 49.51 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.455 -0.778 . . . . 0.0 109.377 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.667 ' HB ' HG22 ' A' ' 34' ' ' ILE . 4.4 mt -118.15 119.97 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 119.984 -1.697 . . . . 0.0 111.609 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.955 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.6 tp10 -94.07 110.16 21.88 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.896 ' C ' HG22 ' A' ' 31' ' ' THR . . . -125.4 147.37 49.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.986 -1.071 . . . . 0.0 111.041 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.518 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 3.0 tt0 -99.53 101.89 14.83 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 109.916 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.532 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 12.4 Cg_endo -61.11 143.83 99.01 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.012 1.533 . . . . 0.0 110.504 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.511 ' HD3' ' CA ' ' A' ' 61' ' ' GLY . 19.4 Cg_endo -64.14 -71.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.051 1.553 . . . . 0.0 110.334 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -177.89 151.23 0.68 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.164 -0.96 . . . . 0.0 110.281 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.08 -161.0 54.14 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -61.21 132.38 53.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -1.132 . . . . 0.0 110.23 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.24 122.89 22.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 110.244 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 12.3 m-85 -95.96 105.14 17.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.179 -0.951 . . . . 0.0 110.199 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.894 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 1.4 mp -74.27 110.97 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.222 -0.924 . . . . 0.0 109.748 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 87.1 mt -92.1 142.18 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 110.152 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.086 HD11 HG21 ' A' ' 34' ' ' ILE . 3.6 mt -132.51 141.27 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.386 -0.821 . . . . 0.0 109.983 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.543 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 80.95 -156.7 38.41 Favored Glycine 0 N--CA 1.484 1.868 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 98' ' ' GLN . 0.2 OUTLIER -130.59 156.52 42.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.129 -1.218 . . . . 0.0 110.338 -179.548 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.528 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 3.0 mt-10 -30.33 -55.81 0.35 Allowed Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.849 -0.532 . . . . 0.0 110.848 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 73.4 Cg_exo -40.56 -36.98 1.97 Allowed 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.052 1.553 . . . . 0.0 110.686 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.585 ' HA3' ' CG ' ' A' ' 17' ' ' LYS . . . -164.71 49.04 0.29 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.557 ' N ' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -93.85 151.9 19.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.204 -1.174 . . . . 0.0 111.08 -178.57 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.748 HD13 ' CG2' ' A' ' 20' ' ' VAL . 13.6 mt -100.54 179.7 4.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.492 -0.755 . . . . 0.0 110.089 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.575 ' C ' HD12 ' A' ' 101' ' ' LEU . 1.6 mtpt -152.8 135.79 15.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.43 -0.794 . . . . 0.0 110.334 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.654 HD22 HG12 ' A' ' 24' ' ' ILE . 5.2 mp -140.33 116.91 10.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.213 -0.93 . . . . 0.0 110.199 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 3.3 p-10 -87.82 120.26 28.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 0.0 110.318 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.655 ' CE3' HG22 ' A' ' 24' ' ' ILE . 50.7 t-105 -117.52 124.32 48.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.922 . . . . 0.0 110.227 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -72.35 123.14 22.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 110.176 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.43 ' HG2' ' HG2' ' A' ' 83' ' ' PRO . 0.1 OUTLIER -131.43 47.12 2.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 0.0 110.216 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.12 -60.34 2.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.293 -0.88 . . . . 0.0 110.163 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 149.68 -82.72 0.18 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.33 65.95 1.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -1.111 . . . . 0.0 110.208 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.5 p -144.81 -158.3 0.87 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.292 -0.88 . . . . 0.0 110.187 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 53.81 58.27 5.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.893 . . . . 0.0 110.238 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -97.13 56.74 1.41 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 0.0 110.246 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -75.25 -6.37 49.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.17 -0.956 . . . . 0.0 110.152 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -61.04 -63.66 1.22 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 110.228 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 62.7 22.8 13.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 110.176 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -92.56 127.66 38.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.869 . . . . 0.0 110.26 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -83.82 174.84 10.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.163 -0.96 . . . . 0.0 110.215 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.205 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ttm . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.258 0.552 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 47.37 61.0 3.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.205 -0.935 . . . . 0.0 110.17 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 4' ' ' LEU . 0.9 OUTLIER -140.61 110.94 6.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -0.883 . . . . 0.0 110.254 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.467 HD13 ' HA ' ' A' ' 4' ' ' LEU . 3.4 mm? 50.92 101.85 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.326 -0.859 . . . . 0.0 110.213 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.408 ' HG2' ' C ' ' A' ' 4' ' ' LEU . 83.3 mm-40 -139.91 -45.17 0.43 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.238 -0.914 . . . . 0.0 110.285 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.55 128.28 35.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.897 . . . . 0.0 110.152 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.88 97.61 4.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.894 . . . . 0.0 110.257 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 10' ' ' SER . . . 179.96 94.72 0.1 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.439 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER 57.09 -82.02 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.385 -1.068 . . . . 0.0 110.298 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 8' ' ' GLY . 0.2 OUTLIER 60.62 158.3 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.268 -0.895 . . . . 0.0 110.168 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.634 ' CZ ' ' HB2' ' A' ' 44' ' ' PRO . 1.4 t80 -150.37 -74.74 0.16 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.166 -0.959 . . . . 0.0 109.905 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.509 ' HB3' ' HA ' ' A' ' 45' ' ' CYS . 3.9 t -142.15 -119.23 0.1 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.215 -0.928 . . . . 0.0 109.056 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.453 ' O ' ' HG3' ' A' ' 13' ' ' MET . 2.2 ptt? -179.6 95.56 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.569 -1.332 . . . . 0.0 110.655 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 38' ' ' TYR . 20.3 m -60.49 94.17 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.527 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 0.5 OUTLIER -99.75 -1.14 38.5 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.021 -1.049 . . . . 0.0 112.363 -178.028 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.592 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -66.46 -108.12 0.01 OUTLIER Glycine 0 N--CA 1.493 2.44 0 C-N-CA 118.942 -1.599 . . . . 0.0 109.301 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.537 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -136.98 177.79 7.59 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.958 -1.319 . . . . 0.0 110.22 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.007 ' CE2' HG23 ' A' ' 47' ' ' ILE . 26.7 m-85 -137.57 144.62 42.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.012 -1.055 . . . . 0.0 111.826 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.459 ' HB2' ' CG ' ' A' ' 39' ' ' GLU . 11.5 ttpt -114.54 117.84 32.05 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.702 -0.624 . . . . 0.0 109.411 179.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.564 ' CG2' HD13 ' A' ' 99' ' ' LEU . 46.1 t -59.66 132.45 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.78 -1.2 . . . . 0.0 108.958 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.592 HG23 ' HA ' ' A' ' 36' ' ' VAL . 73.6 t -106.84 -26.24 3.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.561 ' HB3' ' CG ' ' A' ' 35' ' ' ARG . 3.4 tttt -156.87 133.15 9.81 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -52.12 156.49 1.6 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.65 0.738 . . . . 0.0 111.374 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.804 HG13 HD13 ' A' ' 90' ' ' ILE . 0.6 OUTLIER -52.99 132.79 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.505 -0.747 . . . . 0.0 109.944 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.788 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -109.62 170.9 7.77 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.5 pm0 -115.93 134.5 54.91 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.78 -1.2 . . . . 0.0 110.37 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.94 HG21 ' CD ' ' A' ' 80' ' ' GLU . 16.0 p -92.4 175.55 6.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.474 -0.766 . . . . 0.0 110.387 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -88.96 27.34 1.36 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.466 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -130.89 6.68 4.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.201 -0.937 . . . . 0.0 110.194 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.59 3.03 61.3 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.92 HG22 ' C ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -96.65 -177.59 3.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.335 -1.097 . . . . 0.0 110.31 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.788 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -138.88 153.84 25.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.668 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.702 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 55.5 t -119.78 130.68 73.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 O-C-N 121.003 -1.061 . . . . 0.0 112.41 -177.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.002 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -114.61 120.84 65.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 121.408 -0.807 . . . . 0.0 109.412 178.51 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.561 ' CG ' ' HB3' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -106.52 113.59 27.2 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.865 HG11 HD13 ' A' ' 92' ' ' ILE . 1.7 m -132.05 -169.78 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 C-N-CA 119.689 -0.805 . . . . 0.0 109.283 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.529 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 9.9 tt0 -134.83 127.66 31.23 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.962 ' HB2' HG21 ' A' ' 70' ' ' VAL . 1.6 t80 -60.46 124.02 19.07 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 118.796 -1.161 . . . . 0.0 110.033 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.459 ' CG ' ' HB2' ' A' ' 19' ' ' LYS . 22.6 mm-40 -103.5 -22.23 13.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.243 -0.911 . . . . 0.0 109.25 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.592 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -64.94 -161.2 0.57 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.557 ' HA ' ' CD ' ' A' ' 73' ' ' LYS . 3.3 p-10 -143.21 93.98 2.56 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.598 -0.943 . . . . 0.0 110.054 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -150.92 15.24 0.9 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.606 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER 48.39 -160.0 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.366 0 O-C-N 121.033 -1.274 . . . . 0.0 109.298 179.422 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.634 ' HB2' ' CZ ' ' A' ' 11' ' ' TYR . 85.7 Cg_exo -43.19 95.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 122.946 0.971 . . . . 0.0 110.622 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.674 ' O ' HG23 ' A' ' 69' ' ' ILE . 11.6 p -140.94 170.92 14.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.536 -0.728 . . . . 0.0 110.637 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.769 ' HG3' HD11 ' A' ' 69' ' ' ILE . 20.7 mttt -87.32 165.71 15.42 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.438 -0.789 . . . . 0.0 111.413 -178.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.051 HD11 ' CG2' ' A' ' 70' ' ' VAL . 12.6 mm -108.64 124.87 33.12 Favored Pre-proline 0 C--N 1.303 -1.415 0 O-C-N 121.18 -0.95 . . . . 0.0 112.643 -177.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.639 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 34.7 Cg_exo -63.24 146.17 93.72 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 124.023 1.538 . . . . 0.0 110.436 178.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.914 ' CZ ' HG23 ' A' ' 90' ' ' ILE . 10.2 t80 -155.22 160.22 40.69 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.147 -0.971 . . . . 0.0 110.6 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.938 ' O ' HD12 ' A' ' 91' ' ' ILE . 19.2 tp10 -177.69 115.49 0.09 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.307 -0.87 . . . . 0.0 110.212 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.639 HD11 ' HB1' ' A' ' 81' ' ' ALA . 43.4 mt -105.94 63.6 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.205 -0.934 . . . . 0.0 110.372 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.504 ' O ' ' N ' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -154.63 -67.17 0.13 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.14 -0.975 . . . . 0.0 110.262 179.831 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.473 ' HB2' HD11 ' A' ' 91' ' ' ILE . 0.6 OUTLIER 61.59 -73.83 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.296 -0.878 . . . . 0.0 110.595 179.815 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 52' ' ' MET . 0.3 OUTLIER -67.92 -7.46 28.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.206 -0.934 . . . . 0.0 110.427 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 52' ' ' MET . 1.5 tt0 -149.8 55.74 0.96 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.189 -0.944 . . . . 0.0 110.268 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.478 ' HG2' ' OE2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -98.76 77.87 2.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.935 . . . . 0.0 110.301 -179.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 58' ' ' HIS . 5.9 ttt180 -109.92 -29.74 8.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.215 -0.928 . . . . 0.0 110.136 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 44.4 t-80 -177.54 -60.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.251 -0.906 . . . . 0.0 110.369 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.409 HG22 ' H ' ' A' ' 59' ' ' VAL . 34.4 m -86.78 159.61 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.195 -0.941 . . . . 0.0 110.394 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 61' ' ' GLY . 0.9 OUTLIER -178.47 -173.68 0.35 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -0.867 . . . . 0.0 110.17 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 60' ' ' LEU . . . -51.39 -176.45 0.03 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.511 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -115.33 167.4 10.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -1.182 . . . . 0.0 110.039 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.756 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -130.93 110.76 11.5 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.387 -0.821 . . . . 0.0 109.916 179.672 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.911 ' CG1' HG21 ' A' ' 31' ' ' THR . 4.9 mm -69.98 -25.6 28.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-O 122.15 0.976 . . . . 0.0 108.53 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.627 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.251 0.6 OUTLIER -110.95 30.1 7.17 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.658 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 63' ' ' LEU . 40.3 t -11.9 112.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.394 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.534 ' ND2' ' HD3' ' A' ' 46' ' ' LYS . 13.7 t-20 41.63 69.63 1.99 Allowed Pre-proline 0 C--N 1.299 -1.598 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.463 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.554 ' O ' ' HA ' ' A' ' 46' ' ' LYS . 1.4 Cg_endo -51.88 -174.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.886 1.466 . . . . 0.0 109.456 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.769 HD11 ' HG3' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -142.81 143.58 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 119.148 -1.021 . . . . 0.0 112.06 -179.136 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.051 ' CG2' HD11 ' A' ' 47' ' ' ILE . 22.2 t -101.91 159.6 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 176.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.3 m -116.67 -14.53 10.82 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.046 -1.062 . . . . 0.0 111.853 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 73' ' ' LYS . 19.6 mt-10 -142.0 22.51 2.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.619 -1.301 . . . . 0.0 111.756 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.598 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 0.8 OUTLIER 66.7 -1.57 1.29 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.095 -1.003 . . . . 0.0 111.087 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.465 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 9.7 t0 -142.47 -0.35 1.24 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.944 -1.098 . . . . 0.0 110.574 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.613 ' O ' HG23 ' A' ' 77' ' ' VAL . 39.4 t -72.76 108.43 4.41 Favored Pre-proline 0 N--CA 1.486 1.344 0 O-C-N 120.977 -1.077 . . . . 0.0 109.218 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.596 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 2.3 Cg_endo -47.25 127.41 13.01 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.743 1.391 . . . . 0.0 109.684 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.943 HG21 HG22 ' A' ' 70' ' ' VAL . 58.7 t -115.46 143.43 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.954 -1.091 . . . . 0.0 111.611 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.679 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 4.0 m120 -106.18 134.12 49.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.551 -0.718 . . . . 0.0 109.525 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.67 ' HB ' HG22 ' A' ' 34' ' ' ILE . 4.2 mt -117.5 119.75 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 119.988 -1.695 . . . . 0.0 111.402 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.94 ' CD ' HG21 ' A' ' 27' ' ' THR . 1.8 tp10 -95.24 110.74 22.68 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.92 ' C ' HG22 ' A' ' 31' ' ' THR . . . -126.46 150.1 48.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.077 -1.014 . . . . 0.0 111.004 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.511 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 9.6 tp10 -101.83 101.68 19.45 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.354 -0.841 . . . . 0.0 110.127 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.533 ' HD3' ' CG1' ' A' ' 32' ' ' ILE . 20.3 Cg_endo -66.71 144.56 72.28 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.08 1.568 . . . . 0.0 110.427 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.438 ' O ' ' HB3' ' A' ' 85' ' ' PHE . 15.1 Cg_endo -62.8 -74.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 124.052 1.554 . . . . 0.0 110.327 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.438 ' HB3' ' O ' ' A' ' 84' ' ' PRO . 17.5 p90 177.21 154.42 0.26 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.913 . . . . 0.0 110.282 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.429 ' HA2' ' HB2' ' A' ' 106' ' ' LYS . . . 78.24 -161.68 49.04 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -64.77 140.92 58.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -1.147 . . . . 0.0 110.12 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -149.31 159.0 44.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.352 -0.842 . . . . 0.0 110.243 -179.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' A' ' 89' ' ' TYR . 8.1 m-85 -132.2 108.14 9.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.325 -0.859 . . . . 0.0 110.153 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.914 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 1.3 mp -74.16 108.39 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -0.906 . . . . 0.0 109.482 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.938 HD12 ' O ' ' A' ' 50' ' ' GLU . 7.0 mt -92.09 142.37 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.131 -0.98 . . . . 0.0 110.42 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.002 HD11 HG21 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -129.61 138.26 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.545 -0.722 . . . . 0.0 109.521 -179.905 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.524 ' O ' ' HB2' ' A' ' 48' ' ' PRO . . . 86.06 -161.87 34.9 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.554 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -121.89 148.38 25.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 O-C-N 121.264 -1.139 . . . . 0.0 110.129 -179.721 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.581 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.2 OUTLIER -18.07 -58.02 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.145 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 9.3 Cg_endo -52.62 70.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 124.198 1.631 . . . . 0.0 112.148 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 91.34 2.89 70.08 Favored Glycine 0 N--CA 1.495 2.584 0 O-C-N 120.875 -1.141 . . . . 0.0 110.912 178.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.521 ' HB2' ' N ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -51.64 159.12 0.82 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.965 -1.315 . . . . 0.0 110.229 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.564 HD13 ' CG2' ' A' ' 20' ' ' VAL . 5.7 mt -96.24 174.68 6.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.224 -0.922 . . . . 0.0 110.297 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.909 ' C ' HD12 ' A' ' 101' ' ' LEU . 3.8 ttmt -152.71 143.09 22.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.34 -0.85 . . . . 0.0 110.328 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.909 HD12 ' C ' ' A' ' 100' ' ' LYS . 5.6 mp -144.59 113.45 6.79 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.168 -0.957 . . . . 0.0 110.222 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.491 ' HA ' ' O ' ' A' ' 88' ' ' SER . 9.8 t-20 -79.64 131.18 35.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.243 -0.91 . . . . 0.0 110.334 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 -127.73 123.87 36.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 0.0 110.196 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -82.9 128.02 34.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 0.0 110.285 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.15 47.88 1.6 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.138 -0.976 . . . . 0.0 110.232 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.429 ' HB2' ' HA2' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -115.67 138.41 51.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.256 -0.902 . . . . 0.0 110.179 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.28 -149.82 16.97 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.39 -46.54 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.27 -1.135 . . . . 0.0 110.221 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.9 t -171.68 29.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.169 -0.957 . . . . 0.0 110.247 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.41 35.25 2.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.905 . . . . 0.0 110.167 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.46 161.18 16.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 110.267 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 47.5 87.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 110.24 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.97 -179.94 4.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.925 . . . . 0.0 110.141 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -143.94 -73.5 0.27 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.237 -0.915 . . . . 0.0 110.135 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 62.09 -150.39 0.37 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 110.254 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.427 ' O ' ' O ' ' A' ' 117' ' ' HIS . 9.3 t60 -85.83 -15.7 41.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.321 -0.862 . . . . 0.0 110.219 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.427 ' O ' ' O ' ' A' ' 116' ' ' HIS . 36.7 t-80 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.146 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.4 mtm . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.272 0.558 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 2' ' ' ASP . 36.7 p-10 -82.58 -165.84 1.14 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.208 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER -119.8 22.17 11.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.302 -0.874 . . . . 0.0 110.229 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.477 ' O ' ' CB ' ' A' ' 5' ' ' GLN . 0.5 OUTLIER -43.17 146.78 0.4 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.231 -0.918 . . . . 0.0 110.244 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.477 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER 171.28 56.4 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -0.923 . . . . 0.0 110.197 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.429 ' O ' ' HB2' ' A' ' 10' ' ' SER . 0.7 OUTLIER -54.24 -57.69 10.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.217 -0.927 . . . . 0.0 110.098 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -6.14 47.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.9 . . . . 0.0 110.062 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.67 -25.97 63.97 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.469 ' O ' ' O ' ' A' ' 10' ' ' SER . 13.4 mtm -140.15 -91.43 0.17 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -1.169 . . . . 0.0 110.23 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.51 ' HA ' ' CE ' ' A' ' 46' ' ' LYS . 8.1 t 56.09 161.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.2 -0.938 . . . . 0.0 110.147 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -92.37 -72.89 0.57 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.137 -0.977 . . . . 0.0 110.137 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.45 ' O ' ' HB3' ' A' ' 13' ' ' MET . 3.1 t -136.28 -6.89 2.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.086 -1.009 . . . . 0.0 111.067 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.654 ' O ' HG23 ' A' ' 15' ' ' THR . 4.2 ttp 55.98 81.59 0.12 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.952 -1.093 . . . . 0.0 108.683 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.587 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 35.8 m -56.39 101.54 0.06 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.483 -0.761 . . . . 0.0 109.491 -178.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.654 HG23 ' O ' ' A' ' 13' ' ' MET . 39.6 p -95.79 -5.8 41.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 111.652 -178.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.598 ' HA3' ' HA3' ' A' ' 40' ' ' GLY . . . -61.21 -117.65 0.01 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.54 ' CG ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -138.51 173.08 11.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.956 -1.32 . . . . 0.0 110.139 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.999 ' CE2' HG23 ' A' ' 47' ' ' ILE . 30.8 m-85 -132.69 141.51 48.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.012 -1.055 . . . . 0.0 111.693 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.474 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 14.9 ttpt -110.51 119.84 40.47 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.627 -0.67 . . . . 0.0 109.444 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.475 HG22 HD13 ' A' ' 99' ' ' LEU . 31.4 t -60.23 132.74 25.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 120.91 -1.119 . . . . 0.0 109.205 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.637 HG23 ' HA ' ' A' ' 36' ' ' VAL . 90.1 t -106.04 -27.12 3.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.582 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 14.1 tttt -156.96 133.45 9.95 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -51.26 160.17 0.57 Allowed 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.702 0.763 . . . . 0.0 111.72 -178.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.695 HG23 HG22 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -57.93 133.45 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 CA-C-O 121.579 0.704 . . . . 0.0 110.248 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.599 ' HB3' ' HB ' ' A' ' 33' ' ' VAL . . . -112.05 158.35 19.68 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 1.6 pm0 -110.67 132.77 53.91 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 120.295 -1.503 . . . . 0.0 110.27 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.938 HG21 ' OE2' ' A' ' 80' ' ' GLU . 1.8 p -91.21 175.44 6.94 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.163 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -80.8 -16.7 53.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.238 -0.914 . . . . 0.0 110.495 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -80.6 1.53 29.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 0.0 110.292 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.92 9.33 61.03 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.894 HG21 ' CG1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -98.31 174.8 6.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -1.097 . . . . 0.0 110.395 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.876 HD11 ' CG ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -129.22 142.96 42.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.621 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 26.7 t -110.91 131.1 63.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 O-C-N 121.388 -0.82 . . . . 0.0 111.775 -177.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.027 HG21 HD11 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -119.34 121.3 66.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.456 -0.777 . . . . 0.0 109.349 178.809 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.582 ' HB3' ' HB3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -106.14 111.62 24.31 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.737 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.86 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.5 m -131.44 -167.92 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.175 -178.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.471 ' N ' HG23 ' A' ' 36' ' ' VAL . 10.6 tt0 -135.59 129.25 32.63 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.938 ' HB2' HG21 ' A' ' 70' ' ' VAL . 1.7 t80 -60.2 122.33 14.19 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 118.544 -1.262 . . . . 0.0 110.361 -178.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.474 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 4.6 mt-10 -112.05 39.26 2.45 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.453 -0.779 . . . . 0.0 108.973 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.598 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -133.06 -160.64 9.56 Favored Glycine 0 N--CA 1.484 1.894 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.451 ' HA ' ' HD2' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -121.98 141.9 50.86 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.537 -0.978 . . . . 0.0 110.267 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 154.92 -11.43 0.43 Allowed Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.857 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.607 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 0.7 OUTLIER 54.88 -153.29 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 120.542 -1.563 . . . . 0.0 108.119 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.607 ' CD ' ' CB ' ' A' ' 43' ' ' SER . 83.1 Cg_exo -41.83 97.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.322 -0.864 0 N-CA-C 108.904 -1.229 . . . . 0.0 108.904 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.733 ' O ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -145.89 170.82 15.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.794 -0.567 . . . . 0.0 109.958 -177.647 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.682 ' HG3' HD11 ' A' ' 69' ' ' ILE . 33.8 mttm -87.29 176.11 7.7 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.417 -0.802 . . . . 0.0 111.653 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.085 HD11 ' CG2' ' A' ' 70' ' ' VAL . 16.2 mm -122.47 129.05 25.21 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.305 -0.872 . . . . 0.0 112.405 -178.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.622 ' HD2' ' CZ ' ' A' ' 18' ' ' PHE . 24.8 Cg_exo -67.47 146.55 74.82 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.689 1.593 . . . . 0.0 111.246 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.728 ' CD2' HD21 ' A' ' 63' ' ' LEU . 9.7 t80 -155.53 154.55 31.93 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.419 -0.8 . . . . 0.0 109.741 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.888 ' HG2' HD12 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -164.14 125.26 2.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.842 -1.161 . . . . 0.0 110.661 179.666 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.979 HG21 ' HB3' ' A' ' 83' ' ' PRO . 11.1 mt -123.91 123.3 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.493 -0.754 . . . . 0.0 109.842 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.484 ' O ' ' N ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -129.41 -58.31 1.12 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.187 -0.946 . . . . 0.0 110.379 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.511 ' OD2' ' HA ' ' A' ' 87' ' ' ASP . 25.5 t0 66.56 -67.48 0.16 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.254 -0.904 . . . . 0.0 110.12 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 52' ' ' MET . 1.7 tt -44.66 -69.19 0.14 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 110.073 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.535 ' O ' ' CB ' ' A' ' 56' ' ' LYS . 13.2 tt0 -142.11 -81.63 0.21 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.261 -0.899 . . . . 0.0 109.965 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER 166.3 35.97 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.38 -0.825 . . . . 0.0 110.134 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.574 ' O ' ' CG ' ' A' ' 58' ' ' HIS . 6.2 mtp85 -146.58 26.75 1.14 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.201 -0.937 . . . . 0.0 110.418 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.574 ' CG ' ' O ' ' A' ' 57' ' ' ARG . 4.4 m-70 -165.8 105.65 0.71 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.938 . . . . 0.0 110.408 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 59' ' ' VAL . 6.3 p -76.88 97.81 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.317 -0.864 . . . . 0.0 110.022 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.537 HD23 ' HG3' ' A' ' 84' ' ' PRO . 0.6 OUTLIER -103.07 16.84 25.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 110.387 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 83' ' ' PRO . . . -110.5 172.68 15.64 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.525 ' HB3' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -122.85 165.99 15.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.174 -1.192 . . . . 0.0 110.433 -179.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.819 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -131.8 111.27 11.48 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.701 179.269 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.894 ' CG1' HG21 ' A' ' 31' ' ' THR . 5.2 mm -69.13 -30.26 45.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-O 122.126 0.965 . . . . 0.0 108.576 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.612 ' CG2' ' O ' ' A' ' 65' ' ' THR 0.253 0.6 OUTLIER -104.98 29.92 5.94 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.554 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 63' ' ' LEU . 48.0 t -12.65 110.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.247 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 19.6 t-20 44.23 69.1 2.62 Favored Pre-proline 0 C--N 1.299 -1.612 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.048 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.553 ' O ' ' HA ' ' A' ' 46' ' ' LYS . 2.3 Cg_endo -50.18 -178.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 124.033 1.544 . . . . 0.0 109.474 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.733 HG23 ' O ' ' A' ' 45' ' ' CYS . 0.8 OUTLIER -140.71 143.93 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 119.183 -1.007 . . . . 0.0 112.104 -178.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.085 ' CG2' HD11 ' A' ' 47' ' ' ILE . 20.2 t -99.78 170.33 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.425 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 5.2 m -126.73 -17.2 5.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.959 -1.088 . . . . 0.0 111.173 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 7.4 mt-10 -140.01 15.67 2.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.944 -1.097 . . . . 0.0 110.918 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 11.4 ttpp 73.59 -7.11 1.63 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.307 -0.871 . . . . 0.0 110.781 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.466 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 5.3 t70 -137.68 1.46 2.34 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.024 -1.048 . . . . 0.0 110.096 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.576 ' O ' HG23 ' A' ' 77' ' ' VAL . 12.4 t -72.74 108.28 4.21 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 121.128 -0.982 . . . . 0.0 108.921 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.629 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 1.9 Cg_endo -47.52 130.19 17.7 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.801 1.421 . . . . 0.0 110.071 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.682 HG21 HG22 ' A' ' 70' ' ' VAL . 60.1 t -118.01 145.43 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.022 -1.049 . . . . 0.0 111.415 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.697 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 3.9 m120 -105.6 134.53 48.56 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.511 -0.743 . . . . 0.0 109.537 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.652 ' HB ' HG22 ' A' ' 34' ' ' ILE . 3.4 mt -117.88 119.89 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 119.953 -1.717 . . . . 0.0 111.358 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.938 ' OE2' HG21 ' A' ' 27' ' ' THR . 2.4 tp10 -95.45 106.86 18.97 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.861 ' C ' HG22 ' A' ' 31' ' ' THR . . . -112.19 147.39 36.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.09 -1.006 . . . . 0.0 110.655 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 3.0 tt0 -113.2 53.89 0.53 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.408 -0.807 . . . . 0.0 110.932 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.979 ' HB3' HG21 ' A' ' 51' ' ' ILE . 23.1 Cg_endo -66.16 159.74 48.21 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 123.675 1.355 . . . . 0.0 110.402 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.537 ' HG3' HD23 ' A' ' 60' ' ' LEU . 11.5 Cg_endo -60.58 84.6 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.948 1.499 . . . . 0.0 109.827 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.423 ' HB2' ' O ' ' A' ' 84' ' ' PRO . 0.2 OUTLIER 65.19 -168.58 0.21 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.273 -0.892 . . . . 0.0 109.856 -179.495 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 105' ' ' LYS . . . -54.64 109.27 1.16 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.73 ' CG ' HD12 ' A' ' 90' ' ' ILE . 7.6 p-10 -84.32 41.48 0.83 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.359 -1.083 . . . . 0.0 110.216 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.532 ' O ' ' N ' ' A' ' 103' ' ' TRP . 31.3 p 39.68 -121.06 0.34 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.409 -0.807 . . . . 0.0 111.089 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.526 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 24.6 m-85 -78.19 100.75 6.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.877 -1.14 . . . . 0.0 111.853 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.805 HG22 ' HB2' ' A' ' 101' ' ' LEU . 0.7 OUTLIER -74.46 168.25 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.017 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.888 HD12 ' HG2' ' A' ' 50' ' ' GLU . 94.7 mt -131.21 143.36 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.318 -1.489 . . . . 0.0 111.868 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.027 HD11 HG21 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -133.96 138.06 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.502 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.536 ' CA ' ' HB2' ' A' ' 48' ' ' PRO . . . 86.18 -158.96 32.07 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.541 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -123.89 149.53 28.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 O-C-N 121.061 -1.258 . . . . 0.0 110.411 -179.462 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.587 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 5.4 mt-10 -20.35 -57.39 0.07 OUTLIER Pre-proline 0 N--CA 1.501 2.078 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.563 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 9.7 Cg_endo -53.9 70.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 124.108 1.583 . . . . 0.0 111.898 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 95' ' ' GLU . . . 91.42 6.75 65.9 Favored Glycine 0 N--CA 1.494 2.512 0 O-C-N 120.967 -1.083 . . . . 0.0 110.896 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.503 ' HB3' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -52.42 161.21 0.71 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.972 -1.31 . . . . 0.0 110.019 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.527 ' CD1' ' O ' ' A' ' 18' ' ' PHE . 4.9 mt -95.77 170.06 9.58 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.189 -0.944 . . . . 0.0 110.773 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -152.61 142.74 22.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.5 -0.75 . . . . 0.0 109.722 179.573 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.805 ' HB2' HG22 ' A' ' 90' ' ' ILE . 4.0 mp -138.89 117.68 12.32 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.98 -1.075 . . . . 0.0 110.878 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -59.92 146.26 42.93 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.283 -0.886 . . . . 0.0 110.201 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.532 ' N ' ' O ' ' A' ' 88' ' ' SER . 9.1 t-105 -167.84 58.64 0.07 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.212 -0.93 . . . . 0.0 110.417 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.521 ' O ' ' N ' ' A' ' 106' ' ' LYS . 6.9 t80 -63.28 110.05 1.76 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.119 -0.988 . . . . 0.0 110.535 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.486 ' O ' ' HA3' ' A' ' 86' ' ' GLY . 0.9 OUTLIER 56.39 -81.83 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.416 -0.803 . . . . 0.0 110.616 179.72 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 104' ' ' PHE . 0.5 OUTLIER -169.41 -65.34 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.149 -0.969 . . . . 0.0 110.227 -179.827 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 160.63 -92.26 0.11 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 38.0 p -107.62 94.28 5.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.234 -1.157 . . . . 0.0 110.247 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.63 108.47 10.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.892 . . . . 0.0 110.206 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.11 30.27 6.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 110.177 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.18 -39.86 0.09 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 110.208 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.418 ' O ' ' HB3' ' A' ' 113' ' ' HIS . 1.3 t60 -95.54 122.02 37.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.878 . . . . 0.0 110.196 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.439 ' CD2' ' N ' ' A' ' 114' ' ' HIS . 49.8 p-80 -176.37 -151.36 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.202 -0.936 . . . . 0.0 110.2 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.439 ' N ' ' CD2' ' A' ' 113' ' ' HIS . 8.6 p-80 179.39 -173.94 0.2 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.277 -0.889 . . . . 0.0 110.189 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.403 ' O ' ' CB ' ' A' ' 116' ' ' HIS . 43.9 m-70 -145.59 -89.54 0.1 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.195 -0.941 . . . . 0.0 110.258 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.403 ' CB ' ' O ' ' A' ' 115' ' ' HIS . 0.1 OUTLIER 173.73 134.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.931 . . . . 0.0 110.186 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.231 179.899 . . . . . . . . 1 1 . 1 stop_ save_